[
{"Name" : "ORZID ADJ THERA BASED ON ABX SUSP", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID ALLERGIC TO RECOMMENDED DRUGS", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID ALT OTHER REASON", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID AZITHROMYCIN 1GM PO ONCE & CEFTRIAXONE 1GM Q24H", "DisplayText" : "Azithromycin 1GM PO ONCE & Ceftriaxone 1GM Q24H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1GM PO ONCE", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID CEFTRIAXONE 125MG IM & AZITHROMYCIN 1000MG PO ONCE", "DisplayText" : "Ceftriaxone 125MG IM ONCE & Azithromycin 1000MG PO ONCE", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 125MG IM ONCE", "DisplayText" : "Ceftriaxone 125MG IM ONCE", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJUZID AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1GM PO ONCE", "Text" : ""}
]},
{"Name" : "ORZID CEFTRIAXONE 1GM Q24H & DOXYCYCLINE 100MG Q12H 7 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H & Doxycycline 100MG PO Q12H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : ""}
]},
{"Name" : "ORZID CEFTRIAXONE 250MG IM & AZITHROMYCIN 1GM PO", "DisplayText" : "Azithromycin 1GM PO ONCE & Ceftriaxone 250MG IM ONCE", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1GM PO ONCE", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJUZID CEFTRIAXONE 250MG IM ONCE", "DisplayText" : "Ceftriaxone 250MG IM ONCE", "Text" :""}
]},
{"Name" : "ORZID DECREASED RENAL CLEARANCE", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID DRUG INTERACTION", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "Term" : "This page gives the user the opportunity to select an alternative drug.  Created by Greg Filice 31-Dec-02", "DisplayText" : "Alternative Drug Needed? ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "NEED AN ALTERNATIVE ANTIMICROBIAL?"}, 
{"Row" : 3, "Column" : 1, "Text" : "If you cannot use the recommended antimicrobials or you believe another one"}, 
{"Row" : 4, "Column" : 1, "Text" : "would be better for your patient, you can order another drug.  Please indicate"}, 
{"Row" : 5, "Column" : 1, "Text" : "the reason you need an alternative drug below."}, 
{"Row" : 9, "Column" : 1, "Item" : "ZZORZ SET ABX LIVER SECRETORY", "DisplayText" : "Liver secretory or metabolic impairment", "Text" : "Liver secretory or metabolic impairment", "Mnemonic" : "[3]"},
{"Row" : 7, "Column" : 1, "Item" : "ZZORZ SET ABX ALLERGIC TO RECOMMENDED DRUGS", "DisplayText" : "", "Text" : "Patient allergic to recommended drug(s)", "Mnemonic" : "[1]"},
{"Row" : 10, "Column" : 1, "Item" : "ZZORZ SET ABX DRUG INTERACTION", "DisplayText" : "", "Text" : "Drug interaction", "Mnemonic" : "[4]"},
{"Row" : 11, "Column" : 1, "Item" : "ZZORZ SET ABX MULTIPLE INFECTIONS", "DisplayText" : "", "Text" : "Patient has multiple infections requiring antimicrobials", "Mnemonic" : "[5]"},
{"Row" : 12, "Column" : 1, "Item" : "ZZORZ SET ABX ISOLATE NOT SUSC TO RECOMD DRUG", "DisplayText" : "", "Text" : "Adjust therapy based on antimicrobial susceptibility", "Mnemonic" : "[6]"},
{"Row" : 20, "Column" : 1, "Text" : "Clarification/Comments:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG ALLERGIES", "DisplayText" : "Drug allergies", "Text" : "Information about drug allergies...", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "ZZORZID3 GMENU CONTACT CDSS PROJECT", "DisplayText" : "Contact the CDSS Project Staff", "Text" : "Please Click Here to send comments to the CDSS team", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "ZZORZ SET ABX DECREASED RENAL CLR", "DisplayText" : "", "Text" : "Decreased renal clearance", "Mnemonic" : "[2]"},
{"Row" : 13, "Column" : 1, "Item" : "ZZORZ SET ABX OTHER ADVERSE DRUG AFFECT", "DisplayText" : "", "Text" : "Other adverse drug affect", "Mnemonic" : "[7]"},
{"Row" : 14, "Column" : 1, "Item" : "ZZORZ SET ABX ALTERNATIVE OTHER REASON", "DisplayText" : "", "Text" : "Other reason", "Mnemonic" : "[8]"},
{"Row" : 16, "Column" : 1, "Text" : "Note:  Alternative antimicrobial selections will be reviewed and we may contact"}, 
{"Row" : 17, "Column" : 1, "Text" : "prescribers to learn more about situations that need alternatives, improve the"}, 
{"Row" : 18, "Column" : 1, "Text" : "CDSS, and in some cases offer suggestions."}
]},
{"Name" : "ORZID LIVER SECRETORY OR METABLIC IMPAIRMENT", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID MULTIPLE INFECTIONS", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID OTHER ADVERSE DRUG AFFECT", "DisplayText" : "Other adverse drug affect", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID SET DISABLE QUICK ORDER", "DisplayText" : "DISABLE QUICK ORDER", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Follow facility specific guidelines for prescribing and dispensing oseltamivir", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Text" : "(Tamiflu).", "Header" : 1}
]},
{"Name" : "ORZID VANCOMYCIN ENEMA INSTRUCTIONS", "DisplayText" : "Vancomycin Enema Instructions  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : ""},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Nursing"}
]},
{"Name" : "ORZID2 ACUTE PROSTATITIS", "DisplayText" : "Acute Prostatitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Acute Prostatitis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Acute bacterial prostatitis is an acute infection in young and middle aged", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "men that is usually caused by the same organisms that cause urinary tract", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "infection. I is mostly caused by gram negative bacteria such as E. coli,", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "coliforms, and enterococcus species but sexually transmitted pathogens", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "such as Neisseria gonorrhoeae and Chlamydia trachomatis can also be the", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "cause in sexually active men. Typical symptoms include fever, chills,", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "malaise, myalgia, dysuria, pelvic/perineal pain, and cloudy urine. The", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "prostate is generally warm, red, firm, and very tender. Complications that", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "can occur, especially with a delay in antibiotics, include bacteremia,", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "epididymitis, prostatic abscess, extension or metastasis to other", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "locations, and conversion to chronic prostatitis.", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Not at risk of STI", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Primary"}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 14 DAYS", "Text" : ""},
{"Row" : 21, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" :""},
{"Row" : 24, "Column" : 1, "Text" : "With risk of STI", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID CEFTRIAXONE 250MG IM THEN DOXY 100MG PO BID 7DAYS", "DisplayText" : "Ceftriaxone 250MG IM THEN Doxycycline 100MG PO BID 7 DAYS", "Text" : ""},
{"Row" : 28, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "*Meyrier A, Fekete T. Acute bacterial prostatitis. UpToDate. July 2014"}, 
{"Row" : 30, "Column" : 1, "Text" : "*Acute Bacterial Prostatitis. Sanford Guide. August 26, 2013"}, 
{"Row" : 33, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}
]},
{"Name" : "ORZID2 ACUTE SINUSITIS", "DisplayText" : "Acute Sinusitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Acute Sinusitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Most cases of acute sinusitis are viral. Most of these resolve within 7 days."}, 
{"Row" : 5, "Column" : 1, "Text" : "Nasal congestion, purulent nasal discharge, and tooth or facial pain can be"}, 
{"Row" : 6, "Column" : 1, "Text" : "treated with decongstants, analgesics, and nasal saline. Bacterial infection"}, 
{"Row" : 7, "Column" : 1, "Text" : "is more likely the causative agent when symptoms are present for >/= 10 days,"}, 
{"Row" : 8, "Column" : 1, "Text" : "fever >/= 102, and purulent discharge or facial pain for 3-4 consecutive days"}, 
{"Row" : 9, "Column" : 1, "Text" : "or worsening symptoms following a typical viral infection. Antimicrobials"}, 
{"Row" : 10, "Column" : 1, "Text" : "are indicated in these instances. Nasal saline and intranasal corticosteroids"}, 
{"Row" : 11, "Column" : 1, "Text" : "are beneficial adjunctive therapy."}, 
{"Row" : 12, "Column" : 1, "Text" : "*If symptoms fail to respond or recur after 3-5 days of antimicrobial, puncture"}, 
{"Row" : 13, "Column" : 1, "Text" : "and aspiration of sinuses is necessary to identify pathogens. ENT"}, 
{"Row" : 14, "Column" : 1, "Text" : "consultation is recommended."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "*Mild to Moderate Disease cases for first 10 days of illness: treat with"}, 
{"Row" : 18, "Column" : 1, "Text" : "decongestants, analgesics, and nasal saline spray"}, 
{"Row" : 20, "Column" : 1, "Text" : "*Mild to moderate cases that have not improved in 10 days despite treatment"}, 
{"Row" : 21, "Column" : 1, "Text" : "with decongestants, analgesics, and nasal saline spray"}, 
{"Row" : 24, "Column" : 1, "Text" : "-Penicillin Allergy"}, 
{"Row" : 22, "Column" : 1, "Text" : "-Recommended Treatment"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 5 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H 5 DAYS", "Text" : "Amoxicillin 875/Clavulanate 125MG PO Q12H 5 DAYS"},
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO BID 5 DAYS", "DisplayText" : "Doxycycline 100MG PO BID 5 DAYS", "Text" : "Doxycycline 100MG PO BID 5 DAYS"},
{"Row" : 27, "Column" : 1, "Text" : "*Severe Sinusitis"}, 
{"Row" : 28, "Column" : 1, "Text" : "-Recommended Treatment"}, 
{"Row" : 30, "Column" : 1, "Text" : "-Fluoroquinolone Allergy"}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "Levofloxacin 500MG PO Q24H"},
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 5 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H 5 DAYS", "Text" : "Amoxicillin 875/Clavulanate 125MG PO Q12H 5 DAYS"},
{"Row" : 33, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H 5 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H 5 DAYS", "Text" : "Ceftriaxone 1GM IVPB Q24H 5 DAYS"},
{"Row" : 35, "Column" : 1, "Item" : "PSJIZID AMPICILLIN/SULBACTAM 3GM Q6H 7 DAYS", "DisplayText" : "Ampicillin/Sulbactam 3GM Q6H", "Text" : "Ampicillin/Sulbactam 3GM Q6H 7 DAYS"},
{"Row" : 39, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "*Gilbert, DN et al eds. The Sanford Guide to Antimicrobial Therapy, 44th ed."}, 
{"Row" : 41, "Column" : 1, "Text" : "Sperryville, VA: Antimicrobial Therapy INC 2014. Page 112"}, 
{"Row" : 42, "Column" : 1, "Text" : "*Hwang P, et al. Acute sinsusitis + rhinosinusitis in adults. Up-To-Date"}, 
{"Row" : 43, "Column" : 1, "Text" : "website. Updated 2/26/14. Accessed 3/5/15 from http://www.uptodate.com/"}, 
{"Row" : 44, "Column" : 1, "Text" : "contents/acute-sinusitis-and-rhinosinusitis-in-adults-treatment"}, 
{"Row" : 45, "Column" : 1, "Text" : "*Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guidelines"}, 
{"Row" : 46, "Column" : 1, "Text" : "for acute bacterial rhinosinusitis in children and adults. Clin Infect"}, 
{"Row" : 47, "Column" : 1, "Text" : "Infect Dis. 2012 54(8):e72-e112. Aring et al. Am Fam Phys. 2011"}, 
{"Row" : 48, "Column" : 1, "Text" : "*Falagas ME, Karegeorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness"}, 
{"Row" : 49, "Column" : 1, "Text" : "and safety of short vs. long duration of antibiotic therapy for acute"}, 
{"Row" : 50, "Column" : 1, "Text" : "bacterial sinusis: a meta-analysis of randomized trials. Br J Clin"}, 
{"Row" : 51, "Column" : 1, "Text" : "Pharmacol. 2009 67(2):161-71."}, 
{"Row" : 52, "Column" : 1, "Text" : "*Ahovou-saloranta A, Rautakorpi UM, Borisenko OV, Liira H, Williams JW, Makela M"}, 
{"Row" : 53, "Column" : 1, "Text" : "Antibiotics for acute maxillary sinusitis in adultes. Cochrane Database"}, 
{"Row" : 54, "Column" : 1, "Text" : "Syst Rev. 2014:2:CD000243"}, 
{"Row" : 59, "Column" : 1, "Text" : "This Menu Updated January 2019", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 34, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 ADJ THERAPY BASED ON ABX SUSCEP", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 ALLERGIC TO RECOMMENDED DRUGS", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 ALTERNATIVE OTHER REASON", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 APPENDICITIS", "DisplayText" : "Appendicitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 APPENDICITIS WITH PERFORATION", "DisplayText" : "Appendicitis With Perforation", "Text" : ""},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 APPENDICITIS WITHOUT PERFORATION", "DisplayText" : "Appendicitis Without Perforation", "Text" : ""}
]},
{"Name" : "ORZID2 APPENDICITIS WITH PERFORATION", "DisplayText" : "Appendicitis With Perforation  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Appendicitis With Perforation", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Zosyn 3.375GM IVPB Q6H"},
{"Row" : 29, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "*\"Sanford\" keyword: Appendicitis"}, 
{"Row" : 34, "Column" : 1, "Text" : "This Menu Updated June 2019", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 15, "Column" : 1, "Text" : "Alternative for Penicillin Allergy"}, 
{"Row" : 24, "Column" : 1, "Text" : "ALternative for Penicillin Allergy"}, 
{"Row" : 3, "Column" : 1, "Text" : "Duration of antimicrobial therapy:"}, 
{"Row" : 4, "Column" : 1, "Text" : "*Treat until normalization of temperature, WBC and GI tract functioning."}, 
{"Row" : 5, "Column" : 1, "Text" : "Generally 4-5 days after adequate source control has been achieved and"}, 
{"Row" : 6, "Column" : 1, "Text" : "contaminated material cleared from the intra-abdominal space."}, 
{"Row" : 16, "Column" : 1, "Item" : "ZZPSJIZID MOXIFLOXACIN 400MG IVPB Q24H", "DisplayText" : "", "Text" : "Moxifloxacin 400MG IVPB Q24H"},
{"Row" : 19, "Column" : 1, "Text" : "*Severe Disease"}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : "Zosyn 4.5GM IVPB Q6H"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 AZTREONAM 2GM Q8+METRONIDAZOLE 500MG Q8+VANCO PTD", "DisplayText" : "Aztreonam 2GM Q8H + Metronidazole 500MG Q8H + VANCO Pharmacy to Dose", "Text" : "Aztreonam 2GM Q8H + Metronidazole 500MG Q8H + VANCO Pharmacy to Dose"},
{"Row" : 31, "Column" : 1, "Text" : "*Up-to-Date: Management of acute appendicitis in adults"}, 
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H", "Text" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H"},
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM IVPB Q8H", "DisplayText" : "Meropenem 1GM IVPB Q8H", "Text" : "Meropenem 1GM IVPB Q8H"},
{"Row" : 10, "Column" : 1, "Text" : "Mild to Moderate Disease", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 APPENDICITIS WITHOUT PERFORATION", "DisplayText" : "Appendicitis Without Perforation  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Appendicitis Without Perforation", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "*Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "This Menu Updated June 2019", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 4, "Column" : 1, "Text" : "*In cases without evidence of perforation or rupture, antimicrobials are"}, 
{"Row" : 5, "Column" : 1, "Text" : "necessary only just before surgery.  Administer 60 minutes before the"}, 
{"Row" : 6, "Column" : 1, "Text" : "first incision is made."}, 
{"Row" : 9, "Column" : 1, "Item" : "PSJIZID CEFOXITIN 2GM IVPB ONCE", "DisplayText" : "Cefoxitin 2GM IVPB ONCE", "Text" : ""},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 CEFAZOLIN 2GM IVPB ONCE/METRONIDAZOLE 500MG IVPB ONCE", "DisplayText" : "Cefazolin 2GM IVPB ONCE + Metronidazole 500MG IVPB ONCE", "Text" : "Cefazolin 2GM (give 3GM IF >= 120KG) + Metronidazole 500MG"},
{"Row" : 13, "Column" : 1, "Text" : "*Beta-Lactam Allergy"}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 AZTREONAM 2GM IV + CLINDAMYCIN 900MG IV ONCE", "DisplayText" : "Aztreonam 2GM + Clindamycin 900MG ONCE", "Text" : "Aztreonam 2GM + Clindamycin 900MG ONCE"},
{"Row" : 18, "Column" : 1, "Text" : "*Up-to-Date: Management of acute appendicitis in adults"}, 
{"Row" : 19, "Column" : 1, "Text" : "*Sanford guide: Key word \"appendicitis\""}
]},
{"Name" : "ORZID2 ARTHRITIS ASSOCIATED WITH LYME DISEASE", "DisplayText" : "Arthritis Associated with Lyme Disease  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Most cases respond to a 28day course of oral antimicrobials. If symptoms", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "persist or recur, consult ID or Rheumatology", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 28D", "DisplayText" : "Doxycycline 100MG PO Q12H 28 DAYS", "Text" : ""},
{"Row" : 8, "Column" : 1, "Text" : "-OR-"}, 
{"Row" : 9, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN 500MG PO Q8H 28D", "DisplayText" : "AmoxicilliN 500MG PO Q8H 28 DAYS", "Text" : ""},
{"Row" : 15, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "*Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 20, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "*Up-To-Date"}
]},
{"Name" : "ORZID2 ASPIRATION PNEUMONIA", "DisplayText" : "Aspiration Pneumonia  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Aspiration Pneumonia", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "*Aspiration of oropharyngeal or gastric contents induces inflammation and"}, 
{"Row" : 4, "Column" : 1, "Text" : "is often accompanied by fever and/or an infiltrate. Bacterial pneumonia"}, 
{"Row" : 5, "Column" : 1, "Text" : "occurs in a minority of patients who aspirate, typically about 3 days"}, 
{"Row" : 6, "Column" : 1, "Text" : "later. The patient usually improves for the first 2 days and then worsens"}, 
{"Row" : 7, "Column" : 1, "Text" : "as bacterial pneumonia develops with increased fever, new or progressive"}, 
{"Row" : 8, "Column" : 1, "Text" : "infiltrates, leukocytosis, and newly purulent sputum."}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment"}, 
{"Row" : 11, "Column" : 1, "Text" : "*Therapy directed towards anaerobic pathogens is usually unnecessary."}, 
{"Row" : 12, "Column" : 1, "Text" : "If pneumonia is confirmed, treat as:"}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Community Acquired Pneumonia", "Text" : "Community Acquired Pneumonia"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 NOSOCOMIAL PNEUMONIA", "DisplayText" : "Nosocomial Pneumonia", "Text" : "Nosocomial Pneomonia"},
{"Row" : 17, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "*Chastre J JAMA 2003, 290:2588"}, 
{"Row" : 19, "Column" : 1, "Text" : "*Craven DE Infect Dis Clin N Am 2004, 18:939"}, 
{"Row" : 20, "Column" : 1, "Text" : "*Dennesen PJ Am J Repir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 21, "Column" : 1, "Text" : "*Luna PJ Am J Repir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 22, "Column" : 1, "Text" : "*\"Mandell\" PJ Am J Repir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 23, "Column" : 1, "Text" : "*Mandell LA Clin Infect Dis 2003, 37:1405"}, 
{"Row" : 24, "Column" : 1, "Text" : "*Roig J J Antimicrob Chemother 2003, 51:1119"}, 
{"Row" : 25, "Column" : 1, "Text" : "*Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 26, "Column" : 1, "Text" : "*Anonymous N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 28, "Column" : 1, "Text" : "This Menu Updated January 2019", "Header" : 1}
]},
{"Name" : "ORZID2 AZITHRO 500MG PO/CEFTRIAXONE 1GM IVPB/VANCO PTD", "DisplayText" : "Azithromycin 500MG PO 3 DAYS + Ceftriaxone 1GM IVPB + VANCO Pharmacy to Dose", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID AZITHROMYCIN 500MG PO 3 DAYS", "DisplayText" : "Azithromycin 500MG PO 3 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""},
{"Row" : 3.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""}
]},
{"Name" : "ORZID2 AZITHROMYCIN 500MG PO 3 DAYS/ZOSYN 4.5GM Q6H/VANCO PTD", "DisplayText" : "Azithromycin 500MG PO 3 DAYS + Zosyn 4.5GM Q6H + Vanco Pharmacy to Dose  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID AZITHROMYCIN 500MG PO Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG PO Q24H 3 DAYS", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : ""},
{"Row" : 3.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""}
]},
{"Name" : "ORZID2 AZITHROMYCIN 500MG PO Q24H/ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Azithromycin 500MG PO Q24H + ZOSYN 4.5GM IVPB Q6H 3 DAYS  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID AZITHROMYCIN 500MG PO 3 DAYS", "DisplayText" : "Azithromycin 500MG PO 3 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : ""}
]},
{"Name" : "ORZID2 AZTREONAM 2GM IV + CLINDAMYCIN 900MG IV ONCE", "DisplayText" : "Aztreonam 2GM + Clindamycin 900MG ONCE  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID AZTREONAM 2GM IVPB ONCE", "DisplayText" : "Aztreonam 2GM IVPB ONCE", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID CLINDAMYCIN 900MG IVPB ONCE", "DisplayText" : "Clindamycin 900MG IVPB ONCE", "Text" : ""}
]},
{"Name" : "ORZID2 AZTREONAM 2GM IVPB Q8H/LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Aztreonam 2GM IVPB Q8H + Levofloxacin 500MG IVPB Q24H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID AZTREONAM 2GM IVPB Q8H", "DisplayText" : "Aztreonam 2GM IVPB Q8H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID2 AZTREONAM 2GM IVPB Q8H/LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Aztreonam 2GM IVPB Q8H + Levofloxacin 750MG PO Q24H ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID AZTREONAM 2GM IVPB Q8H", "DisplayText" : "Aztreonam 2GM IVPB Q8H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJUZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750MG PO Q24H", "Text" : ""}
]},
{"Name" : "ORZID2 AZTREONAM 2GM Q8+METRONIDAZOLE 500MG Q8+VANCO PTD", "DisplayText" : "Aztreonam 2GM Q8H + Metronidazole 500MG Q8H + VANCO Pharmacy to Dose  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID AZTREONAM 2GM IVPB Q8H", "DisplayText" : "Aztreonam 2GM IVPB Q8H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" :""},
{"Row" : 3.0 , "Item" : "PSJU VANCO PHARMACY TO DOSE", "DisplayText" : "Vancomycin Pharmacy to Dose", "Text" : ""}
]},
{"Name" : "ORZID2 BACTERIAL MENINGITIS EMPIRIC TREATMENT", "DisplayText" : "Bacterial Meningitis Empiric Treatment  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Empiric Treatment of Bacterial Meningitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Obtain CSF for gram stain/culture and Herpes PCR. Administer antimicrobials"}, 
{"Row" : 5, "Column" : 1, "Text" : "within 30minutes of presentation"}, 
{"Row" : 6, "Column" : 1, "Text" : "*Intravenous dexamethasone therapy improves outcomes for meningitis with some"}, 
{"Row" : 7, "Column" : 1, "Text" : "bacteria (s. pneumonia) so may be given empirically until organism is"}, 
{"Row" : 8, "Column" : 1, "Text" : "identified. Dexamethasone must be given before (10-20minutes) or concurrent"}, 
{"Row" : 9, "Column" : 1, "Text" : "with first dose of antibiotics"}, 
{"Row" : 10, "Column" : 1, "Text" : "*If meningococcal meningitis is identified, antimicrobial prophylaxis should be"}, 
{"Row" : 11, "Column" : 1, "Text" : "considered for close contacts. Contact ID for advice and assistance"}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID DEXAMETHASONE 0.15MG/KG IVPB Q6H 4 DAYS", "DisplayText" : "Dexamethasone 0.15MG/KG IVPB Q6H 4 DAYS", "Text" : "Dexamethasone 0.15MG/KG IVPB Q6H 4 DAYS"},
{"Row" : 17, "Column" : 1, "Text" : "*For adults < 50yo without alcoholism, debilitating disease, or any other"}, 
{"Row" : 18, "Column" : 1, "Text" : "condition associated with impaired cellular immunity"}, 
{"Row" : 14, "Column" : 1, "Text" : "*Unless CSF culture or gram stain results are not indicative of S. pneumoia"}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 VANCO Q8H/CEFTRIAXONE 2GM Q12H/ACYCLOVIR 10MG/KG Q8H", "DisplayText" : "Vancomycin Q8H + Ceftriaxone 2GM Q12H + Acyclovir 10mg/kg Q8H", "Text" : "Vancomycin Q8H + Ceftriaxone 2GM Q12H + Acyclovir 10mg/kg Q8H"},
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IVPB Q4H", "DisplayText" : "Ampicillin 2GM IVPB Q4H", "Text" : "-If >50yo: add Ampicillin 2G Q4H"},
{"Row" : 22, "Column" : 1, "Text" : "*For adults with normal renal function and with alcoholism, debilitating"}, 
{"Row" : 23, "Column" : 1, "Text" : "disease, or any condition associated with impaired cellular immunity"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 VANCO Q8/AMP 2GM Q4/CEFEPIME 2GM Q8/ACYCLOVIR 10MG/KG Q8", "DisplayText" : "Vancomyin Q8H + Ampcillin 2GM Q4H + Cefepime 2G Q8H + Acyclovir 10mg/kg Q8H", "Text" : "Vancomyin Q8H + Ampcillin 2GM Q4H + Cefepime 2G Q8H + Acyclovir 10mg/kg"},
{"Row" : 25, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 VANCO Q8/AMP 2G Q4/MEROPENEM 2G Q8/ACYCLOVIR 10MG/KG Q8", "DisplayText" : "Vancomycin Q8H + Ampicillin 2GM Q4H + Meropenem 2GM Q8H + Acyclovir 10mg/kg Q8H", "Text" : "Vancomycin Q8H+Ampicillin 2GM Q4H+Meropenem 2GM Q8H+Acyclovir 10mg/kg Q8H"},
{"Row" : 28, "Column" : 1, "Text" : "*Adults with normal renal function and a severe beta lactam allergy"}, 
{"Row" : 29, "Column" : 1, "Item" : "ZZORZID2 VANCO Q8H/MOXI IV Q24H/ACYCLOVIR 10MG/KG Q8H", "DisplayText" : "", "Text" : "Vancomycin Q8H + Moxifloxacin 400MG Q24H + Acyclovir 10MG/KG Q8H"},
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID BACTRIM 5MG/KG IVPB Q8H", "DisplayText" : "Bactrim 5MG/KG IVPB Q8H", "Text" : "-If >50yo and/or immunocompromised: Bactrim 5mg/kg Q8H"},
{"Row" : 33, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "*Tunkel A. Clinical Infect Dis 2004, 39:1279"}, 
{"Row" : 35, "Column" : 1, "Text" : "*Initial therapy and prognosis of bacterial meningitis in adults,"}, 
{"Row" : 36, "Column" : 1, "Text" : "UpToDate. Updated Feb 24, 2015"}, 
{"Row" : 40, "Column" : 1, "Text" : "This Menu Updated January 2019", "Header" : 1}
]},
{"Name" : "ORZID2 BISMUTH + OMEP + METRONID + TETRACY H.PYLORI", "DisplayText" : "Bismuth Quadruple  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID2 BISMUTH 524MG QID X14 DAYS H.PYLORI", "DisplayText" : "BISMUTH 524MG QID X14 DAYS", "Text" : ""},
{"Row" : 2.0 , "Item" : "ORZID2 OMEPRAZOLE 20MG BID X14 DAYS H.PYLORI", "DisplayText" : "Omeprazole 20MG BID X14 DAYS", "Text" :""},
{"Row" : 3.0 , "Item" : "ORZID2 METRONIDAZOLE 500MG TID X14 DAYS H.PYOLORI", "DisplayText" : "METRONIDAZOLE 500MG TID X14 DAYS", "Text" : ""},
{"Row" : 4.0 , "Item" : "ORZID2 TETRACAYCLINE 500MG QID X14 DAYS H.PYLORI", "DisplayText" : "TETRACYCLINE 500MG QID X14 DAYS", "Text" :""}
]},
{"Name" : "ORZID2 BRONCHITIS/EXACERBATION OF COPD", "DisplayText" : "Bronchitis/Exacerbation of COPD", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Bronchitis/Exacerbation of COPD", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Acute bronchitis should not be treated with antimicrobials except in specific"}, 
{"Row" : 5, "Column" : 1, "Text" : "circumstances. If pneumonia is suspected, order a chest x-ray. If an"}, 
{"Row" : 6, "Column" : 1, "Text" : "infiltrate is not present, the patient does not have pneumonia and does not"}, 
{"Row" : 7, "Column" : 1, "Text" : "need to be treated for it."}, 
{"Row" : 8, "Column" : 1, "Text" : "*Acute Bronchitis in an otherwise HEALTHY PATIENT"}, 
{"Row" : 9, "Column" : 1, "Text" : "-Antimicrobials provide no benefit. If bronchitis persisted beyond 2 weeks,"}, 
{"Row" : 10, "Column" : 1, "Text" : "additional diagnostic workupis needed to find a cause. If a patient has"}, 
{"Row" : 11, "Column" : 1, "Text" : "persistent cough with inspiratory \"whoop\" consider a diagnosis of pertussis"}, 
{"Row" : 12, "Column" : 1, "Text" : "*Acute bronchitis in a patient with COPD"}, 
{"Row" : 14, "Column" : 1, "Text" : "corticosteroids. Antimicrobials provide small benefit for about 50% of"}, 
{"Row" : 15, "Column" : 1, "Text" : "patients. Typically, antimicrobials shorten duration of symptoms by about"}, 
{"Row" : 16, "Column" : 1, "Text" : "half a day. Antibiotics should only be used for severe cases. Repeated"}, 
{"Row" : 17, "Column" : 1, "Text" : "courses of antimicrobials are associated with colonization by resistant"}, 
{"Row" : 13, "Column" : 1, "Text" : "-Cornerstones of therapy include oxygen, bronchodilators, and in some cases"}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Preferred Treatment"}, 
{"Row" : 22, "Column" : 1, "Text" : "-Normal Renal Function"}, 
{"Row" : 34, "Column" : 1, "Text" : "-Alternative for Pencillin Allergy"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125 PO BID 7DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125 BID 7 DAYS", "Text" : "Amoxicillin 875/Clavulanate 125MG PO BID 7 DAYS"},
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID CEFUROXIME 500MG PO BID 7 DAYS", "DisplayText" : "Cefuroxime 500MG PO BID 7 DAYS", "Text" : "Cefuroxime 500MG PO BID 7 DAYS"},
{"Row" : 27, "Column" : 1, "Text" : "-Imparied Renal Function"}, 
{"Row" : 28, "Column" : 1, "Text" : "*CrCl 10-30ml/min"}, 
{"Row" : 30, "Column" : 1, "Text" : "*CrCl <10ml/min"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 500/125 PO Q24H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 500/125 PO Q24H 7 DAYS", "Text" : "Amoxicillin 500/Clavulanate 125MG PO Q24H 7 DAYS"}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 500/125 PO BID 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 500/125 PO BID 7 DAYS", "Text" : "Amoxicillin 500/Clavulanate 125MG PO BID 7 DAYS"},
{"Row" : 32, "Column" : 1, "Item" : "PSJUZID CEFUROXIME 250MG PO Q24H 7 DAYS", "DisplayText" : "Cefuroxime 250MG PO Q24H 7 DAYS", "Text" : "Cefuroxime 250MG PO Q24H 7 DAYS"},
{"Row" : 35, "Column" : 1, "Text" : "*Normal Renal Function"}, 
{"Row" : 37, "Column" : 1, "Text" : "*CrCl 20-49ml/min"}, 
{"Row" : 39, "Column" : 1, "Text" : "*CrCl <20ml/min"}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG Q24H 7 DAYS", "DisplayText" : "Levofloxacin 500MG Q24H 7 DAYS", "Text" : "Levofloxacin 500MG PO Q24H 7 DAYS"},
{"Row" : 38, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO 1 DAY THEN 250MG PO Q24H 6 DAYS", "DisplayText" : "Levofloxacin 500MG PO 1 DAY THEN 250MG PO Q24H 6 DAYS", "Text" : "Levofloxacin 500MG PO 1 DAY Then 250MG PO Q24H 6 DAYS"},
{"Row" : 40, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO 1 DAY THEN 250MG PO Q48H 6 DAYS", "DisplayText" : "Levofloxacin 500MG PO 1 DAY THEN 250MG PO Q48 6 DAYS", "Text" : "Levofloxacin 500MG PO 1 DAY Then 250MG PO Q48H 6 DAYS"},
{"Row" : 43, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "*Siddiqi A, Sethi S. Int J COPD 2008"}, 
{"Row" : 45, "Column" : 1, "Text" : "*Sanford Guide \"Bronchitis, Chronic with Acute Exacerbation\""}, 
{"Row" : 46, "Column" : 1, "Text" : "Accessed 11 March 2014"}, 
{"Row" : 47, "Column" : 1, "Text" : "*UpToDate \"Management of infection in acute exacerbation of chronic obstructive"}, 
{"Row" : 48, "Column" : 1, "Text" : "pulmonary disease\" Accessed 11 March 2014"}, 
{"Row" : 49, "Column" : 1, "Text" : "*Murphy TF, et al. Chest 2000"}, 
{"Row" : 52, "Column" : 1, "Text" : "This Menu Updated January 2019", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 CARDIOVASCULAR", "DisplayText" : "Cardiovascular  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Endocarditis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 NATIVE VALVE ENDOCARDITIS", "DisplayText" : "Native Valve Endocarditis", "Text" :""},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 PROSTHETIC VALVE ENDOCARDITIS", "DisplayText" : "Prosthetic Valve Endocarditis", "Text" : ""}
]},
{"Name" : "ORZID2 CEFAZOLIN 2GM IVPB ONCE/METRONIDAZOLE 500MG IVPB ONCE", "DisplayText" : "Cefazolin 2GM IVPB ONCE + Metronidazole 500MG IVPB ONCE", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFAZOLIN 2GM IV ONCE", "DisplayText" : "Cefazolin 2gm iv once", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB ONCE", "DisplayText" : "Metronidazole 500MG IVPB ONCE", "Text" : ""}
]},
{"Name" : "ORZID2 CEFTAZADIME 2GM IVPB Q8H/LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Ceftazadime 2GM IVPB Q8H + Levofloxacin 500MG IVPB Q24H", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTAZIDIME 2GM IVPB Q8H", "DisplayText" : "Ceftazidime 2GM IVPB Q8H", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID2 CEFTAZADIME 2GM IVPB Q8H/VANCO 7 DAYS", "DisplayText" : "Ceftazadime 2GM IVPB Q8H + Vancomycin", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTAZIDIME 2GM IVPB Q8H", "DisplayText" : "Ceftazidime 2GM IVPB Q8H", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""}
]},
{"Name" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/AZITHROMYCIN 500MG IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Axithromycin 500MG IVPB Q24H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID AZITHROMYCIN 500MG IVPB Q24H", "DisplayText" : "Azithromycin 500MG IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/DOXYCYCLINE 100MG PO BID", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Doxycycline 100MG PO BID", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" :""}
]},
{"Name" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 CEFTRIAXONE 1GM IVPB/AZITHROMYCIN 500MG IVPB 3 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB + Azithromycin 500MG IVPB Q24H 3 DAYS", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H 3 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H 3 DAYS", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID AZITHROMYCIN 500MG IVPB Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG IVPB Q24H X3DAYS", "Text" : ""}
]},
{"Name" : "ORZID2 CEFTRIAXONE 1GM IVPB/AZITHROMYCIN 500MG PO 3 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Azithromycin 500MG PO 3 DAYS  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJUZID AZITHROMYCIN 500MG PO 3 DAYS", "DisplayText" : "Azithromycin 500MG PO 3 DAYS", "Text" :""}
]},
{"Name" : "ORZID2 CEFTRIAXONE 2GM IVPB Q4H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H + Metronidazole 500MG IVPB Q8H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 CELLULITIS", "DisplayText" : "Cellulitis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Cellulitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Cellulitis refers to inflammation of the skin and subcutaneous tissue", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "and is often associated with bacterial pathogens. The most common", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "pathogens are group A streptocooci and staphylococcus aureus. Group", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "B streptococci are associated with cellulitis in elderly people, in those", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "with diabetes mellitus, and on feet and legs of people with athlete's", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "foot (tinea pedis)", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Mild to moderate cases can be treated with oral antimicrobials. Severe", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "cases should be treated initially with intravenous antimicrobials. Switch", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "to oral drugs after clinical improvement", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Mild to Moderate Cellulitis- Treat 10-14 days", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID DICLOXACILLIN 500MG PO Q6H", "DisplayText" : "Dicloxacillin 500MG PO Q6H", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "PSJUZID CEPHALEXIN 500MG PO Q6H", "DisplayText" : "Cephalexin 500MG PO Q6H", "Text" : ""},
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : ""},
{"Row" : 22, "Column" : 1, "Text" : "Treatment of community acquired MRSA", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO Q12H", "DisplayText" : "Sulfamethoxacole/Trimethoprim 800/160MG PO Q12H", "Text" : ""},
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID MINOCYCLINE 100MG PO Q12H", "DisplayText" : "Minocycline 100MG PO Q12H", "Text" :""},
{"Row" : 27, "Column" : 1, "Text" : "Severe Cellulitis", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q12H", "DisplayText" : "Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID NAFCILLIN 2GM IVPB Q4H", "DisplayText" : "Nafcillin 2GM IVPB Q4H", "Text" :""},
{"Row" : 32, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IVPB Q8H", "DisplayText" : "Cefazolin 2GM IVPB Q8H", "Text" :""},
{"Row" : 34, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H", "Text" :""},
{"Row" : 37, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : ""},
{"Row" : 40, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "*Schwartz, MN New Eng J Med 2004. 350:904"}, 
{"Row" : 42, "Column" : 1, "Text" : "*\"Sanford\" keyword: cellulitis"}, 
{"Row" : 43, "Column" : 1, "Text" : "*\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 44, "Column" : 1, "Text" : "*Up-To-Date"}, 
{"Row" : 46, "Column" : 1, "Text" : "THIS MENU LAST UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 19, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 24, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 29, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 31, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 36, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 CENTRAL NERVOUS SYSTEM", "DisplayText" : "Central Nervous System", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 BACTERIAL MENINGITIS EMPIRIC TREATMENT", "DisplayText" : "Bacterial Meningitis Empiric Treatment", "Text" : ""},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 HERPES SIMPLEX ENCEPHALITIS", "DisplayText" : "Herpes Simplex Encephalitis", "Text" : ""}
]},
{"Name" : "ORZID2 CHOLECYSTITIS", "DisplayText" : "Cholecystitis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Cholecystitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "This Menu Updated June 2019", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Adequate biliary drainage is the definitive treatment.Antimicrobials should"}, 
{"Row" : 5, "Column" : 1, "Text" : "be prescribed only if signs of infection such as leukocytosis or fever"}, 
{"Row" : 6, "Column" : 1, "Text" : "are present. Surgery and gastroenterology involvement are essential."}, 
{"Row" : 7, "Column" : 1, "Text" : "*Most cases are associated with E. coli, Enterococcus, Klebsiella and"}, 
{"Row" : 8, "Column" : 1, "Text" : "Enterobacter."}, 
{"Row" : 11, "Column" : 1, "Text" : "Mild to Moderate Severity"}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Zosyn 3.375GM IVPB Q6H"},
{"Row" : 13, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H", "Text" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H"},
{"Row" : 16, "Column" : 1, "Item" : "ZZPSJIZID MOXIFLOXACIN 400MG IVPB Q24H", "DisplayText" : "", "Text" : "Moxifloxacin 400MG IV Q24H"},
{"Row" : 18, "Column" : 1, "Text" : "Severe Infection, advanced age, immunocompromised patient or high risk"}, 
{"Row" : 19, "Column" : 1, "Text" : "(travel to area with high rates of antibiotic resistant organisms or known"}, 
{"Row" : 20, "Column" : 1, "Text" : "colonization with such organisms)"}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : "Zosyn 4.5GM IVPB Q6H"},
{"Row" : 22, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM IVPB Q8H", "DisplayText" : "Meropenem 1GM IVPB Q8H", "Text" : "Meropenem 1GM IVPB Q8H"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 AZTREONAM 2GM Q8+METRONIDAZOLE 500MG Q8+VANCO PTD", "DisplayText" : "Aztreonam 2GM Q8H + Metronidazole 500MG Q8H + VANCO Pharmacy to Dose", "Text" : "Aztreonam 2GM Q8H + Metronidazole 500MG Q8H + VANCO Pharmacy to Dose"},
{"Row" : 31, "Column" : 1, "Text" : "*Sanford guide: Gallbladder infections, acute cholecystitis"}, 
{"Row" : 15, "Column" : 1, "Text" : "If beta-lactam allergy:"}, 
{"Row" : 24, "Column" : 1, "Text" : "If beta-lactam allergy:"}, 
{"Row" : 30, "Column" : 1, "Text" : "*UpToDate: Treatment of acute calculous cholecystitis"}
]},
{"Name" : "ORZID2 CHRONIC PROSTATITIS", "DisplayText" : "Chronic Prostatitis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Chronic Prostatitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Chronic bacterial prostatitis involves chronic inflammation of the prostate", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "with positive urine or prostatic fluid cultures. Patients may present with", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "recurrent urinary tract infections with repeated isolation of the same", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "pathogen in the urine. Some patients may be asymptomatic but have", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "recurrent bacteremia. Common symptoms may include urinary frequency,", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "dysuria, urgency, perineal discomfort, and low grade fever. Common", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "pathogens associated with infection are Enterobacteriaceae, Enterococci,", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "P. aeruginosa, and less commonly Burkholderia pseudomallei", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Primary Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 750MG PO Q24H 28 DAYS", "DisplayText" : "Levofloxacin 750MG PO Q24H 28 DAYS", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO BID 42 DAYS", "DisplayText" : "Bactrim DS PO BID 42 DAYS", "Text" :""},
{"Row" : 20, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Meyrier A, Fekete T. Chronic Bacterial Prostatitis. UpToDate. July 2014"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Chronic A, Fekete T. Chronic Bacterial Prostatitis. UpToDate. July 2014"}, 
{"Row" : 25, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}
]},
{"Name" : "ORZID2 CIPRO 400MG IVPB Q12H/METRONIDAZOLE 500MG IVPB Q6H", "DisplayText" : "Ciprofloxacin 400MG IVPB Q12H + Metronidazole 500MG IVPB Q6H ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 CLOSTRIDIUM DIFFICILE MAIN", "DisplayText" : "Clostridium Difficile Main Menu", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Clostridium Difficile", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Discontinue any antimicrobials that might have induced C. difficile if possible", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "and avoid high-risk antibiotics. The preferred route of antimicrobial", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "therapy is by mouth. Intravenous vancomycin does not get into the colonic", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "contents and is not effective.", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJUZID VANCOMYCIN 125MG PO Q6H X 10D", "DisplayText" : "Vancomycin 125MG PO Q6H FOR 10 DAYS", "Text" : ""},
{"Row" : 12, "Column" : 1, "Text" : "Initial Episode", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Recurrence", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID VANCOMYCIN TAPER 10D, 7D, 7D, 14D", "DisplayText" : "Vancomycin Taper", "Text" :""},
{"Row" : 18, "Column" : 1, "Text" : "Alternative Agent", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "May consider the use of fidaxomicin in veterans with recurrent infections"}, 
{"Row" : 20, "Column" : 1, "Text" : "or those at high risk for recurrence. Fidaxomicin requires prior"}, 
{"Row" : 21, "Column" : 1, "Text" : "authorization/NF request and has national criteria for use."}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID FIDAXOMICIN 200MG PO BID 10 DAYS", "DisplayText" : "Fidaxomicin 200MG PO BID X 10 DAYS", "Text" :""},
{"Row" : 24, "Column" : 1, "Item" : "ORZ NON FORMULARY CONSULT", "DisplayText" : "PRIOR AUTH/NF CONSULT", "Text" : ""},
{"Row" : 26, "Column" : 1, "Text" : "Fulminant Clostridium Difficile", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Hypotension or shock, ileus, megacolon."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VANCO 500MG PO Q6H + METRONIDAZOLE 500MG IV Q8H", "DisplayText" : "Vanocmycin 500MG PO Q6H + Metronidazole 500MG IV Q8H", "Text" :""},
{"Row" : 30, "Column" : 1, "Text" : "If Ileus is present, rectal vancomycin may be administered as a retention enema."}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID VANCOMYCIN 500MG IN 100ML NS RETENTION ENEMA Q6H", "DisplayText" : "Vancomycin 500MG Retention Enema", "Text" : ""},
{"Row" : 35, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Johnson, S, et al. Clinical Practice Guideline by the Infectious Diseases"}, 
{"Row" : 37, "Column" : 1, "Text" : "Society of America (IDSA) and Society for Healthcare Epidemiology of America"}, 
{"Row" : 38, "Column" : 1, "Text" : "(SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile"}, 
{"Row" : 39, "Column" : 1, "Text" : "Infection in Adults. Clinical Infectious Diseases. 2021."}, 
{"Row" : 41, "Column" : 1, "Text" : "Last Updated May 2022", "Header" : 1}
]},
{"Name" : "ORZID2 CLOSTRIDIUM DIFFICILE WITH ILEUS OR TOXIC MEGACOLON", "DisplayText" : "Clostridium Difficile WITH Ileus or Toxic Megacolon ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Clostridium Difficile WITH Ileus or Toxic Megacolon", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "PSJUZID VANCO 500MG PO Q6H + METRONIDAZOLE 500MG IV Q8H", "DisplayText" : "Vanocmycin 500MG PO Q6H + Metronidazole 500MG IV Q8H", "Text" :""},
{"Row" : 8, "Column" : 1, "Text" : "If ileus present, rectal Vancomycin may be administered as a retention enema"}, 
{"Row" : 9, "Column" : 1, "Item" : "PSJUZID VANCOMYCIN 500MG IN 100ML NS RETENTION ENEMA Q6H", "DisplayText" : "Vancomycin 500MG Retention Enema", "Text" : ""},
{"Row" : 12, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "*McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for"}, 
{"Row" : 14, "Column" : 1, "Text" : "Clostridium difficile Infection in Adults and Children: 2017 Update by the"}, 
{"Row" : 15, "Column" : 1, "Text" : "Infectious Diseases Society of America (IDSA) and Society for Healthcare"}, 
{"Row" : 16, "Column" : 1, "Text" : "Epidemiology of America (SHEA). Clin Infect Dis. 2018"}, 
{"Row" : 20, "Column" : 1, "Text" : "THIS MENU UPDATED JUNE 2018", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Text" : "(Fulmiant disease - previously referred to as severe, complicated)"}
]},
{"Name" : "ORZID2 CLOSTRIDIUM DIFFICILE WITHOUT ILEUS OR TOXIC MEGACOLON", "DisplayText" : "Clostridium Difficile WITHOUT Ileus or Toxic Megacolon ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Clostridium Difficile WITHOUT Ileus or Toxic Megacolon", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Initial Episode", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "PSJUZID VANCOMYCIN 125MG PO Q6H X 10D", "DisplayText" : "Vancomycin 125MG PO Q6H FOR 10 DAYS", "Text" : ""},
{"Row" : 8, "Column" : 1, "Text" : "First Recurrence", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Item" : "PSJUZID VANCOMYCIN TAPER 10D, 7D, 7D, 14D", "DisplayText" : "Vancomycin Taper", "Text" :""},
{"Row" : 11, "Column" : 1, "Text" : "Second or Subsequent Recurrence", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJUZID VANCOMYCIN TAPER 14D, 7D, 7D, 28D", "DisplayText" : "Vancomycin Taper", "Text" :""},
{"Row" : 15, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "*McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for"}, 
{"Row" : 17, "Column" : 1, "Text" : "Clostridium difficile Infection in Adults and Children: 2017 Update by the"}, 
{"Row" : 18, "Column" : 1, "Text" : "Infectious Diseases Society of America (IDSA) and Society for Healthcare"}, 
{"Row" : 19, "Column" : 1, "Text" : "Epidemiology of America (SHEA). Clin Infect Dis. 2018"}, 
{"Row" : 23, "Column" : 1, "Text" : "This Menu Updated June 2018", "Header" : 1}
]},
{"Name" : "ORZID2 COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Community Acquired Pneumonia", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Community Acquired Pnuemonia", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Nonsevere CAP:", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Severe CAP (see criteria in menu link below)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IVPB/AZITHROMYCIN 500MG PO 3 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Azithromycin 500MG PO 3 DAYS", "Text" : ""},
{"Row" : 6, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 750MG PO Q24H 5 DAYS", "DisplayText" : "Levofloxacin 750MG PO Q24H 5 DAYS", "Text" : ""},
{"Row" : 12, "Column" : 1, "Text" : "Empiric Therapy if risk factors for MRSA or Pseudomonas are NOT present:", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IVPB/AZITHROMYCIN 500MG PO 3 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Azithromycin 500MG PO 3 DAYS", "Text" : ""},
{"Row" : 15, "Column" : 1, "Text" : "Patient previously had positive MRSA culture:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 AZITHRO 500MG PO/CEFTRIAXONE 1GM IVPB/VANCO PTD", "DisplayText" : "Azithromycin 500MG PO 3 DAYS + Ceftriaxone 1GM IVPB + VANCO Pharmacy to Dose", "Text" :""},
{"Row" : 18, "Column" : 1, "Text" : "<IF PENICILLIN ALLERGY>"}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 LEVOFLOXACIN 750MG PO Q24H/VANCO PTD", "DisplayText" : "Levofloxacin 750MG PO Q24H + Vanco Pharmacy to Dose", "Text" : "Levofloxacin 750MG PO Q24H + Vanco Pharmacy to Dose"},
{"Row" : 21, "Column" : 1, "Text" : "Patient previously had positive Pseudomonas culture:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 COMMUNITY ACQUIRED PNEUMONIA CRITERIA", "DisplayText" : "Community Aquired Pneumonia Criteria for Severe Pneumonia", "Text" : ""},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 AZITHROMYCIN 500MG PO Q24H/ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Azithromycin 500MG PO Q24H + ZOSYN 4.5GM IVPB Q6H 3 DAYS", "Text" : "Azithromycin 500MG PO Q24H 3 DAYS + ZOSYN 4.5GM IVPB Q6H"},
{"Row" : 24, "Column" : 1, "Text" : "<IF PENICILLIN ALLERGY>"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 AZTREONAM 2GM IVPB Q8H/LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Aztreonam 2GM IVPB Q8H + Levofloxacin 750MG PO Q24H", "Text" : "Aztreonam 2GM IVPB Q8H + Levofloxacin 750MG PO Q24H"},
{"Row" : 27, "Column" : 1, "Text" : "Patient has been hospitalized with IV antibiotics in the last 90 days:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 AZITHROMYCIN 500MG PO 3 DAYS/ZOSYN 4.5GM Q6H/VANCO PTD", "DisplayText" : "Azithromycin 500MG PO 3 DAYS + Zosyn 4.5GM Q6H + Vanco Pharmacy to Dose", "Text" : ""},
{"Row" : 30, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "*Antimicrobial Therapy, Inc. Sanford Guide Web Edition. Sanford Guide"}, 
{"Row" : 32, "Column" : 1, "Text" : "Web Edition. https://dva.sanfordguide.com/. Published 2019. Accessed"}, 
{"Row" : 33, "Column" : 1, "Text" : "December 4, 2019."}, 
{"Row" : 34, "Column" : 1, "Text" : "*Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with"}, 
{"Row" : 35, "Column" : 1, "Text" : "Community-acquired Pneumonia. An Official Clinical Practice Guideline"}, 
{"Row" : 36, "Column" : 1, "Text" : "of the American Thoracic Society and Infectious Diseases Society of"}, 
{"Row" : 37, "Column" : 1, "Text" : "America. Am J Respir Crit Care Med. 2019 200(7)."}, 
{"Row" : 38, "Column" : 1, "Text" : "doi:10.1164/rccm.201908-1581st."}, 
{"Row" : 42, "Column" : 1, "Text" : "THIS MENU UPDATED DECEMBER 2019", "Header" : 1}
]},
{"Name" : "ORZID2 COMMUNITY ACQUIRED PNEUMONIA CRITERIA", "DisplayText" : "Community Aquired Pneumonia Criteria for Severe Pneumonia ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Criteria for Severe Pneumonia", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "1 major criterion or 3 minor criteria"}, 
{"Row" : 6, "Column" : 1, "Text" : "Minor:", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "*Respiratory rate >= 30 breaths/min"}, 
{"Row" : 8, "Column" : 1, "Text" : "*PaO2/FlO2 ratio <= 250"}, 
{"Row" : 9, "Column" : 1, "Text" : "*Multilobar infiltrates"}, 
{"Row" : 10, "Column" : 1, "Text" : "*Confusion/disorientation"}, 
{"Row" : 11, "Column" : 1, "Text" : "*Uremia (BUN >= 20 mg/dL)"}, 
{"Row" : 12, "Column" : 1, "Text" : "*Leukopenia (WBC < 4000 cells/mcL)"}, 
{"Row" : 13, "Column" : 1, "Text" : "*Thrombocytopenia (platelets < 100,000/mcL)"}, 
{"Row" : 14, "Column" : 1, "Text" : "*Hypothermia (core temperature < 36 degrees C)"}, 
{"Row" : 15, "Column" : 1, "Text" : "*Hypotension requiring aggressive fluid resuscitation"}, 
{"Row" : 17, "Column" : 1, "Text" : "Major:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "*Septic shock with need for vasopressin"}, 
{"Row" : 19, "Column" : 1, "Text" : "*Respiratory failure requiring mechanical ventilation"}
]},
{"Name" : "ORZID2 COMPLICATED CYSTITIS", "DisplayText" : "Complicated Cystitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Complicated Cystitis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "*All urinary tract infection in males are considered complicated", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "*Mild urinary tract infection in males are considered complicated", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" :""},
{"Row" : 10, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO Q12H 7 DAYS", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS PO Q12H 7 DAYS", "Text" : ""},
{"Row" : 12, "Column" : 1, "Text" : "*Severe Disease or Patient Unable to Take Oral Therapy", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""},
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 400MG IVPB Q12H", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H 7 DAYS", "DisplayText" : "Zosyn 3.375GM Q6H 7 DAYS", "Text" : ""},
{"Row" : 20, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Gupta K, et al. International Clinical Practice Guidelines for treatment for"}, 
{"Row" : 22, "Column" : 1, "Text" : "Acute Uncomplicated Cystitis and Pyelonephritis in Women. IDSA. 2010"}, 
{"Row" : 25, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 14, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 16, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 CYSTITIS", "DisplayText" : "Cystitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Cystitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Cystitis refers to infection of the urinary bladder, but inflammation often", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "extends into the urethra. Typical symptoms and signs include dysuria, increased", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "urinary frequency, urgency, and/or suprapubic tenderness.", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "*Most cases of uncomplicated cystitis occur in pre-menopausal, non-pregnant,", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "sexually active young women. In men with mild to moderate symptoms without", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "complicating conditions and without recent treatment relapse or recurrence,", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "cystitis is considered uncomplicated. Most cases of complicated cystitis are", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "associasted with Escherichia coli, but more resistant pathogens occur, including", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "the Gram positive pathogens staphylococci and enterococci. Urine culture should", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "be obtained before antimicrobials are given.", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "*Complicating conditions- consider complicated if one or more of the following", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "present", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "tubes, neurogenic bladder)"}, 
{"Row" : 19, "Column" : 1, "Text" : "*Metabolic abnormalities that reduce local host defenses (ie diabetes,"}, 
{"Row" : 20, "Column" : 1, "Text" : "pregnancy, neutropenia, pelvic irradiation)"}, 
{"Row" : 21, "Column" : 1, "Text" : "*Unusual or resistant pathogen"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Treatment failure or relapse or recurrence of infection"}, 
{"Row" : 17, "Column" : 1, "Text" : "*Structural abnormalities (ie presence of obstruction, catheter or nephrostomy"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 UNCOMPLICATED CYSTITIS", "DisplayText" : "Uncomplicated Cystitis", "Text" :""},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 COMPLICATED CYSTITIS", "DisplayText" : "Complicated Cystitis", "Text" : ""}
]},
{"Name" : "ORZID2 DECREASED RENAL CLEARANCE", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 DIABETIC FOOT INFECTION", "DisplayText" : "Diabetic Foot Infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Diabetic Foot Infection", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Definitions:", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Mild: local infection involving only the skin and subcutaneous", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "tissue (no involvement of deeper tissue and no systemic toxicity).", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "If erythema must be >0.5cm to </=2cm around the site", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Moderate: may involve deeper tissue but no systemic toxicity. If", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "erythema >/=2cm around the ulcer", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Severe: deep infection or local infection with systemic toxicity", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Pseudomonas: suspect and treat for pseudomonas if either of the following:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "recently traveled to warm climate location or frequent exposure of the", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "foot to water.", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Oral regimens for Mild to Moderate infections", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJUZID CEPHALEXIN 500MG PO Q6H + DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Cephalexin 500MG PO Q6H + Doxycycline 100MG PO Q12H", "Text" : ""},
{"Row" : 23, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO Q12H", "DisplayText" : "Sulfamethoxacole/Trimethoprim 800/160MG PO Q12H", "Text" : ""},
{"Row" : 26, "Column" : 1, "Item" : "PSJUZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : ""},
{"Row" : 28, "Column" : 1, "Text" : "Intravenous regimens for Moderate to Severe infections", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID CEFTAROLINE 600MG IVPB Q12H", "DisplayText" : "Ceftaroline 600MG IVPB Q12H", "Text" : ""},
{"Row" : 31, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM Q6H & VANCO PHARMACY TO DOSE", "DisplayText" : "Piperacillin/Tazobactam 4.5GM Q6H & Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 33, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 34, "Column" : 1, "Item" : "ZZPSJIZID LEVOFLOXACIN 750MG IVPB + VANCO PHARMACY TO DOSE", "DisplayText" : "", "Text" : ""},
{"Row" : 36, "Column" : 1, "Item" : "PSJIZID ERTAPENEM 1GM Q24H & VANCO PHARMACY TO DOSE", "DisplayText" : "Ertapenem 1GM Q24H & Vanco Pharmacy To Dose", "Text" :""},
{"Row" : 38, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "*Lipsky BA, et al. Clin Infect Dis 2012, 54: 132 IDSA Clinical Practice"}, 
{"Row" : 40, "Column" : 1, "Text" : "Guideline for the Diagnosis and Treatment of Diabetic Foot Infections"}, 
{"Row" : 41, "Column" : 1, "Text" : "*Gilbert DN, et al. The Sanford Guide to Antimicrobial Therapy 2016"}, 
{"Row" : 42, "Column" : 1, "Text" : "40th ed. Diabetic Foot Infection"}, 
{"Row" : 45, "Column" : 1, "Text" : "THIS MENU LAST UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 30, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 35, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 DIVERTICULITIS", "DisplayText" : "Diverticulitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Diverticulitis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Mild Disease (treat for 7-10 days)", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Moderate Disease (treat for 7-10 days)", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Severe, Life Threatening Disease", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "PSJUZID CIPRO 500MG PO Q12H + METRONIDAZOLE 500MG PO Q6H", "DisplayText" : "Ciprofloxacin 500MG PO Q12H + Metronidazole 500MG PO Q6H", "Text" : ""},
{"Row" : 8, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H", "Text" : ""},
{"Row" : 10, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO Q12H + METRONIDAZOLE 500MG PO Q6H", "DisplayText" : "Sulfamethoxazole/Trimethoprim 800/160MG PO Q12H + Metronidazole 500MG PO Q6H", "Text" :""},
{"Row" : 12, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "Alternative: Levofloxacin 500MG PO Q24H"},
{"Row" : 15, "Column" : 1, "Text" : "*If symptoms fail to respond withing 48-72 hours, consult general surgery"}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin/Sulbactam 3GM IVPB Q6H", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CIPRO 400MG Q12H + METRONIDAZOLE 500MG Q6H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H + Metronidazole 500MG IV Q6H", "Text" : "Penicillin Allergy: Ciprofloxacin 400MG IV Q12H + Metronidazole 500MG IV Q6H"},
{"Row" : 21, "Column" : 1, "Text" : "*Consult general surgery"}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" :""},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : ""},
{"Row" : 26, "Column" : 1, "Text" : "Penicillin Allergy:"}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID AZTREONAM 2GM IV Q8H + METRONIDAZOLE 500MG Q8H", "DisplayText" : "Aztreonam 2GM IV Q8H + Metronidazole 500MG IV Q8H", "Text" : "Aztreonam 2GM IV Q8H + Metronidazole 500MG IV Q8H"},
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID CIPRO 400MG IV Q12H + METRONIDAZOLE 500MG IV Q8H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H + Metronidazole 500MG IV Q8H", "Text" : "Ciprofloxacin 400MG IV Q12H + Metronidazole 500MG IV Q8H"},
{"Row" : 33, "Column" : 1, "Text" : "*\"Sanford\" keyword: diverticulitis"}, 
{"Row" : 34, "Column" : 1, "Text" : "*Solomkin JS Clin Infect Dis 2003, 37:997"}, 
{"Row" : 35, "Column" : 1, "Text" : "*Up-To-Date"}, 
{"Row" : 37, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 9, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 23, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 28, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 DRUG INTERACTION", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 EMPYEMA", "DisplayText" : "Empyema", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Empyema", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Empyema is usually a complication of pneumonia. Blood cultures should be drawn"}, 
{"Row" : 5, "Column" : 1, "Text" : "and whenever possible, diagnostic thoracentesis should be performed before"}, 
{"Row" : 6, "Column" : 1, "Text" : "antimicrobials are begun to guide therapy. Drainage is essential, and a"}, 
{"Row" : 7, "Column" : 1, "Text" : "chest tube is often required. Pulmonary and ID consultation is essential"}, 
{"Row" : 8, "Column" : 1, "Text" : "*Treat for 2-4 weeks and adjust treatment based on clinical response"}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "*Preferred Treatment"}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H", "Text" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H"},
{"Row" : 14, "Column" : 1, "Text" : "*Alternative Treatment"}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 LEVO 500MG IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H + Metronidazole 500MG IVPB Q8H", "Text" : "Levofloxacin 500MG IVPB Q24H + Metronidazole 500MG IVPB Q8H"},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H", "Text" : "Levofloxacin 500MG IVPB Q24H"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "**May substitute Clindamycin 600MG IVPB Q8H for Metronidazole"},
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "*Septimus EJ. Pleural effusion and empyema. In: Mandell GL, Bennett JC, Dolin"}, 
{"Row" : 24, "Column" : 1, "Text" : "R, eds. Mandell Douglas and Bennett's: Principles and Practice of"}, 
{"Row" : 25, "Column" : 1, "Text" : "Infectious Disease. Vol 1. 7th ed. Philadelphia, PA: Elsevier"}, 
{"Row" : 26, "Column" : 1, "Text" : "*Kasper Infectious Disease. Vol 1. 7th ed. Philadelphia, PA: Elsevier."}, 
{"Row" : 27, "Column" : 1, "Text" : "In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds."}, 
{"Row" : 28, "Column" : 1, "Text" : "Harrison's Principles of Internal Medicine. 18th ed. New York, NY:"}, 
{"Row" : 29, "Column" : 1, "Text" : "McGraw-Hill 2012: 1331-1339."}, 
{"Row" : 30, "Column" : 1, "Text" : "*Up-To-Date: Parapneumonic effusion and empyema in adults"}, 
{"Row" : 31, "Column" : 1, "Text" : "*Sanford Guide: Empyema"}, 
{"Row" : 34, "Column" : 1, "Text" : "This Menu Updated January 2019", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 EPIDIDYMITIS", "DisplayText" : "Epididymitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Epididymitis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Most cases in men under age 35 are associated with N. gonorrheoeae and C.", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "trachmatis. Most cases in older men are associated with enteric gram", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "negative rods. Management should include bed rest, analgesics, and scrotal", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "elevation. Older men should have their residual urinary volume checked.", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "If the residual volume is elevated, the patient should be seen by a", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "urologist as epididymitis is unlikely to respond if the prostate is", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "blocking the vas deferens.", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment in men </= 35 or for cases associated with gonococci or chlamydia", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID CEFTRIAXONE 250MG IM THEN DOXY 100MG PO BID 7DAYS", "DisplayText" : "Ceftriaxone 250MG IM THEN Doxycycline 100MG PO BID 7 DAYS", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 10 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO 10 DAYS", "Text" : ""},
{"Row" : 21, "Column" : 1, "Text" : "Treatment in men > 35 years (except for cases with gonococci or chlamydia)", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 10 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO 10 DAYS", "Text" : ""},
{"Row" : 24, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H 10 DAYS", "DisplayText" : "Ciprofloxacin 400MG IVPB Q12H 10 DAYS", "Text" :""},
{"Row" : 28, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "*\"Sanford\" keyword: Epididymitis"}, 
{"Row" : 31, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}
]},
{"Name" : "ORZID2 ERYTHEMA MIGRANS ASSOCIATED WITH LYME DISEASE", "DisplayText" : "Erythema Migrans Associated with Lyme Disease ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Erythema migrans is the first manifestation of Lyme disease in half of", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "cases. It is typically an erythematous circular rash with induation and", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "central clearing (although other patterns occur) and it usually", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "develops at the site of the bite and/or in one or more distant", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "locations. The rash occurs 3-30 days after the bite. Rashes with onset", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "less than 3 days after a tick biter are not from Lyme Disease", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "A recent study showed that a 10 day course of antimicrobialsis as", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "effective as a 21 day course in treating erythema migrans", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN 500MG PO Q8H + DOXY 100MG PO Q12H 10D", "DisplayText" : "Amoxicillin 500MG PO Q8H + Doxycycline 100MG PO Q12H 10 DAYS", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "*Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 20, "Column" : 1, "Text" : "*\"Sanford\" keyword: Lyme disease"}, 
{"Row" : 21, "Column" : 1, "Text" : "*Wormser keyword: Lyme disease"}, 
{"Row" : 25, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}
]},
{"Name" : "ORZID2 GASTROINTESTINAL AND INTRA-ABDOMINAL", "DisplayText" : "Gastrointestinal and Intra-Abdominal ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Gastrointesinal and Intra-Abdominal", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 CHOLECYSTITIS", "DisplayText" : "Cholecystitis", "Text" :""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 CLOSTRIDIUM DIFFICILE MAIN", "DisplayText" : "Clostridium Difficile Main Menu", "Text" :""},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 DIVERTICULITIS", "DisplayText" : "Diverticulitis", "Text" :""},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 H. PYLORI", "DisplayText" : "H. Pylori", "Text" : ""},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 SPONTANEOUS BACTERIAL PERITONITIS (SBP)", "DisplayText" : "Spontaneous Bacterial Peritonitis (SBP)", "Text" : ""},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 APPENDICITIS", "DisplayText" : "Appendicitis", "Text" : ""}
]},
{"Name" : "ORZID2 GENITOURINARY", "DisplayText" : "Genitourinary", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 CYSTITIS", "DisplayText" : "Cystitis", "Text" : ""},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 EPIDIDYMITIS", "DisplayText" : "Epididymitis", "Text" : ""},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 PROSTATITIS", "DisplayText" : "Prostatitis", "Text" : ""},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 PYELONEPHRITIS", "DisplayText" : "Pyelonephritis", "Text" : ""},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 URETHRITIS ASSOCIATED WITH SEXUALLY TRANSMITTED DISEASE", "DisplayText" : "Urethritis Associated with Sexually Transmitted Disease", "Text" :""}
]},
{"Name" : "ORZID2 GENTAMICIN 1MG/KG IVPB Q8H/NAFCILLIN 2GM IVPB Q4H", "DisplayText" : "Gentamicin 1MG/KG IVPB Q8H + Nafcillin 2GM IVPB Q4H ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID GENTAMICIN 1 MG/KG IV Q8H", "DisplayText" : "Gentamicin 1MG/KG IV Q8H", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID NAFCILLIN 2GM IVPB Q4H", "DisplayText" : "Nafcillin 2GM IVPB Q4H", "Text" :""}
]},
{"Name" : "ORZID2 GENTAMICIN 80MG IVPB ONCE/METRONIDAZOLE 500MG IVPB ONCE", "DisplayText" : "Gentamicin 80MG IVPB ONCE + Metronidazole 500MG IVPB ONCE ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID GENTAMICIN 80MG IV ONCE", "DisplayText" : "Gentamicin 80 mg iv once", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB ONCE", "DisplayText" : "Metronidazole 500MG IVPB ONCE", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 7, "Column" : 1, "Text" : "APPROACH TO URINARY TRACT INFECTIONS (UTI)"}, 
{"Row" : 10, "Column" : 1, "Text" : "detectable bacteria.  When bacteriuria (>= 10000 bacteria/ml urine) occurs in"}, 
{"Row" : 22, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Cystitis refers to infection of the urinary bladder but inflammation often"}, 
{"Row" : 31, "Column" : 1, "Text" : "extends into the urethra.  Typical symptoms and signs include dysuria, increased"}, 
{"Row" : 32, "Column" : 1, "Text" : "urinary frequency, urgency, and/or suprapubic tenderness."}, 
{"Row" : 34, "Column" : 1, "Text" : "Pyelonephritis refers to infection of the kidney, renal pelvis or ureter."}, 
{"Row" : 35, "Column" : 1, "Text" : "Typical symptoms and signs include flank pain or tenderness, chills and/or"}, 
{"Row" : 36, "Column" : 1, "Text" : "fever.  The urinalysis may have white cell casts. Signs or symptoms of cystitis"}, 
{"Row" : 37, "Column" : 1, "Text" : "are often present also."}, 
{"Row" : 44, "Column" : 1, "Text" : "> Structural abnormalities (e.g. presence of obstruction, catheter or"}, 
{"Row" : 45, "Column" : 1, "Text" : "nephrostomy tubes, neurogenic bladder)"}, 
{"Row" : 46, "Column" : 1, "Text" : "> Metabolic abnormalities that reduce local host defenses (e.g. diabetes,"}, 
{"Row" : 47, "Column" : 1, "Text" : "pregnancy, neutropenia, pelvic irradiation)"}, 
{"Row" : 52, "Column" : 1, "Text" : "Prevention of urinary tract infections in patients who are incontinent of urine,", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "In most infants, children, and young adults, urine typically has few or no"}, 
{"Row" : 11, "Column" : 1, "Text" : "these groups, it often results from a recognizable risk factor like congenital"}, 
{"Row" : 12, "Column" : 1, "Text" : "or acquired structural abnormalities in children or young adults or sexual"}, 
{"Row" : 13, "Column" : 1, "Text" : "intercourse in young women.  As men and women progress through middle age and"}, 
{"Row" : 14, "Column" : 1, "Text" : "beyond, bacteriuria is increasingly prevalent because of laxity of the urinary"}, 
{"Row" : 15, "Column" : 1, "Text" : "sphincter and urethra or supporting pelvic structures and prostatic hypertrophy."}, 
{"Row" : 16, "Column" : 1, "Text" : "Asymptomatic bacteriuria is present in the majority of elderly people with"}, 
{"Row" : 17, "Column" : 1, "Text" : "chronic illness.  Asymptomatic bacteriuria is not harmful and should not be"}, 
{"Row" : 18, "Column" : 1, "Text" : "treated with antimicrobials except in pregnant women or just before and during"}, 
{"Row" : 19, "Column" : 1, "Text" : "urological surgery."}, 
{"Row" : 25, "Column" : 1, "Text" : "When patients present with urinary tract infection (UTI) symptoms, obtain"}, 
{"Row" : 26, "Column" : 1, "Text" : "urinalysis with microscopic examination.  Depending on symptoms and signs,"}, 
{"Row" : 27, "Column" : 1, "Text" : "clinicians should also order semi-quantitative urine culture, blood cultures,"}, 
{"Row" : 28, "Column" : 1, "Text" : "renal ultrasound, or cystoscopy."}, 
{"Row" : 39, "Column" : 1, "Text" : "Complicated or uncomplicated?", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Treatment and follow-up plans depend on whether an infection is considered"}, 
{"Row" : 41, "Column" : 1, "Text" : "\"complicated\" or \"uncomplicated.\"  Infection is considered complicated when one"}, 
{"Row" : 42, "Column" : 1, "Text" : "or more of the following is present:"}, 
{"Row" : 48, "Column" : 1, "Text" : "> Unusual or resistant pathogen"}, 
{"Row" : 49, "Column" : 1, "Text" : "> Treatment failure or relapse or recurrence of infection"}, 
{"Row" : 55, "Column" : 1, "Text" : "Use indwelling (Foley) catheters only when needed for careful fluid management"}, 
{"Row" : 56, "Column" : 1, "Text" : "or in cases where diapers or intermittent straight-catheterization are not"}, 
{"Row" : 57, "Column" : 1, "Text" : "possible.  Indwelling catheters substantially increase the risk of symptomatic"}, 
{"Row" : 58, "Column" : 1, "Text" : "urinary tract infection and subsequent septicemia and death.  Treatment of"}, 
{"Row" : 59, "Column" : 1, "Text" : "recurrent infections in people with indwelling catheters selects for resistant"}, 
{"Row" : 60, "Column" : 1, "Text" : "organisms, which are difficult to treat.  These resistant organisms represent a"}, 
{"Row" : 61, "Column" : 1, "Text" : "threat to the catheterized patients and others in the environment."}, 
{"Row" : 63, "Column" : 1, "Text" : "Individuals who cannot drain their bladders are best managed with intermittent"}, 
{"Row" : 64, "Column" : 1, "Text" : "straight catheterization.  The bladder should be drained 5 or 6 times daily to"}, 
{"Row" : 65, "Column" : 1, "Text" : "simulate normal bladder function and effectively prevent cystitis.  Individuals"}, 
{"Row" : 66, "Column" : 1, "Text" : "who are incontinent from structural, physiological, or mental dysfunction should"}, 
{"Row" : 67, "Column" : 1, "Text" : "wear diapers. This keeps the bladder and urethra free of foreign bodies, allows"}, 
{"Row" : 68, "Column" : 1, "Text" : "them to drain, and reduces the incidence of urinary tract infection to"}, 
{"Row" : 69, "Column" : 1, "Text" : "background levels.  Modern, disposable diapers are convenient, non-obtrusive,"}, 
{"Row" : 70, "Column" : 1, "Text" : "and inexpensive."}, 
{"Row" : 72, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "618061", "DisplayText" : "", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX DRUG ALLERGIES", "DisplayText" : "Drug allergies  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID3 GMENU CONTACT CDSS PROJECT", "DisplayText" : "Contact the CDSS Project Staff", "Text" : "Contact CDSS project staff", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "DRUG ALLERGIES"}, 
{"Row" : 8, "Column" : 1, "Text" : "Importance of history", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "The nature and circumstances of a possible previous reaction including the"}, 
{"Row" : 10, "Column" : 1, "Text" : "timing should be considered.  In many cases, previous reactions are clearly"}, 
{"Row" : 11, "Column" : 1, "Text" : "not due to drug allergy."}, 
{"Row" : 13, "Column" : 1, "Text" : "Types of reactions", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Type I or immediate reactions present with urticaria, angioedema, bronchospasm,"}, 
{"Row" : 15, "Column" : 1, "Text" : "or anaphylaxis and occur within minutes or hours of exposure."}, 
{"Row" : 17, "Column" : 1, "Text" : "Type III or late reactions present with a rash, usually macular and/or papular"}, 
{"Row" : 18, "Column" : 1, "Text" : "and occur 3 to 14 days after exposure."}, 
{"Row" : 20, "Column" : 1, "Text" : "Repeated exposures lead to reactions that are of the same type."}, 
{"Row" : 22, "Column" : 1, "Text" : "Beta-lactam allergies", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Patients allergic to penicillins will have a cross-reaction to cephalosporins 3%"}, 
{"Row" : 24, "Column" : 1, "Text" : "to 5% of the time.  Patients allergic to cephalosporins will have a cross-"}, 
{"Row" : 25, "Column" : 1, "Text" : "reaction to penicillins 3% to 5% of the time.  Neither penicillin- or"}, 
{"Row" : 26, "Column" : 1, "Text" : "cephalosporin-allergic patients will react to aztreonam."}, 
{"Row" : 28, "Column" : 1, "Text" : "Therapeutic implications", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "If a patient has had a Type III reaction in the past, it is relatively safe to"}, 
{"Row" : 30, "Column" : 1, "Text" : "treat with the same class again.  Often the rash will not recur.  If it does, it"}, 
{"Row" : 31, "Column" : 1, "Text" : "will rarely be life threatening and will often disappear even if the drug is"}, 
{"Row" : 32, "Column" : 1, "Text" : "continued."}, 
{"Row" : 34, "Column" : 1, "Text" : "Desensitization", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "A patient with previous Type I reaction to a beta-lactam can be desensitized and"}, 
{"Row" : 36, "Column" : 1, "Text" : "then receive therapeutic doses of the same class within a day.  Severe"}, 
{"Row" : 37, "Column" : 1, "Text" : "reactions during desensitization are uncommon.  Pharmacy service must be"}, 
{"Row" : 38, "Column" : 1, "Text" : "contacted for assistance and drug preparation.  Infectious Disease consultation"}, 
{"Row" : 39, "Column" : 1, "Text" : "strongly recommended."}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX PENICILLIN DESENS PROTOCOL", "DisplayText" : "Penicillin Desensitization Protocol", "Text" : "Penicillin Desensitization Protocol", "Mnemonic" : "06"},
{"Row" : 44, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 45, "Column" : 1, "Text" : "JAMA 2001, 285:249"}, 
{"Row" : 46, "Column" : 1, "Text" : "Mayo Clinic Proc 1999, 74:290"}, 
{"Row" : 47, "Column" : 1, "Text" : "NEJM 2001, 345:804"}
]},
{"Name" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page ", "Version" : "Fargo", "Contents" : [
{"Row" : 7, "Column" : 1, "Text" : "++ IMPORTANT DRUG PROPERTIES PAGE ++", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ACYCLOVIR PO", "DisplayText" : "Acyclovir PO", "Text" : "Acyclovir PO", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ACYCL IV", "DisplayText" : "Acyclovir IV", "Text" : "Acyclovir IV", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMANTADINE PO", "DisplayText" : "Amantadine PO", "Text" : "Amantadine PO", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMBISOME IV", "DisplayText" : "Ambisome IV", "Text" : "Ambisome IV", "Mnemonic" : "14"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMIKACIN IV", "DisplayText" : "Amikacin IV", "Text" : "Amikacin IV", "Mnemonic" : "16"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMOXICILLIN PO", "DisplayText" : "Amoxicillin PO", "Text" : "Amoxicillin PO", "Mnemonic" : "18"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMOX/CLAV PO", "DisplayText" : "Amoxicillin-clavulanate PO", "Text" : "Amoxicillin-clavulanate PO", "Mnemonic" : "20"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMPHOTERICIN B IV", "DisplayText" : "Amphotericin B IV", "Text" : "Amphotericin B IV", "Mnemonic" : "22"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMPICILLIN IV", "DisplayText" : "Ampicillin IV", "Text" : "Ampicillin IV", "Mnemonic" : "24"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMPIC/SULBACT IV", "DisplayText" : "Ampicillin-sulbactam IV", "Text" : "Ampicillin-sulbactam IV", "Mnemonic" : "26"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ATOVAQUONE PO", "DisplayText" : "Atovaquone PO", "Text" : "Atovaquone PO", "Mnemonic" : "28"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AZITHROMYCIN PO", "DisplayText" : "Azithromycin PO", "Text" : "Azithromycin PO", "Mnemonic" : "30"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AZITH IV", "DisplayText" : "Azithromycin IV", "Text" : "Azithromycin IV", "Mnemonic" : "32"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AZTREONAM IV", "DisplayText" : "Aztreonam IV", "Text" : "Aztreonam IV", "Mnemonic" : "34"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP BENZATHINE PENICILLIN IM", "DisplayText" : "Benzathine Penicillin IM", "Text" : "Benzathine penicillin IM", "Mnemonic" : "36"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CASPOFUNGIN IV", "DisplayText" : "Caspofungin IV", "Text" : "Caspofungin IV", "Mnemonic" : "38"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFAZOLIN IV", "DisplayText" : "Cefazolin IV", "Text" : "Cefazolin IV", "Mnemonic" : "40"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFEPIME IV", "DisplayText" : "Cefepime IV", "Text" : "Cefepime IV", "Mnemonic" : "42"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFOTETAN IV", "DisplayText" : "Cefotetan IV", "Text" : "Cefotetan IV", "Mnemonic" : "44"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFOXITIN IV", "DisplayText" : "Cefoxitin IV", "Text" : "Cefoxitin IV", "Mnemonic" : "46"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTAZIDIME IV", "DisplayText" : "Ceftazidime IV", "Text" : "Ceftazidime IV", "Mnemonic" : "48"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTIZOXIME IV", "DisplayText" : "Ceftizoxime IV", "Text" : "Ceftizoxime IV", "Mnemonic" : "50"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTRIAXONE IM", "DisplayText" : "Ceftriaxone IM", "Text" : "Ceftriaxone IM", "Mnemonic" : "52"},
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTRIAX INTRAVENOUS", "DisplayText" : "Ceftriaxone IV", "Text" : "Ceftriaxone IV", "Mnemonic" : "54"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFUROXIME PO", "DisplayText" : "Cefuroxime PO", "Text" : "Cefuroxime PO", "Mnemonic" : "56"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEPHALEXIN PO", "DisplayText" : "Cephalexin PO", "Text" : "Cephalexin PO", "Mnemonic" : "58"},
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CHLORAMPHENICOL IV", "DisplayText" : "Chloramphenicol IV", "Text" : "Chloramphenicol IV", "Mnemonic" : "60"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CIPROFLOXACIN PO", "DisplayText" : "Ciprofloxacin PO", "Text" : "Ciprofloxacin PO", "Mnemonic" : "62"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV CIPROFLOXACIN", "DisplayText" : "Ciprofloxacin IV", "Text" : "Ciprofloxacin IV", "Mnemonic" : "64"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CLARITHROMYCIN PO", "DisplayText" : "Clarithromycin PO", "Text" : "Clarithromycin PO", "Mnemonic" : "66"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CLINDAMYCIN PO", "DisplayText" : "Clindamycin PO", "Text" : "Clindamycin PO", "Mnemonic" : "68"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV CLINDAMYCIN", "DisplayText" : "Clindamycin IV", "Text" : "Clindamycin IV", "Mnemonic" : "70"},
{"Row" : 42, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP VAGINAL CLINDAMYCIN", "DisplayText" : "Clindamycin Vaginal", "Text" : "Clindamycin Vaginal", "Mnemonic" : "72"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CLOTRIMAZOLE TOPICAL", "DisplayText" : "Clotrimazole Topical", "Text" : "Clotrimazole Topical", "Mnemonic" : "74"},
{"Row" : 44, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP VAG CLOTRIMAZOLE", "DisplayText" : "Clotrimazole vaginal", "Text" : "Clotrimazole Vaginal", "Mnemonic" : "76"},
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DAPTOMYCIN IV", "DisplayText" : "Daptomycin IV", "Text" : "Daptomycin IV", "Mnemonic" : "78"},
{"Row" : 46, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DICLOXACILLIN PO", "DisplayText" : "Dicloxacillin PO", "Text" : "Dicloxacillin PO", "Mnemonic" : "80"},
{"Row" : 47, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DOXYCYCLINE PO", "DisplayText" : "Doxycycline PO", "Text" : "Doxycycline PO", "Mnemonic" : "82"},
{"Row" : 48, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV DOXYCYCLINE", "DisplayText" : "Doxycycline IV", "Text" : "Doxycycline IV", "Mnemonic" : "84"},
{"Row" : 49, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ERTAPENEM IV", "DisplayText" : "Ertapenem IV", "Text" : "Ertapenem IV", "Mnemonic" : "86"},
{"Row" : 50, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP OPHTHALMIC ERYTHROMYCIN", "DisplayText" : "Erythromycin Ophthalmic", "Text" : "Erythromycin Ophthalmic", "Mnemonic" : "88"},
{"Row" : 51, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ERYTHROMYCIN PO", "DisplayText" : "Erythromycin PO", "Text" : "Erythromycin PO", "Mnemonic" : "90"},
{"Row" : 52, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV ERYTHROMYCIN", "DisplayText" : "Erythromycin IV", "Text" : "Erythromycin IV", "Mnemonic" : "92"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP FLUCONAZOLE PO", "DisplayText" : "Fluconazole PO", "Text" : "Fluconazole PO", "Mnemonic" : "94"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV FLUCONAZOLE", "DisplayText" : "Fluconazole IV", "Text" : "Fluconazole IV", "Mnemonic" : "96"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP FOSCARNET IV", "DisplayText" : "Foscarnet IV", "Text" : "Foscarnet IV", "Mnemonic" : "98"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP GANCICLOVIR IV", "DisplayText" : "Ganciclovir IV", "Text" : "Ganciclovir IV", "Mnemonic" : "100"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP GATIFLOXACIN PO", "DisplayText" : "Gatifloxacin PO", "Text" : "Gatifloxacin PO", "Mnemonic" : "102"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV GATIFLOXACIN", "DisplayText" : "Gatifloxacin IV", "Text" : "Gatifloxacin IV", "Mnemonic" : "104"},
{"Row" : 16, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP GENTAMICIN IV", "DisplayText" : "", "Text" : "Gentamicin IV", "Mnemonic" : "106"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP ITRACONAZOLE IV", "DisplayText" : "Itraconazole IV", "Text" : "Itraconazole IV", "Mnemonic" : "108"},
{"Row" : 19, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP LINEZOLID PO", "DisplayText" : "Linezolid PO", "Text" : "Linezolid PO", "Mnemonic" : "110"},
{"Row" : 20, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV LINEZOLID", "DisplayText" : "Linezolid IV", "Text" : "Linezolid IV", "Mnemonic" : "112"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP METRONIDAZOLE PO", "DisplayText" : "Metronidazole PO", "Text" : "Metronidazole PO", "Mnemonic" : "114"},
{"Row" : 22, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV METRONIDAZOLE", "DisplayText" : "Metronidazole IV", "Text" : "Metronidazole IV", "Mnemonic" : "116"},
{"Row" : 23, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VAGINAL METRONIDAZOLE", "DisplayText" : "Metronidazole Vaginal", "Text" : "Metronidazole Vaginal", "Mnemonic" : "118"},
{"Row" : 24, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MINOCYCLINE PO", "DisplayText" : "Minocycline PO", "Text" : "Minocycline PO", "Mnemonic" : "120"},
{"Row" : 25, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MOXIFLOXACIN OPHTHALMIC", "DisplayText" : "Moxifloxacin Ophthalmic", "Text" : "Moxifloxacin Ophthalmic", "Mnemonic" : "121"},
{"Row" : 28, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NAFCILLIN IV", "DisplayText" : "Nafcillin IV", "Text" : "Nafcillin IV", "Mnemonic" : "124"},
{"Row" : 29, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NEOMYCIN PO", "DisplayText" : "Neomycin PO", "Text" : "Neomycin PO", "Mnemonic" : "126"},
{"Row" : 31, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NITROFURANTOIN PO", "DisplayText" : "Nitrofurantoin PO", "Text" : "Nitrofurantoin PO", "Mnemonic" : "128"},
{"Row" : 32, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP OSELTAMIVIR PO", "DisplayText" : "Oseltamivir PO", "Text" : "Oseltamivir PO", "Mnemonic" : "130"},
{"Row" : 34, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PENICILLIN PO", "DisplayText" : "Penicillin PO", "Text" : "Penicillin PO", "Mnemonic" : "132"},
{"Row" : 35, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV PENICILLIN", "DisplayText" : "Penicillin IV", "Text" : "Penicillin IV", "Mnemonic" : "134"},
{"Row" : 36, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PIPERACILLIN-TAZOBACTAM IV", "DisplayText" : "Piperacillin-tazobactam IV", "Text" : "Piperacillin-tazobactam IV", "Mnemonic" : "136"},
{"Row" : 37, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PYRIMETHAMINE", "DisplayText" : "Pyrimethamine PO", "Text" : "Pyrimethamine PO", "Mnemonic" : "138"},
{"Row" : 38, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP QUINUPRISTIN-DALFOPRISIN", "DisplayText" : "Quinupristin-dalfoprisin", "Text" : "Quinupristin-dalfoprisin IV", "Mnemonic" : "140"},
{"Row" : 41, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIFAXIMIN PO", "DisplayText" : "Rifaximin PO", "Text" : "Rifaximin PO", "Mnemonic" : "144"},
{"Row" : 40, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIFAMPIN IV", "DisplayText" : "Rifampin IV", "Text" : "Rifampin IV", "Mnemonic" : "142"},
{"Row" : 42, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIMANTADINE PO", "DisplayText" : "Rimantadine PO", "Text" : "Rimantadine PO", "Mnemonic" : "146"},
{"Row" : 43, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP STREPTOMYCIN IV", "DisplayText" : "Streptomycin IV", "Text" : "Streptomycin IV", "Mnemonic" : "148"},
{"Row" : 44, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP SULFACETAMIDE OPHTHALMIC", "DisplayText" : "Sulfacetamide Ophthalmic", "Text" : "Sulfacetamide Ophthalmic", "Mnemonic" : "150"},
{"Row" : 45, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP SULFADIAZINE PO", "DisplayText" : "Sulfadiazine PO", "Text" : "Sulfadiazine PO", "Mnemonic" : "152"},
{"Row" : 46, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TERCONAZOLE 0.4% VAGINAL", "DisplayText" : "Terconazole 0.4% Vaginal", "Text" : "Terconazole 0.4% Vaginal", "Mnemonic" : "154"},
{"Row" : 47, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TETRACYCLINE PO", "DisplayText" : "Tetracycline PO", "Text" : "Tetracycline PO", "Mnemonic" : "156"},
{"Row" : 48, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TICARCILLIN-CLAVULANATE IV", "DisplayText" : "Ticarcillin-clavulanate IV", "Text" : "Ticarcillin-clavulanate IV", "Mnemonic" : "158"},
{"Row" : 49, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TOBRAMYCIN IV", "DisplayText" : "Tobramycin IV", "Text" : "Tobramycin IV", "Mnemonic" : "160"},
{"Row" : 50, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TRIMETHOPRIM-SULFAMETHOXAZOLE PO", "DisplayText" : "Trimethoprim-sulfamethoxazole PO", "Text" : "Trimethoprim-sulfamethoxazole PO", "Mnemonic" : "162"},
{"Row" : 51, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV TRIMETHOPRIM-SULFA", "DisplayText" : "Trimethoprim-sulfamethoxazole IV", "Text" : "Trimethoprim-sulfamethoxazole IV", "Mnemonic" : "164"},
{"Row" : 52, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VALACYCLOVIR PO", "DisplayText" : "Valacyclovir PO", "Text" : "Valacyclovir PO", "Mnemonic" : "166"},
{"Row" : 53, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VALGANCICLOVIR PO", "DisplayText" : "Valganciclovir PO", "Text" : "Valganciclovir PO", "Mnemonic" : "168"},
{"Row" : 54, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VANCOMYCIN IV", "DisplayText" : "Vancomycin IV", "Text" : "Vancomycin IV", "Mnemonic" : "170"},
{"Row" : 55, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VORICONAZOLE PO", "DisplayText" : "Voriconazole PO", "Text" : "Voriconazole PO", "Mnemonic" : "172"},
{"Row" : 56, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP ZANAMIVIR INH", "DisplayText" : "Zanamivir INH", "Text" : "Zanamivir INH", "Mnemonic" : "174"},
{"Row" : 33, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PAROMOMYCIN PO", "DisplayText" : "Paromomycin PO", "Text" : "Paromomycin PO", "Mnemonic" : "131"},
{"Row" : 39, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIFABUTIN PO", "DisplayText" : "Ribabutin PO", "Text" : "Rifabutin PO", "Mnemonic" : "141"},
{"Row" : 53, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ETHAMBUTOL PO", "DisplayText" : "Ethambutol PO", "Text" : "Ethambutol PO", "Mnemonic" : "93"},
{"Row" : 11, "Column" : 2, "Item" : "ORZID2 GMENU IDP FLUCYTOSINE PO", "DisplayText" : "Flucytosine PO", "Text" : "Flucytosine PO", "Mnemonic" : "97"},
{"Row" : 30, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NITAZOXANIDE PO", "DisplayText" : "Nitazoxanide PO", "Text" : "Nitazoxanide PO", "Mnemonic" : "127"},
{"Row" : 17, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IODOQUINOL PO", "DisplayText" : "Iodoquinol PO", "Text" : "Iodoquinol PO", "Mnemonic" : "107"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ALBENDAZOLE PO", "DisplayText" : "Albendazole PO", "Text" : "Albendazole PO", "Mnemonic" : "11"},
{"Row" : 26, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MOXIFLOX PO", "DisplayText" : "Moxifloxacin PO", "Text" : "Moxifloxacin PO", "Mnemonic" : "122"},
{"Row" : 27, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MOXIFL IV", "DisplayText" : "Moxifloxacin IV", "Text" : "Moxifloxacin IV", "Mnemonic" : "123"}
]},
{"Name" : "ORZID2 GMENU ABX DUKE CRITERIA", "DisplayText" : "Modified Duke Diagnostic Criteria ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "04"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "MODIFIED DUKE DIAGNOSTIC CRITERIA"}, 
{"Row" : 10, "Column" : 1, "Text" : "The Duke criteria are used to diagnose endocarditis on clinical grounds."}, 
{"Row" : 11, "Column" : 1, "Text" : "Endocarditis may also be diagnosed by pathology results."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX DUKE LISTING", "DisplayText" : "Duke Diagnostic Criteria Listing", "Text" : "Duke Criteria Diagnostic Listing", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Requirements for DEFINITE diagnosis of endocarditis", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : ">>  Two major criteria <OR>"}, 
{"Row" : 20, "Column" : 1, "Text" : ">>  One major criterion and three minor criteria <OR>"}, 
{"Row" : 21, "Column" : 1, "Text" : ">>  Five minor criteria"}, 
{"Row" : 23, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Requirements for POSSIBLE diagnosis of endocarditis", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : ">>  One major criterion and one minor criterion <OR>"}, 
{"Row" : 28, "Column" : 1, "Text" : ">>  Three minor criteria"}, 
{"Row" : 30, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Requirements for REJECTION of diagnosis of endocarditis", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : ">>  Firm alternative diagnosis explaining evidence of endocarditis <OR>"}, 
{"Row" : 35, "Column" : 1, "Text" : ">>  Resolution of endocarditis syndrome with antibiotic therapy for less than 4"}, 
{"Row" : 36, "Column" : 1, "Text" : "days <OR>"}, 
{"Row" : 37, "Column" : 1, "Text" : ">>  No pathological evidence of endocarditis at surgery or autopsy, with"}, 
{"Row" : 38, "Column" : 1, "Text" : "antibiotic therapy for less than 4 days <OR>"}, 
{"Row" : 39, "Column" : 1, "Text" : ">>  Does not meet criteria for possible endocarditis as above."}, 
{"Row" : 42, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 43, "Column" : 1, "Text" : "Baddour LM et al.  Circulation 2005, 111: 3167"}, 
{"Row" : 4, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU ABX DUKE LISTING", "DisplayText" : "Duke Diagnostic Criteria Listing  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "04"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "MAJOR criteria", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : ">  Blood culture positive", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Typical endocarditis microorganisms: viridans streptococci,"}, 
{"Row" : 15, "Column" : 1, "Text" : "Streptococcus bovis, \"HACEK\" group organisms (Haemophilus"}, 
{"Row" : 16, "Column" : 1, "Text" : "parainfluenzae, Haemophilus aphrophilus, Haemophilus"}, 
{"Row" : 17, "Column" : 1, "Text" : "paraphrophilus, Haemophilus influenzae, Actinobacillus"}, 
{"Row" : 18, "Column" : 1, "Text" : "actinomycetemcomitans, Cardiobacterium hominis, Eikenella"}, 
{"Row" : 19, "Column" : 1, "Text" : "corrodens, Kingella kingae and Kingella denitrificans),"}, 
{"Row" : 20, "Column" : 1, "Text" : "Staphylococcus aureus or community-acquired enterococci in the"}, 
{"Row" : 21, "Column" : 1, "Text" : "absence of a primary focus  <OR>"}, 
{"Row" : 23, "Column" : 1, "Text" : "* Persistently positive blood cultures"}, 
{"Row" : 24, "Column" : 1, "Text" : "Microorganisms compatible with endocarditis, such as Staphylococcus"}, 
{"Row" : 25, "Column" : 1, "Text" : "aureus, Enterococcus,Streptococcus species, Enterobacteriaceae,"}, 
{"Row" : 26, "Column" : 1, "Text" : "Pseudomonas, or Candida species from persistently positive blood"}, 
{"Row" : 34, "Column" : 1, "Text" : "* Single culture positive for Coxiella burnetti"}, 
{"Row" : 36, "Column" : 1, "Text" : ">  Echocardiogram positive for endocarditis", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "* An echodense, intracardiac mass attached to valve or supporting"}, 
{"Row" : 39, "Column" : 1, "Text" : "structures, in the path of regurgitant jets, or a mass present on"}, 
{"Row" : 40, "Column" : 1, "Text" : "implanted material in the absence of an alternative anatomic"}, 
{"Row" : 41, "Column" : 1, "Text" : "explanation <OR>"}, 
{"Row" : 43, "Column" : 1, "Text" : "* Paravalvular abscess <OR>"}, 
{"Row" : 45, "Column" : 1, "Text" : "* New partial dehiscence of prosthetic valve or new valvular"}, 
{"Row" : 46, "Column" : 1, "Text" : "regurgitation (worsening or changing or preexisting murmur is not"}, 
{"Row" : 47, "Column" : 1, "Text" : "sufficient for a major criterion)"}, 
{"Row" : 49, "Column" : 1, "Text" : "* Transesphophageal echocardiograph (TEE) is recommended for"}, 
{"Row" : 50, "Column" : 1, "Text" : "patients with prosthetic valves. Transthoracic echocardiograph"}, 
{"Row" : 51, "Column" : 1, "Text" : "(TTE) is often adequate for patients suspected of having native"}, 
{"Row" : 52, "Column" : 1, "Text" : "valve endocarditis, especially on the aortic valve, but TEE may"}, 
{"Row" : 53, "Column" : 1, "Text" : "be needed for these patients as well.  Contact cardiology for"}, 
{"Row" : 54, "Column" : 1, "Text" : "more information."}, 
{"Row" : 56, "Column" : 1, "Text" : "___________________________________________", "Header" : 1}, 
{"Row" : 58, "Column" : 1, "Text" : "___________________________________________", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "MINOR criteria", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "* Echocardiographic evidence for endocarditis, defined as"}, 
{"Row" : 60, "Column" : 1, "Text" : ">  Predisposing heart condition or intravenous drug user", "Header" : 1}, 
{"Row" : 62, "Column" : 1, "Text" : ">  Fever", "Header" : 1}, 
{"Row" : 63, "Column" : 1, "Text" : "Temperature over 38 degree Celsius (100.4 degree Fahreinheit)"}, 
{"Row" : 65, "Column" : 1, "Text" : ">  Vascular phenomena", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Text" : "Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm,"}, 
{"Row" : 67, "Column" : 1, "Text" : "intracranial hemorrhage, conjunctival hemorrhages, or Janeway's"}, 
{"Row" : 68, "Column" : 1, "Text" : "lesions"}, 
{"Row" : 70, "Column" : 1, "Text" : ">  Immunologic phenomena", "Header" : 1}, 
{"Row" : 71, "Column" : 1, "Text" : "Glomerulonephritis, Osler's nodes, Roth's spots, or rheumatoid factor"}, 
{"Row" : 73, "Column" : 1, "Text" : ">  Microbiological evidence", "Header" : 1}, 
{"Row" : 79, "Column" : 1, "Text" : ">  Echocardiographic evidence", "Header" : 1}, 
{"Row" : 80, "Column" : 1, "Text" : "Echocardiographic evidence that is consistent with endocarditis, but"}, 
{"Row" : 81, "Column" : 1, "Text" : "doesn't meet a major criterion."}, 
{"Row" : 27, "Column" : 1, "Text" : "cultures defined as follows:"}, 
{"Row" : 28, "Column" : 1, "Text" : "* At least two positive cultures of blood samples drawn at"}, 
{"Row" : 29, "Column" : 1, "Text" : "least 12 hours apart, <OR>"}, 
{"Row" : 30, "Column" : 1, "Text" : "* Three of three, or a majority of four or more separate"}, 
{"Row" : 31, "Column" : 1, "Text" : "cultures of blood (with first and last sample drawn at least"}, 
{"Row" : 32, "Column" : 1, "Text" : "one hour apart)"}, 
{"Row" : 74, "Column" : 1, "Text" : "A case with a positive blood culture, but with results that don't meet"}, 
{"Row" : 75, "Column" : 1, "Text" : "the blood culture criteria listed above.  A single positive culture"}, 
{"Row" : 76, "Column" : 1, "Text" : "for coagulase-negative staphylococci or cultures yielding organisms"}, 
{"Row" : 77, "Column" : 1, "Text" : "that do not cause endocarditis."}, 
{"Row" : 84, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 85, "Column" : 1, "Text" : "Baddour LM et al.  Circulation 2005, 111: 3167"}, 
{"Row" : 13, "Column" : 1, "Text" : "* 2 separate blood culture results of"}, 
{"Row" : 4, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU ABX E COLI INFECT", "DisplayText" : "Diarrhea with Enterohemorrhagic E. coli ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Text" : "Enterohemorrhagic E. coli disease is usually associated with bloody diarrhea."}, 
{"Row" : 15, "Column" : 1, "Text" : "It is more common in people who have eaten raw hamburger and seed sprouts."}, 
{"Row" : 17, "Column" : 1, "Text" : "When E. coli predominates in a stool culture, the microbiology laboratory will"}, 
{"Row" : 18, "Column" : 1, "Text" : "determine if the E. coli are O157:H7.  If they are, this will be reported.  If"}, 
{"Row" : 19, "Column" : 1, "Text" : "not, the report will read \"normal flora.\"  If enterohemorrhagic E. coli are"}, 
{"Row" : 20, "Column" : 1, "Text" : "suspected, the microbiology laboratory should be notified so that further"}, 
{"Row" : 21, "Column" : 1, "Text" : "testing can be done."}, 
{"Row" : 23, "Column" : 1, "Text" : "Do not use antimotility or antimicrobial agents as they often increase exposure"}, 
{"Row" : 24, "Column" : 1, "Text" : "to shiga-toxin and increase the risk of hemolytic uremia syndrome (HUS)."}, 
{"Row" : 27, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Diarrhea with Enterohemorrhagic Escherichia Coli/ Shiga Toxin-Producing", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Escherichia Coli (STEC)", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 30, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 35, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX ELEMENTS OF CDSS ADVICE PAGE", "DisplayText" : "Elements of a CDSS Advice Page ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL VISN 23 ANTIMICROBIAL CDSS", "DisplayText" : "VISN 23 Antimicrobial CDSS mailgroup", "Text" : "Contact CDSS project staff", "Mnemonic" : "02"},
{"Row" : 5, "Column" : 1, "Text" : "ELEMENTS OF A CDSS ADVICE PAGE"}, 
{"Row" : 7, "Column" : 1, "Text" : "Advice pages are comprised of the following elements:"}, 
{"Row" : 9, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "TYPICALLY present on an advice page", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "1.  Diagnosis or condition label-centered at the top of each advice page."}, 
{"Row" : 15, "Column" : 1, "Text" : "2.  Treatment.  Empirical treatment as well as treatment for selected pathogens"}, 
{"Row" : 16, "Column" : 1, "Text" : "is presented with links to antimicrobial quick orders unless stated otherwise."}, 
{"Row" : 17, "Column" : 1, "Text" : "In addition to the drug, dose, and route, each quick order text includes the"}, 
{"Row" : 18, "Column" : 1, "Text" : "drug's approximate cost per day and coding for important drug properties of"}, 
{"Row" : 19, "Column" : 1, "Text" : "note. Drugs clustered together are considered equivalent."}, 
{"Row" : 21, "Column" : 1, "Text" : "3.  Help.  At the top of the each advice page.  There are links to a variety"}, 
{"Row" : 22, "Column" : 1, "Text" : "of resources (susceptibilities, important drug properties, section-specific"}, 
{"Row" : 23, "Column" : 1, "Text" : "consults, etc.)."}, 
{"Row" : 25, "Column" : 1, "Text" : "4.  References.  At the bottom on each advice page.  These are link key"}, 
{"Row" : 26, "Column" : 1, "Text" : "references for the recommendation s on the page."}, 
{"Row" : 28, "Column" : 1, "Text" : "5.  Review date.  The expert panel review date is noted at the bottom of"}, 
{"Row" : 29, "Column" : 1, "Text" : "the page."}, 
{"Row" : 31, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "DISCRETIONARY advice page components", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "1.  (Treatment) Alternative.  Following the (preferred) Treatment section with"}, 
{"Row" : 36, "Column" : 1, "Text" : "quick orders for common alternative antimicrobials. Antimicrobial listed under"}, 
{"Row" : 37, "Column" : 1, "Text" : "each alternative header are equivalents among those listed.  A broader selection"}, 
{"Row" : 38, "Column" : 1, "Text" : "of medications can be accessed through the \"Need an alternative\" page within the"}, 
{"Row" : 39, "Column" : 1, "Text" : "help section.  For some conditions we recommend alternative antimicrobials when"}, 
{"Row" : 40, "Column" : 1, "Text" : "recommended drugs are not suitable for an individual patient.  Unless otherwise"}, 
{"Row" : 41, "Column" : 1, "Text" : "stated drugs clustered together under \"Alternatives\" are considered equivalent."}, 
{"Row" : 43, "Column" : 1, "Text" : "If none of the recommended or alternative drugs is suitable you can find more"}, 
{"Row" : 44, "Column" : 1, "Text" : "drugs by clicking on the \"Need an alternative\" link at the top of the page."}, 
{"Row" : 46, "Column" : 1, "Text" : "2.  Consults.  At the top of the page, these are consultation requests pertinent"}, 
{"Row" : 47, "Column" : 1, "Text" : "to the clinical problem addressed by the page.  Links to context-specific"}, 
{"Row" : 48, "Column" : 1, "Text" : "consults can be found on advice pages, as appropriate.  For example, the herpes"}, 
{"Row" : 49, "Column" : 1, "Text" : "simplex encephalitis page contains a link to q request for neurology consult."}, 
{"Row" : 51, "Column" : 1, "Text" : "3.  Resources.  Pertinent to the clinical problem and addressed by the page"}, 
{"Row" : 52, "Column" : 1, "Text" : "is provided for example.  For some pages, supplemental resources have been"}, 
{"Row" : 53, "Column" : 1, "Text" : "identified (e.g., PORT score calculator for Community Aquired Pneumonia,"}, 
{"Row" : 54, "Column" : 1, "Text" : "diagnostic tools, Epidemiology, etc.) the information is included on the advice"}, 
{"Row" : 55, "Column" : 1, "Text" : "page."}
]},
{"Name" : "ORZID2 GMENU ABX ENTAMOEBA HISTOLYTICA", "DisplayText" : "Entoemeba histolytica ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : ">>  Treatment for INTESTINAL", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH ENTAMOEBA HISTOLYTICA"}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJUZID METRONIDAZOLE 750MG 7 DAYS THEN PAROMOMYCIN 7 DAYS", "DisplayText" : "Metronidaolze 750MG Q8H 7 DAYS THEN Paromomycin 25-35MG/KG 7 DAYS", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "UpToDate. Intestinal Entamoeba histolytica amebiasis. Last updated 11/06/17."}, 
{"Row" : 20, "Column" : 1, "Text" : "Sanford Guide- web edition \"Amebiasis, Entamoeba histolytica\""}, 
{"Row" : 21, "Column" : 1, "Text" : "Last accessed 12/12/17"}, 
{"Row" : 25, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX EPIDIDYMITIS", "DisplayText" : "Epididymitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 13, "Column" : 1, "Text" : "Most cases in men under age 35 are associated with N. gonorrhoeae and  C."}, 
{"Row" : 14, "Column" : 1, "Text" : "trachomatis.  Most cases in older men are associated with enteric Gram negative"}, 
{"Row" : 15, "Column" : 1, "Text" : "rods.  Management should include bed rest, analgesics, and  scrotal elevation."}, 
{"Row" : 16, "Column" : 1, "Text" : "Older men should have their residual urinary volume checked.  If the residual"}, 
{"Row" : 17, "Column" : 1, "Text" : "volume is elevated, the patient should be seen by a urologist as epididymitis is"}, 
{"Row" : 18, "Column" : 1, "Text" : "unlikely to respond if the prostate is blocking the vas deferens."}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment in men <= 35 years or for cases associated with gonococci or chlamydia", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Treatment in men > 35 years (except for cases with gonococci or Chlamydia)", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 11, "Column" : 1, "Text" : "EPIDIDYMITIS"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 250MG IM ONCE DOXYCL 100MG PO Q12H", "DisplayText" : "CEFTRIAXONE 250MG IM ONCE DOXYCL 100MG PO Q12H", "Text" : "Ceftriaxone 250 mg IM once ($16.71/day) [M] <AND> doxycycline 100 mg PO q12h", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Text" : "for 10 days ($0.15/day) [D,I]"}, 
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" keyword: Epididymitis"}, 
{"Row" : 33, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "20"}
]},
{"Name" : "ORZID2 GMENU ABX GENITAL HERPES", "DisplayText" : "Genital herpes  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT DOWNTOWN-INPT", "DisplayText" : "Fee Basis (Downtown Inpatient)", "Text" : "Need help with Dermatology?  Consult Dermatology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GENITAL HERPES"}, 
{"Row" : 12, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Initial treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment of the initial episode decreases the duration of pain, lesions, and"}, 
{"Row" : 18, "Column" : 1, "Text" : "viral shedding by 1 to 2 days.  Treatment of the initial episode does not"}, 
{"Row" : 19, "Column" : 1, "Text" : "decrease likelihood of recurrent episodes.  Treat for 10 days."}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h ($0.29/day) [R]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h ($9/day) [R]", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "Episodic therapy for relapses", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Treatment of recurrent episodes must be started within 24 hours of symptom"}, 
{"Row" : 29, "Column" : 1, "Text" : "onset.  Treatment decreases the duration of pain and lesions, and viral shedding"}, 
{"Row" : 30, "Column" : 1, "Text" : "by 1 to 2 days.  Consider suppressive treatment for patients with more than 6"}, 
{"Row" : 31, "Column" : 1, "Text" : "episodes per year."}, 
{"Row" : 33, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h for 5 days ($0.29/day) [R]  < OR >", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 800MG PO TID", "DisplayText" : "Acyclovir 800MG PO TID", "Text" : "Acyclovir 800 mg PO q8h for 2 days ($0.58/day) [R]  < OR >", "Mnemonic" : "18"},
{"Row" : 37, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 500MG PO BID", "DisplayText" : "Valacyclovir 500MG PO BID", "Text" : "Valacyclovir 500 mg PO q12h for 3 days ($4/day) [R]", "Mnemonic" : "20"},
{"Row" : 39, "Column" : 1, "Text" : "Chronic therapy for suppression of symptomatic episodes", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Suppressive therapy is indicated in patients with more than 6 episodes per year."}, 
{"Row" : 41, "Column" : 1, "Text" : "Suppressive therapy is optional, and some patients may find episodic treatment"}, 
{"Row" : 42, "Column" : 1, "Text" : "more convenient.  The frequency of recurrences usually decreases after 1 to 5"}, 
{"Row" : 43, "Column" : 1, "Text" : "years, and suppressive therapy should be stopped every few years to see if it is"}, 
{"Row" : 44, "Column" : 1, "Text" : "still needed."}, 
{"Row" : 46, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO BID", "DisplayText" : "Acyclovir 400MG PO BID", "Text" : "Acyclovir 400 mg PO q12h ($0.19/day) [R]", "Mnemonic" : "22"},
{"Row" : 48, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 500MG PO Q24H", "DisplayText" : "Valacyclovir 500MG PO Q24H", "Text" : "Valacyclovir 500 mg PO Q24h ($4/day) [R]", "Mnemonic" : "24"},
{"Row" : 54, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 58, "Column" : 1, "Text" : "Immunocompromised patients in whom genital herpes simplex disease is often"}, 
{"Row" : 59, "Column" : 1, "Text" : "severe include: patients with HIV infection, organ transplants, malnourishment,"}, 
{"Row" : 62, "Column" : 1, "Text" : "Treatment for mild to moderate disease", "Header" : 1}, 
{"Row" : 63, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 64, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h ($0.29/day) [R]", "Mnemonic" : "26"},
{"Row" : 66, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 67, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h ($9/day) [R]", "Mnemonic" : "28"},
{"Row" : 69, "Column" : 1, "Text" : "Treatment for severe disease", "Header" : 1}, 
{"Row" : 72, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 5MG/KG IV Q8H", "DisplayText" : "Acyclovir 5 mg/kg IV Q8H", "Text" : "Acyclovir 5mg/kg IV q8h ($85/day) [R]", "Mnemonic" : "30"},
{"Row" : 75, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "32"},
{"Row" : 60, "Column" : 1, "Text" : "eczema or severe burns, and in patients receiving immunosuppressive"}, 
{"Row" : 70, "Column" : 1, "Text" : "Infectious Diseases consult encouraged."}, 
{"Row" : 71, "Column" : 1, "Text" : "Treat for 7 days."}, 
{"Row" : 77, "Column" : 1, "Text" : "\"Mandell\" chapter: Herpes simplex virus"}, 
{"Row" : 78, "Column" : 1, "Text" : "\"Sanford\" keyword: Herpes simplex"}, 
{"Row" : 51, "Column" : 1, "Text" : "For a patient with more than 9 episodes per year", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1000 MG PO Q24H", "DisplayText" : "VALACYCLOVIR 1000 MG PO Q24h", "Text" : "Valacyclovir 1000 mg PO Q24h ($4/day) [R]", "Mnemonic" : "25"}
]},
{"Name" : "ORZID2 GMENU ABX GIARDIA", "DisplayText" : "Diarrhea with Giardia lamblia  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH GIARDIA LAMBLIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment is only necessary when the patient has symptoms attributable to"}, 
{"Row" : 13, "Column" : 1, "Text" : "giardiasis."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID NITAZOXANIDE 500MG PO Q12H 3 DAYS", "DisplayText" : "Nitazoxanide 500MG PO Q12H 3 DAYS", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID METRONIDAZOLE 250MG PO Q8H 7 DAYS", "DisplayText" : "Metronidazole 250MG PO Q8H 7 DAYS", "Text" : ""},
{"Row" : 25, "Column" : 1, "Text" : "UpToDate. Giardiasis: Treatment and prevention. Last updated 11/30/17."}, 
{"Row" : 27, "Column" : 1, "Text" : "Sanford Guide- web edition \"Giardia duodenalis (G. intestinalis,"}, 
{"Row" : 28, "Column" : 1, "Text" : "G. lamblia)\" Last accessed 12/12/17."}, 
{"Row" : 30, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 31, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 35, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX GONOCOCCAL", "DisplayText" : "Gonococcal Urethritis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "GONOCOCCAL URETHRITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZID CEFTRIAXONE 250MG IM & AZITHROMYCIN 1GM PO", "DisplayText" : "Azithromycin 1GM PO ONCE & Ceftriaxone 250MG IM ONCE", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : ""},
{"Row" : 20, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "CDC. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Morbidity"}, 
{"Row" : 23, "Column" : 1, "Text" : "and Mortality Weekly Report. 2015:64(3):51-64."}
]},
{"Name" : "ORZID2 GMENU ABX HEPATITIS A", "DisplayText" : "Hepatitis A  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 7, "Column" : 1, "Text" : "HEPATITIS A"}, 
{"Row" : 9, "Column" : 1, "Text" : "Disease Management", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Most acute disease is self-limited, and the virus does not cause chronic"}, 
{"Row" : 11, "Column" : 1, "Text" : "disease.  No specific antiviral therapy is available."}, 
{"Row" : 13, "Column" : 1, "Text" : "Patients who appear to be developing fulminant hepatitis, including those with"}, 
{"Row" : 14, "Column" : 1, "Text" : "mental status changes should receive supportive treatment.  Fulminant hepatitis"}, 
{"Row" : 15, "Column" : 1, "Text" : "is suggested by increased prothrombin time, cholestasis, ascites, decreased"}, 
{"Row" : 16, "Column" : 1, "Text" : "liver size, or decreasing serum albumin.  Supportive treatment includes"}, 
{"Row" : 17, "Column" : 1, "Text" : "maintenance of fluid and electrolyte balance, monitoring and possible correction"}, 
{"Row" : 18, "Column" : 1, "Text" : "of coagulation defects, treatment of hepatic encephalopathy, and good nutrition"}, 
{"Row" : 19, "Column" : 1, "Text" : "with a low-protein diet."}, 
{"Row" : 21, "Column" : 1, "Text" : "Prevention for persons with continuing high risk of disease", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Vaccine should be offered to persons at high risk of hepatitis A infection: men"}, 
{"Row" : 23, "Column" : 1, "Text" : "who have sex with men, travelers to endemic areas likely to be exposed, illegal"}, 
{"Row" : 24, "Column" : 1, "Text" : "drug users, persons at occupational risk of disease, persons with chronic liver"}, 
{"Row" : 25, "Column" : 1, "Text" : "disease or clotting factor disorders."}, 
{"Row" : 29, "Column" : 1, "Text" : "Prevention for persons with a specific, defined exposure", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Post-exposure prophylaxis should be offered to persons with substantial exposure"}, 
{"Row" : 31, "Column" : 1, "Text" : "to hepatitis A.  Specifically, persons exposed to acute hepatitis through"}, 
{"Row" : 32, "Column" : 1, "Text" : "household or sexual contact, persons who attend or work in a day care center"}, 
{"Row" : 33, "Column" : 1, "Text" : "with a recent case, or employee or patron of a restaurant with a food handler"}, 
{"Row" : 34, "Column" : 1, "Text" : "with hepatitis. Post exposure prophylaxis must be given within 2 weeks of"}, 
{"Row" : 35, "Column" : 1, "Text" : "exposure.  Vaccine can be given at the same time as immune-globulin."}, 
{"Row" : 37, "Column" : 1, "Text" : "Give Immune globulin 0.02 ml/kg IM x 1 <AND>"}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 27, "Column" : 1, "Text" : "Give Hepatitis A vaccine 1 ml IM x 2, separated by 6 to 12 months"}, 
{"Row" : 38, "Column" : 1, "Text" : "Give Hepatitis A vaccine 1 ml IM x 2, separated by 6 to 12 months"}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gasroenterology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 43, "Column" : 1, "Text" : "\"Mandell\" chapter: Acute viral hepatitis"}, 
{"Row" : 44, "Column" : 1, "Text" : "Up-to-date accessed 8/02/11"}
]},
{"Name" : "ORZID2 GMENU ABX HEPATITIS B", "DisplayText" : "Hepatitis B  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 8, "Column" : 1, "Text" : "HEPATITIS B"}, 
{"Row" : 10, "Column" : 1, "Text" : "Acute disease management", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Most acute hepatitis B disease is mild and self-limited.  Patients who appear to"}, 
{"Row" : 12, "Column" : 1, "Text" : "be developing fulminant hepatitis, including those with mental status changes"}, 
{"Row" : 13, "Column" : 1, "Text" : "should receive supportive treatment.  Fulminant hepatitis is suggested by"}, 
{"Row" : 14, "Column" : 1, "Text" : "increased prothrombin time, cholestasis, ascites, decreased liver size, or"}, 
{"Row" : 15, "Column" : 1, "Text" : "decreasing serum albumin.  Supportive treatment includes maintenance of fluid"}, 
{"Row" : 16, "Column" : 1, "Text" : "and electrolyte balance, monitoring and possible correction of coagulation"}, 
{"Row" : 17, "Column" : 1, "Text" : "defects, treatment of hepatic encephalopathy, and good nutrition with a low-"}, 
{"Row" : 18, "Column" : 1, "Text" : "protein diet. Antiviral therapy is not indicated.  Gastroenterology consult"}, 
{"Row" : 19, "Column" : 1, "Text" : "encouraged."}, 
{"Row" : 21, "Column" : 1, "Text" : "Chronic disease management", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Antiviral therapy for chronic hepatitis B is a complicated, highly specialized"}, 
{"Row" : 23, "Column" : 1, "Text" : "task. Consult with gastroenterology and infectious disease."}, 
{"Row" : 25, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Vaccinate persons at high risk of disease including men who have sex with men,"}, 
{"Row" : 27, "Column" : 1, "Text" : "illegal drug users, and health care workers with substantial exposure to blood"}, 
{"Row" : 28, "Column" : 1, "Text" : "or body fluids."}, 
{"Row" : 29, "Column" : 1, "Text" : "Give Hepatitis B vaccine 1 dose IM in deltoid at 0, then 1 or 2 months, and"}, 
{"Row" : 30, "Column" : 1, "Text" : "again at 4 to 6 months."}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 35, "Column" : 1, "Text" : "\"Mandell\" chapter: Acute viral hepatitis"}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Mandell\" chapter: Chronic viral hepatitis"}, 
{"Row" : 37, "Column" : 1, "Text" : "Up-to-date accessed 8/02/11"}
]},
{"Name" : "ORZID2 GMENU ABX HEPATITIS C", "DisplayText" : "Hepatitis C  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 7, "Column" : 1, "Text" : "HEPATITIS C"}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment of acute disease", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Most acute disease is asymptomatic or mild.  Patients with acute hepatitis C"}, 
{"Row" : 11, "Column" : 1, "Text" : "should be referred to the Hepatitis C clinic.  Treatment may be indicated for"}, 
{"Row" : 12, "Column" : 1, "Text" : "disease that persists beyond 2 months"}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZ LIVER WELLNESS CLINIC CONSULT", "DisplayText" : "Liver Wellness", "Text" : "Hepatitis C clinic referral", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "Chronic disease treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Antiviral therapy for chronic hepatitis C is a complicated, highly specialized"}, 
{"Row" : 18, "Column" : 1, "Text" : "task.  Refer to the Hepatitis C clinic."}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gastroenterology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 23, "Column" : 1, "Text" : "\"Mandell\" chapter: Acute viral hepatitis"}, 
{"Row" : 24, "Column" : 1, "Text" : "\"Mandell\" chapter: Chronic viral hepatitis"}, 
{"Row" : 25, "Column" : 1, "Text" : "Strader D  Hepatol 2004, 39: 1147"}, 
{"Row" : 26, "Column" : 1, "Text" : "Up-to-date accessed 8/02/11"}
]},
{"Name" : "ORZID2 GMENU ABX HERPES WHITLOW", "DisplayText" : "Herpes Whitlow  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT DOWNTOWN-INPT", "DisplayText" : "Fee Basis (Downtown Inpatient)", "Text" : "Need help with Dermatology?  Consult Dermatology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "HERPES WHITLOW (DIGIT OR HAND CELLULITIS)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h ($0.29/day) [R]", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Text" : "Alternative for easier compliance schedule", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h ($9/day) [R]", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "\"Mandell\" chapter: Herpes simplex virus"}, 
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" keyword: Whitlow, herpetic"}
]},
{"Name" : "ORZID2 GMENU ABX IDP ACYCL IV", "DisplayText" : "Acyclovir IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Acyclovir IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "10 mg/kg IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Confusion, anxiety, somnolence, renal impairment (especially in patients who are"}, 
{"Row" : 27, "Column" : 1, "Text" : "inadequately hydrated), thrombotic thrombocytopenic purpura/hemolytic uremic"}, 
{"Row" : 28, "Column" : 1, "Text" : "syndrome (especially in immunocompromised patients)."}, 
{"Row" : 17, "Column" : 1, "Text" : "25-50Give usual dose q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-24Give usual dose q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10  Give 50% of usual dose q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis Give 50% of usual dose q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP ACYCLOVIR PO", "DisplayText" : "Acyclovir PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Acyclovir PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-800 mg PO TID to 5x/day"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Nausea, vomiting, and diarrhea."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-25  Give 50% of the usual dose"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 Give 33% of the usual dose"}, 
{"Row" : 19, "Column" : 1, "Text" : "HemodialysisGive 33% of the usual dose"}
]},
{"Name" : "ORZID2 GMENU ABX IDP ALBENDAZOLE PO", "DisplayText" : "Albendazole PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Albendazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea, vomiting, headache, rare blood dyscrasias, rare hepatotoxicity, rare"}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMANTADINE PO", "DisplayText" : "Amantadine PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amantadine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients who are 65 years of age or older give 100 mg PO once daily."}, 
{"Row" : 17, "Column" : 1, "Text" : "Regardless of age:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "< 15200 mg every 7 days"}, 
{"Row" : 24, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Dizziness, hallucinations, nervousness, CNS stimulation, nausea, increased"}, 
{"Row" : 29, "Column" : 1, "Text" : "seizure risk in patients with a history of seizures."}, 
{"Row" : 22, "Column" : 1, "Text" : "Hemodialysis  200 mg every 7 days"}, 
{"Row" : 20, "Column" : 1, "Text" : "15-29 200 mg on first day then 100 every other day"}, 
{"Row" : 19, "Column" : 1, "Text" : "30-50 200 mg on day one, then 100 mg daily."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMBISOME IV", "DisplayText" : "Ambisome IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ambisome IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "3 to 5 mg/kg q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "The dosing for ambisome and other lipid-associated amphotericin products are"}, 
{"Row" : 16, "Column" : 1, "Text" : "DIFFERENT than the dosing for conventional amphotericin B."}, 
{"Row" : 18, "Column" : 1, "Text" : "Dose in consultation with an infectious disease physician, according to response"}, 
{"Row" : 19, "Column" : 1, "Text" : "of infection and patient tolerance."}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Corticosteroids can potentiate hypokalemia caused by amphotericin products."}, 
{"Row" : 23, "Column" : 1, "Text" : "Potassium concentrations should be monitored during amphotericin therapy."}, 
{"Row" : 24, "Column" : 1, "Text" : "amphotericin and digoxin are used concurrently.  Potassium and digoxin"}, 
{"Row" : 25, "Column" : 1, "Text" : "concentrations should be monitored during amphotericin."}, 
{"Row" : 27, "Column" : 1, "Text" : "Azole antifungal agents and amphotericin have displayed antagonistic effects in"}, 
{"Row" : 28, "Column" : 1, "Text" : "vitro.  They should generally not be used concurrently except under the care of"}, 
{"Row" : 29, "Column" : 1, "Text" : "an infectious disease specialist."}, 
{"Row" : 31, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Infusion reactions, hypotension, renal failure, electrolyte abnormalities occur,"}, 
{"Row" : 33, "Column" : 1, "Text" : "but at a lower rate than with conventional amphotericin B.  Slowing the infusion"}, 
{"Row" : 34, "Column" : 1, "Text" : "rate may prevent some infusion reactions."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMIK DOSING TABLE", "DisplayText" : "Amikacin Dosing Table ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Website", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amikacin Dosing Table", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 16, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 18, "Column" : 1, "Text" : "infection -  q24hrecommended recommended  established< 5"}, 
{"Row" : 19, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 20, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 21, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 11, "Column" : 1, "Text" : "IndicationDose for  Dose for Dose for  Desired Desired", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "creatininecreatinine  creatininepeak  trough", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "clearance clearance  clearance(mcg/ml) (mcg/ml)", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "negative15 mg/kg Not  Not Not"}, 
{"Row" : 14, "Column" : 1, "Text" : ">50 ml/min10-50 ml/min<10 ml/min", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 23, "Column" : 1, "Text" : "negative 7.5 mg/kg  2.3-5.3 1.5-2.3"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection -  q12h mg/kg mg/kg  20-30  < 2"}, 
{"Row" : 25, "Column" : 1, "Text" : "multiple q12-18hq24-48h"}, 
{"Row" : 26, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 27, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 28, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 29, "Column" : 1, "Text" : "tract 15 mg/kgNot  NotNot"}, 
{"Row" : 30, "Column" : 1, "Text" : "infection - q24h recommended recommended  established< 5"}, 
{"Row" : 31, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 32, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 33, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 34, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 35, "Column" : 1, "Text" : "tract7.5 mg/kg2.3-5.3 1.5-2.3"}, 
{"Row" : 36, "Column" : 1, "Text" : "infection -  q12hmg/kg mg/kg  15-20< 4"}, 
{"Row" : 37, "Column" : 1, "Text" : "multiple  q12-18h  q24-48h"}, 
{"Row" : 38, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 39, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 41, "Column" : 1, "Text" : "Pharmacy at MVAMC will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 42, "Column" : 1, "Text" : "Call a pharmacist at x3128 for more information."}, 
{"Row" : 44, "Column" : 1, "Text" : "Once daily dosing may be an option for many indications in patients with"}, 
{"Row" : 45, "Column" : 1, "Text" : "creatinine clearance of greater than 50 ml/min.  The dose is 15 mg/kg IV q24h."}, 
{"Row" : 46, "Column" : 1, "Text" : "Target trough concentrations are less than 6 mcg/ml.  Ideal peak concentrations"}, 
{"Row" : 47, "Column" : 1, "Text" : "are not established.  Order a trough concentration to be drawn prior to the 2nd"}, 
{"Row" : 48, "Column" : 1, "Text" : "dose."}, 
{"Row" : 50, "Column" : 1, "Text" : "Using multiple daily dose regimens, for a moderate to severe infection, doses"}, 
{"Row" : 51, "Column" : 1, "Text" : "should be calculated to achieve a peak concentration of 20-30 mcg/ml and a"}, 
{"Row" : 52, "Column" : 1, "Text" : "trough of 1-4 mcg/ml."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMIKACIN IV", "DisplayText" : "Amikacin IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amikacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "15-20 mg/kg QD or divided into 2 to 3 daily doses."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMIK DOSING TABLE", "DisplayText" : "Amikacin Dosing Table", "Text" : "Link to amikacin dosing table", "Mnemonic" : "08"},
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Potentiates the effects of neuromuscular blockers."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nephrotoxicity, ototoxicity, neuromuscular blockade."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMOX/CLAV PO", "DisplayText" : "Amoxicillin-clavulanate PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amoxicillin-clavulanate PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "875-125 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Diarrhea, nausea/vomiting, rash, rare anaphylaxis."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-30  250-500 mg q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 250-500 mg q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis  250-500 mg q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMOXICILLIN PO", "DisplayText" : "Amoxicillin PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amoxicillin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500-1000 mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Rash, diarrhea, nausea/vomiting, rare anaphylaxis."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-30250-500 mg q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  250-500 mg q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMPHOTERICIN B IV", "DisplayText" : "Amphotericin B IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amphotericin B IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "0.6 to 1 mg/kg q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose in consultation with an infectious disease physician, according to response"}, 
{"Row" : 16, "Column" : 1, "Text" : "of infection and patient tolerance."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Corticosteroids can potentiate hypokalemia caused by amphotericin products."}, 
{"Row" : 20, "Column" : 1, "Text" : "Potassium concentrations should be monitored during amphotericin therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Low potassium concentrations can contribute to digoxin toxicity when"}, 
{"Row" : 23, "Column" : 1, "Text" : "amphotericin and digoxin are used concurrently.  Potassium and digoxin"}, 
{"Row" : 24, "Column" : 1, "Text" : "concentrations should be monitored during amphotericin."}, 
{"Row" : 26, "Column" : 1, "Text" : "Azole antifungal agents and amphotericin have displayed antagonistic effects in"}, 
{"Row" : 27, "Column" : 1, "Text" : "vitro.  They should generally not be used concurrently except under the care of"}, 
{"Row" : 28, "Column" : 1, "Text" : "an infectious disease specialist."}, 
{"Row" : 30, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Infusion reactions, hypotension, renal failure, electrolyte abnormalities.  Pre-"}, 
{"Row" : 32, "Column" : 1, "Text" : "medication with acetaminophen 650 mg, hydrocortisone 25 mg, and diphenhydramine"}, 
{"Row" : 33, "Column" : 1, "Text" : "50 mg  and slowing the infusion rate may prevent some infusion reactions."}, 
{"Row" : 34, "Column" : 1, "Text" : "Sodium loading with 250 ml 0.9% NaCl reduces risk of nephrotoxicity."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMPIC/SULBACT IV", "DisplayText" : "Ampicillin-sulbactam IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ampicillin-sulbactam IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1.5-3 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "15-291.5-3 gm q12h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Diarrhea, rash, rare anaphylaxis, pain at injection site."}, 
{"Row" : 18, "Column" : 1, "Text" : "5-14  1.5-3 gm q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis 1.5-3 gm q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMPICILLIN IV", "DisplayText" : "Ampicillin IV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ampicillin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q4-6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Rash, allergy, nausea, diarrhea, rare anaphylaxis, rare leukopenia, rare"}, 
{"Row" : 26, "Column" : 1, "Text" : "seizures."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-50  1-2 gm q6h-q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 1-2 gm q12-24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis1-2 gm IV after each hemodialysis"}
]},
{"Name" : "ORZID2 GMENU ABX IDP ATOVAQUONE PO", "DisplayText" : "Atovaquone PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" :"", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Atovaquone PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "750 mg PO BID-QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Rifampin may decrease atovaquone levels.  Do not use these together."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Anxiety, asthenia, rash, liver transaminase elevations."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AZITH IV", "DisplayText" : "Azithromycin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Azithromycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg IV once, then 250 mg IV QD for 4 days."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Fewer drug interactions than erythromycin and clarithromycin.  Monitor"}, 
{"Row" : 19, "Column" : 1, "Text" : "international normalized ratio (INR) frequently in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nausea, diarrhea, rare QT interval prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AZITHROMYCIN PO", "DisplayText" : "Azithromycin PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Azithromycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg PO once, then 250 mg PO QD for 4 days"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Fewer drug interactions than erythromycin and clarithromycin.  Monitor"}, 
{"Row" : 19, "Column" : 1, "Text" : "international normalized ratio (INR) frequently in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nausea, diarrhea, rare QT interval prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AZTREONAM IV", "DisplayText" : "Aztreonam IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Aztreonam IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Give usual dose for the initial dose, then maintenance doses should be adjusted"}, 
{"Row" : 16, "Column" : 1, "Text" : "as follows:"}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "10-30  50% of usual dose q8h"}, 
{"Row" : 20, "Column" : 1, "Text" : "< 10 25% of usual dosage q8h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hemodialysis25% of usual dose q8h"}, 
{"Row" : 23, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Toxic epidermal necrosis, injection site reaction, rare anaphylaxis, rare"}, 
{"Row" : 28, "Column" : 1, "Text" : "neutropenia, rare hepatotoxicity."}
]},
{"Name" : "ORZID2 GMENU ABX IDP BENZATHINE PENICILLIN IM", "DisplayText" : "Benzathine Penicillin IM ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Benzathine Penicillin (dose in million units) IM", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1.2 million units IM once"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Rash, rare anaphylaxis."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CASPOFUNGIN IV", "DisplayText" : "Caspofungin IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Caspofungin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "70 mg IV on day 1, then 50 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with mild hepatic insufficiency (Child-Pugh score 5-6), no dosing"}, 
{"Row" : 16, "Column" : 1, "Text" : "adjustment is needed. For patients with moderate hepatic insufficiency (Child-"}, 
{"Row" : 17, "Column" : 1, "Text" : "Pugh score 7-9), decrease the maintenance dose to 35 mg QD. For patients with"}, 
{"Row" : 18, "Column" : 1, "Text" : "severe hepatic insufficiency (Child-Pugh score over 9), no dosing information is"}, 
{"Row" : 19, "Column" : 1, "Text" : "available.  Consult infectious diseases for advice."}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Caspofungin levels are decreased when caspofungin is used along with  enzyme"}, 
{"Row" : 23, "Column" : 1, "Text" : "inducers (such as rifampin, carbamazepine, efavirenz, nevirapine, dexamethasone,"}, 
{"Row" : 24, "Column" : 1, "Text" : "phenytoin).  In these cases, increase the maintenance dose of caspofungin to 70"}, 
{"Row" : 25, "Column" : 1, "Text" : "mg QD."}, 
{"Row" : 27, "Column" : 1, "Text" : "Caspofungin may decrease tacrolimus levels.  Monitor tacrolimus levels when the"}, 
{"Row" : 28, "Column" : 1, "Text" : "drugs are used concurrently, as tacrolimus dose adjustments may be necessary"}, 
{"Row" : 29, "Column" : 1, "Text" : "while the patient is taking caspofungin."}, 
{"Row" : 31, "Column" : 1, "Text" : "The risk of cyclosporine toxicity is increased in patients who are also on"}, 
{"Row" : 32, "Column" : 1, "Text" : "caspofungin.  Avoid this combination."}, 
{"Row" : 34, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Infusion reactions, rash, nausea/vomiting, hepatotoxicity."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFAZOLIN IV", "DisplayText" : "Cefazolin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefazolin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:"}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-301-2 gm q12h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Slightly increased risk of bleeding with heparin, warfarin, or other"}, 
{"Row" : 23, "Column" : 1, "Text" : "anticoagulant."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Rash, rare anaphylaxis, rare blood dyscrasias."}, 
{"Row" : 18, "Column" : 1, "Text" : "<101-2 gm q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis 1-2 gm q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFEPIME IV", "DisplayText" : "Cefepime IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefepime IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-601-2 gm q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "11-291-2 gm q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Phlebitis, rash, rare anaphylaxis and at high doses, encephalopathy and"}, 
{"Row" : 25, "Column" : 1, "Text" : "seizures."}, 
{"Row" : 19, "Column" : 1, "Text" : "< 11  1 gm q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis, give 1 gm IV once, then 500 mg QD"}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFOTETAN IV", "DisplayText" : "Cefotetan IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefotetan IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-301-2 gm QD"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  1-2 gm every other day"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis  0.5 gm QD on days between dialysis AND"}, 
{"Row" : 20, "Column" : 1, "Text" : "1-2 gm pt on the day of dialysis"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Increased risk of bleeding with heparin, warfarin, or other anticoagulant."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Nausea/vomiting, elevated liver transaminase levels, rare anaphylaxis, rare"}, 
{"Row" : 27, "Column" : 1, "Text" : "bleeding, rare hemolytic anemia."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFOXITIN IV", "DisplayText" : "Cefoxitin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefoxitin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-501-2 gm q8-12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-291-2 gm q12-24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "5-9 0.5-1 gm q12-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "< 5 0.5-1 gm q24-48h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hemodialysis 0.5-1 gm q24-48 h AND"}, 
{"Row" : 22, "Column" : 1, "Text" : "1-2 gm after hemodialysis"}, 
{"Row" : 24, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Injection site pain, diarrhea, rare anaphylaxis."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTAZIDIME IV", "DisplayText" : "Ceftazidime IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftazidime IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-501-2 gm q12h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Phlebitis, rash, rare anaphylaxis, and at high doses, encephalopathy or"}, 
{"Row" : 27, "Column" : 1, "Text" : "seizures."}, 
{"Row" : 18, "Column" : 1, "Text" : "10-30 mL/min  1-2 gm q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10  1-2 gm q48-72h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis 1-2 gm q48-72h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTIZOXIME IV", "DisplayText" : "Ceftizoxime IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftizoxime IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "50-79500 mg-1.5 gm q8h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis 250-500 mg q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Fever, injection site pain, rare transient liver transaminase elevation,"}, 
{"Row" : 27, "Column" : 1, "Text" : "rare anaphylaxis."}, 
{"Row" : 18, "Column" : 1, "Text" : "5-49  250 mg-1 gm q12h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 5 250-500 mg q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTRIAX INTRAVENOUS", "DisplayText" : "Ceftriaxone IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftriaxone IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 gm IV q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Moderate increase in cyclosporine concentrations.  Monitor cyclosporine blood"}, 
{"Row" : 19, "Column" : 1, "Text" : "concentrations and the patient for signs of cyclosporine-related nephrotoxicity"}, 
{"Row" : 20, "Column" : 1, "Text" : "or neurotoxicity."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Rash, diarrhea, reversible gall bladder disease, transient increases in liver"}, 
{"Row" : 24, "Column" : 1, "Text" : "transaminases levels, rare anaphylaxis."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTRIAXONE IM", "DisplayText" : "Ceftriaxone IM  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftriaxone IM", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "125 mg IM once"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Moderate increase in cyclosporine concentrations.  Monitor cyclosporine blood"}, 
{"Row" : 19, "Column" : 1, "Text" : "concentrations and monitor the patient for signs of cyclosporine-related"}, 
{"Row" : 20, "Column" : 1, "Text" : "nephrotoxicity or neurotoxicity."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Rash, diarrhea, reversible gall bladder disease, transient increases in liver"}, 
{"Row" : 24, "Column" : 1, "Text" : "transaminase levels, rare anaphylaxis."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFUROXIME PO", "DisplayText" : "Cefuroxime PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefuroxime PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with creatinine clearance less than 10 mL/min, including patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "on hemodialysis, give 250-500 mg q24h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Diarrhea, nausea/vomiting, rare anaphylaxis, rare transient liver transaminase"}, 
{"Row" : 23, "Column" : 1, "Text" : "elevation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEPHALEXIN PO", "DisplayText" : "Cephalexin PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cephalexin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-40250-500 mg q8-12h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare anaphylaxis, rare transient liver transaminase"}, 
{"Row" : 25, "Column" : 1, "Text" : "elevation."}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  250-500 mg q12h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP CHLORAMPHENICOL IV", "DisplayText" : "Chloramphenicol IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Chloramphenicol IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "0.5-1 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Avoid use in patients with severe hepatic failure."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Phenobarbital and rifampin may decrease chloramphenicol concentrations."}, 
{"Row" : 20, "Column" : 1, "Text" : "May increase concentrations of warfarin and phenytoin, monitor international"}, 
{"Row" : 21, "Column" : 1, "Text" : "normalized ratio (INR) and phenytoin concentrations during chloramphenicol"}, 
{"Row" : 22, "Column" : 1, "Text" : "therapy."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Aplastic anemia, bone marrow suppression, Gray's syndrome, delerium."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CIPROFLOXACIN PO", "DisplayText" : "Ciprofloxacin PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ciprofloxacin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "< 30250 mg q12h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Calcium, dairy products, iron, zinc, magnesium, aluminum  inhibit the absorption"}, 
{"Row" : 22, "Column" : 1, "Text" : "of oral ciprofloxacin.  Give ciprofloxacin 2 hours before or 6 hours after these"}, 
{"Row" : 23, "Column" : 1, "Text" : "drugs."}, 
{"Row" : 25, "Column" : 1, "Text" : "Increases effects of caffeine and theophylline by inhibiting  metabolism."}, 
{"Row" : 26, "Column" : 1, "Text" : "Monitor the patient for signs of agitation or anxiety."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, confusion, CNS"}, 
{"Row" : 30, "Column" : 1, "Text" : "stimulation, rare seizures, rare QT interval prolongation."}, 
{"Row" : 18, "Column" : 1, "Text" : "Hemodialysis  250-500 mg q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP CLARITHROMYCIN PO", "DisplayText" : "Clarithromycin PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clarithromycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500mg PO q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with CrCl less than 30 ml/min, cut dose in half or increase dosing"}, 
{"Row" : 16, "Column" : 1, "Text" : "interval to q24h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Increases the levels of many drugs.  Some that are especially clinically"}, 
{"Row" : 20, "Column" : 1, "Text" : "significant include warfarin, statins, sildenafil, calcium channel blockers."}, 
{"Row" : 21, "Column" : 1, "Text" : "Consult Micromedex, Up-to-date, and/or a pharmacist for more information."}, 
{"Row" : 23, "Column" : 1, "Text" : "May prolong the QT interval, especially when combined with CYP 3A4 substrates or"}, 
{"Row" : 24, "Column" : 1, "Text" : "inhibitors, or other pro-arrhythmic agents.  Avoid concurrent use, if possible."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare hepatotoxicity, and rare QT interval"}, 
{"Row" : 28, "Column" : 1, "Text" : "prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CLINDAMYCIN PO", "DisplayText" : "Clindamycin PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clindamycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "300 mg PO q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with hepatic failure, give 300 mg q8h."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, pseudomembranous colitis, rare jaundice."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CLOTRIMAZOLE TOPICAL", "DisplayText" : "Clotrimazole Topical  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clotrimazole topical", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Apply to affected area topically QID."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP DAPTOMYCIN IV", "DisplayText" : "Daptomycin IV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Daptomycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "4 mg/kg IV q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with creatinine clearance less than 30 mL/min, including patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "on hemodialysis, give 4 mg/kg IV q48h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Temporarily discontinue HMG-CoA reductase inhibitors (\"statins\") during"}, 
{"Row" : 20, "Column" : 1, "Text" : "daptomycin therapy, due to risk of rhabdomyolysis."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Myalgias, rhabdomyolysis, injection site reaction, renal failure, elevated liver"}, 
{"Row" : 24, "Column" : 1, "Text" : "transaminase levels."}
]},
{"Name" : "ORZID2 GMENU ABX IDP DICLOXACILLIN PO", "DisplayText" : "Dicloxacillin PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Dicloxacillin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Induces warfarin metabolism, decreasing the effect of warfarin.  When these"}, 
{"Row" : 19, "Column" : 1, "Text" : "drugs are used together, monitor international normalized ratio (INR) frequently"}, 
{"Row" : 20, "Column" : 1, "Text" : "and for several weeks after dicloxacillin therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Diarrhea, nausea/vomiting, rash, rare anaphylaxis."}
]},
{"Name" : "ORZID2 GMENU ABX IDP DOSING TABLE GENTAMICIN", "DisplayText" : "", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gentamicin Dosing Table", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "IndicationDose for  Dose for Dose for  Desired Desired", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "creatinine creatinine  creatinine  peaktrough", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "clearance  clearance clearance  (mcg/ml)  (mcg/ml)", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : ">50 ml/min10-50 ml/min<10 ml/min", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 17, "Column" : 1, "Text" : "negative 5 mg/kg  NotNot Not"}, 
{"Row" : 18, "Column" : 1, "Text" : "infection - q24hrecommended recommended established<1.5"}, 
{"Row" : 19, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 20, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 21, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 23, "Column" : 1, "Text" : "negative 2 mg/kg load,0.3-0.5"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection - then 1.7 0.5-1.2mg/kg6-8  <2"}, 
{"Row" : 25, "Column" : 1, "Text" : "multiple mg/kg q8h mg/kg q12h  q24-48h"}, 
{"Row" : 26, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 27, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 29, "Column" : 1, "Text" : "tract  5 mg/kg  NotNot Not"}, 
{"Row" : 30, "Column" : 1, "Text" : "infection - q24hrecommended recommended established<1.5"}, 
{"Row" : 31, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 32, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 33, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 35, "Column" : 1, "Text" : "tract1.5 mg/kg0.5-1  0.3-0.5"}, 
{"Row" : 36, "Column" : 1, "Text" : "infection -q8hmg/kg q12h  mg/kg4-6  <2"}, 
{"Row" : 37, "Column" : 1, "Text" : "multiple  q24-48h"}, 
{"Row" : 38, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 39, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Synergy *  1 mg/kg  0.5 mg/kg0.5 mg/kg 3-4<2"}, 
{"Row" : 41, "Column" : 1, "Text" : "q8hq12-24h  q24-72h"}, 
{"Row" : 42, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "* Gentamicin is used for synergy in severe staphylococcus aureus infections, and"}, 
{"Row" : 45, "Column" : 1, "Text" : "streptococcal and enterococcal endocarditis.  Use multiple daily dosing for"}, 
{"Row" : 46, "Column" : 1, "Text" : "enterococcal and staphylococcal endocarditis."}, 
{"Row" : 48, "Column" : 1, "Text" : "Pharmacy (x3128) will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 50, "Column" : 1, "Text" : "Once daily dosing may be an option for many indications in patients with a"}, 
{"Row" : 51, "Column" : 1, "Text" : "creatinine clearance greater than 50 ml/min.  The dose is 5 mg/kg q24h.  Target"}, 
{"Row" : 52, "Column" : 1, "Text" : "trough concentrations are less than 1.5 mcg/ml.  Ideal peak concentrations are"}, 
{"Row" : 53, "Column" : 1, "Text" : "not established.  Order a trough concentration to be drawn prior to the second"}, 
{"Row" : 54, "Column" : 1, "Text" : "dose."}
]},
{"Name" : "ORZID2 GMENU ABX IDP DOXYCYCLINE PO", "DisplayText" : "Doxycycline PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Doxycycline PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Enzyme inducers such as phenytoin, phenobarbital, and carbamazepine decrease"}, 
{"Row" : 19, "Column" : 1, "Text" : "levels of doxycycline.  Consider doubling the doxycycline dose or choosing an"}, 
{"Row" : 20, "Column" : 1, "Text" : "alternative agent."}, 
{"Row" : 22, "Column" : 1, "Text" : "Iron salts, calcium, and other antacids reduce PO absorption of doxycycline.  If"}, 
{"Row" : 23, "Column" : 1, "Text" : "iron must be used at the same time as doxycycline, give doxycycline 2 hours"}, 
{"Row" : 24, "Column" : 1, "Text" : "before or 4 hours after the iron dose."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash, nausea/vomiting."}
]},
{"Name" : "ORZID2 GMENU ABX IDP DS TOBRAMYCIN", "DisplayText" : "Tobramycin Dosing Table  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Tobramycin Dosing table", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "IndicationDose for  Dose for Dose for  Desired Desired", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "creatinine creatinine creatinine  peak  trough", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "clearance clearanceclearance (mcg/ml)(mcg/ml)", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : ">50 ml/min10-50 ml/min<10 ml/min", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 17, "Column" : 1, "Text" : "negative  5 mg/kgNotNotNot"}, 
{"Row" : 18, "Column" : 1, "Text" : "infection -  q24hrecommended recommended  established  <1.5"}, 
{"Row" : 19, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 20, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 21, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 23, "Column" : 1, "Text" : "negative  2 mg/kg load, 0.3-0.5"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection -  then 1.7 0.5-1.2  mg/kg6-8<2"}, 
{"Row" : 25, "Column" : 1, "Text" : "multiple  mg/kg q8hmg/kg q12hq24-48h"}, 
{"Row" : 26, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 27, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 29, "Column" : 1, "Text" : "tract  5 mg/kgNot Not  Not"}, 
{"Row" : 30, "Column" : 1, "Text" : "infection -  q24hrecommended recommendedestablished <1.5"}, 
{"Row" : 31, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 32, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 33, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 35, "Column" : 1, "Text" : "tract  1.5 mg/kg 0.5-1 0.3-0.5"}, 
{"Row" : 36, "Column" : 1, "Text" : "infection -  q8h mg/kg q12hmg/kg  4-6 <2"}, 
{"Row" : 37, "Column" : 1, "Text" : "multiple  q24-48h"}, 
{"Row" : 38, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 39, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Pharmacy (x3128) will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 42, "Column" : 1, "Text" : "Once daily dosing may be an option for many indications in patients with a"}, 
{"Row" : 43, "Column" : 1, "Text" : "creatinine clearance greater than 50 ml/min.  The dose is 5 mg/kg q24h.  Target"}, 
{"Row" : 44, "Column" : 1, "Text" : "trough concentrations are less than 1.5 mcg/ml.  Ideal peak concentrations are"}, 
{"Row" : 45, "Column" : 1, "Text" : "not established.  Order a trough concentration to be drawn prior to the second"}, 
{"Row" : 46, "Column" : 1, "Text" : "dose."}
]},
{"Name" : "ORZID2 GMENU ABX IDP ERTAPENEM IV", "DisplayText" : "Ertapenem IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ertapenem IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 gm IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with a creatinine clearance less than 30 mL/min, including patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "on hemodialysis, give 500 mg/day."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Ertapenem may decrease valproic acid (Depakote) levels.Monitor valproic acid"}, 
{"Row" : 20, "Column" : 1, "Text" : "levels during ertapenem therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Infusion site reactions, confusion, and nausea/vomiting.  Seizures are less"}, 
{"Row" : 24, "Column" : 1, "Text" : "common with ertapenem than with other carbapenems.  Ertapenem can be used with"}, 
{"Row" : 25, "Column" : 1, "Text" : "caution in patients with histories of seizure disorder."}
]},
{"Name" : "ORZID2 GMENU ABX IDP ERYTHROMYCIN PO", "DisplayText" : "Erythromycin PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Erythromycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Erythromycin increases the levels of many drugs.  Some that are especially"}, 
{"Row" : 19, "Column" : 1, "Text" : "clinically significant include warfarin, statins, sildenafil, calcium channel"}, 
{"Row" : 20, "Column" : 1, "Text" : "blockers.  Consult Micromedex, Up-to-date, and/or a pharmacist for more"}, 
{"Row" : 21, "Column" : 1, "Text" : "information."}, 
{"Row" : 23, "Column" : 1, "Text" : "Erythromycin may prolong the QT interval, especially when combined with"}, 
{"Row" : 24, "Column" : 1, "Text" : "cytochrome p450 3A4 enzyme substrates or inhibitors, or other pro-arrhythmic"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents.  Avoid concurrent use, if possible."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare hepatotoxicity, rare interval prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP ETHAMBUTOL PO", "DisplayText" : "Ethambutol PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ethambutol PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "15 mg/kg q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Creatinine clearance(ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Do not give within 4 hours of any aluminum containing products"}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Nausea/vomiting, hyperuricemia, mania, optic neuritis - requires vision"}, 
{"Row" : 24, "Column" : 1, "Text" : "monitoring, peripheral neuropathy, rare blood dyscrasias."}, 
{"Row" : 16, "Column" : 1, "Text" : "10-5015 mg/kg PO q36h"}, 
{"Row" : 17, "Column" : 1, "Text" : "<1015 mg/kg PO q48h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP FLUCONAZOLE PO", "DisplayText" : "Fluconazole PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Fluconazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with renal impairment, administer the usual loading dose, then"}, 
{"Row" : 16, "Column" : 1, "Text" : "adjust the maintenance dose according to renal function."}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "< 50 Give half the usual dose q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Fluconazole increases levels of several drugs, especially in higher doses."}, 
{"Row" : 24, "Column" : 1, "Text" : "Drugs whose effects are significantly increased by fluconazole include warfarin,"}, 
{"Row" : 25, "Column" : 1, "Text" : "HMG-CoA reductase inhibitors (\"statins\"), benzodiazepines, calcium channel"}, 
{"Row" : 26, "Column" : 1, "Text" : "blockers, cyclosporine, tacrolimus,sirolimus.  Consult Micromedex, Up-to-date,"}, 
{"Row" : 27, "Column" : 1, "Text" : "or a pharmacist for more information."}, 
{"Row" : 29, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Headache, nausea, rash, hepatotoxicity, rare QT interval prolongation."}, 
{"Row" : 20, "Column" : 1, "Text" : "HemodialysisGive usual dose after each dialysis"}
]},
{"Name" : "ORZID2 GMENU ABX IDP FOSCARNET IV", "DisplayText" : "Foscarnet IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Foscarnet IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "90 mg/kg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Adjust for renal function - must divide Cockroft-Gault derived creatinine"}, 
{"Row" : 17, "Column" : 1, "Text" : "clearance by patients weight.  Doses listed are for induction therapy only."}, 
{"Row" : 18, "Column" : 1, "Text" : "Consult infectious diseases for more information."}, 
{"Row" : 20, "Column" : 1, "Text" : "Cockroft-Gault CrCl per kgDose", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "(mL/min/kg)", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Use with ciprofloxacin increases seizure risk."}, 
{"Row" : 35, "Column" : 1, "Text" : "Increased nephrotoxicity when used with other nephrotoxic agents,such as"}, 
{"Row" : 36, "Column" : 1, "Text" : "aminoglycosides, amphotericin, cyclosporine, or ganciclovir."}, 
{"Row" : 38, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Nephrotoxicity, anemia, fever, diarrhea, electrolyte disturbances."}, 
{"Row" : 24, "Column" : 1, "Text" : "> 1.490 q12h"}, 
{"Row" : 25, "Column" : 1, "Text" : "1.0-1.470 q12h"}, 
{"Row" : 26, "Column" : 1, "Text" : "0.8-1.050 q12h"}, 
{"Row" : 27, "Column" : 1, "Text" : "0.6-0.880 q24h"}, 
{"Row" : 28, "Column" : 1, "Text" : "0.5-0.660 q24h"}, 
{"Row" : 29, "Column" : 1, "Text" : "0.4-0.550 q24h"}, 
{"Row" : 30, "Column" : 1, "Text" : "< 0.4not recommended"}
]},
{"Name" : "ORZID2 GMENU ABX IDP GANCICLOVIR IV", "DisplayText" : "Ganciclovir IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ganciclovir IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "5 mg/kg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Increased risk of nephrotoxicity with other nephrotoxic drugs such as"}, 
{"Row" : 27, "Column" : 1, "Text" : "aminoglycosides, amphotericin, cyclosporine, or foscarnet."}, 
{"Row" : 29, "Column" : 1, "Text" : "Didanosine and zidovudine can decrease ganciclovir levels, potentially"}, 
{"Row" : 30, "Column" : 1, "Text" : "decreasing ganciclovir's efficacy.  An alternative to ganciclovir should be used"}, 
{"Row" : 31, "Column" : 1, "Text" : "for patients on didanosine or zidovudine."}, 
{"Row" : 33, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Nephrotoxicity, neutropenia, thrombocytopenia, anemia, nausea/vomiting."}, 
{"Row" : 18, "Column" : 1, "Text" : "(ml/min)THERAPY  Therapy", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "clearancefor INDUCTION for MAINTENANCE", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "CreatinineDose adjustment  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "50-692.5 mg/kg q12h2.5 mg/kg q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "25-492.5 mg/kg q24h1.25 mg/kg q24h"}, 
{"Row" : 21, "Column" : 1, "Text" : "10-241.25 mg/kg q24h 0.625 mg/kg q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "< 10  1.25 mg/kg 3 times/week0.625 mg/kg 3 times/week"}, 
{"Row" : 23, "Column" : 1, "Text" : "Hemodialysis 1.25 mg//kg 3 times/week 0.625 mg//kg 3 times/week"}
]},
{"Name" : "ORZID2 GMENU ABX IDP GATIFLOXACIN PO", "DisplayText" : "Gatifloxacin PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gatifloxacin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "< 40 400 mg once, then 200 mg QD"}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Zinc, iron, magnesium, and aluminum decrease the oral absorption of"}, 
{"Row" : 21, "Column" : 1, "Text" : "gatifloxacin.  Give gatifloxacin 2 hours before or 6 hours after these metal"}, 
{"Row" : 22, "Column" : 1, "Text" : "ions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 25, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, rare QT interval"}, 
{"Row" : 29, "Column" : 1, "Text" : "prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP GENTAMICIN IV", "DisplayText" : "", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gentamicin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "5 mg/kg IV QD for treatment of gram negative infections, 1 mg/kg q8h along with"}, 
{"Row" : 13, "Column" : 1, "Text" : "a beta-lactam antibiotic for synergy against gram positive bacteria."}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DOSING TABLE GENTAMICIN", "DisplayText" : "", "Text" : "Link to gentamicin dosing table", "Mnemonic" : "08"},
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Potentiates effects of neuromuscular blockers."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Nephrotoxicity, ototoxicity, neuromuscular blockade."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IODOQUINOL PO", "DisplayText" : "Iodoquinol PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Iodoquinol PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "650mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, urticaria, peripheral neuropathy, optic neuritis"}
]},
{"Name" : "ORZID2 GMENU ABX IDP ITRACONAZOLE IV", "DisplayText" : "Itraconazole IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Itraconazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "The intravenous route is contraindicated in patients with creatinine clearance"}, 
{"Row" : 16, "Column" : 1, "Text" : "less than 30 ml/min, due to renal accumulation of the formulation's cyclodextrin"}, 
{"Row" : 17, "Column" : 1, "Text" : "vehicle."}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Itraconazole increase the levels of many drugs, including warfarin, HMG-CoA"}, 
{"Row" : 21, "Column" : 1, "Text" : "reductase inhibitors (\"statins\"), benzodiazepines, calcium channel blockers,"}, 
{"Row" : 22, "Column" : 1, "Text" : "cyclosporine, tacrolimus, and sirolimus.  Consult Micromedex, Up-to-date, or a"}, 
{"Row" : 23, "Column" : 1, "Text" : "pharmacist for more information."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Hepatotoxicity, nausea, rash, edema."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV CIPROFLOXACIN", "DisplayText" : "Ciprofloxacin IV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ciprofloxacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "5-29  200-400 mg q18-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Increases effects of caffeine and theophylline by inhibiting metabolism. Monitor"}, 
{"Row" : 22, "Column" : 1, "Text" : "the patient for signs of agitation or anxiety."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, confusion, CNS"}, 
{"Row" : 26, "Column" : 1, "Text" : "stimulation, rare seizures, rare QT interval prolongation."}, 
{"Row" : 18, "Column" : 1, "Text" : "Hemodialysis 400 mg q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV CLINDAMYCIN", "DisplayText" : "Clindamycin IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clindamycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "600 mg IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with hepatic failure, give 600 mg q12h."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, pseudomembranous colitis, rare jaundice."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV DOXYCYCLINE", "DisplayText" : "Doxycycline IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Doxycycline IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Enzyme inducers such as phenytoin, phenobarbital, and carbamazepine decrease"}, 
{"Row" : 19, "Column" : 1, "Text" : "levels of doxycycline.  Consider doubling the doxycycline dose or choosing an"}, 
{"Row" : 20, "Column" : 1, "Text" : "alternative agent."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV ERYTHROMYCIN", "DisplayText" : "Erythromycin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Erythromycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Erythromycin increases the levels of many drugs.  Some that are especially"}, 
{"Row" : 19, "Column" : 1, "Text" : "clinically significant include warfarin, statins, sildenafil, calcium channel"}, 
{"Row" : 20, "Column" : 1, "Text" : "blockers.  Consult Micromedex, Up-to-date, and/or a pharmacist for more"}, 
{"Row" : 21, "Column" : 1, "Text" : "information."}, 
{"Row" : 23, "Column" : 1, "Text" : "Erythromycin may prolong the QT interval, especially when combined with"}, 
{"Row" : 24, "Column" : 1, "Text" : "cytochrome p450 3A4 enzyme substrates or inhibitors, or other pro-arrhythmic"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents.  Avoid concurrent use, if possible."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare hepatotoxicity, rare interval prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV FLUCONAZOLE", "DisplayText" : "Fluconazole IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Fluconazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with renal impairment, administer the usual loading dose, then"}, 
{"Row" : 16, "Column" : 1, "Text" : "adjust the maintenance dose according to renal function."}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "< 50  Give half the usual dose q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "HemodialysisGive usual dose after each dialysis"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Fluconazole increases levels of several drugs, especially in higher doses."}, 
{"Row" : 24, "Column" : 1, "Text" : "Drugs whose effects are significantly increased by fluconazole include warfarin,"}, 
{"Row" : 25, "Column" : 1, "Text" : "HMG-CoA reductase inhibitors (\"statins\"), benzodiazepines, calcium channel"}, 
{"Row" : 26, "Column" : 1, "Text" : "blockers, cyclosporine, tacrolimus,sirolimus.  Consult Micromedex, Up-to-date,"}, 
{"Row" : 27, "Column" : 1, "Text" : "or a pharmacist for more information."}, 
{"Row" : 29, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Headache, nausea, rash, hepatotoxicity, rare QT interval prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV GATIFLOXACIN", "DisplayText" : "Gatifloxacin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gatifloxacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 21, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse effects include nausea/vomiting, diarrhea, hypo- or hyperglycemia,"}, 
{"Row" : 25, "Column" : 1, "Text" : "dizziness, rare QT interval prolongation."}, 
{"Row" : 17, "Column" : 1, "Text" : "< 40400 mg once, then 200 mg QD"}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV LINEZOLID", "DisplayText" : "Linezolid IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Linezolid IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "600 mg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Increased risk of serotonin syndrome when is given with  serotonergic agents,"}, 
{"Row" : 19, "Column" : 1, "Text" : "including selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine,"}, 
{"Row" : 20, "Column" : 1, "Text" : "paroxetine, sertraline, and citalopram, tricyclic antidepressants (TCAs) such as"}, 
{"Row" : 21, "Column" : 1, "Text" : "amitriptyline, nortriptyline, imipramine, and doxepin, and other drugs such as"}, 
{"Row" : 22, "Column" : 1, "Text" : "mirtazapine, clomipramine, venlafaxine, trazodone, sibutramine, meperidine,"}, 
{"Row" : 23, "Column" : 1, "Text" : "dextromethorphan. Wait 14 days after any of these drugs are discontinued before"}, 
{"Row" : 24, "Column" : 1, "Text" : "starting linezolid.  If linezolid must be given concurrently with any of these"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents, monitor the patient closely for signs and symptoms of serotonin syndrome"}, 
{"Row" : 26, "Column" : 1, "Text" : "such as sweating, nausea/vomiting, fever, muscle weakness and dysreflexia."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Diarrhea, myelosuppression, headache, nausea, optic and peripheral neuropathy."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV METRONIDAZOLE", "DisplayText" : "Metronidazole IV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Metronidazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1000 mg IV q12h OR 500 mg IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with creatinine clearance less than 10 mL/minute, including"}, 
{"Row" : 16, "Column" : 1, "Text" : "patients on hemodialysis, give 500 mg q12h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Metronidazole increases the effects of warfarin.  Monitor the international"}, 
{"Row" : 20, "Column" : 1, "Text" : "normalized ration (INR) frequently during metronidazole therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Metronidazole increases lithium concentrations.  Monitor lithium concentrations"}, 
{"Row" : 23, "Column" : 1, "Text" : "during metronidazole therapy."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Metallic taste, nausea, disulfuram reaction."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV PENICILLIN", "DisplayText" : "Penicillin IV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Penicillin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "2-4 million units IV q4-6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-502-4 million units q6h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-292-4 million units q8h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10 2-4 million units q12h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Rash, diarrhea, rare anaphylaxis, rare hemolytic anemia, and at higher doses,"}, 
{"Row" : 26, "Column" : 1, "Text" : "interstitial nephritis and seizures."}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV TRIMETHOPRIM-SULFA", "DisplayText" : "Trimethoprim-sulfamethoxazole IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "10-20 mg/kg/day divided into 2-4 doses.  Mg/kg doses are basedon the"}, 
{"Row" : 13, "Column" : 1, "Text" : "trimethoprim component."}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "For patients with creatinine clearance less than 30ml/min, give half of the"}, 
{"Row" : 17, "Column" : 1, "Text" : "usual dose."}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Increases international normalized ratio (INR) in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Monitor INR daily."}, 
{"Row" : 23, "Column" : 1, "Text" : "Contraindicated with dofetilide, it doubles dofetilide serum concentrations."}, 
{"Row" : 25, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole may increase digoxin  or unbound  phenytoin"}, 
{"Row" : 26, "Column" : 1, "Text" : "concentrations.  If these either of these drugs must be used concurrently with"}, 
{"Row" : 27, "Column" : 1, "Text" : "trimethoprim-sulfamethoxazole, monitor serum concentrations of digoxin or"}, 
{"Row" : 28, "Column" : 1, "Text" : "unbound pheytoin."}, 
{"Row" : 30, "Column" : 1, "Text" : "Avoid using trimethoprim-sulfamethoxazole with methotrexate due to an increased"}, 
{"Row" : 31, "Column" : 1, "Text" : "risk of bone marrow toxicity."}, 
{"Row" : 33, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Rash, nausea/vomiting, rare severe allergic reaction including Stevens-Johnson"}, 
{"Row" : 35, "Column" : 1, "Text" : "syndrome, rare blood dyscrasias."}
]},
{"Name" : "ORZID2 GMENU ABX IDP LINEZOLID PO", "DisplayText" : "Linezolid PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Linezolid PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "600 mg PO q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Increased risk of serotonin syndrome when is given with  serotonergic agents,"}, 
{"Row" : 19, "Column" : 1, "Text" : "including selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine,"}, 
{"Row" : 20, "Column" : 1, "Text" : "paroxetine, sertraline, and citalopram, tricyclic antidepressants (TCAs) such as"}, 
{"Row" : 21, "Column" : 1, "Text" : "amitriptyline, nortriptyline, imipramine, and doxepin, and other drugs such as"}, 
{"Row" : 22, "Column" : 1, "Text" : "mirtazapine, clomipramine, venlafaxine, trazodone, sibutramine, meperidine,"}, 
{"Row" : 23, "Column" : 1, "Text" : "dextromethorphan.  Wait 14 days after any of these drugs are discontinued before"}, 
{"Row" : 24, "Column" : 1, "Text" : "starting linezolid.  If linezolid must be given concurrently with any of these"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents, monitor the patient closely for signs and symptoms of serotonin syndrome"}, 
{"Row" : 26, "Column" : 1, "Text" : "such as sweating, nausea/vomiting, fever, muscle weakness and dysreflexia."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Diarrhea, myelosuppression, headache, nausea, optic peripheral neuropathy."}
]},
{"Name" : "ORZID2 GMENU ABX IDP METRONIDAZOLE PO", "DisplayText" : "Metronidazole PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Metronidazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with creatinine clearance less than 10 mL/minute, including"}, 
{"Row" : 16, "Column" : 1, "Text" : "patients on hemodialysis, give 500 mg q12h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Metronidazole increases the effects of warfarin.  Monitor the international"}, 
{"Row" : 20, "Column" : 1, "Text" : "normalized ration (INR) frequently during metronidazole therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Metronidazole increases lithium concentrations.  Monitor lithium concentrations"}, 
{"Row" : 23, "Column" : 1, "Text" : "during metronidazole therapy."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Metallic taste, nausea, disulfuram reaction."}
]},
{"Name" : "ORZID2 GMENU ABX IDP MINOCYCLINE PO", "DisplayText" : "Minocycline PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Minocycline PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Iron salts reduce PO absorption of minocycline.  If iron must be continued while"}, 
{"Row" : 19, "Column" : 1, "Text" : "on minocycline, give minocycline 2 hours before or 4 hours after iron dose."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash, and dizziness."}
]},
{"Name" : "ORZID2 GMENU ABX IDP MOXIFL IV", "DisplayText" : "Moxifloxacin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Moxifloxacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg iv qd"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dosage adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 19, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse drug reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, Clostridium"}, 
{"Row" : 23, "Column" : 1, "Text" : "difficile disease, and rare QT interval prolongation."}
]},
{"Name" : "ORZID2 GMENU ABX IDP MOXIFLOX PO", "DisplayText" : "Moxifloxacin PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Moxifloxacin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg  po qd"}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Zinc, iron, magnesium, and aluminum decrease the oral absorption of"}, 
{"Row" : 19, "Column" : 1, "Text" : "gatifloxacin.  Give moxifloxacin 2 hours before or 6 hours after these metal"}, 
{"Row" : 20, "Column" : 1, "Text" : "ions."}, 
{"Row" : 22, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 23, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse drug reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, Clostridium"}, 
{"Row" : 27, "Column" : 1, "Text" : "difficile disease, and rare QT interval prolongation."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dosage adjustments for renal or hepatic insufficiency:", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP MOXIFLOXACIN OPHTHALMIC", "DisplayText" : "Moxifloxacin Ophthalmic  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Moxifloxacin ophthalmic", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 drop in affected eye TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP NAFCILLIN IV", "DisplayText" : "Nafcillin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Nafcillin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q4-6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Nafcillin induces the metabolism of warfarin and decreases the international"}, 
{"Row" : 19, "Column" : 1, "Text" : "normalized ratio (INR).  Monitor INR during and for several weeks after"}, 
{"Row" : 20, "Column" : 1, "Text" : "nafcillin therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Nafcillin may decrease levels of cyclosporine.  If these drugs must be used"}, 
{"Row" : 23, "Column" : 1, "Text" : "concurrently, monitor cyclosporine levels."}, 
{"Row" : 25, "Column" : 1, "Text" : "Probenecid may increase levels of nafcillin.  If these drugs must be used"}, 
{"Row" : 26, "Column" : 1, "Text" : "together, monitor for signs of nafcillin toxicity."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Phlebitis, diarrhea, rash, rare anaphylaxis, rare hepatotoxicity, rare"}, 
{"Row" : 30, "Column" : 1, "Text" : "myelosuppression, rare interstitial nephritis."}
]},
{"Name" : "ORZID2 GMENU ABX IDP NEOMYCIN PO", "DisplayText" : "Neomycin PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Neomycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 gm PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-50 1 gm q12-18h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  1 gm q18-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, nephrotoxicity, ototoxicity, and neuromuscular"}, 
{"Row" : 25, "Column" : 1, "Text" : "blockade."}
]},
{"Name" : "ORZID2 GMENU ABX IDP NITAZOXANIDE PO", "DisplayText" : "Nitazoxanide PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Nitazoxanide PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Not studied in hepatic and renal failure"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea, vomiting, headache"}
]},
{"Name" : "ORZID2 GMENU ABX IDP NITROFURANTOIN PO", "DisplayText" : "Nitrofurantoin PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Nitrofurantoin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Contraindicated in patients with creatinine clearance less than 60 ml/min."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Contraindicated with fluconazole due to  additive risk of hepatotoxicity."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, rare peripheral neuropathy, rare interstitial pneumonitis, rare"}, 
{"Row" : 22, "Column" : 1, "Text" : "hepatotoxicity."}
]},
{"Name" : "ORZID2 GMENU ABX IDP OPHTHALMIC ERYTHROMYCIN", "DisplayText" : "Erythromycin Ophthalmic  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Erythromycin ophthalmic", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Apply 1/2\" ribbon to affected eye QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Temporary blurred vision after application."}
]},
{"Name" : "ORZID2 GMENU ABX IDP OSELTAMIVIR PO", "DisplayText" : "Oseltamivir PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Oseltamivir PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "75 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : ">>  Influenza treatment:"}, 
{"Row" : 16, "Column" : 1, "Text" : "In patients with creatinine clearance less than 30 mL/min, give 75 mg once a day"}, 
{"Row" : 17, "Column" : 1, "Text" : "for 5 days."}, 
{"Row" : 19, "Column" : 1, "Text" : ">>  Influenza prophylaxis:"}, 
{"Row" : 20, "Column" : 1, "Text" : "In patients with creatinine clearance less than 30 mL/min, give 75 mg every"}, 
{"Row" : 21, "Column" : 1, "Text" : "other day."}, 
{"Row" : 23, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Insomnia, vertigo, nausea/vomiting."}
]},
{"Name" : "ORZID2 GMENU ABX IDP PAROMOMYCIN PO", "DisplayText" : "Paromomycin PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Paromomycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500-750mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "May reduce digoxin levels"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea, vomiting, abdominal cramps"}
]},
{"Name" : "ORZID2 GMENU ABX IDP PENICILLIN PO", "DisplayText" : "Penicillin PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Penicillin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with creatinine clearance less than 10 ml/min, decrease the dose by"}, 
{"Row" : 16, "Column" : 1, "Text" : "25%."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Rash, diarrhea, rare hemolytic anemia."}
]},
{"Name" : "ORZID2 GMENU ABX IDP PIPERACILLIN-TAZOBACTAM IV", "DisplayText" : "Piperacillin-tazobactam IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Piperacillin-tazobactam IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "3.375-4.5 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine  Dose adjustmentDose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "clearancefor NOSOCOMIAL for all indications", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "(ml/min) PNEUMONIAEXCEPT nosocomial pneumonia", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "20-40  3.375 gm q6h2.25 gm q6h"}, 
{"Row" : 20, "Column" : 1, "Text" : "< 202.25 gm q6h 2.25 gm q8h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hemodialysis 2.25 gm q8h 2.25 gm q12h"}, 
{"Row" : 23, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 27, "Column" : 1, "Text" : "Rash, injection site reaction, diarrhea, rare anaphylaxis, rare blood"}, 
{"Row" : 28, "Column" : 1, "Text" : "dyscrasias."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP PYRIMETHAMINE", "DisplayText" : "Pyrimethamine PO", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Pyrimethamine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "75 mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Additive risk of bone marrow suppression with sulfa drugs, methotrexate, or"}, 
{"Row" : 19, "Column" : 1, "Text" : "zidovudine.  If the drugs must be used together, monitor complete blood count"}, 
{"Row" : 20, "Column" : 1, "Text" : "(CBC) frequently."}, 
{"Row" : 22, "Column" : 1, "Text" : "Pyrimethamine inhibits the metabolism of warfarin, phenytoin, phenthiazine"}, 
{"Row" : 23, "Column" : 1, "Text" : "antipsychotics, tricyclic antidepressants (TCAs), selective serotonin reuptake"}, 
{"Row" : 24, "Column" : 1, "Text" : "inhibitors (SSRIs), venlafaxine, and beta-blockers."}, 
{"Row" : 26, "Column" : 1, "Text" : "Pyrimethamine can decrease the effectiveness of drugs that are activated by"}, 
{"Row" : 27, "Column" : 1, "Text" : "cytochrome p450 2D6 enzyme, including codeine, hydrocodone, oxycodone, and"}, 
{"Row" : 28, "Column" : 1, "Text" : "tramadol."}, 
{"Row" : 30, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Rash, nausea/vomiting, leukopenia, rare Stevens-Johnson syndrome, and at high"}, 
{"Row" : 32, "Column" : 1, "Text" : "doses, arrhythmias."}
]},
{"Name" : "ORZID2 GMENU ABX IDP QUINUPRISTIN-DALFOPRISIN", "DisplayText" : "Quinupristin-dalfoprisin ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Quinupristin-dalfoprisin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "7.5 mg/kg IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "HMG-CoA reductase inhibitors (\"statins\") should be temporarily discontinued"}, 
{"Row" : 19, "Column" : 1, "Text" : "during quinupristin-dalfopristin therapy due to an increased risk of myalgias"}, 
{"Row" : 20, "Column" : 1, "Text" : "and rhabdomyolysis."}, 
{"Row" : 22, "Column" : 1, "Text" : "Quinupristin-dalfopristin is a moderately potent enzyme inhibitor that increases"}, 
{"Row" : 23, "Column" : 1, "Text" : "he effects of many drugs.  Consult Micromedex, Up-to-date, or a pharmacist for"}, 
{"Row" : 24, "Column" : 1, "Text" : "more information."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Arthralgias/myalgias, infusion site reactions and pain, rash,"}, 
{"Row" : 28, "Column" : 1, "Text" : "hyperbilirubinemia."}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIFABUTIN PO", "DisplayText" : "Ribabutin PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rifabutin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "300mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with CrCL less than 30 ml/min, decrease dose by 50%"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Rifampin is a potent enzyme inducer, and reduces therapeutic levels of many"}, 
{"Row" : 19, "Column" : 1, "Text" : "drugs. Some of the most clincally important drugs affected include warfarin,"}, 
{"Row" : 20, "Column" : 1, "Text" : "oral contraceptives, corticosteroids, cyclosporine, \"azole\" antifungal agents,"}, 
{"Row" : 21, "Column" : 1, "Text" : "HIV protease inhibitors, and some anti-arrhythmic medications.  Many other drugs"}, 
{"Row" : 22, "Column" : 1, "Text" : "also interact with rifampin.  Consult Micromedex, Up-to-date, or a pharmacist"}, 
{"Row" : 23, "Column" : 1, "Text" : "for more information."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Hepatotoxicity, thrombocytopenia, and nausea/vomiting.  Rifampin may turn urine"}, 
{"Row" : 27, "Column" : 1, "Text" : "and other bodily fluids reddish-orange."}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIFAMPIN IV", "DisplayText" : "Rifampin IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rifampin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "300 mg IV BID-TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Rifampin is a potent enzyme inducer, and reduces therapeutic levels of many"}, 
{"Row" : 19, "Column" : 1, "Text" : "drugs, including warfarin, oral contraceptives, corticosteroids, cyclosporine,"}, 
{"Row" : 20, "Column" : 1, "Text" : "\"azole\" antifungal agents, HIV protease inhibitors, and some anti-arrhythmic"}, 
{"Row" : 21, "Column" : 1, "Text" : "medications.  Many other drugs also interact with rifampin.  Consult Micromedex,"}, 
{"Row" : 22, "Column" : 1, "Text" : "Up-to-date, or a pharmacist for more information."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Hepatotoxicity, thrombocytopenia, and nausea/vomiting.  Rifampin may turn urine"}, 
{"Row" : 26, "Column" : 1, "Text" : "and other bodily fluids reddish-orange."}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIFAXIMIN PO", "DisplayText" : "Rifaximin PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rifaximin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Constipation, headache, and nausea."}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIMANTADINE PO", "DisplayText" : "Rimantadine PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rimantadine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients who are over 65 years, or have significant hepatic impairment or a"}, 
{"Row" : 16, "Column" : 1, "Text" : "creatinine clearance less than 10 ml/min, give 100 mg QD."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Dizziness, nervousness, nausea, decrease in the seizure threshhold.  Central"}, 
{"Row" : 23, "Column" : 1, "Text" : "nervous system-related side effects are less likely with rimantadine than with"}, 
{"Row" : 24, "Column" : 1, "Text" : "amantadine."}
]},
{"Name" : "ORZID2 GMENU ABX IDP STREPTOMYCIN IV", "DisplayText" : "Streptomycin IV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Streptomycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "7.5 mg/kg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Dose for  Dose for  Dose for Desired Desired", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "creatininecreatininecreatinine  peak trough", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "clearance clearance clearance(mcg/ml)(mcg/ml)", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : ">50 ml/min  10-50 ml/min  <10 ml/min", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "7.5 mg/kg  7.5 mg/kg 7.5 mg/kg  20-30  <5"}, 
{"Row" : 22, "Column" : 1, "Text" : "q12hq24-72hq72-96h"}, 
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Pharmacy at MVAMC will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 26, "Column" : 1, "Text" : "Call a pharmacist at x3128 for more information."}, 
{"Row" : 28, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Potentiates the effects of neuromuscular blockers."}, 
{"Row" : 31, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Fever, eosinophilia, facial paresthesia, nephrotoxicity, ototoxicity,"}, 
{"Row" : 33, "Column" : 1, "Text" : "neuromuscular blockade."}
]},
{"Name" : "ORZID2 GMENU ABX IDP SULFACETAMIDE OPHTHALMIC", "DisplayText" : "Sulfacetamide Ophthalmic ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Sulfacetamide ophthalmic", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 drops to affected eye q3h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP SULFADIAZINE PO", "DisplayText" : "Sulfadiazine PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Sulfadiazine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Decreases cyclosporine concentrations, and increases phenytoin concentrations."}, 
{"Row" : 19, "Column" : 1, "Text" : "Monitor cyclosporine or phenytoin concentrations frequently during sulfadiazine"}, 
{"Row" : 20, "Column" : 1, "Text" : "therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Sulfadiazine may increase risk of hypoglycemia when given with sulfonylureas."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Rash, rare Stevens-Johnson syndrome, diarrhea, nausea, blood dyscrasias, renal"}, 
{"Row" : 26, "Column" : 1, "Text" : "failure."}
]},
{"Name" : "ORZID2 GMENU ABX IDP TERCONAZOLE 0.4% VAGINAL", "DisplayText" : "Terconazole 0.4% Vaginal ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Terconazole 0.4% vaginal", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 applicatorful vaginally qhs"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP TETRACYCLINE PO", "DisplayText" : "Tetracycline PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Tetracycline PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "50-80 250-500 mg  q8-12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-50 250-500 mg q12-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis  250-500 mg q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Iron salts, calcium, magnesium, aluminum, zinc and antacids reduce oral"}, 
{"Row" : 24, "Column" : 1, "Text" : "absorption of tetracycline.  If these metal ions or antacids must be continued"}, 
{"Row" : 25, "Column" : 1, "Text" : "while on tetracycline, give tetracycline 2 hours before or 6 hours after the"}, 
{"Row" : 26, "Column" : 1, "Text" : "dose."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash."}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10250-500 mg q24h"}
]},
{"Name" : "ORZID2 GMENU ABX IDP TICARCILLIN-CLAVULANATE IV", "DisplayText" : "Ticarcillin-clavulanate IV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ticarcillin-clavulanate IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "3.1 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-302 gm q8h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Rash, allergic reaction, rare neutropenia, rare hypokalemia, seizures at high"}, 
{"Row" : 27, "Column" : 1, "Text" : "doses."}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 without hepatic dysfunction2 gm q12h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10 with hepatic dysfunction  2 gm q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis2 gm q12 plus 3.1 gm after dialysis"}
]},
{"Name" : "ORZID2 GMENU ABX IDP TOBRAMYCIN IV", "DisplayText" : "Tobramycin IV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Tobramycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "5 mg/kg IV QD for treatment of gram negative infections, 1mg/kg q8h along with a"}, 
{"Row" : 13, "Column" : 1, "Text" : "beta-lactam antibiotic for synergy against gram positive bacteria."}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DS TOBRAMYCIN", "DisplayText" : "Tobramycin Dosing Table", "Text" : "Link to tobramycin dosing table", "Mnemonic" : "08"},
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Potentiates the effects of neuromuscular blockers."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Nephrotoxicity, ototoxicity, neuromuscular blockade."}
]},
{"Name" : "ORZID2 GMENU ABX IDP TRIMETHOPRIM-SULFAMETHOXAZOLE PO", "DisplayText" : "Trimethoprim-sulfamethoxazole PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment: 1 DS tablet (160-800 mg) BID"}, 
{"Row" : 13, "Column" : 1, "Text" : "Prophylaxis: 1 SS tablet (80-400 mg) QD"}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "For patients with creatinine clearance less than 30 ml/min, give half of the"}, 
{"Row" : 17, "Column" : 1, "Text" : "usual dose."}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Increases international normalized ratio (INR) in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Monitor INR daily."}, 
{"Row" : 23, "Column" : 1, "Text" : "Contraindicated with dofetilide, it doubles dofetilide serum concentrations."}, 
{"Row" : 25, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole may increase digoxin or unbound  phenytoin"}, 
{"Row" : 26, "Column" : 1, "Text" : "concentrations.  If these either of these drugs must be used concurrently with"}, 
{"Row" : 27, "Column" : 1, "Text" : "trimethoprim-sulfamethoxazole, monitor serum concentrations of digoxin or"}, 
{"Row" : 28, "Column" : 1, "Text" : "unbound pheytoin."}, 
{"Row" : 30, "Column" : 1, "Text" : "Avoid using trimethoprim-sulfamethoxazole with methotrexate due to an increased"}, 
{"Row" : 31, "Column" : 1, "Text" : "risk of bone marrow toxicity."}, 
{"Row" : 33, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Rash, nausea/vomiting, rare severe allergic reaction including Stevens-Johnson"}, 
{"Row" : 35, "Column" : 1, "Text" : "syndrome, rare blood dyscrasias."}
]},
{"Name" : "ORZID2 GMENU ABX IDP VAG CLOTRIMAZOLE", "DisplayText" : "Clotrimazole vaginal  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clotrimazole vaginal", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "One applicatorful intravaginally every night at bedtime."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP VAGINAL CLINDAMYCIN", "DisplayText" : "Clindamycin Vaginal", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clindamycin vaginal", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 applicatorful vaginally every night at bedtime."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP VAGINAL METRONIDAZOLE", "DisplayText" : "Metronidazole Vaginal ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Metronidazole vaginal", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 applicatorful vaginally every night at bedtime"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP VALACYCLOVIR PO", "DisplayText" : "Valacyclovir PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Valacyclovir PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500-1000 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with a creatinine clearance less than 50 ml/min, consult package"}, 
{"Row" : 16, "Column" : 1, "Text" : "insert for specific dosing recommendations.  In general, in patients with"}, 
{"Row" : 17, "Column" : 1, "Text" : "creatinine clearance between 10-49 ml/min, give 500 mg q12-24 hours."}, 
{"Row" : 19, "Column" : 1, "Text" : "In patients with creatine clearance less than 10 ml/min, including patients on"}, 
{"Row" : 20, "Column" : 1, "Text" : "hemodialysis, give 500 mg q24h."}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Headache, nausea/vomiting, rare hemolytic uremic syndrome, rare thrombotic"}, 
{"Row" : 27, "Column" : 1, "Text" : "thrombocytopenic purpura."}
]},
{"Name" : "ORZID2 GMENU ABX IDP VALGANCICLOVIR PO", "DisplayText" : "Valganciclovir PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Valganciclovir PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "900 mg PO Q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine Dose adjustment Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "clearance for INDUCTIONfor MAINTENANCE", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "(ml/min)THERAPY  THERAPY", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "40-59 450 mg q12h  450 mg QD"}, 
{"Row" : 20, "Column" : 1, "Text" : "25-39 450 mg QD 450 mg q48h"}, 
{"Row" : 21, "Column" : 1, "Text" : "10-24 450 mg q48h  450 mg twice weekly"}, 
{"Row" : 23, "Column" : 1, "Text" : "Valganciclovir is not recommended in patients receiving hemodialysis. For"}, 
{"Row" : 24, "Column" : 1, "Text" : "patients on hemodialysis (CrCl<10 mL/minute), it is recommended that ganciclovir"}, 
{"Row" : 25, "Column" : 1, "Text" : "be used. Consult infectious diseases or nephrology service for more information."}, 
{"Row" : 27, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 30, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Neutropenia, anemia, thrombocytopenia, nausea/vomiting, headache."}
]},
{"Name" : "ORZID2 GMENU ABX IDP VANCOMYCIN IV", "DisplayText" : "Vancomycin IV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Vancomycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 gm IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose is based on weight, renal function, and indication for use.  Consult"}, 
{"Row" : 16, "Column" : 1, "Text" : "infectious disease and pharmacy.  Usual trough needed for efficacy is 8 to 14"}, 
{"Row" : 17, "Column" : 1, "Text" : "mcg/ml - higher troughs may be desirable for such diseases as pneumonia,"}, 
{"Row" : 18, "Column" : 1, "Text" : "meningitis, and endocarditis.  Consult infectious diseases and pharmacy for more"}, 
{"Row" : 19, "Column" : 1, "Text" : "information."}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Diffuse flushing and redness upon infusion, rare nephrotoxicity, rare"}, 
{"Row" : 26, "Column" : 1, "Text" : "ototoxicity, rare neutropenia."}
]},
{"Name" : "ORZID2 GMENU ABX IDP VORICONAZOLE PO", "DisplayText" : "Voriconazole PO ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Voriconazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with mild-moderate liver insufficiency (Child-Pugh score 5-9) - use"}, 
{"Row" : 16, "Column" : 1, "Text" : "the standard loading dose, and reduce the maintenance dose by 50%."}, 
{"Row" : 18, "Column" : 1, "Text" : "For patients with severe liver insufficiency (Child-Pugh score greater than 9) -"}, 
{"Row" : 19, "Column" : 1, "Text" : "use only if benefit outweights risk and monitor closely for toxicity."}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Voriconazole is a strong enzyme inhibitor with many drug interactions, including"}, 
{"Row" : 23, "Column" : 1, "Text" : "cyclosporine (cut the dose of cyclosporine into one-half while patient is taking"}, 
{"Row" : 24, "Column" : 1, "Text" : "voriconazole), tacrolimus (cut the tacrolimus dose into one-third while the"}, 
{"Row" : 25, "Column" : 1, "Text" : "patient is taking voriconazole), warfarin, sirolimus, HMG-CoA reductase"}, 
{"Row" : 26, "Column" : 1, "Text" : "inhibitors (\"statins\"), benzodiazepines, calcium channel blockers, more."}, 
{"Row" : 27, "Column" : 1, "Text" : "Consult Micromedex, Up-to-date, or a pharmacist for more information."}, 
{"Row" : 29, "Column" : 1, "Text" : "Voriconazole levels are decreased in the presence of cytochrome p450 enzyme"}, 
{"Row" : 30, "Column" : 1, "Text" : "inducers.  When it is administered concurrently with rifampin, phenytoin,"}, 
{"Row" : 31, "Column" : 1, "Text" : "carbamazepine, phenobarbital or other inducers, double the voriconazole dose."}, 
{"Row" : 33, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Visual disturbances, edema, nausea/vomiting, hepatotoxicity."}
]},
{"Name" : "ORZID2 GMENU ABX IDP ZANAMIVIR INH", "DisplayText" : "Zanamivir INH", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Zanamivir INH", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "2 inhalations of 5 mg each, q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Bronchospasm, cough, diarrhea, headache."}
]},
{"Name" : "ORZID2 GMENU ABX IMPETIGO", "DisplayText" : "Impetigo  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 9, "Column" : 1, "Text" : "IMPETIGO"}, 
{"Row" : 11, "Column" : 1, "Text" : "Impetigo is a superficial skin infection that rarely causes systemic symptoms."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Alternative for patient with numerous lesions or whose symptoms have not", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "responded to topical treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJZID MUPIROCIN OINTMENT Q8H X5 DAYS", "DisplayText" : "Mupirocin Oint Q8H 5 DAYS", "Text" :""},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID DICLOXACILLIN 250MG PO QID X7 DAYS", "DisplayText" : "Dicloxacillin 250MG PO QID 7 DAYS", "Text" : ""},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 250MG QID X7 DAYS", "DisplayText" : "Cephalexin 250MG QID 7 DAYS", "Text" : ""},
{"Row" : 26, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternative for Beta-Lactam Allergy:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO QID", "DisplayText" : "Clindamycin 300MG PO QID", "Text" : ""},
{"Row" : 28, "Column" : 1, "Text" : "Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management"}, 
{"Row" : 29, "Column" : 1, "Text" : "of Skin and Soft Tissue Infections: 2104 Update by the Infectious Disease"}, 
{"Row" : 30, "Column" : 1, "Text" : "Society of America. Clinical Infectious Diseases. 2014."}
]},
{"Name" : "ORZID2 GMENU ABX INFECT CONTROL STD PRECAUTIONS", "DisplayText" : "Standard precautions  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "02"},
{"Row" : 5, "Column" : 1, "Text" : "STANDARD PRECAUTIONS"}, 
{"Row" : 7, "Column" : 1, "Text" : "Any patient may be infected with potential pathogens on skin, in non-sterile"}, 
{"Row" : 8, "Column" : 1, "Text" : "body cavities, and in tissues and bodily fluids.  Practice standard precautions"}, 
{"Row" : 9, "Column" : 1, "Text" : "with all patients.  Wash hands or use alcohol handrub before and after contact"}, 
{"Row" : 10, "Column" : 1, "Text" : "with patients or fomites.  Use gloves, gowns, masks, and protective eyewear when"}, 
{"Row" : 11, "Column" : 1, "Text" : "needed to prevent exposure or transmission of body substances."}
]},
{"Name" : "ORZID2 GMENU ABX INFECT CTRL AIRBORNE PRECAUT", "DisplayText" : "Airborne precautions  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "02"},
{"Row" : 5, "Column" : 1, "Text" : "AIRBORNE PRECAUTIONS"}, 
{"Row" : 7, "Column" : 1, "Text" : "Use for chickenpox, disseminated zoster, and measles.  In addition to standard"}, 
{"Row" : 8, "Column" : 1, "Text" : "precautions, place patient in a private, negative-pressure room.  Doors to the"}, 
{"Row" : 9, "Column" : 1, "Text" : "room must remain closed."}
]},
{"Name" : "ORZID2 GMENU ABX INFECT CTRL CONTACT PRECAUT", "DisplayText" : "Contact precautions", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "02"},
{"Row" : 5, "Column" : 1, "Text" : "CONTACT PRECAUTIONS"}, 
{"Row" : 7, "Column" : 1, "Text" : "Use for patients known to be colonized by or infected with vancomycin-resistant"}, 
{"Row" : 8, "Column" : 1, "Text" : "enterococcus (VRE) or other multi-drug resistant bacteria.  In addition to"}, 
{"Row" : 9, "Column" : 1, "Text" : "standard precautions, place the patient in a private room.  Discard disposal"}, 
{"Row" : 10, "Column" : 1, "Text" : "items after use with this patient.  Disinfect reusable items between use with"}, 
{"Row" : 11, "Column" : 1, "Text" : "different patients  (e.g., commode, blood pressure cuff, thermometer,"}, 
{"Row" : 12, "Column" : 1, "Text" : "stethoscope, slide board).  Wear gloves when entering the room, and change"}, 
{"Row" : 13, "Column" : 1, "Text" : "gloves between separate tasks on the same patient.  Wear a gown for any contact"}, 
{"Row" : 14, "Column" : 1, "Text" : "with the patient or environmental surfaces.  Wash hands or apply alcohol handrub"}, 
{"Row" : 15, "Column" : 1, "Text" : "after removing gloves."}
]},
{"Name" : "ORZID2 GMENU ABX INFECT CTRL DRPLETS PRECAUT", "DisplayText" : "Droplet precautions", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "02"},
{"Row" : 5, "Column" : 1, "Text" : "DROPLET PRECAUTIONS"}, 
{"Row" : 7, "Column" : 1, "Text" : "Use for diphtheria, epiglottitis, meningococcal disease, respiratory or systemic"}, 
{"Row" : 8, "Column" : 1, "Text" : "Haemophilus influenzae disease, pertussis.  Place the patient in a private room"}, 
{"Row" : 9, "Column" : 1, "Text" : "if possible.  If a private room is not available, place a barrier, such as a"}, 
{"Row" : 11, "Column" : 1, "Text" : "droplet precautions until 24 hours of antimicrobial therapy have been given. In"}, 
{"Row" : 12, "Column" : 1, "Text" : "addition to standard precautions, wear a surgical mask when coming within three"}, 
{"Row" : 13, "Column" : 1, "Text" : "feet of the patient."}, 
{"Row" : 10, "Column" : 1, "Text" : "between patients.  For H. influenzae and meningococcal disease, continue droplet"}
]},
{"Name" : "ORZID2 GMENU ABX INFECT CTRL NEUT PRECAUT", "DisplayText" : "Neutropenic precautions  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "02"},
{"Row" : 5, "Column" : 1, "Text" : "NEUTROPENIC PRECAUTIONS"}, 
{"Row" : 7, "Column" : 1, "Text" : "Use for patients with absolute neutrophil count (ANC) less than 500 cells/ml."}, 
{"Row" : 8, "Column" : 1, "Text" : "In addition to standard precautions, place the patient in a private,positive-"}, 
{"Row" : 9, "Column" : 1, "Text" : "pressure room.  All visitors must wash hands or use alcohol handrub before"}, 
{"Row" : 10, "Column" : 1, "Text" : "entering the room, after contact with the patient or fomites, and after leaving"}, 
{"Row" : 11, "Column" : 1, "Text" : "the room.  Persons with respiratory illnesses should avoid entering the room or,"}, 
{"Row" : 12, "Column" : 1, "Text" : "if entry is necessary, they should wear a mask."}
]},
{"Name" : "ORZID2 GMENU ABX INFECT CTRL SPEC RESTP PRECAUT", "DisplayText" : "Special respiratory precautions", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "02"},
{"Row" : 5, "Column" : 1, "Text" : "SPECIAL RESPIRATORY PRECAUTIONS"}, 
{"Row" : 7, "Column" : 1, "Text" : "Use for tuberculosis.  In addition to standard precautions, place patient in a"}, 
{"Row" : 8, "Column" : 1, "Text" : "private, negative-pressure room.  Doors to the room must remain closed.  A"}, 
{"Row" : 9, "Column" : 1, "Text" : "personal respirator, N95 or PAPR, is required for entry into the room."}
]},
{"Name" : "ORZID2 GMENU ABX INFECT INVOLVES CARD DEVICES", "DisplayText" : "Infections involves cardiovascular devices (excluding valves)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "INFECTIONS INVOLVING CARDIOVASCULAR DEVICES (EXCLUDING VALVES)"}, 
{"Row" : 13, "Column" : 1, "Text" : "Most of these infections are associated with Staphylococcus aureus and"}, 
{"Row" : 14, "Column" : 1, "Text" : "coagulase-negative staphylococci.  Many of these staphylococci are resistant to"}, 
{"Row" : 15, "Column" : 1, "Text" : "methicillin, so initial therapy with vancomycin is required. Consultation with"}, 
{"Row" : 17, "Column" : 1, "Text" : "vancomycin or for those who have vancymycin-resistent infections."}, 
{"Row" : 19, "Column" : 1, "Text" : "Blood cultures should be drawn prior to the initiation of antimicrobial therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Device removal is necessary for cure in most cases.  However, it may be"}, 
{"Row" : 23, "Column" : 1, "Text" : "difficult depending on the nature of the device and specific clinical"}, 
{"Row" : 27, "Column" : 1, "Text" : "If the device removal is not possible add rifampin."}, 
{"Row" : 32, "Column" : 1, "Text" : "____________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "____________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Device removal", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment in cases where device removal IS PLANNED", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R]", "Mnemonic" : "14"},
{"Row" : 39, "Column" : 1, "Text" : "Treatment in cases where surgery CANNOT BE PERFORMED", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZ SET ABX VANCO+RIFAMP 300MG PO Q8H", "DisplayText" : "VANCO 1 GM IV Q12H RIFAMPIN 300 MG PO Q8H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R] <AND> rifampin 300 mg PO/NG q8h", "Mnemonic" : "16"},
{"Row" : 41, "Column" : 1, "Text" : "($4/day) [DI]  < OR >"}, 
{"Row" : 43, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1 GM IV Q12H RIFAMPIN 300 MG IV Q8H", "DisplayText" : "VANCO 1 GM IV Q12H RIFAMPIN 300 MG IV Q8H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R] <AND> rifampin 300 mg IV q8h ($89/day)", "Mnemonic" : "18"},
{"Row" : 44, "Column" : 1, "Text" : "[DI]"}, 
{"Row" : 47, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 48, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Infections of Prosthetic Valves and Intravascular"}, 
{"Row" : 49, "Column" : 1, "Text" : "Devices\""}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Text" : "Infectious Diseases is encouraged for patients with severe allergies to"}, 
{"Row" : 20, "Column" : 1, "Text" : "Infectious Disease and Cardiothoracic surgery consultations are encouraged."}, 
{"Row" : 24, "Column" : 1, "Text" : "circumstances.  Device removal should be discussed with Cardiology, Infectious"}, 
{"Row" : 29, "Column" : 1, "Text" : "Duration of therapy should be determined in concert with Cardiology, Infectious"}, 
{"Row" : 25, "Column" : 1, "Text" : "Disease, or Cardiothoracic surgery consultants."}, 
{"Row" : 30, "Column" : 1, "Text" : "Disease, or Cardiothoracic surgery consultants."}
]},
{"Name" : "ORZID2 GMENU ABX INFLUENZA", "DisplayText" : "Influenza ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "SEASONAL INFLUENZA"}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 75MG PO BID", "DisplayText" : "Oseltamivir 75MG PO BID", "Text" : "Oseltamivir 75 mg PO q12h ($8/day) [R]", "Mnemonic" : "16"},
{"Row" : 39, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Annual vaccination is recommended for high risk persons, their caretakers, their"}, 
{"Row" : 44, "Column" : 1, "Text" : "household contacts, and healthcare workers who care for high-risk patients."}, 
{"Row" : 45, "Column" : 1, "Text" : "High risk persons are those > 50 years of age, nursing home residents, those"}, 
{"Row" : 46, "Column" : 1, "Text" : "with chronic pulmonary or cardiac conditions, chronic metabolic diseases (e.g.,"}, 
{"Row" : 47, "Column" : 1, "Text" : "diabetes mellitus, renal failure), immunosuppression, and women in their 2nd or"}, 
{"Row" : 48, "Column" : 1, "Text" : "3rd trimester of pregnancy."}, 
{"Row" : 49, "Column" : 1, "Text" : "Give influenza vaccine."}, 
{"Row" : 51, "Column" : 1, "Text" : "The use of antiviral drugs for prevention of influenza in high risk persons is"}, 
{"Row" : 52, "Column" : 1, "Text" : "only recommended during an outbreak.  Consult with the public health department"}, 
{"Row" : 53, "Column" : 1, "Text" : "if an outbreak is suspected."}, 
{"Row" : 68, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 13, "Column" : 1, "Text" : "The infection control section (ext 3668) should be notified if a patient has"}, 
{"Row" : 14, "Column" : 1, "Text" : "suspected or confirmed influenza disease."}, 
{"Row" : 21, "Column" : 1, "Text" : "Treatment is effective only if started within 48 hours of onset of illness."}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment for acute disease", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treat for 5 days."}, 
{"Row" : 58, "Column" : 1, "Text" : "Give Influenza vaccine <AND>"}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 69, "Column" : 1, "Text" : "CDC MMWR 2006, 55: 1"}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment depends on type.  A rapid influenza test to confirm diagnosis"}, 
{"Row" : 17, "Column" : 1, "Text" : "and determine type (A or B) is encouraged."}, 
{"Row" : 18, "Column" : 1, "Text" : "CPRS Order Pathway for Rapid Influenza Test:"}, 
{"Row" : 19, "Column" : 1, "Text" : "Laboratory-->Special Test Menu-->Micro-->Influenza A/B Ag(Meritcare)"}, 
{"Row" : 35, "Column" : 1, "Text" : "Influenza A (strain H3N2) OR Influenza B", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Influenza A (strain H1N1) or Type Unknown", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "For Age 65 and older"}, 
{"Row" : 31, "Column" : 1, "Text" : "For Age 64 and younger"}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZ SET ABX OSELTAMIVIR 75 MG PO BID RIMANTADINE 100 MG PO Q24H", "DisplayText" : "Oseltamivir 75 mg po q12h  <AND> Rimantadine 100 mg po q24h", "Text" : "Oseltamivir 75 mg po q12h ($8/day) [R]  <AND>", "Mnemonic" : "12"},
{"Row" : 29, "Column" : 1, "Text" : "Rimantadine 100 mg PO q24h ($1/day) [R,O]"}, 
{"Row" : 32, "Column" : 1, "Item" : "ORZ SET ABX OSELTAMIVIR 75MG Q12H RIMANTADINE 100MG Q12H", "DisplayText" : "Oseltamivir 75 mg po q12h  <AND> Rimantadine 100 mg po q12h", "Text" : "Oseltamivir 75 mg po q12h ($8/day) [R]  <AND>", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "Rimantadine 100 mg po q12h ($2/day) [R,O]"}, 
{"Row" : 54, "Column" : 1, "Text" : "<<To be maximally effective as chemoprophylaxis, the drug"}, 
{"Row" : 55, "Column" : 1, "Text" : "must be taken each day for the duration of influenza in the community.>>"}, 
{"Row" : 71, "Column" : 1, "Text" : "http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279r"}, 
{"Row" : 70, "Column" : 1, "Text" : "CDC Health Advisory (12/19/08):"}, 
{"Row" : 57, "Column" : 1, "Text" : "Influenza A (strain H1N1) OR Type Unknown", "Header" : 1}, 
{"Row" : 59, "Column" : 1, "Text" : "For Age 65 and Older"}, 
{"Row" : 61, "Column" : 1, "Text" : "For Age 64 and Younger"}, 
{"Row" : 60, "Column" : 1, "Item" : "PSJZID RIMANTADINE 100 MG PO Q24H", "DisplayText" : "Rimantadine 100 mg po q24h", "Text" : "Rimantadine 100 mg PO q24h ($1/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 62, "Column" : 1, "Item" : "PSJZID RIMANTADINE 100 MG PO Q12H", "DisplayText" : "Rimantadine 100 mg po q12h", "Text" : "Rimantadine 100 mg po q12h ($2/day) [R,O]", "Mnemonic" : "20"},
{"Row" : 65, "Column" : 1, "Text" : "Give Influenza vaccine <AND>"}, 
{"Row" : 64, "Column" : 1, "Text" : "Influenza A (strain H3N2) OR Influenza B", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 75 MG PO Q24H", "DisplayText" : "Oseltamivir 75 mg po q24h", "Text" : "Oseltamivir 75 mg po q24h ($4/day) [R]", "Mnemonic" : "22"},
{"Row" : 11, "Column" : 1, "Text" : "Follow facility specific guidelines for prescribing and dispensing Oseltamivir", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "(Tamiflu).", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX ISOSPORA", "DisplayText" : "Diarrhea with Isospora belli", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "I. belli is associated with diarrhea in persons with HIV/AIDS and only rarely in"}, 
{"Row" : 13, "Column" : 1, "Text" : "immunocompetent persons."}, 
{"Row" : 15, "Column" : 1, "Text" : ">>  Treatment of persons WITHOUT HIV/AIDS", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : ""},
{"Row" : 20, "Column" : 1, "Text" : "Consult Infectious Disease"}, 
{"Row" : 19, "Column" : 1, "Text" : ">>  Treatment of persons WITH HIV/AIDS", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Diarrhea with Cystoisospora Belli"}, 
{"Row" : 25, "Column" : 1, "Text" : "UpToDate. Management of Cystoisospora (Isospora) infections"}, 
{"Row" : 26, "Column" : 1, "Text" : "Last updated 07/25/17"}, 
{"Row" : 28, "Column" : 1, "Text" : "Sanford Guide- web edition \"Cystoisospora belli\" Last accessed 12/12/17."}, 
{"Row" : 30, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 31, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 35, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX MICROSPORIDIA", "DisplayText" : "Microsporidia", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH MICROSPORIDIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial therapy is necessary in immunocompromised patients, but not for"}, 
{"Row" : 13, "Column" : 1, "Text" : "immunocompetent patients.  Treatment must include dietary supplementation for"}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID ALBENDAZOLE 400MG PO Q12H 21 DAYS", "DisplayText" : "Albendazole 400MG PO Q12H 21 DAYS", "Text" : ""},
{"Row" : 23, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "weight loss. In persons with AIDS, combination anti-retroviral therapy (cART)"}, 
{"Row" : 15, "Column" : 1, "Text" : "is beneficial because recovery of host defenses helps to control"}, 
{"Row" : 16, "Column" : 1, "Text" : "microsporidial disease."}, 
{"Row" : 25, "Column" : 1, "Text" : "UpToDate. Microsporidiosis. Last updated 11/03/17"}, 
{"Row" : 27, "Column" : 1, "Text" : "Sanford Guide- web edition \"Microsporidiosis\" Last accessed 12/12/17."}, 
{"Row" : 29, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 30, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 35, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX MORE ABOUT NOSOCOMIAL PNEUMO", "DisplayText" : "More about Nosocomial pneumonia...", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MORE ABOUT NOSOCOMIAL PNEUMONIA"}, 
{"Row" : 9, "Column" : 1, "Text" : "Types of nosocomial pneumonia", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Hospital acquired pneumonia (HAP): Pneumonia occurring 48 hours or more after"}, 
{"Row" : 11, "Column" : 1, "Text" : "hospital admission."}, 
{"Row" : 12, "Column" : 1, "Text" : "Ventilator-associated pneumonia (VAP): Pneumonia occurring more than 48-72 hours"}, 
{"Row" : 13, "Column" : 1, "Text" : "after endotracheal intubation."}, 
{"Row" : 14, "Column" : 1, "Text" : "Healthcare associated pneumonia (HCAP): Pneumonia occurring in any patient who"}, 
{"Row" : 15, "Column" : 1, "Text" : "> was hospitalized for 2 or more days during the last 90 days"}, 
{"Row" : 16, "Column" : 1, "Text" : "> resided in a long term care facility for 2 or more of the last 90 days"}, 
{"Row" : 17, "Column" : 1, "Text" : "> received intravenous antibiotics, chemotherapy, or wound care in the last"}, 
{"Row" : 18, "Column" : 1, "Text" : "30 days"}, 
{"Row" : 19, "Column" : 1, "Text" : "> received hemodialysis in the last 90 days"}, 
{"Row" : 21, "Column" : 1, "Text" : "Criteria for diagnosis of pneumonia", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "1.  Presence of new or progressive infiltrate <AND>"}, 
{"Row" : 23, "Column" : 1, "Text" : "2.  At least two of the following:"}, 
{"Row" : 24, "Column" : 1, "Text" : "> Fever > 38 C (100.4 F)"}, 
{"Row" : 25, "Column" : 1, "Text" : "> Leukocytosis or leukopenia"}, 
{"Row" : 26, "Column" : 1, "Text" : "> Purulent bronchial secretions"}, 
{"Row" : 28, "Column" : 1, "Text" : "HAP, VAP, or HCAP suspected", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Gram stain and culture of a lower respiratory tract sample and blood cultures"}, 
{"Row" : 30, "Column" : 1, "Text" : "are important for guiding therapy.  If a respiratory secretion gram stain from a"}, 
{"Row" : 31, "Column" : 1, "Text" : "patient with no change in antimicrobial therapy during the previous 72 hours has"}, 
{"Row" : 32, "Column" : 1, "Text" : "few bacteria, bacterial pneumonia is unlikely."}, 
{"Row" : 35, "Column" : 1, "Text" : "Duration of therapy", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Treat for 8 days for most cases of VAP, HAP, and HCAP.  If antimicrobial therapy"}, 
{"Row" : 37, "Column" : 1, "Text" : "lasts longer than 1 week, patients are more likely to experience colonization"}, 
{"Row" : 38, "Column" : 1, "Text" : "with resistant gram negative bacteria.  Longer treatment durations are needed"}, 
{"Row" : 39, "Column" : 1, "Text" : "for Pseudomonas aeruginosa (14 days), Acinetobacter baumanni (14 days), and"}, 
{"Row" : 40, "Column" : 1, "Text" : "Legionella pneumophila (10 to 21 days)."}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary", "Mnemonic" : "04"},
{"Row" : 44, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 45, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 46, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 47, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 48, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003, 37: 1405"}, 
{"Row" : 49, "Column" : 1, "Text" : "Roig J  J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 50, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 51, "Column" : 1, "Text" : "Up-to-date accessed 6/24/12"}, 
{"Row" : 52, "Column" : 1, "Text" : "Anonymous  Am J Respir Crit Care Med 2005, 171: 388"}
]},
{"Name" : "ORZID2 GMENU ABX MYOCARDITIS", "DisplayText" : "Myocarditis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MYOCARDITIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Myocarditis is most commonly associated with enterovirus or coxsackie virus"}, 
{"Row" : 10, "Column" : 1, "Text" : "infection.  Less common pathogens include pyogenic bacteria, rickettsia,"}, 
{"Row" : 11, "Column" : 1, "Text" : "toxoplasmosis, and fungi."}, 
{"Row" : 13, "Column" : 1, "Text" : "Empirical antimicrobial treatment is not indicated.  Consult cardiology and/or"}, 
{"Row" : 14, "Column" : 1, "Text" : "infectious disease for more assistance."}, 
{"Row" : 16, "Column" : 1, "Text" : "Avoid non-steroidal anti-inflammatory drugs (NSAIDS) and corticosteroids in"}, 
{"Row" : 17, "Column" : 1, "Text" : "these patients, as the use of NSAIDs in myocarditis has been associated with"}, 
{"Row" : 18, "Column" : 1, "Text" : "worse outcomes."}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 23, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Myocarditis and Pericarditis\""}
]},
{"Name" : "ORZID2 GMENU ABX NON-CHOLERA", "DisplayText" : "Vibrio non-cholera ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Non-cholera vibrio are associated with gastroenteritis, septicemia, and wound"}, 
{"Row" : 13, "Column" : 1, "Text" : "infections.  Vibrio vulnificans infections are acquired from contact with"}, 
{"Row" : 14, "Column" : 1, "Text" : "seawater or seafood, especially raw oysters.  V. vulnificans cases are more"}, 
{"Row" : 15, "Column" : 1, "Text" : "severe than cases with other species.  V. parahaemolyticus causes"}, 
{"Row" : 16, "Column" : 1, "Text" : "gastroenteritis."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment of Gastroenteritis", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment of Severe Disease", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH NON-CHOLERA VIBRIO"}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 3 DAYS", "Text" :""},
{"Row" : 26, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO BID 5 DAYS", "DisplayText" : "Doxycycline 100MG PO BID 5 DAYS", "Text" :""},
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID CEFTRIAXONE 1GM + DOXY 100MG IVPB Q12H 14 DAYS", "DisplayText" : "Ceftriaxone 1GM + Doxycycline 100MG", "Text" : ""},
{"Row" : 28, "Column" : 1, "Text" : "UpToDate. Infections due to non-O1/O139 Vibrio cholera. Last updated 06/12"}, 
{"Row" : 30, "Column" : 1, "Text" : "Sanford Guide- web edition \"Vibrio parahaemolyticus\" and"}, 
{"Row" : 31, "Column" : 1, "Text" : "\"Gastroenteritis, Vibrio sp.\" Last accessed 12/12/17."}, 
{"Row" : 33, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 34, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 36, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX NOSOCOMIAL A. BAUMANNII", "DisplayText" : "Nosocomial pneumonia with Acinetobacter baumannii", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "618061", "DisplayText" : "", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "NOSOCOMIAL PNEUMONIA WITH ACINETOBACTER BAUMANNII"}, 
{"Row" : 13, "Column" : 1, "Text" : "are often resistant to most therapies."}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "Infectious Diseases consultation is essential for cases with Acinetobacter which"}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 22, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 23, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 24, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 25, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 26, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003, 37: 1405"}, 
{"Row" : 27, "Column" : 1, "Text" : "Roig J  J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 28, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 29, "Column" : 1, "Text" : "Up-to-date accessed 6/24/12"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous  Am J Respir Crit Care Med 2005, 171: 388"}
]},
{"Name" : "ORZID2 GMENU ABX NOSOCOMIAL ESBL+ ENTEROBACT", "DisplayText" : "Extended-spectrum beta-lactamase producing (ESBL+) Enterobacteriaceae ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "618061", "DisplayText" : "", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "NOSOCOMIAL PNEUMONIA WITH EXTENDED-SPECTRUM BETA-LACTAMASE PRODUCING (ESBL+)"}, 
{"Row" : 13, "Column" : 1, "Text" : "The MVAMC microbiology laboratory tests for extended spectrum beta-lactamases in"}, 
{"Row" : 14, "Column" : 1, "Text" : "all E. coli, Klebsiella, and Proteus isolates that display susceptibility"}, 
{"Row" : 15, "Column" : 1, "Text" : "patterns suggestive of ESBL production.  Other Enterobacteriaceae produce ESBL"}, 
{"Row" : 16, "Column" : 1, "Text" : "less commonly but practical tests are not available for these.  If ESBL is"}, 
{"Row" : 18, "Column" : 1, "Text" : "microbiology laboratory for more information."}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID ERTAPENEM 1GM IV Q24H", "DisplayText" : "Ertapenem 1GM IVPB Q24H", "Text" : "Ertapenem 1 gm IV q24h ($28/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 11, "Column" : 1, "Text" : "ENTEROBACTERIACEAE"}, 
{"Row" : 17, "Column" : 1, "Text" : "suspected regardless of testing, consult Infectious Diseases and/or the"}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 26, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 27, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 28, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 29, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 30, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 31, "Column" : 1, "Text" : "Roig J  J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 32, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-date accessed 2/10"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous  Am J Respir Crit Care Med 2005, 171: 388"}
]},
{"Name" : "ORZID2 GMENU ABX NOT BENEFITED PHARYNGITIS", "DisplayText" : "PHARYNGITIS  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 6, "Column" : 1, "Text" : "PHARYNGITIS", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Acute pharyngitis is common, accounting for 2 percent of all"}, 
{"Row" : 9, "Column" : 1, "Text" : "ambulatory visits in the United States.  The major treatable pathogen, group"}, 
{"Row" : 10, "Column" : 1, "Text" : "A streptococcus (GAS), is the cause of pharyngitis in only approximately 10"}, 
{"Row" : 11, "Column" : 1, "Text" : "percent of adults who seek medical care.  The vast majority of patients"}, 
{"Row" : 12, "Column" : 1, "Text" : "receive presumptive antibiotic therapy for pharyngitis which in most cases is"}, 
{"Row" : 13, "Column" : 1, "Text" : "unnecessary and results in adverse effects including death, increases costs,"}, 
{"Row" : 14, "Column" : 1, "Text" : "and adds to pressure on antimicrobial resistance.  Typical causes of"}, 
{"Row" : 15, "Column" : 1, "Text" : "pharyngitis include viruses in about , beta-hemolytic streptococci other"}, 
{"Row" : 16, "Column" : 1, "Text" : "than group A in 18%, Mycoplasma pneumoniae in 10%, Chlamydophila pneumoniae"}, 
{"Row" : 17, "Column" : 1, "Text" : "in 8%, Group A streptococci in 5%, and no microbe identified in 1/3."}, 
{"Row" : 19, "Column" : 1, "Text" : "Rheumatic fever is rare in the United States, especially in adults, so"}, 
{"Row" : 20, "Column" : 1, "Text" : "that some authorities recommend no treatment even if GAS is a potential cause"}, 
{"Row" : 21, "Column" : 1, "Text" : "of pharyngitis.Others feel it is important to detect GAS  since antibiotic"}, 
{"Row" : 22, "Column" : 1, "Text" : "therapy can slightly shorten the acute illness, prevent acute rheumatic fever"}, 
{"Row" : 23, "Column" : 1, "Text" : "and possibly prevent suppurative sequelae.  Other potential causes of"}, 
{"Row" : 24, "Column" : 1, "Text" : "pharyngitis that should be considered and diagnosed if likely include"}, 
{"Row" : 25, "Column" : 1, "Text" : "Epstein-Barr virus (EBV) mononucleosis, primary HIV infection, influenza,"}, 
{"Row" : 26, "Column" : 1, "Text" : "gonococcal pharyngitis, diphtheria, and suppurative pharyngeal infections."}, 
{"Row" : 28, "Column" : 1, "Text" : "The Centor criteria are used to predict whether GAS pharyngitis is present."}, 
{"Row" : 30, "Column" : 1, "Text" : "*  Tonsillar exudates"}, 
{"Row" : 31, "Column" : 1, "Text" : "*  Tender anterior cervical adenopathy"}, 
{"Row" : 32, "Column" : 1, "Text" : "*  Fever by history"}, 
{"Row" : 33, "Column" : 1, "Text" : "*  Absence of cough"}, 
{"Row" : 35, "Column" : 1, "Text" : "If three or four of these criteria are met, the positive predictive value is"}, 
{"Row" : 36, "Column" : 1, "Text" : "40 to 60 percent.  If fewer than three criteria are present, the likelihood"}, 
{"Row" : 37, "Column" : 1, "Text" : "GAS is causing pharyngitis is less than 20 percent.  If 3 or > Centor criteria"}, 
{"Row" : 38, "Column" : 1, "Text" : "are met, obtain a throat culture for group A streptococcus.  Treat"}, 
{"Row" : 39, "Column" : 1, "Text" : "empirically for GAS if the patient has severe symptoms or treat later for GAS"}, 
{"Row" : 40, "Column" : 1, "Text" : "if the throat culture is positive."}, 
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 44, "Column" : 1, "Text" : "\"Mandell\" chapter: Pharyngitis"}, 
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Infectious Diseases", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU ABX NOT BENEFITTED BACTERURIA", "DisplayText" : "BACTERURIA, CANDIDURIA, AND PYURIA", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 6, "Column" : 1, "Text" : "BACTERURIA, CANDIDURIA, AND PYURIA", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Bacteruria, (>= 100,000 bacteria per ml of urine) is found in  1 or 2"}, 
{"Row" : 9, "Column" : 1, "Text" : "percent of healthy young children.  Bacteruria becomes more common in females"}, 
{"Row" : 10, "Column" : 1, "Text" : "after menarche, occurring in ~5 percent of young women.  The incidence"}, 
{"Row" : 11, "Column" : 1, "Text" : "increases substantially after middle age such that from 10 to 16 percent of"}, 
{"Row" : 12, "Column" : 1, "Text" : "healthy people over age 55 years living in the community have bacteruria."}, 
{"Row" : 13, "Column" : 1, "Text" : "The incidence is 15 to 40% of people over age 55 living in long-term care"}, 
{"Row" : 14, "Column" : 1, "Text" : "institutions.  The incidence in people with chronic diseases is increased"}, 
{"Row" : 15, "Column" : 1, "Text" : "compared with healthy people.  Candiduria is less common, but the"}, 
{"Row" : 16, "Column" : 1, "Text" : "implications of candiduria are similar to those of bacteruria."}, 
{"Row" : 18, "Column" : 1, "Text" : "Table 2. Prevelene of asymptomatic bacteriuria in selected populations.", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "_____________________________________________________________________________"}, 
{"Row" : 20, "Column" : 1, "Text" : "Population Prevelence"}, 
{"Row" : 21, "Column" : 1, "Text" : "_____________________________________________________________________________"}, 
{"Row" : 22, "Column" : 1, "Text" : "Healthy, premenopausal women  1.0-5.0"}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnant women  1.9-9.5"}, 
{"Row" : 24, "Column" : 1, "Text" : "Postmenopausal women aged 50-70  2.8-8.6"}, 
{"Row" : 25, "Column" : 1, "Text" : "Diabetic Patients"}, 
{"Row" : 26, "Column" : 1, "Text" : "Women 9.0-27"}, 
{"Row" : 27, "Column" : 1, "Text" : "Men0.7"}, 
{"Row" : 28, "Column" : 1, "Text" : "Elderly persons in the community"}, 
{"Row" : 29, "Column" : 1, "Text" : "Women10.8-16"}, 
{"Row" : 30, "Column" : 1, "Text" : "Men3.6"}, 
{"Row" : 31, "Column" : 1, "Text" : "Elderly persons in a long-term care facility"}, 
{"Row" : 32, "Column" : 1, "Text" : "Women 25-50"}, 
{"Row" : 33, "Column" : 1, "Text" : "Men 15"}, 
{"Row" : 34, "Column" : 1, "Text" : "Patients with spinal cord injuries"}, 
{"Row" : 35, "Column" : 1, "Text" : "Intermittent catheter use 23-89"}, 
{"Row" : 36, "Column" : 1, "Text" : "Sphincterotomy & condom catheter in place 57"}, 
{"Row" : 37, "Column" : 1, "Text" : "Patients undergoing hemodialysis  28"}, 
{"Row" : 38, "Column" : 1, "Text" : "Patients with indwelling catheter use"}, 
{"Row" : 39, "Column" : 1, "Text" : "Short-term 9"}, 
{"Row" : 40, "Column" : 1, "Text" : "Long-term  1"}, 
{"Row" : 41, "Column" : 1, "Text" : "_____________________________________________________________________________"}, 
{"Row" : 43, "Column" : 1, "Text" : "Pyuria is common in persons with bacteruria.  Pyuria is present with"}, 
{"Row" : 44, "Column" : 1, "Text" : "asymptomatic bacteruria in ~32% of young women, 30%-70% of pregnant women,"}, 
{"Row" : 45, "Column" : 1, "Text" : "70% of diabetic women, 90% of elderly institutionalized patients, 90% of"}, 
{"Row" : 46, "Column" : 1, "Text" : "hemodialysis patients, 30%-75% of bacteruric patients with short-term"}, 
{"Row" : 47, "Column" : 1, "Text" : "catheters in place, and 50%-100% of individuals with long-term indwelling"}, 
{"Row" : 48, "Column" : 1, "Text" : "catheters in place.  Thus, by itself, the presence of pyuria is not"}, 
{"Row" : 49, "Column" : 1, "Text" : "sufficient to diagnose bacteruria, and the presence or absence of pyuria does"}, 
{"Row" : 50, "Column" : 1, "Text" : "not differentiate symptomatic from asymptomatic urinary infection."}, 
{"Row" : 51, "Column" : 1, "Text" : "Many studies, including randomized clinical trials have shown that"}, 
{"Row" : 52, "Column" : 1, "Text" : "treatment of asymptomatic bacteruria, with or without pyuria is of no"}, 
{"Row" : 53, "Column" : 1, "Text" : "benefit, except in three well-defined circumstances.  Antimicrobial therapy"}, 
{"Row" : 54, "Column" : 1, "Text" : "is always accompanied by risk of harms, including drug reactions, Clostridium"}, 
{"Row" : 55, "Column" : 1, "Text" : "difficile colitis, anaphylaxis and death.  Except in circumstances specified"}, 
{"Row" : 56, "Column" : 1, "Text" : "below, it is best to not order urinalysis or urine culture in asymptomatic"}, 
{"Row" : 57, "Column" : 1, "Text" : "persons.  If bacteruria or pyuria is discovered in an asymptomatic person for"}, 
{"Row" : 58, "Column" : 1, "Text" : "some reason, antimicrobial therapy should not be given except as specified"}, 
{"Row" : 59, "Column" : 1, "Text" : "below."}, 
{"Row" : 61, "Column" : 1, "Text" : "Pregnant women", "Header" : 1}, 
{"Row" : 62, "Column" : 1, "Text" : "Pregnant women have an increased incidence of bacteruria, from 2 to"}, 
{"Row" : 63, "Column" : 1, "Text" : "10%.  The risk of pyelonephritis in pregnant women with bacteruria is"}, 
{"Row" : 64, "Column" : 1, "Text" : "increased 25-fold.  Antimicrobial therapy to eradicate bacteruria in pregnant"}, 
{"Row" : 65, "Column" : 1, "Text" : "women reduces the risk of pyelonephritis.  Pregnant women should be tested"}, 
{"Row" : 66, "Column" : 1, "Text" : "for bacteruria and treated if it is detected."}, 
{"Row" : 68, "Column" : 1, "Text" : "Genitourinary surgery", "Header" : 1}, 
{"Row" : 69, "Column" : 1, "Text" : "Persons with bacteruria (defined for this situation as 10,000 or more"}, 
{"Row" : 70, "Column" : 1, "Text" : "bacteria/ml) who undergo traumatic genitourinary procedures associated with"}, 
{"Row" : 71, "Column" : 1, "Text" : "mucosal bleeding are at increased risk for post-procedure bacteremia and"}, 
{"Row" : 72, "Column" : 1, "Text" : "sepsis.  Persons about to have genitourinary procedures associated with"}, 
{"Row" : 73, "Column" : 1, "Text" : "mucosal bleeding should be tested for bacteruria.  If bacteruria is detected,"}, 
{"Row" : 74, "Column" : 1, "Text" : "antimicrobial therapy should be initiated shortly before the procedure."}, 
{"Row" : 75, "Column" : 1, "Text" : "Antimicrobial therapy should not be continued beyond the procedure, unless an"}, 
{"Row" : 76, "Column" : 1, "Text" : "indwelling catheter remains in place."}, 
{"Row" : 78, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 79, "Column" : 1, "Text" : "Nicolle, LE, et al:Infectious Diseases Society of America"}, 
{"Row" : 80, "Column" : 1, "Text" : "Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in"}, 
{"Row" : 81, "Column" : 1, "Text" : "Adults. Clin Infect Dis 2005"}, 
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"}
]},
{"Name" : "ORZID2 GMENU ABX OROLABIAL HERPES", "DisplayText" : "Orolabial Herpes", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT DOWNTOWN-INPT", "DisplayText" : "Fee Basis (Downtown Inpatient)", "Text" : "Need help with Dermatology?  Consult Dermatology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "OROLABIAL HERPES"}, 
{"Row" : 12, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Antiviral therapy is not beneficial after formation of vesicles.  However, when"}, 
{"Row" : 17, "Column" : 1, "Text" : "started as soon as prodromal symptoms of burning or tingling occur, antivirals"}, 
{"Row" : 18, "Column" : 1, "Text" : "reduce duration of pain and lesions."}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO 5X/DAYS", "DisplayText" : "Acyclovir 400MG PO 5x/days", "Text" : "Acyclovir 400 mg PO 5x/day for 5 days ($0.48/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Immunocompromised patients in whom herpes simplex infections can be more severe"}, 
{"Row" : 27, "Column" : 1, "Text" : "include: patients with HIV infection, organ transplant recipients, patients"}, 
{"Row" : 28, "Column" : 1, "Text" : "undergoing chemotherapy, malnourished patients, and those with compromised skin"}, 
{"Row" : 29, "Column" : 1, "Text" : "integrity."}, 
{"Row" : 31, "Column" : 1, "Text" : "Treatment for mild to moderate disease", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 33, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO 5X/DAYS", "DisplayText" : "Acyclovir 400MG PO 5x/days", "Text" : "Acyclovir 400 mg PO 5x/day ($0.48/day) [R] < OR >", "Mnemonic" : "14"},
{"Row" : 34, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm q12h for 7 days ($9/day) [R]", "Mnemonic" : "16"},
{"Row" : 36, "Column" : 1, "Text" : "Treatment for severe disease", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Treat 7 days."}, 
{"Row" : 38, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 5MG/KG IV Q8H", "DisplayText" : "Acyclovir 5 mg/kg IV Q8H", "Text" : "Acyclovir 5mg/kg IV q8h ($85/day) [R]", "Mnemonic" : "18"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Text" : "\"Mandell\" chapter: Herpes simplex virus"}, 
{"Row" : 44, "Column" : 1, "Text" : "\"Sanford\" keyword: Herpes simplex"}, 
{"Row" : 45, "Column" : 1, "Text" : "Jensen LA Ann Pharmacother 2004, 38: 705"}
]},
{"Name" : "ORZID2 GMENU ABX PARAINFLUENZA", "DisplayText" : "Parainfluenza", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "PARAINFLUENZA"}, 
{"Row" : 8, "Column" : 1, "Text" : "No specific antimicrobial therapy is indicated.  Contact infectious diseases for"}, 
{"Row" : 9, "Column" : 1, "Text" : "more information on management of this disease."}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU ABX PENICILLIN DESENS PROTOCOL", "DisplayText" : "Penicillin Desensitization Protocol  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID3 GMENU CONTACT CDSS PROJECT", "DisplayText" : "Contact the CDSS Project Staff", "Text" : "Contact CDSS project staff", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "PENICILLIN DESENSITIZATION PROTOCOL"}, 
{"Row" : 8, "Column" : 1, "Text" : "Pharmacy Service must be involved.  Contact satellite pharmacist at ext. 2040 or"}, 
{"Row" : 9, "Column" : 1, "Text" : "page 648-6746.  Infectious Diseases Consult strongly recommended."}, 
{"Row" : 11, "Column" : 1, "Text" : "When penicillin is the drug of choice for an infectious disease in a patient"}, 
{"Row" : 12, "Column" : 1, "Text" : "with Type I penicillin allergy, one option is to desensitize the patient."}, 
{"Row" : 13, "Column" : 1, "Text" : "Severe reactions cannot be predicted accurately with skin testing in the"}, 
{"Row" : 14, "Column" : 1, "Text" : "clinical setting."}, 
{"Row" : 16, "Column" : 1, "Text" : "Penicillin Desensitization", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "> Perform in an ICU or similar setting."}, 
{"Row" : 18, "Column" : 1, "Text" : "> Discontinue all beta-adrenergic antagonists."}, 
{"Row" : 19, "Column" : 1, "Text" : "> Have IV line in place and EKG and spirometer ready."}, 
{"Row" : 20, "Column" : 1, "Text" : "> Once desensitization has been accomplished, therapy with this drug must not"}, 
{"Row" : 22, "Column" : 1, "Text" : "> A history of Stevens Johnson syndrome, exfoliative dermatitis, or erythroderma"}, 
{"Row" : 25, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "ORAL ROUTE", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Oral route is preferred if oral preparation is available and GI tract is"}, 
{"Row" : 30, "Column" : 1, "Text" : "functional.  1/3 of patients will develop transient reaction, usually mild."}, 
{"Row" : 32, "Column" : 1, "Text" : "Step (15 min intervals)  [1] [2] [3] [4] [5] [6] [7] [8]", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Concentration (mg/ml)0.5 0.5 0.5 0.5 0.5 0.5 0.5 5.0"}, 
{"Row" : 34, "Column" : 1, "Text" : "Volume (ml) 0.1 0.2 0.4 0.8 1.6 3.2 6.4 1.2"}, 
{"Row" : 21, "Column" : 1, "Text" : "lapse or the risk of allergic reactions increases."}, 
{"Row" : 23, "Column" : 1, "Text" : "are nearly absolute contraindications to desensitization."}, 
{"Row" : 36, "Column" : 1, "Text" : "Step (15 min intervals)  [9][10][11][12][13][14]", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Concentration (mg/ml)5.0 5.0  50  50  50  50"}, 
{"Row" : 38, "Column" : 1, "Text" : "Volume (ml) 2.4 4.8 1.0 2.0 4.0 8.0"}, 
{"Row" : 40, "Column" : 1, "Text" : "After step 14, observe 30 minutes.  If no reaction, give 1 gm IV."}, 
{"Row" : 42, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "PARENTERAL ROUTE", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Step (15 min intervals)  [1] [2] [3] [4] [5] [6] [7] [8]", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Concentration (mg/ml)0.1 0.1 0.1 0.1 1.0 1.0 1.0  10"}, 
{"Row" : 48, "Column" : 1, "Text" : "Volume (ml) 0.1 0.2 0.4 0.80.160.320.640.12"}, 
{"Row" : 50, "Column" : 1, "Text" : "Step (15 min intervals)  [9][10][11][12][13][14][15][16]", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "Concentration (mg/ml) 10  10 100 100 100 10010001000"}, 
{"Row" : 52, "Column" : 1, "Text" : "Volume (ml)0.240.48 0.1 0.2 0.4 0.80.160.32"}, 
{"Row" : 54, "Column" : 1, "Text" : "Step (15 min intervals)  [17]", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "Concentration (mg/ml)1000"}, 
{"Row" : 56, "Column" : 1, "Text" : "Volume (ml) 0.64"}, 
{"Row" : 58, "Column" : 1, "Text" : "After step 17, observe 30 minutes.  If no reaction, give 1 gm IV."}, 
{"Row" : 61, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 62, "Column" : 1, "Text" : "\"Sanford\" key term: allergy"}, 
{"Row" : 63, "Column" : 1, "Text" : "Allergy: Principles and Practice 1993, p1726"}, 
{"Row" : 64, "Column" : 1, "Text" : "Curr Clin Topics Inf Dis 1993, 13:131"}
]},
{"Name" : "ORZID2 GMENU ABX PERICARDITIS", "DisplayText" : "Pericarditis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PERICARDITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Most cases arise from non-infectious causes, or are associated with viruses."}, 
{"Row" : 13, "Column" : 1, "Text" : "Antimicrobial therapy is not indicated unless pericardial fluid is purulent.  If"}, 
{"Row" : 14, "Column" : 1, "Text" : "so, empirical therapy should guided by gram stain.  If gram stain is negative,"}, 
{"Row" : 15, "Column" : 1, "Text" : "treat with:"}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZ SET ABX VAN 1 GM IV Q12H CIPRO 400 MG IV Q12H", "DisplayText" : "VANCO 1 GM IV Q12H CIPRO 400 MG IV Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R] <AND> ciprofloxacin 400 mg IV q12h", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "($5.92/day) [R,DI]"}, 
{"Row" : 20, "Column" : 1, "Text" : "Cardiology consultation is essential.  Infectious diseases consultation is"}, 
{"Row" : 21, "Column" : 1, "Text" : "recommended if an infectious origin is suspected."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Myocarditis and Pericarditis\""}
]},
{"Name" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "FORSTER,KEITH A  CLINICAL PHARMACIST"}, 
{"Row" : 7, "Column" : 1, "Text" : "OFFICE PHONE:3995"}, 
{"Row" : 8, "Column" : 1, "Text" : "VOICE PAGER:  MAIL CODE:11C-G"}, 
{"Row" : 9, "Column" : 1, "Text" : "DIGITAL PAGER:856 ROOM:GOLD"}, 
{"Row" : 11, "Column" : 1, "Text" : "HASS,JONATHAN PAUL  CLINICAL PHARMACIST"}, 
{"Row" : 12, "Column" : 1, "Text" : "OFFICE PHONE:3304"}, 
{"Row" : 13, "Column" : 1, "Text" : "VOICE PAGER:  MAIL CODE:11C"}, 
{"Row" : 14, "Column" : 1, "Text" : "DIGITAL PAGER:735 ROOM:1006"}, 
{"Row" : 16, "Column" : 1, "Text" : "KOO,JI MCLINICAL PHARMACY COORDINATOR"}, 
{"Row" : 17, "Column" : 1, "Text" : "OFFICE PHONE:3160"}, 
{"Row" : 18, "Column" : 1, "Text" : "VOICE PAGER:  MAIL CODE:11C-D"}, 
{"Row" : 19, "Column" : 1, "Text" : "DIGITAL PAGER:842 ROOM:3133"}, 
{"Row" : 21, "Column" : 1, "Text" : "GOODKIN,JACQUELINE DCLINICAL PHARMACIST"}, 
{"Row" : 22, "Column" : 1, "Text" : "OFFICE PHONE:2898"}, 
{"Row" : 23, "Column" : 1, "Text" : "VOICE PAGER:  MAIL CODE:119"}, 
{"Row" : 24, "Column" : 1, "Text" : "DIGITAL PAGER:792 ROOM:3078"}, 
{"Row" : 26, "Column" : 1, "Text" : "KRENZ,TAMMY L CLINICAL PHARMACIST"}, 
{"Row" : 27, "Column" : 1, "Text" : "OFFICE PHONE:3859"}, 
{"Row" : 28, "Column" : 1, "Text" : "VOICE PAGER:  MAIL CODE:119"}, 
{"Row" : 29, "Column" : 1, "Text" : "DIGITAL PAGER:949 ROOM:1045"}, 
{"Row" : 31, "Column" : 1, "Text" : "WOLF,PAMELA K CLINICAL PHARMACIST"}, 
{"Row" : 32, "Column" : 1, "Text" : "OFFICE PHONE:3152"}, 
{"Row" : 33, "Column" : 1, "Text" : "VOICE PAGER:  MAIL CODE:116A"}, 
{"Row" : 34, "Column" : 1, "Text" : "DIGITAL PAGER:756 ROOM:4060"}
]},
{"Name" : "ORZID2 GMENU ABX PID", "DisplayText" : "Pelvic Inflammatory Disease ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic (getting guidance)", "Mnemonic" : "12"},
{"Row" : 9, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "PELVIC INFLAMMATORY DISEASE"}, 
{"Row" : 14, "Column" : 1, "Text" : "Pelvic inflammatory disease (PID) refers to bacterial infection of the upper"}, 
{"Row" : 15, "Column" : 1, "Text" : "female reproductive tract.  Likely bacterial pathogens include Neisseria"}, 
{"Row" : 16, "Column" : 1, "Text" : "gonorrhoeae, Chlamydia trachomatis, anaerobes, enteric Gram-negative rods, and"}, 
{"Row" : 17, "Column" : 1, "Text" : "Streptococcus agalactiae.  PID should be considered in sexually active women"}, 
{"Row" : 18, "Column" : 1, "Text" : "with pelvic tenderness and  signs of lower genital tract inflammation.  Signs"}, 
{"Row" : 19, "Column" : 1, "Text" : "and  symptoms may be mild or non-specific, and  providers should have a low"}, 
{"Row" : 20, "Column" : 1, "Text" : "threshold to initiate treatment. Male sex partners of patients with PID should"}, 
{"Row" : 21, "Column" : 1, "Text" : "be examined and  treated if they had sexual contact within the 60 days preceding"}, 
{"Row" : 22, "Column" : 1, "Text" : "the patient's onset of symptoms."}, 
{"Row" : 24, "Column" : 1, "Text" : "Judge severity of infection based on clinical signs and symptoms, including"}, 
{"Row" : 25, "Column" : 1, "Text" : "blood pressure, pulse, mental status, and degree of fever."}, 
{"Row" : 27, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 32, "Column" : 1, "Item" : "ORZ SET ABX CIPROFL 500MG PO Q12H METRONIDAZOLE 500MG PO Q12H", "DisplayText" : "CIPROFL 500MG PO Q12H METRONIDAZOLE 500MG PO Q12H", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] <AND> metronidazole 500 mg PO", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Item" : "ORZ SET ABX CEFTR 250MG IM DOXYC 100MG PO METRO 500MG PO", "DisplayText" : "Ceftriaxone 250MG IM, Doxycycline 100MG PO BID Metroni 500MG PO BID", "Text" : "Ceftriaxone 250 mg IM once($16/day) [M] <AND> doxycycline 100 mg PO q12h", "Mnemonic" : "18"},
{"Row" : 38, "Column" : 1, "Text" : "Preferred treatment of sex partner", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Treat for both Chlamydia and  Gonorrhea"}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZ SET ABX CEF 125MG IM ONCE DOXYCL 100MG PO Q12H", "DisplayText" : "CEFTRIAX 125MG IM ONCE DOXYCL 100MG PO Q12H", "Text" : "Ceftriaxone 125 mg IM once ($16/day) [M] <AND> doxycycline 100 mg PO q12h for 7", "Mnemonic" : "20"},
{"Row" : 41, "Column" : 1, "Text" : "days ($0.16/day) [DI]  < OR >"}, 
{"Row" : 43, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAX 125MG IM ONCE AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "CEFTRIAX 125MG IM ONCE AZITHROMYCIN 1GM PO ONCE", "Text" : "Ceftriaxone 125 mg IM once ($16/day) [M] <AND> azithromycin 1 gm PO once", "Mnemonic" : "22"},
{"Row" : 44, "Column" : 1, "Text" : "($4.09/day) [M]"}, 
{"Row" : 46, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Item" : "ORZ SET ABX CIP 500MG PO ONCE DOXYCL 100MG PO Q12H", "DisplayText" : "CIPROFL 500MG PO ONCE DOXYCL 100MG PO Q12H", "Text" : "Ciprofloxacin 500 mg PO once ($0.18/day) [R,DI] <AND> doxycycline 100 mg PO", "Mnemonic" : "24"},
{"Row" : 50, "Column" : 1, "Item" : "ORZ SET ABX CIPROFL 500MG PO ONCE AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "CIPROFL 500MG PO ONCE AZITHROMYCIN 1GM PO ONCE", "Text" : "Ciprofloxacin 500 mg PO once($0.18/day) [E,DI] <AND> azithromycin 1 gm PO once", "Mnemonic" : "26"},
{"Row" : 51, "Column" : 1, "Text" : "($4.09/day) [M]"}, 
{"Row" : 53, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 58, "Column" : 1, "Item" : "ORZ SET ABX CEFOTETAN 2GM IV Q12H DOXYCL 100MG PO Q12H", "DisplayText" : "CEFOTETAN 2GM IV Q12H DOXYCL 100MG PO Q12H", "Text" : "Cefotetan 2 gm IV q12h ($44/day) [R] <AND> doxycycline 100 mg PO q12h", "Mnemonic" : "28"},
{"Row" : 59, "Column" : 1, "Text" : "($0.16/day) [DI]  < OR >"}, 
{"Row" : 61, "Column" : 1, "Item" : "ORZ SET ABX CEFOT 2GM IV Q12H DOXYCL 100MG IV Q12H", "DisplayText" : "CEFOTETAN 2GM IV Q12H DOXYCL 100MG IV Q12H", "Text" : "Cefotetan 2 gm IV q12h ($44/day) [R] <AND> doxycycline 100 mg IV q12h", "Mnemonic" : "30"},
{"Row" : 62, "Column" : 1, "Text" : "($14/day) [DI]  < OR >"}, 
{"Row" : 64, "Column" : 1, "Item" : "ORZ SET ABX CLINDAMYCIN 900MG IV Q8H GENT 5 MG/KG QD", "DisplayText" : "CLINDAMYCIN 900MG IV Q8H GENT 5 MG/KG QD", "Text" : "Clindamycin 900 mg IV q8h ($25/day) [H,O] <AND> gentamicin 5 mg/kg Q24h", "Mnemonic" : "32"},
{"Row" : 65, "Column" : 1, "Text" : "($3/day) [R, O]"}, 
{"Row" : 67, "Column" : 1, "Text" : "Preferred treatment of sex partner", "Header" : 1}, 
{"Row" : 68, "Column" : 1, "Text" : "Treat for both Chlamydia and  Gonorrhea."}, 
{"Row" : 69, "Column" : 1, "Item" : "ORZ SET ABX CEF 125MG IM ONCE DOXYCL 100MG PO Q12H", "DisplayText" : "CEFTRIAX 125MG IM ONCE DOXYCL 100MG PO Q12H", "Text" : "Ceftriaxone 125 mg IM once ($16/day) [M] <AND> doxycycline 100 mg PO q12h for 7", "Mnemonic" : "34"},
{"Row" : 70, "Column" : 1, "Text" : "days($0.16/day) [DI]  < OR >"}, 
{"Row" : 72, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAX 125MG IM ONCE AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "CEFTRIAX 125MG IM ONCE AZITHROMYCIN 1GM PO ONCE", "Text" : "Ceftriaxone 125 mg IM once ($16/day) [M] <AND> azithromycin 1 gm PO once", "Mnemonic" : "36"},
{"Row" : 73, "Column" : 1, "Text" : "($4.09/day) [M]"}, 
{"Row" : 75, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 76, "Column" : 1, "Item" : "ORZ SET ABX CIP 500MG PO ONCE DOXYCL 100MG PO Q12H", "DisplayText" : "CIPROFL 500MG PO ONCE DOXYCL 100MG PO Q12H", "Text" : "Ciprofloxacin 500 mg PO once ($0.18/day) [R,DI] <AND> doxycycline 100 mg PO", "Mnemonic" : "38"},
{"Row" : 79, "Column" : 1, "Item" : "ORZ SET ABX CIPROFL 500MG PO ONCE AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "CIPROFL 500MG PO ONCE AZITHROMYCIN 1GM PO ONCE", "Text" : "Ciprofloxacin 500 mg PO once($0.18/day) [R,DI] <AND> azithromycin 1 gm PO once", "Mnemonic" : "40"},
{"Row" : 80, "Column" : 1, "Text" : "($4.09/day) [M]"}, 
{"Row" : 83, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "42"},
{"Row" : 85, "Column" : 1, "Text" : "MMWR 2002, 51: RR-06 Sexually transmitted diseases: treatment guide"}, 
{"Row" : 86, "Column" : 1, "Text" : "\"Sanford\" 2005, keyword \"pelvic inflammatory disease\""}, 
{"Row" : 33, "Column" : 1, "Text" : "q12h  ($0.32/day) [DI] < OR >"}, 
{"Row" : 36, "Column" : 1, "Text" : "($0.16/day) [DI] <AND> metronidazole 500 mg PO q12h  ($0.32/day) [DI]"}, 
{"Row" : 48, "Column" : 1, "Text" : "q12h  for 7 days ($0.16/day) [DI] < OR >"}, 
{"Row" : 77, "Column" : 1, "Text" : "q12h  for 7 days($0.16/day) [DI] < OR >"}
]},
{"Name" : "ORZID2 GMENU ABX PRIM INFECT CHICKENPOX", "DisplayText" : "Primary infection (Chickenpox) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Need help with Gastroenterology?  Consult Inpatient Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT DOWNTOWN-INPT", "DisplayText" : "Fee Basis (Downtown Inpatient)", "Text" : "Need help with Dermatology?  Consult Dermatology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Vaccinate susceptible persons, including persons with immunocompromised family"}, 
{"Row" : 19, "Column" : 1, "Text" : "members, teachers, health care workers, child care workers, institutional"}, 
{"Row" : 20, "Column" : 1, "Text" : "residents and workers, college students, inmates, and adults and adolescents"}, 
{"Row" : 21, "Column" : 1, "Text" : "living in households with children.  Test antibody first in adults who have"}, 
{"Row" : 22, "Column" : 1, "Text" : "uncertain history of chickenpox or vaccination."}, 
{"Row" : 23, "Column" : 1, "Text" : "Give Varicella vaccine x 2, 2nd dose 4-8 weeks after 1st dose"}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Therapy must be started within 24 hrs onset of rash.  Treat for 5 to 7 days."}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 800MG PO 5X/D", "DisplayText" : "Acyclovir 800MG PO 5x/d", "Text" : "Acyclovir 800 mg PO 5x/d ($0.96/day) [R]", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q8H", "DisplayText" : "Valacyclovir 1gm po q8h", "Text" : "Valacyclovir 1 gm PO q8h ($13/day) [R]", "Mnemonic" : "16"},
{"Row" : 32, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Immunocompromised patients without prior immunity to varicella who are at risk"}, 
{"Row" : 38, "Column" : 1, "Text" : "for disease include: patients with malignancy, current immunosuppressive"}, 
{"Row" : 39, "Column" : 1, "Text" : "therapy, or HIV infection.  Vaccination is not recommended while patients are"}, 
{"Row" : 40, "Column" : 1, "Text" : "immunocompromised.  For household or healthcare-associated exposure to"}, 
{"Row" : 41, "Column" : 1, "Text" : "varicella, varicella zoster immune globulin should be given within 96 hours of"}, 
{"Row" : 45, "Column" : 1, "Text" : "Treatment for mild to moderate disease", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 800MG PO 5X/D", "DisplayText" : "Acyclovir 800MG PO 5x/d", "Text" : "Acyclovir 800 mg PO 5x/day ($1/day) [R]  < OR >", "Mnemonic" : "18"},
{"Row" : 48, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q8H", "DisplayText" : "Valacyclovir 1gm po q8h", "Text" : "Valacyclovir 1000 mg PO q8h ($13/day) [R]", "Mnemonic" : "20"},
{"Row" : 50, "Column" : 1, "Text" : "Treatment for severe disease, or if mild to moderate disease doesn't improve on", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "above therapy", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Text" : "Treat for 7 days."}, 
{"Row" : 53, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 10MG/KG IV Q8H", "DisplayText" : "Acyclovir 10MG/KG IV Q8H", "Text" : "Acyclovir 10-12 mg/kg IV q8h ($169/day) [R]", "Mnemonic" : "22"},
{"Row" : 56, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 11, "Column" : 1, "Text" : "PRIMARY INFECTION (CHICKENPOX)"}, 
{"Row" : 46, "Column" : 1, "Text" : "Treat for 7 days."}, 
{"Row" : 42, "Column" : 1, "Text" : "exposure.  This product is currently unavailable as the manufacturer has ceased"}, 
{"Row" : 43, "Column" : 1, "Text" : "production.  Contact Infectious Diseases for more information."}, 
{"Row" : 58, "Column" : 1, "Text" : "\"Sanford\" keyword: Varicella"}, 
{"Row" : 59, "Column" : 1, "Text" : "\"Mandell\" chapter: Varicella"}
]},
{"Name" : "ORZID2 GMENU ABX REF JOURN (A-C)", "DisplayText" : "Journal References (Author Lastname: A-C)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Anonymous.  Antibiotic prophylaxis for urological patients with total joint"}, 
{"Row" : 4, "Column" : 1, "Text" : "replacement.  Advisory statement, American Urological Association And"}, 
{"Row" : 5, "Column" : 1, "Text" : "American Academy Of Orthopaedic Surgeons.  J Urol 2003, 169: 1796"}, 
{"Row" : 6, "Column" : 1, "Text" : "Anonymous.  Antifungal drugs.  Med Letter Treatment Guidelines 2005, 3: 7"}, 
{"Row" : 7, "Column" : 1, "Text" : "Anonymous.  Antimicrobial prophylaxis in surgery.  Med Lett 2001, 43: 92"}, 
{"Row" : 8, "Column" : 1, "Text" : "Anonymous.  ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery."}, 
{"Row" : 9, "Column" : 1, "Text" : "Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 10, "Column" : 1, "Text" : "Anonymous.  Choice of antibacterial drugs.  Med Letter Treatment Guidelines"}, 
{"Row" : 11, "Column" : 1, "Text" : "2004, 2: 13"}, 
{"Row" : 12, "Column" : 1, "Text" : "Anonymous.  Guidelines for the management of adults with hospital-acquired,"}, 
{"Row" : 13, "Column" : 1, "Text" : "ventilator-associated, and healthcare-associated pneumonia.  Am J Respir"}, 
{"Row" : 14, "Column" : 1, "Text" : "Crit Care Med 2005, 171: 388"}, 
{"Row" : 15, "Column" : 1, "Text" : "Anonymous.  Prevention of wound infection and sepsis in surgical patients.  Med"}, 
{"Row" : 16, "Column" : 1, "Text" : "Lett 2001, 43: 92"}, 
{"Row" : 17, "Column" : 1, "Text" : "Baddour et al. Infective endocarditis: diagnosis, antimicrobial therapy, and"}, 
{"Row" : 18, "Column" : 1, "Text" : "management of complications.  AHA scientific statement.  Circulation 2005,"}, 
{"Row" : 19, "Column" : 1, "Text" : "111: e394-e433."}, 
{"Row" : 20, "Column" : 1, "Text" : "Baddour LM, et al.  Nonvalvular cardiovascular device-related infections.  AHA"}, 
{"Row" : 21, "Column" : 1, "Text" : "Scientific Statement.  Circulation 2003, 108: 2015-31."}, 
{"Row" : 22, "Column" : 1, "Text" : "Bartlett JG.  Antibiotic-associated diarrhea.  NEJM 2002, 346:334"}, 
{"Row" : 23, "Column" : 1, "Text" : "Baum J.  Infections of the eye.  Clin Infect Dis 1995, 21: 479"}, 
{"Row" : 24, "Column" : 1, "Text" : "Beutner KR, et al.  Valacyclovir compared with acyclovir for improved therapy"}, 
{"Row" : 25, "Column" : 1, "Text" : "for herpes zoster in immunocompetent adults.  Antimicrob Ag Chemother 1995,"}, 
{"Row" : 26, "Column" : 1, "Text" : "39:1546."}, 
{"Row" : 27, "Column" : 1, "Text" : "Bisno AL, et al.  Practice guidelines for the diagnosis and management of group"}, 
{"Row" : 28, "Column" : 1, "Text" : "A streptococcal pharyngitis.  Clin Infect Dis 2002, 35: 113"}, 
{"Row" : 29, "Column" : 1, "Text" : "Boivin G, et al.  Predicting influenza infections during epidemics with use of a"}, 
{"Row" : 30, "Column" : 1, "Text" : "clinical case definition. Clin Infect Dis 2000, 31: 1166."}, 
{"Row" : 31, "Column" : 1, "Text" : "Bratzler, DW, et al.  Antimicrobial prophylaxis for surgery: an advisory"}, 
{"Row" : 32, "Column" : 1, "Text" : "statement from the national surgical infection prevention project.  Clin"}, 
{"Row" : 33, "Column" : 1, "Text" : "Infect Dis 2004, 38: 1706"}, 
{"Row" : 34, "Column" : 1, "Text" : "Byl B, et al.  Antibiotic prophylaxis for infectious complications after"}, 
{"Row" : 35, "Column" : 1, "Text" : "therapeutic endoscopic retrograde cholangiopancreatography: a randomized,"}, 
{"Row" : 36, "Column" : 1, "Text" : "double-blind, placebo-controlled study.  Clin Infect Dis 1995, 20: 1236"}, 
{"Row" : 37, "Column" : 1, "Text" : "Calderone RR, et al.  Overview and classification of spinal infections.  Ortho"}, 
{"Row" : 38, "Column" : 1, "Text" : "Clin N Amer 1996, 27: 1"}, 
{"Row" : 39, "Column" : 1, "Text" : "Casburn-Jones AC, et al.  Management of infectious diarrhea.  Gut 2004, 53:296-"}, 
{"Row" : 40, "Column" : 1, "Text" : "305"}, 
{"Row" : 41, "Column" : 1, "Text" : "Center for Disease Control.  MMWR 2002, 51: 73-6"}, 
{"Row" : 42, "Column" : 1, "Text" : "Center for Disease Control and Prevention. Sexually transmitted diseases"}, 
{"Row" : 43, "Column" : 1, "Text" : "treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002, 51(No. RR-6):1"}, 
{"Row" : 44, "Column" : 1, "Text" : "Chastre J et al.  Comparison of 8 vs 15 days of antibiotic therapy for"}, 
{"Row" : 45, "Column" : 1, "Text" : "ventilator-associated pneumonia in adults.  JAMA 2003, 290: 2588"}, 
{"Row" : 46, "Column" : 1, "Text" : "Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of"}, 
{"Row" : 47, "Column" : 1, "Text" : "prophylactic administration of antibiotics and the risk of surgical-wound"}, 
{"Row" : 48, "Column" : 1, "Text" : "infection. New England Journal of Medicine. 1992,326(5):281-286"}, 
{"Row" : 49, "Column" : 1, "Text" : "Cohen JI, et al.  Recent advances in varicella-zoster infection.  Ann Intern Med"}, 
{"Row" : 50, "Column" : 1, "Text" : "1999,130:922."}, 
{"Row" : 51, "Column" : 1, "Text" : "Couch RB.  Prevention and treatment of influenza.  N Engl J Med 2000, 343: 1778."}, 
{"Row" : 52, "Column" : 1, "Text" : "Cox NJ, Subbaro K.Influenza.  Lancet 354:1277, 1999."}, 
{"Row" : 53, "Column" : 1, "Text" : "Craven DE et al.  Healthcare-associated pneumonia in adults: management"}, 
{"Row" : 54, "Column" : 1, "Text" : "principles to improve outcomes. Infect Dis Clin N Am 2004, 18:939"}, 
{"Row" : 55, "Column" : 1, "Text" : "Cunha BA.  Osteomyelitis in elderly patients.  Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 1, "Column" : 1, "Text" : "CDSS Journal References (Author Lastname: A-C)", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX REF JOURN (D-J)", "DisplayText" : "Journal References (Author Lastname: D-J)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Delzell JE et al  Urinary tract infections during pregnancy.  Am Fam Physician"}, 
{"Row" : 4, "Column" : 1, "Text" : "2000, 61: 713"}, 
{"Row" : 5, "Column" : 1, "Text" : "Dennesen PJ et al.  Resolution of infectious parameters after antimicrobial"}, 
{"Row" : 6, "Column" : 1, "Text" : "therapy in patients with ventilator-associated pneumonia.  Am J Respir Crit"}, 
{"Row" : 7, "Column" : 1, "Text" : "Care Med 2001, 163: 1371"}, 
{"Row" : 8, "Column" : 1, "Text" : "Dryden MS, et al.  Empirical treatment of severe community-acquired diarrhea"}, 
{"Row" : 9, "Column" : 1, "Text" : "with ciprofloxacin.  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 10, "Column" : 1, "Text" : "Dupont HL, et al.  Persistent diarrhea in travelers.  Clin Infect Dis 1996,"}, 
{"Row" : 11, "Column" : 1, "Text" : "22:124"}, 
{"Row" : 12, "Column" : 1, "Text" : "Dupont HL, et al.  Rifaximin versus ciprofloxacin for the treatment of"}, 
{"Row" : 13, "Column" : 1, "Text" : "traveler's diarrhea.  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dworkin RH.  Prevention of postherpetic neuralgia.  Lancet 1999, 353:1636."}, 
{"Row" : 15, "Column" : 1, "Text" : "Frazee LA, et al.  Long-term prophylaxis of spontaneous bacterial peritonitis in"}, 
{"Row" : 16, "Column" : 1, "Text" : "patients with cirrhosis.  Ann Pharmacother 2005, 39: 908"}, 
{"Row" : 17, "Column" : 1, "Text" : "Gerding D, et al.  Clostridium-difficile associated diarrhea and colitis.  Inf"}, 
{"Row" : 18, "Column" : 1, "Text" : "Cont Hosp Epi 1995, 16:459"}, 
{"Row" : 19, "Column" : 1, "Text" : "Gorecki P, Schein M, Rucinski JC, Wise L. Antibiotic administration in patients"}, 
{"Row" : 20, "Column" : 1, "Text" : "undergoing common surgical procedures in a community teaching hospital: the"}, 
{"Row" : 21, "Column" : 1, "Text" : "chaos continues. World Journal of Surgery. 1999,23(5):429-432, discussion"}, 
{"Row" : 22, "Column" : 1, "Text" : "433."}, 
{"Row" : 23, "Column" : 1, "Text" : "Gould IM. A review of the role of antimicrobial policies in the control of"}, 
{"Row" : 24, "Column" : 1, "Text" : "antibiotic resistance. Journal of Antimicrobial Chemotherapy. 1999,43:459-"}, 
{"Row" : 25, "Column" : 1, "Text" : "465."}, 
{"Row" : 26, "Column" : 1, "Text" : "Guerrant RL, et al.  Practice guidelines for the management of infectious"}, 
{"Row" : 27, "Column" : 1, "Text" : "diarrhea.  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 28, "Column" : 1, "Text" : "Hanssen AD, Osmon DR. The use of prophylactic antimicrobial agents during and"}, 
{"Row" : 29, "Column" : 1, "Text" : "after hip arthroplasty. Clinical Orthopaedics & Related Research."}, 
{"Row" : 30, "Column" : 1, "Text" : "1999(369):124-138."}, 
{"Row" : 31, "Column" : 1, "Text" : "Harris A, et al.  Meta-analysis of antibiotic prophylaxis in endoscopic"}, 
{"Row" : 32, "Column" : 1, "Text" : "retrograde cholangiopancreatography (ERCP).  Endoscopy 1999, 31: 718"}, 
{"Row" : 33, "Column" : 1, "Text" : "Hewlett EL, et al.  Pertussis - not just for kids.  NEJM 2005, 352: 1215"}, 
{"Row" : 34, "Column" : 1, "Text" : "Hooton et al.  Acute uncomplicated cystitis in an era of increasing antibiotic"}, 
{"Row" : 35, "Column" : 1, "Text" : "resistance: a proposed approach to empiric therapy.  Clin Infect Dis"}, 
{"Row" : 36, "Column" : 1, "Text" : "2004:39:75"}, 
{"Row" : 37, "Column" : 1, "Text" : "Hughes WT, et al.  2002 guidelines for the use of antimicrobial agents in"}, 
{"Row" : 38, "Column" : 1, "Text" : "neutropenic patients with cancer.  Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 39, "Column" : 1, "Text" : "Interagency Task Force on Antimicrobial Resistance. A public health action plan"}, 
{"Row" : 40, "Column" : 1, "Text" : "to combat antimicrobial resistance.  Part I:  Domestic issues. Centers for"}, 
{"Row" : 41, "Column" : 1, "Text" : "Disease Control and Prevention, Atlanta, Georgia. 2000."}, 
{"Row" : 42, "Column" : 1, "Text" : "Jaeckel et al.  Treatment of acute hepatitis C with interferon alfa-2b.  NEJM"}, 
{"Row" : 43, "Column" : 1, "Text" : "2001, 345: 1452."}, 
{"Row" : 44, "Column" : 1, "Text" : "Jensen L et al.  Oral antivirals for the acute treatment of recurrent herpes"}, 
{"Row" : 45, "Column" : 1, "Text" : "labialis.  Ann Pharmacother 2004, 38:705."}, 
{"Row" : 46, "Column" : 1, "Text" : "Johnson RT.  Acute encephalitis. Clin Infect Dis 1996, 23:219."}, 
{"Row" : 47, "Column" : 1, "Text" : "Joshi N, et al.  Infections in patients with diabetes mellitus.  New Eng J Med"}, 
{"Row" : 48, "Column" : 1, "Text" : "1999, 341: 1906."}, 
{"Row" : 1, "Column" : 1, "Text" : "CDSS Journal References (Author Lastname: D-J)", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX REF JOURN (K-N)", "DisplayText" : "Journal References (Author Lastname: K-N)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Lew DP, et al.  Osteomyelitis.  Lancet 2004, 364: 369"}, 
{"Row" : 4, "Column" : 1, "Text" : "Lipsky BA et al.  Diagnosis and treatment of diabetic foot infections.  Clin"}, 
{"Row" : 5, "Column" : 1, "Text" : "Infect Dis 2004, 39: 885"}, 
{"Row" : 6, "Column" : 1, "Text" : "Little P et al.  Information leaflet and antibiotic prescribing strategies for"}, 
{"Row" : 7, "Column" : 1, "Text" : "acute lower respiratory tract infection.  JAMA 2005, 293: 3029"}, 
{"Row" : 8, "Column" : 1, "Text" : "Ljungman P, et al.  Treatment of interstitial pneumonitis due to cytomegalovirus"}, 
{"Row" : 9, "Column" : 1, "Text" : "with ganciclovir and intravenous immune globulin: experience of European"}, 
{"Row" : 10, "Column" : 1, "Text" : "bone marrow donor transplant group.  Clin Infect Dis 1992 14:831-5."}, 
{"Row" : 11, "Column" : 1, "Text" : "Luna CM, et al.  Resolution of ventilator-associated pneumonia: prospective"}, 
{"Row" : 12, "Column" : 1, "Text" : "evaluation of the clinical pulmonary infection score as an early clinical"}, 
{"Row" : 13, "Column" : 1, "Text" : "predictor of outcome.  Crit Care Med 2003, 31: 676"}, 
{"Row" : 14, "Column" : 1, "Text" : "Madigosky WS.  Does acyclovir help herpes simplex virus cold sores if treatment"}, 
{"Row" : 15, "Column" : 1, "Text" : "is delayed?  J Fam Prac 2004, 53: 923."}, 
{"Row" : 16, "Column" : 1, "Text" : "Magnus G.  Perioperative antibiotic prophylaxis in urology.  Curr Opin Urol"}, 
{"Row" : 17, "Column" : 1, "Text" : "2001, 11: 81"}, 
{"Row" : 18, "Column" : 1, "Text" : "Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital."}, 
{"Row" : 19, "Column" : 1, "Text" : "American Journal of the Medical Sciences. 1978,275:271-282."}, 
{"Row" : 20, "Column" : 1, "Text" : "Mandell LA, Bartlett JG, Dowell SF, et al, Update of practice guidelines for the"}, 
{"Row" : 21, "Column" : 1, "Text" : "management of community-acquired pneumonia in immunocompetent adults., Clin"}, 
{"Row" : 22, "Column" : 1, "Text" : "Infect Dis 2003,37:1405"}, 
{"Row" : 23, "Column" : 1, "Text" : "Mangram AJ, et al.  Guideline for Prevention of Surgical Site Infection, Infect"}, 
{"Row" : 24, "Column" : 1, "Text" : "Control Hosp Epidemiol 1999, 20: 247"}, 
{"Row" : 25, "Column" : 1, "Text" : "Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention"}, 
{"Row" : 26, "Column" : 1, "Text" : "of Surgical Site Infection, 1999. Infection Control and Hospital"}, 
{"Row" : 27, "Column" : 1, "Text" : "Epidemiology. 1999,20(4):250-278."}, 
{"Row" : 28, "Column" : 1, "Text" : "Mathisen GE, et al.  Brain abscess.  Clin Infect Dis 1997, 25: 763."}, 
{"Row" : 29, "Column" : 1, "Text" : "McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose"}, 
{"Row" : 30, "Column" : 1, "Text" : "antimicrobial prophylaxis for major surgery:  a systematic review."}, 
{"Row" : 31, "Column" : 1, "Text" : "Australia & New Zealand Journal of Surgery. 1998,68:388-396."}, 
{"Row" : 32, "Column" : 1, "Text" : "McGowan JE, Jr. Do intensive hospital antibiotic control programs prevent the"}, 
{"Row" : 33, "Column" : 1, "Text" : "spread of antibiotic resistance? Infection Control & Hospital Epidemiology."}, 
{"Row" : 34, "Column" : 1, "Text" : "1994,7:478-483."}, 
{"Row" : 35, "Column" : 1, "Text" : "Merrill et al Treating postoperative mediastinitis.  Ann Thorac Surg 2004, 78:"}, 
{"Row" : 36, "Column" : 1, "Text" : "608-12."}, 
{"Row" : 37, "Column" : 1, "Text" : "Morris A, Kellner JD, Low DE. The superbugs: evolution, dissemination and"}, 
{"Row" : 38, "Column" : 1, "Text" : "fitness. [Review] 70. Current Opinion in Microbiology. 1998,1(5):524-529."}, 
{"Row" : 39, "Column" : 1, "Text" : "Mulhern JG, et al.  Trough serum vancomycin levels predict the relapse of gram-"}, 
{"Row" : 40, "Column" : 1, "Text" : "positive peritonitis in peritoneal dialysis patients.  Am J Kidney Dis"}, 
{"Row" : 41, "Column" : 1, "Text" : "1995, 25: 611"}, 
{"Row" : 42, "Column" : 1, "Text" : "Murphy TF, et al.  The role of bacteria in exacerbations of COPD.  Chest 2000,"}, 
{"Row" : 43, "Column" : 1, "Text" : "118:204"}, 
{"Row" : 44, "Column" : 1, "Text" : "Naber et al.Chronic prostatitis - an infectious disease?  JAC 2000, 46:157"}, 
{"Row" : 45, "Column" : 1, "Text" : "Nathens AB et al.  Management of the critically ill patient with severe acute"}, 
{"Row" : 46, "Column" : 1, "Text" : "pancreatitis.  Crit Care Med 2004, 32: 2524-2536"}, 
{"Row" : 47, "Column" : 1, "Text" : "Nichols RL. Preventing surgical site infections: a surgeon's perspective."}, 
{"Row" : 48, "Column" : 1, "Text" : "Emerging Infectious Diseases. 2001,7(2):220-224."}, 
{"Row" : 49, "Column" : 1, "Text" : "Nicolle et al IDSA guidelines for the diagnosis and treatment of asymptomatic"}, 
{"Row" : 50, "Column" : 1, "Text" : "bacteriuria in adults.  Clin Infect Dis 2005, 40: 643"}, 
{"Row" : 51, "Column" : 1, "Text" : "Novella M, et al.  Continuous versus inpatient prophylaxis of the first episode"}, 
{"Row" : 52, "Column" : 1, "Text" : "of spontaneous bacterial peritonitis with norfloxacin.  Hepatol 1997, 25:"}, 
{"Row" : 53, "Column" : 1, "Text" : "532"}, 
{"Row" : 1, "Column" : 1, "Text" : "CDSS Journal References (Author Lastname: K-N)", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX REF JOURN (P-R)", "DisplayText" : "Journal References (Author Lastname: P-R)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 4, "Column" : 1, "Text" : "2004, 38: 161"}, 
{"Row" : 5, "Column" : 1, "Text" : "Parish LC et al.  Controversies about the decubitus ulcer.  Dermatol Clin 2004,"}, 
{"Row" : 6, "Column" : 1, "Text" : "22: 87."}, 
{"Row" : 7, "Column" : 1, "Text" : "Parsi MA, et al.  Spontaneous bacterial peritonitis: recent data on incidence"}, 
{"Row" : 8, "Column" : 1, "Text" : "and treatment.  Clev Clin J Med 2004, 71: 569"}, 
{"Row" : 9, "Column" : 1, "Text" : "Payne TH. Computer decision support systems. Chest. 2000,118:47S-52S."}, 
{"Row" : 10, "Column" : 1, "Text" : "Peterson LR.  Penicillins for treatment of pneumococcal pneumonia: does in vitro"}, 
{"Row" : 11, "Column" : 1, "Text" : "resistance really matter?  Clin Infect Dise 2006, 42: 224"}, 
{"Row" : 12, "Column" : 1, "Text" : "Pharmacy Benefits Management-Medical Advisory Panel. The Pharmacologic"}, 
{"Row" : 13, "Column" : 1, "Text" : "Management of Helicobacter pylori in Peptic Ulcer Disease and Dyspepsia."}, 
{"Row" : 14, "Column" : 1, "Text" : "VHA PBM-SHG Publication No. 98-0009.  Hines, IL: Pharmacy Benefits"}, 
{"Row" : 15, "Column" : 1, "Text" : "Management Strategic Health Group, Veterans Health Administration,"}, 
{"Row" : 16, "Column" : 1, "Text" : "Department of Veterans Affairs. February 1998."}, 
{"Row" : 17, "Column" : 1, "Text" : "Piraino B, et al.  Peritoneal dialysis-related infections recommendations: 2005"}, 
{"Row" : 18, "Column" : 1, "Text" : "update.  Perit Dial Int 2005, 25: 107."}, 
{"Row" : 19, "Column" : 1, "Text" : "Ray S, et al.  Neuroretinitis.  Int Ophth Clin 2001, 41: 83."}, 
{"Row" : 20, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology.  2nd ed.  London, UK: Mosby"}, 
{"Row" : 21, "Column" : 1, "Text" : "International Limited 2001."}, 
{"Row" : 22, "Column" : 1, "Text" : "Roig J, et al.  Legionnaire's disease: a rational approach to therapy.  J"}, 
{"Row" : 23, "Column" : 1, "Text" : "Antimicrob Chemother 2003, 51: 1119-29"}, 
{"Row" : 24, "Column" : 1, "Text" : "Roitt I, Brostoff J, Male D, eds.  Immunology.  5th ed.  London, UK: Mosby"}, 
{"Row" : 25, "Column" : 1, "Text" : "International Limited 1998."}, 
{"Row" : 26, "Column" : 1, "Text" : "Rolston KVI.  The infectious diseases society of America 2002 guidelines for the"}, 
{"Row" : 27, "Column" : 1, "Text" : "use of antimicrobial agents in neutropenic patients with cancer and"}, 
{"Row" : 28, "Column" : 1, "Text" : "neutropenia: salient features and comments.  Clin Infect Dis 2004, 39: S44"}, 
{"Row" : 29, "Column" : 1, "Text" : "Ronald A The etiology of urinary tract infection: traditional and emerging"}, 
{"Row" : 30, "Column" : 1, "Text" : "pathogens.  Dis Mon 2003, 49: 71"}, 
{"Row" : 31, "Column" : 1, "Text" : "Runyon BA, et al.  Short course versus long course antibiotic treatment of"}, 
{"Row" : 32, "Column" : 1, "Text" : "spontaneous bacterial peritonitis.  Gastroenterol 1991, 100: 1737"}, 
{"Row" : 1, "Column" : 1, "Text" : "CDSS Journal References (Author Lastname: P-R)", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX REF JOURN (S-V)", "DisplayText" : "Journal References (Author Lastname: S-V)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Saag MS, et al.  Practice guidelines for the management of cryptococcal disease."}, 
{"Row" : 4, "Column" : 1, "Text" : "Clin Infect Dis 2000, 30: 710"}, 
{"Row" : 5, "Column" : 1, "Text" : "Sapico FL.  Microbiology and antimicrobial therapy of spinal infections.  Ortho"}, 
{"Row" : 6, "Column" : 1, "Text" : "Clin N Amer 1996, 27:9"}, 
{"Row" : 7, "Column" : 1, "Text" : "Scheid DC, et al.  Acute bacterial rhinosinusitis in adults.  Am Fam Phys 2004,"}, 
{"Row" : 8, "Column" : 1, "Text" : "70: 1697"}, 
{"Row" : 9, "Column" : 1, "Text" : "Scher KS. Studies on the duration of antibiotic administration for surgical"}, 
{"Row" : 10, "Column" : 1, "Text" : "prophylaxis. The American Surgeon. 1997,63:59-63."}, 
{"Row" : 11, "Column" : 1, "Text" : "Schwartz MN.  Cellulitis.  New Eng J Med 2004, 350: 904"}, 
{"Row" : 12, "Column" : 1, "Text" : "Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of"}, 
{"Row" : 13, "Column" : 1, "Text" : "America and Infectious Diseases Society of American Joint Committee on the"}, 
{"Row" : 14, "Column" : 1, "Text" : "prevention of antimicrobial resistance:  guidelines for the prevention of"}, 
{"Row" : 15, "Column" : 1, "Text" : "antimicrobial resistance in hospitals. Infection Control & Hospital"}, 
{"Row" : 16, "Column" : 1, "Text" : "Epidemiology. 1997,18:275-291."}, 
{"Row" : 17, "Column" : 1, "Text" : "Singh N et al.  Short-course empiric antibiotic therapy for patients with"}, 
{"Row" : 18, "Column" : 1, "Text" : "pulmonary infiltrates in the intensive care unit.  Am J Resp Crit Care Med"}, 
{"Row" : 19, "Column" : 1, "Text" : "2000, 162: 505"}, 
{"Row" : 20, "Column" : 1, "Text" : "Sipsas NV, et al.  Perspectives for the management of febrile neutropenic"}, 
{"Row" : 21, "Column" : 1, "Text" : "patients with cancer in the 21st century.  Cancer 2005, 103: 1103."}, 
{"Row" : 22, "Column" : 1, "Text" : "Snow V, et al.Principles of appropriate antibiotic use for acute sinusitis in"}, 
{"Row" : 23, "Column" : 1, "Text" : "adults. Ann Intern Med 2001, 1234: 495"}, 
{"Row" : 24, "Column" : 1, "Text" : "Snow V, et al.  Principles of appropriate antibiotic use for acute pharyngitis"}, 
{"Row" : 25, "Column" : 1, "Text" : "for adults.  Ann Intern Med 2001, 134: 506"}, 
{"Row" : 26, "Column" : 1, "Text" : "Soares-Weiser K, et al.  Antibiotic prophylaxis for cirrhotic patients with"}, 
{"Row" : 27, "Column" : 1, "Text" : "gastrointestinal bleeding.  Cochrane Database of Systematic Reviews 3, 2005"}, 
{"Row" : 28, "Column" : 1, "Text" : "Solomkin JS, et al.  Guidelines for the selection of anti-infective agents for"}, 
{"Row" : 29, "Column" : 1, "Text" : "complicated intra-abdominal infections.  Clin Infect Dis 2003, 37: 997"}, 
{"Row" : 30, "Column" : 1, "Text" : "Song F, Glenny AM. Antimicrobial prophylaxis in colorectal surgery: a systematic"}, 
{"Row" : 31, "Column" : 1, "Text" : "review of randomized controlled trials. British Journal of Surgery."}, 
{"Row" : 32, "Column" : 1, "Text" : "1998,85(9):1232-1241."}, 
{"Row" : 33, "Column" : 1, "Text" : "Stevens DL, et al.  Practice guidelines for the diagnosis and management of skin"}, 
{"Row" : 34, "Column" : 1, "Text" : "and soft-tissue infections.  Clin Infect Dis 2005, 41: 1373."}, 
{"Row" : 35, "Column" : 1, "Text" : "Strader DB, et al.  Diagnosis, management, and treatment of hepatitis C."}, 
{"Row" : 36, "Column" : 1, "Text" : "Hepatology 2004, 39:1147-71."}, 
{"Row" : 37, "Column" : 1, "Text" : "Stulberg DL, et al.  Common bacterial skin infections.  Am Fam Phys 2002, 66:"}, 
{"Row" : 38, "Column" : 1, "Text" : "119"}, 
{"Row" : 39, "Column" : 1, "Text" : "Such J et al.  Spontaneous bacterial peritonitis.  Clin Infect Dis 1998, 27: 669"}, 
{"Row" : 40, "Column" : 1, "Text" : "Tay BK et al.  Spinal infections.  J Amer Acad Ortho Surg 2002, 10: 188"}, 
{"Row" : 41, "Column" : 1, "Text" : "Thielman, NM.  Acute infectious diarrhea.  NEJM 2004, 350: 38"}, 
{"Row" : 42, "Column" : 1, "Text" : "Tunkel et al.  Practice guidelines for the management of bacterial meningitis."}, 
{"Row" : 43, "Column" : 1, "Text" : "Clin Infect Dis 2004, 39: 1267-84."}, 
{"Row" : 44, "Column" : 1, "Text" : "Van der Valk P et al.  Clinical predictors of bacterial involvement in"}, 
{"Row" : 45, "Column" : 1, "Text" : "exacerbations of chronic obstructive pulmonary disease.  CID 2004, 39: 980"}, 
{"Row" : 46, "Column" : 1, "Text" : "Vincent MT, et al.  Pharyngitis.  Am Fam Phys 2004, 69: 1465"}, 
{"Row" : 1, "Column" : 1, "Text" : "CDSS Journal References (Author Lastname: S-V)", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX REF JOURN (W-Z)", "DisplayText" : "Journal References (Author Lastname: W-Z)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Weinstein L, et al.  Gas gangrene.  New Eng J Med 1973, 289: 1129"}, 
{"Row" : 4, "Column" : 1, "Text" : "Westphal JF.  Biliary tract infections.  Drugs 1999, 57: 81-91."}, 
{"Row" : 5, "Column" : 1, "Text" : "Wheat J, et al.  Practice guidelines for the management of patients with"}, 
{"Row" : 6, "Column" : 1, "Text" : "Histoplasmosis.  Clin Infect Dis 2000, 30: 688"}, 
{"Row" : 7, "Column" : 1, "Text" : "Whitely RJ, et al.  Herpes simplex virus infections.  Lancet 2001, 357: 1513."}, 
{"Row" : 8, "Column" : 1, "Text" : "Whitely RJ, et al.  Herpes zoster: risk categories for persistent pain.  J"}, 
{"Row" : 9, "Column" : 1, "Text" : "Infect Dis 1999,179:9."}, 
{"Row" : 10, "Column" : 1, "Text" : "Wald A.  New therapies and prevention strategies for genital herpes.  Clin"}, 
{"Row" : 11, "Column" : 1, "Text" : "Infect Dis 1999, 28(Suppl 1):S4."}, 
{"Row" : 12, "Column" : 1, "Text" : "Wallace MR, et al.  Treatment of adult varicella with acyclovir.  Ann Int Med"}, 
{"Row" : 13, "Column" : 1, "Text" : "1992, 117:358."}, 
{"Row" : 14, "Column" : 1, "Text" : "Warren et al.  Guidelines for antimicrobial treatment of uncomplicated acute"}, 
{"Row" : 15, "Column" : 1, "Text" : "bacterial cystitis and acute pyelonephritis in women.  Clin Infect Dis"}, 
{"Row" : 16, "Column" : 1, "Text" : "1999, 29:745"}, 
{"Row" : 17, "Column" : 1, "Text" : "Woods RK, et al.  Current guidelines for antibiotic prophylaxis of surgical"}, 
{"Row" : 18, "Column" : 1, "Text" : "wounds.  Am Fam Phys 1998, 57:2731"}, 
{"Row" : 19, "Column" : 1, "Text" : "Wormser GP, et al.  Duration of antibiotic therapy for early Lyme disease.  Ann"}, 
{"Row" : 20, "Column" : 1, "Text" : "Intern Med 2003, 138: 697."}, 
{"Row" : 21, "Column" : 1, "Text" : "Wormser GP, et al.  Practice guidelines for the treatment of Lyme disease.  Clin"}, 
{"Row" : 22, "Column" : 1, "Text" : "Infect Dis 2000, 31 (Supp 1): S1"}, 
{"Row" : 23, "Column" : 1, "Text" : "Zimmerli W, et al.  Prosthetic-joint infections.  New Eng J Med 2004, 351:1645"}, 
{"Row" : 1, "Column" : 1, "Text" : "CDSS Journal References (Author Lastname: W-Z)", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES BOOK", "DisplayText" : "Book References", "Text" : "Book references", "Mnemonic" : "02"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES WEBSITE", "DisplayText" : "Website References", "Text" : "Website references", "Mnemonic" : "04"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES JOURNAL", "DisplayText" : "Journal References", "Text" : "Journal references", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU ABX REFERENCES BOOK", "DisplayText" : "Book References ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "CDSS Book References (common to most CDSS guidelines)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA. The Sanford Guide to"}, 
{"Row" : 6, "Column" : 1, "Text" : "Antimicrobial Therapy. 35th ed. Hyde Park, VT: Antimicrobial Therapy Inc,"}, 
{"Row" : 7, "Column" : 1, "Text" : "2005."}, 
{"Row" : 10, "Column" : 1, "Text" : "Kasper DL, Braunwald E, Fauci AS, et al., eds. Harrison's Principles of Internal"}, 
{"Row" : 11, "Column" : 1, "Text" : "Medicine. 16th ed. Mcgraw-Hill, 2005."}, 
{"Row" : 12, "Column" : 1, "Text" : "Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious"}, 
{"Row" : 13, "Column" : 1, "Text" : "Diseases. 6th ed. Philadelphia, PA: Churchill-Livingston, 2005."}, 
{"Row" : 8, "Column" : 1, "Text" : "Johns Hopkins Point of Care Information Technology (POC-IT): ABX Guide."}, 
{"Row" : 9, "Column" : 1, "Text" : "www.hopkins-abxguide.org"}
]},
{"Name" : "ORZID2 GMENU ABX REFERENCES JOURNAL", "DisplayText" : "Journal References ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "CDSS Journal References", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 GMENU ABX REF JOURN (A-C)", "DisplayText" : "Journal References (Author Lastname: A-C)", "Text" : "Go to CDSS Journal References (Author Lastname: A-C)", "Mnemonic" : "02"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX REF JOURN (D-J)", "DisplayText" : "Journal References (Author Lastname: D-J)", "Text" : "Go to CDSS Journal References (Author Lastname: D-J)", "Mnemonic" : "04"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ABX REF JOURN (K-N)", "DisplayText" : "Journal References (Author Lastname: K-N)", "Text" : "Go to CDSS Journal References (Author Lastname: K-N)", "Mnemonic" : "06"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX REF JOURN (P-R)", "DisplayText" : "Journal References (Author Lastname: P-R)", "Text" : "Go to CDSS Journal References (Author Lastname: P-R)", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX REF JOURN (S-V)", "DisplayText" : "Journal References (Author Lastname: S-V)", "Text" : "Go to CDSS Journal References (Author Lastname: S-V)", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU ABX REF JOURN (W-Z)", "DisplayText" : "Journal References (Author Lastname: W-Z)", "Text" : "Go to CDSS Journal References (Author Lastname: W-Z)", "Mnemonic" : "12"}
]},
{"Name" : "ORZID2 GMENU ABX REFERENCES WEBSITE", "DisplayText" : "Website References ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "Up-to-date (view up-to-date web site)www.uptodate.com"}, 
{"Row" : 3, "Column" : 1, "Text" : "CDSS Website References (common to most CDSS guidelines)", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX RSV", "DisplayText" : "RSV ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "RSV"}, 
{"Row" : 8, "Column" : 1, "Text" : "No specific antimicrobial therapy is indicated.  Contact infectious diseases for"}, 
{"Row" : 9, "Column" : 1, "Text" : "more information on management of this disease."}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU ABX SALMONELLA SPECIES", "DisplayText" : "Diarrhea with Salmonella ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH SALMONELLA (NON TYPHI SPECIES)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment is not recommended for mild or moderate cases.  Antimicrobials can"}, 
{"Row" : 13, "Column" : 1, "Text" : "prolong the carrier state and increase the risk of relapse.  If disease is"}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" :""},
{"Row" : 22, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "severe, treatment is indicated for severe disease or if patients greater"}, 
{"Row" : 15, "Column" : 1, "Text" : "than 50 years old with suspected atherosclerosis, immunosuppressed, cardiac"}, 
{"Row" : 16, "Column" : 1, "Text" : "disease (valvular or endovascular), or joint disease."}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""},
{"Row" : 28, "Column" : 1, "Text" : "UpToDate. Nontyphoidal Salmonella: Gastrointestinal infection and carriage."}, 
{"Row" : 29, "Column" : 1, "Text" : "Last updated 02/18/16"}, 
{"Row" : 31, "Column" : 1, "Text" : "Sanford Guide- web edition \"Gastroenteritis, Salmonella: Non-typhi\""}, 
{"Row" : 32, "Column" : 1, "Text" : "Last accessed 12/12/17."}, 
{"Row" : 34, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 35, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 37, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX SALMONELLA TYPHI AND PARATYPHI", "DisplayText" : "Salmonella Typhi and Paratyphi ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "Treatment is not recommended for mild to moderate gastroenteritis. Treat"}, 
{"Row" : 6, "Column" : 1, "Text" : "patients with severe illness, immunosuppressed, or others at risk of"}, 
{"Row" : 7, "Column" : 1, "Text" : "complication or invasive disease."}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Item" : "PSJUZID AZITHROMYCIN 1GM PO ONCE THEN 500MG Q24H 5 DAYS", "DisplayText" : "Azithromycin 1GM ONCE then 500MG Q24H 5 DAYS", "Text" : ""},
{"Row" : 13, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "UpToDate. Treatment and prevention of enteric (typhoid and paratyphoid) fever."}, 
{"Row" : 19, "Column" : 1, "Text" : "Last updated 11/27/17."}, 
{"Row" : 21, "Column" : 1, "Text" : "Sanford Guide- web edition \"Salmonella sp.\" Last accessed 12/12/17."}, 
{"Row" : 22, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 23, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 25, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX SECOND PERITONITIS", "DisplayText" : "Secondary Peritonitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "SECONDARY PERITONITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Secondary peritonitis occurs after spillage of colonic flora into the peritoneum"}, 
{"Row" : 13, "Column" : 1, "Text" : "from such things as a ruptured viscus, perforated appendicitis, gastrointestinal"}, 
{"Row" : 14, "Column" : 1, "Text" : "trauma, or diverticulitis."}, 
{"Row" : 16, "Column" : 1, "Text" : ">>  Treatment of MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Piperacillin-tazobactam 3.375 g IV q6h ($33/day) [R]", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ZZORZ SET ABX CIPROFLO 400MG IV Q12H METRO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> metronidazole 1 g IV", "Mnemonic" : "16"},
{"Row" : 21, "Column" : 1, "Text" : "q12h ($4/day) [DI]"}, 
{"Row" : 23, "Column" : 1, "Text" : ">>  Treatment of SEVERE disease (typically necessitating ICU admission)", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 26, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "ZZORZ SET ABX CIPROFLO 400MG IV Q12H METRO 1GM IV Q12H", "DisplayText" : "", "Text" : "Metronidazole 1 gm IV q12h ($4/day) [DI] <AND> ciprofloxacin 400 mg IV q12h", "Mnemonic" : "20"},
{"Row" : 30, "Column" : 1, "Item" : "ZZORZ SET ABX AZTREON 2GM IV Q8H METRO 1GM IV Q12H", "DisplayText" : "", "Text" : "Metronidazole 1 gm IV q12h ($4/day) [DI] <AND> aztreonam 2 gm IV q8h", "Mnemonic" : "22"},
{"Row" : 31, "Column" : 1, "Text" : "($50/day) [R]"}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 28, "Column" : 1, "Text" : "($5.92/day) [R,DI] < OR >"}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" keyword: Peritonitis"}, 
{"Row" : 37, "Column" : 1, "Text" : "Solomkin JS Clin Infect Dis 2003, 37:997"}
]},
{"Name" : "ORZID2 GMENU ABX SHIGELLA SPECIES", "DisplayText" : "Diarrhea with Shigella species (bacillary dysentery)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole resistance occurs in up to 20% of isolates,"}, 
{"Row" : 13, "Column" : 1, "Text" : "especially in foreign travelers."}, 
{"Row" : 18, "Column" : 1, "Text" : ">>  Treatment if there is NO recent foreign travel", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : ">>  Treatment if there is RECENT FOREIGN TRAVEL", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH SHIGELLA (BACILLARY DYSENTERY)"}, 
{"Row" : 14, "Column" : 1, "Text" : "reserve therapy for immunocompromised patient or those with severe or"}, 
{"Row" : 15, "Column" : 1, "Text" : "complicated disease"}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 750MG PO Q24H 3 DAYS", "DisplayText" : "Ciprofloxacin 750MG PO Q24H 3 DAYS", "Text" :""},
{"Row" : 20, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H 5 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H 5 DAYS", "Text" : ""},
{"Row" : 24, "Column" : 1, "Item" : "PSJUZID AZITHROMYCIN 500MG PO Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG PO Q24H 3 DAYS", "Text" : ""},
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H 5 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H 5 DAYS", "Text" : ""},
{"Row" : 31, "Column" : 1, "Text" : "UpToDate. Shigella infection: Treatment and prevention in adults."}, 
{"Row" : 32, "Column" : 1, "Text" : "Last updated 07/15/17."}, 
{"Row" : 34, "Column" : 1, "Text" : "Sanford Guide- web edition \"Shigella sp.\" Last accessed 12/12/17."}, 
{"Row" : 36, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 37, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 40, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX SPON BACT PERITONITIS", "DisplayText" : "Acute spontaneous bacterial peritonitis (SBP) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "SBP is infection of the peritoneal cavity in the absence of an apparent trauma"}, 
{"Row" : 13, "Column" : 1, "Text" : "or other obvious cause. SBP occurs primarily in people with end-stage liver"}, 
{"Row" : 14, "Column" : 1, "Text" : "disease and ascites.  The diagnosis is made when a peritoneal fluid sample has"}, 
{"Row" : 15, "Column" : 1, "Text" : "more than 250 polymorphonuclear leukocyte cells per microliter, or when"}, 
{"Row" : 16, "Column" : 1, "Text" : "bacterial pathogens are isolated."}, 
{"Row" : 18, "Column" : 1, "Text" : "Long-term SBP prophylaxis is indicated for patients who survive their first"}, 
{"Row" : 19, "Column" : 1, "Text" : "episode of SBP.  Short-term SBP prophylaxis is indicated for patients with"}, 
{"Row" : 20, "Column" : 1, "Text" : "variceal bleeding, or for patients who have low-protein refractory ascites (<1"}, 
{"Row" : 21, "Column" : 1, "Text" : "gm albumin/dl ascitic fluid).  Some give long-term antimicrobials to patients"}, 
{"Row" : 22, "Column" : 1, "Text" : "with low-protein refractory ascites.  Consult Gastroenterology for more"}, 
{"Row" : 23, "Column" : 1, "Text" : "information."}, 
{"Row" : 25, "Column" : 1, "Text" : "Acute SBP", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Treat for 5 days."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :"", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H", "Text" :"", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "Prophylaxis in a patient with a PREVIOUS SBP EPISODE", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJZID TRIMETHOPRIM/SULFAMETHOXAZOLE 1 DS TABLET PO Q24H", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds tablet po q24h", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q24h($0.09/day) [R,DI]  < OR >", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Item" : "PSJZID CIPROFL 750MG PO Q WEEK", "DisplayText" : "Ciprofloxacin 750mg po q week", "Text" : "Ciprofloxacin 750 mg PO q week ($0.14/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 37, "Column" : 1, "Text" : "Prophylaxis in a patient with CIRRHOSIS and VARICEAL HEMORRHAGE", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO q12h for 7 days ($0.18/day) [R,DI]", "Mnemonic" : "20"},
{"Row" : 40, "Column" : 1, "Text" : "Prophylaxis for HOSPITALIZED PATIENTS with refractory low-protein ascites", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "(less than 1 gm/dL peritoneal fluid)."}, 
{"Row" : 42, "Column" : 1, "Text" : "Give antimicrobial prophylaxis until discharge."}, 
{"Row" : 43, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI]", "Mnemonic" : "22"},
{"Row" : 46, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 49, "Column" : 1, "Text" : "Such J  Clin Infect Dis  1998, 27: 669"}, 
{"Row" : 51, "Column" : 1, "Text" : "Parsi MA  Clev Clin J Med  2004, 71: 569"}, 
{"Row" : 52, "Column" : 1, "Text" : "Frazee LA  Ann Pharmacother  2005, 39: 908"}, 
{"Row" : 53, "Column" : 1, "Text" : "Runyon BA  Gastroenterol 1991, 100: 1737"}, 
{"Row" : 54, "Column" : 1, "Text" : "Novella M  Hepatol 1997, 25: 532"}, 
{"Row" : 55, "Column" : 1, "Text" : "Soares-Weiser K  Cochrane Database Systematic Reviews 3, 2005"}, 
{"Row" : 48, "Column" : 1, "Text" : "\"Sanford\" keyword: Peritonitis"}, 
{"Row" : 50, "Column" : 1, "Text" : "Up-to-Date"}, 
{"Row" : 10, "Column" : 1, "Text" : "SPONTANEOUS BACTERIAL PERITONITIS (SBP)"}
]},
{"Name" : "ORZID2 GMENU ABX STASIS DERMATITIS", "DisplayText" : "Stasis Dermatitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 6, "Column" : 1, "Text" : "STASIS DERMATITIS", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Stasis dermatitis is a common condition that is often confused with"}, 
{"Row" : 9, "Column" : 1, "Text" : "bacterial cellulitis.  Stasis dermatitis does not benefit from antimicrobial"}, 
{"Row" : 10, "Column" : 1, "Text" : "therapy.  It is important to distinguish between the two.  The provider"}, 
{"Row" : 11, "Column" : 1, "Text" : "should be mindful of the fact that bacterial cellulitis can occur on skin"}, 
{"Row" : 12, "Column" : 1, "Text" : "with underlying stasis dermatitis. (See link below for bacterial cellulitis)"}, 
{"Row" : 14, "Column" : 1, "Text" : "Common risk factors for venous stasis include advancing age, family"}, 
{"Row" : 15, "Column" : 1, "Text" : "history of venous disease, increased body mass index, smoking, a history of"}, 
{"Row" : 16, "Column" : 1, "Text" : "trauma, prior venous thrombosis and pregnancy. Chronic venous disease and"}, 
{"Row" : 17, "Column" : 1, "Text" : "arterial vascular disease have some common risk factors (eg, smoking,"}, 
{"Row" : 18, "Column" : 1, "Text" : "obesity) and pathophysiological processes.  The most common symptoms reported"}, 
{"Row" : 19, "Column" : 1, "Text" : "by patients with chronic venous disease are limb discomfort (tired, heavy"}, 
{"Row" : 20, "Column" : 1, "Text" : "legs), pain, and limb swelling. Swelling is often worse with prolonged"}, 
{"Row" : 21, "Column" : 1, "Text" : "standing and improves with leg elevation and walking.  The skin of the"}, 
{"Row" : 22, "Column" : 1, "Text" : "anterior surfaces of the lower legs often has brown or blue-grey"}, 
{"Row" : 23, "Column" : 1, "Text" : "hyperpigmentation."}, 
{"Row" : 25, "Column" : 1, "Text" : "People with venous stasis are prone to develop stasis dermatitis which"}, 
{"Row" : 26, "Column" : 1, "Text" : "is one of the most common and earliest dermatologic signs of chronic venous"}, 
{"Row" : 27, "Column" : 1, "Text" : "insufficiency. Stasis dermatitis is an inflammatory process that presents as"}, 
{"Row" : 28, "Column" : 1, "Text" : "an eczematous rash characterized by itching, erythema, scaling, weeping,"}, 
{"Row" : 29, "Column" : 1, "Text" : "erosions, and crusting.  Longstanding cases may develop lipodermatosclerosis,"}, 
{"Row" : 30, "Column" : 1, "Text" : "a fibrosing panniculitis of the subcutaneous tissue. Lipodermatosclerosis"}, 
{"Row" : 31, "Column" : 1, "Text" : "typically starts with a firm area of induration at the medial ankle. As the"}, 
{"Row" : 32, "Column" : 1, "Text" : "process progresses, the entire leg lower leg can become involved with"}, 
{"Row" : 33, "Column" : 1, "Text" : "extension up to the mid leg in more advanced cases.  The skin overlying the"}, 
{"Row" : 34, "Column" : 1, "Text" : "panniculitis is typically heavily pigmented and bound down to the"}, 
{"Row" : 35, "Column" : 1, "Text" : "subcutaneous tissues. Brawny edema above the fibrotic area and on the foot"}, 
{"Row" : 36, "Column" : 1, "Text" : "below is seen in advanced cases. Leukocytosis and fever are common in people"}, 
{"Row" : 37, "Column" : 1, "Text" : "with stasis dermatitis."}, 
{"Row" : 39, "Column" : 1, "Text" : "Chronic venous disease is the most common cause of leg ulcers.  They"}, 
{"Row" : 40, "Column" : 1, "Text" : "are usually found low on the medial ankle over a perforating vein, or along"}, 
{"Row" : 41, "Column" : 1, "Text" : "the course of the great or small saphenous veins.  They occur more proximally"}, 
{"Row" : 42, "Column" : 1, "Text" : "if precipitated by trauma. Venous ulcers are not found on the forefoot or"}, 
{"Row" : 43, "Column" : 1, "Text" : "above the level of the knee.  Venous ulcers can be multiple or single, and"}, 
{"Row" : 44, "Column" : 1, "Text" : "can be exquisitely tender, shallow, exudative and have a granulation base."}, 
{"Row" : 45, "Column" : 1, "Text" : "The ulcer borders are usually irregular but not undermined. They can extend"}, 
{"Row" : 46, "Column" : 1, "Text" : "circumferentially around the leg if left untreated."}, 
{"Row" : 48, "Column" : 1, "Text" : "Arterial ulcers are typically painful, and punched out or stellate. The"}, 
{"Row" : 49, "Column" : 1, "Text" : "surrounding skin is red and taut. Some arterial ulcers are pale - others have"}, 
{"Row" : 50, "Column" : 1, "Text" : "a black or yellow eschar. They are often associated with trauma and commonly"}, 
{"Row" : 51, "Column" : 1, "Text" : "occur on the foot over pressure points. There may be other signs of arterial"}, 
{"Row" : 52, "Column" : 1, "Text" : "insufficiency on the lower limb including thin atrophic or hairless skin,"}, 
{"Row" : 53, "Column" : 1, "Text" : "poor pedal pulses, diminished capillary refill, or hypertrophic deformed"}, 
{"Row" : 54, "Column" : 1, "Text" : "nails."}, 
{"Row" : 56, "Column" : 1, "Text" : "Patients with stasis or lipodermatosclerosis are prone to bouts of"}, 
{"Row" : 57, "Column" : 1, "Text" : "bacterial cellulitis, usually caused by Staphylococcus aureus or encapsulated"}, 
{"Row" : 58, "Column" : 1, "Text" : "streptococci.  Typically, stasis dermatitis develops slowly, over a week or"}, 
{"Row" : 59, "Column" : 1, "Text" : "more.  It is often bilateral.  The onset of bacterial cellulitis is usually"}, 
{"Row" : 60, "Column" : 1, "Text" : "abrupt, typically developing over 1 or 2 days.  Bacterial cellulitis often"}, 
{"Row" : 61, "Column" : 1, "Text" : "starts in one area and spreads to adjacent areas.  Bacterial cellulitis is"}, 
{"Row" : 62, "Column" : 1, "Text" : "unilateral.  Both can present with fever and leukocytosis."}, 
{"Row" : 64, "Column" : 1, "Text" : "In a patient with stasis and cellulitis and the physician is uncertain"}, 
{"Row" : 65, "Column" : 1, "Text" : "about whether bacterial cellulitis is present, the physician should consider"}, 
{"Row" : 66, "Column" : 1, "Text" : "a trial of bed rest, leg elevation, and if there is fluid overload, diuresis."}, 
{"Row" : 67, "Column" : 1, "Text" : "If the cellulitis improves in 24-48 hours, antibacterial therapy and the"}, 
{"Row" : 68, "Column" : 1, "Text" : "attendant adverse reactions can be avoided.  If it is clear that bacterial"}, 
{"Row" : 69, "Column" : 1, "Text" : "cellulitis has occurred, antimicrobial therapy should be given."}, 
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"}
]},
{"Name" : "ORZID2 GMENU ABX SYPHILIS", "DisplayText" : "Syphilis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "SYPHILIS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Evaluation and management are complex.  Consult Infectious Diseases."}
]},
{"Name" : "ORZID2 GMENU ABX TRICH VAGINITIS", "DisplayText" : "Trichomonas Vaginitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "12"},
{"Row" : 9, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "TRICHOMONAS VAGINITIS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Male sexual partners of women with trichomonas vaginitis will not have symptoms"}, 
{"Row" : 15, "Column" : 1, "Text" : "but should be treated to prevent recurrent vaginitis in the female sexual"}, 
{"Row" : 16, "Column" : 1, "Text" : "partner."}, 
{"Row" : 18, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "The discharge is purulent, malodorous, and  thin.  The vaginal pH is greater"}, 
{"Row" : 20, "Column" : 1, "Text" : "than 4.5.  Diagnosis is most accurate when trichomonads are observed on a wet"}, 
{"Row" : 21, "Column" : 1, "Text" : "mount or identified in culture."}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment of symptomatic woman", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Pregnant women with trichomonas infection may be treated with metronidazole"}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 2GM PO ONCE", "DisplayText" : "Metronidazole 2GM PO once", "Text" : "Metronidazole 2 gm PO once ($0.64/day) [DI]  < OR >", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 500MG PO Q12H", "DisplayText" : "Metronidazole 500MG PO q12h", "Text" : "Metronidazole 500 mg PO q12h for 7 days ($0.64/day) [DI]", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "Treatment of male sex partners", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 2GM PO ONCE", "DisplayText" : "Metronidazole 2GM PO once", "Text" : "Metronidazole 2 gm PO once ($0.64/day) [DI]", "Mnemonic" : "20"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "", "Mnemonic" : "22"},
{"Row" : 25, "Column" : 1, "Text" : "during any trimester."}, 
{"Row" : 37, "Column" : 1, "Text" : "CDC MMWR 2002, 51: RR-06"}, 
{"Row" : 38, "Column" : 1, "Text" : "\"Sanford\" keyword: Trichomoniasis"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Mandell\" chapter: Vulvovaginitis and cervicitis"}
]},
{"Name" : "ORZID2 GMENU ABX TYPHLITIS", "DisplayText" : "Neutropenic Enterocolitis (Typhlitis)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 9, "Column" : 1, "Text" : "Neutropenic enterocolitis, also known as \"typhlitis\" or \"necrotizing"}, 
{"Row" : 10, "Column" : 1, "Text" : "enterocolitis\", is a severe abdominal infection that occurs in neutropenic"}, 
{"Row" : 11, "Column" : 1, "Text" : "patients, especially in those with acute leukemia.  Test stool for Clostridium"}, 
{"Row" : 12, "Column" : 1, "Text" : "difficile culture and toxin."}, 
{"Row" : 15, "Column" : 1, "Text" : "Hematology-Oncology, Infectious Diseases, and Surgery consults are essential."}, 
{"Row" : 16, "Column" : 1, "Text" : "Broad spectrum antimicrobials that include anaerobic coverage should be"}, 
{"Row" : 17, "Column" : 1, "Text" : "initiated promptly."}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ZZORZ SET ABX CEFTAZ 2 GM IV Q8H METRO 1000MG IV Q12H", "DisplayText" : "", "Text" : "Ceftazidime 2 gm IV q8h ($36/day) [R] <AND> metronidazole 1000 mg IV q12h", "Mnemonic" : "16"},
{"Row" : 21, "Column" : 1, "Text" : "($4/day) [DI]  < OR >"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "ZZORZ SET ABX AZTREON 2GM IV Q8H METRO 1GM IV Q12H", "DisplayText" : "", "Text" : "Aztreonam 2 gm IV q8h ($50/day) [R] <AND> metronidazole 1000 mg IV q12h", "Mnemonic" : "20"},
{"Row" : 27, "Column" : 1, "Text" : "($4/day) [DI]"}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 7, "Column" : 1, "Text" : "NEUTROPENIC ENTEROCOLITIS (TYPHLITIS)"}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Mandell\" chapter: Diverticulities and typhlitis"}
]},
{"Name" : "ORZID2 GMENU ABX UNCOMP CYSTITIS", "DisplayText" : "Uncomplicated Cystitis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 10, "Column" : 1, "Text" : "UNCOMPLICATED CYSTITIS"}, 
{"Row" : 20, "Column" : 1, "Text" : "Suppression", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "For pre-menopausal women with 3 or more episodes per year of recurrent"}, 
{"Row" : 22, "Column" : 1, "Text" : "uncomplicated cystitis, suppressive therapy is indicated after infection is"}, 
{"Row" : 23, "Column" : 1, "Text" : "eradicated."}, 
{"Row" : 16, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJZID SULFAMETHOXAZOLE/TRIMETHOPRIM SS PO Q24H 3 DAYS", "DisplayText" : "Sulfamethoxazole/Trimethoprim SS PO Q24H", "Text" :""},
{"Row" : 27, "Column" : 1, "Item" : "PSJZID SULFAMETHOXAZOLE/TRIMETHPRIM DS 1 TAB ONCE POST-COITUS", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS 1 TAB ONCE POST-COITUS", "Text" :""},
{"Row" : 26, "Column" : 1, "Item" : "PSJZID SULFAMETHOXAZOLE/TRIMETHOPRIM DS 2 TABS ONCE", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS 2 TABS PO ONCE", "Text" : ""},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 13, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Urinary tract infections in male patients are always considered complicated."}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 3 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H", "Text" :""},
{"Row" : 29, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 500MG PO Q12H 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID NITROFURANTOIN (MACROBID) 100MG PO Q6H 5 DAYS", "DisplayText" : "Nitrofurantoin (Macrobid) 100MG PO Q6H", "Text" : ""},
{"Row" : 31, "Column" : 1, "Text" : "Gupta, K, et al.  International Clinical Practice Guidelines for Treatment for"}, 
{"Row" : 32, "Column" : 1, "Text" : "Acute Uncomplicated Cystitis and Pyelonephritis in Women. IDSA. 2010"}, 
{"Row" : 33, "Column" : 1, "Text" : "Sanford \"Cystitis\" and \"Pyelonephritis\" Accessed March 2014"}
]},
{"Name" : "ORZID2 GMENU ABX UP-TO-DATE", "DisplayText" : "UP-TO-DATE REFERNCE SELECT TO SHOW DATE ACCESSED ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "UP-TO-DATE ACCESSED 2/10"}
]},
{"Name" : "ORZID2 GMENU ABX UPPER RESPIRATORY INFECTIONS (URI)", "DisplayText" : "Upper respiratory infection (URI) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "Upper respiratory infection (URI)", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Upper respiratory infections include several common syndromes including"}, 
{"Row" : 9, "Column" : 1, "Text" : "pharyngitis (see below) and bronchitis (see below).  Most are caused by"}, 
{"Row" : 10, "Column" : 1, "Text" : "viruses and there is no benefit from antimicrobial therapy.  If a patient"}, 
{"Row" : 11, "Column" : 1, "Text" : "presents with a \"URI,\" consider specific syndromes that do respond to"}, 
{"Row" : 12, "Column" : 1, "Text" : "antimicrobial therapy like herpes simplex stomatitis or thrush.  If no"}, 
{"Row" : 13, "Column" : 1, "Text" : "condition that benefits  from antimicrobial therapy is present,"}, 
{"Row" : 14, "Column" : 1, "Text" : "antimicrobials will almost certainly not help but will likely select for"}, 
{"Row" : 15, "Column" : 1, "Text" : "antimicrobial resistance and may lead to other adverse effects."}
]},
{"Name" : "ORZID2 GMENU ABX URINE CULTURE MENU", "Term" : "8.15.23 Created per Jessica Dietz/Antimicrobial Stewardship Committee. ACR", "DisplayText" : "Urine Culture", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "URINE CULTURE MAIN ORDER MENU", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Urine Culture is NOT indicated for the following conditions alone:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "- Cloudy urine"}, 
{"Row" : 7, "Column" : 1, "Text" : "- Malodorous urine"}, 
{"Row" : 8, "Column" : 1, "Text" : "- Discolored urine"}, 
{"Row" : 9, "Column" : 1, "Text" : "- When a urinary catheter is placed"}, 
{"Row" : 10, "Column" : 1, "Text" : "- Automatic on admission"}, 
{"Row" : 11, "Column" : 1, "Text" : "- End of therapy re-testing"}, 
{"Row" : 13, "Column" : 1, "Text" : "Urine cultures should be ordered in patients with symptoms of a urinary tract", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "infection, during pregnancy at appropriate screening intervals, and prior", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "to an invasive urologic procedure.", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Select indication for urine culture your patient has to place lab order:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (FEVER/SEPSIS NO OTHER CAUSE)", "DisplayText" : "Fever or sepsis with no other identifiable cause", "Text" : ""},
{"Row" : 20, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (DYSURIA,FREQ,URG)", "DisplayText" : "Dysuria, frequency, or urgency", "Text" : ""},
{"Row" : 22, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (PAIN:FLANK,SUPRAPUBIC,PELVIC", "DisplayText" : "Flank, suprapubic, or pelvic pain", "Text" : ""},
{"Row" : 24, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (CVA tenderness)", "DisplayText" : "CVA tenderness", "Text" : ""},
{"Row" : 26, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (ACUTE HEMATURIA)", "DisplayText" : "Acute hematuria", "Text" : ""},
{"Row" : 28, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (PRE-0P SCREENING UROLOGIC)", "DisplayText" : "Pre-operative screening for urologic procedure", "Text" :""},
{"Row" : 30, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (PREGNANT SCREENING)", "DisplayText" : "Pregnant and due for screening", "Text" : ""},
{"Row" : 32, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (SCI OR NEUROGENIC BLADDER)", "DisplayText" : "Increased bladder spasticity or autonomic dysreflexia in patients with", "Text" :""},
{"Row" : 35, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (ALTERED MENTAL STATUS)", "DisplayText" : "Altered mental status with no other identifiable cause", "Text" : ""},
{"Row" : 33, "Column" : 1, "Text" : "spinal cord injury or neurologic deficit"}, 
{"Row" : 36, "Column" : 1, "Text" : "(note that UC not usually indicated, call ID with questions)"}, 
{"Row" : 38, "Column" : 1, "Item" : "LRTZ MB URINE CULTURE CLEAN CATCH (PRE-0P SCREENING UROLOGIC)", "DisplayText" : "Pre-operative screening for urologic procedure", "Text" : "OR/IR Sterile Aspirate Collection Only"}
]},
{"Name" : "ORZID2 GMENU ABX URINE CULTURE MENU-ADD ON", "Term" : "11.3.23 Created SEPARATE ADD ON MENU per Jessica Dietz/Antimicrobial Stewardship Committee. ACR", "DisplayText" : "Urine Culture - ADD ON", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "URINE CULTURE ADD-ON ORDER MENU", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Urine Culture is NOT indicated for the following conditions alone:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "- Cloudy urine"}, 
{"Row" : 7, "Column" : 1, "Text" : "- Malodorous urine"}, 
{"Row" : 8, "Column" : 1, "Text" : "- Discolored urine"}, 
{"Row" : 9, "Column" : 1, "Text" : "- When a urinary catheter is placed"}, 
{"Row" : 10, "Column" : 1, "Text" : "- Automatic on admission"}, 
{"Row" : 11, "Column" : 1, "Text" : "- End of therapy re-testing"}, 
{"Row" : 13, "Column" : 1, "Text" : "Urine cultures should be ordered in patients with symptoms of a urinary tract", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "infection, during pregnancy at appropriate screening intervals, and prior", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "to an invasive urologic procedure.", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Select indication for urine culture your patient has to place lab order:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (FEVER/SEPSIS NO OTHER CAUSE) IC", "DisplayText" : "Fever or sepsis with no other identifiable cause", "Text" : ""},
{"Row" : 20, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (DYSURIA,FREQ,URG) IC", "DisplayText" : "Dysuria, frequency, or pelvic pain", "Text" :""},
{"Row" : 22, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (PAIN:FLANK,SUPRAPUBIC,PELVIC IC", "DisplayText" : "Flank, suprapubic, or pelvic pain", "Text" : ""},
{"Row" : 24, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (CVA tenderness) IC", "DisplayText" : "CVA tenderness", "Text" : ""},
{"Row" : 26, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (ACUTE HEMATURIA) IC", "DisplayText" : "Acute hematuria", "Text" : ""},
{"Row" : 28, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (PRE-0P SCREENING UROLOGIC) IC", "DisplayText" : "Pre-operative screening for urologic procedure", "Text" :""},
{"Row" : 30, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (PREGNANT SCREENING) IC", "DisplayText" : "Pregnant and due for screening", "Text" : ""},
{"Row" : 32, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (SCI OR NEUROGENIC BLADDER) IC", "DisplayText" : "Increased bladder spasticity or autonomic dysreflexia in patients with", "Text" :""},
{"Row" : 35, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (ALTERED MENTAL STATUS) IC", "DisplayText" : "Altered mental status with no other identifiable cause", "Text" : ""},
{"Row" : 33, "Column" : 1, "Text" : "spinal cord injury or neurologic deficit"}, 
{"Row" : 36, "Column" : 1, "Text" : "(note that UC not usually indicated, call ID with questions)"}, 
{"Row" : 38, "Column" : 1, "Item" : "LRTZ URINE CULTURE CLEAN CATCH (PRE-0P SCREENING UROLOGIC) IC", "DisplayText" : "Pre-operative screening for urologic procedure", "Text" : "OR/IR Sterile Aspirate Collection Only"}
]},
{"Name" : "ORZID2 GMENU ABX UTI2", "DisplayText" : "Urinary Tract Infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "06"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Text" : "URINARY TRACT INFECTION (UTI)"}, 
{"Row" : 9, "Column" : 1, "Text" : "Cystitis refers to infection of the urinary bladder, but inflammation often"}, 
{"Row" : 10, "Column" : 1, "Text" : "extends into the urethra. Typical symptoms and  signs include dysuria, increased"}, 
{"Row" : 11, "Column" : 1, "Text" : "urinary frequency, urgency, and/or suprapubic tenderness."}, 
{"Row" : 13, "Column" : 1, "Text" : "Most cases of UNCOMPLICATED CYSTITIS occur in pre-menopausal, non-pregnant,"}, 
{"Row" : 14, "Column" : 1, "Text" : "sexually active young women. In men with mild to moderate symptoms without"}, 
{"Row" : 15, "Column" : 1, "Text" : "complicating conditions and  without recent treatment relapse or recurrence,"}, 
{"Row" : 16, "Column" : 1, "Text" : "cystitis is considered uncomplicated.  Most cases of COMPLICATED CYSTITIS are"}, 
{"Row" : 17, "Column" : 1, "Text" : "associated with Escherichia coli, but more resistant pathogens occur, including"}, 
{"Row" : 18, "Column" : 1, "Text" : "the Gram positive pathogens staphylococci and  enterococci.  Urine culture"}, 
{"Row" : 19, "Column" : 1, "Text" : "should be obtained before antimicrobials are given."}, 
{"Row" : 21, "Column" : 1, "Text" : "Complicating conditions", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Cystitis is considered complicated when one or more of the following is present:"}, 
{"Row" : 24, "Column" : 1, "Text" : "> Structural abnormalities (e.g. presence of obstruction, catheter or"}, 
{"Row" : 25, "Column" : 1, "Text" : "nephrostomy tubes, neurogenic bladder)"}, 
{"Row" : 26, "Column" : 1, "Text" : "> Metabolic abnormalities that reduce local host defenses (e.g. diabetes,"}, 
{"Row" : 27, "Column" : 1, "Text" : "pregnancy, neutropenia, pelvic irradiation)"}, 
{"Row" : 28, "Column" : 1, "Text" : "> Unusual or resistant pathogen"}, 
{"Row" : 29, "Column" : 1, "Text" : "> Treatment failure or relapse or recurrence of infection"}, 
{"Row" : 31, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "When a patient presents with symptoms of cystitis, urinalysis should be"}, 
{"Row" : 36, "Column" : 1, "Text" : "performed to check for the presence of white blood cells.  Increased numbers of"}, 
{"Row" : 37, "Column" : 1, "Text" : "leukocytes (usually >25) in the presence of cystitis symptoms indicates"}, 
{"Row" : 38, "Column" : 1, "Text" : "inflammation and  thus cystitis.  The bacterial etiology is so predictable that"}, 
{"Row" : 39, "Column" : 1, "Text" : "urine culture is unnecessary and  empirical treatment is indicated.  The"}, 
{"Row" : 40, "Column" : 1, "Text" : "clinical significance of pyuria in the absence of cystitis symptoms is unclear."}, 
{"Row" : 41, "Column" : 1, "Text" : "Antimicrobial therapy is not indicated for pyuria in the absence of symptoms."}, 
{"Row" : 43, "Column" : 1, "Text" : "____________________________________", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "____________________________________", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"}
]},
{"Name" : "ORZID2 GMENU ABX VAGINITIS", "DisplayText" : "Bacterial Vaginosis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "12"},
{"Row" : 9, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "BACTERIAL VAGINOSIS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Vaginitis usually presents with discharge, itching, irritation, odor, or pain."}, 
{"Row" : 15, "Column" : 1, "Text" : "Bacterial vaginosis is the most common form of vaginitis. The vaginal flora is"}, 
{"Row" : 16, "Column" : 1, "Text" : "disrupted by one or more of the following common pathogens: Gardnerella"}, 
{"Row" : 17, "Column" : 1, "Text" : "vaginalis, Mycoplasma hominis, or Gram negative anaerobes.  Vaginal pH should"}, 
{"Row" : 18, "Column" : 1, "Text" : "be measured and  the specimen should be examined under the microscope."}, 
{"Row" : 20, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "The vaginal pH is greater than 4.5, the discharge is homogenous and  gray-white,"}, 
{"Row" : 22, "Column" : 1, "Text" : "and  the specimen has a positive amine or \"whiff\" test characterized by a fishy"}, 
{"Row" : 23, "Column" : 1, "Text" : "odor before or after addition of 10% KOH."}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 500MG PO Q12H", "DisplayText" : "Metronidazole 500MG PO q12h", "Text" : "Metronidazole 500 mg PO q12h for 7 days ($0.64/day) [DI]  < OR >", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q12H", "DisplayText" : "Clindamycin 300MG PO q12h", "Text" : "Clindamycin 300 mg PO q12h for 7 days ($3.36/day) [H,O]  < OR >", "Mnemonic" : "20"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 28, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 0.75% GEL VAGINAL QHS", "DisplayText" : "Metronidazole 0.75% gel vaginal QHS", "Text" : "Metronidazole topical gel, contents of 1 applicator intravaginally QHS for 5", "Mnemonic" : "18"},
{"Row" : 29, "Column" : 1, "Text" : "days ($0.64/day) [DI]"}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 2% CRM VAG 1APPLFUL CREAM QHS", "DisplayText" : "Clindamycin 2% cream vaginal 1 applicatorful Cream QHS", "Text" : "Clindamycin phosphate vaginal cream 5 gram (contents of 1 applicator)", "Mnemonic" : "22"},
{"Row" : 35, "Column" : 1, "Text" : "intravaginally QHS for 5 days ($3.36/day) [H,O]"}, 
{"Row" : 40, "Column" : 1, "Text" : "\"Mandell\" chapter: Vulvovaginitis and cervicitis"}, 
{"Row" : 41, "Column" : 1, "Text" : "Up-to-Date website accessed 8/2/11"}
]},
{"Name" : "ORZID2 GMENU ANAPLASMA PHATOCYTOPHILUM", "DisplayText" : "Anaplasma phagocytophilum (Human Granulocytotropic Anaplasmosis)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ANAPLASMA PHAGOCYTOPHILUM (HUMAN GRANULOCYTOTROPIC ANAPLASMOSIS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h ($0.16/day) [DI]  < OR >", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID DOXYCYCLINE 100MG IVPB Q12H", "DisplayText" : "Doxycycline 100MG IVPB Q12H", "Text" : "Doxycycline 100 mg IV q12h ($14/day) [DI]", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}
]},
{"Name" : "ORZID2 GMENU ANTIVIRAL TREATMENT 2014-2015", "DisplayText" : "Antiviral Treatment Recommendations  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Disease", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "Antiviral Therapy Recommendations:", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Who to Treat:", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "The decision to treat should be based on clinical symptoms and/or presence of"}, 
{"Row" : 12, "Column" : 1, "Text" : "a high risk condition, and should NOT be delayed until laboratory test"}, 
{"Row" : 13, "Column" : 1, "Text" : "results are available."}, 
{"Row" : 15, "Column" : 1, "Text" : "It is important to use antiviral drugs early to treat influenza in people"}, 
{"Row" : 16, "Column" : 1, "Text" : "are very sick with influenza (for example hospitalized people) and people"}, 
{"Row" : 17, "Column" : 1, "Text" : "are sick with influenza and have a greater chance of getting severe"}, 
{"Row" : 5, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary Consult", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Text" : "complications. If a patient is not in a high-risk group or is not hospital"}, 
{"Row" : 19, "Column" : 1, "Text" : "healthcare providers should use clinical judgment to guide treatment decisions."}, 
{"Row" : 20, "Column" : 1, "Text" : "People who have a greater chance of serious influenza complications include:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Adults 65 years and older"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Pregnant women and women up to 2 weeks from end of pregnancy"}, 
{"Row" : 23, "Column" : 1, "Text" : "*People with certain chronic medical conditions (such as asthma, heart"}, 
{"Row" : 24, "Column" : 1, "Text" : "failure, chronic lung disease) and people with a weak immune system (due to"}, 
{"Row" : 25, "Column" : 1, "Text" : "illnesses such as diabetes and HIV) or people with neurologic and"}, 
{"Row" : 26, "Column" : 1, "Text" : "neurodevelopment conditions (including disorders of brain and spinal cord)"}, 
{"Row" : 27, "Column" : 1, "Text" : "*People younger than 19 years of age who are receiving long-term aspirin"}, 
{"Row" : 28, "Column" : 1, "Text" : "therapy"}, 
{"Row" : 29, "Column" : 1, "Text" : "* American Indians/Alaska Natives"}, 
{"Row" : 30, "Column" : 1, "Text" : "*People who are morbidly obese (i.e., body-mass index greater than or"}, 
{"Row" : 31, "Column" : 1, "Text" : "equal to 40)"}, 
{"Row" : 33, "Column" : 1, "Text" : "Antiviral Treatment:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "If indicated, antivirals should be started as soon as possible.  Maximal"}, 
{"Row" : 35, "Column" : 1, "Text" : "benefit occurs when started within 48 hours of symptom onset.  However,"}, 
{"Row" : 36, "Column" : 1, "Text" : "antivirals should not be withheld if symptoms began more than 48 hours prior"}, 
{"Row" : 37, "Column" : 1, "Text" : "and the patient meets criteria for treatment and remains severely ill."}, 
{"Row" : 39, "Column" : 1, "Text" : "Oseltamivir or zanamivir are the only two antiviral drugs the Center for"}, 
{"Row" : 40, "Column" : 1, "Text" : "Disease Control is recommending for this influenza season. Neither"}, 
{"Row" : 41, "Column" : 1, "Text" : "amantadine nor rimantadine are recommended for treatment or"}, 
{"Row" : 42, "Column" : 1, "Text" : "chemoprophylaxis this influenza season."}, 
{"Row" : 44, "Column" : 1, "Text" : "Treatment Dosing:", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Patients with chronic respiratory disease like asthma or chronic obstructive"}, 
{"Row" : 46, "Column" : 1, "Text" : "pulmonary disease may have bronchospasm with zanamivir, and zanamivir shou"}, 
{"Row" : 47, "Column" : 1, "Text" : "avoided in these patients. If zanamivir must be used, and patients are using"}, 
{"Row" : 48, "Column" : 1, "Text" : "inhaled bronchodilator, zanamivir should be taken just after the bronchodilator"}, 
{"Row" : 50, "Column" : 1, "Text" : "Duration of antiviral treatment is 5 days.  Extending the treatment may be"}, 
{"Row" : 51, "Column" : 1, "Text" : "needed for those patients with prolonged illness or who are immnunosuppressed."}, 
{"Row" : 53, "Column" : 1, "Text" : "Recommended:", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 75MG PO BID", "DisplayText" : "Oseltamivir 75MG PO BID", "Text" : "Oseltamivir 75 mg po bid for 5 days ($14/day) [R]", "Mnemonic" : "14"},
{"Row" : 56, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 60, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "Centers for Disease Control (CDC)"}, 
{"Row" : 62, "Column" : 1, "Text" : "(http://www.cdc.gov/flu/about/season/index.htm)"}, 
{"Row" : 57, "Column" : 1, "Text" : "Requires Infectious Disease Approval"}, 
{"Row" : 58, "Column" : 1, "Text" : "Zanamivir 2 inhalations (2 x 5 mg) BID for 5 days ($8/day) [O]"}
]},
{"Name" : "ORZID2 GMENU APPENDICITIS W/O PERFORATION", "DisplayText" : "Appendicitis without perforation  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "In cases without evidence of perforation or rupture, antimicrobials are"}, 
{"Row" : 13, "Column" : 1, "Text" : "necessary only just before and during surgery.  Administer antimicrobials 60"}, 
{"Row" : 14, "Column" : 1, "Text" : "minutes before the first incision is made."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZ SET ABX CEFAZ 2GM IV X1 METRO 500MG IV X1", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV  ($1.86/day) [R] <AND> metronidazole 500 mg IV ($1/day)", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "ORZ SET ABX GENT 80MG IV X1 METRO 500MG IV X1", "DisplayText" : "", "Text" : "Gentamicin 80 mg IV  ($1/day) [R,O] <AND> metronidazole 500 mg IV", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 28, "Column" : 1, "Text" : "Solomkin JS  Clin Infect Dis 2003, 37: 997-1005"}, 
{"Row" : 29, "Column" : 1, "Text" : "Up-to-date  accessed 4/21/12"}, 
{"Row" : 18, "Column" : 1, "Text" : "[DI] both given over 20 minutes beginning 60 minutes before incision  < OR >"}, 
{"Row" : 21, "Column" : 1, "Text" : "($1/day) [DI] both given over 20 minutes beginning 60 minutes before"}, 
{"Row" : 22, "Column" : 1, "Text" : "incision"}, 
{"Row" : 10, "Column" : 1, "Text" : "APPENDICITIS WITHOUT PERFORATION"}, 
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" keyword: Appendicitis"}
]},
{"Name" : "ORZID2 GMENU APPENDICITIS WITH PERFORATION", "DisplayText" : "Appendicitis with perforation  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GENERAL SURG INP", "DisplayText" : "General surgery", "Text" : "General Surgery consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "APPENDICITIS WITH PERFORATION"}, 
{"Row" : 13, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "MODERATE TO SEVERE disease", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Treat for 5 to 7 days."}, 
{"Row" : 19, "Column" : 1, "Item" : "ZZORZ SET ABX CEFTRIAX 1 GM IV QD METRONIDAZOLE 1GM IV Q12H", "DisplayText" : "", "Text" : "Ceftriaxone 1-2 gm IV q24h ($17-34/day) [M] <AND> metronidazole 1 g IV q12h", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "($4/day) [DI]  < OR >"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($33/day) [R]", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZ SET ABX CIPROF 400MG IV Q12 METRON 500MG IV Q6H", "DisplayText" : "Ciprofloxacin 400mg iv q12h Metronidazole 500mg iv q6h", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> metronidazole 500mg IV", "Mnemonic" : "20"},
{"Row" : 27, "Column" : 1, "Text" : "q6h ($4/day) [DI]"}, 
{"Row" : 29, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Life threatening disease (ICU admission)", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "22"},
{"Row" : 36, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZ SET ABX CIPROF 400MG IV Q12 METRON 500MG IV Q6H", "DisplayText" : "Ciprofloxacin 400mg iv q12h Metronidazole 500mg iv q6h", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> metronidazole 500 mg IV", "Mnemonic" : "24"},
{"Row" : 38, "Column" : 1, "Text" : "q6h ($4/day) [DI]"}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 45, "Column" : 1, "Text" : "Up-to-date accessed 1/24/11"}, 
{"Row" : 43, "Column" : 1, "Text" : "\"Sanford\" keyword: Appendicitis"}, 
{"Row" : 44, "Column" : 1, "Text" : "Solomkin JS  Clin Infect Dis 2003, 37: 997"}
]},
{"Name" : "ORZID2 GMENU APPRO FOOT ULCER W/ INFECT", "DisplayText" : "Approach to foot ulcers with infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT PODIATRY INP", "DisplayText" : "PODIATRY INP", "Text" : "Podiatry consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Orthopedic surgery consult", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Whenever possible, material should be obtained for Gram stain and culture."}, 
{"Row" : 13, "Column" : 1, "Text" : "Specimens from deep ulcer biopsy, aspiration, or bone biopsy are superior to"}, 
{"Row" : 14, "Column" : 1, "Text" : "wound swab or drainage.  Pathogen identification is especially important because"}, 
{"Row" : 15, "Column" : 1, "Text" : "therapy is often given for weeks."}, 
{"Row" : 17, "Column" : 1, "Text" : "While foot ulcers in patients with diabetes typically have many bacterial"}, 
{"Row" : 18, "Column" : 1, "Text" : "species on the surface, disease is usually caused by only one or two.  When"}, 
{"Row" : 19, "Column" : 1, "Text" : "Staphylococcus aureus is present in a surface culture, it is usually a pathogen"}, 
{"Row" : 20, "Column" : 1, "Text" : "in the deeper tissues.  Therapy can usually be directed against the predominant"}, 
{"Row" : 21, "Column" : 1, "Text" : "or virulent organisms found on surface cultures and need not be active against"}, 
{"Row" : 22, "Column" : 1, "Text" : "every isolate.  To reduce uncertainty it is better to obtain deeper cultures."}, 
{"Row" : 24, "Column" : 1, "Text" : "Bacteria that are most likely to be responsible for invasive infection include"}, 
{"Row" : 25, "Column" : 1, "Text" : "S. aureus, streptococci, enteric gram-negative bacilli, Pseudomonas aeruginosa,"}, 
{"Row" : 26, "Column" : 1, "Text" : "and anaerobes typical of the human enteric flora.  When there is no evidence"}, 
{"Row" : 27, "Column" : 1, "Text" : "that would direct therapy to any single organism, empirical therapy should be"}, 
{"Row" : 28, "Column" : 1, "Text" : "directed against these organisms."}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 33, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}, 
{"Row" : 10, "Column" : 1, "Text" : "APPROACH TO FOOT ULCER WITH INFECTION"}
]},
{"Name" : "ORZID2 GMENU BABESIA SPP.", "DisplayText" : "Babesia species ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BABESIA SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Consult Infectious Diseases in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZ SET ABX CLINDAM 600MG PO Q8H QUININE 600MG PO Q8H", "DisplayText" : "", "Text" : "Clindamycin 600 mg PO q8h ($3.36/day) [H,O] <AND> quinine 600 mg PO q8h", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Text" : "($0.78/day) [M] for 7 days"}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX AZITHRO 500 THEN 250 Q24H ATOVAQUONE 750 Q12H", "DisplayText" : "", "Text" : "Azithromycin 500 mg PO once ($8) on day 1, then 250 mg PO Q24h ($4/day) [M] for", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "6 days <AND> atovaquone 750 mg PO q12h ($19/day) [M] for 7 days"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" keyword: Babesia"}
]},
{"Name" : "ORZID2 GMENU BACTEREMIA CANDIDA SPP.", "DisplayText" : "Bacteremia associated with Candida spp. ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 11, "Column" : 1, "Text" : "Consult Infectious Diseases.  Antifungal treatment is indicated for all cases of"}, 
{"Row" : 12, "Column" : 1, "Text" : "candidemia.  Treat until 14 days after the last positive blood culture."}, 
{"Row" : 14, "Column" : 1, "Text" : "Most Candida can be treated with fluconazole.  If the patient is critically ill,"}, 
{"Row" : 15, "Column" : 1, "Text" : "if the patient has recently taken an \"azole\" antifungal, or if Candida krusei or"}, 
{"Row" : 16, "Column" : 1, "Text" : "C. glabrata are present, amphotericin should be used initially."}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 400 mg PO q24h ($0.40/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID ORZ FLUCONAZOLE 400MG IV Q24H", "DisplayText" : "Fluconazole 400MG IV Q24H", "Text" : "Fluconazole 400 mg IV q24h ($13/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 26, "Column" : 1, "Text" : "Alternative for critically ill patients, patients who have recently taken", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "\"azole\" antifungals, or if C. glabrata or C. krusei are suspected", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin 1 mg/kg IV q24h ($23/day) [R,O]", "Mnemonic" : "14"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 9, "Column" : 1, "Text" : "FUNGEMIA ASSOCIATED WITH CANDIDA SPP."}, 
{"Row" : 18, "Column" : 1, "Text" : "If the patient has substantial renal disease, but is not dialysis-dependent,"}, 
{"Row" : 19, "Column" : 1, "Text" : "consider liposomal amphotericin or caspofungin.  Call Infectious Diseases for"}, 
{"Row" : 20, "Column" : 1, "Text" : "advice."}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" keyword: Antifungals"}, 
{"Row" : 35, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 36, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID2 GMENU BACTEREMIA LISTERIA", "DisplayText" : "Bacteremia associated with Listeria monocytogenes", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BACTEREMIA ASSOCIATED WITH LISTERIA MONOCYTOGENES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Consult Infectious Diseases in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment for Listeria", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IVPB Q4H", "DisplayText" : "Ampicillin 2GM IVPB Q4H", "Text" : "Ampicillin 2 gm IV q4h ($68/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Item" : "ORZ SET ABX AMPICIL 2G Q4H GENT 1.7MG/KG IV Q8H", "DisplayText" : "", "Text" : "Ampicillin 2 gm IV q4h ($68/day) [R] and gentamicin 1.7 mg/kg IV q8h", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Text" : "($3/day) [R,O]"}, 
{"Row" : 18, "Column" : 1, "Text" : "Alternative treatment for Listeria in patient with penicillin allergy", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID TRIMETHOPRIM/SULFAMETH 5/25 MG/KG IV Q12H", "DisplayText" : "Trimethoprim (5 mg/kg)/sulfamethoxazole (25 mg/kg) IV q12h", "Text" : "Trimethoprim 5 mg/kg - sulfamethoxazole 25 mg/kg IV q12h ($14/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 27, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID2 GMENU BITE WNDS EIKENELLA CORRODENS", "DisplayText" : "Bite wounds with Eikenella corrodens ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ VIT D 1,25 2WK", "DisplayText" : "Vit D 1,25", "Text" : "Consult Orthopedic surgery"},
{"Row" : 8, "Column" : 1, "Item" : "PSO ITRACONAZOLE 100MG", "DisplayText" : "Itraconazole 100mg 2 BID", "Text" : "Consult Rheumatology"},
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH EIKENELLA CORRODENS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO BID", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" :""},
{"Row" : 17, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID AMPICILLIN/SULBACTAM 1.5GM IVPB Q6H", "DisplayText" : "Ampicillin/Sulbactam 1.5GM IVPB Q6H", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levfloxacin 750MG PO Q24H", "Text" :""},
{"Row" : 22, "Column" : 1, "Text" : "1.Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management of"}, 
{"Row" : 23, "Column" : 1, "Text" : "Skin and Soft Tissue Infections: 2104 Update by the Infectious Disease"}, 
{"Row" : 24, "Column" : 1, "Text" : "Society of America. Clinical Infectious Diseases. 2014."}, 
{"Row" : 26, "Column" : 1, "Text" : "2. Sanford Guide: Bites. Accessed September 10 2014."}, 
{"Row" : 28, "Column" : 1, "Text" : "3. Up to Date: Initial Management of Animal and Human Bites. August 12, 2014."}, 
{"Row" : 21, "Column" : 1, "Text" : "References", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU BITE WNDS P. MULTOCIDA", "DisplayText" : "Bite wounds with Pasteurella multocida  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ VIT D 1,25 2WK", "DisplayText" : "Vit D 1,25", "Text" : "Consult Orthopedic surgery"},
{"Row" : 8, "Column" : 1, "Item" : "PSO ITRACONAZOLE 100MG", "DisplayText" : "Itraconazole 100mg 2 BID", "Text" : "Consult Rheumatology"},
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH PASTEURELLA MULTOCIDA"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO BID", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h ($1.56/day) [R] < OR >"},
{"Row" : 17, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : ""},
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID AMPICILLIN/SULBACTAM 1.5GM IVPB Q6H", "DisplayText" : "Ampicillin/Sulbactam 1.5GM IVPB Q6H", "Text" : ""},
{"Row" : 22, "Column" : 1, "Text" : "1. Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management of"}, 
{"Row" : 23, "Column" : 1, "Text" : "Skin and Soft Tissue Infections: 2104 Update by the Infectious Disease"}, 
{"Row" : 24, "Column" : 1, "Text" : "Society of America. Clinical Infectious Diseases. 2014."}, 
{"Row" : 26, "Column" : 1, "Text" : "2. Sanford Guide: Bites. Accessed September 10 2014."}, 
{"Row" : 28, "Column" : 1, "Text" : "3. Up to Date: Initial Management of Animal and Human Bites. August 12, 2014."}, 
{"Row" : 21, "Column" : 1, "Text" : "References", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU BITE WNDS S. AUREUS", "DisplayText" : "Bite wounds with Staphylococcus aureus  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ VIT D 1,25 2WK", "DisplayText" : "Vit D 1,25", "Text" : "Consult Orthopedic surgery"},
{"Row" : 7, "Column" : 1, "Item" : "PSO ITRACONAZOLE 100MG", "DisplayText" : "Itraconazole 100mg 2 BID", "Text" : "Consult Rheumatology"},
{"Row" : 10, "Column" : 1, "Text" : "BITE WOUNDS WITH STAPHYLOCOCCUS AUREUS"}, 
{"Row" : 12, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Methicillin-SUSCEPTIBLE S. aureus", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H", "Text" :""},
{"Row" : 24, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Methicillin-RESISTANT S. aureus", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H", "Text" :""},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IVPB Q8H", "DisplayText" : "Cefazolin 2GM IVPB Q8H", "Text" :""},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 500MG PO Q6H", "DisplayText" : "Cephalexin 500MG PO Q6H", "Text" : ""},
{"Row" : 20, "Column" : 1, "Text" : "Alternative for Penicillin Allergy:", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q12H", "DisplayText" : "Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 32, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : ""},
{"Row" : 36, "Column" : 1, "Text" : "1. Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management of"}, 
{"Row" : 37, "Column" : 1, "Text" : "Skin and Soft Tissue Infections: 2104 Update by the Infectious Disease"}, 
{"Row" : 38, "Column" : 1, "Text" : "Society of America. Clinical Infectious Diseases. 2014."}, 
{"Row" : 40, "Column" : 1, "Text" : "2. Sanford Guide: Bites. Accessed September 10 2014."}, 
{"Row" : 42, "Column" : 1, "Text" : "3. Up to Date: Initial Management of Animal and Human Bites. August 12, 2014."}, 
{"Row" : 34, "Column" : 1, "Text" : "References", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU BITE WNDS STREPTOCOCCI", "DisplayText" : "Bite wounds with Streptococci  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ VIT D 1,25 2WK", "DisplayText" : "Vit D 1,25", "Text" : "Consult Orthopedic surgery"},
{"Row" : 8, "Column" : 1, "Item" : "PSO ITRACONAZOLE 100MG", "DisplayText" : "Itraconazole 100mg 2 BID", "Text" : "Consult Rheumatology"},
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH STREPTOCOCCI"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IVPB Q8H", "DisplayText" : "Cefazolin 2GM IVPB Q8H", "Text" :""},
{"Row" : 15, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 500MG PO Q6H", "DisplayText" : "Cephalexin 500MG PO Q6H", "Text" : ""},
{"Row" : 17, "Column" : 1, "Text" : "Alternative for Penicillin Allergy", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levfloxacin 750MG PO Q24H", "Text" :""},
{"Row" : 22, "Column" : 1, "Text" : "1. Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management of"}, 
{"Row" : 23, "Column" : 1, "Text" : "Skin and Soft Tissue Infections: 2104 Update by the Infectious Disease"}, 
{"Row" : 24, "Column" : 1, "Text" : "Society of America. Clinical Infectious Diseases. 2014."}, 
{"Row" : 26, "Column" : 1, "Text" : "2. Sanford Guide: Bites. Accessed September 10 2014."}, 
{"Row" : 28, "Column" : 1, "Text" : "3.Up to Date: Initial Management of Animal and Human Bites. August 12, 2014."}, 
{"Row" : 21, "Column" : 1, "Text" : "References", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU BITE WOUNDS", "DisplayText" : "Bite wounds  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Consult orthopedic surgery"},
{"Row" : 10, "Column" : 1, "Text" : "BITE WOUNDS"}, 
{"Row" : 25, "Column" : 1, "Text" : "Pathogen-directed bite wound therapy", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU BITE WNDS P. MULTOCIDA", "DisplayText" : "Bite wounds with Pasteurella multocida", "Text" : "Pasteurella multocida"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU BITE WNDS EIKENELLA CORRODENS", "DisplayText" : "Bite wounds with Eikenella corrodens", "Text" : "Eikenella corrodens"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU BITE WNDS S. AUREUS", "DisplayText" : "Bite wounds with Staphylococcus aureus", "Text" : "Staphylococcus aureus"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU BITE WNDS STREPTOCOCCI", "DisplayText" : "Bite wounds with Streptococci", "Text" : "Streptococci"},
{"Row" : 31, "Column" : 1, "Text" : "Pre-emptive therapy for deep wounds and empirical therapy of wounds that appear", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "infected", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO BID", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin/Clavulanate 875/125MG BID X7 DAYS"},
{"Row" : 36, "Column" : 1, "Text" : "Alternative for patients with penicillin allergy", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Bite wounds are prone to infection because of the pathogenic oral flora carried"}, 
{"Row" : 13, "Column" : 1, "Text" : "into tissue by teeth. For trival,superficial wounds antibiotic therapy may"}, 
{"Row" : 14, "Column" : 1, "Text" : "not be necessary and the area should be cleansed and the patient observed for"}, 
{"Row" : 15, "Column" : 1, "Text" : "signs and symptoms of infection. Otherwise patient should be treated"}, 
{"Row" : 16, "Column" : 1, "Text" : "preemptively with antibiotics."}, 
{"Row" : 18, "Column" : 1, "Text" : "The recommended duration for preemptive antibiotics is 3-5 days"}, 
{"Row" : 20, "Column" : 1, "Text" : "For wounds that later develop evidence of infection recommended duration of"}, 
{"Row" : 21, "Column" : 1, "Text" : "treatment is 5-10 days unless the infection involves a joint in which case a"}, 
{"Row" : 22, "Column" : 1, "Text" : "longer duration may be required (see joint infection recommendations)."}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID AMPICILLIN/SULBACTAM 1.5GM IVPB Q6H", "DisplayText" : "Ampicillin/Sulbactam 1.5GM IVPB Q6H", "Text" : ""},
{"Row" : 37, "Column" : 1, "Item" : "PSJZID MOXIFLOXACIN 400MG PO Q24H", "DisplayText" : "Moxifloxacin 400MG PO Q24H", "Text" : ""},
{"Row" : 38, "Column" : 1, "Item" : "PSJI MOXIFLOXACIN IVPB MENU", "DisplayText" : "Moxifloxacin", "Text" : ""},
{"Row" : 42, "Column" : 1, "Text" : "1. Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management of"}, 
{"Row" : 43, "Column" : 1, "Text" : "Skin and Soft Tissue Infections: 2104 Update by the Infectious Disease Society"}, 
{"Row" : 44, "Column" : 1, "Text" : "of America. Clinical Infectious Diseases. 2014."}, 
{"Row" : 46, "Column" : 1, "Text" : "2. Sanford Guide: Bites. Accessed September 10 2014."}, 
{"Row" : 48, "Column" : 1, "Text" : "3. Up to Date: Initial Management of Animal and Human Bites. August 12, 2014."}, 
{"Row" : 41, "Column" : 1, "Text" : "References", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU CAP ACQUIRED NURSING HOME SETTING", "DisplayText" : "Pneumonia acquired in a NURSING HOME setting  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PNEUMONIA ACQUIRED IN A NURSING HOME SETTING"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment for nursing home resident ADMITTED TO THE HOSPITAL", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Pneumonia acquired in a nursing home is likely to be associated with resistant"}, 
{"Row" : 14, "Column" : 1, "Text" : "bacteria.  Cases should be treated like cases acquired in the hospital."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment for a nursing home resident SENT BACK TO THE NURSING HOME", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500mg PO Q24H ($0.19/Day)[R,DI]", "Text" : "Levofloxacin 500 mg PO q24h ($0.19/day) for 7 days [R,DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 26, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 27, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 28, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 29, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 30, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003, 37: 1405"}, 
{"Row" : 31, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 32, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-date"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Am J Respir Crit Care Med 2005, 171: 388"}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ SET ABX AMOX-CLAV 875 AZITH 500MG PO 3 DAYS", "DisplayText" : "", "Text" : "Amoxicillin-clavulanate 875-125 mg PO q12h ($1.56/day) for 7 days [R]", "Mnemonic" : "17"},
{"Row" : 22, "Column" : 1, "Text" : "<AND> Azithromycin 500 mg PO daily for 3 days ($8.18/day)"}
]},
{"Name" : "ORZID2 GMENU CAP OUTPATIENT TREATED SETTING", "DisplayText" : "CAP treated in an OUTPATIENT setting ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 9, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA (CAP) TREATED IN AN OUTPATIENT SETTING"}, 
{"Row" : 11, "Column" : 1, "Text" : "NOTE: These are INPATIENT orders.  To transfer these orders to outpatient,", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "highlight the order in the \"MEDS\" tab of CPRS, click on the heading \"Action\",", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "then click on \"Transfer to Outpatient\".", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred outpatient treatment for PREVIOUSLY HEALTHY PATIENT", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "(without chronic obstructive pulmonary disease, diabetes, renal failure,"}, 
{"Row" : 17, "Column" : 1, "Text" : "congestive heart failure, or malignancy)"}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Preferred outpatient treatment for PATIENTS WITH COMORBIDITIES", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "(chronic obstructive pulmonary disease, diabetes, renal failure, congestive"}, 
{"Row" : 26, "Column" : 1, "Text" : "heart failure, or malignancy)"}, 
{"Row" : 30, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary"},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG PO Q24H", "Text" : ""},
{"Row" : 22, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" :""},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID CEFUROXIME 500MG Q12H 7D AND AZITHROMYCIN 500MG Q24H 3D", "DisplayText" : "Cefuroxime 500MG Q12H <AND> Azithromycin 500MG Q24H", "Text" : ""},
{"Row" : 31, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 750MG Q24H 5 DAYS", "DisplayText" : "Levofloxacin 750MG Q24H", "Text" : ""},
{"Row" : 32, "Column" : 1, "Item" : "PSOZID CEFUROXIME 500MG Q12H 7D AND DOXYCYCLINE 100MG Q12H 7D", "DisplayText" : "Cefuroxime 500MG Q12H <AND> Doxycycline 100MG Q12H", "Text" : ""},
{"Row" : 36, "Column" : 1, "Text" : "UptoDate. www.uptodate.com. Accessed 3/24-3/26/14"}, 
{"Row" : 37, "Column" : 1, "Text" : "Infection Disease Society of America. www.idsa.org. Accessed 3/24-3/26/14"}, 
{"Row" : 38, "Column" : 1, "Text" : "Sanford Guide.www.sanfordguide.com. Accessed 3/24-3/26/14"}
]},
{"Name" : "ORZID2 GMENU CAPD VANCO 2400MG CEFTAZ 1GM HEP 1000U PD", "DisplayText" : "Peritonitis associated with CAPD Med Orders Menu ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Pick a Peritoneal Dialysis Soln Low Mag %", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZ SET ABX PD 1.5% VANCO 2400MG CEFTAZ 1GM HEP 1000U", "DisplayText" : "", "Text" : "Peritoneal Dialysis Soln Low Mag 1.5%", "Mnemonic" : "02"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ SET ABX PD 2.5% VANCO 2400MG CEFTAZ 1GM HEP 1000U", "DisplayText" : "", "Text" : "Peritoneal Dialysis Soln Low Mag 2.5%", "Mnemonic" : "04"},
{"Row" : 9, "Column" : 1, "Item" : "ORZ SET ABX PD 4.25% VANCO 2400MG CEFTAZ 1GM HEP 1000U", "DisplayText" : "", "Text" : "Peritoneal Dialysis Soln Low Mag 4.25%", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU CAPD VANCOM 2400MG GENT 40MG HEP 1000U PD", "DisplayText" : "Peritonitis associated with CAPD Med Orders Menu ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Pick a Peritoneal Dialysis Soln Low Mag %", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZ SET ABX PD 1.5% 2L VANCO 2400MG GENT 40MG HEP 1000U", "DisplayText" : "", "Text" : "Peritoneal Dialysis Soln Low Mag 1.5%", "Mnemonic" : "02"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ SET ABX PD 2.5% 2L VANCOM 2400MG GENT 40MG HEP 1000U", "DisplayText" : "", "Text" : "Peritoneal Dialysis Soln Low Mag 2.5%", "Mnemonic" : "04"},
{"Row" : 9, "Column" : 1, "Item" : "ORZ SET ABX PD 4.25% 2L VANCOM 2400MG GENT 40MG HEP 1000U", "DisplayText" : "", "Text" : "Peritoneal Dialysis Soln Low Mag 4.25%", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU CMI DEFECTS", "DisplayText" : "Cell-mediated immunity (CMI) defects ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "CELL-MEDIATED IMMUNITY (CMI) DEFECTS"}, 
{"Row" : 8, "Column" : 1, "Text" : "Patients with reduced CMI include those with HIV/AIDS, hematologic malignancies,"}, 
{"Row" : 9, "Column" : 1, "Text" : "cytotoxic chemotherapy, and congenital abnormalities.  Patients with cell-"}, 
{"Row" : 10, "Column" : 1, "Text" : "mediated immune defects are more susceptible to infections from ubiquitous"}, 
{"Row" : 11, "Column" : 1, "Text" : "microorganisms that do not usually cause infection in healthy patients.  The"}, 
{"Row" : 12, "Column" : 1, "Text" : "specific organisms that are more likely to be associated with disease vary"}, 
{"Row" : 13, "Column" : 1, "Text" : "depending on the specific type of immune defect present, but include:"}, 
{"Row" : 14, "Column" : 1, "Text" : "Pneumocystis jirovecii (formerly Pneumocystis carinii), Mycobacterium avium,"}, 
{"Row" : 15, "Column" : 1, "Text" : "Mycobacterium tuberculosis, Salmonella spp., Candida spp., Aspergillus spp.,"}, 
{"Row" : 16, "Column" : 1, "Text" : "Toxoplasma gondii, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus,"}, 
{"Row" : 17, "Column" : 1, "Text" : "and Cryptosporidium parvum."}, 
{"Row" : 19, "Column" : 1, "Text" : "These infectious diseases usually have a subacute or chronic presentation.  The"}, 
{"Row" : 20, "Column" : 1, "Text" : "best approach in most circumstances is for the clinician to conduct a methodical"}, 
{"Row" : 21, "Column" : 1, "Text" : "diagnostic workup to identify the specific pathogen and guide therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Empirical antimicrobials are not indicated for patients with CMI defects who"}, 
{"Row" : 23, "Column" : 1, "Text" : "present only with fever.  Contact Infectious Disease for more information."}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 28, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 29, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU COMM ACQ DIARRHEA", "DisplayText" : "Community acquired diarrhea ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY ACQUIRED DIARRHEA (NO RECENT TRAVEL)"}, 
{"Row" : 12, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Acute (< 14 days of symptoms)", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Empirical antimicrobials should be given only in cases of severe acute disease."}, 
{"Row" : 18, "Column" : 1, "Text" : "If the patient has taken antimicrobials in the preceding two months, consider"}, 
{"Row" : 19, "Column" : 1, "Text" : "Clostridium difficile infection."}, 
{"Row" : 22, "Column" : 1, "Text" : "Cases with enterohemorrhagic E. coli typically have bloody diarrhea, abdominal"}, 
{"Row" : 23, "Column" : 1, "Text" : "pain, and tenderness but no fever.  In these cases anti-motility agents and"}, 
{"Row" : 24, "Column" : 1, "Text" : "antimicrobials increase the risk of hemolytic uremic syndrome and should not be"}, 
{"Row" : 25, "Column" : 1, "Text" : "given.  If there is blood, abdominal pain, tenderness, or dehydration and fever,"}, 
{"Row" : 26, "Column" : 1, "Text" : "send stool for culture and O&P."}, 
{"Row" : 27, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Subacute or chronic (> 14 days of symptoms)", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Empiric antimicrobial therapy is not indicated.  Investigate for the cause of"}, 
{"Row" : 32, "Column" : 1, "Text" : "diarrhea.  Gastroenterology and/or Infectious Diseases involvement is"}, 
{"Row" : 33, "Column" : 1, "Text" : "encouraged."}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 39, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 40, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296-305"}, 
{"Row" : 41, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 43, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 44, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 45, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 38, "Column" : 1, "Text" : "\"Sanford\" keyword: Diarrhea"}, 
{"Row" : 42, "Column" : 1, "Text" : "Up-to-Date accessed 5/24/12"}
]},
{"Name" : "ORZID2 GMENU DIAGNOSIS PERTUSSIS", "DisplayText" : "Diagnosis of Pertussis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "DIAGNOSIS OF PERTUSSIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Laboratory testing is recommended to confirm a clinical diagnosis of pertussis."}, 
{"Row" : 10, "Column" : 1, "Text" : "Nasopharyngeal samples should be obtained with calcium alginate swabs.  The"}, 
{"Row" : 11, "Column" : 1, "Text" : "appropriate diagnostic strategy depends upon the duration of coughing symptoms."}, 
{"Row" : 13, "Column" : 1, "Text" : ">>  During the first 3 weeks of coughing", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Obtain two nasopharyngeal samples, one for culture and one for PCR"}, 
{"Row" : 16, "Column" : 1, "Text" : ">>  Between 3 and 4 weeks of coughing", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Obtain nasopharyngeal sample for PCR"}, 
{"Row" : 18, "Column" : 1, "Text" : "Obtain serum sample for IgG antibodies to Bordetella pertussis"}, 
{"Row" : 20, "Column" : 1, "Text" : ">>  More than 4 weeks of coughing", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Obtain serum sample for IgG antibodies to Bordetella pertussis"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 26, "Column" : 1, "Text" : "Hewlett EL NEJM 2005, 352: 1215"}, 
{"Row" : 27, "Column" : 1, "Text" : "Up-to-date website: Pertussis"}, 
{"Row" : 29, "Column" : 1, "Text" : "CDC MMWR 2006, 55(RR03): 1-34"}, 
{"Row" : 28, "Column" : 1, "Text" : "\"Sanford\" keyword: Pertussis"}, 
{"Row" : 30, "Column" : 1, "Text" : "\"Mandell\" chapter: Bordetella species"}
]},
{"Name" : "ORZID2 GMENU DISSEMINATED M. AVIUM", "DisplayText" : "Disseminated Mycobacterium avium disease treatment  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 12, "Column" : 1, "Text" : "Many of these patients have HIV/AIDS.  Management is complex.  Consult"}, 
{"Row" : 13, "Column" : 1, "Text" : "Infectious Diseases."}, 
{"Row" : 15, "Column" : 1, "Text" : "Rifabutin is optional for disseminated disease.  Rifabutin can improve cure"}, 
{"Row" : 16, "Column" : 1, "Text" : "rates, but may decrease blood concentrations of many drugs.  Consult Infectious"}, 
{"Row" : 17, "Column" : 1, "Text" : "Diseases or Pharmacy for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Two-drug treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX CLARITHROMYCIN 500 PO Q12H EHTAMBUTOL 15 Q24H", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO q12h  ($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZ SET ABX AZITHRO 250MG PO Q24H ETHAMBUTOL 15 PO Q24H", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO Q24h ($4/day) [M] <AND> ethambutol 15 mg/kg PO Q24h [R]", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Three-drug treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZ SET ABX CLARITHROMYCIN, ETHAMBUTOL, RIFABUTIN", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO q12h($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg PO", "Mnemonic" : "14"},
{"Row" : 38, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Item" : "ORZ SET ABX AZITH 250, ETHAMBUTOL, RIFABUTIN 300", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO Q24h ($4/day) M <AND> ethambutol 15 mg/kg PO Q24h [R]", "Mnemonic" : "16"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 10, "Column" : 1, "Text" : "DISSEMINATED MYCOBACTERIUM AVIUM DISEASE"}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCT PHARMACY CONSULT BLUE TEAM", "DisplayText" : "PHARMACY CONSULT BLUE TEAM", "Text" : "Consult Pharmacy", "Mnemonic" : "07"},
{"Row" : 45, "Column" : 1, "Text" : "\"Sanford\" keyword: MAC"}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Mandell\" chapter: Mycobacterium avium complex"}, 
{"Row" : 25, "Column" : 1, "Text" : "PO q24h ($2.52/day) [R]"}, 
{"Row" : 36, "Column" : 1, "Text" : "q24h ($2.52/day) [R] <AND> rifabutin 300 mg PO q24h ($4.18/day) [R,DI]"}, 
{"Row" : 40, "Column" : 1, "Text" : "<AND> rifabutin 300 mg q24h ($4.18/day) [R,DI]"}
]},
{"Name" : "ORZID2 GMENU EARLY TREATMENT OR CHEMOPROPHYLAXIS", "DisplayText" : "Early Treatment or Chemoprophylaxis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Disease", "Mnemonic" : "08"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary Consult", "Mnemonic" : "06"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 52, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "Centers for Disease Control (CDC)"}, 
{"Row" : 54, "Column" : 1, "Text" : "(http://www.cdc.gov/flu/about/season/index.htm)"}, 
{"Row" : 8, "Column" : 1, "Text" : "Early treatment as alternative to chemoprophylaxis:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "In most cases, if a person is suspected of having been exposed to influenza"}, 
{"Row" : 10, "Column" : 1, "Text" : "early treatment should signs or symptoms develop is preferred rather than"}, 
{"Row" : 11, "Column" : 1, "Text" : "chemoprophylaxis."}, 
{"Row" : 13, "Column" : 1, "Text" : "The provider should explain the early signs and symptoms of influenza to the"}, 
{"Row" : 14, "Column" : 1, "Text" : "patient and advise the patient to immediately contact a health care provider"}, 
{"Row" : 15, "Column" : 1, "Text" : "for evaluation and possible early treatment if these symptoms or signs"}, 
{"Row" : 16, "Column" : 1, "Text" : "develop. Influenza-like symptoms or signs include fever, cough, sore throat"}, 
{"Row" : 17, "Column" : 1, "Text" : "runny or stuffy nose, body aches, headache, chills, fatigue, vomiting, and"}, 
{"Row" : 18, "Column" : 1, "Text" : "diarrhea. Influenza can present without fever."}, 
{"Row" : 19, "Column" : 1, "Text" : "Health care providers should use clinical judgment regarding situations where"}, 
{"Row" : 20, "Column" : 1, "Text" : "early recognition of illness and treatment might be an appropriate"}, 
{"Row" : 21, "Column" : 1, "Text" : "alternative to chemoprophylaxis."}, 
{"Row" : 23, "Column" : 1, "Text" : "Early treatment alternative or chemoprophylaxis may be considered for:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "*Persons who are part of a high-risk group and are household or close"}, 
{"Row" : 25, "Column" : 1, "Text" : "contacts of someone with influenza-like illness"}, 
{"Row" : 26, "Column" : 1, "Text" : "*Health care personnel who have occupational exposures"}, 
{"Row" : 28, "Column" : 1, "Text" : "Chemoprophylaxis can be considered for:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "*Resident of a long term care facility that had close contact with another"}, 
{"Row" : 30, "Column" : 1, "Text" : "resident or staff with influenza-like illness."}, 
{"Row" : 31, "Column" : 1, "Text" : "*Atypical situations (such as case clusters).  Contact state"}, 
{"Row" : 32, "Column" : 1, "Text" : "Department of Health for consultation."}, 
{"Row" : 34, "Column" : 1, "Text" : "Antiviral Chemoprophylaxis Dosing:", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Duration of antiviral treatment is 10 days.  Among long-term care residentS"}, 
{"Row" : 36, "Column" : 1, "Text" : "the antiviral use should be re-evaluated after 10 days. If no further"}, 
{"Row" : 37, "Column" : 1, "Text" : "exposures have occurred, antivirals should be discontinued."}, 
{"Row" : 39, "Column" : 1, "Text" : "Zanamivir is not recommended for patients with chronic respiratory disease"}, 
{"Row" : 40, "Column" : 1, "Text" : "as asthma or chronic obstructive pulmonary disease. These patients may have"}, 
{"Row" : 41, "Column" : 1, "Text" : "bronchospasm with zanamivir. If zanamivir must be used, and patients are using"}, 
{"Row" : 42, "Column" : 1, "Text" : "an inhaled bronchodilator, zanamivir should be taken just after the"}, 
{"Row" : 43, "Column" : 1, "Text" : "bronchodilator."}, 
{"Row" : 45, "Column" : 1, "Text" : "Recommended:", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "Requires Infectious Disease Approval"}, 
{"Row" : 50, "Column" : 1, "Text" : "Zanamivir 2 inhalations (2 x 5 mg)daily for 10 days($4/day) [O]"}, 
{"Row" : 46, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 75 MG PO Q24H", "DisplayText" : "Oseltamivir 75 mg po q24h", "Text" : "Oseltamivir 75 mg po q day for 10 days ($7/day) [R]", "Mnemonic" : "14"}
]},
{"Name" : "ORZID2 GMENU EC NV CX NEG", "DisplayText" : "Native Valve Endocarditis with Negative Culture  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "04"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "NATIVE VALVE ENDOCARDITIS WITH CULTURE-NEGATIVE RESULTS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Cultures are often negative in cases of infection with fastidious organisms like"}, 
{"Row" : 11, "Column" : 1, "Text" : "Abiotrophia (formerly \"nutritionally variant Streptococci\"), Bartonella,"}, 
{"Row" : 12, "Column" : 1, "Text" : "Coxiella, Chlamydia, Legionella spp., or Trophyrema or when antimicrobials are"}, 
{"Row" : 13, "Column" : 1, "Text" : "given before blood cultures are obtained.  Consult Infectious Diseases and"}, 
{"Row" : 14, "Column" : 1, "Text" : "Cardiology."}, 
{"Row" : 4, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "06"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"}
]},
{"Name" : "ORZID2 GMENU EC NV ENTEROCOCCI", "DisplayText" : "Native Valve Endocarditis with Enterococci ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "NATIVE VALVE ENDOCARDITIS WITH ENTEROCOCCI"}, 
{"Row" : 13, "Column" : 1, "Text" : "Duration of therapy", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Duration of therapy depends on duration of symptoms, susceptibility of the"}, 
{"Row" : 15, "Column" : 1, "Text" : "enterococcus isolate to antimicrobials, and the effectiveness of the"}, 
{"Row" : 16, "Column" : 1, "Text" : "antimicrobials that can be used.  For patients who have experienced symptoms for"}, 
{"Row" : 17, "Column" : 1, "Text" : "less than 3 months and who can be treated with ampicillin or penicillin, treat"}, 
{"Row" : 18, "Column" : 1, "Text" : "for 4 to 6 weeks.  Treat all other patients including any patient receiving"}, 
{"Row" : 20, "Column" : 1, "Text" : "more information."}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug choice", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Choose both a cell wall active drug AND an aminoglycoside based on bacterial"}, 
{"Row" : 24, "Column" : 1, "Text" : "susceptibility and any history of adverse reaction to antimicrobials in the"}, 
{"Row" : 25, "Column" : 1, "Text" : "patient.  For strains resistant to penicillin, aminoglycosides, and vancomycin,"}, 
{"Row" : 28, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "1. Cell-wall active drugs", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IVPB Q4H", "DisplayText" : "Ampicillin 2GM IVPB Q4H", "Text" : "Ampicillin 2 gm IV q4h ($68/day) [R]", "Mnemonic" : "14"},
{"Row" : 35, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R]", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "2. Aminoglycosides", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 1 MG/KG IV Q8H", "DisplayText" : "Gentamicin 1MG/KG IV Q8H", "Text" : "Gentamicin 1 mg/kg IV q8h ($3/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 45, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Item" : "PSJIZID STREPTOMYCIN 7.5 MG/KG IV Q12H", "DisplayText" : "Streptomycin 7.5 MG/KG IV Q12H", "Text" : "Streptomycin 7.5 mg/kg IV q12h ($3/day) [R]", "Mnemonic" : "20"},
{"Row" : 49, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 52, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Endocarditis and intravascular infections\""}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 26, "Column" : 1, "Text" : "consult Infectious Diseases."}, 
{"Row" : 19, "Column" : 1, "Text" : "vancomycin for at least 6 weeks.  Consult Cardiology or Infectious Diseases for"}, 
{"Row" : 51, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 53, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}
]},
{"Name" : "ORZID2 GMENU EC NV FUNGI", "DisplayText" : "Native Valve Endocarditis with Fungi ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "04"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "NATIVE VALVE ENDOCARDITIS WITH FUNGI"}, 
{"Row" : 4, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "06"},
{"Row" : 10, "Column" : 1, "Text" : "Consult Infectious Diseases, Cardiology, and Cardiothoracic surgery."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"}
]},
{"Name" : "ORZID2 GMENU EC NV GNB", "DisplayText" : "Native Valve Endocarditis with Gram Negative Bacilli", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "NATIVE VALVE ENDOCARDITIS WITH GRAM NEGATIVE BACILLI OTHER"}, 
{"Row" : 12, "Column" : 1, "Text" : "THAN \"HACEK\" ORGANISMS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Pseudomonas aeruginosa and various Enterobacteriaceae are uncommon endocarditis"}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment for Enterobacteriaceae", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAX 2GM IV Q24H GENT 1.7 MG/KG IV Q8H", "DisplayText" : "CEFTRIAX 2GM IV Q4H GENT 1.7 MG/KG IV Q8H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) [M] <AND> gentamicin 1.7 mg/kg IV q8h", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "($3/day)[R,O]"}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment for Pseudomonas", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Over 95% of pseudomonas cases occur in IV drug users."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX CEF 2GM IV Q8H TOBRA 8 MG/KG IV Q24H", "DisplayText" : "CEFTAZIDIME 2GM IV Q8H TOBRA 8 MG/KG IV Q24H", "Text" : "Ceftazidime 2 gm IV q8h ($36/day) [R] <AND> tobramycin 8 mg/kg IV q24h", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Text" : "($11/day) [R,O]"}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Endocarditis and intravascular infections\""}, 
{"Row" : 15, "Column" : 1, "Text" : "pathogens.  Risk factors include cirrhosis and IV drug use.  Consult Infectious"}, 
{"Row" : 16, "Column" : 1, "Text" : "Diseases and Cardiothoracic surgery in all cases."}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 30, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 32, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}
]},
{"Name" : "ORZID2 GMENU EC NV HACEK", "DisplayText" : "Native Valve Endocarditis with \"HACEK\" bacteria  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "NATIVE VALVE ENDOCARDITIS WITH \"HACEK\" BACTERIA"}, 
{"Row" : 13, "Column" : 1, "Text" : "These are fastidious gram negative bacilli, including Haemophilus"}, 
{"Row" : 14, "Column" : 1, "Text" : "parainfluenzae, Haemophilus aphrophilus, Haemophilus paraphrophilus, Haemophilus"}, 
{"Row" : 15, "Column" : 1, "Text" : "influenzae, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis,"}, 
{"Row" : 16, "Column" : 1, "Text" : "Eikenella corrodens, Kingella kingae and Kingella denitrificans.  It may take up"}, 
{"Row" : 17, "Column" : 1, "Text" : "three weeks for the microbiology laboratory to isolate these organisms."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment options are limited for patients with allergies to beta-lactam"}, 
{"Row" : 21, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Treat for 4 weeks."}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJI CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) [M] < OR >", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin/Sulbactam 3GM IVPB Q6H", "Text" : "Ampicillin-sulbactam 3 gm IV q6h ($33/day) [R]", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 33, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Endocarditis and intravascular infections\""}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "antibiotics.  Consult Infectious Diseases for advice."}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 34, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}
]},
{"Name" : "ORZID2 GMENU EC NV STREPTOCOCCI", "DisplayText" : "Native Valve Endocarditis with Streptococci", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "NATIVE VALVE ENDOCARDITIS WITH STREPTOCOCCI"}, 
{"Row" : 13, "Column" : 1, "Text" : "Therapy is based on susceptibility to penicillin."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment of HIGHLY SUSCEPTIBLE viridans streptococci and Streptococcus bovis", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "(penicillin MIC < = 0.12 mcg/ml)"}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID PENICILLIN G 3 MILLION UNITS IV Q4H", "DisplayText" : "Penicillin G 3 million units IV Q4H", "Text" : "Penicillin G 3 million units IV q4h ($1.62/day) [R] for 4 weeks  < OR >", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "PSJI CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) [M] for 4 weeks  < OR >", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX CEFT 2GM IV Q24H GENT 1 MG/KG Q8H", "DisplayText" : "CEFTRIAX 2GM IV Q24H GENT 1 MG/KG IV Q8H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) for 2 weeks <AND> gentamicin 1 mg/kg IV", "Mnemonic" : "20"},
{"Row" : 25, "Column" : 1, "Text" : "q8h ($3/day) [R,O] for 2 weeks"}, 
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R] for 4 weeks", "Mnemonic" : "22"},
{"Row" : 30, "Column" : 1, "Text" : "Treatment of Viridans streptococci or S. bovis that is RELATIVELY RESISTANT to", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "penicillin (MIC greater than 0.12 and less than or equal to 0.5 mcg/ml)"}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZ SET ABX CEFT 2GM IV Q24H GENT 1 MG/KG Q8H", "DisplayText" : "CEFTRIAX 2GM IV Q24H GENT 1 MG/KG IV Q8H", "Text" : "Ceftriaxone 2 gm IV q24h ($14/day) for 4 weeks <AND> gentamicin 1 mg/kg IV", "Mnemonic" : "26"},
{"Row" : 37, "Column" : 1, "Text" : "q8h ($3/day) [R,O] for 2 weeks"}, 
{"Row" : 39, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg q12h ($6/day) [R] for 4 weeks", "Mnemonic" : "28"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "30"},
{"Row" : 46, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Endocarditis and intravascular infections\""}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 45, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 47, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ SET ABX PENICILLIN 3MU IV Q4H GENT 1 MG/KG Q8H", "DisplayText" : "PENICILLIN 3MU IV Q4H GENT 1 MG/KG Q8H", "Text" : "Penicillin G 3 million units IV q4h ($1.62/day) [R] for 2 weeks <AND>", "Mnemonic" : "18"},
{"Row" : 22, "Column" : 1, "Text" : "gentamicin 1 mg/kg IV q8h ($3/day) [R,O] for 2 weeks  < OR >"}, 
{"Row" : 33, "Column" : 1, "Item" : "ZZORZ SET ABX PENICILLIN 4MU IV Q4H GENT 1 MG/KG IV Q8H", "DisplayText" : "", "Text" : "Pencillin G 4 million units IV q4h ($2.16/day) [R] for 4 weeks <AND>", "Mnemonic" : "24"},
{"Row" : 34, "Column" : 1, "Text" : "gentamicin 1 mg/kg IV q8h ($3/day) [R,O] for 2 weeks  < OR >"}
]},
{"Name" : "ORZID2 GMENU EC PV CX NEGATIVE", "DisplayText" : "Prosthetic Valve Endocarditis with Culture Negative ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "PROSTHETIC VALVE ENDOCARDITIS WITH CULTURE-NEGATIVE ENDOCARDITIS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Cultures are often negative in cases of infection with fastidious organisms like"}, 
{"Row" : 11, "Column" : 1, "Text" : "Abiotrophia (formerly \"nutritionally variant Streptococci\"), Bartonella,"}, 
{"Row" : 12, "Column" : 1, "Text" : "Coxiella, Chlamydia, Legionella spp., or Trophyrema or when antimicrobials are"}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "Baddour LM et al.  Circulation 2005, 111: 3167"}, 
{"Row" : 13, "Column" : 1, "Text" : "given before blood cultures are obtained.  Consult Infectious Diseases and"}, 
{"Row" : 14, "Column" : 1, "Text" : "Cardiology."}
]},
{"Name" : "ORZID2 GMENU EC PV EMP THERAPY", "DisplayText" : "Prosthetic Valve Endocarditis--Empicaral Therapy ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PROSTHETIC VALVE ENDOCARDITIS--EMPIRICAL THERAPY"}, 
{"Row" : 13, "Column" : 1, "Text" : "Early surgical consultation is essential."}, 
{"Row" : 15, "Column" : 1, "Text" : "If a patient is hemodynamically stable and the diagnosis is uncertain,"}, 
{"Row" : 16, "Column" : 1, "Text" : "antimicrobial therapy can safely be withheld until the diagnosis is clear and"}, 
{"Row" : 17, "Column" : 1, "Text" : "blood culture results are available to guide therapy.  In all cases, be sure"}, 
{"Row" : 18, "Column" : 1, "Text" : "adequate numbers of blood cultures are obtained before antimicrobials are given."}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZ SET ABX VANCO 15MG/KG IV Q12H RIFAMP 300MG PO GENT 1MG/KG", "DisplayText" : "Vanco 15 MG/KG IV Q12H Rifamp 300MG PO Q8H Gent 1 MG/KG IV Q8H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R] <AND> gentamicin 1 mg/kg IV q8h", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Text" : "($3/day) [R,O] <AND> rifampin 300 mg PO/NG q8h ($4/day) [DI,O]"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Infections of Prosthetic Valves and Intravascular"}, 
{"Row" : 28, "Column" : 1, "Text" : "Devices\""}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 26, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 29, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}
]},
{"Name" : "ORZID2 GMENU EC PV ENTEROCOCCI", "DisplayText" : "Prosthetic Valve Endocarditis with Enterococci", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PROSTHETIC VALVE ENDOCARDITIS WITH ENTEROCOCCI"}, 
{"Row" : 13, "Column" : 1, "Text" : "Choose both a cell wall active drug AND an aminoglycoside based on"}, 
{"Row" : 14, "Column" : 1, "Text" : "susceptibility data and patient allergy and adverse reaction history. Treat for"}, 
{"Row" : 15, "Column" : 1, "Text" : "6 weeks."}, 
{"Row" : 19, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "1.  Cell-wall active drugs", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IVPB Q4H", "DisplayText" : "Ampicillin 2GM IVPB Q4H", "Text" : "Ampicillin 2 gm IV q4h ($68/day) [R]", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R]", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "_________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "2.  Aminoglycosides", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 1 MG/KG IV Q8H", "DisplayText" : "Gentamicin 1MG/KG IV Q8H", "Text" : "Gentamicin 1 mg/kg IV q8h ($3/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 36, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "PSJIZID STREPTOMYCIN 7.5 MG/KG IV Q12H", "DisplayText" : "Streptomycin 7.5 MG/KG IV Q12H", "Text" : "Streptomycin 7.5 mg/kg IV/IM q12h ($3/day) [R]", "Mnemonic" : "20"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 43, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Infections of Prosthetic Valves and Intravascular"}, 
{"Row" : 44, "Column" : 1, "Text" : "Devices\""}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Text" : "For vancomycin resistant enterococcus (VRE), consult Infectious Diseases."}, 
{"Row" : 42, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 45, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}
]},
{"Name" : "ORZID2 GMENU EC PV FUNGI", "DisplayText" : "Prosthetic Valve Endocarditis with Fungi", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "04"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "PROSTHETIC VALVE ENDOCARDITIS WITH FUNGI"}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Text" : "Baddour LM et al.  Circulation 2005, 111: 3167"}, 
{"Row" : 10, "Column" : 1, "Text" : "Consult Infectious Diseases, Cardiology, and Cardiothoracic surgery."}, 
{"Row" : 4, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU EC PV GNB", "DisplayText" : "Prosthetic Valve Endocarditis with Gram Negative Bacilli  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PROSTHETIC VALVE ENDOCARDITIS WITH GRAM NEGATIVE BACILLI OTHER"}, 
{"Row" : 12, "Column" : 1, "Text" : "THAN \"HACEK\" ORGANISMS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Pseudomonas aeruginosa and various enterobacteriaceae are uncommon endocarditis"}, 
{"Row" : 15, "Column" : 1, "Text" : "pathogens.  Risk factors include cirrhosis, IV drug use, and prosthetic valves."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment for Enterobacteriaceae", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAX 2GM IV Q24H GENT 1.7 MG/KG IV Q8H", "DisplayText" : "CEFTRIAX 2GM IV Q4H GENT 1.7 MG/KG IV Q8H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) [M]  <AND> gentamicin 1.7 mg/kg IV q8h", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "($3/day) [R,O]"}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment for Pseudomonas", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Over 95% of pseudomonas-associated endocarditis is found in IV drug users."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX CEF 2GM IV Q8H TOBRA 8 MG/KG IV Q24H", "DisplayText" : "CEFTAZIDIME 2GM IV Q8H TOBRA 8 MG/KG IV Q24H", "Text" : "Ceftazidime 2 gm IV q8h ($36/day) [R] <AND> tobramycin 8 mg/kg q24h", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Text" : "($11/day) [R,O]"}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Infections of Prosthetic Valves and Intravascular"}, 
{"Row" : 32, "Column" : 1, "Text" : "Devices\""}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Text" : "Consult Infectious Diseases and Cardiothoracic surgery in all cases."}, 
{"Row" : 30, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 33, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}
]},
{"Name" : "ORZID2 GMENU EC PV HACEK", "DisplayText" : "Prosthetic Valve Endocarditis with \"HACEK\" bacteria ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Text" : "These are fastidious gram negative bacilli, including Haemophilus"}, 
{"Row" : 14, "Column" : 1, "Text" : "parainfluenzae, Haemophilus aphrophilus, Haemophilus paraphrophilus, Haemophilus"}, 
{"Row" : 15, "Column" : 1, "Text" : "influenzae, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis,"}, 
{"Row" : 16, "Column" : 1, "Text" : "Eikenella corrodens, Kingella kingae and Kingella denitrificans.  It may take up"}, 
{"Row" : 17, "Column" : 1, "Text" : "3 weeks for the microbiology laboratory to isolate these organisms."}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment options are limited for patients with allergies to beta-lactam"}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Treat for 4 weeks."}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJI CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) < OR >", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin/Sulbactam 3GM IVPB Q6H", "Text" : "Ampicillin-sulbactam 3 gm IV q6h ($33/day) [R]", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 34, "Column" : 1, "Text" : "\"Mandell\" 2005, chapter \"Infections of Prosthetic Valves and Intravascular"}, 
{"Row" : 35, "Column" : 1, "Text" : "Devices\""}, 
{"Row" : 20, "Column" : 1, "Text" : "antibiotics.  Consult Infectious Diseases for advice."}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "10"},
{"Row" : 11, "Column" : 1, "Text" : "PROSTHETIC VALVE ENDOCARDITIS WITH \"HACEK\" ORGANISMS"}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" keyword: Endocarditis"}, 
{"Row" : 36, "Column" : 1, "Text" : "Baddour LM Circulation 2005, 111: 3167"}
]},
{"Name" : "ORZID2 GMENU EHRLICHIA CHAFFEENSIS", "DisplayText" : "Ehrlichia chaffeensis (Human Monocytotropic Ehrlichiosis) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "EHRLICHIA CHAFFEENSIS (HUMAN MONOCYTOTROPIC EHRLICHIOSIS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h ($0.16/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID DOXYCYCLINE 100MG IVPB Q12H", "DisplayText" : "Doxycycline 100MG IVPB Q12H", "Text" : "Doxycycline 100 mg IV q12h ($14/day) [DI]", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}
]},
{"Name" : "ORZID2 GMENU EMP INTRAV W/ VANCO", "DisplayText" : "Empirical intravenous regimens WITH vancomycin", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ OSMO OPT ND", "DisplayText" : "Osmo (MeritCare)", "Text" : "Hematology-Oncology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "EMPIRICAL INTRAVENOUS REGIMENS WITH VANCOMYCIN"}, 
{"Row" : 12, "Column" : 1, "Text" : "Discontinue vancomycin after 3 days unless culture results indicate that"}, 
{"Row" : 13, "Column" : 1, "Text" : "continued therapy is needed.  Gentamicin is optional.  Contact Hematology-"}, 
{"Row" : 14, "Column" : 1, "Text" : "Oncology or Infectious Diseases for advice."}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 25, "Column" : 1, "Text" : "Hughes WT Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 26, "Column" : 1, "Text" : "Rolston KVI Clin Infect Dis 2004, 39: S44"}, 
{"Row" : 27, "Column" : 1, "Text" : "Sipsas NV  Cancer 2005, 103: 1103"}, 
{"Row" : 17, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID VANCO 15MG/KG Q12H & ZOSYN 4.5GM Q6H", "DisplayText" : "Vancomycin 15MG/KG IVPB Q12H & Zosyn 4.5GM IVPB Q6H", "Text" : ""},
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID VANCO 15MG/KG Q12H & CEFTAZIDIME 2GM Q8H", "DisplayText" : "Vancomycin 15MG/KG IVPB Q12H & Ceftazidime 2GM IVPB Q8H", "Text" :""},
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID VANCO 15MG/KG Q12H & MEROPENEM 1GM Q8H", "DisplayText" : "Vancomycin 15MG/KG IVPB Q12H & Meropenem 1GM IVPB Q8H", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU EMP INTRAV W/O VANCO", "DisplayText" : "Empirical intravenous regimens WITHOUT vancomycin", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ OSMO OPT ND", "DisplayText" : "Osmo (MeritCare)", "Text" : "Hematology-Oncology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "EMPIRICAL INTRAVENOUS REGIMENS WITHOUT VANCOMYCIN"}, 
{"Row" : 12, "Column" : 1, "Text" : "Gentamicin is optional.  Contact Hematology-Oncology or Infectious Diseases for"}, 
{"Row" : 13, "Column" : 1, "Text" : "advice."}, 
{"Row" : 15, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 24, "Column" : 1, "Text" : "Hughes WT  Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 25, "Column" : 1, "Text" : "Rolston KVI Clin Infect Dis 2004, 39: S44"}, 
{"Row" : 26, "Column" : 1, "Text" : "Sipsas NV  Cancer 2005, 103: 1103"}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFEPIME 2GM IV Q8H", "DisplayText" : "Cefepime 2GM IVPB Q8H", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM IVPB Q8H", "DisplayText" : "Meropenem 1GM IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 GMENU ENDOOPTHALMITIS", "DisplayText" : "Endophthalmitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "Report persistent nausea/vomiting", "DisplayText" : "Report persistent nausea/vomiting", "Text" : "Consult Ophthamology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ENDOPHTHALMITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Endophthalmitis presents with eye pain and visual loss.  Endophthalmitis is a"}, 
{"Row" : 13, "Column" : 1, "Text" : "medical emergency.  Call ophthalmology immediately.  The opthalmologist will"}, 
{"Row" : 14, "Column" : 1, "Text" : "obtain a vitreous fluid sample for gram stain and culture and begin"}, 
{"Row" : 15, "Column" : 1, "Text" : "intravitreous antimicrobials."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment with intravitreous antimicrobials", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Systemic antifungal therapy for Candidal endophthalmitis", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Infectious Disease involvement is essential."}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 1 mg/kg IV q24h ($23/day) [R,O]", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 32, "Column" : 1, "Text" : "Baum J Clin Infect Dis 1995, 21: 479"}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1MG INTRAVITREOUS AMIK 0.4MG INTR INJ", "DisplayText" : "Vancomycin 1mg intravitreous inj Amikacin 0.4mg intravitreous inj", "Text" : "Vancomycin 1 mg intravitreous injection <AND> amikacin 0.4 mg intravitreous", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "injection ($25/day) [M] < OR >"}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1MG INTRA INJ CEFTAZ 2.25MG INTRA INJ", "DisplayText" : "Vancomycin 1mg intravitreous inject Ceftazidime 2.25mg intrav inj", "Text" : "Vancomycin 1 mg intravitreous injection <AND> ceftazidime 2.25 mg", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "intravitreous injection ($25/day) [M]"}, 
{"Row" : 31, "Column" : 1, "Text" : "\"Mandell\" chapter: Endophthalmitis"}
]},
{"Name" : "ORZID2 GMENU ERCP PROPHYLAXIS", "DisplayText" : "ERCP Prophylaxis (in absence of infection) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Text" : "ERCP PROPHYLAXIS (IN ABSENCE OF INFECTION)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobials are not indicated if obstruction or intervention is unlikely.  If"}, 
{"Row" : 13, "Column" : 1, "Text" : "obstruction is present or intervention is likely, give 1 hour before ERCP:"}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX GENT 1MG/KG ONCE AMPICILLIN 1GM IV ONCE", "DisplayText" : "Getamicin 1 mg/kg once Ampicillin 1gm iv once", "Text" : "Gentamicin 1 mg/kg IV over 20 minutes ($3/day) [R,O]  <AND> ampicillin 1 gm", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Text" : "IV over 20 minutes ($6/day) [R]  both beginning 60 minutes before incision"}, 
{"Row" : 19, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "620988", "DisplayText" : "", "Text" : "Gatifloxacin 400 mg IV over 60 minutes, beginning 120 minutes before", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "incision ($12/day) [R,DI]"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "Solomkin JS  Clin Infect Dis  2003, 37: 997"}, 
{"Row" : 27, "Column" : 1, "Text" : "Anonymous  Med Lett  2001, 43: 92"}, 
{"Row" : 28, "Column" : 1, "Text" : "Woods RK  Am Fam Phys 1998, 57: 2731"}, 
{"Row" : 29, "Column" : 1, "Text" : "Westphal JF Drugs 1999, 57: 81-91"}
]},
{"Name" : "ORZID2 GMENU FEVER OF UNK ORIGIN", "DisplayText" : "Fever of unknown origin  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "FEVER OF UNKNOWN ORIGIN"}, 
{"Row" : 8, "Column" : 1, "Text" : "Cases with fever of unknown origin are often classified in four categories:(1)"}, 
{"Row" : 9, "Column" : 1, "Text" : "classical, (2) neutropenic, (3) nosocomial, and (4) fever in persons with"}, 
{"Row" : 10, "Column" : 1, "Text" : "HIV/AIDS.  Empirical antimicrobial therapy rarely indicated in these patients."}, 
{"Row" : 11, "Column" : 1, "Text" : "Note that for fever of unknown origin in neutropenic patients refers to"}, 
{"Row" : 12, "Column" : 1, "Text" : "persistent fever that has remained undiagnosed after extensive diagnostic work"}, 
{"Row" : 13, "Column" : 1, "Text" : "and empirical antimicrobial therapy.  New fever in patients with profound"}, 
{"Row" : 14, "Column" : 1, "Text" : "neutropenia is a different syndrome and does require empirical antmicrobials"}, 
{"Row" : 15, "Column" : 1, "Text" : "therapy.  Infectious Diseases should be involved in any case where empirical"}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM NEUT FEVER", "DisplayText" : "Neutropenic fever", "Text" : "Link to neutropenic fever", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "treatment for fever of unknown origin is being considered."}
]},
{"Name" : "ORZID2 GMENU FOLLICULITIS", "DisplayText" : "Folliculitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT DOWNTOWN-INPT", "DisplayText" : "Fee Basis (Downtown Inpatient)", "Text" : "Dermatology consult"},
{"Row" : 10, "Column" : 1, "Text" : "FOLLICULITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Folliculitis is usually associated with Staphylococcus aureus.  In patients"}, 
{"Row" : 13, "Column" : 1, "Text" : "exposed to swimming pools or hot tubs, folliculitis may be associated with"}, 
{"Row" : 14, "Column" : 1, "Text" : "Pseudomonas aeruginosa. Candida albicans can cause folliculitis in patients"}, 
{"Row" : 15, "Column" : 1, "Text" : "receiving antimicrobials and/or corticosteroids. For folliculitis in patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "with severe acne, consult Dermatology."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Treat with daily saline compresses until symtpoms resolve"}, 
{"Row" : 24, "Column" : 1, "Text" : "Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management"}, 
{"Row" : 25, "Column" : 1, "Text" : "of Skin and Soft Tissue Infections: 2104 Update by the"}, 
{"Row" : 26, "Column" : 1, "Text" : "Infectious Disease Society of America. Clinical Infectious Diseases. 2014."}, 
{"Row" : 28, "Column" : 1, "Text" : "Sanford Guide: Folliculitis. Accessed September 10 2014."}, 
{"Row" : 30, "Column" : 1, "Text" : "Up to Date: Folliculitis. January 30, 2014."}, 
{"Row" : 23, "Column" : 1, "Text" : "References", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU FOOT ULCER DRUG SELECTION", "DisplayText" : "Drug Selection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PODIATRY INP", "DisplayText" : "PODIATRY INP", "Text" : "Podiatry consult", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Orthopedic surgery consult", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "DRUG SELECTION"}, 
{"Row" : 10, "Column" : 1, "Text" : "MILD TO MODERATE INFECTIONS are treated with drugs that cover Gram positive"}, 
{"Row" : 11, "Column" : 1, "Text" : "cocci such as S. aureus and Streptococcus spp unless there is reason to suspect"}, 
{"Row" : 12, "Column" : 1, "Text" : "a different pathogen."}, 
{"Row" : 14, "Column" : 1, "Text" : "SEVERE INFECTIONS or infections that have failed previous antimicrobial therapy"}, 
{"Row" : 15, "Column" : 1, "Text" : "should be treated initially with broad-spectrum intravenous antimicrobials."}, 
{"Row" : 17, "Column" : 1, "Text" : "If methicillin-resistant S. aureus (MRSA) is suspected, use vancomycin for"}, 
{"Row" : 18, "Column" : 1, "Text" : "severe cases and trimethoprim-sulfamethoxazole or minocycline for mild or"}, 
{"Row" : 19, "Column" : 1, "Text" : "moderate cases."}, 
{"Row" : 21, "Column" : 1, "Text" : "Use oral antimicrobial therapy for mild-moderate cases.  Use intravenous therapy"}, 
{"Row" : 22, "Column" : 1, "Text" : "for severe cases or when oral therapy is not feasible."}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}
]},
{"Name" : "ORZID2 GMENU FOOT ULCER W/ INFECT SURR TISSUES", "DisplayText" : "Diabetic Foot Infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PODIATRY INP", "DisplayText" : "PODIATRY INP", "Text" : "Podiatry consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Orthopedic surgery consult", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "DIABETIC FOOT INFECTION"}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Definitions", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "MILD: local infection involving only the skin and the subcutaneous tissue"}, 
{"Row" : 15, "Column" : 1, "Text" : "(no involvement of deeper tissue and no systemic toxicity). If erythema,"}, 
{"Row" : 16, "Column" : 1, "Text" : "must be >0.5cm to <= 2cm around the ulcer."}, 
{"Row" : 17, "Column" : 1, "Text" : "MODERATE: may involve deeper tissue, but no systemic toxicity. If erythema,"}, 
{"Row" : 18, "Column" : 1, "Text" : "must be >= 2cm around the ulcer."}, 
{"Row" : 19, "Column" : 1, "Text" : "SEVERE: deep infection or local infection with systemic toxicity"}, 
{"Row" : 20, "Column" : 1, "Text" : "PSEUDOMONAS: suspect and treat for Pseudomonas if either of the following:"}, 
{"Row" : 21, "Column" : 1, "Text" : "recently traveled to warm climate location or frequent exposure of the foot to"}, 
{"Row" : 22, "Column" : 1, "Text" : "water."}, 
{"Row" : 25, "Column" : 1, "Text" : "Oral regimens for MILK TO MODERATE infections", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJZID2 CEPHALEXIN 500MG Q6H & DOXYCYCLINE 100MG BID", "DisplayText" : "Cephalexin 500MG Q6H & Doxycycline 100MG BID", "Text" : ""},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJZID SULFAMETHOXAZOLE/TRIMETHOPRIM DS 1 TAB PO Q12H", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS 1 TAB PO Q12H", "Text" :""},
{"Row" : 29, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : ""},
{"Row" : 33, "Column" : 1, "Text" : "Intravenous Regimens for MODERATE TO SEVERE Infections", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID CEFTAROLINE 600MG IVPB Q12H", "DisplayText" : "Ceftaroline 600MG IVPB Q12H", "Text" : ""},
{"Row" : 35, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM Q6H & VANCO PHARMACY TO DOSE", "DisplayText" : "Piperacillin/Tazobactam 4.5GM Q6H & Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 37, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Item" : "ZZPSJIZID LEVO 750MG Q24H & VANCO PHARMACY TO DOSE", "DisplayText" : "", "Text" : ""},
{"Row" : 39, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 40, "Column" : 1, "Item" : "PSJIZID ERTAPENEM 1GM Q24H & VANCO PHARMACY TO DOSE", "DisplayText" : "Ertapenem 1GM Q24H & Vanco Pharmacy To Dose", "Text" :""},
{"Row" : 44, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Lipsky BA, et al.  Clin Infect Dis 2012, 54: 132 IDSA Clinical Practice"}, 
{"Row" : 47, "Column" : 1, "Text" : "Guideline for the Diagnosis and Treatment of Diabetic Foot Infections"}, 
{"Row" : 48, "Column" : 1, "Text" : "Gilbert DN, et al. The Sanford Guide to Antimicrobial Therapy 2016,"}, 
{"Row" : 49, "Column" : 1, "Text" : "40th ed. Diabetic Foot Infection."}
]},
{"Name" : "ORZID2 GMENU FOOT ULCER W/O INFECT SURR TISSUES", "DisplayText" : "Foot ulcers WITHOUT infection of surrounding tissues", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PODIATRY INP", "DisplayText" : "PODIATRY INP", "Text" : "Podiatry consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "FOOT ULCERS WITHOUT INFECTION OF SURROUNDING TISSUES"}, 
{"Row" : 10, "Column" : 1, "Text" : "Antibiotic therapy, topical or systemic, is not recommended for clinically"}, 
{"Row" : 11, "Column" : 1, "Text" : "unifected Diabetic Foot Ulcers (DFU). There is no evidence of benefit for"}, 
{"Row" : 12, "Column" : 1, "Text" : "using antimicrobial therapy in DFU, but there is an increase of adverse effects."}, 
{"Row" : 13, "Column" : 1, "Text" : "financial costs, and risk of antibiotic resistance. Most DFUs need to be"}, 
{"Row" : 14, "Column" : 1, "Text" : "carefully cleaned and debrided to remove tissue that impedes wound healing"}, 
{"Row" : 15, "Column" : 1, "Text" : "and harbors infection. Dressing should optimally be changed once daily and"}, 
{"Row" : 16, "Column" : 1, "Text" : "application of clean wound covering."}, 
{"Row" : 18, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Lipsky BA, et al. Diabetes Metab Res Rev. 2015 Jan:32 Suppl 1:45-74. IWGDF"}, 
{"Row" : 21, "Column" : 1, "Text" : "guidance on the diagnosis and management of foot infections in persons"}, 
{"Row" : 22, "Column" : 1, "Text" : "with diabetes"}
]},
{"Name" : "ORZID2 GMENU FOOT ULCER WITH DM", "DisplayText" : "Foot ulcer in patient with diabetes mellitus  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURG INP", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "FOOT ULCER IN PATIENT WITH DIABETES MELLITUS"}, 
{"Row" : 14, "Column" : 1, "Text" : "may not be present in patients with neuropathy.  In patients with substantial"}, 
{"Row" : 15, "Column" : 1, "Text" : "vascular disease, erythema and warmth may not be present and instead the tissues"}, 
{"Row" : 16, "Column" : 1, "Text" : "will be dusky, mottled, or cool.  Capillary refill may be impaired.  Patients"}, 
{"Row" : 17, "Column" : 1, "Text" : "with diabetes and ulcers are at risk for gangrenous infections.  If there is any"}, 
{"Row" : 18, "Column" : 1, "Text" : "suggestion of gangrene, consult surgery immediately."}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU FOOT ULCER W/O INFECT SURR TISSUES", "DisplayText" : "Foot ulcers WITHOUT infection of surrounding tissues", "Text" : "Foot ulcers WITHOUT infection of surrounding tissues", "Mnemonic" : "08"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU FOOT ULCER W/ INFECT SURR TISSUES", "DisplayText" : "Diabetic Foot Infection", "Text" : "Foot ulcers WITH infection of surrounding tissues", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}, 
{"Row" : 9, "Column" : 1, "Text" : "Foot ulcers in patients with diabetes mellitus are colonized with bacteria"}, 
{"Row" : 10, "Column" : 1, "Text" : "Antimicrobials should not be used to treat colonization."}, 
{"Row" : 12, "Column" : 1, "Text" : "Cases with infection of surrounding tissues signified by erythema, warmth,"}, 
{"Row" : 13, "Column" : 1, "Text" : "tenderness, or purulent discharge should be treated with antimicrobials. Pain"}
]},
{"Name" : "ORZID2 GMENU FUNGI ASPERGILLUS SPP.", "DisplayText" : "Aspergillus spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ASPERGILLUS SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "For localized disease (\"fungus ball\"), antifungal therapy is ineffective."}, 
{"Row" : 12, "Column" : 1, "Text" : "Consult Surgery and Pulmonary for cases of localized disease without systemic"}, 
{"Row" : 13, "Column" : 1, "Text" : "infection.  Treat invasive disease with intravenous antifungals initially, then"}, 
{"Row" : 14, "Column" : 1, "Text" : "switch to oral antifungals for a total duration of therapy of at least 10 weeks."}, 
{"Row" : 15, "Column" : 1, "Text" : "Consult Infectious Diseases in all cases."}, 
{"Row" : 17, "Column" : 1, "Text" : "Preferred intravenous therapy", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID VORICONAZOLE 6MG/KG Q12H THEN 4MG/KG IV Q12H", "DisplayText" : "Voriconazole 6mg/kg iv q12h then 4mg/kg iv q12h for 2 doses", "Text" : "Voriconazole 6 mg/kg IV q12h for 2 doses, then 4 mg/kg IV q12h ($198/day)", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "[R,H,DI] < OR >"}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 1-1.5 mg/kg IV q24h ($23/day)  [R,O]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "Alternative intravenous therapy", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID ITRACONAZOLE 200MG IV Q12H THEN Q24H", "DisplayText" : "Itraconazole 200mg iv q12h for 2 days then 200mg iv q24h", "Text" : "Itraconazole 200 mg IV q12h for 2 days then 200 mg IV Q24h ($82/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID CASPOFUNGIN 70MG IV ONCE THEN 50MG IV Q24H", "DisplayText" : "Caspofungin 70mg iv once then 50mg iv q24h", "Text" : "Caspofungin 70 mg IV once then 50 mg IV Q24h ($224/day) [H,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID AMPHO B LIPOSOMAL 5MG/KG IV Q24H", "DisplayText" : "Amphotericin B Liposomal (Ambisome) 5 mg/kg iv q24h", "Text" : "Liposomal amphotericin (Ambisome) 3-5 mg/kg IV q24h ($400/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "Oral medications for use after disease has stabilized", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJZID VORICONAZOLE 200MG PO BID", "DisplayText" : "Voriconazole 200mg po bid", "Text" : "Voriconazole 200 mg PO q12h ($36/day) [R,H,DI] < OR >", "Mnemonic" : "20"},
{"Row" : 33, "Column" : 1, "Item" : "PSJZID ITRACONAZOLE 200MG PO Q12H", "DisplayText" : "Itraconazole 200mg po q12h", "Text" : "Itraconazole 200 mg PO q12h ($18/day) [DI]", "Mnemonic" : "22"},
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 38, "Column" : 1, "Text" : "Stevens DA Clin Infect Dis 2000, 30: 696"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" keyword: Aspergillosis"}
]},
{"Name" : "ORZID2 GMENU FUNGI BLASTOMYCES DERMATIDIS", "DisplayText" : "Blastomyces dermatidis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BLASTOMYCES DERMATITIDIS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Contact Infectious Diseases in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Disease outside of thecentral nervous system", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "or oral therapy for use after intravenous amphotericin", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJZID ITRACONAZOLE 200MG PO Q12H", "DisplayText" : "Itraconazole 200mg po q12h", "Text" : "Itraconazole 200 mg PO q12h  ($18/day) [DI]", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Change to oral itraconazole after the patient's condition has stabilized."}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 0.6 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 0.6 mg/kg iv q24h", "Text" : "Amphotericin B 0.3-0.6 mg/kg IV q24h ($23/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 400-800 mg PO q24h ($0.40/day) [R,DI] < OR >", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID ORZ FLUCONAZOLE 400MG IV Q24H", "DisplayText" : "Fluconazole 400MG IV Q24H", "Text" : "Fluconazole 400-800 mg IV Q24h ($13-26/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID AMPHO B LIPOSOMAL 5MG/KG IV Q24H", "DisplayText" : "Amphotericin B Liposomal (Ambisome) 5 mg/kg iv q24h", "Text" : "Liposomal amphotericin (Ambisome) 3-5 mg/kg IV q24h ($400/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 32, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Central nervous system infection", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 0.7-1 mg/kg IV q24h ($23/day) [R,O]", "Mnemonic" : "20"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 42, "Column" : 1, "Text" : "\"Sanford\" keyword: Blastomycosis"}
]},
{"Name" : "ORZID2 GMENU FUNGI C. NEOFORMANS W/ HIV", "DisplayText" : "Cryptococcus neoformans--Treatment for patients with HIV  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Text" : "CRYPTOCOCCUS NEOFORMANS--TREATMENT FOR PATIENTS WITH HIV"}, 
{"Row" : 7, "Column" : 1, "Item" : "Minor Surgery Clinic", "DisplayText" : "Minor Surgery Clinic", "Text" : "HIV (MRTC) consult", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Consult HIV expert in all cases. Begin treatment with amphotericin and"}, 
{"Row" : 13, "Column" : 1, "Text" : "flucytosine and consult Infectious Diseases for assistance."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment of CENTRAL NERVOUS SYSTEM or BLOODSTREAM infection", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX AMPHO B 0.7-1MG/KG IV Q24H FLUCYTO 25MG/KG", "DisplayText" : "", "Text" : "Amphotericin B 0.7-1 mg/kg IV q24h ($23/day) [R,O] <AND> flucytosine 25", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Text" : "mg/kg PO q6h ($69/day) [R,O]"}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment PULMONARY or OTHER LOCALIZED infection or switch to oral therapy after", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "disease has stabilized", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 200-400 mg PO Q24h ($0.40/day) [R,DI] < OR >", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID ITRACONAZOLE 200MG PO Q12H", "DisplayText" : "Itraconazole 200mg po q12h", "Text" : "Itraconazole 200 mg PO q12h ($18/day) [DI]", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 27, "Column" : 1, "Text" : "Saag MS  Clin Infect Dis 2000, 30: 710"}
]},
{"Name" : "ORZID2 GMENU FUNGI CANDIDA GLABRATA", "DisplayText" : "Candida glabrata", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CANDIDA GLABRATA"}, 
{"Row" : 11, "Column" : 1, "Text" : "C. glabrata is often resistant to fluconazole and occasionally has some degree"}, 
{"Row" : 12, "Column" : 1, "Text" : "of resistance to amphotericin.  When amphotericin B is used, use 1 mg/kg/day if"}, 
{"Row" : 13, "Column" : 1, "Text" : "possible."}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 0.7-1 mg/kg IV q24h ($23/day) [R,O] < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CASPOFUNGIN 70MG IV ONCE THEN 50MG IV Q24H", "DisplayText" : "Caspofungin 70mg iv once then 50mg iv q24h", "Text" : "Caspofungin 70 mg IV once then 50 mg IV Q24h ($224/day) [H,DI]", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID VORICONAZOLE 6MG/KG Q12H THEN 4MG/KG IV Q12H", "DisplayText" : "Voriconazole 6mg/kg iv q12h then 4mg/kg iv q12h for 2 doses", "Text" : "Voriconazole 6mg/kg IV q12h for 2 doses, then 4mg/kg IV q12h ($198/day)", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Text" : "[R,H,DI] < OR >"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJZID VORICONAZOLE 400MG PO Q12H THEN 200MG Q12H", "DisplayText" : "Voriconazole 400mg po q12h for 2 doses then 200mg po q12h", "Text" : "Voriconazole 400 mg PO q12h for 2 doses, then 200 mg PO BID ($36/day)", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID AMPHO B LIPOSOMAL 5MG/KG IV Q24H", "DisplayText" : "Amphotericin B Liposomal (Ambisome) 5 mg/kg iv q24h", "Text" : "Liposomal amphotericin (Ambisome) 3-5 mg/kg IV q24h ($400/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 30, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 31, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID2 GMENU FUNGI CANDIDA KRUSEI", "DisplayText" : "Candida krusei  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CANDIDA KRUSEI"}, 
{"Row" : 11, "Column" : 1, "Text" : "C. krusei is resistant to fluconazole, and often has some degree of resistance"}, 
{"Row" : 12, "Column" : 1, "Text" : "to amphotericin.  When amphotericin B is used, use 1 mg/kg/day if possible."}, 
{"Row" : 14, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 0.7-1 mg/kg IV q24h ($23/day) [R,O] < OR >", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID CASPOFUNGIN 70MG IV ONCE THEN 50MG IV Q24H", "DisplayText" : "Caspofungin 70mg iv once then 50mg iv q24h", "Text" : "Caspofungin 70 mg IV once then 50 mg IV Q24h ($224/day) [H,DI]", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID VORICONAZOLE 6MG/KG Q12H THEN 4MG/KG IV Q12H", "DisplayText" : "Voriconazole 6mg/kg iv q12h then 4mg/kg iv q12h for 2 doses", "Text" : "Voriconazole 6mg/kg IV q12h for 2 doses, then 4mg/kg IV q12h ($198/day)", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "[R,H,DI] < OR >"}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJZID VORICONAZOLE 400MG PO Q12H THEN 200MG Q12H", "DisplayText" : "Voriconazole 400mg po q12h for 2 doses then 200mg po q12h", "Text" : "Voriconazole 400 mg PO q12h for 2 doses, then 200 mg PO q12h ($36/day)", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "[R,H,DI] < OR >"}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID AMPHO B LIPOSOMAL 5MG/KG IV Q24H", "DisplayText" : "Amphotericin B Liposomal (Ambisome) 5 mg/kg iv q24h", "Text" : "Liposomal amphotericin (Ambisome) 3-5 mg/kg IV q24h ($400/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 30, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 31, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID2 GMENU FUNGI COCCIDIOIDOMYCES", "DisplayText" : "Coccidioidomyces", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "COCCIDIOIDOMYCES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Pulmonary and Infectious Diseases consultations are essential for diagnosis and"}, 
{"Row" : 12, "Column" : 1, "Text" : "treatment."}, 
{"Row" : 14, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Observation alone is indicated for some cases. Consult Infectious Diseases for"}, 
{"Row" : 19, "Column" : 1, "Text" : "more information.  If antifungal treatment is indicated:"}, 
{"Row" : 21, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJZID ITRACONAZOLE 200MG PO Q12H", "DisplayText" : "Itraconazole 200mg po q12h", "Text" : "Itraconazole 200 mg PO q12h ($18/day) [DI]", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 400 mg PO q24h ($0.40/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "SEVERE disease (diffuse pneumonia or central nervous system infection)", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 0.5-1 mg/kg IV q24h ($23/day) [R,O]", "Mnemonic" : "14"},
{"Row" : 34, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "PSJIZID ORZ FLUCONAZOLE 400MG IV Q24H", "DisplayText" : "Fluconazole 400MG IV Q24H", "Text" : "Fluconazole 400-800 mg IV q24h ($13-26/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Text" : "Galgiani JN Clin Infect Dis 2005, 41: 1217"}
]},
{"Name" : "ORZID2 GMENU FUNGI HISTOPLASMA CAPSULATUM", "DisplayText" : "Histoplasma capsulatum", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "Minor Surgery Clinic", "DisplayText" : "Minor Surgery Clinic", "Text" : "HIV (MRTC) consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "HISTOPLASMA CAPSULATUM"}, 
{"Row" : 12, "Column" : 1, "Text" : "Intravenous antifungals are indicated initially for severe or progressive"}, 
{"Row" : 13, "Column" : 1, "Text" : "disease.After disease has stabilized, oral antifungals may be used to"}, 
{"Row" : 14, "Column" : 1, "Text" : "complete the course, which ranges from weeks to months.  Contact Infectious"}, 
{"Row" : 15, "Column" : 1, "Text" : "Diseases and Pulmonary services for advice.  Contact HIV expert for advice on"}, 
{"Row" : 16, "Column" : 1, "Text" : "cases involving patients with HIV."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred initial therapy for MENINGITIS, SEVERE PULMONARY or DISSEMINATED", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "DISEASE", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 0.7-1 mg/kg IV q24h ($23/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID AMPHO B LIPOSOMAL 5MG/KG IV Q24H", "DisplayText" : "Amphotericin B Liposomal (Ambisome) 5 mg/kg iv q24h", "Text" : "Liposomal amphotericin (Ambisome) 3-5 mg/kg IV q24h ($400/day) [R,O]", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "Treatment after disease has STABILIZED", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Itraconazole is more effective than fluconazole, but fluconazole may be used in"}, 
{"Row" : 28, "Column" : 1, "Text" : "patients who cannot tolerate itraconazole."}, 
{"Row" : 30, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJZID ITRACONAZOLE 200MG PO Q12H", "DisplayText" : "Itraconazole 200mg po q12h", "Text" : "Itraconazole 200 mg PO q12h ($18/day) [DI]", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 400-800 mg PO Q24h ($0.40/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 39, "Column" : 1, "Text" : "Wheat J, et al.  Practice guidelines for the management of patients with"}, 
{"Row" : 40, "Column" : 1, "Text" : "Histoplasmosis.  Clin Infect Dis 2000, 30: 68"}
]},
{"Name" : "ORZID2 GMENU FUNGI W/O HIV C. NEOFORM", "DisplayText" : "Cryptococcus neoformans--Treatment for patient without HIV", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CRYPTOCOCCUS NEOFORMANS--TREATMENT FOR PATIENTS WITHOUT HIV"}, 
{"Row" : 11, "Column" : 1, "Text" : "Consult Infectious Diseases."}, 
{"Row" : 13, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Infection OUTSIDE of the central nervous system", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment of MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 200-400 mg PO Q24h ($0.40/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID ITRACONAZOLE 200MG PO Q12H", "DisplayText" : "Itraconazole 200mg po q12h", "Text" : "Itraconazole 200 mg PO q12h ($18/day) [DI] < OR >", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN B 1 MG/KG IV Q24H", "DisplayText" : "Amphotericin B 1 mg/kg iv q24h", "Text" : "Amphotericin B 0.5-1 mg/kg IV q24h ($23/day) [R,O]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "Treatment of SEVERE disease", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Begin induction treatment with amphotericin and flucytosine and consult"}, 
{"Row" : 24, "Column" : 1, "Text" : "Infectious Diseases for assistance."}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZ SET ABX AMPHO B 0.7-1MG/KG IV Q24H FLUCYTO 25MG/KG", "DisplayText" : "", "Text" : "Amphotericin B 0.7-1 mg/kg IV q24h ($23/day) [R,O] <AND> flucytosine 25", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "mg/kg PO q6h ($69/day) [R,O]"}, 
{"Row" : 29, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Infection INSIDE the central nervous system", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Begin induction treatment with amphotericin and flucytosine and consult"}, 
{"Row" : 34, "Column" : 1, "Text" : "Infectious Diseases for assistance."}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZ SET ABX AMPHO B 0.7-1MG/KG IV Q24H FLUCYTO 25MG/KG", "DisplayText" : "", "Text" : "Amphotericin B 0.7-1 mg/kg IV q24h ($23/day)  [R,O] <AND> flucytosine 25", "Mnemonic" : "18"},
{"Row" : 38, "Column" : 1, "Text" : "mg/kg PO q6h ($69/day) [R,O]"}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Text" : "Saag MS Clin Infect Dis 2000, 30: 710"}
]},
{"Name" : "ORZID2 GMENU FURUNCLES AND CARBUNCLES", "DisplayText" : "Furuncles and carbuncles ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ OSTOMY INPT CONSULT", "DisplayText" : "Ostomy/Wound/Continence", "Text" : "Wound care (ET) nurse consult", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "A furuncle is an inflamed nodule that usually develops as a complication of"}, 
{"Row" : 13, "Column" : 1, "Text" : "folliculitis.  A carbuncle is a more extensive lesion that extends further into"}, 
{"Row" : 14, "Column" : 1, "Text" : "the subcutaneous tissue.  Nearly all furuncles and carbuncles are caused by S."}, 
{"Row" : 15, "Column" : 1, "Text" : "aureus.  Mild cases without evidence of invasive infections are treated with"}, 
{"Row" : 16, "Column" : 1, "Text" : "moist heat.  Contact a wound care nurse for more information.  Incise and drain"}, 
{"Row" : 17, "Column" : 1, "Text" : "deeper infections."}, 
{"Row" : 19, "Column" : 1, "Text" : "For cases with cellulitis or deep invasion, treat with antimicrobials for 5 to"}, 
{"Row" : 20, "Column" : 1, "Text" : "14 days."}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJZID DICLOXACILLIN 500MG PO Q6H", "DisplayText" : "Dicloxacillin 500MG PO q6h", "Text" : "Dicloxacillin 250-500 mg PO q6h ($0.24-0.48/day) [DI]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJZID ERYTHROMYCIN 500MG PO Q6H", "DisplayText" : "Erythromycin 500MG PO q6h", "Text" : "Erythromycin 250-500 mg PO q6h ($0.21-0.42/day) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 150-300 mg PO q6h ($1.68-3.36/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Text" : "If methicillin-RESISTANT Staphylococcus aureus (MRSA) is suspected or proved", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJZID MINOCYCLINE 100MG PO Q12H", "DisplayText" : "Minocycline 100 mg PO q12h", "Text" : "Minocycline 100 mg PO q12h ($1/day) [DI] < OR >", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "20"},
{"Row" : 32, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R]", "Mnemonic" : "22"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 10, "Column" : 1, "Text" : "FURUNCLES AND CARBUNCLES"}, 
{"Row" : 37, "Column" : 1, "Text" : "Up-to-Date website: Furuncle, carbuncle"}, 
{"Row" : 38, "Column" : 1, "Text" : "\"Sanford\" keyword: Furuncle, carbuncle"}
]},
{"Name" : "ORZID2 GMENU GIARDIA LAMBLIA", "DisplayText" : "Giardia lamblia ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "GIARDIA LAMBLIA"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treat patients with symptoms attributable to giardiasis only, for 5 days."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJZID METRON 500MG PO Q8H", "DisplayText" : "Metronidazole 500mg po q8h", "Text" : "Metronidazole 250-750 mg PO q8h for 5 days ($0.24-0.72/day) [DI]", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "\"Sanford\" keyword: Giardia"}
]},
{"Name" : "ORZID2 GMENU GN INT RS GNB", "DisplayText" : "Interim results:  Gram-negative Bacilli ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "INTERIM RESULTS: GRAM-NEGATIVE BACILLI"}, 
{"Row" : 17, "Column" : 1, "Text" : "Some antimicrobial combinations are synergistic in vitro against some Gram-"}, 
{"Row" : 18, "Column" : 1, "Text" : "negative bacilli.Combination therapy has not been shown to improve outcomes"}, 
{"Row" : 19, "Column" : 1, "Text" : "in most circumstances.  Single drug therapy is used in most cases.  Contact"}, 
{"Row" : 20, "Column" : 1, "Text" : "Infectious Diseases for more information."}, 
{"Row" : 22, "Column" : 1, "Text" : "Use susceptibility information to select an antimicrobial when a pathogen is"}, 
{"Row" : 23, "Column" : 1, "Text" : "identified."}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M]", "Mnemonic" : "10"},
{"Row" : 28, "Column" : 1, "Text" : "Alternative if Pseudomonas is suspected", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O] < OR >", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Piperacillin-tazobactam 3.375 mg q6h ($33) [R]", "Mnemonic" : "14"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 11, "Column" : 1, "Text" : "Pseudomonas, Bordetella, and Brucella spp. usually grow aerobically (but can"}, 
{"Row" : 12, "Column" : 1, "Text" : "show up in an anaerobic bottle).  Bacteroides, Fusobacterium, Porphyromonas, and"}, 
{"Row" : 13, "Column" : 1, "Text" : "Prevotella spp. usually grow anaerobically (but can show up in an aerobic"}, 
{"Row" : 14, "Column" : 1, "Text" : "bottle).  Most other gram-negative bacilli are facultative, i.e. they can grow"}, 
{"Row" : 15, "Column" : 1, "Text" : "in aerobic or anaerobic culture conditions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment before pathogen is identified", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Alternative for CRITICALLY ILL patients", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZ SET ABX GENT 5 MG/KG IV Q24H PIP/TAZO 3.375MG Q6H", "DisplayText" : "", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O] <AND> piperacillin-tazobactam", "Mnemonic" : "16"},
{"Row" : 34, "Column" : 1, "Text" : "3.375 mg q6h ($33/day) [R]"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents Anonymous Med Letter"}, 
{"Row" : 40, "Column" : 1, "Text" : "Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FIN CAMPYLOBACTER SPP.", "DisplayText" : "Campylobacter spp. ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CAMPYLOBACTER SPECIES"}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O]  < OR >", "Mnemonic" : "10"},
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "Treatment of central nervous system infections", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q12H", "DisplayText" : "Ceftriaxone 2GM IVPB Q12H", "Text" : "Ceftriaxone 2 gm IV q12h ($68/day) [M] < OR >", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal Optimal therapy depends on both the disease or syndrome and the"}, 
{"Row" : 12, "Column" : 1, "Text" : "pathogen.  See diagnosis/syndrome section for more information.  Drugs"}, 
{"Row" : 13, "Column" : 1, "Text" : "recommended below are best for most cases.  If susceptibility results or other"}, 
{"Row" : 14, "Column" : 1, "Text" : "factors make these inappropriate for this case, click \"need an alternative"}, 
{"Row" : 15, "Column" : 1, "Text" : "antimicrobial.\""}, 
{"Row" : 17, "Column" : 1, "Text" : "For information on gastroenteritis (usually involving C. jejuni), refer to the"}, 
{"Row" : 18, "Column" : 1, "Text" : "Gastrointestinal and Intraabdominal infection section."}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment of extraintestinal infectious not involving the central nervous system", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "infections", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 33, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FIN ENTEROBACTER SPP.", "DisplayText" : "Enterobacter spp.  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "MILD TO MODERATE infections", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O]", "Mnemonic" : "20"},
{"Row" : 26, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "SEVERE infections", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZ SET ABX PIPER/TAZO 3.375 Q6H GENT 5MG/KG Q24H", "DisplayText" : "", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($33/day) [R] <AND> gentamicin 5", "Mnemonic" : "22"},
{"Row" : 31, "Column" : 1, "Text" : "mg/kg IV q24h ($3/day) [R,O] < OR >"}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "26"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "28"},
{"Row" : 9, "Column" : 1, "Text" : "ENTEROBACTER SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZ SET ABX CIPRO 400 IV Q12H GENT 5MG/KG IV Q24H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]  <AND> gentamicin 5 mg/kg IV", "Mnemonic" : "24"},
{"Row" : 34, "Column" : 1, "Text" : "q24h ($3/day) [R,O] < OR >"}, 
{"Row" : 41, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 42, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FIN M. CATARRHALIS", "DisplayText" : "Moraxella catarrhalis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "MORAXELLA CATARRHALIS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO BID", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h  ($1.56/day) R < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H 4DAYS", "DisplayText" : "Azithromycin 500MG PO ONCE, then 250MG Q24H X 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO q24h ($4/day) [M]", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "for 4 days"}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 28, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 29, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FIN N. GONORRHOEAE", "DisplayText" : "Neisseria gonorrhoeae ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "NEISSERIA GONORRHOEAE"}, 
{"Row" : 14, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID PENICILLIN G 3 MILLION UNITS IV Q4H", "DisplayText" : "Penicillin G 3 million units IV Q4H", "Text" : "Penicillin 3 million units IV q4h ($2.16/day) [R]", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FIN P. MULTICIDA", "DisplayText" : "Pasteurella multocida ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 9, "Column" : 1, "Text" : "PASTEURELLA MULTOCIDA"}, 
{"Row" : 14, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO BID", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h  ($1.56/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin/Sulbactam 3GM IVPB Q6H", "Text" : "Ampicillin-sulbactam 1.5-3 gm IV q6h ($33/day) [R]", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h  ($0.16/day) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID DOXYCYCLINE 100MG IVPB Q12H", "DisplayText" : "Doxycycline 100MG IVPB Q12H", "Text" : "Doxycycline 100 mg IV q12h  ($14/day) [DI]", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FIN SALMONELLA SPP.", "DisplayText" : "Salmonella spp. ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SALMONELLA SPECIES"}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJZID AMOXCILLIN 500MG PO Q8H 3 DAYS", "DisplayText" : "Amoxcillin 500MG PO Q8H", "Text" : "Amoxicillin 500 mg PO q8h ($0.42/day) [R] < OR >", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For gastroenteritis antimicrobials are not usually indicated.  Please refer to"}, 
{"Row" : 17, "Column" : 1, "Text" : "the Gastrointestinal and Intra-abdominal infections section for more"}, 
{"Row" : 18, "Column" : 1, "Text" : "information."}, 
{"Row" : 20, "Column" : 1, "Text" : "For localized or systemic extraintestinal infections", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 35, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FIN SHIGELLA SPP.", "DisplayText" : "Shigella spp. (bacillary dysentery)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SHIGELLA SPECIES"}, 
{"Row" : 19, "Column" : 1, "Text" : "Preferred treatment for systemic infections", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For gastroenteritis, please refer to the Gastrointestinal and Intra-abdominal"}, 
{"Row" : 17, "Column" : 1, "Text" : "infections section for more information."}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 36, "Column" : 1, "Text" : "Reviewed January 2006"}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H 4DAYS", "DisplayText" : "Azithromycin 500MG PO ONCE, then 250MG Q24H X 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO q24h ($4/day)", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "[M] for 4 days < OR >"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL A. BAUMANNI", "DisplayText" : "Acinetobacter baumanni", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ACINETOBACTER BAUMANNII"}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O]", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID AMIKACIN 7.5 MG/KG IV Q12H", "DisplayText" : "Amikacin 7.5 MG/KG IV Q12h", "Text" : "Amikacin 7.5 mg/kg IV q12h ($8/day) [R,O] < OR >", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Item" : "ORZ SET ABX CEFTAZ 2GM Q8H AMIK 7.5 MG/KG Q12H", "DisplayText" : "", "Text" : "Ceftazidime 2 gm IV q8h ($36/day) [R] <AND> amikacin 7.5 mg/kg IV q12h", "Mnemonic" : "14"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Text" : "Isolation of Acinetobacter baumannii from a culture often represents"}, 
{"Row" : 12, "Column" : 1, "Text" : "contamination or colonization and not disease.  For questions about whether a"}, 
{"Row" : 13, "Column" : 1, "Text" : "patient should be treated, contact Infectious Diseases."}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "not known, start therapy with imipenem or amikacin.  If the isolate is"}, 
{"Row" : 20, "Column" : 1, "Text" : "susceptible,Consult Infectious Diseases for more information."}, 
{"Row" : 29, "Column" : 1, "Text" : "($8/day) [R,O]  < OR >"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 18, "Column" : 1, "Text" : "Many isolates are resistant to multiple antimicrobials.  If susceptibilities are"}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents Anonymous Med Letter"}, 
{"Row" : 37, "Column" : 1, "Text" : "Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL BORDETELLA SPP.", "DisplayText" : "Bordetella species ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BORDETELLA SPECIES"}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJZID ERYTHROM 500MG PO Q8H", "DisplayText" : "Erythromycin 500MG PO q8h", "Text" : "Erythromycin 500 mg PO q8h for 14 days ($0.28/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID AZITHROMYCIN 500MG IV THEN 250MG IV Q24H", "DisplayText" : "AZITHROMYCIN 500MG IV THEN 250MG IV Q24H", "Text" : "Azithromycin 500 mg IV once ($15/day) [M] on day 1, then 250 mg IV q24h", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Text" : "($7.62/day) [M] for 4 days"}, 
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO q12h  for 14 days ($0.18/day)", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "[R,DI] < OR >"}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID TRIMETHOPRIM/SULFAMETH 5/25 MG/KG IV Q12H", "DisplayText" : "Trimethoprim (5 mg/kg)/sulfamethoxazole (25 mg/kg) IV q12h", "Text" : "Trimethoprim 5 mg/kg - sulfamethoxazole 25 mg/kg IV q12h ($14/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 30, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "20"},
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "22"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 40, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H 4DAYS", "DisplayText" : "Azithromycin 500MG PO ONCE, then 250MG Q24H X 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) [M] on day 1, then 250 mg PO q24h", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Text" : "($4/day) [M]  for 4 days < OR >"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL BRUCELLA SPP.", "DisplayText" : "Brucella spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BRUCELLA SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Treat for 45 days.  Treat with doxycycline and streptomycin for the first 14-21"}, 
{"Row" : 13, "Column" : 1, "Text" : "days, then finish the course with doxycycline alone."}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZ SET ABX DOXY 100 PO Q12H STREPTOMYCIN 1GM IM Q24H", "DisplayText" : "", "Text" : "Doxycycline 100 mg PO q12h ($0.16/day) [DI] <AND> streptomycin 1 gm IM q24h", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Text" : "($3/day)  [R,O] < OR >"}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX DOXY 100 IV Q12H STREPTOMYCIN 1GM IV Q24H", "DisplayText" : "", "Text" : "Doxycycline 100 mg IV q12h ($14/day) [DI] <AND> streptomycin 1 gm IV q24h", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "($3/day)  [R,O]"}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Treat with both drugs for 45 days."}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZ SET ABX DOXYCY 100MG PO Q12H RIFAMP 600MG PO Q24H", "DisplayText" : "", "Text" : "Doxycycline 100 mg PO q12h  ($0.16/day) [DI] <AND> rifampin 600 mg PO q24h", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "($2.56/day)  [DI,O]"}, 
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" \"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL CITROBACTER SPP.", "DisplayText" : "Citrobacter spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O]", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : "Imipenem 500 mg IV q6h ($60/day) [R,O] < OR >", "Mnemonic" : "18"},
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Piperacillin-tazobactam 3.375gm IV q6h ($33/day) [R]", "Mnemonic" : "20"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "15"},
{"Row" : 9, "Column" : 1, "Text" : "CITROBACTER SPP."}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents Anonymous Med Letter"}, 
{"Row" : 33, "Column" : 1, "Text" : "Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL ESCHERICHIA COLI", "DisplayText" : "Escherichia coli", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ESCHERICHIA COLI"}, 
{"Row" : 19, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "MILD TO MODERATE infections including cystitis", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 26, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "SEVERE infections", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "14"},
{"Row" : 31, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For gastroenteritis, please refer to the Gastrointestinal and Intra-abdominal"}, 
{"Row" : 17, "Column" : 1, "Text" : "infections section."}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 37, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL HAEMOPHILUS SPP.", "DisplayText" : "Haemophilus spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "HAEMOPHILUS SPECIES"}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO BID", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h  ($1.56/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M]", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL KLEBSIELLA SPP.", "DisplayText" : "Klebsiella spp. ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "MILD TO MODERATE infections including cystitis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO q12h  ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet q12h  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "MODERATE TO SEVERE infections", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "14"},
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 9, "Column" : 1, "Text" : "KLEBSIELLA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL PROTEUS SPP.", "DisplayText" : "Proteus spp. ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "MILD TO MODERATE infections including cystitis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "SEVERE infections", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O]", "Mnemonic" : "16"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 9, "Column" : 1, "Text" : "PROTEUS SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID TICARCILLIN/CLAVULANATE 3.1GM IV Q6H", "DisplayText" : "Ticarcillin/Clavulanate 3.1gm IV Q6H", "Text" : "Ticarcillin-clavulanate 3.1 gm IV q6h ($42/day) [R] < OR >", "Mnemonic" : "15"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents Anonymous Med Letter"}, 
{"Row" : 35, "Column" : 1, "Text" : "Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-NEG FINAL SERRATIA SPP.", "DisplayText" : "Serratia spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] < OR >", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID TICARCILLIN/CLAVULANATE 3.1GM IV Q6H", "DisplayText" : "Ticarcillin/Clavulanate 3.1gm IV Q6H", "Text" : "Ticarcillin-clavulanate 3.1 gm IV q6h ($42/day) [R]  < OR >", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 9, "Column" : 1, "Text" : "SERRATIA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-POS FI ANAEROBIC COCCI", "DisplayText" : "Anaerobic Gram-positive cocci (including Peptostreptococcus) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ANAEROBIC GRAM-POSITIVE COCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "Anaerobic Gram-positive cocci, including peptostreptococci, are often involved"}, 
{"Row" : 12, "Column" : 1, "Text" : "in mixed aerobic/anaerobic infections.  Beta-lactams (like ampicillin and"}, 
{"Row" : 13, "Column" : 1, "Text" : "penicillin) and clindamycin are the drugs of choice against anaerobic gram-"}, 
{"Row" : 14, "Column" : 1, "Text" : "positive cocci.  Beta-lactam/beta-lactamase inhibitors are active against"}, 
{"Row" : 15, "Column" : 1, "Text" : "peptostreptococci, so no additional \"anaerobic\" antimicrobials are needed"}, 
{"Row" : 16, "Column" : 1, "Text" : "specifically to cover peptostreptococcus when drugs such as ampicillin-"}, 
{"Row" : 17, "Column" : 1, "Text" : "sulbactam, ticarcillin-clavulanate, or piperacillin-tazobactam are used."}, 
{"Row" : 19, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 20, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID PENICILLIN G 3 MILLION UNITS IV Q4H", "DisplayText" : "Penicillin G 3 million units IV Q4H", "Text" : "Penicillin 3 million units IV q4h ($2.16/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID AMPICIL 2GM IV Q6H", "DisplayText" : "Ampicillin 2GM IVPB Q6H", "Text" : "Ampicillin 2 gm IV q6h ($45/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID AMOXCILLIN 500MG PO Q8H 3 DAYS", "DisplayText" : "Amoxcillin 500MG PO Q8H", "Text" : "Amoxicillin 500 mg PO q8h ($0.42/day) [R]", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600 mg IV q8h ($4.33/day) [H,O] < OR >", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($3.36/day) [H,O]", "Mnemonic" : "18"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 35, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-POS FI BACILLUS SPP.", "DisplayText" : "Bacillus species", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BACILLUS SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "B. cereus", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "disease/syndrome sections for more information."}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($5.88/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600 mg IV q8h ($4.33/day) [H,O] < OR >", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($3.36/day) [H,O]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "B. anthracis", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Start combination therapy and contact Infectious Diseases immediately."}, 
{"Row" : 28, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "ORZ SET ABX CIPROFL 400 IV Q12H DOXY 100 IV Q12H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> doxycycline 100 mg IV", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Text" : "q12h ($16/day) [DI]"}, 
{"Row" : 32, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 42, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 43, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZ SET ABX CIPROFLOX 400 IV Q12H PENICIL 3MU IV Q4H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> penicillin 3 million", "Mnemonic" : "18"},
{"Row" : 34, "Column" : 1, "Text" : "units IV q4h ($2.16/day) [R] < OR >"}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZ SET ABX PENICIL 3MU Q4H DOXYC 100 IV Q12H", "DisplayText" : "", "Text" : "Penicillin 3 million units IV q4H ($2.16/day) [R,DI] <AND> doxycycline 100", "Mnemonic" : "20"},
{"Row" : 37, "Column" : 1, "Text" : "mg IV q12h ($16/day) [DI]"}
]},
{"Name" : "ORZID2 GMENU GRAM-POS FI CORYNEBACTERIUM SPP.", "DisplayText" : "Corynebacterium spp.  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CORYNEBACTERIUM SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "_______________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "_______________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Corynebacterium jeikeium", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "disease/syndrome sections for more information."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($5.88/day) [R]", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Contact Infectious Diseases for advice."}, 
{"Row" : 24, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Corynebacterium diphtheriae", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Diphtheria is usually severe and often fatal.  Antitoxin is the most important"}, 
{"Row" : 29, "Column" : 1, "Text" : "treatment.  Contact Infectious Diseases immediately."}, 
{"Row" : 31, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJZID ERYTHROM 500MG PO Q8H", "DisplayText" : "Erythromycin 500MG PO q8h", "Text" : "Erythromycin 500 mg PO q8h ($0.28/day) [DI] < OR >", "Mnemonic" : "12"},
{"Row" : 33, "Column" : 1, "Item" : "PSJIZID ERYTHROMYCIN 500MG IV Q6H", "DisplayText" : "Erythromycin 500mg iv q6h", "Text" : "Erythromycin 500 mg IV q6h ($6.52/day) [DI]", "Mnemonic" : "14"},
{"Row" : 35, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($3.36/day) [H,O] < OR >", "Mnemonic" : "16"},
{"Row" : 37, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600 mg IV q8h ($4.20/day) [H,O]", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 42, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 43, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-POS FI LISTERIA SPP.", "DisplayText" : "Listeria spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "LISTERIA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 13, "Column" : 1, "Text" : "For meningitis, please refer to the meningitis section for treatment advice."}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX AMPICIL 2G Q4H GENT 1.7MG/KG IV Q8H", "DisplayText" : "", "Text" : "Ampicillin 2 gm IV q4h ($68/day) [R] <AND> gentamicin 1.7 mg/kg IV q8h", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "($3/day) [R,O]"}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID TRIMETH/SULFA 5-25 MG/KG IV Q6H", "DisplayText" : "Trimeth/sulfa 5-25 mg/kg iv q6h", "Text" : "Trimethoprim 5 mg/kg - sulfamethoxazole 25 mg/kg IV q6h ($51/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-POS FI PROPIONIBACT SPP.", "DisplayText" : "Propionibacterium spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "PROPIONIBACTERIUM SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Isolation of Propionibacterium species from a culture often represents"}, 
{"Row" : 12, "Column" : 1, "Text" : "contamination or colonization and not disease.  For questions about whether a"}, 
{"Row" : 13, "Column" : 1, "Text" : "patient should be treated, contact Infectious Diseases."}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "disease/syndrome sections for more information."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID PENICILLIN 2MU IV Q4H", "DisplayText" : "Penicillin 2 million units iv q4h", "Text" : "Penicillin 2 million units IV q4h ($2.16/day) [R]", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600 mg IV q8h ($4.33/day) [H,O] < OR >", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($5.88/day) [R]", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 28, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 29, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID2 GMENU GRAM-POS INT RS COCCI PAIRS", "DisplayText" : "Interim results:  Gram-positive cocci in pairs", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "INTERIM RESULTS: GRAM-POSITIVE COCCI IN PAIRS"}, 
{"Row" : 8, "Column" : 1, "Text" : "Aerobic Gram-positive cocci in pairs are usually streptococci, staphylococci, or"}, 
{"Row" : 9, "Column" : 1, "Text" : "enterococci.These bacteria can be isolated under either aerobic or anaerobic"}, 
{"Row" : 10, "Column" : 1, "Text" : "conditions.  Gram-positive cocci in pairs and clusters are usually"}, 
{"Row" : 11, "Column" : 1, "Text" : "staphylococci.  Gram-positive cocci in pairs and chains are usually streptococci"}, 
{"Row" : 12, "Column" : 1, "Text" : "or enterococci.  Gram-positive cocci in \"chains\" are likely streptococci.  If"}, 
{"Row" : 13, "Column" : 1, "Text" : "the lab reports Gram-positive cocci in \"short chains\", enterococci are likely."}, 
{"Row" : 15, "Column" : 1, "Text" : "Click the links below for further information"}, 
{"Row" : 17, "Column" : 1, "Text" : "Staphylococci", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU H. PYLORI INFECT", "DisplayText" : "Helicobacter pylori infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 10, "Column" : 1, "Text" : "HELICOBACTER PYLORI INFECTION"}, 
{"Row" : 12, "Column" : 1, "Text" : "H. pylori infection is associated with peptic ulcers, gastritis, gastric"}, 
{"Row" : 13, "Column" : 1, "Text" : "adenocarcinoma, and gastric lymphoma.  Antimicrobials should be given to"}, 
{"Row" : 14, "Column" : 1, "Text" : "patients with confirmed H. pylori infection.Antisecretory therapy is usually"}, 
{"Row" : 15, "Column" : 1, "Text" : "given concurrently.  Contact Gastroenterology for more information."}, 
{"Row" : 17, "Column" : 1, "Text" : "FIRST OCCURRENCE: triple therapy for 14 days", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJUZID OMEPRAZOLE 20MG PO BID", "DisplayText" : "Omeprazole 20MG PO BID", "Text" :""},
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN 1GM PO BID", "DisplayText" : "Amoxicillin 1GM PO BID", "Text" :""},
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID CLARITHROMYCIN 500MG PO BID", "DisplayText" : "Clarithromycin 500MG PO BID", "Text" : ""},
{"Row" : 22, "Column" : 1, "Text" : "PENICILLIN ALLERGY, FIRST OCCURRENCE: triple therapy for 14 days", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID OMEPRAZOLE 20MG PO BID", "DisplayText" : "Omeprazole 20MG PO BID", "Text" :""},
{"Row" : 24, "Column" : 1, "Item" : "PSJUZID METRONIDAZOLE 500MG PO BID", "DisplayText" : "Metronidazole 500MG PO BID", "Text" : ""},
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID CLARITHROMYCIN 500MG PO BID", "DisplayText" : "Clarithromycin 500MG PO BID", "Text" : ""},
{"Row" : 27, "Column" : 1, "Text" : "RE-OCCURRENCE OR RECENT OR REPEAT EXPOSURE TO CLARITHROMYCIN OR", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "METRONIDAZOLE: quadruple therapy for 14 days", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJUZID OMEPRAZOLE 20MG PO BID", "DisplayText" : "Omeprazole 20MG PO BID", "Text" :""},
{"Row" : 30, "Column" : 1, "Item" : "PSJUZID BISMUTH 524MG PO QID", "DisplayText" : "Bismuth 524MG PO QID", "Text" : ""},
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN 1GM PO BID", "DisplayText" : "Amoxicillin 1GM PO BID", "Text" :""},
{"Row" : 32, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO BID 14 DAYS", "DisplayText" : "Doxycycline 100MG PO BID", "Text" : ""},
{"Row" : 34, "Column" : 1, "Text" : "PENICILLIN ALLERGY, RE-OCCURRENCE OR RECENT OR REPEAT EXPOSURE TO", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "CLARITHROMYCIN OR METRONIDAZOLE: quadruple therapy for 14 days", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJUZID OMEPRAZOLE 20MG PO BID", "DisplayText" : "Omeprazole 20MG PO BID", "Text" :""},
{"Row" : 37, "Column" : 1, "Item" : "PSJUZID BISMUTH 524MG PO QID", "DisplayText" : "Bismuth 524MG PO QID", "Text" : ""},
{"Row" : 38, "Column" : 1, "Item" : "PSJUZID METRONIDAZOLE 500MG PO BID", "DisplayText" : "Metronidazole 500MG PO BID", "Text" : ""},
{"Row" : 39, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO BID 14 DAYS", "DisplayText" : "Doxycycline 100MG PO BID", "Text" : ""},
{"Row" : 41, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Crowe S. Treatment regimens for Helicobacter pylori.  Up to Date.  July, 2014"}, 
{"Row" : 44, "Column" : 1, "Text" : "Gastric/Duodenal Ulcer, Helicobacter pylori.  Sanford Guide.  February 6, 2014"}, 
{"Row" : 46, "Column" : 1, "Text" : "Chey W, Wong B.  American College of Gastroenterology Guideline on the"}, 
{"Row" : 47, "Column" : 1, "Text" : "Management of Helicobacter pylori Infection.  American Journal of"}, 
{"Row" : 48, "Column" : 1, "Text" : "Gastroenterology.  2007."}
]},
{"Name" : "ORZID2 GMENU IDP FLUCYTOSINE PO", "DisplayText" : "Flucytosine PO  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX LINKS", "DisplayText" : "Micromedex links", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP-TO-DATE LINKS", "DisplayText" : "Up-To-Date links", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Flucytosine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "25-37.5 mg/kg PO q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "CrCl"}, 
{"Row" : 16, "Column" : 1, "Text" : "(ml/min)"}, 
{"Row" : 17, "Column" : 1, "Text" : "20-40Increase dosing interval to 12 hr"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-20Increase dosing interval to 24 hr"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10  Increase dosing interval to 24-48 hr"}, 
{"Row" : 21, "Column" : 1, "Text" : "Adjust dose and interval to achieve target peak (2 hour post-dose) levels of 70-"}, 
{"Row" : 22, "Column" : 1, "Text" : "80 mcg/ml and trough levels of 30-40 mcg/ml"}, 
{"Row" : 24, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Contraindicated with levomethadyl due to risk of cardiotoxicity."}, 
{"Row" : 26, "Column" : 1, "Text" : "Avoid using with zidovudine due to risk of neutropenia."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Nausea/vomiting, liver transaminase elevation, confusion, rare blood dyscrasias,"}, 
{"Row" : 30, "Column" : 1, "Text" : "rare cardiotoxicity."}
]},
{"Name" : "ORZID2 GMENU IG HIS DEFICIENCY", "DisplayText" : "Immunoglobulin (Humoral immune system) deficiency", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "IMMUNOGLOBULIN DEFICIENCY (HUMORAL IMMUNE SYSTEM)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Antibody deficiency typically leads to recurrent, severe respiratory tract"}, 
{"Row" : 12, "Column" : 1, "Text" : "infections associated with encapsulated bacteria, especially Streptococcus"}, 
{"Row" : 13, "Column" : 1, "Text" : "pneumoniae and Haemophilus influenzae, and to a lesser extent, Staphylococcus"}, 
{"Row" : 14, "Column" : 1, "Text" : "aureus. Recurrent otitis media, sinusitis, and pneumonia are common syndromes."}, 
{"Row" : 15, "Column" : 1, "Text" : "Gastrointestinal disease associated with Salmonella, Shigella, Campylobacter, or"}, 
{"Row" : 16, "Column" : 1, "Text" : "rotavirus is also common in some patients."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred empirical treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M]", "Mnemonic" : "10"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Chloramphenicol is not currently available.  Contact Infectious Diseases for"}, 
{"Row" : 23, "Column" : 1, "Text" : "advice."}, 
{"Row" : 28, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 29, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM ALTERED MICRO FLORA", "DisplayText" : "Altered microbial flora  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "ALTERED MICROBIAL FLORA"}, 
{"Row" : 8, "Column" : 1, "Text" : "A rich, diverse microbial flora lives on or in skin, mucosal surfaces, and"}, 
{"Row" : 9, "Column" : 1, "Text" : "respiratory and gastrointestinal tracts of healthy people.  This flora prevents"}, 
{"Row" : 10, "Column" : 1, "Text" : "disease by inhibiting the growth of potential pathogens.  Disruption of the"}, 
{"Row" : 11, "Column" : 1, "Text" : "normal flora, usually by antimicrobial therapy, reduces this barrier and"}, 
{"Row" : 12, "Column" : 1, "Text" : "increases the risk of infectious disease.  Patients exposed to broad-spectrum"}, 
{"Row" : 13, "Column" : 1, "Text" : "antimicrobials are at greater risk for colonization with resistant bacteria,"}, 
{"Row" : 14, "Column" : 1, "Text" : "fungal infections, and Clostridium difficile colitis.  During hospitalization,"}, 
{"Row" : 15, "Column" : 1, "Text" : "many patients become colonized with more resistant organisms like methicillin-"}, 
{"Row" : 16, "Column" : 1, "Text" : "resistant Staphylococcus aureus and resistant Gram-negative bacilli."}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 22, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM BASIC CONCEPTS", "DisplayText" : "Basic concepts  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "BASIC CONCEPTS"}, 
{"Row" : 8, "Column" : 1, "Text" : "Humans are protected by a broad array of host defenses that fall into two major"}, 
{"Row" : 9, "Column" : 1, "Text" : "categories: innate and immune host defenses.  Innate defense operate"}, 
{"Row" : 10, "Column" : 1, "Text" : "continuously without specific antigenic stimulation and immune defenses are"}, 
{"Row" : 11, "Column" : 1, "Text" : "primed by and respond to antigenic stimulation."}, 
{"Row" : 13, "Column" : 1, "Text" : "Each type of host defense protects against a specific set of organisms.  As a"}, 
{"Row" : 14, "Column" : 1, "Text" : "result, infectious diseases more common because of host defense defects in an"}, 
{"Row" : 15, "Column" : 1, "Text" : "individual patient are usually predictable from that patient's host defense"}, 
{"Row" : 16, "Column" : 1, "Text" : "defects.  For example, antibody or complement deficiencies predispose patients"}, 
{"Row" : 17, "Column" : 1, "Text" : "to disease with encapsulated organisms but not fungi.  Defects in cell-mediated"}, 
{"Row" : 18, "Column" : 1, "Text" : "immunity predispose patients to infections with mycobacteria or cytomegalovirus"}, 
{"Row" : 19, "Column" : 1, "Text" : "but not Escherichia coli or influenza virus.  Suspected cases of infectious"}, 
{"Row" : 20, "Column" : 1, "Text" : "disease must be evaluated in the context of the patient's host defects."}, 
{"Row" : 21, "Column" : 1, "Text" : "Management, including possible antimicrobial therapy, should be initiated on the"}, 
{"Row" : 22, "Column" : 1, "Text" : "basis of the most likely offending pathogens."}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM COMP DEFICIENCY", "DisplayText" : "Complement deficiency ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "COMPLEMENT DEFICIENCY"}, 
{"Row" : 18, "Column" : 1, "Text" : "Patients presenting with fever or other symptoms suggesting systemic bacterial"}, 
{"Row" : 19, "Column" : 1, "Text" : "infection should be treated immediately with antimicrobials active against these"}, 
{"Row" : 20, "Column" : 1, "Text" : "pathogens."}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred empirical treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M]", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "Chloramphenicol is not currently available.  Contact Infectious Diseases for"}, 
{"Row" : 27, "Column" : 1, "Text" : "advice."}, 
{"Row" : 11, "Column" : 1, "Text" : "Complement deficiency can be inherited or acquired.  Acquired defects are"}, 
{"Row" : 12, "Column" : 1, "Text" : "usually a consequence of other diseases like systemic lupus erythematosus."}, 
{"Row" : 13, "Column" : 1, "Text" : "Complement deficiency leads to increased rates of infections, usually of the"}, 
{"Row" : 14, "Column" : 1, "Text" : "upper respiratory tract, but also occasionally with bacteremia or meningitis."}, 
{"Row" : 15, "Column" : 1, "Text" : "Pathogens are usually Streptococcus pneumoniae, Neisseria meningitidis, and"}, 
{"Row" : 16, "Column" : 1, "Text" : "Neisseria gonorrhea."}, 
{"Row" : 32, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 33, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM DIABETES MELLITUS", "DisplayText" : "Diabetes Mellitus  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "DIABETES MELLITUS"}, 
{"Row" : 8, "Column" : 1, "Text" : "Hyperglycemia increases the risk of infectious diseases in diabetic patients,"}, 
{"Row" : 9, "Column" : 1, "Text" : "and increased blood glucose slows infection resolution.  Diabetic patients are"}, 
{"Row" : 10, "Column" : 1, "Text" : "prone to a variety of infections including urinary tract infections,"}, 
{"Row" : 11, "Column" : 1, "Text" : "cholecystitis, and bacteremia.  Peripheral neuropathy and arterial insufficiency"}, 
{"Row" : 12, "Column" : 1, "Text" : "predispose to infections of skin, soft tissue, and bone infection in the lower"}, 
{"Row" : 13, "Column" : 1, "Text" : "legs and feet."}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 19, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}, 
{"Row" : 20, "Column" : 1, "Text" : "Joshi N  New Eng J Med 1999, 341: 1906"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM HYPOCHLORHYDRIA", "DisplayText" : "Hypochlorhydria ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "HYPOCHLORHYDRIA"}, 
{"Row" : 8, "Column" : 1, "Text" : "Diminished gastric acid allows increased numbers of bacteria in the stomach and"}, 
{"Row" : 9, "Column" : 1, "Text" : "predisposes to infection with several potentially pathogenic bacterial species."}, 
{"Row" : 10, "Column" : 1, "Text" : "These changes increase the risk of nosocomial pneumonia and possibly the risk of"}, 
{"Row" : 11, "Column" : 1, "Text" : "community-acquired respiratory infections.  However, interventions to"}, 
{"Row" : 12, "Column" : 1, "Text" : "decontaminate the upper gastrointestinal tract do not prevent infectious"}, 
{"Row" : 13, "Column" : 1, "Text" : "disease."}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 19, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM MALIGNANCY", "DisplayText" : "Malignancy", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Consult Hematology-Oncology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MALIGNANCY"}, 
{"Row" : 9, "Column" : 1, "Text" : "Malignancies affect host defenses in many ways.  Hematogenous malignancies can"}, 
{"Row" : 10, "Column" : 1, "Text" : "diminish the effectiveness of neutrophils and other cells involved in host"}, 
{"Row" : 11, "Column" : 1, "Text" : "defense.  Tumors often disrupt mucous membranes or blood vessels and allow"}, 
{"Row" : 12, "Column" : 1, "Text" : "contaminating organisms into hollow cavities or the bloodstream.  Chemotherapy"}, 
{"Row" : 13, "Column" : 1, "Text" : "used to treat these malignancies often impairs mucus membranes and suppresses"}, 
{"Row" : 14, "Column" : 1, "Text" : "neutrophil production and function."}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM NEUT FEVER", "DisplayText" : "Neutropenic fever", "Text" : "Neutropenic fever", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "Ordinarily, empirical antimicrobials are not indicated for patients with"}, 
{"Row" : 17, "Column" : 1, "Text" : "malignancy and fever unless they have neutropenia or a specific infectious"}, 
{"Row" : 18, "Column" : 1, "Text" : "disease."}, 
{"Row" : 25, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 26, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM MALNUTRITION", "DisplayText" : "Malnutrition ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "MALNUTRITION"}, 
{"Row" : 8, "Column" : 1, "Text" : "Adequate nutrition is necessary for optimal host defense function.  A few days"}, 
{"Row" : 9, "Column" : 1, "Text" : "of malnutrition can decrease host defenses, mainly cell-mediated immunity. The"}, 
{"Row" : 10, "Column" : 1, "Text" : "degree of compromised immunity increases with the duration of malnutrition."}, 
{"Row" : 11, "Column" : 1, "Text" : "However, nutritional replacement has not been shown to improve outcomes in"}, 
{"Row" : 12, "Column" : 1, "Text" : "patients with mild-moderate malnutrition.  Enteral nutritional replacement is"}, 
{"Row" : 13, "Column" : 1, "Text" : "far superior to and safer than intravenous hyperalimentation."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Empirical antimicrobials are not indicated for malnourished patients with fever"}, 
{"Row" : 17, "Column" : 1, "Text" : "but without evidence of a specific infectious disease."}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 22, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 23, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM NEUROL DYSFUNCTION", "DisplayText" : "Neurological dysfunction ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "NEUROLOGICAL DYSFUNCTION"}, 
{"Row" : 8, "Column" : 1, "Text" : "Several types of neurological dysfunction predispose patients to infectious"}, 
{"Row" : 9, "Column" : 1, "Text" : "diseases.  Comatose patients are unable to keep weight off dependent tissues,"}, 
{"Row" : 10, "Column" : 1, "Text" : "predisposing them to decubitus ulcers and pressure necrosis.  Atelectasis is"}, 
{"Row" : 11, "Column" : 1, "Text" : "common in obtunded patients who cannot cough or breathe deeply.  When patients"}, 
{"Row" : 12, "Column" : 1, "Text" : "require artificial ventilation, intubation compounds the risk of respiratory"}, 
{"Row" : 13, "Column" : 1, "Text" : "infection."}, 
{"Row" : 15, "Column" : 1, "Text" : "Neurological dysfunction of the bladder can interfere with normal bladder"}, 
{"Row" : 16, "Column" : 1, "Text" : "emptying and predisposes patients to bacteriuria.  The risk of bacteruria"}, 
{"Row" : 17, "Column" : 1, "Text" : "increases if patients are catheterized.  Antimicrobial treatment is not"}, 
{"Row" : 18, "Column" : 1, "Text" : "indicated for asymptomatic bacteriuria.  It provides no benefit and increases"}, 
{"Row" : 19, "Column" : 1, "Text" : "risk of colonization with resistant organisms."}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 21, "Column" : 1, "Text" : "Neurological dysfunction predisposes patients to aspiration of oropharyngeal or"}, 
{"Row" : 22, "Column" : 1, "Text" : "gastric contents.  Aspiration causes fever, inflammation, and/or pulmonary"}, 
{"Row" : 23, "Column" : 1, "Text" : "infiltrate, but does not require antimicrobial treatment. Bacterial pneumonia"}, 
{"Row" : 24, "Column" : 1, "Text" : "occurs in a minority of patients who experience significant aspiration,"}, 
{"Row" : 25, "Column" : 1, "Text" : "typically about 3 days later.  Typically, the patient improves for the first 2"}, 
{"Row" : 26, "Column" : 1, "Text" : "days and then worsens as bacterial pneumonia develops with increased fever, new"}, 
{"Row" : 27, "Column" : 1, "Text" : "or progressive infiltrates, leukocytosis, and newly purulent sputum."}, 
{"Row" : 33, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 34, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM NEUT FEVER", "DisplayText" : "Neutropenic fever  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Hematology-Oncology consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "NEUTROPENIC FEVER"}, 
{"Row" : 9, "Column" : 1, "Text" : "The risk of severe, rapidly progressive infections increases when the absolute"}, 
{"Row" : 10, "Column" : 1, "Text" : "neutrophil count (ANC, segmented neutrophils plus bands) is less than 500"}, 
{"Row" : 11, "Column" : 1, "Text" : "cells/microliter.  The risk increases dramatically when the ANC is <100"}, 
{"Row" : 12, "Column" : 1, "Text" : "cells/microliter.  Because of these risks, patients with fever and neutropenia"}, 
{"Row" : 13, "Column" : 1, "Text" : "to this degree should receive empirical antimicrobial therapy immediately."}, 
{"Row" : 14, "Column" : 1, "Text" : "Empirical therapy should also be given to patients with fever and ANC 500-1000"}, 
{"Row" : 15, "Column" : 1, "Text" : "cells/microliter when the concentration is expected to be <500 cells/microliter"}, 
{"Row" : 16, "Column" : 1, "Text" : "within the next 48 hours.  For this purpose, fever is defined as a single"}, 
{"Row" : 17, "Column" : 1, "Text" : "temperature greater than 38.3 degrees Celsius."}, 
{"Row" : 19, "Column" : 1, "Text" : "Initial therapy", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Since infection can be rapidly progressive and severe, broad-spectrum"}, 
{"Row" : 21, "Column" : 1, "Text" : "antimicrobials are given urgently to patients with neutropenic fever as defined"}, 
{"Row" : 22, "Column" : 1, "Text" : "above.  Vancomycin should only be given when there are clear indications for its"}, 
{"Row" : 23, "Column" : 1, "Text" : "use."}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER CAND ORAL THERA", "DisplayText" : "Neutropenic fever--Patient is a candidate for oral therapy", "Text" : "If patient IS a candidate for oral therapy", "Mnemonic" : "08"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER CAND NOT ORAL THERA", "DisplayText" : "Neutropenic fever--Patient is NOT a candidate for oral therapy", "Text" : "If patient is NOT a candidate for oral therapy", "Mnemonic" : "10"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER SCORING TOOL", "DisplayText" : "Scoring tool to identify low risk febrile neutropenic patients", "Text" : "Link to a scoring tool that identifies low risk patients for oral therapy", "Mnemonic" : "12"},
{"Row" : 41, "Column" : 1, "Text" : "Modifcation to therapy", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER MOD THERAPY", "DisplayText" : "Modification to Neutropenic fever therapy", "Text" : "Modification to neutropenic fever therapy", "Mnemonic" : "14"},
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 47, "Column" : 1, "Text" : "Hughes WT  Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 48, "Column" : 1, "Text" : "Rolston KVI Clin Infect Dis 2004, 39: S44"}, 
{"Row" : 49, "Column" : 1, "Text" : "Sipsas NV  Cancer 2005, 103: 1103"}, 
{"Row" : 25, "Column" : 1, "Text" : "Candidates for empirical treatment with oral antimicrobials include those who:"}, 
{"Row" : 26, "Column" : 1, "Text" : "-Are able to seek immediate medical care if their condition worsens at home"}, 
{"Row" : 27, "Column" : 1, "Text" : "-Are outpatient at the time of fever development"}, 
{"Row" : 28, "Column" : 1, "Text" : "-Have no associated comorbid illness which would independently indicate"}, 
{"Row" : 29, "Column" : 1, "Text" : "inpatient treatment or close observation"}, 
{"Row" : 30, "Column" : 1, "Text" : "-Have an anticipated duration of neutropenia </= 100 cells/mcL for <7 days"}, 
{"Row" : 31, "Column" : 1, "Text" : "-Have a good performance status (ECOG 0-1)"}, 
{"Row" : 32, "Column" : 1, "Text" : "-Do not have renal or hepatic insufficiency"}, 
{"Row" : 33, "Column" : 1, "Text" : "*OR*"}, 
{"Row" : 34, "Column" : 1, "Text" : "-Have a MASCC Risk Index score of 21 or greater"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM NEUTROPENIA", "DisplayText" : "Neutropenia  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Hematology-Oncology consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "NEUTROPENIA"}, 
{"Row" : 9, "Column" : 1, "Text" : "Patients with neutropenia are at risk of infection from pyogenic organisms"}, 
{"Row" : 10, "Column" : 1, "Text" : "including Staphylococcus aureus, streptococci, Gram-negative bacilli,"}, 
{"Row" : 11, "Column" : 1, "Text" : "Pseudomonas aeruginosa, candida, and certain filamentous fungi, most notably"}, 
{"Row" : 12, "Column" : 1, "Text" : "Aspergillus and the zygomycetes.  The risk is inversely related to the absolute"}, 
{"Row" : 13, "Column" : 1, "Text" : "neutrophil count (ANC), the disease or condition associated with neutropenia,"}, 
{"Row" : 14, "Column" : 1, "Text" : "duration of neutropenia, and the presence of other host defense defects or"}, 
{"Row" : 15, "Column" : 1, "Text" : "underlying diseases."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM SPLEEN ABS/DYSFUNCT", "DisplayText" : "Absent or Dysfunctional Spleen ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ABSENT OR DYSFUNCTIONAL SPLEEN"}, 
{"Row" : 11, "Column" : 1, "Text" : "Patients with absent or dysfunctional spleens are at risk of sepsis, most"}, 
{"Row" : 12, "Column" : 1, "Text" : "commonly with Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus"}, 
{"Row" : 13, "Column" : 1, "Text" : "influenzae.  Less common pathogens include Babesia microtii (from Ixodes tick"}, 
{"Row" : 14, "Column" : 1, "Text" : "bites), Capnocytophaga phagocytosis, and Capnocytophaga canimorsus (from dog"}, 
{"Row" : 15, "Column" : 1, "Text" : "bites)."}, 
{"Row" : 17, "Column" : 1, "Text" : "The risk of severe infection is related to the reason for splenectomy and the"}, 
{"Row" : 18, "Column" : 1, "Text" : "time since splenectomy.  Risk is greatest during the first year after"}, 
{"Row" : 19, "Column" : 1, "Text" : "splenectomy and then decreases with time but never reaches the risk level of"}, 
{"Row" : 20, "Column" : 1, "Text" : "immunocompetent patients.  Patients who have had a splenectomy as a result of"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hodgkin disease or thalassemia are at greatest risk of infection.  The risk is"}, 
{"Row" : 22, "Column" : 1, "Text" : "intermediate in patients who have had splenectomy for spherocytosis, idiopathic"}, 
{"Row" : 23, "Column" : 1, "Text" : "thrombocytopenic purpura, or portal hypertension, and lowest in patients who"}, 
{"Row" : 24, "Column" : 1, "Text" : "lost their spleen from trauma."}, 
{"Row" : 26, "Column" : 1, "Text" : "When asplenic patients present with fever or other symptoms suggesting systemic"}, 
{"Row" : 27, "Column" : 1, "Text" : "bacterial infection, obtain blood cultures and treat immediately with"}, 
{"Row" : 28, "Column" : 1, "Text" : "antimicrobials active against the likely pathogens.  For early empirical"}, 
{"Row" : 29, "Column" : 1, "Text" : "treatment, some patients are given a supply of antimicrobials and instructed to"}, 
{"Row" : 30, "Column" : 1, "Text" : "take them when they first become ill and then to seek medical attention"}, 
{"Row" : 31, "Column" : 1, "Text" : "immediately thereafter.  Some patients at high risk of infection are treated"}, 
{"Row" : 32, "Column" : 1, "Text" : "with antimicrobials continuously to prevent infections.  Contact Infectious"}, 
{"Row" : 33, "Column" : 1, "Text" : "Diseases for more information."}, 
{"Row" : 35, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Give Haemophilus influenzae, meningococcal and pneumococcal vaccines to prevent"}, 
{"Row" : 37, "Column" : 1, "Text" : "infection with these potential pathogens."}, 
{"Row" : 39, "Column" : 1, "Text" : "Empirical therapy if there is NOT evidence of CNS infection", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M]", "Mnemonic" : "12"},
{"Row" : 42, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Empirical therapy if PNEUMOCOCCAL MENINGITIS is suspected", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Item" : "ORZ SET ABX CEFT 1GM IV Q24H VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] <AND> vancomycin 15 mg/kg IV q12h", "Mnemonic" : "16"},
{"Row" : 50, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Text" : "Chloramphenicol is not currently available.  Contact Infectious Diseases for"}, 
{"Row" : 44, "Column" : 1, "Text" : "advice."}, 
{"Row" : 51, "Column" : 1, "Text" : "Chloramphenicol is not currently available.  Contact Infectious Diseases for"}, 
{"Row" : 52, "Column" : 1, "Text" : "advice."}, 
{"Row" : 57, "Column" : 1, "Text" : "Up-to-date: Immunology"}, 
{"Row" : 58, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 59, "Column" : 1, "Text" : "\"Roitt\" chapter:  Immunology"}, 
{"Row" : 48, "Column" : 1, "Text" : "($6/day) [R]"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM STRESS", "DisplayText" : "Stress ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "STRESS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Critically ill patients are usually profoundly stressed.  The risk of infection"}, 
{"Row" : 14, "Column" : 1, "Text" : "is subtle and the defects are non-specific."}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 8, "Column" : 1, "Text" : "Acute psychological stress is associated with immune stimulation and increased"}, 
{"Row" : 9, "Column" : 1, "Text" : "cellular host defenses.  However, chronic stress decrease humoral and cell-"}, 
{"Row" : 10, "Column" : 1, "Text" : "mediated immunity.  Chronic stress has been correlated with increased risk of"}, 
{"Row" : 11, "Column" : 1, "Text" : "respiratory tract infection."}, 
{"Row" : 19, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 20, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU IMMUNOCOM TOBACCO SMOKE", "DisplayText" : "Tobacco smoke", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 8, "Column" : 1, "Text" : "Active or passive exposure to tobacco smoke is associated with increased"}, 
{"Row" : 9, "Column" : 1, "Text" : "susceptibility to respiratory infectious diseases and several systemic"}, 
{"Row" : 10, "Column" : 1, "Text" : "infectious diseases with bacterial and viral pathogens.  Compounds found in"}, 
{"Row" : 11, "Column" : 1, "Text" : "tobacco or tobacco smoke interfere with several host defense mechanisms in the"}, 
{"Row" : 12, "Column" : 1, "Text" : "respiratory tract and elsewhere in the body."}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Text" : "TOBACCO SMOKE"}, 
{"Row" : 17, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 18, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU INFECT DIARRHEA/GASTRO", "DisplayText" : "Infectious diarrhea/Gastroenteritis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 8, "Column" : 1, "Text" : "Most episodes of acute diarrhea are self limited and do not need to be evaluated"}, 
{"Row" : 9, "Column" : 1, "Text" : "or treated.  In most mild to moderate cases, antimicrobial therapy does not"}, 
{"Row" : 10, "Column" : 1, "Text" : "provide benefit and may prolong symptoms or shedding.  Antimicrobial therapy is"}, 
{"Row" : 11, "Column" : 1, "Text" : "detrimental in cases involving enterohemorrhagic Escherichia coli."}, 
{"Row" : 13, "Column" : 1, "Text" : "The decision for whether to obtain stool culture and O&P or not depends on"}, 
{"Row" : 14, "Column" : 1, "Text" : "severity, duration, and host factors like likelihood of specific infectious"}, 
{"Row" : 15, "Column" : 1, "Text" : "agents and severity of any underlying diseases.  Send stool sample for culture"}, 
{"Row" : 16, "Column" : 1, "Text" : "and O&P and consider prescribing antimicrobials when patients are dehydrated,"}, 
{"Row" : 17, "Column" : 1, "Text" : "stools are visibly bloody, temperature is >38.4 C, there is no improvement after"}, 
{"Row" : 18, "Column" : 1, "Text" : "48 hours, the case is part of a new community outbreak, there is severe"}, 
{"Row" : 19, "Column" : 1, "Text" : "abdominal pain in a person >50 years old, the patient is >69 years old, or the"}, 
{"Row" : 20, "Column" : 1, "Text" : "patient is substantially immunocompromised.  Replace fluid losses and correct"}, 
{"Row" : 21, "Column" : 1, "Text" : "electrolyte imbalances."}, 
{"Row" : 23, "Column" : 1, "Text" : "Cases with enterohemorrhagic E. coli typically have bloody diarrhea, abdominal"}, 
{"Row" : 24, "Column" : 1, "Text" : "pain, and tenderness but no fever.  In these cases anti-motility agents and"}, 
{"Row" : 25, "Column" : 1, "Text" : "antimicrobials increase the risk of hemolytic uremic syndrome and should not be"}, 
{"Row" : 26, "Column" : 1, "Text" : "given."}, 
{"Row" : 29, "Column" : 1, "Text" : "Treatment of diarrhea with specific organisms", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "\"Sanford\": key term: diarrhea"}, 
{"Row" : 32, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 33, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296-305"}, 
{"Row" : 34, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 35, "Column" : 1, "Text" : "Up-to-Date: Diarrhea"}, 
{"Row" : 36, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 37, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 38, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 6, "Column" : 1, "Text" : "INFECTIOUS DIARRHEA / GASTROENTERITIS"}
]},
{"Name" : "ORZID2 GMENU INFLUENZA 2011-12", "DisplayText" : "INFLUENZA 2011-2012 INPATIENT ", "Version" : "Fargo", "Contents" : [
{"Row" : 8, "Column" : 1, "Text" : "NOVEL H1N1 INFLUENZA"}, 
{"Row" : 10, "Column" : 1, "Text" : "Follow facility specific guidelines for prescribing and dispensing Oseltamivir", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "(Tamiflu).", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Definitions of Influenza Cases", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "CDC defines a confirmed case of H1N1 infection as a person with an acute febrile"}, 
{"Row" : 15, "Column" : 1, "Text" : "respiratory illness with laboratory confirmed H1N1 infection at CDC."}, 
{"Row" : 17, "Column" : 1, "Text" : "A probable case of H1N1 infection is defined as a person with an acute febrile"}, 
{"Row" : 18, "Column" : 1, "Text" : "respiratory illness who is positive for influenza A, but negative for H1 and H3"}, 
{"Row" : 19, "Column" : 1, "Text" : "by influenza RT-PCR."}, 
{"Row" : 21, "Column" : 1, "Text" : "CDC defines suspected cases of H1N1 infection as a person with acute febrile"}, 
{"Row" : 22, "Column" : 1, "Text" : "respiratory illness with onset"}, 
{"Row" : 23, "Column" : 1, "Text" : ">within 7 days of close contact with a person who is a confirmed case of"}, 
{"Row" : 24, "Column" : 1, "Text" : "H1N1 infection, or"}, 
{"Row" : 25, "Column" : 1, "Text" : ">within 7 days of travel to community either within the United States or"}, 
{"Row" : 26, "Column" : 1, "Text" : "internationally where there are one or more confirmed cases of H1N1"}, 
{"Row" : 27, "Column" : 1, "Text" : "infection, or"}, 
{"Row" : 28, "Column" : 1, "Text" : ">resides in a community where there are one or more confirmed cases of"}, 
{"Row" : 29, "Column" : 1, "Text" : "H1N1 infection."}, 
{"Row" : 31, "Column" : 1, "Text" : "Acute respiratory illness is defined as recent onset of at least two of the"}, 
{"Row" : 32, "Column" : 1, "Text" : "following: rhinorrhea or nasal congestion\\sore throat or cough (with or without"}, 
{"Row" : 33, "Column" : 1, "Text" : "fever or feverishness.)"}, 
{"Row" : 35, "Column" : 1, "Text" : "CDC Recommendations", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment:", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Treatment is effective only if started within 48 hours of onset of illness."}, 
{"Row" : 39, "Column" : 1, "Text" : "At present CDC recommends that treatment be considered for patients with"}, 
{"Row" : 40, "Column" : 1, "Text" : "confirmed, probable or suspected cases of H1N1.  Hospitalized patients and"}, 
{"Row" : 41, "Column" : 1, "Text" : "patients at higher risk for influenza complications [those with chronic"}, 
{"Row" : 42, "Column" : 1, "Text" : "cardiopulmonary disease, diabetes or renal disease] should have priority."}, 
{"Row" : 44, "Column" : 1, "Text" : "Recommended treatment dosing:", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Oseltamivir 75 mg po bid for five days ($8/day) [R]"}, 
{"Row" : 46, "Column" : 1, "Text" : "For Creatinine Clearance less than 30 ml/min reduce dose to:"}, 
{"Row" : 47, "Column" : 1, "Text" : "Oseltamivir 75 mg po q day for five days ($4/day) [R]"}, 
{"Row" : 49, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Text" : "Prophylaxis dosing:", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "Oseltamivir 75 mg po q day for ten days ($4/day) [R]"}, 
{"Row" : 52, "Column" : 1, "Text" : "For Creatinine Clearance less than 30 ml/min reduce dose to:"}, 
{"Row" : 53, "Column" : 1, "Text" : "Oseltamivir 75 mg po every other day for ten days ($4/day) [R]"}, 
{"Row" : 55, "Column" : 1, "Text" : "Prophylaxis is recommended for:", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "influenza (e.g., persons with certain chronic medical conditions, persons"}, 
{"Row" : 58, "Column" : 1, "Text" : "65 or older, children younger than 5 years old and pregnant women) of a"}, 
{"Row" : 59, "Column" : 1, "Text" : "confirmed or probable case."}, 
{"Row" : 60, "Column" : 1, "Text" : ">Health care workers or public health workers who were not using"}, 
{"Row" : 61, "Column" : 1, "Text" : "appropriate personal protective equipment during close contact with an ill"}, 
{"Row" : 62, "Column" : 1, "Text" : "confirmed, probable, or suspect case of swine-origin influenza A (H1N1)"}, 
{"Row" : 63, "Column" : 1, "Text" : "virus infection during the case's infectious period."}, 
{"Row" : 65, "Column" : 1, "Text" : "Prophylaxis can be considered for:", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Text" : ">Household close contacts who are at high-risk for complications of"}, 
{"Row" : 67, "Column" : 1, "Text" : "influenza (e.g., persons with certain chronic medical conditions, persons"}, 
{"Row" : 68, "Column" : 1, "Text" : "65 years or older, children younger than 5 years old, and pregnant women)"}, 
{"Row" : 69, "Column" : 1, "Text" : "of a suspected case."}, 
{"Row" : 70, "Column" : 1, "Text" : ">Children attending school or daycare who are at high-risk for"}, 
{"Row" : 71, "Column" : 1, "Text" : "complications of influenza (children with certain chronic medical"}, 
{"Row" : 72, "Column" : 1, "Text" : "conditions) and who had close contact (face-to-face) with a confirmed,"}, 
{"Row" : 73, "Column" : 1, "Text" : "probable, or suspected case."}, 
{"Row" : 74, "Column" : 1, "Text" : ">Health care workers who are at high-risk for complications of influenza"}, 
{"Row" : 75, "Column" : 1, "Text" : "(e.g., persons with certain chronic medical conditions, persons 65 or"}, 
{"Row" : 76, "Column" : 1, "Text" : "older, and pregnant women) who are working in an area of the healthcare"}, 
{"Row" : 77, "Column" : 1, "Text" : "facility that contains patients with confirmed swine-origin influenza A"}, 
{"Row" : 78, "Column" : 1, "Text" : "(H1N1) cases, or who is caring for patients with any acute febrile"}, 
{"Row" : 79, "Column" : 1, "Text" : "respiratory illness."}, 
{"Row" : 56, "Column" : 1, "Text" : ">Household close contacts who are at high-risk for complications of"}, 
{"Row" : 80, "Column" : 1, "Text" : ">Travelers to Mexico who are at high-risk for complications of influenza"}, 
{"Row" : 81, "Column" : 1, "Text" : "(e.g., persons with certain chronic medical conditions, persons 65 or"}, 
{"Row" : 82, "Column" : 1, "Text" : "older, children younger than 5 years old, and pregnant women)."}, 
{"Row" : 83, "Column" : 1, "Text" : ">First responders who are at high-risk for complications of influenza"}, 
{"Row" : 84, "Column" : 1, "Text" : "(e.g., persons with certain chronic medical conditions, persons 65 or"}, 
{"Row" : 85, "Column" : 1, "Text" : "older, children younger than 5 years old, and pregnant women) and who are"}, 
{"Row" : 86, "Column" : 1, "Text" : "working in areas with confirmed cases of swine-origin influenza A (H1N1)"}, 
{"Row" : 87, "Column" : 1, "Text" : "virus infection."}, 
{"Row" : 89, "Column" : 1, "Text" : "References:", "Header" : 1}, 
{"Row" : 90, "Column" : 1, "Text" : "CDC Advisory"}, 
{"Row" : 91, "Column" : 1, "Text" : "http://www.cdc.gov/h1n1flu/recommendations.htm"}, 
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion", "Mnemonic" : "06"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]=minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Disease", "Mnemonic" : "10"}
]},
{"Name" : "ORZID2 GMENU INFLUENZA VACCINE 2014-2015", "DisplayText" : "Influenza Vaccine  ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "Vaccination Recommendations:", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Routine TRIVALENT Influenza Vaccine", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Routine influenza vaccination is recommended for all persons aged 6 months"}, 
{"Row" : 9, "Column" : 1, "Text" : "and older.  It prevents against novel H1N1, H3N2, and influenza B."}, 
{"Row" : 10, "Column" : 1, "Item" : "PSJZID INFLUENZA VACCINE 2014-2015", "DisplayText" : "Influenza Vaccine 2013-2014", "Text" : "Influenza Vaccine 2014-2015", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "High Dose Influenza Vaccine", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJZID INFLU HIGH DOSE VACCINE 2014-2015", "DisplayText" : "Influenza High Dose Vaccine 2014-2015", "Text" : "Influenza HIGH DOSE Vaccine 2014-2015", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Text" : "High dose influenza vaccination is recommended for patients greater than"}, 
{"Row" : 14, "Column" : 1, "Text" : "65 years of age AND severly immunocompromised OR at the discretion"}, 
{"Row" : 15, "Column" : 1, "Text" : "of Infectious Disease."}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Disease", "Mnemonic" : "04"}
]},
{"Name" : "ORZID2 GMENU INFLUENZA VACCINE OUTPT", "DisplayText" : "Influenza Vaccine 2011-2012 ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "Vaccination Recommendations:", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Routine Influenza Vaccine", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Routine influenza vaccination is recommended for all persons aged 6 months"}, 
{"Row" : 9, "Column" : 1, "Text" : "and older.  It prevents against novel H1N1, H3N2, and influenza B."}, 
{"Row" : 10, "Column" : 1, "Item" : "PSJZID INFLUENZA VACCINE 2014-2015", "DisplayText" : "Influenza Vaccine 2013-2014", "Text" : "Influenza Vaccine 2011-2012", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "High Dose Influenza Vaccine", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJZID INFLU HIGH DOSE VACCINE 2014-2015", "DisplayText" : "Influenza High Dose Vaccine 2014-2015", "Text" : "Influenza HIGH DOSE Vaccine 2011-2012", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Text" : "High dose influenza vaccination is recommended for patients greater than"}, 
{"Row" : 14, "Column" : 1, "Text" : "65 years of age AND severly immunocompromised OR at the discretion"}, 
{"Row" : 15, "Column" : 1, "Text" : "of Infectious Disease."}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Disease", "Mnemonic" : "04"}
]},
{"Name" : "ORZID2 GMENU INT LRG UNIF RDS AEROBIC BOT", "DisplayText" : "Large uniform rods in an aerobic bottle ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 12, "Column" : 1, "Text" : "Bacillus subtilis is usually a contaminant, Bacillus cereus is uncommon but"}, 
{"Row" : 13, "Column" : 1, "Text" : "usually pathogenic.  If Bacillus anthracis is suspected or isolated contact"}, 
{"Row" : 14, "Column" : 1, "Text" : "Infectious Diseases immediately."}, 
{"Row" : 16, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "For non-anthracis Bacillus spp. associated with disease", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kgIV q12h ($5.88/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 900MG IV Q8H", "DisplayText" : "Clindamycin 900MG IV Q8H", "Text" : "Clindamycin 900 mg IV q8h ($25/day) [H,O]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "For Bacillus anthracis", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Start combination therapy and contact Infectious Diseases immediately."}, 
{"Row" : 30, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZ SET ABX CIPROFL 400 IV Q12H DOXY 100 IV Q12H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> doxycycline 100 mg IV", "Mnemonic" : "14"},
{"Row" : 32, "Column" : 1, "Text" : "q12h ($16/day) [DI]"}, 
{"Row" : 34, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 9, "Column" : 1, "Text" : "LARGE UNIFORM BACILLI IN AN AEROBIC BOTTLE"}, 
{"Row" : 11, "Column" : 1, "Text" : "LARGE UNIFORM BACILLI in an AEROBIC bottle usually suggest Bacillus species."}, 
{"Row" : 44, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 46, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 47, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2005, 3: 7"}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZ SET ABX CIPROFLOX 400 IV Q12H PENICIL 3MU IV Q4H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> penicillin 3 million", "Mnemonic" : "16"},
{"Row" : 36, "Column" : 1, "Text" : "units IV q4h ($2.16/day) [R] < OR >"}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZ SET ABX PENICIL 3MU Q4H DOXYC 100 IV Q12H", "DisplayText" : "", "Text" : "Penicillin 3 million units IV q4H ($2.16/day) [R,DI] <AND> doxycycline 100", "Mnemonic" : "18"},
{"Row" : 39, "Column" : 1, "Text" : "mg IV q12h ($16/day) [DI]"}
]},
{"Name" : "ORZID2 GMENU INT RPT CLOSTRIDIUM", "DisplayText" : "INTERIM REPORT OF CLOSTRIDIUM  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "INTERIM REPORT OF CLOSTRIDIUM", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Combination therapy is recommended for necrotizing infections."}, 
{"Row" : 8, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM + VANCO 15MG/KG + CLINDA 900MG", "DisplayText" : "Zosyn 4.5GM + Vanco 15MG/KG + Clindamycin 900MG", "Text" : ""},
{"Row" : 10, "Column" : 1, "Text" : "REFERENCES:", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "UpToDate \"Clostridial myonecrosis\""}
]},
{"Name" : "ORZID2 GMENU INT RPT GNC", "DisplayText" : "Interim report of Gram-negative cocci", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "INTERIM REPORT OF GRAM-NEGATIVE COCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "Gram-negative cocci may represent meningococci, gonococci, or Moraxella."}, 
{"Row" : 17, "Column" : 1, "Text" : "If meningococci are identified, penicillin susceptibilities should be available"}, 
{"Row" : 18, "Column" : 1, "Text" : "before changing antibiotics."}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID2 GMENU INT RPT GPC IN PAIRS", "DisplayText" : "Interim report of Gram-positive cocci in pairs", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "INTERIM REPORT OF GRAM-POSITIVE COCCI IN PAIRS"}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 11, "Column" : 1, "Text" : "A preliminary report of gram-positive cocci in pairs suggests staphylococci,"}, 
{"Row" : 12, "Column" : 1, "Text" : "streptococci, or enterococci.  If the patient is severely ill, is likely"}, 
{"Row" : 13, "Column" : 1, "Text" : "colonized with resistant organisms, or if staphylococci or enterococci are"}, 
{"Row" : 14, "Column" : 1, "Text" : "likely, treat with vancomycin until susceptibility results are known."}, 
{"Row" : 15, "Column" : 1, "Text" : "Cephalosporins are not active against enterococci or methicillin-resistant"}, 
{"Row" : 16, "Column" : 1, "Text" : "staphylococcus aureus.  If streptococci are likely, treat with cefazolin."}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 33, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2005, 3: 7"}, 
{"Row" : 20, "Column" : 1, "Text" : "Recommended:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Alternative for Vancomycin Allergy:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID DAPTOMYCIN 6MG/KG IVPB Q24H", "DisplayText" : "Daptomycin 6MG/KG IVPB", "Text" :""},
{"Row" : 25, "Column" : 1, "Text" : "AND CONTACT INFECTIOUS DISEASE PHYSICIAN"}, 
{"Row" : 26, "Column" : 1, "Text" : "(Note: if pneumonia is suspected source, daptomycin CANNOT be used as"}, 
{"Row" : 27, "Column" : 1, "Text" : "monotherapy)"}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU INT RPT GPC PAIRS/CLUSTERS", "DisplayText" : "Interim report of Gram-positive cocci in pairs and clusters  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 3, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "INTERIM REPORT OF GRAM-POSITIVE COCCI IN PAIRS AND CLUSTERS"}, 
{"Row" : 10, "Column" : 1, "Text" : "This suggests STAPHYLOCOCCI.  Empirical therapy should cover methicillin-"}, 
{"Row" : 11, "Column" : 1, "Text" : "resistant Staphylococcus aureus.  If a susceptible isolate is identified, beta-"}, 
{"Row" : 12, "Column" : 1, "Text" : "lactam antimicrobials should be used as they are most effective at killing"}, 
{"Row" : 13, "Column" : 1, "Text" : "staphylococci.  When a final pathogen is identified, treatment depends on which"}, 
{"Row" : 14, "Column" : 1, "Text" : "specific bacterium is identified."}, 
{"Row" : 16, "Column" : 1, "Text" : "Empirical treatment for STAPHYLOCOCCUS", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R]", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 23, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID2 GMENU INT RPT LISTERIA, DIPHTHEROIDS, OR CORYNEBACTERIA", "DisplayText" : "INTERIM REPORT OF LISTERIA, DIPHTHEROIDS, OR CORYNEBACTERIA  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "INTERIM REPORT OF LISTERIA, DIPHTHEROIDS, OR CORYNEBACTERIA", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "SMALL PLEOMORPHIC BACILLI in AEROBIC bottle are usually diphtheroids."}, 
{"Row" : 6, "Column" : 1, "Text" : "These are usually contaminants. Rarely such organisms prove to be Listeria"}, 
{"Row" : 7, "Column" : 1, "Text" : "monocytogenes, which when present in a blood culture is likely a pathogen."}, 
{"Row" : 8, "Column" : 1, "Text" : "Listeria is more likely in patient with impaired cell-mediated immunity,"}, 
{"Row" : 9, "Column" : 1, "Text" : "pregnant women, elderly, patients on immunosuppressive theraphy for"}, 
{"Row" : 10, "Column" : 1, "Text" : "transplantation."}, 
{"Row" : 13, "Column" : 1, "Text" : "LISTERIA:", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM + GENTAMICIN 2MG/KG ONCE THEN PTD", "DisplayText" : "Ampcillin 2GM + Gentamycin 2MG/KG", "Text" : ""},
{"Row" : 15, "Column" : 1, "Text" : "-OR-"}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID PENICILLIN G 4MILLION + GENTAMICIN 2MG/KG", "DisplayText" : "Penicillin G 4 Million + Gentamicin 2MG/KG", "Text" : ""},
{"Row" : 20, "Column" : 1, "Text" : "ALTERNATIVE:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID BACTRIM 5MG/KG IVPB Q8H", "DisplayText" : "Bactrim 5MG/KG IVPB Q8H", "Text" : ""},
{"Row" : 22, "Column" : 1, "Text" : "-OR-"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID MEROPENEM 2GM IVPB Q8H", "DisplayText" : "Meropenem 2GM IVPB Q8H", "Text" :""},
{"Row" : 27, "Column" : 1, "Text" : "DIPHTHEROIDS OR COYNEBACTER (if felt to be true pathogen, not contaminant)", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 29, "Column" : 1, "Text" : "CONTACT INFECTIOUS DISEASE"}, 
{"Row" : 33, "Column" : 1, "Text" : "REFERENCES:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "UpToDate \"Antimicrobial theraphy of prosthetic valve endocarditis."}, 
{"Row" : 35, "Column" : 1, "Text" : "Updated 02/07/17"}
]},
{"Name" : "ORZID2 GMENU INT RPT PROPIONIBACTERIA", "DisplayText" : "INTERIM REPORT OF PROPIONIBACTERIA", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "INTERIM REPORT OF PROPIONIBACTERIA", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Propionibacteria are often contaminants of blood cultures, but can be"}, 
{"Row" : 6, "Column" : 1, "Text" : "pathogenic in a small percentage of cases. Pathogenic infection i s often"}, 
{"Row" : 7, "Column" : 1, "Text" : "related to indwelling foreign material (ex: prosthetic heart valve,"}, 
{"Row" : 8, "Column" : 1, "Text" : "prosthetic join) or recent trauma or surgery."}, 
{"Row" : 11, "Column" : 1, "Text" : "CNS INFECTION", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q12H", "DisplayText" : "Ceftriaxone 2GM IVPB Q12H", "Text" :""},
{"Row" : 14, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "NON-CNS INFECTION:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""},
{"Row" : 21, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 25, "Column" : 1, "Text" : "REFERENCES:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Park HJ, Na S, Park SY, et al. Clinical significance of Propionibacterium"}, 
{"Row" : 27, "Column" : 1, "Text" : "acnes recovered from blood cultures: analysis of 524 episodes."}, 
{"Row" : 28, "Column" : 1, "Text" : "J.Clin Microbiol. 2011."}, 
{"Row" : 30, "Column" : 1, "Text" : "Sanford Guide: \"Propionibacterium acnes\" accessed 3/30/17."}, 
{"Row" : 32, "Column" : 1, "Text" : "Sohail MR, Gray AL, Baddour LM, et al. Infective endocarditis due to"}, 
{"Row" : 33, "Column" : 1, "Text" : "Propionibacterium species. Clin Microbiol Infect. 2009 Apr: 15(4):387-94."}
]},
{"Name" : "ORZID2 GMENU INT SM RODS AEROBIC BOT", "DisplayText" : "Small pleomorphic rods in aerobic bottle", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 12, "Column" : 1, "Text" : "usually contaminants. Rarely such organisms prove to be Listeria monocytogenes,"}, 
{"Row" : 13, "Column" : 1, "Text" : "which when present in a blood culture is likely a pathogen.  Listeria is more"}, 
{"Row" : 14, "Column" : 1, "Text" : "likely in patients with impaired cell-mediated immunity, pregnant women,"}, 
{"Row" : 15, "Column" : 1, "Text" : "elderly, patients on immunosuppressive therapy for transplantation."}, 
{"Row" : 17, "Column" : 1, "Text" : "If there is a strong suspicion of Listeria", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IVPB Q4H", "DisplayText" : "Ampicillin 2GM IVPB Q4H", "Text" : "Ampicillin 2 gm IV q4h ($68/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "ORZ SET ABX AMPICIL 2G Q4H GENT 1.7MG/KG IV Q8H", "DisplayText" : "", "Text" : "Ampicillin 2 gm IV q4h ($68/day) [R] and gentamicin 1.7 mg/kg IV q8h", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "($3/day) [R,O]"}, 
{"Row" : 23, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX TMP/SMX IV Q12H CLINDA 600 IV Q8H", "DisplayText" : "", "Text" : "Trimethoprim 5 mg/kg - sulfamethoxazole 25 mg/kg IV q12h ($14/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "< AND > clindamycin 600mg IV q8h ($17) [H,O]"}, 
{"Row" : 27, "Column" : 1, "Text" : "If therapy is indicated and Listeria is not suspected", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID PENICILLIN G 3 MILLION UNITS IV Q4H", "DisplayText" : "Penicillin G 3 million units IV Q4H", "Text" : "Penicillin 3 million units IV q4h ($2.16/day) [R]", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600mg IV q8h ($17/day) [H,O]", "Mnemonic" : "18"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 9, "Column" : 1, "Text" : "SMALL PLEOMORPHIC BACILLI IN AEROBIC BOTTLE"}, 
{"Row" : 11, "Column" : 1, "Text" : "SMALL PLEOMORPHIC BACILLI in AEROBIC bottle are usually diphtheroids.  These are"}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" keyword: Antimicrobial Therapy"}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Mandell\" chapter:  Principles and Practice of Infectious Diseases"}, 
{"Row" : 38, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 39, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID2 GMENU INTRAVAS CATH CANDIDA SPP", "DisplayText" : "Intravascular catheter-associated Candida Spp. infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "INTRAVASCULAR CATHETER-ASSOCIATED CANDIDA SPP. INFECTION"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Remove catheter and treat for 14 days AFTER the date of the last positive blood"}, 
{"Row" : 13, "Column" : 1, "Text" : "culture.  Treat intravenously until the patient's condition is stable and blood"}, 
{"Row" : 14, "Column" : 1, "Text" : "cultures are negative for Candida.  Finish the 14 day course with oral"}, 
{"Row" : 15, "Column" : 1, "Text" : "fluconazole."}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID AMPHOTERICIN 0.8 MG/KG IV Q24H", "DisplayText" : "Amphotericin 0.8 mg/kg iv q24h", "Text" : "Amphotericin 0.5-0.8 mg/kg IV q24h ($23/day) [R,O] < OR >", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID ORZ FLUCONAZOLE 400MG IV Q24H", "DisplayText" : "Fluconazole 400MG IV Q24H", "Text" : "Fluconazole 400 mg IV q24h ($13.36/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 400 mg PO q24h ($0.40) [R,DI]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Text" : "Mermel LA Clin Infect Dis 2001, 32: 1249"}, 
{"Row" : 25, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU INTRAVAS CATH GNB", "DisplayText" : "Intravascular catheter-associated Gram-negative Bacilli infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "INTRAVASCULAR CATHETER-ASSOCIATED GRAM-NEGATIVE BACILLI INFECTION"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treat for 10 to 14 days."}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($33/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID GENTAMICIN 5 MG/KG IV Q24H", "DisplayText" : "Gentamicin 5 mg/kg IV Q24H", "Text" : "Gentamicin 5mg/kg IV q24h ($3/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 22, "Column" : 1, "Text" : "Mermel LA Clin Infect Dis 2001, 32: 1249"}, 
{"Row" : 23, "Column" : 1, "Text" : "Up-to-date"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment if the catheter is REMOVED (preferred)", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment if catheter REMOVAL IS NOT POSSIBLE (less desirable)", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "16"}
]},
{"Name" : "ORZID2 GMENU LYME ACUTE NEURO DISEASE", "DisplayText" : "Acute neurological disease associated with Lyme disease", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ACUTE NEUROLOGICAL DISEASE ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treat isolated facial palsy (Bell palsy) with oral antimicrobials.  Treat more"}, 
{"Row" : 12, "Column" : 1, "Text" : "extensive neurological disease with intravenous antimicrobials."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment of ISOLATED FACIAL PARESTHESIA (Bell's palsy)", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h  ($0.16/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSJZID AMOXCILLIN 500MG PO Q8H 3 DAYS", "DisplayText" : "Amoxcillin 500MG PO Q8H", "Text" : "Amoxicillin 500 mg PO q8h ($0.42/day) [R]", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "Treatment of neurological disease other than Bell's palsy", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Treat for 14 to 28 days."}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJI CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) [M]", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 27, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU LYME ARTHRITIS", "DisplayText" : "Arthritis associated with Lyme disease  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Text" : "ARTHRITIS ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Most cases respond to a 28 day course of oral antimicrobials.  If symptoms"}, 
{"Row" : 13, "Column" : 1, "Text" : "persist or recur, consult Infectious Diseases or Rheumatology."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h  ($0.16/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSJZID AMOXCILLIN 500MG PO Q8H 3 DAYS", "DisplayText" : "Amoxcillin 500MG PO Q8H", "Text" : "Amoxicillin 500 mg PO q8h ($0.42/day) [R]", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY INP", "DisplayText" : "RHEUMATOLOGY INP", "Text" : "Consult Rheumatology", "Mnemonic" : "09"},
{"Row" : 22, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 23, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU LYME CARDIAC DISEASE", "DisplayText" : "Cardiac disease associated with Lyme disease  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Text" : "CARDIAC DISEASE ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treat for 14 to 21 days.  Cardiology consult recommended."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment of FIRST DEGREE or SECOND DEGREE heart block", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h  ($0.16/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Item" : "PSJZID AMOXCILLIN 500MG PO Q8H 3 DAYS", "DisplayText" : "Amoxcillin 500MG PO Q8H", "Text" : "Amoxicillin 500 mg PO q8h ($0.42) [R]", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "Treatment of THIRD DEGREE heart block or other manifestation", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJI CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 2 gm IV q24h ($34/day) [M]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT CARDIOLOGY INP", "DisplayText" : "Cardiology INP", "Text" : "Consult Cardiology", "Mnemonic" : "09"},
{"Row" : 24, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 25, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU LYME DISEASE", "DisplayText" : "Lyme disease ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "LYME DISEASE"}, 
{"Row" : 8, "Column" : 1, "Text" : "Lyme disease results from the transmission of Borrelia burgdorferi from an"}, 
{"Row" : 9, "Column" : 1, "Text" : "Ixodes spp. tick bite.  Patients who display signs of illness or fever within 30"}, 
{"Row" : 10, "Column" : 1, "Text" : "days of removing an attached tick should be evaluated for tick-borne illness."}, 
{"Row" : 11, "Column" : 1, "Text" : "In the upper Midwest these are Lyme disease, human anaplasmosis (formerly"}, 
{"Row" : 12, "Column" : 1, "Text" : "granulocytic ehrlichiosis, HGE), and babesiosis.  Patients who have been bitten"}, 
{"Row" : 13, "Column" : 1, "Text" : "by an Ixodes spp. tick (\"deer tick\") but who do not display signs or symptoms of"}, 
{"Row" : 14, "Column" : 1, "Text" : "infection should not be treated with antimicrobials unless they have been"}, 
{"Row" : 16, "Column" : 1, "Text" : "In the U.S., these areas exist only in small foci in the mid-Atlantic states."}, 
{"Row" : 17, "Column" : 1, "Text" : "Preventive antimicrobial treatment may be beneficial in certain patients who"}, 
{"Row" : 18, "Column" : 1, "Text" : "have been bitten while in endemic areas.  Contact Infectious Diseases for more"}, 
{"Row" : 19, "Column" : 1, "Text" : "information."}, 
{"Row" : 21, "Column" : 1, "Text" : "Except for erythema migrans, Lyme disease is a complicated, difficult disease to"}, 
{"Row" : 22, "Column" : 1, "Text" : "diagnose and treat.  Infectious Diseases consultation is strongly encouraged."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU LYME ERYTHEMA MIGRANS", "DisplayText" : "Erythema migrans associated with Lyme disease", "Text" : "Erythema migrans associated with Lyme disease", "Mnemonic" : "06"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU LYME ACUTE NEURO DISEASE", "DisplayText" : "Acute neurological disease associated with Lyme disease", "Text" : "Acute neurological disease associated with Lyme disease", "Mnemonic" : "08"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU LYME ARTHRITIS", "DisplayText" : "Arthritis associated with Lyme disease", "Text" : "Arthritis associated with Lyme disease", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU LYME CARDIAC DISEASE", "DisplayText" : "Cardiac disease associated with Lyme disease", "Text" : "Cardiac disease associated with Lyme disease", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Text" : "exposed in an area with an extremely high risk of Lyme disease from tick bites."}
]},
{"Name" : "ORZID2 GMENU LYME ERYTHEMA MIGRANS", "DisplayText" : "Erythema migrans associated with Lyme disease ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ERYTHEMA MIGRANS ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Erythema migrans is the first manifestation of Lyme disease in half of cases."}, 
{"Row" : 12, "Column" : 1, "Text" : "It is typically an erythematous circular rash with induration and central"}, 
{"Row" : 13, "Column" : 1, "Text" : "clearing (although other patterns occur) and it usually develops at the site of"}, 
{"Row" : 14, "Column" : 1, "Text" : "the bite and/or in one or more distant locations.  The rash occurs 3 to 30 days"}, 
{"Row" : 15, "Column" : 1, "Text" : "after the bite.  Rashes with onset less than 3 days after a tick bite are not"}, 
{"Row" : 16, "Column" : 1, "Text" : "from Lyme disease."}, 
{"Row" : 18, "Column" : 1, "Text" : "A recent study showed that a 10 day course of antimicrobials is as effective as"}, 
{"Row" : 19, "Column" : 1, "Text" : "a 21 day course in treating erythema migrans."}, 
{"Row" : 21, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h  ($0.16/day) [DI]  < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID AMOXCILLIN 500MG PO Q8H 3 DAYS", "DisplayText" : "Amoxcillin 500MG PO Q8H", "Text" : "Amoxicillin 500 mg PO q8h ($0.42/days) [R]", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 30, "Column" : 1, "Text" : "\"Sanford\" keyword: Lyme disease"}, 
{"Row" : 31, "Column" : 1, "Text" : "Wormser GP Ann Intern Med 2003, 138: 697"}, 
{"Row" : 32, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU M. AVIUM INTRACELLULARE", "DisplayText" : "Mycobacterium avium intracellulare complex (a.k.a MAI or MAC)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MYCOBACTERIUM AVIUM INTRACELLULARE (MAI OR MAC)"}, 
{"Row" : 9, "Column" : 1, "Text" : "Most isolates at the Minneapolis VAMC represent colonization in patients with"}, 
{"Row" : 10, "Column" : 1, "Text" : "chronic lung disease.  These patients should not be treated with antimicrobials."}, 
{"Row" : 12, "Column" : 1, "Text" : "Occassionally, MAI causes pulmonary disease in patients who are not"}, 
{"Row" : 13, "Column" : 1, "Text" : "immunosuppressed.  Diagnosis and management are complex.  Consult Infectious"}, 
{"Row" : 14, "Column" : 1, "Text" : "Diseases and/or Pulmonary."}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU M. AVIUM PNEUMONIA", "DisplayText" : "Mycobacterium avium pneumonia", "Text" : "Treatment for pneumonia", "Mnemonic" : "08"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU PROPHYLAXIS M. AVIUM", "DisplayText" : "Prophylaxis against Mycobacterium avium disease...", "Text" : "Prophylaxis for Mycobacterium avium", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Text" : "MAI causes systemic disease commonly in patients with HIV/AIDS.  Most of these"}, 
{"Row" : 17, "Column" : 1, "Text" : "cases do not involve the lungs.  After treatment, long-term prophylaxis is"}, 
{"Row" : 18, "Column" : 1, "Text" : "usually given.  Consult Infectious Diseases in all cases."}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU DISSEMINATED M. AVIUM", "DisplayText" : "Disseminated Mycobacterium avium disease treatment", "Text" : "Treatment for disseminated disease", "Mnemonic" : "10"}
]},
{"Name" : "ORZID2 GMENU M. AVIUM PNEUMONIA", "DisplayText" : "Mycobacterium avium pneumonia  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary Consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Three-drug regimens", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ SET ABX CLARITHROMYCIN, ETHAMBUTOL, RIFABUTIN", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO q12h($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg PO", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZ SET ABX AZITH 250, ETHAMBUTOL, RIFABUTIN 300", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO Q24h ($4/day) M <AND> ethambutol 15 mg/kg PO Q24h [R]", "Mnemonic" : "18"},
{"Row" : 28, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Four-drug regimens", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZ SET ABX CLARITH, ETHAMBUTOL, RIFABUTIN, STREPTOM", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO q12h  ($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg", "Mnemonic" : "20"},
{"Row" : 38, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Item" : "ORZ SET ABX AZITHRO 250, ETHAMBUTOL, RIFABUTIN, STREPTO", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO Q24h ($4/day) [M] <AND> ethambutol 15 mg/kg PO Q24h [R]", "Mnemonic" : "22"},
{"Row" : 44, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 10, "Column" : 1, "Text" : "MYCOBACTERIUM AVIUM PNEUMONIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Diagnosis and treatment are complex. Regimens containing 3 or 4 drugs are"}, 
{"Row" : 13, "Column" : 1, "Text" : "usually recommended, but two drug regimens may be sufficient in some cases."}, 
{"Row" : 14, "Column" : 1, "Text" : "Consult Infectious Diseases and/or Pulmonary in all cases."}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Sanford\" keyword: MAC"}, 
{"Row" : 47, "Column" : 1, "Text" : "\"Mandell\" chapter: Mycobacterium avium Complex"}, 
{"Row" : 22, "Column" : 1, "Text" : "q24h ($2.52/day) [R] <AND> rifabutin 300 mg PO q24h ($4.18/day) [R,DI]"}, 
{"Row" : 26, "Column" : 1, "Text" : "<AND> rifabutin 300 mg q24h ($4.18/day) [R,DI]"}, 
{"Row" : 34, "Column" : 1, "Text" : "PO q24h ($2.52/day) [R] <AND> rifabutin 300 mg PO q24h ($4.18/day) [R,DI]"}, 
{"Row" : 35, "Column" : 1, "Text" : "<AND> streptomycin 15 mg/kg (no more than 1 gm/day) IM 3 times/week ($3/day)"}, 
{"Row" : 36, "Column" : 1, "Text" : "[R,O]"}, 
{"Row" : 41, "Column" : 1, "Text" : "(no more than 1 gm/day) IM 3 times/week ($3/day) [R,O]"}, 
{"Row" : 40, "Column" : 1, "Text" : "[R] <AND> rifabutin 300 mg q24h ($4.18/day) [R,DI] <AND> streptomycin 15 mg/kg"}
]},
{"Name" : "ORZID2 GMENU M. PNEUMONIAE", "DisplayText" : "Mycoplasma pneumoniae ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "MYCOPLASMA PNEUMONIAE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 7 DAYS", "Text" : "Doxycycline 100 mg PO q12h ($0.16/day) [DI]  < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H 4DAYS", "DisplayText" : "Azithromycin 500MG PO ONCE, then 250MG Q24H X 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO Q24h ($4/day) for", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "4 days [M]"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Text" : "\"Sanford\" keyword: Mycoplasma pneumoniae"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500mg PO Q24H ($0.19/Day)[R,DI]", "Text" : "", "Mnemonic" : "14"}
]},
{"Name" : "ORZID2 GMENU M. TUBERCULOSIS", "DisplayText" : "Mycobacterium tuberculosis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MYCOBACTERIUM TUBERCULOSIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Management of tuberculosis is complex.  Contact Infectious Diseases and/or"}, 
{"Row" : 10, "Column" : 1, "Text" : "Pulmonary service for more information."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU NECROT INFECT DIRECT THERAPY", "DisplayText" : "Pathogen-directed therapy of necrotizing infections ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "NECROTIZING INFECTIONS--PATHOGEN-DIRECTED THERAPY"}, 
{"Row" : 11, "Column" : 1, "Text" : "________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "________________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Clostridial infections", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 900MG IV Q8H", "DisplayText" : "Clindamycin 900MG IV Q8H", "Text" : "Clindamycin 900 mg IV q8h ($25/day) [H,O]", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "_______________________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "_______________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Group A Streptococcal infections (S. pyogenes)", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 900MG IV Q8H", "DisplayText" : "Clindamycin 900MG IV Q8H", "Text" : "Clindamycin 900 mg IV q8h ($25/day) [H,O]  < OR >", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R]", "Mnemonic" : "18"},
{"Row" : 33, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Polymicrobial infections", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "These are more common in injection drug users, or in patients who have had"}, 
{"Row" : 38, "Column" : 1, "Text" : "recent abdominal surgery or trauma, vulvo-vaginal infection, or genital or"}, 
{"Row" : 39, "Column" : 1, "Text" : "rectal abscess."}, 
{"Row" : 41, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Item" : "ORZ SET ABX PIP/TAZO 3.375 CLINDA 900 VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($33/day) [R] <AND> clindamycin 900", "Mnemonic" : "20"},
{"Row" : 44, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 45, "Column" : 1, "Item" : "ORZ SET ABX CEFT CLINDA 900MG IV Q8H VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] <AND> clindamycin 900 mg IV q8h", "Mnemonic" : "22"},
{"Row" : 48, "Column" : 1, "Item" : "ORZ SET ABX ERTAPENEM 1GM IV Q24H VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ertapenem 1 gm IV Q24h ($28/day) [R] <AND> vancomycin 15 mg/kg", "Mnemonic" : "24"},
{"Row" : 51, "Column" : 1, "Text" : "Alternatives for penicillin allergy", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Item" : "ORZ SET ABX CIPRO 400 CLINDA 900 VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> clindamycin 900 mg IV", "Mnemonic" : "26"},
{"Row" : 55, "Column" : 1, "Item" : "ORZ SET ABX GENT 5MG/KG CLINDA 900 VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O] <AND> clindamycin 900 mg IV q8h", "Mnemonic" : "28"},
{"Row" : 59, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "30"},
{"Row" : 61, "Column" : 1, "Text" : "Weinstein L New Eng J Med 1973, 289: 1129"}, 
{"Row" : 66, "Column" : 1, "Text" : "Stevens DL Clin Infect Dis 2005, 41: 1373"}, 
{"Row" : 62, "Column" : 1, "Text" : "\"Sanford\" keyword: Gas gangrene"}, 
{"Row" : 63, "Column" : 1, "Text" : "Johns Hopkins"}, 
{"Row" : 64, "Column" : 1, "Text" : "Up-to-Date"}, 
{"Row" : 65, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 16, "Column" : 1, "Item" : "ZZORZ SET ABX PENICI 4MU IV Q4H CLINDA 900MG IV Q8H", "DisplayText" : "", "Text" : "Penicillin 4 million units IV q4h ($2.16/day) [R] <AND> clindamycin 900 mg", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Text" : "IV q8h ($25/day) [H,O]"}, 
{"Row" : 26, "Column" : 1, "Item" : "ZZORZ SET ABX PENICI 4MU IV Q4H CLINDA 900MG IV Q8H", "DisplayText" : "", "Text" : "Penicillin 4 million units IV q4h ($2.16/day) [R] <AND> clindamycin 900 mg", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "IV q8h ($25/day) [H,O]"}, 
{"Row" : 43, "Column" : 1, "Text" : "mg IV q8h ($25/day) [H,O] <AND> vancomycin 15mg/kg IV q12h ($6/day) [R]"}, 
{"Row" : 46, "Column" : 1, "Text" : "($25/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R]  < OR >"}, 
{"Row" : 49, "Column" : 1, "Text" : "IV q12h ($6/day) [R]"}, 
{"Row" : 53, "Column" : 1, "Text" : "q8h ($25/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R] < OR >"}, 
{"Row" : 56, "Column" : 1, "Text" : "($25/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R]"}
]},
{"Name" : "ORZID2 GMENU NECROT INFECT EMP THERAPY", "DisplayText" : "Empirical therapy for Necrotizing infections  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "EMPIRICAL THERAPY FOR NECROTIZING INFECTIONS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Empirical antimicrobials", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZ SET ABX PIP/TAZO 3.375 CLINDA 900 VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($33/day) [R] <AND> clindamycin 900", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZ SET ABX CEFT CLINDA 900MG IV Q8H VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] <AND> clindamycin 900 mg IV q8h", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX ERTAPENEM 1GM IV Q24H VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ertapenem 1 gm IV Q24h ($28/day) [R] <AND> vancomycin 15 mg/kg IV q12h ($6/day)", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Text" : "[R]"}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternatives for penicillin allergy", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZ SET ABX CIPRO 400 CLINDA 900 VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> clindamycin 900 mg IV", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Item" : "ORZ SET ABX GENT 5MG/KG CLINDA 900 VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Gentamicin 5 mg/kg IV q24h ($3/day) [R,O] <AND> clindamycin 900 mg IV q8h", "Mnemonic" : "18"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 31, "Column" : 1, "Text" : "Weinstein L New Eng J Med 1973, 289: 1129"}, 
{"Row" : 36, "Column" : 1, "Text" : "Stevens DL Clin Infect Dis 2005, 41: 1373"}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" keyword: Gas gangrene"}, 
{"Row" : 33, "Column" : 1, "Text" : "Johns Hopkins website"}, 
{"Row" : 34, "Column" : 1, "Text" : "Up-to-Date website: Gas gangrene"}, 
{"Row" : 35, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 13, "Column" : 1, "Text" : "mg IV q8h ($25/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R]"}, 
{"Row" : 16, "Column" : 1, "Text" : "($6.50/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R] < OR >"}, 
{"Row" : 23, "Column" : 1, "Text" : "q8h ($6.50/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R]  < OR >"}, 
{"Row" : 26, "Column" : 1, "Text" : "($6.50/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R]"}
]},
{"Name" : "ORZID2 GMENU NECROTIZING INFECTIONS", "DisplayText" : "Necrotizing infections", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURG INP", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "NECROTIZING INFECTIONS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Call Surgery immediately and consult Infectious Diseases in all cases."}, 
{"Row" : 11, "Column" : 1, "Text" : "Necrotizing infections involve tissues skin and/or deeper structures, including"}, 
{"Row" : 12, "Column" : 1, "Text" : "fascia and muscle.  These infections destroy tissue, often rapidly, and are"}, 
{"Row" : 13, "Column" : 1, "Text" : "often fatal if not treated promptly and appropriately.  Necrotizing infections"}, 
{"Row" : 14, "Column" : 1, "Text" : "usually result from trauma, surgery, and/or ischemia.  These infections can be"}, 
{"Row" : 15, "Column" : 1, "Text" : "monomicrobial (e.g., with streptococci or clostridia) or polymicrobial (usually"}, 
{"Row" : 16, "Column" : 1, "Text" : "with a mixture of aerobes and anaerobes).  Fournier gangrene is usually"}, 
{"Row" : 17, "Column" : 1, "Text" : "associated with mixed infection.  Myonecrosis is most commonly associated with"}, 
{"Row" : 18, "Column" : 1, "Text" : "Clostridium species."}, 
{"Row" : 20, "Column" : 1, "Text" : "Necrotizing infections differ from cellulitis in several ways.  Necrotic"}, 
{"Row" : 21, "Column" : 1, "Text" : "infections typically have one or more of the following: (1) severe, constant"}, 
{"Row" : 22, "Column" : 1, "Text" : "pain, (2) bullae, (3) bruising or necrosis of overlying skin, (4) gas in tissues"}, 
{"Row" : 23, "Column" : 1, "Text" : "which can be felt or seen on images, (5) edema that extends beyond areas of"}, 
{"Row" : 24, "Column" : 1, "Text" : "erythema, (6) local anesthesia, and (7) signs of systemic toxicity, such as"}, 
{"Row" : 25, "Column" : 1, "Text" : "fever, leukocytosis, delirium, or renal failure."}, 
{"Row" : 27, "Column" : 1, "Text" : "Necrotizing infections must be treated with both antimicrobial therapy and"}, 
{"Row" : 28, "Column" : 1, "Text" : "surgical procedures (excision and/or drainage).  Call surgery to see the patient"}, 
{"Row" : 29, "Column" : 1, "Text" : "immediately in all cases.  Obtain tissue and blood cultures and begin empirical"}, 
{"Row" : 30, "Column" : 1, "Text" : "antimicrobials.  For several necrotic diseases and/or pathogens, a combination"}, 
{"Row" : 31, "Column" : 1, "Text" : "of two antimicrobials is recommended including a bactericidal antimicrobial"}, 
{"Row" : 32, "Column" : 1, "Text" : "active at the cell wall or membrane (e.g., beta-lactam or glycopeptide) and an"}, 
{"Row" : 33, "Column" : 1, "Text" : "antimicrobial that rapidly inhibits protein synthesis and thus inhibits toxin"}, 
{"Row" : 34, "Column" : 1, "Text" : "production, typically clindamycin."}, 
{"Row" : 39, "Column" : 1, "Text" : "Pathogen-directed treatment regimens", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU NECROT INFECT DIRECT THERAPY", "DisplayText" : "Pathogen-directed therapy of necrotizing infections", "Text" : "Pathogen-directed therapy of necrotizing infections", "Mnemonic" : "10"}, 
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 36, "Column" : 1, "Text" : "Empirical antimicrobials", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU NECROT INFECT EMP THERAPY", "DisplayText" : "Empirical therapy for Necrotizing infections", "Text" : "Empirical therapy of necrotizing infections", "Mnemonic" : "08"},
{"Row" : 45, "Column" : 1, "Text" : "Weinstein L New Eng J Med 1973, 289: 1129"}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Sanford\" keyword: Gas gangrene"}, 
{"Row" : 47, "Column" : 1, "Text" : "Johns Hopkins website: Gas gangrene"}, 
{"Row" : 48, "Column" : 1, "Text" : "Up-to-Date website: Gas gangrene"}, 
{"Row" : 49, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 50, "Column" : 1, "Text" : "Stevens DL Clin Infect Dis 2005, 41: 1373"}
]},
{"Name" : "ORZID2 GMENU NEUT FEVER CAND NOT ORAL THERA", "DisplayText" : "Neutropenic fever--Patient is NOT a candidate for oral therapy  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "NEUTROPENIC FEVER--PATIENT IS NOT A CANDIDATE FOR ORAL THERAPY"}, 
{"Row" : 8, "Column" : 1, "Text" : "Vancomycin is ONLY INDICATED in patients at high risk of serious Gram-positive"}, 
{"Row" : 9, "Column" : 1, "Text" : "infection, namely those with:"}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU EMP INTRAV W/O VANCO", "DisplayText" : "Empirical intravenous regimens WITHOUT vancomycin", "Text" : "Empirical intravenous regimens WITHOUT vancomycin", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU EMP INTRAV W/ VANCO", "DisplayText" : "Empirical intravenous regimens WITH vancomycin", "Text" : "Empirical intravenous regimens WITH vancomycin", "Mnemonic" : "08"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 26, "Column" : 1, "Text" : "Hughes WT Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 27, "Column" : 1, "Text" : "Rolston KVI Clin Infect Dis 2004, 39: S44"}, 
{"Row" : 28, "Column" : 1, "Text" : "Sipsas NV  Cancer 2005, 103: 1103"}, 
{"Row" : 11, "Column" : 1, "Text" : ">>Catheter-related infection"}, 
{"Row" : 12, "Column" : 1, "Text" : ">>Blood cultures positive for Gram-positive bacteria prior to final"}, 
{"Row" : 13, "Column" : 1, "Text" : "identification & susceptibility testing"}, 
{"Row" : 14, "Column" : 1, "Text" : ">>Known colonization with penicillin/cephalosporin-resistant pneumococci"}, 
{"Row" : 15, "Column" : 1, "Text" : "or methicillin-resistant Staphylococcus aureus"}, 
{"Row" : 16, "Column" : 1, "Text" : ">>Hypotension or septic shock without an identified pathogen, or"}, 
{"Row" : 17, "Column" : 1, "Text" : ">>Soft tissue infection"}
]},
{"Name" : "ORZID2 GMENU NEUT FEVER CAND ORAL THERA", "DisplayText" : "Neutropenic fever--Patient is a candidate for oral therapy", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Hematology-Oncology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "NEUTROPENIC FEVER--PATIENT IS A CANDIDATE FOR ORAL THERAPY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Can the patient be treated with oral therapy?", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER SCORING TOOL", "DisplayText" : "Scoring tool to identify low risk febrile neutropenic patients", "Text" : "Link to a scoring tool that identifies low risk patients for oral therapy", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID CIPRO 500MG PO BID & AMOX/CLAV 875/125MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO Q12H & Amox/Clav 875/125MG PO BID", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "Beta Lactam Allergy", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : ""},
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "NCCN Guidelines Version 1.2013. Prevention and Treatment of Cancer-Related"}, 
{"Row" : 25, "Column" : 1, "Text" : "Infections."}
]},
{"Name" : "ORZID2 GMENU NEUT FEVER MOD THERAPY", "DisplayText" : "Modification to Neutropenic fever therapy  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Hematology-Oncology consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MODIFICATION TO NEUTROPENIC FEVER THERAPY"}, 
{"Row" : 9, "Column" : 1, "Text" : "Determine efficacy of the initial regimen during the first 3 to 5 days."}, 
{"Row" : 10, "Column" : 1, "Text" : "Decisions about therapy should be made based on (1) whether an infectious"}, 
{"Row" : 11, "Column" : 1, "Text" : "disease has been diagnosed (e.g., pneumonia or cellulitis), (2) whether the"}, 
{"Row" : 12, "Column" : 1, "Text" : "fever has resolved, and (3) the clinical course."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER PT BECOME AFEBRILE", "DisplayText" : "Patients who BECOME AFEBRILE in the first 3 to 5 days of treatment", "Text" : "Patients who BECOME AFEBRILE in the first 3 to 5 days of treatment", "Mnemonic" : "08"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER PT FEVER PERSISTS", "DisplayText" : "Patients whose FEVER PERSISTS throughout the first 3 to 5 days of treatment", "Text" : "Patients whose FEVER PERSISTS throughout the first 3 to 5 days of treatment", "Mnemonic" : "10"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Text" : "If a specific infectious disease and/or pathogen is identified, ensure that the"}, 
{"Row" : 15, "Column" : 1, "Text" : "antimicrobial regimen is adequate to treat that pathogen or disease, and"}, 
{"Row" : 16, "Column" : 1, "Text" : "continue broad-spectrum antimicrobial therapy."}, 
{"Row" : 25, "Column" : 1, "Text" : "Hughes WT Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 26, "Column" : 1, "Text" : "Rolston KVI Clin Infect Dis 2004, 39: S44"}, 
{"Row" : 27, "Column" : 1, "Text" : "Sipsas NV  Cancer 2005, 103: 1103"}
]},
{"Name" : "ORZID2 GMENU NEUT FEVER PT BECOME AFEBRILE", "DisplayText" : "Patients who BECOME AFEBRILE in the first 3 to 5 days of treatment ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Hematology-Oncology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PATIENTS WITH NEUTROPENIC FEVER WHO BECOME AFEBRILE IN THE FIRST 3 TO 5 DAYS OF"}, 
{"Row" : 11, "Column" : 1, "Text" : "TREATMENT"}, 
{"Row" : 13, "Column" : 1, "Text" : ">>  Treatment if an INFECTIOUS CAUSE WAS IDENTIFIED and has resolved", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "(The infectious disease associated with the fever has resolved, the pathogen has"}, 
{"Row" : 15, "Column" : 1, "Text" : "been controlled or eradicated, and the patient seems well)"}, 
{"Row" : 16, "Column" : 1, "Text" : "Stop antimicrobials after treatment for pathogen/disease is completed, often"}, 
{"Row" : 17, "Column" : 1, "Text" : "after 7 days."}, 
{"Row" : 19, "Column" : 1, "Text" : ">>  Treatment if infectious cause of fever WAS NOT identified", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "To determine a patients risk level refer to"}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER SCORING TOOL", "DisplayText" : "Scoring tool to identify low risk febrile neutropenic patients", "Text" : "\"Scoring tool to identify low risk febrile neutropenic patients\"", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "Treatment for \"low risk\" patients", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Consider a change to oral therapy"}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID CIPRO 500MG PO BID & AMOX/CLAV 875/125MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO Q12H & Amox/Clav 875/125MG PO BID", "Text" : ""},
{"Row" : 27, "Column" : 1, "Text" : "Treatment for \"high risk\" patients", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Continue same antimicrobials for 7 days"}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "Hughes WT Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 34, "Column" : 1, "Text" : "Rolston KVI Clin Infect Dis 2004, 39: S44"}, 
{"Row" : 35, "Column" : 1, "Text" : "Sipsas NV  Cancer 2005, 103: 1103"}
]},
{"Name" : "ORZID2 GMENU NEUT FEVER PT FEVER PERSISTS", "DisplayText" : "Patients whose FEVER PERSISTS throughout the first 3 to 5 days of treatment ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Hematology-Oncology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PATIENTS WITH NEUTROPENIC FEVER WHOSE FEVER PERSISTS THROUGHOUT THE FIRST 3 TO 5"}, 
{"Row" : 11, "Column" : 1, "Text" : "DAYS OF TREATMENT"}, 
{"Row" : 13, "Column" : 1, "Text" : "If no infectious disease has been diagnosed but the patient is clinically"}, 
{"Row" : 14, "Column" : 1, "Text" : "stable, continue the current regimen.  If vancomycin was part of initial therapy"}, 
{"Row" : 15, "Column" : 1, "Text" : "but culture results have not yielded a pathogen that must be treated with"}, 
{"Row" : 16, "Column" : 1, "Text" : "vancomycin, discontinue it to minimize development of resistance."}, 
{"Row" : 19, "Column" : 1, "Text" : "CONSULT INFECTIOUS DISEASE", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU NEUT FEVER SCORING TOOL", "DisplayText" : "Scoring tool to identify low risk febrile neutropenic patients  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Hematology-Oncology consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "SCORING TOOL TO IDENTIFY LOW RISK FEBRILE NEUTROPENIC PATIENTS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Patients with minimal risk of severe or rapidly progressive infection can be"}, 
{"Row" : 10, "Column" : 1, "Text" : "treated with oral antimicrobials safely.  Many can be treated as outpatients."}, 
{"Row" : 11, "Column" : 1, "Text" : "Use the scoring index to identify febrile neutropenic patients who at"}, 
{"Row" : 12, "Column" : 1, "Text" : "sufficiently low risk for severe infections and can be treated with outpatient"}, 
{"Row" : 13, "Column" : 1, "Text" : "oral antimicrobials."}, 
{"Row" : 15, "Column" : 1, "Text" : "SCORING INDEX", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Severity of symptoms of illness (choose one only)"}, 
{"Row" : 21, "Column" : 1, "Text" : "No hypotension  5"}, 
{"Row" : 24, "Column" : 1, "Text" : "No dehydration  3"}, 
{"Row" : 25, "Column" : 1, "Text" : "Outpatient status at onset of fever3"}, 
{"Row" : 26, "Column" : 1, "Text" : "Age less than 60 years2"}, 
{"Row" : 22, "Column" : 1, "Text" : "No chronic obstructive pulmonary disease4"}, 
{"Row" : 20, "Column" : 1, "Text" : "Moderate symptoms  3"}, 
{"Row" : 19, "Column" : 1, "Text" : "No symptoms or mild symptoms5"}, 
{"Row" : 17, "Column" : 1, "Text" : "CharacteristicScore", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Sum total __"}, 
{"Row" : 30, "Column" : 1, "Text" : "Interpretation", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "The highest possible score is 26. A risk index score of 21 or greater indicates"}, 
{"Row" : 32, "Column" : 1, "Text" : "that the patient is likely to be at LOW RISK for complications and morbidity."}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 33, "Column" : 1, "Text" : "This is a guide.  Always use clinical judgement."}, 
{"Row" : 23, "Column" : 1, "Text" : "Solid tumor or no previous fungal infection4"}, 
{"Row" : 38, "Column" : 1, "Text" : "Klastersky J, et al. J Clin Oncol 2000:18(16):3038-51"}
]},
{"Name" : "ORZID2 GMENU OSTEOM EMPIRICAL THERAPY", "DisplayText" : "Empirical therapy for Osteomyelitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Orthopedic consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ADD MENU NEUROSURGERY CONSULT", "DisplayText" : "Neurosurgery Consult", "Text" : "Neurosurgery consult", "Mnemonic" : "12"},
{"Row" : 9, "Column" : 1, "Item" : "GMRCT PODIATRY INP", "DisplayText" : "PODIATRY INP", "Text" : "Podiatry consult", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "EMPIRICAL THERAPY FOR OSTEOMYELITIS"}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZ SET ABX TICAR-CLAV 3.1GM IV Q6H VANCO 1GM IV Q12H", "DisplayText" : "Ticarcillin-clavulanate 3.1gm iv q6h Vanco 1gm iv q12h", "Text" : "Ticarcillin-clavulanate 3.1 gm IV q6h ($42/day) [R] <AND> vancomycin", "Mnemonic" : "24"},
{"Row" : 31, "Column" : 1, "Item" : "ORZ SET ABX CEFT 1GM IV Q24H VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M] <AND> vancomycin 15 mg/kg IV q12h", "Mnemonic" : "26"},
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX CIPRO 400MG IV Q12H VANCO 1GM IV Q12H", "DisplayText" : "CIPRO 400MG IV Q12H VANCO 1GM IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> vancomycin", "Mnemonic" : "28"}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "30"},
{"Row" : 40, "Column" : 1, "Text" : "\"Sanford\": key term: Osteomyelitis"}, 
{"Row" : 41, "Column" : 1, "Text" : "\"Mandell\" Chapter: Osteomyelitis"}, 
{"Row" : 42, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 43, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 44, "Column" : 1, "Text" : "Johns Hopkins website"}, 
{"Row" : 14, "Column" : 1, "Text" : "Therapy should be modified when culture results and patient response to therapy"}, 
{"Row" : 15, "Column" : 1, "Text" : "are known.  If cultures cannot be obtained, the oral regimens listed below can"}, 
{"Row" : 16, "Column" : 1, "Text" : "be used for empirical therapy or to complete a treatment course after the"}, 
{"Row" : 17, "Column" : 1, "Text" : "patient's disease has improved.Consult Infectious Diseases for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "ORAL treatment for MILD to MODERATE disease or for completion of treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "course", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJZID SULFAMETHOXAZOLE/TRIMETHOPRIM DS 1 TAB PO Q12H", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS 1 TAB PO Q12H", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($3.36/day) [R,DI] < OR >", "Mnemonic" : "18"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 500MG PO Q6H 7 DAYS", "DisplayText" : "Cephalexin 500MG PO Q6H", "Text" : "Cephalexin 500 mg PO q6h ($0.36/day) [R] < OR >", "Mnemonic" : "20"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500mg PO Q24H ($0.19/Day)[R,DI]", "Text" : "", "Mnemonic" : "22"},
{"Row" : 27, "Column" : 1, "Text" : "INTRAVENOUS treatment for MODERATE to SEVERE disease", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "15 mg/kg IV q12h ($6/day) [R] < OR >"}, 
{"Row" : 32, "Column" : 1, "Text" : "($6/day) [R]  < OR >"}, 
{"Row" : 35, "Column" : 1, "Text" : "15 mg/kg IV q12h ($6/day) [R]"}
]},
{"Name" : "ORZID2 GMENU OSTEOM WITH GNB", "DisplayText" : "Osteomyelitis with Gram Negative Bacilli (other than Pseudomonas)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "OSTEOMYELITIS WITH GRAM NEGATIVE BACILLI (OTHER THAN PSEUDOMONAS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M]  < OR >", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID TICARCILLIN/CLAVULANATE 3.1GM IV Q6H", "DisplayText" : "Ticarcillin/Clavulanate 3.1gm IV Q6H", "Text" : "Ticarcillin-clavulanate 3.1 gm q6h ($42/day) [R]  < OR >", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin/Sulbactam 3GM IVPB Q6H", "Text" : "Ampicillin-sulbactam 3 gm IV q6h ($33/day) [R]  < OR >", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Item" : "PSJZID AMOXICILLIN-CLAVULANATE 875-125 MG PO Q12H", "DisplayText" : "Amoxicillin-Clavulanate 875-125 MG PO Q12H", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h ($1.56/day) [R]  < OR >", "Mnemonic" : "16"},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500mg PO Q24H ($0.19/Day)[R,DI]", "Text" : "", "Mnemonic" : "18"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 25, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 26, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 23, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 24, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 27, "Column" : 1, "Text" : "Johns Hopkins website: Osteomyelitis"}
]},
{"Name" : "ORZID2 GMENU OSTEOM WITH P. AERUGINOSA", "DisplayText" : "Osteomyelitis with Pseudomonas aeruginosa  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "OSTEOMYELITIS WITH PSEUDOMONAS AERUGINOSA"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($33/day) [R]  < OR >", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI]  < OR >", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "PSJZID CIPROFL 750MG PO Q12H", "DisplayText" : "Ciprofloxacin 750mg po q12h", "Text" : "Ciprofloxacin 750 mg PO q12h ($0.27/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 21, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 22, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 19, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 20, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 23, "Column" : 1, "Text" : "Johns Hopkins website: Osteomylitis"}
]},
{"Name" : "ORZID2 GMENU PANCREATITIS", "DisplayText" : "Pancreatitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PANCREATITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobials are not indicated for uncomplicated pancreatitis."}, 
{"Row" : 14, "Column" : 1, "Text" : "In cases of necrotizing pancreatitis without infection, antimicrobial"}, 
{"Row" : 15, "Column" : 1, "Text" : "prophylaxis does not improve patient outcomes.  Antimicrobials increase the risk"}, 
{"Row" : 16, "Column" : 1, "Text" : "of fungal superinfection and should not be used."}, 
{"Row" : 18, "Column" : 1, "Text" : "Antimicrobials are indicated for cases with pancreatic abscess, infected"}, 
{"Row" : 19, "Column" : 1, "Text" : "pancreatic pseudocyst, or infected necrotic pancreas (phlegmon).  The diagnosis"}, 
{"Row" : 20, "Column" : 1, "Text" : "of infection can be difficult and may require aspiration.  Consultation with"}, 
{"Row" : 21, "Column" : 1, "Text" : "Gastroenterology and/or Infectious Diseases is encouraged."}, 
{"Row" : 23, "Column" : 1, "Text" : ">>  Uncomplicated pancreatitis", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "No antimicrobials are indicated."}, 
{"Row" : 26, "Column" : 1, "Text" : ">>  Cases with necrosis", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "In cases with necrosis, aspirate necrotic material (fine needle under CT or"}, 
{"Row" : 28, "Column" : 1, "Text" : "ultrasound guidance) for smear and culture.  Uninfected cases should not receive"}, 
{"Row" : 29, "Column" : 1, "Text" : "antimicrobials."}, 
{"Row" : 31, "Column" : 1, "Text" : ">>  Pancreatic ABSCESS, infected pancreatic pseudocyst, or infected necrotic", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "pancreas (phlegmon).  Duration of therapy is typically 2 to 4 weeks."}, 
{"Row" : 37, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" :""},
{"Row" : 35, "Column" : 1, "Item" : "PSJIZID IMIPENEM 500MG IVPB Q6H", "DisplayText" : "Imipenem 500MG IVPB Q6H", "Text" : ""},
{"Row" : 38, "Column" : 1, "Item" : "PSJIZID LEVOFLOX 500MG Q24H AND METRONIDAZOLE 500MG Q8H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H <AND> Metronidazole 500MG IVPB Q8H", "Text" : ""},
{"Row" : 42, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and Management of"}, 
{"Row" : 44, "Column" : 1, "Text" : "Complicated Intra-abdominal Infection in Adults & Children:"}, 
{"Row" : 45, "Column" : 1, "Text" : "Guidelines by the Surgical Infection Society and the Infectious Diseaseas"}, 
{"Row" : 46, "Column" : 1, "Text" : "Society of America. CID.2010"},
{"Row" : 48, "Column" : 1, "Text" : "Johns Hopkins Antibiotic Guide \"Pancreatitis and Infected Pancreatic Necrosis\""}, 
{"Row" : 49, "Column" : 1, "Text" : "Last updated 2/26/14"}, 
{"Row" : 51, "Column" : 1, "Text" : "Sanford Guide \"Pancreatitis\" Last updated 8/20/14"}
]},
{"Name" : "ORZID2 GMENU PREV INFECT BACT PROPHYL", "DisplayText" : "Prevention of bacterial infection in a patient with malignancy  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Consult Hematology-Oncology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF BACTERIAL INFECTIONS IN A PATIENT WITH MALIGNANCY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial prophylaxis is often given to patients likely to have profound,"}, 
{"Row" : 13, "Column" : 1, "Text" : "prolonged neutropenia.  Profound neutropenia is less than 100 neutrophils and"}, 
{"Row" : 14, "Column" : 1, "Text" : "bands per microliter, and such neutropenia is considered prolonged when it is"}, 
{"Row" : 15, "Column" : 1, "Text" : "expected to last more than 7 days.  Most patients who should receive prophylaxis"}, 
{"Row" : 16, "Column" : 1, "Text" : "have received stem cell transplants or are undergoing induction chemotherapy for"}, 
{"Row" : 17, "Column" : 1, "Text" : "acute leukemia."}, 
{"Row" : 19, "Column" : 1, "Text" : "If antibacterial prophylaxis is indicated", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO q12h  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500mg PO Q24H ($0.19/Day)[R,DI]", "Text" : "", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 7 DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID AMOX/CLAV 500/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 500/125MG PO BID", "Text" : "Amoxicillin-clavulanate 500 mg/125 mg PO q12h  ($1.56/day) [R]", "Mnemonic" : "18"}, 
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 29, "Column" : 1, "Text" : "Hughes WT Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 30, "Column" : 1, "Text" : "\"Mandell\" chapter:  Prophylaxis and Empirical Therapy for Infection in Cancer"}, 
{"Row" : 31, "Column" : 1, "Text" : "Patients"}
]},
{"Name" : "ORZID2 GMENU PREV INFECT FUNGAL PROPHYL", "DisplayText" : "Prevention of fungal infections in a patient with malignancy ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT ONCOLOGY INP", "DisplayText" : "ONCOLOGY INP", "Text" : "Consult Hematology-Oncology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF FUNGAL INFECTIONS IN A PATIENT WITH MALIGNANCY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antifungal chemoprophylaxis is often given to patients undergoing induction"}, 
{"Row" : 13, "Column" : 1, "Text" : "chemotherapy for acute leukemia expected to have profound neutropenia (less than"}, 
{"Row" : 14, "Column" : 1, "Text" : "100 neutrophils and bands per milliliter) for more than 10 days and for patients"}, 
{"Row" : 15, "Column" : 1, "Text" : "receiving allogeneic stem cell transplantation.  For most other patients the"}, 
{"Row" : 16, "Column" : 1, "Text" : "expected benefits do not outweigh the risks of adverse effects and selection of"}, 
{"Row" : 17, "Column" : 1, "Text" : "resistant fungi."}, 
{"Row" : 19, "Column" : 1, "Text" : "Fluconazole is usually given until the absolute neutrophil concentration"}, 
{"Row" : 20, "Column" : 1, "Text" : "increases to more than 500 cells/microliter in patients undergoing induction"}, 
{"Row" : 21, "Column" : 1, "Text" : "chemotherapy for leukemia.  Duration is 100 days for patients undergoing stem"}, 
{"Row" : 22, "Column" : 1, "Text" : "cell transplantation.  Some physicians continue prevention after 100 days if"}, 
{"Row" : 23, "Column" : 1, "Text" : "corticosteroids are part of the immunosuppressive regimen.Contact Hematology-"}, 
{"Row" : 24, "Column" : 1, "Text" : "Oncology for more information."}, 
{"Row" : 26, "Column" : 1, "Text" : "Patients who have had invasive fungal infection in the recent past and who are"}, 
{"Row" : 27, "Column" : 1, "Text" : "about to become neutropenic may require chemoprophylaxis.  Contact Hematology-"}, 
{"Row" : 28, "Column" : 1, "Text" : "Oncology or Infectious Diseases for more information."}, 
{"Row" : 30, "Column" : 1, "Text" : "If antifungal prophylaxis is indicated", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 100MG PO Q24H", "DisplayText" : "Fluconazole 100MG PO q24h", "Text" : "Fluconazole 100-200 mg PO q24h ($0.10-0.20/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 36, "Column" : 1, "Text" : "Hughes WT Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 37, "Column" : 1, "Text" : "Glasmacher A  J Antimicrob Chemother 2005, 56 S1: 23"}, 
{"Row" : 38, "Column" : 1, "Text" : "De Pauw B  J Antimicrob Chemother 2004, 53: 130"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Mandell\" chapter: Principles and Practice of Infectious Diseases"}
]},
{"Name" : "ORZID2 GMENU PREV OF PERTUSSIS", "DisplayText" : "Prevention of Pertussis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ PULMONARY CONSULT INPT", "DisplayText" : "Pulmonary Inpt (eConsult only)", "Text" : "Consult Pulmonary", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "PREVENTION OF PERTUSSIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Pertussis vaccine is given to children. A tetanus-diphtheria-acellular pertussis"}, 
{"Row" : 10, "Column" : 1, "Text" : "vaccine (Tdap) is indicated for adults.  A single dose of Tdap replaces one dose"}, 
{"Row" : 11, "Column" : 1, "Text" : "of tetanus-diphtheria (Td) in the adult immunization schedule. Antimicrobial"}, 
{"Row" : 12, "Column" : 1, "Text" : "prophylaxis is sometimes used during pertussis outbreaks.  Consult Infectious"}, 
{"Row" : 13, "Column" : 1, "Text" : "Diseases for more information on vaccination and antimicrobial prophylaxis."}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 18, "Column" : 1, "Text" : "Hewlett EL NEJM 2005, 352: 1215"}, 
{"Row" : 19, "Column" : 1, "Text" : "Up-to-date website: Pertussis"}, 
{"Row" : 21, "Column" : 1, "Text" : "CDC MMWR 2006, 55(RR03): 1-34"}, 
{"Row" : 20, "Column" : 1, "Text" : "\"Sanford\" keyword: Pertussis"}, 
{"Row" : 22, "Column" : 1, "Text" : "\"Mandell\" chapter: Bordetella species"}
]},
{"Name" : "ORZID2 GMENU PREV PROS JOINT DENTAL", "DisplayText" : "Prevention of prosthetic joint infection before dental procedures  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ DENTAL OPT", "DisplayText" : "DENTAL", "Text" : "Consult Dental service", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Prosthetic joints have a small risk (<1 to 5% for the time the prosthesis is in"}, 
{"Row" : 13, "Column" : 1, "Text" : "place) of infection from hematogenous seeding.  The risk of joint infection"}, 
{"Row" : 14, "Column" : 1, "Text" : "after dental or surgical procedures is exceedingly small.  Existing data do not"}, 
{"Row" : 15, "Column" : 1, "Text" : "support the use of prophylactic antimicrobial prophylaxis for patients with"}, 
{"Row" : 16, "Column" : 1, "Text" : "prosthetic joints undergoing procedures.  Since the overall risk of prosthesis"}, 
{"Row" : 17, "Column" : 1, "Text" : "infection is slightly higher during the first 2 years after implantation, some"}, 
{"Row" : 18, "Column" : 1, "Text" : "physicians give prophylactic antimicrobials for patients during the first 2"}, 
{"Row" : 19, "Column" : 1, "Text" : "years after implantation.  In addition, antimicrobials are given for theoretical"}, 
{"Row" : 20, "Column" : 1, "Text" : "reasons to persons with neutropenia (less than 500 neutrophils and bands per"}, 
{"Row" : 21, "Column" : 1, "Text" : "milliliter)."}, 
{"Row" : 23, "Column" : 1, "Text" : "If antimicrobials are given during dental procedures to prevent prosthetic joint"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection, give the following:"}, 
{"Row" : 26, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJZID AMOXICILLIN 2GM PO ONCE 'C'", "DisplayText" : "Amoxicillin 2gm po once", "Text" : "Amoxicillin 2 gm PO 1 hour before procedure ($0.56/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 2GM PO ONCE 'C'", "DisplayText" : "Cephalexin 2gm po once", "Text" : "Cephalexin 2 gm PO 1 hour before procedure ($0.36/day) [R]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative for patients with penicillin allergy", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJZID CLINDA 600MG PO ONCE '30MIN'", "DisplayText" : "Clindamycin 600mg po once 30 min b4 procedure", "Text" : "Clindamycin 600 mg PO 30 minutes before procedure ($1.68/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "Patients unable to take oral medications", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IV ONCE 'C'", "DisplayText" : "Ampicillin 2GM IVPB ONCE", "Text" : "Ampicillin 2 gm IV over 20 minutes, beginning 60 minutes before incision", "Mnemonic" : "18"},
{"Row" : 35, "Column" : 1, "Text" : "($12/day) [R]  < OR >"}, 
{"Row" : 37, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 1GM IV ONCE 'C'", "DisplayText" : "Cefazolin 1GM IVPB ONCE", "Text" : "Cefazolin 1 gm IV over 20 minutes, beginning 60 minutes before incision", "Mnemonic" : "20"},
{"Row" : 38, "Column" : 1, "Text" : "($2.73/day) [R]"}, 
{"Row" : 40, "Column" : 1, "Text" : "Alternative for patients with penicillin allergy", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes, beginning 60 minutes before incision", "Mnemonic" : "22"},
{"Row" : 42, "Column" : 1, "Text" : "($1.44/day) [H,O]"}, 
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF PROSTHETIC JOINT INFECTION BEFORE DENTAL PROCEDURES"}, 
{"Row" : 47, "Column" : 1, "Text" : "Anonymous J Am Dent Assoc 2003, 134: 895"}
]},
{"Name" : "ORZID2 GMENU PREV PROS JOINT GU", "DisplayText" : "Prevention of prosthetic joint infection before genitourinary proc... ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF PROSTHETIC JOINT INFECTION BEFORE GENITOURINARY PROCEDURES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Prosthetic joints have a small risk (<1 to 5% for the time the prosthesis is in"}, 
{"Row" : 13, "Column" : 1, "Text" : "place) of infection from hematogenous seeding.  The risk of joint infection"}, 
{"Row" : 14, "Column" : 1, "Text" : "after dental or surgical procedures is exceedingly small.  Existing data do not"}, 
{"Row" : 15, "Column" : 1, "Text" : "support the use of prophylactic antimicrobial prophylaxis for patients with"}, 
{"Row" : 16, "Column" : 1, "Text" : "prosthetic joints undergoing procedures.  Since the overall risk of prosthesis"}, 
{"Row" : 17, "Column" : 1, "Text" : "infection is slightly higher during the first 2 years after implantation, some"}, 
{"Row" : 18, "Column" : 1, "Text" : "physicians give prophylactic antimicrobials for patients during the first 2"}, 
{"Row" : 19, "Column" : 1, "Text" : "years after implantation.  In addition, antimicrobials are given for theoretical"}, 
{"Row" : 20, "Column" : 1, "Text" : "reasons to persons with neutropenia (less than 500 neutrophils and bands per"}, 
{"Row" : 21, "Column" : 1, "Text" : "milliliter)."}, 
{"Row" : 23, "Column" : 1, "Text" : "If antimicrobials are given during genitourinary procedures to prevent"}, 
{"Row" : 24, "Column" : 1, "Text" : "prosthetic joint infection, give the following:"}, 
{"Row" : 26, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "ORZ SET ABX AMPICIL 2GM IV ONCE GENT 1.5MG/KG IV ONCE", "DisplayText" : "", "Text" : "Ampicillin 2 gm IV ($12/day) [R] over 20 minutes <AND> gentamicin 1.5 mg/kg", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Text" : "(no more than 120 mg) IV ($3/day) [R,O] over 20 minutes, both beginning 60"}, 
{"Row" : 29, "Column" : 1, "Text" : "minutes before incision  < OR >"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO ONCE 'C'", "DisplayText" : "Ciprofloxacin 500mg po once", "Text" : "Ciprofloxacin 500 mg PO 1 to 2 hours before procedure ($0.09/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1GM IV 60MIN GENT 1.5MG/KG IV 20MIN", "DisplayText" : "", "Text" : "Vancomycin 1 gm IV ($2.94/day) [R] over 60 minutes beginning 120 minutes", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Text" : "before incision <AND> gentamicin 1.5 mg/kg (no more than 120 mg) IV ($3/day)"}, 
{"Row" : 36, "Column" : 1, "Text" : "[R,O] over 20 minutes beginning 60 minutes before incision < OR >"}, 
{"Row" : 38, "Column" : 1, "Item" : "PSJZID CIPROFL 500MG PO ONCE 'C'", "DisplayText" : "Ciprofloxacin 500mg po once", "Text" : "Ciprofloxacin 500 mg PO 1 to 2 hours before procedure ($0.09/day) [R,DI]", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 42, "Column" : 1, "Text" : "Anonymous J Urol  2003, 169: 1796"}
]},
{"Name" : "ORZID2 GMENU PROPHYLAXIS M. AVIUM", "DisplayText" : "Prophylaxis against Mycobacterium avium disease...  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 11, "Column" : 1, "Text" : "Infectious Diseases should be involved in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 1200MG PO Q WEEK", "DisplayText" : "Azithromycin 1200mg po q week", "Text" : "Azithromycin 1200 mg PO q week ($16/day) [M]", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJZID CLARITHROMYCIN 500MG PO Q12H", "DisplayText" : "Clarithromycin 500mg po q12h", "Text" : "Clarithromycin 500 mg PO q12h ($2.84/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 9, "Column" : 1, "Text" : "PROPHYLAXIS AGAINST MYCOBACTERIUM AVIUM DISEASE IN PERSONS WITH HIV/AIDS"}, 
{"Row" : 22, "Column" : 1, "Text" : "\"Sanford\" keyword: MAC"}, 
{"Row" : 23, "Column" : 1, "Text" : "\"Mandell\" chapter: Mycobacterium avium complex"}
]},
{"Name" : "ORZID2 GMENU PROS B/J GNB", "DisplayText" : "Gram Negative Bacilli infections in bone or joint prostheses ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GRAM NEGATIVE BACILLI INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 12, "Column" : 1, "Text" : "PREFERRED TREATMENT", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID CEFEPIME 2GM IVPB Q12H", "DisplayText" : "Cefepime 2GM IVPB Q12H", "Text" :""},
{"Row" : 15, "Column" : 1, "Text" : "ALTERNATIVE TREATMENT", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID AZTREONAM 2GM IVPB Q8H", "DisplayText" : "Aztreonam 2GM IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 GMENU PROS B/J STREPTOCOCCI", "DisplayText" : "Streptococcal infections in bone or joint prostheses", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "STREPTOCOCCAL INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 12, "Column" : 1, "Text" : "PREFERRED TREATMENT", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""},
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IVPB Q8H", "DisplayText" : "Cefazolin 2GM IVPB Q8H", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "ALTERNATIVE FOR BETA-LACTAM ALLERGY", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q12H", "DisplayText" : "Vancomycin Pharmacy to Dose", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU RECURRENT/PERSIST URETHRITIS", "DisplayText" : "Recurrent or persistent urethritis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "618392", "DisplayText" : "", "Text" : "Consult Urology (select \"Other urologic problem\")", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "orz protein s 6m", "DisplayText" : "Protien S", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Need additional help?  Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "ORZ SET ABX METRONIDAZOLE 2GM PO X1 ERYTHRO 500MG PO Q6H", "DisplayText" : "METRONIDAZOLE 2GM PO X1 ERYTHRO 500MG PO Q6H", "Text" : "Metronidazole 2 gm PO ONCE($0.64/day) [DI] <AND> erythromycin base 500 mg PO", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Text" : "RECURRENT OR PERSISTENT URETHRITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment for recurrent or persistent urethritis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "CDC MMWR 2002, 51: RR-06"}, 
{"Row" : 21, "Column" : 1, "Text" : "\"Sanford\" keyword: Urethritis"}, 
{"Row" : 15, "Column" : 1, "Text" : "q6h for 7 days ($0.37/day) [DI]"}
]},
{"Name" : "ORZID2 GMENU SEPTIC ARTH GNB", "DisplayText" : "Septic arthritis (Native joint) with Gram negative bacilli", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH GRAM NEGATIVE BACILLI"}, 
{"Row" : 4, "Column" : 1, "Text" : "PREFERRED TREATMENT", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "PSJIZID CEFTAZIDIME 2GM IVPB Q8H", "DisplayText" : "Ceftazidime 2GM IVPB Q8H", "Text" : ""},
{"Row" : 7, "Column" : 1, "Text" : "ALTERNATIVE TREATMENT", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "PSJIZID AZTREONAM 2GM IVPB Q8H", "DisplayText" : "Aztreonam 2GM IVPB Q8H", "Text" :""},
{"Row" : 9, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU SEPTIC ARTH N. GONORRHOEAE", "DisplayText" : "Septic arthritis (Native joint) with N. gonorrhoeae ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH NEISSERIA GONORRHOEAE"}, 
{"Row" : 4, "Column" : 1, "Text" : "Treat presumptively also for Chlamydia trachomatis infection (asymptomatic"}, 
{"Row" : 5, "Column" : 1, "Text" : "urethritis) and test for HIV.  Infection control will report cases with N."}, 
{"Row" : 6, "Column" : 1, "Text" : "gonorrhea isolated to the Minnesota Department of Health."}, 
{"Row" : 9, "Column" : 1, "Text" : "PREFERRED TREATMENT", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Item" : "ORZID AZITHROMYCIN 1GM PO ONCE & CEFTRIAXONE 1GM Q24H", "DisplayText" : "Azithromycin 1GM PO ONCE & Ceftriaxone 1GM Q24H", "Text" : ""},
{"Row" : 11, "Column" : 1, "Item" : "ORZID CEFTRIAXONE 1GM Q24H & DOXYCYCLINE 100MG Q12H 7 DAYS", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H & Doxycycline 100MG PO Q12H", "Text" : ""},
{"Row" : 13, "Column" : 1, "Text" : "PENICILLIN ALLERGY", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJUZID AZITHROMYCIN 2GM PO ONCE", "DisplayText" : "Azithromycin 2GM PO ONCE", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU SEPTIC ARTH STREPTOCOCCI", "DisplayText" : "Septic arthritis (Native joint) with Streptococci", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 9, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH STREPTOCOCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IVPB Q8H", "DisplayText" : "Cefazolin 2GM IVPB Q8H", "Text" :""},
{"Row" : 14, "Column" : 1, "Text" : "PENICILLIN ALLERGY", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB PER RENAL FUNCTION", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG IVPB PER RENAL FUNCTION", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU SURG 48HRS AFTER PROC", "DisplayText" : "Patients with signs of infection 48 HOURS OR MORE after procedure  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GENERAL SURG INP", "DisplayText" : "General surgery", "Text" : "Consult Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PATIENTS WITH SIGNS OF INFECTION MORE THAN 48 HOURS AFTER PROCEDURE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Most post-operative infections appear at least 4 days after the operation.  If"}, 
{"Row" : 13, "Column" : 1, "Text" : "the wound appears normal to examination surgical site infection is unlikely."}, 
{"Row" : 14, "Column" : 1, "Text" : "Seek other source of fever.  Consider opening wounds that show induration or"}, 
{"Row" : 15, "Column" : 1, "Text" : "erythema.  Obtain material for gram stain and culture whenever possible."}, 
{"Row" : 16, "Column" : 1, "Text" : "Determine whether the patient has signs of invasive or systemic infection like"}, 
{"Row" : 17, "Column" : 1, "Text" : "erythema (diameter greater than 5 centimeters), temperature greater than 38.5"}, 
{"Row" : 18, "Column" : 1, "Text" : "degrees Celsius (101.3 degrees Fahrenheit) or heart rate higher than 100 beats"}, 
{"Row" : 19, "Column" : 1, "Text" : "per minute."}, 
{"Row" : 21, "Column" : 1, "Text" : "If there are no signs of invasive or systemic infection systemic antimicrobials"}, 
{"Row" : 22, "Column" : 1, "Text" : "are unnecessary.  Dressing changes alone are indicated."}, 
{"Row" : 24, "Column" : 1, "Text" : "For wounds that require complicated care", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZ OSTOMY INPT CONSULT", "DisplayText" : "Ostomy/Wound/Continence", "Text" : "Wound care (ET) nurse consult", "Mnemonic" : "14"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ OSTOMY INPT CONSULT", "DisplayText" : "Ostomy/Wound/Continence", "Text" : "Wound care (ET) nurse consult", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Text" : "If there are signs of invasive or systemic infection obtain blood cultures and"}, 
{"Row" : 28, "Column" : 1, "Text" : "wound Gram stain and cultures.  Whenever possible select antimicrobial therapy"}, 
{"Row" : 29, "Column" : 1, "Text" : "based on the Gram stain.  When the Gram stain cannot provide guidance give"}, 
{"Row" : 30, "Column" : 1, "Text" : "empirical therapy as indicated:"}, 
{"Row" : 34, "Column" : 1, "Text" : "Vancomycin should be included in the initial regimen due to the prevalence of"}, 
{"Row" : 35, "Column" : 1, "Text" : "methicillin-resistant Staphylococcus aureus.  However beta-lactam antibiotics"}, 
{"Row" : 36, "Column" : 1, "Text" : "are more effective for susceptible bacteria than is vancomycin.  If methicillin-"}, 
{"Row" : 37, "Column" : 1, "Text" : "susceptible S. aureus is identified switch to an anti-staphylococcal beta-lactam"}, 
{"Row" : 38, "Column" : 1, "Text" : "antibiotic."}, 
{"Row" : 40, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG Q12H", "DisplayText" : "Vanco Pharmacy to Dose 1500MG Q12H", "Text" : "Vancomycin 15 mg/kg IV q12h ($6/day) [R]", "Mnemonic" : "16"},
{"Row" : 45, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin/Sulbactam 3GM IVPB Q6H", "Text" : "Ampicillin-sulbactam 3 gm IV q6h ($32/day) [R] < OR >", "Mnemonic" : "18"},
{"Row" : 47, "Column" : 1, "Item" : "ORZ SET ABX CIPROFL 400 MG IV Q12H CLINDA 600MG IV Q8H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> clindamycin 600 mg IV", "Mnemonic" : "20"},
{"Row" : 49, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($33/day) [R]", "Mnemonic" : "22"},
{"Row" : 51, "Column" : 1, "Text" : "Alternative if methicillin-resistant Staphylococcus aureus is suspected", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Item" : "ORZ SET ABX AMPI/SULB 3GM IV Q6H VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ampicillin-sulbactam 3 gm IV q6h ($32/day) [R] <AND> vancomycin 15 mg/kg IV q12h", "Mnemonic" : "24"},
{"Row" : 55, "Column" : 1, "Item" : "ORZ SET ABX TICAR-CLAV 3.1GM IV Q6H VANCO 1GM IV Q12H", "DisplayText" : "Ticarcillin-clavulanate 3.1gm iv q6h Vanco 1gm iv q12h", "Text" : "Ticarcillin-clavulanate 3.15 mg/kg IV q6h ($41/day) <AND> vancomycin 15 mg/kg IV", "Mnemonic" : "26"},
{"Row" : 58, "Column" : 1, "Item" : "ORZ SET ABX CIPROFL 400 CLINDA 600 VANCO 1GM IV Q12H", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> clindamycin 600 mg IV", "Mnemonic" : "28"},
{"Row" : 61, "Column" : 1, "Item" : "ZZORZ SET ABX CIPROFL, METRONI, VANCO", "DisplayText" : "", "Text" : "Ciprofloxacin 400 mg IV q12h ($5.92/day) [R,DI] <AND> metronidazole 500 mg", "Mnemonic" : "30"},
{"Row" : 65, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "32"},
{"Row" : 32, "Column" : 1, "Text" : "Empirical treatment of INFECTED WOUNDS AFTER \"CLEAN\" SURGERY or wounds on the", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "trunk, head, neck, arms or legs", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Preferred empirical treatment for INFECTED WOUNDS AFTER CLEAN-CONTAMINATED or", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "CONTAMINATED SURGERY", "Header" : 1}, 
{"Row" : 67, "Column" : 1, "Text" : "Stevens DL Clin Infect Dis 2005, 41: 1373."}, 
{"Row" : 68, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 59, "Column" : 1, "Text" : "q8h ($17/day) [H,O] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R] < OR >"}, 
{"Row" : 62, "Column" : 1, "Text" : "IV q6h ($3.76/day) [DI] <AND> vancomycin 15 mg/kg IV q12h ($6/day) [R]"}, 
{"Row" : 53, "Column" : 1, "Text" : "($6/day) [R] < OR >"}, 
{"Row" : 56, "Column" : 1, "Text" : "q12h ($6/day) [R] < OR >"}
]},
{"Name" : "ORZID2 GMENU SURG BILIARY SURGERY", "DisplayText" : "Biliary surgery ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gastroenterology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "BILIARY SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Prophylaxis is indicated for patients over 70 years of age or patients with"}, 
{"Row" : 13, "Column" : 1, "Text" : "acute cholecystitis, common duct stones, biliary obstruction, or a non-"}, 
{"Row" : 14, "Column" : 1, "Text" : "functioning gall bladder."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 1GM IV ONCE 'C'", "DisplayText" : "Cefazolin 1GM IVPB ONCE", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "($1.72/day) [R] < OR >"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 31, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 33, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID2 GMENU SURG CARDIAC SURG", "DisplayText" : "Cardiac surgery and implantation of pacemaker ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CARDIAC SURGERY AND IMPLANTATION OF PACEMAKER"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial prophylaxis is not indicated before cardiac catheterization."}, 
{"Row" : 14, "Column" : 1, "Text" : "No evidence supports the use of post-operative prophylactic antimicrobials."}, 
{"Row" : 15, "Column" : 1, "Text" : "However, due to the potentially devastating consequences of sternal wound"}, 
{"Row" : 16, "Column" : 1, "Text" : "infection, expert opinion supports use of a limited number of post-operative"}, 
{"Row" : 17, "Column" : 1, "Text" : "doses.  Discontinue antimicrobials by 48 hours after the procedure, regardless"}, 
{"Row" : 18, "Column" : 1, "Text" : "of the presence of postoperative drains or tubes."}, 
{"Row" : 20, "Column" : 1, "Text" : "Cefazolin is preferred for prophylaxis, as it is more active than vancomycin"}, 
{"Row" : 21, "Column" : 1, "Text" : "against susceptible staphylococci.  Vancomycin should be used when methicillin-"}, 
{"Row" : 25, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID CEFAZ 2GM IV ONCE THEN 2GM IV Q8H", "DisplayText" : "Cefazolin 2gm iv once then 2gm iv q8h for 5 doses", "Text" : "Cefazolin 2 gm IV ($5.16/day) [R] over 20 minutes beginning 60 minutes", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Text" : "before incision, then 2 gm q8h for 5 doses post-operatively < OR >"}, 
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 26, "Column" : 1, "Text" : "If vancomycin is used give 1000 mg to patients weighing less than 100 kg.  Give"}, 
{"Row" : 27, "Column" : 1, "Text" : "1500 mg if the patient weights 100 or more kg."}, 
{"Row" : 22, "Column" : 1, "Text" : "resistant Staphylococcus aureus infection is likely.  Consult Cardiothoracic"}, 
{"Row" : 23, "Column" : 1, "Text" : "Surgery or Infectious Diseases for more information."}, 
{"Row" : 41, "Column" : 1, "Text" : "Bratzler, DW Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 42, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 43, "Column" : 1, "Text" : "\"Sanford\" keyword: Antimicrobial Therapy"}, 
{"Row" : 44, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 45, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 46, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 47, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE THEN Q12H 3 DOSES", "DisplayText" : "Vanco Pharmacy To Dose 1000MG ONCE, THEN Q12H 3 DOSES", "Text" : "Vancomycin 1 gm IV ($2.94/day) [R] beginning 120 minutes before incision,", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "then 1 gm IV q12h for 3 doses post-operatively  < OR >"}, 
{"Row" : 35, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG ONCE, 1GM Q12H 3 DOSES", "DisplayText" : "Vanco Pharmacy To Dose 1500MG ONCE, 1000MG Q12H 3 DOSES", "Text" : "Vancomycin 1500 mg IV ($4.41/day) [R] beginning 120 minutes before incision,", "Mnemonic" : "16"},
{"Row" : 36, "Column" : 1, "Text" : "then 1 gm IV q12h for 3 doses post-operatively"}
]},
{"Name" : "ORZID2 GMENU SURG COLON AND RECTAL SURG", "DisplayText" : "Colon and rectal surgery ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gastroenterology", "Mnemonic" : "10"},
{"Row" : 11, "Column" : 1, "Text" : "COLON AND RECTAL SURGERY"}, 
{"Row" : 13, "Column" : 1, "Text" : "Bowel cleansing preparations and orally administered antimicrobials are"}, 
{"Row" : 14, "Column" : 1, "Text" : "sufficient for some elective procedures.  For procedures like colectomy, bowel"}, 
{"Row" : 15, "Column" : 1, "Text" : "cleansing preparations and oral antimicrobials are given in addition to"}, 
{"Row" : 18, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Bowel preparation", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Oral antimicrobials", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZ SET ABX METOCLOPRAMIDE 10MG PO ONCE GOLYTELY 4L ONCE", "DisplayText" : "", "Text" : "Metoclopramide 10 mg PO once then Golytely 4 L PO starting in the afternoon", "Mnemonic" : "14"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ GENERAL SURG INP", "DisplayText" : "General surgery", "Text" : "Consult General Surgery", "Mnemonic" : "12"},
{"Row" : 29, "Column" : 1, "Item" : "ORZ SET ABX ERYTH BASE 1GM PO NEOMYCIN 1GM PO", "DisplayText" : "", "Text" : "Erythromycin base 1 g PO ($0.19/day) [DI] <AND> neomycin 1 g PO ($1.40/day)", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Intravenous antimicrobials", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Cefazolin alone may be sufficient if pre-operative bowel preparations and oral"}, 
{"Row" : 38, "Column" : 1, "Text" : "antimicrobials have been given.  If surgery is emergent, metronidazole and"}, 
{"Row" : 39, "Column" : 1, "Text" : "cefazolin should be given."}, 
{"Row" : 41, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "($1.72/day) [R] < OR >"}, 
{"Row" : 45, "Column" : 1, "Item" : "ORZ SET ABX CEFAZO 2GM IV 20MIN METRON 500MG IV X1", "DisplayText" : "", "Text" : "Cefazolin 2gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "20"},
{"Row" : 46, "Column" : 1, "Text" : "($1.72/day) [R] <AND> metronidazole 500 mg IV over 20 minutes beginning 60"}, 
{"Row" : 47, "Column" : 1, "Text" : "minutes before incision (1$/day) [DI]"}, 
{"Row" : 49, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Item" : "PSJIZID GENT 80MG IV ONCE 'C'", "DisplayText" : "Gentamicin 80mg iv once", "Text" : "Gentamicin 80 mg IV over 20 minutes ($1/day) [R,O] beginning 60 minutes", "Mnemonic" : "22"},
{"Row" : 51, "Column" : 1, "Text" : "before incision < OR >"}, 
{"Row" : 53, "Column" : 1, "Item" : "ORZ SET ABX GENTAM 80MG IV 20MIN METRO 500MG IV X1", "DisplayText" : "", "Text" : "Gentamicin 80 mg IV over 20 minutes ($1/day) [R,O] beginning 60 minutes", "Mnemonic" : "24"},
{"Row" : 54, "Column" : 1, "Text" : "before incision <AND> metronidazole 500 mg IV ($1/day) [DI] over 20 minutes"}, 
{"Row" : 55, "Column" : 1, "Text" : "beginning 60 minutes before incision"}, 
{"Row" : 58, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 30, "Column" : 1, "Text" : "[M] for 3 doses each, both given once 3 hours and 4 hours after starting"}, 
{"Row" : 31, "Column" : 1, "Text" : "Golytely, and at 23:00 the day before surgery only"}, 
{"Row" : 23, "Column" : 1, "Text" : "the day before the procedure"}, 
{"Row" : 16, "Column" : 1, "Text" : "intravenous antimicrobials."}, 
{"Row" : 60, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 61, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 62, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 63, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 64, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 65, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 66, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 42, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2gm IV over 20 minutes beginning 60 minutes before incision"}
]},
{"Name" : "ORZID2 GMENU SURG ERCP", "DisplayText" : "Endoscopic Retrograde Cholangiopancreatography (ERCP)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP)"}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID AMPICIL 1GM IV ONCE '20MIN - 60MIN'", "DisplayText" : "Ampicillin 1GM IVPB ONCE 60MIN Prior to Incision", "Text" : "Ampicillin 1 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "($6/day) [R]  < OR >"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX AMPICI 1GM IV 20MIN GENT 80MG IV 20MIN", "DisplayText" : "", "Text" : "Ampicillin 1 gm IV over 20 minutes ($6/day) [R] < AND > gentamicin 80 mg", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "over 20 minutes ($3/day) [R,O] both beginning 60 minutes before incision"}, 
{"Row" : 27, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 37, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 38, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 40, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 41, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 42, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 43, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobials are not indicated in the absence of obstruction or intervention."}, 
{"Row" : 13, "Column" : 1, "Text" : "If obstruction is present or intervention is likely give a Gram-positive"}, 
{"Row" : 14, "Column" : 1, "Text" : "antimicrobial.  Use of gentamicin is optional.  Contact Gastroenterology for"}, 
{"Row" : 15, "Column" : 1, "Text" : "more information.  If drainage is incomplete, prophylactic antimicrobials after"}, 
{"Row" : 16, "Column" : 1, "Text" : "ERCP may be indicated."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU SURG ERCP INCOMP DRAINAGE", "DisplayText" : "Antimicrobial Prophylaxis After ERCP with Incomplete Drainage", "Text" : "Antimicrobial prophylaxis after ERCP with incomplete drainage", "Mnemonic" : "11"},
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy to Dose 1000MG", "Text" : "Vancomycin 1 gm IV beginning 120 minutes before incision ($3/day) [R] < OR >", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Item" : "ORZ SET ABX VANCOM 1GM IV 60MIN GENT 80MG IV ONCE", "DisplayText" : "", "Text" : "Vancomycin 1 gm IV beginning 120 minutes before incision ($3/day) [R]", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "< AND > gentamicin 80 mg ($3/day) [R,O] over 20 minutes beginning 60 minutes"}, 
{"Row" : 32, "Column" : 1, "Text" : "before incision"}
]},
{"Name" : "ORZID2 GMENU SURG ERCP INCOMP DRAINAGE", "DisplayText" : "Antimicrobial Prophylaxis After ERCP with Incomplete Drainage", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "See drug information Page.  Important drug properties: [R]=renal excretion,", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Text" : "[H]=hepatic excretion, [DI]=important drug interactions, [O]=other."}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Need help with Gastroenterology?  Consult Inpatient Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ANTIMICROBIAL PROPHYLAXIS AFTER ERCP WITH INCOMPLETE DRAINAGE"}, 
{"Row" : 12, "Column" : 1, "Text" : "No antimicrobials are needed after ERCP if adequate drainage is accomplished."}, 
{"Row" : 13, "Column" : 1, "Text" : "When drainage is incomplete or if dye may be trapped in the biliary tract,"}, 
{"Row" : 14, "Column" : 1, "Text" : "patients are at a higher risk of sepsis.  In these cases, give a 5 day course of"}, 
{"Row" : 15, "Column" : 1, "Text" : "oral antimicrobials."}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500mg PO Q24H ($0.19/Day)[R,DI]", "Text" : "", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "Byl B  Clin Infect Dis 1995, 20: 1236"}, 
{"Row" : 24, "Column" : 1, "Text" : "Harris A  Endoscopy 1999, 31: 718"}
]},
{"Name" : "ORZID2 GMENU SURG GASTROINTESTINAL SURG", "DisplayText" : "Gastrointestinal surgery ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GASTROINTESTINAL SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Prophylaxis is indicated only in patients with unusual risk for infection."}, 
{"Row" : 13, "Column" : 1, "Text" : ">>  Patients with high gastric pH or acid-suppression therapy,"}, 
{"Row" : 14, "Column" : 1, "Text" : ">>  Patients with decreased gastrointestinal motility due to obstruction,"}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "($5.51/day)[H,O]"}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 15, "Column" : 1, "Text" : "hemorrhage, gastric ulcer, malignancy, or diabetic gastroparesis, or"}, 
{"Row" : 16, "Column" : 1, "Text" : ">>  Obese patients"}, 
{"Row" : 30, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 31, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 33, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 34, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 35, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 36, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision"}
]},
{"Name" : "ORZID2 GMENU SURG GYNECOL SURG", "DisplayText" : "Gynecological surgery ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT GYNECOLOGY INP", "DisplayText" : "GYNECOLOGY INP", "Text" : "Consult Gynecology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GYNECOLOGICAL SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "For abdominal or vaginal hysterectomy cefazolin alone is sufficient for most"}, 
{"Row" : 13, "Column" : 1, "Text" : "procedures.  Metronidazole may be added in cases where additional anaerobic"}, 
{"Row" : 14, "Column" : 1, "Text" : "coverage is desired."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "($1.72/day) [R]"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative if additional anaerobic coverage is desired", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "ZZORZ SET ABX CEFAZO 2 GM '20MIN' METRO 500MG '20MIN'", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV ($1.72/day) [R] <AND> metronidazole 500 mg IV ($1/day]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "[DI] over 20 minutes beginning 60 minutes before incision"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "Bratzler DW Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 31, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 33, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID2 GMENU SURG HERNIA REPAIR", "DisplayText" : "Hernia repair surgery with abdominal mesh  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GENERAL SURG INP", "DisplayText" : "General surgery", "Text" : "Consult General Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "HERNIA REPAIR SURGERY WITH ABDOMINAL MESH"}, 
{"Row" : 12, "Column" : 1, "Text" : "Hernia repair surgery without mesh is a clean surgery that does not require"}, 
{"Row" : 13, "Column" : 1, "Text" : "prophylaxis.  When mesh is implanted, prophylaxis is indicated because infection"}, 
{"Row" : 14, "Column" : 1, "Text" : "is difficult to cure."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "($1.72/day) [R]"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 31, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 33, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision"}
]},
{"Name" : "ORZID2 GMENU SURG MORE INFO UROLO PROC", "DisplayText" : "Infomation on antimicrobial prophylaxis in urological procedures", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "APPROACH TO ANTIMICROBIAL PROPHYLAXIS FOR UROLOGICAL PROCEDURES"}, 
{"Row" : 9, "Column" : 1, "Text" : "Antimicrobial prophylaxis is not indicated for many procedures.  Prophylaxis is"}, 
{"Row" : 10, "Column" : 1, "Text" : "indicated for transurethral resection of the prostate (TURP), uroscopy,"}, 
{"Row" : 11, "Column" : 1, "Text" : "transrectal prostatic needle biopsy, lithotripsy for struvite renal stones,"}, 
{"Row" : 12, "Column" : 1, "Text" : "nephrostomy tube placement, percutaneous surgery, or other procedures where"}, 
{"Row" : 13, "Column" : 1, "Text" : "mucosal entry is likely or the urinary tract will be manipulated.  Consult"}, 
{"Row" : 14, "Column" : 1, "Text" : "Urology for more information."}, 
{"Row" : 16, "Column" : 1, "Text" : "Perform urinalysis and urine culture before a procedure where prophylaxis may be"}, 
{"Row" : 17, "Column" : 1, "Text" : "indicated.  If bacteriuria is present treat for the organism(s) isolated from"}, 
{"Row" : 18, "Column" : 1, "Text" : "urine.  Refer to the urinary tract infection section, or consult Urology and/or"}, 
{"Row" : 19, "Column" : 1, "Text" : "Infectious Disease for more information.  If urine cultures cannot be done, give"}, 
{"Row" : 20, "Column" : 1, "Text" : "antimicrobial prophylaxis as described below."}, 
{"Row" : 22, "Column" : 1, "Text" : "Urine should be sterile before procedures involving manipulation of the urinary"}, 
{"Row" : 23, "Column" : 1, "Text" : "tract.  For patients without chronic foley catheters, perform urinalysis and"}, 
{"Row" : 24, "Column" : 1, "Text" : "culture before procedure, and if bacteriuria is present, treat for 2 to 3 days."}, 
{"Row" : 25, "Column" : 1, "Text" : "Patients with chronic foley catheters will always have bacterial urinary"}, 
{"Row" : 26, "Column" : 1, "Text" : "colonization and therefore should not be treated unless a prosthetic device will"}, 
{"Row" : 27, "Column" : 1, "Text" : "be placed."}, 
{"Row" : 29, "Column" : 1, "Text" : "Urine must be sterile before procedures involving prostheses, like implantation"}, 
{"Row" : 30, "Column" : 1, "Text" : "of penile prosthesis or artificial sphincter.  Perform urinanalysis and culture"}, 
{"Row" : 31, "Column" : 1, "Text" : "before these procedure.  If bacteriuria is present, treat with antimicrobials"}, 
{"Row" : 32, "Column" : 1, "Text" : "for 5 to 7 days."}, 
{"Row" : 34, "Column" : 1, "Text" : "Ciprofloxacin is preferred for prophylaxis, as it is as effective as and less"}, 
{"Row" : 35, "Column" : 1, "Text" : "expensive than ampicillin plus gentamicin."}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 40, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 41, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 42, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 43, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 44, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 45, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 46, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID2 GMENU SURG OPHTHALMIC SURG", "DisplayText" : "Ophthalmic surgery ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT OPHTHALMOLOGY", "DisplayText" : "OPHTHALMOLOGY", "Text" : "Ophthalmology consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "OPHTHALMIC SURGERY"}, 
{"Row" : 9, "Column" : 1, "Text" : "When indicated, ophthalmology will order antimicrobial prophylaxis before"}, 
{"Row" : 10, "Column" : 1, "Text" : "procedures."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU SURG ORTHO SURG JOINT ARTHRO", "DisplayText" : "Orthopedic surgery, including joint arthroplasty ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ ORTHOPEDICS INPT", "DisplayText" : "Orthopedics INPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ORTHOPAEDIC SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Orthopaedic procedures usually do not require antimicrobial prophylaxis."}, 
{"Row" : 13, "Column" : 1, "Text" : "Antimicrobial prophylaxis is indicated in cases involving joint replacement,"}, 
{"Row" : 14, "Column" : 1, "Text" : "internal fixation, or fracture repair."}, 
{"Row" : 16, "Column" : 1, "Text" : "Cefazolin is preferred for prophylaxis, as it is more active than vancomycin"}, 
{"Row" : 17, "Column" : 1, "Text" : "against susceptible staphylococci, the most common surgical pathogens."}, 
{"Row" : 18, "Column" : 1, "Text" : "Vancomycin should be used when methicillin-resistant Staphylococcus aureus"}, 
{"Row" : 19, "Column" : 1, "Text" : "infection, in patients who are colonized or were recently infected with"}, 
{"Row" : 20, "Column" : 1, "Text" : "methicillin-resistant Staphylococcus aureus."}, 
{"Row" : 22, "Column" : 1, "Text" : "No evidence supports the use of post-operative prophylactic antimicrobials."}, 
{"Row" : 23, "Column" : 1, "Text" : "However, due to the serious consequences of post-operative hip infection,"}, 
{"Row" : 24, "Column" : 1, "Text" : "clinical practice is often to give antimicrobials after hip operations.  These"}, 
{"Row" : 25, "Column" : 1, "Text" : "should be continued for no more than 24 hours.  Longer durations provide no"}, 
{"Row" : 26, "Column" : 1, "Text" : "additional benefit and are associated with side effects, increased costs, and"}, 
{"Row" : 27, "Column" : 1, "Text" : "bacterial resistance."}, 
{"Row" : 29, "Column" : 1, "Text" : "Prophylaxis for surgery INVOLVING THE HIP", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "In clinical practice, antimicrobials are usually continued for 24 hours after"}, 
{"Row" : 31, "Column" : 1, "Text" : "the procedure in orthopedic surgery involving the hip."}, 
{"Row" : 34, "Column" : 1, "Text" : "($5.16/day) [R] < OR >"}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG Q12H 2 DOSES", "DisplayText" : "Vanco Pharmacy To Dose 1000MG Q12H 2 DOSES", "Text" : "Vancomycin 1 gm IV q12h for 2 doses beginning 120 min before first incision", "Mnemonic" : "14"},
{"Row" : 37, "Column" : 1, "Text" : "($5.88/day) [R]"}, 
{"Row" : 39, "Column" : 1, "Text" : "Prophylaxis for surgery involving a JOINT OTHER THAN THE HIP", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "One prophylactic dose is sufficient for orthopedic surgery involving joints"}, 
{"Row" : 41, "Column" : 1, "Text" : "other than hips.  For joint replacement, internal fixation, or repair of"}, 
{"Row" : 42, "Column" : 1, "Text" : "fracture."}, 
{"Row" : 44, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "16"},
{"Row" : 45, "Column" : 1, "Text" : "($1.72/day) [R] < OR >"}, 
{"Row" : 50, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 52, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 53, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 54, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 55, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 56, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 57, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 58, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 47, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy to Dose 1000MG", "Text" : "Vancomycin 1 gm IV beginning 120 minutes before incision ($2.94/day) [R]", "Mnemonic" : "18"},
{"Row" : 33, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV q8h for 3 doses beginning 60 min before first incision"}
]},
{"Name" : "ORZID2 GMENU SURG OTHER PROCEDURES", "DisplayText" : "Other Procedures", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "OTHER PROCEDURES"}, 
{"Row" : 8, "Column" : 1, "Text" : "In view of the small number of wound infections that would be prevented by"}, 
{"Row" : 9, "Column" : 1, "Text" : "systemic antimicrobial prophylaxis the risks outweigh benefits for patients who"}, 
{"Row" : 10, "Column" : 1, "Text" : "will have cardiac catheterization, varicose vein surgery, most dermatologic and"}, 
{"Row" : 11, "Column" : 1, "Text" : "plastic surgery, arterial puncture, thoracentesis, paracentesis, repair of"}, 
{"Row" : 12, "Column" : 1, "Text" : "simple lacerations, outpatient treatment of burns, dental extractions, or root"}, 
{"Row" : 13, "Column" : 1, "Text" : "canal therapy."}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 19, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 20, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 21, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 22, "Column" : 1, "Text" : "Magnus G.  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 23, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 24, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID2 GMENU SURG POST-OP WND INFECT", "DisplayText" : "Post-operative wound infection ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ ADD MENU NEUROSURGERY CONSULT", "DisplayText" : "Neurosurgery Consult", "Text" : "Consult Neurosurgery", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "POST-OPERATIVE WOUND INFECTION"}, 
{"Row" : 9, "Column" : 1, "Text" : "Surgical site infections are categorized by the extent of tissues involved."}, 
{"Row" : 10, "Column" : 1, "Text" : "Superficial incisional infections involve only the subcutaneous space and occur"}, 
{"Row" : 11, "Column" : 1, "Text" : "within 30 days of operation.  Deep incisional infections involve deep layers of"}, 
{"Row" : 12, "Column" : 1, "Text" : "soft tissue, such as fascia and muscle, and occur within 30 days of operation,"}, 
{"Row" : 13, "Column" : 1, "Text" : "or within 1 year of operation if prosthetic material was inserted.  Organ/space"}, 
{"Row" : 14, "Column" : 1, "Text" : "infections involve anatomical areas other than the incisional wound that were"}, 
{"Row" : 15, "Column" : 1, "Text" : "opened or manipulated during operation.  Organ/space infections should be"}, 
{"Row" : 16, "Column" : 1, "Text" : "treated as infections of the relevant area of the anatomy.  Return to the main"}, 
{"Row" : 17, "Column" : 1, "Text" : "page and choose the pertinent organ system for advice on management of these"}, 
{"Row" : 18, "Column" : 1, "Text" : "infections."}, 
{"Row" : 20, "Column" : 1, "Text" : "Post-operative wound infections usually occur between 2 and 30 days after the"}, 
{"Row" : 21, "Column" : 1, "Text" : "operation.  Infections within 48 hours of the surgery are uncommon, but are"}, 
{"Row" : 22, "Column" : 1, "Text" : "serious when they do occur.  Symptoms commonly begin to appear no sooner than 5"}, 
{"Row" : 23, "Column" : 1, "Text" : "days after the operation and may take up to 2 weeks to appear."}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU SURG W/I 48HRS PROCEDURE", "DisplayText" : "Patients with signs of infection WITHIN 48 HOURS of procedure", "Text" : "Patients with signs of infection WITHIN 48 HOURS of procedure", "Mnemonic" : "08"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU SURG 48HRS AFTER PROC", "DisplayText" : "Patients with signs of infection 48 HOURS OR MORE after procedure", "Text" : "Patients with signs of infection 48 HOURS OR MORE after procedure", "Mnemonic" : "10"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"}
]},
{"Name" : "ORZID2 GMENU SURG PROPHYL GENRL INFO", "DisplayText" : "Surgical prophylaxis general information", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "SURGICAL PROPHYLAXIS GENERAL INFORMATION"}, 
{"Row" : 8, "Column" : 1, "Text" : "(adapted from Mangram AJ, et al.  Guideline for Prevention of Surgical Site"}, 
{"Row" : 9, "Column" : 1, "Text" : "Infection, Infect Control Hosp Epidemiol 1999, 20: 247)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Potential pathogens are introduced into normally sterile areas of the body"}, 
{"Row" : 12, "Column" : 1, "Text" : "during most surgical procedures.  The purpose of antimicrobial prophylaxis is to"}, 
{"Row" : 13, "Column" : 1, "Text" : "reduce the intraoperative microbial burden so that local host defenses can"}, 
{"Row" : 14, "Column" : 1, "Text" : "eliminate microorganisms and prevent disease.  Prophylaxis cannot be expected to"}, 
{"Row" : 15, "Column" : 1, "Text" : "sterilize tissues."}, 
{"Row" : 17, "Column" : 1, "Text" : "Ideally, prophylaxis for a planned procedure in should be done with an"}, 
{"Row" : 18, "Column" : 1, "Text" : "antimicrobial that has been shown to reduce surgical site infection rates in"}, 
{"Row" : 19, "Column" : 1, "Text" : "clinical trials of similar procedures.  If such data are not available, the"}, 
{"Row" : 20, "Column" : 1, "Text" : "agent should be safe, inexpensive, bactericidal, and active in vitro against the"}, 
{"Row" : 21, "Column" : 1, "Text" : "potential pathogens most likely to result in wound infection."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU SURG THORACIC SURGERY", "DisplayText" : "Thoracic surgery", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Thoracic Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "THORACIC SURGERY"}, 
{"Row" : 13, "Column" : 1, "Text" : "recently infected with methicillin-resistant Staphylococcus aureus (MRSA)."}, 
{"Row" : 15, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX CEFAZO 2GM IV '20MIN' METRON 500 IV '30MIN'", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV  over 20 minutes ($1.72/day) [R] <AND> metronidazole 500", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Text" : "mg IV ($0.94/day) [DI] over 30 minutes both beginning 60 minutes before"}, 
{"Row" : 18, "Column" : 1, "Text" : "incision"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative for patient with severe penicillin allergy", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMY 900MG IV ONCE '30MIN-60MIN'", "DisplayText" : "Clindamycin 900mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes, beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 24, "Column" : 1, "Text" : "Alternative for patient colonized or recently infected with MRSA", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 12, "Column" : 1, "Text" : "Cefazolin is preferred for prophylaxis unless the patient is colonized or was"}, 
{"Row" : 30, "Column" : 1, "Text" : "Bratzler, DW.  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 31, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" keyword: Antimicrobial Therapy"}, 
{"Row" : 33, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 34, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 35, "Column" : 1, "Text" : "Anonymous  J Urol 2003, 169: 1796"}, 
{"Row" : 36, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy to Dose 1000MG", "Text" : "Vancomycin 1 gm IV beginning 120 minutes before incision ($2.94/day) [R]", "Mnemonic" : "16"}
]},
{"Name" : "ORZID2 GMENU SURG TIMING DOSING PROPHYL ABX", "DisplayText" : "Timing and dosing (including re-dosing) of prophylatic antimicrobials ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PHARMACY CONSULT BLUE TEAM", "DisplayText" : "PHARMACY CONSULT BLUE TEAM", "Text" : "Pharmacy consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "TIMING AND DOSING (INCLUDING RE-DOSING) OF PROPHYLACTIC ANTIMICROBIALS"}, 
{"Row" : 9, "Column" : 1, "Text" : "For optimal prevention, antimicrobial concentrations should be above the minimal"}, 
{"Row" : 10, "Column" : 1, "Text" : "inhibitory concentration (MIC) of potential pathogens from initial incision"}, 
{"Row" : 11, "Column" : 1, "Text" : "until closure."}, 
{"Row" : 13, "Column" : 1, "Text" : "There is no advantage to giving post-operative doses. Despite a lack of"}, 
{"Row" : 14, "Column" : 1, "Text" : "demonstrated benefit, post-operative doses are sometimes given in clinical"}, 
{"Row" : 15, "Column" : 1, "Text" : "practice.  If post-operative doses are given, they should be discontinued by 24"}, 
{"Row" : 16, "Column" : 1, "Text" : "hours after closure of the incision."}, 
{"Row" : 18, "Column" : 1, "Text" : "When prophylaxis consists of a single dose as should be the case in the majority"}, 
{"Row" : 19, "Column" : 1, "Text" : "of procedures, adjustment for renal or hepatic dysfunction is not necessary."}, 
{"Row" : 21, "Column" : 1, "Text" : "Infusions for most drugs should begin 60 minutes before the first incision."}, 
{"Row" : 22, "Column" : 1, "Text" : "Infusions of drugs like fluoroquinolones and vancomycin that require longer"}, 
{"Row" : 23, "Column" : 1, "Text" : "infusion times should begin 120 minutes before first incision.  During"}, 
{"Row" : 24, "Column" : 1, "Text" : "procedures that last so long that concentrations might fall below the MICs of"}, 
{"Row" : 25, "Column" : 1, "Text" : "potential pathogens, repeated doses of antimicrobials should be given."}, 
{"Row" : 26, "Column" : 1, "Text" : "Cephalosporins and aminoglycosides should be re-dosed after 3 to 5 hours, while"}, 
{"Row" : 27, "Column" : 1, "Text" : "vancomycin and metronidazole have longer half-lives and maintain adequate"}, 
{"Row" : 28, "Column" : 1, "Text" : "concentrations for over 6 hours.  For more information contact Pharmacy or"}, 
{"Row" : 29, "Column" : 1, "Text" : "Infectious Diseases."}, 
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU SURG UROLOGICAL PROCED", "DisplayText" : "Urological procedures ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "UROLOGICAL PROCEDURES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Many procedures do not need antimicrobial prophylaxis."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU SURG MORE INFO UROLO PROC", "DisplayText" : "Infomation on antimicrobial prophylaxis in urological procedures", "Text" : "Click here for information on antimicrobial prophylaxis in urological", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Text" : "procedures"}, 
{"Row" : 16, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment of bacteriuria before procedures", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Before procedures where prosthetic material will not be placed, treat for 2 to 3"}, 
{"Row" : 21, "Column" : 1, "Text" : "days.  Before procedures where prosthetic material will be placed, treat for 5"}, 
{"Row" : 22, "Column" : 1, "Text" : "to 7 days."}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO q12h ($0.18/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID CIPROFL 400MG IV ONCE '60-120MIN'", "DisplayText" : "Ciprofloxacin 400MG IVPB ONCE", "Text" : "Ciprofloxacin 400 mg IV ($3/day) [R,DI] over 60 minutes beginning 120", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Text" : "minutes before incision < OR >"}, 
{"Row" : 33, "Column" : 1, "Item" : "PSJZID CIPROFLOX 500MG PO ONCE '120MIN'", "DisplayText" : "Ciprofloxacin 500mg po once", "Text" : "Ciprofloxacin 500 mg PO ($0.09/day) [R,DI] beginning 120 minutes before", "Mnemonic" : "18"},
{"Row" : 34, "Column" : 1, "Text" : "incision"}, 
{"Row" : 36, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Bowel preparation and oral antimicrobials should be given in addition to"}, 
{"Row" : 41, "Column" : 1, "Text" : "intravenous antimicrobials."}, 
{"Row" : 52, "Column" : 1, "Text" : "Intravenous antimicrobials", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Item" : "ZZORZ SET ABX CEFAZO 2 GM '20MIN' METRO 500MG '20MIN'", "DisplayText" : "", "Text" : "Cefazolin 2gm IV over 20 minutes ($1.72/day) [R] beginning 60 minutes before", "Mnemonic" : "22"},
{"Row" : 54, "Column" : 1, "Text" : "incision < AND > metronidazole 500 mg IV over 20 minutes ($1/day) [DI] 60"}, 
{"Row" : 55, "Column" : 1, "Text" : "minutes before incision < OR >"}, 
{"Row" : 57, "Column" : 1, "Item" : "ORZ SET ABX GENTAM 80MG IV 20MIN METRO 500MG IV X1", "DisplayText" : "", "Text" : "Gentamicin 80 mg IV over 20 minutes ($1/day) [R,O] beginning 60 minutes", "Mnemonic" : "24"},
{"Row" : 58, "Column" : 1, "Text" : "before incision < AND > metronidazole 500 mg IV ($1/day) [DI] over 20"}, 
{"Row" : 59, "Column" : 1, "Text" : "minutes beginning 60 minutes before incision"}, 
{"Row" : 62, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 27, "Column" : 1, "Text" : "Prophylaxis for cases that do not enter the colo-rectal area", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Prophylaxis for cases that involve incisions through colo-rectal tissues", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Bowel preparation", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Item" : "ORZ SET ABX METOCLOPRAMIDE 10MG PO ONCE GOLYTELY 4L ONCE", "DisplayText" : "", "Text" : "Metoclopramide 10 mg PO once, then Golytely 4 L PO starting in the", "Mnemonic" : "20"},
{"Row" : 45, "Column" : 1, "Text" : "afternoon the day before the procedure"}, 
{"Row" : 47, "Column" : 1, "Text" : "Oral antimicrobials", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Item" : "ORZ SET ABX ERYTH BASE 1GM NEOMYCIN 1GM PO", "DisplayText" : "", "Text" : "Erythromycin base 1 g ($0.19/day) [DI] < AND > neomycin 1 g PO ($1.40/day)", "Mnemonic" : "21"},
{"Row" : 49, "Column" : 1, "Text" : "[R] for 3 doses, both given once 3 hours and 4 hours after starting"}, 
{"Row" : 50, "Column" : 1, "Text" : "Golytely, and at 23:00 the day before surgery only"}, 
{"Row" : 64, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 65, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 66, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 67, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 68, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 69, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 70, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID2 GMENU SURG W/I 48HRS PROCEDURE", "DisplayText" : "Patients with signs of infection WITHIN 48 HOURS of procedure", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ ADD MENU NEUROSURGERY CONSULT", "DisplayText" : "Neurosurgery Consult", "Text" : "Consult Neurosurgery", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "PATIENTS WITH SIGNS OF INFECTION WITHIN 48 HOURS OF PROCEDURE"}, 
{"Row" : 9, "Column" : 1, "Text" : "Fever within 48 hours of procedure is usually due to anesthesia or other non-"}, 
{"Row" : 10, "Column" : 1, "Text" : "infectious factors but Clostridium species and Streptococcus pyogenes can cause"}, 
{"Row" : 11, "Column" : 1, "Text" : "early infections.  Examine the wound of any patient with systemic signs of"}, 
{"Row" : 12, "Column" : 1, "Text" : "infection, like fever, within 48 hours of surgery.  If there are signs of"}, 
{"Row" : 13, "Column" : 1, "Text" : "infection consider opening the wound.  Obtain a STAT Gram stain and culture of"}, 
{"Row" : 14, "Column" : 1, "Text" : "any drainage. If the Gram stain shows evidence of streptococci or clostridia"}, 
{"Row" : 15, "Column" : 1, "Text" : "refer to the section on necrotizing infections.  If signs of wound infection are"}, 
{"Row" : 16, "Column" : 1, "Text" : "absent seek an alternative source of the fever."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU NECROTIZING INFECTIONS", "DisplayText" : "Necrotizing infections", "Text" : "Necrotizing infections", "Mnemonic" : "08"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"}
]},
{"Name" : "ORZID2 GMENU SURG WND CLASS PROPHYL REC", "DisplayText" : "Surgical wound classification and antimicrobial prophylaxis...  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "SURGICAL WOUND CLASSIFICATION AND ANTIMICROBIAL PROPHYLAXIS RECOMMENDATIONS"}, 
{"Row" : 8, "Column" : 1, "Text" : ">>  Clean  <<", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "A wound resulting from a procedure in which no inflammation or infection was"}, 
{"Row" : 10, "Column" : 1, "Text" : "encountered and the respiratory, alimentary, genital, or uninfected urinary"}, 
{"Row" : 11, "Column" : 1, "Text" : "tract was not entered.  Clean wounds are closed at the end of surgery and if"}, 
{"Row" : 12, "Column" : 1, "Text" : "drainage is necessary wounds are closed with drains in place."}, 
{"Row" : 14, "Column" : 1, "Text" : "Antimicrobial prophylaxis is usually not indicated.  Exceptions are procedures"}, 
{"Row" : 15, "Column" : 1, "Text" : "in which prosthetic material will be inserted or for operations in which a"}, 
{"Row" : 16, "Column" : 1, "Text" : "surgical site infection would be catastrophic.  These exceptions include most"}, 
{"Row" : 17, "Column" : 1, "Text" : "cardiac operations, joint replacement, revascularization procedures in legs, and"}, 
{"Row" : 18, "Column" : 1, "Text" : "most neurosurgical operations."}, 
{"Row" : 20, "Column" : 1, "Text" : ">>  Clean contaminated  <<", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Clean-contaminated wounds are those in which the respiratory, alimentary,"}, 
{"Row" : 22, "Column" : 1, "Text" : "genital, or urinary tracts are entered but there is no evidence of infection and"}, 
{"Row" : 23, "Column" : 1, "Text" : "there is no major break in technique.  These include operations on the biliary"}, 
{"Row" : 24, "Column" : 1, "Text" : "tract, appendix, vagina, and oropharynx."}, 
{"Row" : 26, "Column" : 1, "Text" : "Antimicrobial prophylaxis is indicated for most of these procedures."}, 
{"Row" : 28, "Column" : 1, "Text" : ">>  Contaminated  <<", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Contaminated wounds include an open, fresh, accidental wound, or operations with"}, 
{"Row" : 30, "Column" : 1, "Text" : "major breaks in sterile technique, gross spillage from the gastrointestinal"}, 
{"Row" : 31, "Column" : 1, "Text" : "tract, or incisions in which acute, non-purulent inflammation is encountered."}, 
{"Row" : 33, "Column" : 1, "Text" : "Antimicrobials are therapeutic and not prophylactic."}, 
{"Row" : 35, "Column" : 1, "Text" : ">>  Dirty-Infected  <<", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Dirty-infected wounds are old traumatic wounds with devitalized tissue and those"}, 
{"Row" : 37, "Column" : 1, "Text" : "that involve existing infection or perforated viscera.  The organisms usually"}, 
{"Row" : 38, "Column" : 1, "Text" : "have been present in the operative field since before the operation."}, 
{"Row" : 40, "Column" : 1, "Text" : "Antimicrobials are therapeutic and not prophylactic."}, 
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"}
]},
{"Name" : "ORZID2 GMENU TOXI MEGACOLON", "DisplayText" : "Severe disease - Ileus/Toxic megacolon  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References"},
{"Row" : 10, "Column" : 1, "Text" : "ANTIBIOTIC ASSOCIATED COLITIS (CLOSTRIDIUM DIFFICILE COLITIS) WITH ILEUS OR"}, 
{"Row" : 11, "Column" : 1, "Text" : "TOXIC MEGACOLON"}, 
{"Row" : 13, "Column" : 1, "Text" : "Deliver antimicrobials by intravenous, oral and rectal routes.  Gastroenterology"}, 
{"Row" : 14, "Column" : 1, "Text" : "and/or Infectious Diseases consults are essential."}, 
{"Row" : 17, "Column" : 1, "Item" : "ZZORZID2 METRONIDAZOLE 500MG IV Q8H AND VANCOMYCIN 500MG IV Q6H", "DisplayText" : "", "Text" : ""},
{"Row" : 24, "Column" : 1, "Text" : "Sanford Guide. Clostridium Difficile accessed 03/10/14"}, 
{"Row" : 26, "Column" : 1, "Text" : "Surawicz, C, et al. Guidelines for Diagnosis, Treatment and Prevention"}, 
{"Row" : 27, "Column" : 1, "Text" : "of Clostridium difficile Infections. The American Journal of Gastroenterol"}, 
{"Row" : 28, "Column" : 1, "Text" : "April 2013"}, 
{"Row" : 30, "Column" : 1, "Text" : "Cohen, S, et al. Clinical Practice Guidelines for Clostridium difficile"}, 
{"Row" : 31, "Column" : 1, "Text" : "Infection in Adults: 2010 Update by the Society for Healthcare"}, 
{"Row" : 32, "Column" : 1, "Text" : "Epidemiology of American (SHEA) and the Infectious"}, 
{"Row" : 34, "Column" : 1, "Text" : "Disease Society of America (IDSA). Infection Control and Hosptial"}, 
{"Row" : 35, "Column" : 1, "Text" : "Epidemiology. May 2010"}, 
{"Row" : 19, "Column" : 1, "Text" : "May Also Add", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJZID VANCOMYCIN 500MG/NS 100ML ENEMA Q6H", "DisplayText" : "Vancomycin 500MG ENEMA", "Text" :""}
]},
{"Name" : "ORZID2 GMENU TRANSPLANTATION", "DisplayText" : "Transplantation ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "TRANSPLANTATION"}, 
{"Row" : 14, "Column" : 1, "Text" : "Cell-mediated immune defects caused by anti-rejection drugs cause patients to be"}, 
{"Row" : 15, "Column" : 1, "Text" : "especially susceptible to infections with organisms that infrequently cause"}, 
{"Row" : 16, "Column" : 1, "Text" : "disease in healthy people.  They include: Pneumocystis jirovecii (formerly"}, 
{"Row" : 17, "Column" : 1, "Text" : "Pneumocystis carinii), mycobacteria, salmonella, candida, aspergillus,"}, 
{"Row" : 18, "Column" : 1, "Text" : "Toxoplasma gondii, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus,"}, 
{"Row" : 19, "Column" : 1, "Text" : "and cryptosporidia."}, 
{"Row" : 21, "Column" : 1, "Text" : "The approach to fever or other signs or symptoms suggesting the possibility of"}, 
{"Row" : 22, "Column" : 1, "Text" : "an infectious disease depends on the specific defects present in the patient,"}, 
{"Row" : 23, "Column" : 1, "Text" : "the nature of the presenting signs and symptoms and a bedside assessment of the"}, 
{"Row" : 24, "Column" : 1, "Text" : "severity of illness.  Empirical antimicrobials are usually not indicated for"}, 
{"Row" : 25, "Column" : 1, "Text" : "fever alone unless the patient has a host defense defect that predisposes to"}, 
{"Row" : 26, "Column" : 1, "Text" : "rapid progression of illness like severe neutropenia or splenectomy.  Contact"}, 
{"Row" : 27, "Column" : 1, "Text" : "Infectious Diseases for more information."}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 8, "Column" : 1, "Text" : "Organ transplantation is associated with many host defense defects.  Early on,"}, 
{"Row" : 9, "Column" : 1, "Text" : "surgical wounds may become infected.  Preparation for transplantation and anti-"}, 
{"Row" : 10, "Column" : 1, "Text" : "rejection drugs can induce neutropenia.  Later, CMI defects predominate."}, 
{"Row" : 11, "Column" : 1, "Text" : "Patients become infected with exogenous pathogens and also endogenous pathogens"}, 
{"Row" : 12, "Column" : 1, "Text" : "like cytomegalovirus that might have been present in latent or subclinical form."}, 
{"Row" : 32, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 33, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID2 GMENU URETHRITIS ASSOC STD", "DisplayText" : "Urethritis associated with sexually transmitted diseases  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Text" : "The main differential in a person who presents with dysuria is between cystitis"}, 
{"Row" : 14, "Column" : 1, "Text" : "and  urethritis.  Bacterial urethritis is more likely in people with mild"}, 
{"Row" : 15, "Column" : 1, "Text" : "dysuria, onset over a few days, or recent sexual contact."}, 
{"Row" : 17, "Column" : 1, "Text" : "The two most common sexually transmitted urethritis pathogens are Neisseria"}, 
{"Row" : 18, "Column" : 1, "Text" : "gonorrhoeae and  Chlamydia trachomatis.  Nucleic acid amplification tests for"}, 
{"Row" : 19, "Column" : 1, "Text" : "these pathogens are more sensitive than culture and  should be used for patients"}, 
{"Row" : 20, "Column" : 1, "Text" : "at risk for sexually transmitted urethritis."}, 
{"Row" : 23, "Column" : 1, "Text" : "For patients who have recently been treated for urethritis", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "When dysuria is from a sexually transmitted disease, the patient's sexual"}, 
{"Row" : 26, "Column" : 1, "Text" : "partner(s) during the previous 60 days should be evaluated for urethritis."}, 
{"Row" : 27, "Column" : 1, "Text" : "If diagnostic tests for the cause of urethritis are not feasible, therapy for"}, 
{"Row" : 28, "Column" : 1, "Text" : "both N. gonorrhoeae and C. trachomatis should be given to partners."}, 
{"Row" : 30, "Column" : 1, "Text" : "Initial treatment of patients and sex partners", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Patients and partners are often infected with both N. gonorrhoeae and C."}, 
{"Row" : 32, "Column" : 1, "Text" : "trachomatis."}, 
{"Row" : 35, "Column" : 1, "Text" : "Preferred treatment for N. gonorrhoaeae AND C. trachomatis", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "30"},
{"Row" : 11, "Column" : 1, "Text" : "URETHRITIS ASSOCIATED WITH SEXUALLY TRANSMITTED DISEASES"}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZ CEFTRIAXONE 125MG IM & DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Ceftriaxone 125MG IM ONCE & Doxycycline 100MG PO Q12H 7 DAYS", "Text" : ""},
{"Row" : 38, "Column" : 1, "Text" : "-OR-"}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID CEFTRIAXONE 125MG IM & AZITHROMYCIN 1000MG PO ONCE", "DisplayText" : "Ceftriaxone 125MG IM ONCE & Azithromycin 1000MG PO ONCE", "Text" :""},
{"Row" : 46, "Column" : 1, "Text" : "CDC. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Morbidity"}, 
{"Row" : 47, "Column" : 1, "Text" : "and Mortality Weekly Report. 2015:64(3):51-64"}, 
{"Row" : 49, "Column" : 1, "Text" : "Sanford Guide \"Gonorrhea: Urethritis, Cervicitis, Proctitis\" Web Edition."}, 
{"Row" : 50, "Column" : 1, "Text" : "Accessed March 15, 2017"}, 
{"Row" : 52, "Column" : 1, "Text" : "Sanford Guide \"Urethritis, Cervicitis: Chlamydial\" Web Edition. Accessed"}, 
{"Row" : 53, "Column" : 1, "Text" : "March 15, 2017"}
]},
{"Name" : "ORZID2 GMENU UROSEPSIS", "DisplayText" : "Urosepsis ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY INP", "DisplayText" : "UROLOGY INP", "Text" : "Consult Urology"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 11, "Column" : 1, "Text" : "UROSEPSIS"}, 
{"Row" : 16, "Column" : 1, "Text" : "Early intervention is crucial to prevention of death from sepsis.  Patients with"}, 
{"Row" : 17, "Column" : 1, "Text" : "signs and symptoms of severe sepsis, like hypotension or end-organ dysfunction,"}, 
{"Row" : 18, "Column" : 1, "Text" : "should be treated as outlined in the sepsis pathway.  Patients with bacteremia"}, 
{"Row" : 19, "Column" : 1, "Text" : "but without signs and symptoms of severe sepsis should be treated with"}, 
{"Row" : 20, "Column" : 1, "Text" : "antimicrobials for severe urinary tract infection and monitored closely for"}, 
{"Row" : 21, "Column" : 1, "Text" : "signs and symptoms of severe sepsis."}, 
{"Row" : 26, "Column" : 1, "Text" : "Treatment for patients WITHOUT signs and/or symptoms of severe sepsis", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "\"Urosepsis\" may refer to bacteremia or sepsis syndrome resulting from a urinary"}, 
{"Row" : 14, "Column" : 1, "Text" : "tract infection (UTI)."}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment for patients WITH signs and/or symptoms of severe sepsis", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases"},
{"Row" : 33, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""},
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : ""},
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q8H", "DisplayText" : "Zosyn 4.5GM IVPB Q8H", "Text" : ""},
{"Row" : 31, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500MG PO Q12H", "Text" : ""}
]},
{"Name" : "ORZID2 GMENU YERSINIA ENTEROCOLITICA", "DisplayText" : "Diarrhea with Yersinia enterocolitica", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobials are only indicated in cases of severe disease or if the patient"}, 
{"Row" : 13, "Column" : 1, "Text" : "is immunocompromised. Treat intestinal disease 3 to 5 days."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Severe Infection", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH YERSINIA ENTEROCOLITICA"}, 
{"Row" : 27, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID TRIMETHOPRIM/SULFAMETHOXAZOLE DS PO Q12H 5DAYS", "DisplayText" : "Trimethoprim/Sulfamethoxazole DS PO Q12H 5 DAYS", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 5 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 5 DAYS", "Text" :""},
{"Row" : 22, "Column" : 1, "Item" : "PZJIZID CEFTRIAXONE 2 GRAMS Q24H + GENT 5MG/KG Q24H 14DAYS", "DisplayText" : "Ceftriaxone 2GM + Gentamycin 5MG/KG Q24H 14 DAYS", "Text" : ""},
{"Row" : 28, "Column" : 1, "Text" : "UpToDate. Clinical manifestations and diagnosis of Yersinia infections."}, 
{"Row" : 29, "Column" : 1, "Text" : "Last updated 06/12/17"}, 
{"Row" : 31, "Column" : 1, "Text" : "Sanford Guide- web edition \"Gastroenteritis, Yersinia enterocolitica\""}, 
{"Row" : 32, "Column" : 1, "Text" : "Last accessed 12/12/17."}, 
{"Row" : 34, "Column" : 1, "Text" : "2017 Infectious Diseases Society of America Clinical Practice Guidelines"}, 
{"Row" : 35, "Column" : 1, "Text" : "for the Diagnosis and Management of Infectious Diarrhea"}, 
{"Row" : 38, "Column" : 1, "Text" : "Menu Last Updated February 2018", "Header" : 1}
]},
{"Name" : "ORZID2 H. PYLORI", "DisplayText" : "H. Pylori ", "Version" : "Fargo", "Contents" : [
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "*Kim, K. Gastric/Duodenal Ulcer, Helicobacter pylori. Sanford Guude."}, 
{"Row" : 24, "Column" : 1, "Text" : "AUg 31, 2022."}, 
{"Row" : 25, "Column" : 1, "Text" : "*Chey, William D MD, FACG1: Leontiadis, Grigorios I MD, PhD2: Howden,"}, 
{"Row" : 26, "Column" : 1, "Text" : "Colin W MD, FACG3: Moss, Steven F MD, FACG4. ACG Clinical Guideline:"}, 
{"Row" : 27, "Column" : 1, "Text" : "Treatment of Helicobacter pylori Infection. American Journal of"}, 
{"Row" : 28, "Column" : 1, "Text" : "Gastroenterology 112(2):212-239, February 2017."}, 
{"Row" : 29, "Column" : 1, "Text" : "*Lamont, J.T. Treatment regimens for Helicobacter pylori in adults."}, 
{"Row" : 30, "Column" : 1, "Text" : "UpToDate. June 20, 2023."}, 
{"Row" : 33, "Column" : 1, "Text" : "THIS MENU UPDATED SEPTEMBER 2023", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Treatment Regimen:", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "(OMEPRAZOLE + AMOXICILLIN + METRONIDAZOLE + CLARITHROMYCIN)"}, 
{"Row" : 10, "Column" : 1, "Text" : "Alternative Treatment Regimen:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "(BISMUTH + OMEPRAZOLE + METRONIDAZOLE + TETRACYCLINE)"}, 
{"Row" : 14, "Column" : 1, "Text" : "Failure of initial therapy: duration 14 days (Do NOT repeat initial therapy)", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "(OMEPRAZOLE + AMOXICILLIN + LEVOFLOXACIN)"}, 
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 OMEP + AMOX + METRONID + CLARITHRO H.PYLORI", "DisplayText" : "Clarithromycin Quadruple", "Text" : ""},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 BISMUTH + OMEP + METRONID + TETRACY H.PYLORI", "DisplayText" : "Bismuth Quadruple", "Text" : ""},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 OMEP + AMOX + METRONID + CLARITHRO H.PYLORI", "DisplayText" : "Clarithromycin Quadruple", "Text" : ""},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 BISMUTH + OMEP + METRONID + TETRACY H.PYLORI", "DisplayText" : "Bismuth Quadruple", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 OMEPRAZOLE + AMOXICILLIN + LEVOFLOXACIN H.PYLORI", "DisplayText" : "Levofloxacin Therapy", "Text" : ""},
{"Row" : 3, "Column" : 1, "Text" : "Antimicrobials should be given to patient with confirmed H. pylori infections", "Header" : 1}
]},
{"Name" : "ORZID2 HEAD AND NECK", "DisplayText" : "Head and Neck", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Head and Neck", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Ear Infections", "Header" : 1}, 
{"Row" : 3, "Column" : 2, "Text" : "Sinusitus", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Oropharyngeal Infection", "Header" : 1}, 
{"Row" : 8, "Column" : 2, "Text" : "Facial Cellulitis", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 OTITIS EXTERNA", "DisplayText" : "Otitis Externa", "Text" : ""},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 OTITIS MEDIA OLD", "DisplayText" : "Otitis Media", "Text" : ""},
{"Row" : 4, "Column" : 2, "Item" : "ORZID2 ACUTE SINUSITIS", "DisplayText" : "Acute Sinusitis", "Text" : ""},
{"Row" : 5, "Column" : 2, "Item" : "ORZID2 NASAL PACKING", "DisplayText" : "Nasal Packing", "Text" :""},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 THRUSH", "DisplayText" : "Thrush", "Text" : ""},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 PRESEPTAL CELLULITIS", "DisplayText" : "Preseptal Cellulitis", "Text" : ""},
{"Row" : 10, "Column" : 2, "Item" : "ORZID2 ORBITAL CELLULITIS", "DisplayText" : "Orbital Cellulits", "Text" : ""}
]},
{"Name" : "ORZID2 HERPES SIMPLEX ENCEPHALITIS", "DisplayText" : "Herpes Simplex Encephalitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 1, "Column" : 1, "Text" : "Herpes Simplex Virus Encephalitis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "*Early diagnosis and treatment is essential to achieve resolution of infection"}, 
{"Row" : 6, "Column" : 1, "Text" : "and symptoms. Neurology and ID consultations are strongly encouraged"}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "*Treat for 14-21 days"}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 10MG/KG IV Q8H", "DisplayText" : "Acyclovir 10MG/KG IV Q8H", "Text" : ""},
{"Row" : 17, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "This Menu Updated June 2019", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "June 4, 2019"}, 
{"Row" : 18, "Column" : 1, "Text" : "*Klein RS. Herpes simplex virus type 1 encephalitis. UpToDate."}, 
{"Row" : 20, "Column" : 1, "Text" : "*Encephalitis Sanford Guide Online. Published 2019. Accessed May 28, 2019"}
]},
{"Name" : "ORZID2 HERPES ZOSTER", "DisplayText" : "Herpes Zoster", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Herpes Zoster", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Reactivation of Primary Infection (Zoster or \"Shingles\")", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Zoster represents reactivation of varicella-zoster virus. After primary", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "infection, virus remains latent in the sensory dorsal root ganglia.", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Reactivation syndrome is characterized by painful, unilateral, vesicular,", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "dermatomal rash.", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Immunocompetent Patients", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "*Treatment in patients >/=50 may shorten duration of pain and rash."}, 
{"Row" : 12, "Column" : 1, "Text" : "*Treatment in patients <50 years: not beneficial, not recommended"}, 
{"Row" : 19, "Column" : 1, "Text" : "Immunocompromised Patients", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "*Immunocompromised patients at increased risk for complications of"}, 
{"Row" : 21, "Column" : 1, "Text" : "VZV disease include: patients with malignancy, current"}, 
{"Row" : 22, "Column" : 1, "Text" : "immunosuppressive therapy, or HIV. Treatment with antivirals"}, 
{"Row" : 23, "Column" : 1, "Text" : "shortens duration of symptoms and reduces incidence of complications."}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment must be started within 72 hours of onset in order to provide"}, 
{"Row" : 25, "Column" : 1, "Text" : "benefit."}, 
{"Row" : 27, "Column" : 1, "Text" : "*Mild to Moderate Disease"}, 
{"Row" : 37, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "THIS MENU LAST UPDATED JUNE 2019", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "*Treatment may be started after 72hour especially if new lesions occur or"}, 
{"Row" : 16, "Column" : 1, "Text" : "complications are present"}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VALACYCLOVIR 1000MG PO Q8H 7D", "DisplayText" : "Valacyclovir 1000MG PO Q8H 7 DAYS", "Text" : "Valacyclovir 1000MG PO Q8H 7 DAYS"},
{"Row" : 30, "Column" : 1, "Text" : "*Severe disease or progression from mild to moderate disease"}, 
{"Row" : 38, "Column" : 1, "Text" : "*Treatment of herpes zoster in immunocompetent host. UpToDate."}, 
{"Row" : 39, "Column" : 1, "Text" : "Accessed June 5, 2019"}, 
{"Row" : 40, "Column" : 1, "Text" : "*Herpes Zoster. Sanford Guide Web Edition.  Accessed June 5, 2019."}, 
{"Row" : 41, "Column" : 1, "Text" : "*Dworkin R, Johnson R, Gnann J, Levin M, et all. Recommendations for the"}, 
{"Row" : 42, "Column" : 1, "Text" : "Management of Herpes Zoster. Clinical Infectious Diseases. 44: S1-26"}, 
{"Row" : 43, "Column" : 1, "Text" : "Accessed June 5, 2019"}, 
{"Row" : 13, "Column" : 1, "Text" : "*Literature indicates treatment should be started within 72hours"}, 
{"Row" : 14, "Column" : 1, "Text" : "-Treat for 7 days"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 10MG/KG IV Q8H 7-14 DAYS", "DisplayText" : "Acyclovir 10MG/KG IV Q8H 7-14 DAYS", "Text" : "Acyclovir 10MG/KG IV Q8H 7-14 DAYS"}
]},
{"Name" : "ORZID2 ICU", "DisplayText" : "ICU ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Sepsis Empiric Antibiotics", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Site Unknown", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM Q6H + VANCO PHARMACY TO DOSE", "DisplayText" : "Zosyn 4.5 GM Q6H + Vancomycin Pharmacy to Dose", "Text" :""},
{"Row" : 6, "Column" : 1, "Item" : "PSJIZID AZTREONAM 2GM Q8 + VANCO PTD + FLAGYL 500MG Q8H", "DisplayText" : "Aztreonam 2GM IV Q8H + Metronidazole 500MG IV Q8H + Vancomycin Pharmacy to Dose", "Text" : "Aztreonam 2GM IV Q8H + Metronidazole 500MG IV Q8H + Vanco Pharmacy to Dose"},
{"Row" : 7, "Column" : 1, "Text" : "Suspected Intra-Abdominal Infection", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : ""},
{"Row" : 10, "Column" : 1, "Item" : "PSJIZID CIPRO 400MG IV Q12H + METRONIDAZOLE 500MG IV Q8H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H + Metronidazole 500MG IV Q8H", "Text" : "Ciprofloxacin 400MG IV Q12H + Metronidazole 500MG IV Q8H"},
{"Row" : 11, "Column" : 1, "Text" : "Community Acquired Pneumonia", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Health Care Associated/Hospital Acquired Pneumonia", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Suspected Meningitis, CNS Infection", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 BACTERIAL MENINGITIS EMPIRIC TREATMENT", "DisplayText" : "Bacterial Meningitis Empiric Treatment", "Text" : ""},
{"Row" : 17, "Column" : 1, "Text" : "Suspected Native Valve Endocarditis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM Q24H + VANCO PHARMACY TO DOSE", "DisplayText" : "Ceftriaxone 2GM Q24H + Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 19, "Column" : 1, "Text" : "Suspected Prosthetic Valve Endocarditis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 PROSTHETIC VALVE ENDOCARDITIS", "DisplayText" : "Prosthetic Valve Endocarditis", "Text" : ""},
{"Row" : 21, "Column" : 1, "Text" : "Suspected Skin Soft Tissue Infection", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM Q6H + CLINDA 900MG Q8H + VANCO PTD", "DisplayText" : "Zosyn 4.5GM IV Q6H + Clindamycin 900MG IV Q8H + Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID CIPRO 400MG Q12H + CLINDA 900MG Q8H + VANCO PTD", "DisplayText" : "Ciprofloxacin 400MG Q12H + Clindamycin 900MG Q8H + Vancomycin Pharmacy to Dose", "Text" : "Cipro 400MG IV Q12H + Clindamycin 900MG IV Q8H + Vanco Pharmacy to Dose"},
{"Row" : 25, "Column" : 1, "Text" : "Suspected Urosepsis", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 COMPLICATED CYSTITIS", "DisplayText" : "Complicated Cystitis", "Text" : ""},
{"Row" : 27, "Column" : 1, "Text" : "Suspected Severe C. dif Infection", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Neutropenic Fever", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Community Acquired Pneumonia", "Text" :""},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 NOSOCOMIAL PNEUMONIA", "DisplayText" : "Nosocomial Pneumonia", "Text" : ""},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 NEUTROPENIC FEVER NON ORAL THERAPY", "DisplayText" : "Neutropenic Fever Non-Oral Therapy", "Text" :""},
{"Row" : 5, "Column" : 1, "Text" : "Penicillin Allergy:"}, 
{"Row" : 9, "Column" : 1, "Text" : "Penicillin Allergy:"}, 
{"Row" : 23, "Column" : 1, "Text" : "Penicillin Allergy:"}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 CLOSTRIDIUM DIFFICILE MAIN", "DisplayText" : "Clostridium Difficile Main Menu", "Text" :""}
]},
{"Name" : "ORZID2 INFLUENZA", "DisplayText" : "Influenza ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Influenza", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 INFLUENZA TREATMENT", "DisplayText" : "Influenza Treatment", "Text" :""},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 INFLUENZA CHEMOPROPHYLAXIS", "DisplayText" : "Influenza Chemoprophylaxis", "Text" : ""}
]},
{"Name" : "ORZID2 INFLUENZA CANDIDATES FOR SEASONAL CHEMOPROPHYLAXIS", "DisplayText" : "Influenza Candidates for Seasonal Chemoprophylaxis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Candidates for seasonal chemoprophylaxis (no suspected exposure):", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "*Those who are at very high risk of developing complications from influenza or"}, 
{"Row" : 7, "Column" : 1, "Text" : "vaccine is expected to lack efficacy (ex: immunocompromised) or otherwise"}, 
{"Row" : 8, "Column" : 1, "Text" : "unavailable to the patient"}, 
{"Row" : 10, "Column" : 1, "Text" : "*Recipients of hematopoietic stem cell transplant in the first 6-12 months"}, 
{"Row" : 11, "Column" : 1, "Text" : "post-transplant and lung transplant patients"}, 
{"Row" : 15, "Column" : 1, "Text" : "Can consider short-term chmoprophylaxis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Can consider chemoprophylaxis for the duration of the season for:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "*Unvaccinated adults at high risk of complications who are expected to"}, 
{"Row" : 17, "Column" : 1, "Text" : "receive benefit from the vaccine while influenza is detected in the community"}, 
{"Row" : 19, "Column" : 1, "Text" : "*Chemoprophylaxis should be continued for 2 weeks after vaccination until"}, 
{"Row" : 20, "Column" : 1, "Text" : "an immune response is expected"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Healthcare workers and others in close contact with high risk persons (who are"}, 
{"Row" : 23, "Column" : 1, "Text" : "unable to take chemoprophylaxis during periods of influenza activity)"}, 
{"Row" : 24, "Column" : 1, "Text" : "when vaccination is contraindicated or until unavailable"}
]},
{"Name" : "ORZID2 INFLUENZA CHEMOPROPHYLAXIS", "DisplayText" : "Influenza Chemoprophylaxis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "*Antivirals should not be used routinely for chemoprophylaxis outside of"}, 
{"Row" : 4, "Column" : 1, "Text" : "exposure or an institutional outbreak without compelling indications"}, 
{"Row" : 5, "Column" : 1, "Text" : "(see below)"}, 
{"Row" : 7, "Column" : 1, "Text" : "*Can consider empiric initiation of antiviral treatment as alternative to"}, 
{"Row" : 8, "Column" : 1, "Text" : "Chemoprophylaxis"}, 
{"Row" : 10, "Column" : 1, "Text" : "*Switch to treatment dosing in persons receiving chemoprophylaxis or post"}, 
{"Row" : 11, "Column" : 1, "Text" : "exposure prophylaxis who become symptomatic"}, 
{"Row" : 14, "Column" : 1, "Text" : "Influenza Chemoprophylaxis (without exposure):", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Who to Treat:"}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 INFLUENZA CANDIDATES FOR SEASONAL CHEMOPROPHYLAXIS", "DisplayText" : "Influenza Candidates for Seasonal Chemoprophylaxis", "Text" : ""},
{"Row" : 19, "Column" : 1, "Text" : "Post-Exposure Chemoprophylaxsis", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Who to Treat:"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 INFLUENZA POST-EXPOSURE PROPHYLAXIS", "DisplayText" : "Influenza Post-Exposure Prophylaxis", "Text" : ""},
{"Row" : 25, "Column" : 1, "Text" : "Chemoprophylaxis Dose:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJUZID OSELTAMIVIR 75MG PO Q24H", "DisplayText" : "Oseltamivir 75MG PO Q24H", "Text" : ""},
{"Row" : 29, "Column" : 1, "Item" : "PSJUZID OSELTAMIVIR 30MG PO Q24H", "DisplayText" : "Oseltamivir 30MG PO Q24H", "Text" : "CrCl 31-60 ml/min Oseltamivir 30MG PO Q24H"},
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID OSELTAMIVIR 30MG PO Q48H", "DisplayText" : "Oseltamivir 30MG PO Q48H", "Text" : "CrCl <= 30 ml/min Oseltamivir 30MG PO Q48H"},
{"Row" : 35, "Column" : 1, "Text" : "Duration:", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "*For the entire duration of potential exposure (ex: period of influenza"}, 
{"Row" : 37, "Column" : 1, "Text" : "activity) and for 7 days after last known exposure"}, 
{"Row" : 39, "Column" : 1, "Text" : "*If vaccination is received, treat for 2 weeks after vaccination while"}, 
{"Row" : 40, "Column" : 1, "Text" : "awaiting immune response"}, 
{"Row" : 42, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "*Centers for Disease Control (CDC)"}, 
{"Row" : 44, "Column" : 1, "Text" : "https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm"}, 
{"Row" : 45, "Column" : 1, "Text" : "*2018 Infectious Diseases Society of America (IDSA) Influenza Guidelines"}, 
{"Row" : 46, "Column" : 1, "Text" : "https://www.idsociety.org/globalassets/idsa/practice-guidelines/2018-"}, 
{"Row" : 47, "Column" : 1, "Text" : "seasonal-influenza.pdf"}, 
{"Row" : 49, "Column" : 1, "Text" : "This Menu Updated February 2019", "Header" : 1}
]},
{"Name" : "ORZID2 INFLUENZA PEOPLE AT HIGH RISK", "DisplayText" : "Influenza People at High Risk  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "High Risk for Complications:", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "*Adults >=65 years old"}, 
{"Row" : 7, "Column" : 1, "Text" : "*Chronic pulmonary disorders (including asthma)"}, 
{"Row" : 9, "Column" : 1, "Text" : "*Cardiovascular disorders (except hypertension alone)"}, 
{"Row" : 11, "Column" : 1, "Text" : "*Renal, hepatic, hematologic (including sickle cell disease), or metabolic"}, 
{"Row" : 12, "Column" : 1, "Text" : "disorders (including diabetes mellitus)"}, 
{"Row" : 14, "Column" : 1, "Text" : "*Neurologic and neurodevelopment conditions (including disorders of the brain,"}, 
{"Row" : 15, "Column" : 1, "Text" : "spinal cord, peripheral nerve, and muscle such as cerebral palsy, epilepsy"}, 
{"Row" : 16, "Column" : 1, "Text" : "[seizure disorders], stroke, intellectual disability [mental retardation],"}, 
{"Row" : 17, "Column" : 1, "Text" : "moderate to severe developmental delay, muscular dystrophy, or spinal"}, 
{"Row" : 18, "Column" : 1, "Text" : "cord injury)"}, 
{"Row" : 20, "Column" : 1, "Text" : "*Persons with immunosuppression, including that caused by medications or"}, 
{"Row" : 21, "Column" : 1, "Text" : "by HIV infection"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Persons with the highest risk for complications are those who are severely"}, 
{"Row" : 23, "Column" : 1, "Text" : "immunocompromised (eg, hematopoietic stem cell transplant recipients)."}, 
{"Row" : 25, "Column" : 1, "Text" : "*Women who are pregnant or postpartum (within 2 weeks after delivery)"}, 
{"Row" : 27, "Column" : 1, "Text" : "*Patients <19 years old who are receiving aspirin- or salicylate-containing"}, 
{"Row" : 28, "Column" : 1, "Text" : "medications and who might be at risk for experiencing Reye syndrome after"}, 
{"Row" : 29, "Column" : 1, "Text" : "influenza virus infection"}, 
{"Row" : 31, "Column" : 1, "Text" : "*American influenza virus infection"}, 
{"Row" : 33, "Column" : 1, "Text" : "*Persons with extreme obesity (ie. body mass index >=40 kg/m2)"}, 
{"Row" : 35, "Column" : 1, "Text" : "*Residents of nursing homes and other chronic care facilities"}
]},
{"Name" : "ORZID2 INFLUENZA POST-EXPOSURE PROPHYLAXIS", "DisplayText" : "Influenza Post-Exposure Prophylaxis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Post-Exposure Prophylaxis:", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "*Ideally ASAP and within 48 hours after exposure, should NOT administer"}, 
{"Row" : 6, "Column" : 1, "Text" : "once-daily post-exposure chemoprophylaxis >48 hours after exposure,"}, 
{"Row" : 7, "Column" : 1, "Text" : "full treatment dose should be administered as soon as symptoms occur if"}, 
{"Row" : 8, "Column" : 1, "Text" : "treatment is indicated."}, 
{"Row" : 10, "Column" : 1, "Text" : "*Post-exposure prophylaxis for high risk persons or those in an exposed"}, 
{"Row" : 11, "Column" : 1, "Text" : "who are unvaccinated that reside with persons at high risk and the"}, 
{"Row" : 12, "Column" : 1, "Text" : "vaccine is contraindicated, unavailable"}, 
{"Row" : 14, "Column" : 1, "Text" : "*Chemoprophylaxis dosing of oseltamivir and inhaled zanamivir"}, 
{"Row" : 16, "Column" : 1, "Text" : "*Duration: 7 days after most recent exposure to close contact with influenza"}
]},
{"Name" : "ORZID2 INFLUENZA TREATMENT", "DisplayText" : "Influenza Treatment", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Who to Treat:", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "People at High risk for complications from influenza:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 INFLUENZA WHO TO TREAT", "DisplayText" : "Influenza Who to Treat", "Text" :""},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 INFLUENZA PEOPLE AT HIGH RISK", "DisplayText" : "Influenza People at High Risk", "Text" : ""},
{"Row" : 10, "Column" : 1, "Text" : "Antiviral Treatment:", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "*Treat as soon as possible with oral oseltamivir for any patient hospitalized"}, 
{"Row" : 12, "Column" : 1, "Text" : "with influenza"}, 
{"Row" : 14, "Column" : 1, "Text" : "*When indicated, start treatment as soon as possible after illness onset,"}, 
{"Row" : 15, "Column" : 1, "Text" : "ideally within 48 hours of symptom onset. However, antiviral treatment might"}, 
{"Row" : 16, "Column" : 1, "Text" : "have some benefit in patients with severe, complicated or progressive"}, 
{"Row" : 17, "Column" : 1, "Text" : "illness, and in hospitalized patients when started after 48 hours of"}, 
{"Row" : 18, "Column" : 1, "Text" : "illness onset."}, 
{"Row" : 20, "Column" : 1, "Text" : "*Switch to treatment dosing in persons receiving chemoprophylaxis or post"}, 
{"Row" : 21, "Column" : 1, "Text" : "to treatment dosing in persons receiving chemoprophylaxis or post exposure"}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment Dose and Duration:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJUZID OSELTAMIVIR 75MG PO BID 5 DAYS", "DisplayText" : "Oseltamivir 75MG PO BID 5 DAYS", "Text" : ""},
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID OSELTAMIVIR 30MG PO BID 5 DAYS", "DisplayText" : "Oseltamivir 30MG BID 5 DAYS", "Text" : "CrCl 31-60 ml/min Oseltamivir 30MG PO BID"},
{"Row" : 30, "Column" : 1, "Item" : "PSJUZID OSELTAMIVIR 30MG PO Q24H 5 DAYS", "DisplayText" : "Oseltamivir 30MG PO Q24H 5 DAYS", "Text" : "CrCl <=30 ml/min Oseltamivir 30MG PO Q24H"},
{"Row" : 32, "Column" : 1, "Text" : "*May consider longer durations if suspecting immunocompromising condition or"}, 
{"Row" : 33, "Column" : 1, "Text" : "patient require hospitalization for severe lower respiratory tract disease"}, 
{"Row" : 35, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "*Centers for Disease Control (CDC)"}, 
{"Row" : 37, "Column" : 1, "Text" : "https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm"}, 
{"Row" : 38, "Column" : 1, "Text" : "*2018 Infectious Diseases Society of America (IDSA) Influenza Guidelines"}, 
{"Row" : 39, "Column" : 1, "Text" : "https://www.idsociety.org/globalassets/idsa/practice-guidelines/2018-"}, 
{"Row" : 40, "Column" : 1, "Text" : "seasonal-influenza.pdf"}, 
{"Row" : 42, "Column" : 1, "Text" : "This Menu Updated February 2019", "Header" : 1}
]},
{"Name" : "ORZID2 INFLUENZA WHO TO TREAT", "DisplayText" : "Influenza Who to Treat", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Who to Treat (Patients with confirmed or suspected influenza):", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "*Patient of any age hospitalized for influenza"}, 
{"Row" : 7, "Column" : 1, "Text" : "*Outpatients with severe or progressive illness"}, 
{"Row" : 9, "Column" : 1, "Text" : "*Patients >=65 years old"}, 
{"Row" : 11, "Column" : 1, "Text" : "*Patients at high risk of complications (those with chronic medical conditions"}, 
{"Row" : 12, "Column" : 1, "Text" : "or the immune compromised) (Detailed list for conditions that put patients"}, 
{"Row" : 13, "Column" : 1, "Text" : "at high and very high-risk for complications is included below)"}, 
{"Row" : 15, "Column" : 1, "Text" : "*Outpatients with onset of symptoms within 48 hours of presentation"}, 
{"Row" : 17, "Column" : 1, "Text" : "*Patients in close contact with those who are at high risk of complications"}, 
{"Row" : 18, "Column" : 1, "Text" : "from influenza (particularly the immunocompromised)"}, 
{"Row" : 20, "Column" : 1, "Text" : "*Healthcare providers who care for those who may be at high risk for"}, 
{"Row" : 21, "Column" : 1, "Text" : "complications (particularly those who are immunocompromised)"}
]},
{"Name" : "ORZID2 LEVO 500MG IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H + Metronidazole 500MG IVPB Q8H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 LEVOFLOXACIN 750MG IVPB Q24H/VANCO 7 DAYS", "DisplayText" : "Levofloxacin 750MG IVPB Q24H + Vancomycin IVPB", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID LEVOFLOXACIN 750MG IVPB Q24H 7 DAYS", "DisplayText" : "Levofloxacin 750MG IVPB Q24H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""}
]},
{"Name" : "ORZID2 LEVOFLOXACIN 750MG PO Q24H/VANCO PTD", "DisplayText" : "Levofloxacin 750MG PO Q24H + Vanco Pharmacy to Dose ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750MG PO Q24H", "Text" : ""}
]},
{"Name" : "ORZID2 LIVER SECRETORY OR METABOLIC IMPAIR", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 LUNG ABCESS", "DisplayText" : "Lung Abcess  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Lung Abcess", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Pulmonary and/or ID consultations are strongly encouraged for all cases."}, 
{"Row" : 5, "Column" : 1, "Text" : "Obtain samples for gram stain and culture from fine needle aspiration"}, 
{"Row" : 6, "Column" : 1, "Text" : "whenever possible. Sputum culture is less helpful because it will be"}, 
{"Row" : 7, "Column" : 1, "Text" : "contaminated with upper respiratory flora. Classically, lung abscess"}, 
{"Row" : 8, "Column" : 1, "Text" : "is a complication of mixed anaerobic and aerobic pulmonary infection."}, 
{"Row" : 9, "Column" : 1, "Text" : "The initial infection may or may not be clinically apparent. Malaise,"}, 
{"Row" : 10, "Column" : 1, "Text" : "weight loss, fever, chills, and malodorous sputum typically develop"}, 
{"Row" : 11, "Column" : 1, "Text" : "over a period of weeks."}, 
{"Row" : 12, "Column" : 1, "Text" : "*Cavitation and/or abscess can occur in cases of pneumonia from a single"}, 
{"Row" : 13, "Column" : 1, "Text" : "pathogen, commonly Staphylococcus aureus or Pseudomonas aeruginosa."}, 
{"Row" : 14, "Column" : 1, "Text" : "Antmicrobial treatment shout be directed against the specific pathogen."}, 
{"Row" : 15, "Column" : 1, "Text" : "*Treat for 6-8 weeks and adjust treatment based on clinical response. Oral"}, 
{"Row" : 16, "Column" : 1, "Text" : "medications should be used in patients who can take them."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID ZOSYN 3.375GM IVPB Q6H", "DisplayText" : "Zosyn 3.375GM IVPB Q6H", "Text" : "Zosyn 3.375GM IVPB Q6H"},
{"Row" : 24, "Column" : 1, "Text" : "*Alternative"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H", "Text" : "Ceftriaxone 1GM IVPB Q24H + Metronidazole 500MG IVPB Q8H"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 LEVO 500MG IVPB Q24H/METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H + Metronidazole 500MG IVPB Q8H", "Text" : "Levofloxacin 500MG IVPB Q24H + Metronidazole 500MG IVPB Q8H"},
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" : "Metronidazole 500MG IVPB Q8H"},
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "**May Substitute Clindamycin 600MG IVPB Q8H for Metronidazole"},
{"Row" : 30, "Column" : 1, "Text" : "*Preferred Oral Treatment"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H", "Text" : "Amoxicillin 875/Clavulanate 125MG PO Q12H"},
{"Row" : 33, "Column" : 1, "Text" : "*Alternative Oral Treatment"}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO Q24H/METRONIDAZOLE 500MG PO Q8H", "DisplayText" : "Levofloxacin 500MG PO Q24H + Metronidazole 500MG PO Q8H", "Text" : "Levofloxacin 500MG PO Q24H + Metronidazole 500MG PO Q8H"},
{"Row" : 36, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "Levofloxacin 500MG PO Q24H"},
{"Row" : 37, "Column" : 1, "Item" : "PSJUZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "**May substitute CLindamycin 300MG PO Q6H for Metronidazole"},
{"Row" : 41, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "*Septimus EJ. Pleural effusion and empyema. In: Mandell GL, Bennett JC"}, 
{"Row" : 43, "Column" : 1, "Text" : "Dolin R, eds. Mandell Douglas and Bennett's: Principles and Practice of"}, 
{"Row" : 44, "Column" : 1, "Text" : "Infectious Disease. Vol 1. 7th ed. Philadelphia, PA: Elsevier"}, 
{"Row" : 45, "Column" : 1, "Text" : "*Kasper DL, Cohen-Poradosu R. Infections due to mixed anaerobic organisms. In:"}, 
{"Row" : 46, "Column" : 1, "Text" : "Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds."}, 
{"Row" : 47, "Column" : 1, "Text" : "Harrison's Principles of Internal Medicine. 18th ed. New York, NY:"}, 
{"Row" : 48, "Column" : 1, "Text" : "McGraw-Hill"}, 
{"Row" : 49, "Column" : 1, "Text" : "*Up-to-Date: Parapneumonic effusion and empyema in adults"}, 
{"Row" : 50, "Column" : 1, "Text" : "*Sanford Guide: Empyema"}, 
{"Row" : 52, "Column" : 1, "Text" : "This Menu Updated January 2019", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 19, "Column" : 1, "Text" : "*Preferred IV"}, 
{"Row" : 26, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 35, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 LYME'S DISEASE", "DisplayText" : "Lyme's Disease  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Lyme's Disease", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Lyme disease results from the transmission of Borrelia burgorferi from an", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "Ixodes spp. Tick bite. Patients who display signs of illness or fever", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "within 30 days of removing an attached tick should be evaluated for", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "tick-borne illness. In the upper Midwest these are Lyme disease, human", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "anaplasmosis (formerly granulocytic ehrlichiosis, HGE) and babesiosis.", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Patients who have been bitten by and Ixodes spp. Tick (deer tick) but", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "who do not display signs or symptoms of infection should not be", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "treated with antimicrobials unless they have been exposed in an area", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "with an extremely high risk of Lyme disease from tick bites. In the U.S.", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "these areas exist only in small foci in the mid-Atlantic states.", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Preventative antimicrobial treatment may be beneficial in certain", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "patients who have been bitten while in endemic areas. Contact", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Infectious Diseases for more information", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Except for erythema migrans, Lyme disease is a complicated, difficult", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "disease to diagnose and treat. Infectious Disease consultation is", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "strongly encouraged.", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 ERYTHEMA MIGRANS ASSOCIATED WITH LYME DISEASE", "DisplayText" : "Erythema Migrans Associated with Lyme Disease", "Text" : ""},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 NEUROLOGICAL DISEASE ASSOCIATED WITH LYME DISEASE", "DisplayText" : "Neurological Disease Associated with Lyme Disease", "Text" :""},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 ARTHRITIS ASSOCIATED WITH LYME DISEASE", "DisplayText" : "Arthritis Associated with Lyme Disease", "Text" : ""}
]},
{"Name" : "ORZID2 MAIN MENU", "DisplayText" : "Antibiotic Therapy INPT  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Welcome. Please click on the diagnosis or syndrome you wish to treat.", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "SYNDROMES and DISEASES, by ORGAN SYSTEM", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 CENTRAL NERVOUS SYSTEM", "DisplayText" : "Central Nervous System", "Text" : ""},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 HEAD AND NECK", "DisplayText" : "Head and Neck", "Text" : ""},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 PULMONARY", "DisplayText" : "Pulmonary", "Text" : ""},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 CARDIOVASCULAR", "DisplayText" : "Cardiovascular", "Text" : ""},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GASTROINTESTINAL AND INTRA-ABDOMINAL", "DisplayText" : "Gastrointestinal and Intra-Abdominal", "Text" :""},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GENITOURINARY", "DisplayText" : "Genitourinary", "Text" : ""},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 SKIN, SOFT TISSUE", "DisplayText" : "Skin, Soft Tissue", "Text" : ""},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 SYSTEMIC INFECTIOUS DISEASE", "DisplayText" : "Systemic Infectious Disease", "Text" :""},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 ICU", "DisplayText" : "ICU", "Text" : ""}
]},
{"Name" : "ORZID2 MULTIPLE INFECT REQUIRED ABX", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 NASAL PACKING", "DisplayText" : "Nasal Packing", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Nasal Packing (Prevention of Infection)", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Discontinue systemic antimicrobials when the packing is removed"}, 
{"Row" : 6, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Item" : "PSJUZID CEPHALEXIN 500MG PO Q6H", "DisplayText" : "Cephalexin 500MG PO Q6H", "Text" : "Cephalexin 500MG PO Q6H"},
{"Row" : 9, "Column" : 1, "Item" : "PSJUZID DICLOXACILLIN 500MG PO Q6H", "DisplayText" : "Dicloxacillin 500MG PO Q6H", "Text" : "Dicloxacillin 500MG PO Q6H"},
{"Row" : 11, "Column" : 1, "Text" : "*Alternative for Beta-Lactam allergy"}, 
{"Row" : 12, "Column" : 1, "Item" : "PSJUZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300MG PO Q6H"},
{"Row" : 8, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 14, "Column" : 1, "Text" : "*If patient is unable to take PO medication"}, 
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID CEFZOLIN 1GM IVPB Q8H", "DisplayText" : "Cefazolin 1GM IVPB Q8H", "Text" : "Cefazolin 1-2GM IVPB Q8H"},
{"Row" : 17, "Column" : 1, "Text" : "*Alternative if unable to take PO medications and beta-lactam allergy"}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IVPB Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600MG IVPB Q8H"},
{"Row" : 23, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "*\"Mandell\" chapter: Infections of the Oral Cavity, Neck, and Head"}, 
{"Row" : 28, "Column" : 1, "Text" : "This Menu Updated January 2019", "Header" : 1}
]},
{"Name" : "ORZID2 NATIVE VALVE ENDOCARDITIS", "DisplayText" : "Native Valve Endocarditis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Native Valve Endocarditis", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Empiric Treatment", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "*Early Infectious Disease consult recommended."}, 
{"Row" : 4, "Column" : 1, "Text" : "*If patient is not acutely ill and not in heart failure, the preference is to"}, 
{"Row" : 5, "Column" : 1, "Text" : "wait for blood culture results."}, 
{"Row" : 6, "Column" : 1, "Text" : "*If initial 3 blood cultures are negative after 24-48 hours, obtain 2-3 more"}, 
{"Row" : 7, "Column" : 1, "Text" : "blood cultures before starting empiric therapy."}, 
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 VANCOMYCIN/CEFTRIAXONE 2GM Q24H", "DisplayText" : "Vancomycin + Ceftriaxone 2GM IVPB Q24H", "Text" : "VANCOMYCIN PHARMACY TO DOSE + CEFTRIAXONE 2GM IVPB Q24H"},
{"Row" : 12, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 VANCO/GENTAMICIN 1MG/KG Q8H", "DisplayText" : "Vancomycin + Gentamicin 1MG/KG Q8H", "Text" : "VANCOMYCIN PHARMACY TO DOSE + GENTAMICIN 1MG/KG IVPB Q8H"},
{"Row" : 14, "Column" : 1, "Text" : "*Favor vancomycin + gentamicin if the patient has any of the following"}, 
{"Row" : 15, "Column" : 1, "Text" : "characteristics:"}, 
{"Row" : 16, "Column" : 1, "Text" : "IV drug user, indwelling cardiovascular medical devices, alcoholism,"}, 
{"Row" : 17, "Column" : 1, "Text" : "cirrhosis, burns, homeless, body lice"}, 
{"Row" : 20, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Sanford Guide to Antimicrobial Therapy 2019"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Baddour LM, et al. Infective endocarditis in adults: diagnosis, antimicrobial"}, 
{"Row" : 23, "Column" : 1, "Text" : "therapy, and management of complications, a scientific statement for healthcare"}, 
{"Row" : 24, "Column" : 1, "Text" : "professionals from the American Heart Association.  Circulation.  2015"}, 
{"Row" : 25, "Column" : 1, "Text" : "132:1435-1486"}, 
{"Row" : 30, "Column" : 1, "Text" : "THIS MENU UPDATED COTOBER 2019", "Header" : 1}
]},
{"Name" : "ORZID2 NEUROLOGICAL DISEASE ASSOCIATED WITH LYME DISEASE", "DisplayText" : "Neurological Disease Associated with Lyme Disease", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treat neurological disease associated with Lyme disease", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Treat isolated facial palsy (Bell Palsy) with oral antimicrobials"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treat more extensive neurological disease with intravenous antimicrobials"}, 
{"Row" : 18, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "*Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 20, "Column" : 1, "Text" : "*Up-To-Date"}, 
{"Row" : 23, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "PSJUZID DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100MG PO Q12H FOR 14-21 DAYS"},
{"Row" : 7, "Column" : 1, "Text" : "-OR-"}, 
{"Row" : 8, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN 500MG PO Q8H", "DisplayText" : "Amoxicillin 500MG PO Q8H", "Text" : "Amoxicillin 500MG PO Q8H FOR 14-21 DAYS"},
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 2GM IVPB Q24H FOR 14-28 DAYS"}
]},
{"Name" : "ORZID2 NEUTROPENIC FEVER MAIN", "DisplayText" : "Neutropenic Fever  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Neutropenic Fever", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "The risk of severe, rapidly progressive infections increases when the absolute", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "neutrophil count (ANC, segmented neutrophils plus bands) is less than 500", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "cells/microliter. Because of these risks, patient with fever and", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "neutropenia to this degree should receive empirical antimicrobial therapy", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "immediately. Empirical therapy should also be given to patients with fever", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "and ANC 500-1000 cells/microliter when the concentration is expected to", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "be <500 cells/microliter within the next 48hours. For this purpose, fever", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "is defined as a single temperature greater than 38.3 degrees Celsius.", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Initial Therapy: Since infection can be rapidly progressive and severe,", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "broad-spectrum antimicrobials are given urgently to patients with", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "neutropenic fever as defined above. Vancomycin should only be given", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "when there are clear indications for its use.", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Indications for Vancomycin Include:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "*Catheter related infection"}, 
{"Row" : 20, "Column" : 1, "Text" : "*Blood culture positive for gram positive bacteria prior to final"}, 
{"Row" : 21, "Column" : 1, "Text" : "identification and susceptibilities testing"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Known colonization with penicillin/cephalosporin resistant pneumococci"}, 
{"Row" : 23, "Column" : 1, "Text" : "or MRSA"}, 
{"Row" : 24, "Column" : 1, "Text" : "*Hypotension or septic shock without an identified pathogen"}, 
{"Row" : 25, "Column" : 1, "Text" : "*Skin/soft tissue infection"}, 
{"Row" : 27, "Column" : 1, "Text" : "Candidates for empirical treatment with oral antimicrobials include those who:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "*Are able to seek immediate medical care if their condition worsens at home"}, 
{"Row" : 29, "Column" : 1, "Text" : "*Are outpatient at the time of fever development"}, 
{"Row" : 30, "Column" : 1, "Text" : "*Have no associated comorbid illness which would independently indicate"}, 
{"Row" : 31, "Column" : 1, "Text" : "inpatient treatment or close observation"}, 
{"Row" : 32, "Column" : 1, "Text" : "*Have an anticipated duration of neutropenia </= 100cell/mcL for <7 days"}, 
{"Row" : 33, "Column" : 1, "Text" : "*Have a good performance status (ECOG 0-1)"}, 
{"Row" : 34, "Column" : 1, "Text" : "*MASCC risk index score of 21 or greater"}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 NEUTROPENIC FEVER ORAL THERAPY", "DisplayText" : "Neutropenic Fever Oral Therapy", "Text" : ""},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 NEUTROPENIC FEVER NON ORAL THERAPY", "DisplayText" : "Neutropenic Fever Non-Oral Therapy", "Text" :""}
]},
{"Name" : "ORZID2 NEUTROPENIC FEVER NON ORAL THERAPY", "DisplayText" : "Neutropenic Fever Non-Oral Therapy", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment WITHOUT Vancomycin", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : ""},
{"Row" : 6, "Column" : 1, "Item" : "PSJIZID CEFEPIME 2GM IV Q8H", "DisplayText" : "Cefepime 2GM IVPB Q8H", "Text" : ""},
{"Row" : 8, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM IVPB Q8H", "DisplayText" : "Meropenem 1GM IVPB Q8H", "Text" :""},
{"Row" : 10, "Column" : 1, "Text" : "Treatment WITH Vancomycin", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM Q6H & VANCO PHARMACY TO DOSE", "DisplayText" : "Piperacillin/Tazobactam 4.5GM Q6H & Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID CEFEPIME 2GM Q8H + VANCO PHARMACY TO DOSE", "DisplayText" : "Cefepime 2GM Q8H + Vancomycin Pharmacy to Dose", "Text" :""},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM Q8H + VANCO PHARMACY TO DOSE", "DisplayText" : "Meropenem 1GM Q8H + Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 22, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 7, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 15, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 17, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 11, "Column" : 1, "Text" : "*Discontinue Vancomycin within 3 days unless culture results indicate"}, 
{"Row" : 12, "Column" : 1, "Text" : "continued therapy needed."}
]},
{"Name" : "ORZID2 NEUTROPENIC FEVER ORAL THERAPY", "DisplayText" : "Neutropenic Fever Oral Therapy ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "PSJUZID CIPRO 500MG PO Q12H + AUGMENTIN 875 PO Q12H", "DisplayText" : "Ciprofloxacin 500MG PO Q12H + AUGMENTIN 875 PO Q12H", "Text" : ""},
{"Row" : 6, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Item" : "PSJUZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : ""},
{"Row" : 10, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "*NCCN Guidelines Version 1.2013. Prevention and Treatment of Cancer"}, 
{"Row" : 12, "Column" : 1, "Text" : "Related Infections"}, 
{"Row" : 15, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}
]},
{"Name" : "ORZID2 NOSOCOMIAL PNEUMONIA", "DisplayText" : "Nosocomial Pneumonia  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Nosocomial Pneumonia", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Risk Factors", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Current hospitalization of at least 5 days"}, 
{"Row" : 5, "Column" : 1, "Text" : "*Antimicrobial therapy within the past 90 days"}, 
{"Row" : 6, "Column" : 1, "Text" : "*High frequency of antibiotic resistance in the community or in the specific"}, 
{"Row" : 7, "Column" : 1, "Text" : "hospital unit"}, 
{"Row" : 8, "Column" : 1, "Text" : "*Presence of risk factors of HCAP"}, 
{"Row" : 9, "Column" : 1, "Text" : "-Hospitalization for 2 days or more in the preceding 90 days"}, 
{"Row" : 10, "Column" : 1, "Text" : "-Residence in a nursing home or extended care facility"}, 
{"Row" : 11, "Column" : 1, "Text" : "-Home infusion therapy (including antibiotics)"}, 
{"Row" : 12, "Column" : 1, "Text" : "-Chronic dialysis within 30 days"}, 
{"Row" : 13, "Column" : 1, "Text" : "-Home wound care"}, 
{"Row" : 14, "Column" : 1, "Text" : "-Family member with multidrug-resistant pathogen"}, 
{"Row" : 15, "Column" : 1, "Text" : "*Immunosuppressive disease and/or therapy"}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "*If risk factors are present:"}, 
{"Row" : 19, "Column" : 1, "Text" : "-Preferred Treatment"}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 ZOSYN 4.5GM IVPB Q6H/VANCO 7 DAYS", "DisplayText" : "Zosyn 4.5GM IVPB Q6H + Vancomycin IVPB", "Text" : "Zosyn 4.5GM IVPB Q6H + Vancomycin IVPB"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 CEFTAZADIME 2GM IVPB Q8H/VANCO 7 DAYS", "DisplayText" : "Ceftazadime 2GM IVPB Q8H + Vancomycin", "Text" : "Ceftazadime 2GM IVPB Q8H + Vancomycin IVPB"},
{"Row" : 24, "Column" : 1, "Text" : "-Alternative Treatment (if penicillin allergy)"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 LEVOFLOXACIN 750MG IVPB Q24H/VANCO 7 DAYS", "DisplayText" : "Levofloxacin 750MG IVPB Q24H + Vancomycin IVPB", "Text" : "Levofloxacin 750MG IVPB Q24H + Vancomycin IVPB"},
{"Row" : 27, "Column" : 1, "Text" : "*If risk factors are not present"}, 
{"Row" : 28, "Column" : 1, "Text" : "-Preferred Treatment"}, 
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IVPB Q24H/AZITHROMYCIN 500MG IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H + Axithromycin 500MG IVPB Q24H", "Text" : "Ceftriaxone 1GM IVPB Q24H + Azithromycin 500MG IVPB Q24H"},
{"Row" : 32, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "*Anonymous Treatment (if penicillin allergy)"}, 
{"Row" : 34, "Column" : 1, "Text" : "*Sanford Guide Online (Accessed 3/12/14)"}, 
{"Row" : 35, "Column" : 1, "Text" : "*Up-to-date accessed 3/4/14"}, 
{"Row" : 37, "Column" : 1, "Text" : "This Menu Updated April 2014", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 OMEP + AMOX + METRONID + CLARITHRO H.PYLORI", "DisplayText" : "Clarithromycin Quadruple ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID2 OMEPRAZOLE 20MG BID X14 DAYS H.PYLORI", "DisplayText" : "Omeprazole 20MG BID X14 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID2 AMOXICILLIN 1000MG BID X14 DAYS H.PYLORI", "DisplayText" : "Amoxicillin 1000MG BID X14 DAYS", "Text" :""},
{"Row" : 3.0 , "Item" : "ORZID2 METRONIDAZOLE 500MG BID X14 DAYS H.PYOLORI", "DisplayText" : "METRONIDAZOLE 500MG BID X14 DAYS", "Text" : ""},
{"Row" : 4.0 , "Item" : "ORZID2 CLARITHROMYCIN 500MG BID X14 DAYS H.PYLORI", "DisplayText" : "CLARITHROMYCIN 500MG BID X14 DAYS", "Text" : ""}
]},
{"Name" : "ORZID2 OMEPRAZOLE + AMOXICILLIN + LEVOFLOXACIN H.PYLORI", "DisplayText" : "Levofloxacin Therapy  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID2 OMEPRAZOLE 20MG BID X14 DAYS H.PYLORI", "DisplayText" : "Omeprazole 20MG BID X14 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID2 AMOXICILLIN 1000MG BID X14 DAYS H.PYLORI", "DisplayText" : "Amoxicillin 1000MG BID X14 DAYS", "Text" :""},
{"Row" : 3.0 , "Item" : "ORZID2 LEVOFLOXACIN 500MG Q24H X14 DAYS H.PYLORI", "DisplayText" : "LEVOFLOXACIN 500MG Q24H X14 DAYS", "Text" : ""}
]},
{"Name" : "ORZID2 ORBITAL CELLULITIS", "DisplayText" : "Orbital Cellulits  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Orbital Cellulitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Preseptal cellulitis involves soft tissues in front of the orbital septum"}, 
{"Row" : 5, "Column" : 1, "Text" : "and the eyelids. Infection does not involve the orbital contents. Post"}, 
{"Row" : 6, "Column" : 1, "Text" : "septal cellulitis (orbital cellulitis) requires immediate consultation"}, 
{"Row" : 7, "Column" : 1, "Text" : "with otolaryngology and ophthalmology. Urgent surgical drainage may be"}, 
{"Row" : 8, "Column" : 1, "Text" : "be necessary. Most preseptal and/or postseptal cellulitis in adults is"}, 
{"Row" : 9, "Column" : 1, "Text" : "preceded by sinusitis. The most common organisms in adults are streptococci,"}, 
{"Row" : 10, "Column" : 1, "Text" : "haemophilus influenza, anaerobes, and staphylococcus aureus."}, 
{"Row" : 11, "Column" : 1, "Text" : "*Contact otolaryngology or ophthalmology immediately for urgent surgical"}, 
{"Row" : 12, "Column" : 1, "Text" : "drainage. Broad-spectrum empiric antimicrobials should be used until a"}, 
{"Row" : 13, "Column" : 1, "Text" : "pathogen can be identified from the drainage fluid."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "*Primary"}, 
{"Row" : 19, "Column" : 1, "Text" : "*Alternative"}, 
{"Row" : 23, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "*\"Mandell\" chapter. Periocular infections"}, 
{"Row" : 25, "Column" : 1, "Text" : "*Johns Hopkins website. Periocular infections"}, 
{"Row" : 30, "Column" : 1, "Text" : "This Menu Updated December 2015", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 VANCO/CEFTRIAXONE 1GM Q24H/METRONIDAZOLE 500MG Q8H", "DisplayText" : "Vancomycin + Ceftriaxone 1GM Q24H + Metronidazole 500MG Q8H", "Text" : "Vancomycin + Ceftriaxone 1GM Q24H + Metronidazole 500MG Q8H"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 VANCO/CIPRO 400MG Q12H/METRONIDAZOLE 500MG Q8H", "DisplayText" : "Vancomycin + Ciprofloxacin 400MG Q12H + Metronidazole 500MG Q8H", "Text" : "Vancomycin + Ciprofloxacin 400MG Q12H + Metronidazole 500MG Q8H"}
]},
{"Name" : "ORZID2 OTHER ADVERSE DRUG AFFECT", "DisplayText" : "Alternative Antimicrobial Required", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "OR GTX ORDERABLE ITEM", "DisplayText" : "Orderable Item:", "Text" : "Order:"},
{"Row" : 3.0 , "Item" : "OR GTX WORD PROCESSING 1", "DisplayText" : "Comments:", "Text" : "Order:"}
]},
{"Name" : "ORZID2 OTITIS EXTERNA", "DisplayText" : "Otitis Externa  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Otitis Externa", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Mild (Usually does not require antibiotic therapy)"}, 
{"Row" : 7, "Column" : 1, "Text" : "*Moderate/Severe with intact tympanic membrane"}, 
{"Row" : 10, "Column" : 1, "Text" : "*Moderate/Severe with perforated tympanic membrane"}, 
{"Row" : 15, "Column" : 1, "Text" : "*Severe Disease"}, 
{"Row" : 17, "Column" : 1, "Text" : "-Systemic antibiotics indicated along with topical antibiotics for deeper"}, 
{"Row" : 18, "Column" : 1, "Text" : "tissue infection beyond external auditory canal when canal is completely"}, 
{"Row" : 19, "Column" : 1, "Text" : "occluded from edema and also in patients that are severely"}, 
{"Row" : 20, "Column" : 1, "Text" : "immunocompromised"}, 
{"Row" : 25, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "*Drug Treatment for Swimmer's Ear: An Update. Pharmacist's Letter/Prescriber's"}, 
{"Row" : 27, "Column" : 1, "Text" : "Letter 2009:25(8):250808"}, 
{"Row" : 28, "Column" : 1, "Text" : "*Otitis Externa, Swimmer's Ear. (2013, August 26). Retrieved August 25, 2015,"}, 
{"Row" : 29, "Column" : 1, "Text" : "from http://www.webedition-dva-sanfordguide.com/sanford-"}, 
{"Row" : 30, "Column" : 1, "Text" : "guide-online/disease-clinical-condition/swimmers-ear"}, 
{"Row" : 31, "Column" : 1, "Text" : "*Clinical Practice Guideline: Acute Otitis Externa. (2014, March 20). Retrieved"}, 
{"Row" : 32, "Column" : 1, "Text" : "August 26, 2015, from http://www.entnet.org/content/clinical-practice-"}, 
{"Row" : 33, "Column" : 1, "Text" : "guideline-acute-otitis-externa"}, 
{"Row" : 34, "Column" : 1, "Text" : "*External otitis: Treatment. (n.d.). Retrieved August 26, 2015, from"}, 
{"Row" : 35, "Column" : 1, "Text" : "http://www.uptodate.com/contents/external-otitis-treatment?source="}, 
{"Row" : 36, "Column" : 1, "Text" : "machineLearning&search=otitis externa"}, 
{"Row" : 40, "Column" : 1, "Text" : "This Menu Updated August 2015", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "PSJUZID ACETIC ACID 2% OTIC SOLN", "DisplayText" : "Acetic Acid 2% 5 drops 3-4 times/day", "Text" : "Acetic Acid 2% 5 drops 3-4 times/day"},
{"Row" : 8, "Column" : 1, "Item" : "PSJUZID HC/NEOMYCIN/POLYMYXIN OTIC SOLN 4 DROPS QID 10D", "DisplayText" : "Hydrocortisone/Neomycin/Polymyxin 4 drops QID", "Text" : "Hydrocortisone/Neomycin/Polymyxin 4 drops QID"},
{"Row" : 11, "Column" : 1, "Item" : "PSJUZID OFLOXACIN 0.3% OPTH SOLN Q24H 7D", "DisplayText" : "Ofloxacin 0.3% Opthalmic Soln 10 DROPS Q24H", "Text" : "Ofloxacin 0.3% Opthalmic Soln 10 DROPS Q24H"},
{"Row" : 13, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 0.3% OPTH SOLN OTITIS EXTERNA", "DisplayText" : "Ciprofloxacin 0.3% 3 DROPS BID", "Text" : "Ciprofloxacin 0.3% 3 DROPS BID"},
{"Row" : 21, "Column" : 1, "Item" : "PSJUZID CIPRO AND DOXY OTITIS EXTERNA", "DisplayText" : "Ciprofloxacin 500MG BID & Doxycycline 100MG BID", "Text" : "Ciprofloxacin 500MG BID & Doxycycline 100MG BID"},
{"Row" : 16, "Column" : 1, "Text" : "-Consult ENT"}, 
{"Row" : 12, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 OTITIS MEDIA OLD", "DisplayText" : "Otitis Media ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Otitis Media", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*First Line (non-severe)"}, 
{"Row" : 7, "Column" : 1, "Text" : "*First Line (severe - patient with fever, significant pain, and/or marked"}, 
{"Row" : 8, "Column" : 1, "Text" : "erythema OR failure with antibiotics at 48-72h)"}, 
{"Row" : 13, "Column" : 1, "Text" : "*Penicillin Allergy"}, 
{"Row" : 17, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "*Otitis Media: Diagnosis and Treatment. (2013, October 1) Retrieved"}, 
{"Row" : 19, "Column" : 1, "Text" : "August 21, 2015 from http://www.aafp.org/afp/2013/1001/p435.htm."}, 
{"Row" : 20, "Column" : 1, "Text" : "*Otitis Media, Acute, Empiric Therapy. (2015, February 25). Retrieved"}, 
{"Row" : 21, "Column" : 1, "Text" : "August 25, 2015, from http://www.webedition-dva-sanfordguide.com/sanford"}, 
{"Row" : 22, "Column" : 1, "Text" : "guide-online/disease-clinical-condition/otitis-media?searchterm=otitis media"}, 
{"Row" : 23, "Column" : 1, "Text" : "*Acute otitis media in adults (suppurative and serous). (n.d.). Retrieved"}, 
{"Row" : 24, "Column" : 1, "Text" : "August 26, 2015, from http://www.uptodate.com/contents/acute-otitis-media-"}, 
{"Row" : 25, "Column" : 1, "Text" : "in-adults-suppurative-and-serous?source=machineLearning&search=otitis media"}, 
{"Row" : 26, "Column" : 1, "Text" : "adult&selectedTitle=1~150ionRank=1&anchor=H17#H17"}, 
{"Row" : 29, "Column" : 1, "Text" : "This Menu Updated August 2015", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN 500MG PO Q8H 10 DAYS", "DisplayText" : "Amoxicillin 500MG PO Q8H 10 DAYS", "Text" : "Amoxicillin 500MG PO Q8H 10 DAYS"},
{"Row" : 9, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 10 DAYS", "DisplayText" : "Amoxicillin 875/Clavulanate 125MG PO Q12H 10 DAYS", "Text" : "Amoxicillin 875/Clavulanate 125MG PO Q12H 10 DAYS"},
{"Row" : 10, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 11, "Column" : 1, "Item" : "PSJUZID CEFUROXIME 500MG PO Q12H 10 DAYS", "DisplayText" : "Cefuroxime 500MG PO Q12H 10 DAYS", "Text" : "Cefuroxime 500MG PO Q12H 10 DAYS"},
{"Row" : 14, "Column" : 1, "Item" : "PSJUZID AZITHROMYCIN ZPACK", "DisplayText" : "Azithromycin ZPak", "Text" : "Azithromycin ZPak"}
]},
{"Name" : "ORZID2 PNEUMONIA", "DisplayText" : "Pneumonia ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Pneumonia", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Community Acquired Pneumonia", "Text" :""},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 NOSOCOMIAL PNEUMONIA", "DisplayText" : "Nosocomial Pneumonia", "Text" : ""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 ASPIRATION PNEUMONIA", "DisplayText" : "Aspiration Pneumonia", "Text" : ""}
]},
{"Name" : "ORZID2 PRESEPTAL CELLULITIS", "DisplayText" : "Preseptal Cellulitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Preseptal Cellulitis", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Preseptal cellulitis involves soft tissues in front of the orbital septum"}, 
{"Row" : 5, "Column" : 1, "Text" : "and the eyelids. Infection does not involve the orbital contents. Post"}, 
{"Row" : 6, "Column" : 1, "Text" : "septal cellulitis (orbital cellulitis) requires immediate consultation with"}, 
{"Row" : 7, "Column" : 1, "Text" : "otolaryngology and ophthalmology. Urgent surgical drainage may be necessary."}, 
{"Row" : 8, "Column" : 1, "Text" : "Most preseptal and/or postseptal cellulitis in adults is preceded by"}, 
{"Row" : 9, "Column" : 1, "Text" : "sinusitis. The most common organisms in adults are streptococci, haemophilus"}, 
{"Row" : 10, "Column" : 1, "Text" : "influenza, anaerobes, and staphylococcus aureus."}, 
{"Row" : 11, "Column" : 1, "Text" : "*Intravenous antimicrobials are indicated initially for treatment of moderate"}, 
{"Row" : 12, "Column" : 1, "Text" : "to severe disease. Switch to oral antimicrobials when the patient's"}, 
{"Row" : 13, "Column" : 1, "Text" : "symptoms improve and the patient can tolerate oral medications."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "*Mild disease- treat 10-14 days under the guidance of ophthalmology"}, 
{"Row" : 17, "Column" : 1, "Text" : "and/or otolaryngology"}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJUZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H", "Text" : "Amoxicillin 875/Clavulanate 125MG PO Q12H"},
{"Row" : 20, "Column" : 1, "Item" : "PSJUZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300MG PO Q6H"},
{"Row" : 19, "Column" : 1, "Text" : "*Alternative"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Moderate to Severe Disease"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin/Sulbactam 3GM IVPB Q6H", "Text" : "Ampicillin/Sulbactam 3GM IVPB Q6H"},
{"Row" : 29, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "*\"Mandell\" chapter. Periocular infections"}, 
{"Row" : 31, "Column" : 1, "Text" : "*Johns Hopkins website. Periocular infections"}, 
{"Row" : 34, "Column" : 1, "Text" : "This Menu Updated December 2015", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "*Alternative"}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 900MG IV Q8H", "DisplayText" : "Clindamycin 900MG IV Q8H", "Text" : "Clindamycin 900MG IVPB Q8H"}
]},
{"Name" : "ORZID2 PROSTATITIS", "DisplayText" : "Prostatitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 ACUTE PROSTATITIS", "DisplayText" : "Acute Prostatitis", "Text" : ""},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 CHRONIC PROSTATITIS", "DisplayText" : "Chronic Prostatitis", "Text" :""}
]},
{"Name" : "ORZID2 PROSTHETIC VALVE ENDOCARDITIS", "DisplayText" : "Prosthetic Valve Endocarditis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Prosthetic Valve Endocarditis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "*Early Infectious Disease consult is recommended"}, 
{"Row" : 6, "Column" : 1, "Text" : "*At least 3 sets of blood cultures obtained from different venipuncture sites"}, 
{"Row" : 7, "Column" : 1, "Text" : "should be obtained, with the first and last samples drawn at least 1 hour"}, 
{"Row" : 8, "Column" : 1, "Text" : "apart, prior to starting antimicrobial therapy"}, 
{"Row" : 9, "Column" : 1, "Text" : "*Echocardiography should be performed expeditiously in patients suspected"}, 
{"Row" : 10, "Column" : 1, "Text" : "of having IE"}, 
{"Row" : 12, "Column" : 1, "Text" : "and fever may not be prominent"}, 
{"Row" : 11, "Column" : 1, "Text" : "*Initial presentation may be subtle, such as unexplained heart failure"}, 
{"Row" : 15, "Column" : 1, "Text" : "Empiri Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 VANCO/GENTAMICIN 1MG/KG Q8H", "DisplayText" : "Vancomycin + Gentamicin 1MG/KG Q8H", "Text" : "VANCOMYCIN PHARMACY TO DOSE + GENTAMICIN 1MG/KG IVPB Q8H"},
{"Row" : 18, "Column" : 1, "Text" : "*Consider addition of rifampin: Many clinicians delay addition of rifampin"}, 
{"Row" : 19, "Column" : 1, "Text" : "until bacterial inoculum has been reduced to decrease likelihood of"}, 
{"Row" : 20, "Column" : 1, "Text" : "emerging resistance. Hence, pathogen identification and susceptibility"}, 
{"Row" : 21, "Column" : 1, "Text" : "information should generally be available before addition of rifampin."}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJUZID RIFAMPIN 300MG PO Q8H", "DisplayText" : "Rifampin 300MG PO Q8H", "Text" : "RIFAMPIN 300MG PO Q8H"},
{"Row" : 25, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "*The Sanford Guide to Antimicrobial Therapy 2019"}, 
{"Row" : 27, "Column" : 1, "Text" : "*Baddour LM, et al. Infective endocarditis in adults: diagnosis, antimicrobial"}, 
{"Row" : 28, "Column" : 1, "Text" : "therapy, and management of complications, a scientific statement for"}, 
{"Row" : 29, "Column" : 1, "Text" : "healthcare professionals from the American Heart Association."}, 
{"Row" : 30, "Column" : 1, "Text" : "Circulation. 2015,132:1435-1486"}, 
{"Row" : 35, "Column" : 1, "Text" : "THIS MENU UPDATED OCTOBER 2019", "Header" : 1}
]},
{"Name" : "ORZID2 PULMONARY", "DisplayText" : "Pulmonary ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Pulmonary", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 BRONCHITIS/EXACERBATION OF COPD", "DisplayText" : "Bronchitis/Exacerbation of COPD", "Text" :""},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 PNEUMONIA", "DisplayText" : "Pneumonia", "Text" : ""},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 LUNG ABCESS", "DisplayText" : "Lung Abcess", "Text" : ""},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 EMPYEMA", "DisplayText" : "Empyema", "Text" : ""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 INFLUENZA", "DisplayText" : "Influenza", "Text" : ""}
]},
{"Name" : "ORZID2 PYELONEPHRITIS", "DisplayText" : "Pyelonephritis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Pyelonephritis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "*Most cases are caused by Escherichia coli. Judge severity of infection based", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "on clinical signs and symptoms, including blood pressure, pulse, mental", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "status, and degrees of fever. Resistant organisms are more likely if the", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "patient has been in the hospital more than 48hours or received a course", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "of antibiotics. Obtain a urine gram stain immediately to guide therapy.", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Drugs active against enterococcus (ampicillin and piperacillin) or", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "staphylococci needn't be used if gram negative bacilli predominate on", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "smear. In older men with pyelonephritis, obtain a renal ultrasound to rule", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "out obstruction. Consult urology if abnormalities are found.", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "*Mild to Moderate Disease", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" :""},
{"Row" : 18, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 14 DAYS", "Text" : ""},
{"Row" : 20, "Column" : 1, "Text" : "*Alternative for patient who cannot be treated by mouth"}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : ""},
{"Row" : 23, "Column" : 1, "Text" : "*Severe Disease", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "*Consider oral therapy with ciprofloxacin initially or consider beginning with"}, 
{"Row" : 25, "Column" : 1, "Text" : "IV therapy and switching to oral therapy later."}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 14 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H 14 DAYS", "Text" : ""},
{"Row" : 28, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H 14 DAYS", "DisplayText" : "Ciprofloxacin 400MG IVPB Q12H", "Text" : ""},
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q8H 14 DAYS", "DisplayText" : "Zosyn 4.5GM IVPB Q8H 14 DAYS", "Text" :""},
{"Row" : 32, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 14 DAYS", "Text" : ""},
{"Row" : 34, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" :""},
{"Row" : 37, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "*Gupta K, et al. International Clinical Practice Guidelines for treatment"}, 
{"Row" : 39, "Column" : 1, "Text" : "for Acute Uncomplicated Cystitis and Pyelonephritis in Women. IDSA. 2010"}, 
{"Row" : 40, "Column" : 1, "Text" : "*Sanford \"Cystitis\" and \"Pyelonephritis\" Accessed March 2014"}, 
{"Row" : 43, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 27, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 29, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 31, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 33, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 SKIN, SOFT TISSUE", "DisplayText" : "Skin, Soft Tissue  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 CELLULITIS", "DisplayText" : "Cellulitis", "Text" : ""},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 DIABETIC FOOT INFECTION", "DisplayText" : "Diabetic Foot Infection", "Text" : ""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 HERPES ZOSTER", "DisplayText" : "Herpes Zoster", "Text" :""}
]},
{"Name" : "ORZID2 SPONTANEOUS BACTERIAL PERITONITIS (SBP)", "DisplayText" : "Spontaneous Bacterial Peritonitis (SBP) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Spontaneous Bacterial Peritonitis (SBP)", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "SBP is infection of the peritoneal cavity in the absence of an apparent trauma", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "or other obvious cause. SBP occurs primarily in people with end stage liver", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "disease and ascites. The diagnosis is made when a peritoneal fluid sample has", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : ">250 polymorphonuclear leukocyte cells per microliter, or when bacterial", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "pathogens are isolated", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Long-term SBP prophylaxis is indicated for patients who survive their first", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "episode of SPB. Short-term SBP prophylaxis is indicated for patients with", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "variceal bleeding or for patients who have low protein refractory ascites", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "(<1gm albumin/dl ascites fluid). Some give long-term antimicrobials to patients", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "with low-protein refractory ascites. Consult gastroenterology for more", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "information.", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Acute SBP", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 5D", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H 5 DAYS", "Text" : "Preferred Treatment: Ceftriaxone 2GM IVPB Q24H 5 DAYS"},
{"Row" : 21, "Column" : 1, "Text" : "Prophylaxis in a patient with previous SBP episode", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Prophylaxis in patient with cirrhosis and variceal bleeding", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO Q12H 7 DAYS", "Text" :""},
{"Row" : 29, "Column" : 1, "Text" : "Prophylaxis for hospitalized patients with refractory low protein ascites", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Give antimicrobial prophylaxis until discharge"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500MG PO Q12H", "Text" : ""},
{"Row" : 34, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "*\"Sanford\" keyword: peritonitis"}, 
{"Row" : 36, "Column" : 1, "Text" : "*Such J Clin Infect Dis 1998, 27:669"}, 
{"Row" : 37, "Column" : 1, "Text" : "*Up-To-Date"}, 
{"Row" : 38, "Column" : 1, "Text" : "*Parsi MA Clev Clin J Med 2004, 71: 569"}, 
{"Row" : 39, "Column" : 1, "Text" : "*Frazzee LA Ann Pharmacother 2005, 39: 908"}, 
{"Row" : 40, "Column" : 1, "Text" : "*Runyon BA Gastroenterol 1991, 100:1737"}, 
{"Row" : 41, "Column" : 1, "Text" : "*Novella M Hepatol 1997, 25:532"}, 
{"Row" : 42, "Column" : 1, "Text" : "*Soares-Weiser K Cochrane Database Systematic Reviews 3, 2005"}, 
{"Row" : 46, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO Q24H", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS PO Q24H", "Text" :""},
{"Row" : 23, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 750MG PO Q1WEEK", "DisplayText" : "Ciprofloxacin 750MG PO Q1WEEK", "Text" : ""}
]},
{"Name" : "ORZID2 SYSTEMIC INFECTIOUS DISEASE", "DisplayText" : "Systemic Infectious Disease ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 NEUTROPENIC FEVER MAIN", "DisplayText" : "Neutropenic Fever", "Text" : ""},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 LYME'S DISEASE", "DisplayText" : "Lyme's Disease", "Text" : ""}
]},
{"Name" : "ORZID2 THRUSH", "DisplayText" : "Thrush ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Thrush", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Comments", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "*Oropharyngeal candidiasis and esophageal candidiasis are opportunistic"}, 
{"Row" : 5, "Column" : 1, "Text" : "infections that primarily occur in patients on inhaled corticosteroids,"}, 
{"Row" : 6, "Column" : 1, "Text" : "patients that wear dentures, cancer patients on cytotoxic chemotherapy or"}, 
{"Row" : 7, "Column" : 1, "Text" : "radiation to the head and neck, and patients that are HIV seropositive"}, 
{"Row" : 8, "Column" : 1, "Text" : "especially if their CD4+ is less than 200 cells/microliter"}, 
{"Row" : 9, "Column" : 1, "Text" : "*Oropharyngeal candidiasis, usually from candida albicans, appears in one"}, 
{"Row" : 10, "Column" : 1, "Text" : "of two major forms: pseudomembranous form or atrophic form. The"}, 
{"Row" : 11, "Column" : 1, "Text" : "pseudomembranous form is the most common and appears as white plaques"}, 
{"Row" : 12, "Column" : 1, "Text" : "along the tongue, palate, mouth mucosa, or oropharynx. The atrophic form"}, 
{"Row" : 13, "Column" : 1, "Text" : "(denture stomatitis) is most often found underneath upper dentures and"}, 
{"Row" : 14, "Column" : 1, "Text" : "and appears as redness without plaques. Patients are often asymptomatic"}, 
{"Row" : 15, "Column" : 1, "Text" : "but may feel cotton mouth, loss of taste, and occasionally pain during"}, 
{"Row" : 16, "Column" : 1, "Text" : "eating and swallowing. Patients with atrophic form usually have pain"}, 
{"Row" : 17, "Column" : 1, "Text" : "symptoms. Dysphagia and hoarseness are usually associated with lower"}, 
{"Row" : 18, "Column" : 1, "Text" : "tract candidiasis such as esophageal candidiasis."}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Oropharyngeal Candidiasis"}, 
{"Row" : 22, "Column" : 1, "Text" : "-Mild"}, 
{"Row" : 27, "Column" : 1, "Text" : "-Moderate to Severe and/or HIV positive"}, 
{"Row" : 30, "Column" : 1, "Text" : "*Esophageal candidiasis **Requires systemic therapy**"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSJUZID FLUCONAZOLE 200MG PO Q24H 14 DAYS", "DisplayText" : "Fluconazole 200MG PO Q24H 14 DAYS", "Text" : "Fluconazole 200MG PO Q24H 14 DAYS"},
{"Row" : 23, "Column" : 1, "Item" : "PSJUZID CLOTRIMAZOLE TROCHE 10MG PO 5 TIMES/DAY 7 DAYS", "DisplayText" : "Clotrimazole Troche 10MG PO 5 TIMES/DAY 7 DAYS", "Text" : "Clotrimazole Troche 10MG PO 5 TIMES/DAY 7 DAYS"},
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID NYSTATIN SUSP 500000 UNITS S&S QID 7 DAYS", "DisplayText" : "Nystatin Susp 500000 UNITS QID 7 DAYS", "Text" : "Nystatin Susp 500000 UNITS QID 7 DAYS"},
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID FLUCONAZOLE 200MG PO ONCE THEN 100MG Q24H 6 DAYS", "DisplayText" : "Fluconazole PO Q24H", "Text" : "Fluconazole 200MG PO ONCE then 100MG PO Q24H 6 DAYS"},
{"Row" : 35, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "*Pappas Pg, Kauffman Ca, Andes D, et al. Clinical Practice Guidelines for"}, 
{"Row" : 37, "Column" : 1, "Text" : "the Management of Candidiasis: 2009 update by the Infectious Disease"}, 
{"Row" : 38, "Column" : 1, "Text" : "Clinical Infectious Disease 2009: 48:503."}, 
{"Row" : 39, "Column" : 1, "Text" : "*Kauffman C.  Treatment of oropharyngeal and esophageal candidiasis."}, 
{"Row" : 40, "Column" : 1, "Text" : "Up to Date. July 2014."}, 
{"Row" : 41, "Column" : 1, "Text" : "*Kauffman C. Clinical manifestations of oropharyngeal and esophageal"}, 
{"Row" : 42, "Column" : 1, "Text" : "candidiasis.  Up to Date. July 2014."}, 
{"Row" : 43, "Column" : 1, "Text" : "*Oropharyngeal Candidiasis.  Sanford Guide.  July 13, 2014."}, 
{"Row" : 44, "Column" : 1, "Text" : "*Esophageal Candidiasis.  Sanford Guide.  July 14, 2014"}, 
{"Row" : 48, "Column" : 1, "Text" : "This Menu Updated September 2014", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 UNCOMPLICATED CYSTITIS", "DisplayText" : "Uncomplicated Cystitis", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Uncomplicated Cystitis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Preferred Treatment:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO BID", "DisplayText" : "Bactrim DS PO BID", "Text" : ""},
{"Row" : 8, "Column" : 1, "Text" : "Alternative Treatment:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Item" : "PSJUZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500MG PO Q12H", "Text" : ""},
{"Row" : 11, "Column" : 1, "Item" : "PSJUZID NITROFURANTOIN 100MG PO Q6H", "DisplayText" : "Nitrofurantoin 100MG PO Q6H", "Text" : ""},
{"Row" : 13, "Column" : 1, "Text" : "Suppression:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "uncomplicated cystitis, suppressive therapy is indicated after infection"}, 
{"Row" : 16, "Column" : 1, "Text" : "eradicated"}, 
{"Row" : 14, "Column" : 1, "Text" : "*For pre-menopausal women with 3 or more episodes per year of recurrent"}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJUZID BACTRIM SS PO Q24H", "DisplayText" : "Sulfamethoxazole/Trimethoprim SS PO Q24H", "Text" :""},
{"Row" : 19, "Column" : 1, "Item" : "PSJUZID BACTRIM DS 2 TABS PO ONCE", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS 2 TABS ONCE", "Text" : ""},
{"Row" : 21, "Column" : 1, "Item" : "PSJUZID BACTRIM DS PO ONCE POST COITUS", "DisplayText" : "Sulfamethoxazole/Trimethoprim DS 1 TAB ONCE POST COITUS", "Text" :""},
{"Row" : 24, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "*Gupta K, et al. International Clinical Practice Guidelines for treatment"}, 
{"Row" : 26, "Column" : 1, "Text" : "for Acute Uncomplicated Cystitis and Pyelonephritis in Women. IDSA. 2010"}, 
{"Row" : 27, "Column" : 1, "Text" : "*Sanford \"Cystitis\" and \"Pyelonephritis\" Accessed March 2014"}, 
{"Row" : 29, "Column" : 1, "Text" : "THIS MENU UPDATED FEBRUARY 2019", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 18, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 20, "Column" : 1, "Text" : "<OR>"}
]},
{"Name" : "ORZID2 URETHRITIS ASSOCIATED WITH SEXUALLY TRANSMITTED DISEASE", "DisplayText" : "Urethritis Associated with Sexually Transmitted Disease", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Urethritis Associated with Sexually Transmitted Disease", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "The most common sexually transmitted urethritis pathogens are Neisseria"}, 
{"Row" : 5, "Column" : 1, "Text" : "gonorrhoeae and Chlamydia trachomatis. Nucleic acid amplification tests"}, 
{"Row" : 6, "Column" : 1, "Text" : "tests for these pathogens should be completed."}, 
{"Row" : 8, "Column" : 1, "Text" : "Treatment for N. gonorrhoeae", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 500MG IM ONCE STD", "DisplayText" : "Ceftriaxone 500MG IM ONCE", "Text" :""},
{"Row" : 11, "Column" : 1, "Text" : "** For patients weighting >/= 150kg"}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 CEFTRIAXONE 1GM IM ONCE STD", "DisplayText" : "Ceftriaxone 1GM IM ONCE", "Text" : ""},
{"Row" : 15, "Column" : 1, "Text" : "Treatment of C. trachomatis", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 DOXYCYCLINE 100MG PO Q12H X7 DAYS STD", "DisplayText" : "Doxycycline 100MG PO Q12H X7 DAYS", "Text" : ""},
{"Row" : 17, "Column" : 1, "Text" : "--OR--"}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 AZITHROMYCIN 1GM PO ONCE STD", "DisplayText" : "Azithromycin 1GM PO ONCE (recommended in pregnancy)", "Text" : ""},
{"Row" : 21, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "CDC: STD Treatment Guidelines: MMWR (2015)"}, 
{"Row" : 25, "Column" : 1, "Text" : "CDC Update to Treatment Guidelines for Gonococcal Infection: MMWR (2020)"}, 
{"Row" : 27, "Column" : 1, "Text" : "North Dakota Health Alert Network: New Recommended Treatment for"}, 
{"Row" : 28, "Column" : 1, "Text" : "Gonococcal Infections. 2021."}, 
{"Row" : 33, "Column" : 1, "Text" : "UPDATED FEBRUARY 2021", "Header" : 1}
]},
{"Name" : "ORZID2 VANCO 15MG/KG Q12H & CEFTRIAXONE 1GM Q24H", "DisplayText" : "Vancomycin 15MG/KG Q12H & Ceftriaxone 1GM Q24H", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q12H", "DisplayText" : "Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID2 VANCO Q8/AMP 2G Q4/MEROPENEM 2G Q8/ACYCLOVIR 10MG/KG Q8", "DisplayText" : "Vancomycin Q8H + Ampicillin 2GM Q4H + Meropenem 2GM Q8H + Acyclovir 10mg/kg Q8H", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q8H", "DisplayText" : "Vanco Pharmacy To Dose 15MG/KG Q8H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID AMPICILLIN 2GM IVPB Q4H", "DisplayText" : "Ampicillin 2GM IVPB Q4H", "Text" : ""},
{"Row" : 3.0 , "Item" : "PSJIZID MEROPENEM 2GM IVPB Q8H", "DisplayText" : "Meropenem 2GM IVPB Q8H", "Text" :""},
{"Row" : 4.0 , "Item" : "PSJIZID ACYCLOVIR 10MG/KG IV Q8H", "DisplayText" : "Acyclovir 10MG/KG IV Q8H", "Text" : ""}
]},
{"Name" : "ORZID2 VANCO Q8/AMP 2GM Q4/CEFEPIME 2GM Q8/ACYCLOVIR 10MG/KG Q8", "DisplayText" : "Vancomyin Q8H + Ampcillin 2GM Q4H + Cefepime 2G Q8H + Acyclovir 10mg/kg Q8H ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q8H", "DisplayText" : "Vanco Pharmacy To Dose 15MG/KG Q8H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID AMPICILLIN 2GM IVPB Q4H", "DisplayText" : "Ampicillin 2GM IVPB Q4H", "Text" : ""},
{"Row" : 3.0 , "Item" : "PSJIZID CEFEPIME 2GM IV Q8H", "DisplayText" : "Cefepime 2GM IVPB Q8H", "Text" : ""},
{"Row" : 4.0 , "Item" : "PSJIZID ACYCLOVIR 10MG/KG IV Q8H", "DisplayText" : "Acyclovir 10MG/KG IV Q8H", "Text" : ""}
]},
{"Name" : "ORZID2 VANCO Q8H/CEFTRIAXONE 2GM Q12H/ACYCLOVIR 10MG/KG Q8H", "DisplayText" : "Vancomycin Q8H + Ceftriaxone 2GM Q12H + Acyclovir 10mg/kg Q8H", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q8H", "DisplayText" : "Vanco Pharmacy To Dose 15MG/KG Q8H", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q12H", "DisplayText" : "Ceftriaxone 2GM IVPB Q12H", "Text" :""},
{"Row" : 3.0 , "Item" : "PSJIZID ACYCLOVIR 10MG/KG IV Q8H", "DisplayText" : "Acyclovir 10MG/KG IV Q8H", "Text" : ""}
]},
{"Name" : "ORZID2 VANCO/CEFTRIAXONE 1GM Q24H/METRONIDAZOLE 500MG Q8H", "DisplayText" : "Vancomycin + Ceftriaxone 1GM Q24H + Metronidazole 500MG Q8H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID CEFTRIAXONE 1GM IVPB Q24H", "DisplayText" : "Ceftriaxone 1GM IVPB Q24H", "Text" :""},
{"Row" : 3.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 VANCO/CIPRO 400MG Q12H/METRONIDAZOLE 500MG Q8H", "DisplayText" : "Vancomycin + Ciprofloxacin 400MG Q12H + Metronidazole 500MG Q8H ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : ""},
{"Row" : 3.0 , "Item" : "PSJIZID METRONIDAZOLE 500MG IVPB Q8H", "DisplayText" : "Metronidazole 500MG IVPB Q8H", "Text" :""}
]},
{"Name" : "ORZID2 VANCO/GENT 1MG/KG Q8H/RIAMPIN 300MG PO Q8H", "DisplayText" : "Vancomycin + Gentamicin 1MG/KG Q8H + Rifampin 300MG PO Q8H", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID GENTAMICIN 1 MG/KG IV Q8H", "DisplayText" : "Gentamicin 1MG/KG IV Q8H", "Text" : ""},
{"Row" : 3.0 , "Item" : "PSJUZID RIFAMPIN 300MG PO Q8H", "DisplayText" : "Rifampin 300MG PO Q8H", "Text" : ""}
]},
{"Name" : "ORZID2 VANCO/GENTAMICIN 1MG/KG Q8H", "DisplayText" : "Vancomycin + Gentamicin 1MG/KG Q8H", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID GENTAMICIN 1 MG/KG IV Q8H", "DisplayText" : "Gentamicin 1MG/KG IV Q8H", "Text" : ""}
]},
{"Name" : "ORZID2 VANCOMYCIN 15MG/KG Q12H & CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Vancomycin 15MG/KG Q12H & Ciprofloxacin 400MG Q12H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG IVPB Q12H", "DisplayText" : "Vancomycin Pharmacy to Dose", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID CIPROFLOXACIN 400MG IVPB Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : ""}
]},
{"Name" : "ORZID2 VANCOMYCIN/CEFTRIAXONE 2GM Q24H", "DisplayText" : "Vancomycin + Ceftriaxone 2GM IVPB Q24H  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID2 ZOSYN 4.5GM IVPB Q6H/LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H + Levofloxacin 500MG IVPB Q24H ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H", "DisplayText" : "Zosyn 4.5GM IVPB Q6H", "Text" : ""},
{"Row" : 2.0 , "Item" : "PSJIZID LEVOFLOXACIN 500MG IVPB Q24H", "DisplayText" : "Levofloxacin 500MG IVPB Q24H", "Text" :""}
]},
{"Name" : "ORZID2 ZOSYN 4.5GM IVPB Q6H/VANCO 7 DAYS", "DisplayText" : "Zosyn 4.5GM IVPB Q6H + Vancomycin IVPB  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "PSJIZID ZOSYN 4.5GM IVPB Q6H 7 DAYS", "DisplayText" : "Zosyn 4.5MG Q6H 7 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "PSJUZID VANCO PHARMACY TO DOSE 15MG/KG", "DisplayText" : "Vanco Pharmacy to Dose 15MG/KG", "Text" : ""}
]},
{"Name" : "ORZID3 ABSCESSES (CUTANEOUS ABSCESS, FUNUNCLES, CARBUNCLES)", "DisplayText" : "Abscesses (Cutaneous Abscess, Furuncles, Carbuncles)", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "CUTANEOUS ABSCESSES/PURULENT CELLULITIS", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "PERIRECTAL ABSCESSES", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Mild Disease Treatment After Abscess Has Been Drained:", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Alternative for Beta Lactam Allergy:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "FURUNCLES AND CARBUNCLES", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Antibiotics only indicated for purulent infection with cellulitis or deep", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "invasion after incision and drainage.", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Stevens, DL, et al. Practice Guidelines for the Diagnosis and Management"}, 
{"Row" : 27, "Column" : 1, "Text" : "of Skin and Soft Tissue Infections. IDSA. 2014."}, 
{"Row" : 29, "Column" : 1, "Text" : "Sanford Guide: Skin Abscess, Boils, Furuncles (accessed June 2020)"}, 
{"Row" : 31, "Column" : 1, "Text" : "Sanford Guide: Diverticulitis, perirectal abscess (accessed June 2020)"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-Date: Skin abscess (accessed June 2020)"}, 
{"Row" : 36, "Column" : 1, "Text" : "LAST UPDATED JUNE 2020", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO BID 7 DAYS ABSCESSES", "DisplayText" : "Doxycycline 100MG PO BID 7 DAYS", "Text" :""},
{"Row" : 9, "Column" : 1, "Item" : "ORZID3 AUGMENTIN 875MG PO BID 7DAYS ABSCESSES", "DisplayText" : "Augmentin 875MG PO BID X7 DAYS", "Text" : ""},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 BACTRIM DS & METRONIDAZOLE 500MG PO ABSCESSES", "DisplayText" : "Bactrim DS PO BID X7 DAYS & Metronidazole 500MG PO X7 DAYS", "Text" :""},
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO BID 5DAYS ABSCESSES", "DisplayText" : "Doxycycline 100MG PO BID X5 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 ACUTE BACTERIAL PROSTATITIS", "DisplayText" : "Acute Bacterial Prostatitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment if NOT at risk of STI", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Alternative for Fluoroquinolone Allergy", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment if risk of STI", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Acute Bacterial Prostatitis. Sanford Guide. June 8, 2020"}, 
{"Row" : 18, "Column" : 1, "Text" : "Meyrier A, Fekete T. Acute Bacterial Prostatitis. Up To Date. May 2020"}, 
{"Row" : 20, "Column" : 1, "Text" : "LAST UPDATED JUNE 2020", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 CIPROFLOXACIN 500MG PO BID X14 DAYS PROSTATITIS", "DisplayText" : "Ciprofloxacin 500MG PO BID X14 DAYS", "Text" : ""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 BACTRIM DS PO BID X14 DAYS PROSTATITIS", "DisplayText" : "Bactrim DS PO BID X14 DAYS", "Text" : ""},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 CEFTRIAXONE IM THEN DOXYCYCLINE PO PROSTATITIS", "DisplayText" : "Ceftriaxone 500MG IM X1 DOSE THEN DOXYCYCLINE 100MG PO BID X10 DAYS", "Text" :""}
]},
{"Name" : "ORZID3 ACUTE SINUSITIS", "DisplayText" : "Acute Sinusitis ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Most cases are viral and resolve within 7 days. Treat symptoms with", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "analgesics, and nasal saline.", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Acute Sinusitis:", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "For cases that have not improved in 10 days despite symptomatic treatment."}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Alternative for Penicillin Allergy:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment Failure:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "LAST UPDATED MAY 2020", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 AUGMENTIN 875MG ACUTE SINUSITIS", "DisplayText" : "Augmentin 875MG Q12H PO X5 DAYS", "Text" :""},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO ACUTE SINUSITIS", "DisplayText" : "Doxycycline 100MG Q12H PO X5 DAYS", "Text" : ""},
{"Row" : 16, "Column" : 1, "Text" : "If symptoms worsen or no improvement is seen after 3-5 days of treatment"}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 LEVOFLOXACIN 500MG PO ACUTE SINUSITIS", "DisplayText" : "Levofloxacin 500MG Q24H PO X7 DAYS", "Text" :""},
{"Row" : 23, "Column" : 1, "Text" : "Chow et al, IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis"}, 
{"Row" : 24, "Column" : 1, "Text" : "in Children and Adults. Clinical Infectious Diseases. 15 April 2012:54(8)"}, 
{"Row" : 25, "Column" : 1, "Text" : "e72-e112"}, 
{"Row" : 27, "Column" : 1, "Text" : "Rosenfeld et al, Clinical Practice Guideline Update: Adult Sinusitis."}, 
{"Row" : 28, "Column" : 1, "Text" : "Otolayngology-Head and Neck Surgery. 1 April 2015:152(2)."}, 
{"Row" : 30, "Column" : 1, "Text" : "Sanford Guide: Sinusitis, Acute, Empiric Therapy (accessed 5-27-20)"}, 
{"Row" : 32, "Column" : 1, "Text" : "Sanford Guide: Sinusitis, Acute, Treatment Failure (accessed 5-27-20)"}
]},
{"Name" : "ORZID3 AUGMENTIN 875MG BID & BACTRIM DS BID 14DAYS FOOT ULCER", "DisplayText" : "Augmentin 875MG PO BID X14 DAYS & Bactrim DS PO BID X14 DAYS ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID3 AUGMENTIN 875MG BID 14DAYS FOOT ULCER", "DisplayText" : "Augmentin 875MG PO BID X14 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID3 BACTRIM DS BID 14DAYS FOOT ULCER", "DisplayText" : "Bactrim DS BID X14 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 BACTERIAL PROSTATITIS", "DisplayText" : "Bacterial Prosatitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 ACUTE BACTERIAL PROSTATITIS", "DisplayText" : "Acute Bacterial Prostatitis", "Text" : ""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 CHRONIC BACTERIAL PROSTATITIS", "DisplayText" : "Chronic Bacterial Prostatitis", "Text" : ""}
]},
{"Name" : "ORZID3 BACTRIM DS & METRONIDAZOLE 500MG PO ABSCESSES", "DisplayText" : "Bactrim DS PO BID X7 DAYS & Metronidazole 500MG PO X7 DAYS", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID3 BACTRIM DS PO BID 7DAYS ABSCESSES", "DisplayText" : "Bactrim DS PO BID X7 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID3 METRONIDAZOLE 500MG PO Q6H 7DAYS ABSCESSES", "DisplayText" : "Metronidazole 500MG PO Q6H X7 DAYS", "Text" :""}
]},
{"Name" : "ORZID3 BISMUTH + OMEP + METRONID + TETRACY H.PYLORI", "DisplayText" : "Bismuth Quadruple  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID3 BISMUTH SUBSALICYLATE 524MG PO TID X14 DAYS H.PYLORI", "DisplayText" : "Bismuth Subsalicylate 524MG PO QID X14 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID3 OMEPRAZOLE 20MG PO BID X14 DAYS H.PYLORI", "DisplayText" : "Omeprazole 20MG PO BID X14 DAYS", "Text" :""},
{"Row" : 3.0 , "Item" : "ORZID3 METRONIDAZOLE 500MG PO TID X14 DAYS H.PYLORI", "DisplayText" : "Metronidazole 500MG PO TID X14 DAYS", "Text" : ""},
{"Row" : 4.0 , "Item" : "ORZID3 TETRACYCLINE 500MG PO QID X14 DAYS H.PYLORI", "DisplayText" : "Tetracycline 500MG PO QID X14 DAYS", "Text" :""}
]},
{"Name" : "ORZID3 BRONCHITIS/COPD EXACERBATION", "DisplayText" : "Bronchitis/COPD Exacerbation", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "In acute bronchitis in an otherwise healthy patient antibiotics show no benefit", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "In the setting of COPD exacerbation antibiotics provide small benefit and", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "should only be used in severe cases - when sputum is newly purulent", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "or if purulent sputum has increased in volume.", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment of Moderate COPD Exacerbation:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment of Severe COPD Exacerbation:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "LAST UPDATED MAY 2020", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO BRONCHITIS/COPD EXACERBATION", "DisplayText" : "Doxycycline 100MG PO BID X5 DAYS", "Text" : ""},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 AUGMENTIN 875 PO BRONCHITIS/COPD EXACERBATION", "DisplayText" : "Augmentin 875MG PO BID X5 DAYS", "Text" : ""},
{"Row" : 16, "Column" : 1, "Text" : "Sanford Guide: Bronchitis, Chronic with Acute Exacerbation (accessed 5-22-20)"}, 
{"Row" : 18, "Column" : 1, "Text" : "Global Imitative for Chronic Obstructive Lung Disease (GOLD). 2020."}, 
{"Row" : 20, "Column" : 1, "Text" : "Hunter, et al. COPD: Management of Acute Exacerbations and Chronic Stable"}, 
{"Row" : 21, "Column" : 1, "Text" : "Disease. American Family Physician. 2001 Aug 15:64(4):603-613."}
]},
{"Name" : "ORZID3 CEFTRIAXONE IM THEN DOXYCYCLINE PO PROSTATITIS", "DisplayText" : "Ceftriaxone 500MG IM X1 DOSE THEN DOXYCYCLINE 100MG PO BID X10 DAYS", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID3 CEFTRIAXONE 500MG IM ONCE PROSTATITIS", "DisplayText" : "Ceftriaxone 500MG IM ONCE", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID3 DOXYCYCLINE 100MG PO BID X10 DAYS PROSTATITIS", "DisplayText" : "Doxycycline 100MG PO BID X10 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 CEFUROXIME & DOXYCYCLINE COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Cefuroxime 500MG PO BID & Doxycycline 100MG PO BID X5 DAYS", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID3 DOXYCYCLINE X5DAYS COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Doxycycline 100MG PO BID X5 DAYS", "Text" : ""},
{"Row" : 2.0 , "Item" : "ORZID3 CEFUROXIME 500MG PO BID COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Cefuroxime 500MG PO BID X5 DAYS", "Text" :""}
]},
{"Name" : "ORZID3 CELLULITIS", "DisplayText" : "Cellulitis", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment for Mild Cellulitis", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Alternative for Penicillin Allergy or Suspected MRSA Infection", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "** If purulent see ordering menu for Abscesses**"}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment for Moderate to Severe Cellulitis", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS"}, 
{"Row" : 15, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Stevens DL Clinical Infectious Disease 2014:59"}, 
{"Row" : 18, "Column" : 1, "Text" : "Sanford Guide: Cellulitis (Accessed June 2020)"}, 
{"Row" : 20, "Column" : 1, "Text" : "Up to Date: Cellulitis (Accessed June 2020)"}, 
{"Row" : 24, "Column" : 1, "Text" : "LAST UPDATED JUNE 2020", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 CEPHALEXIN 500MG QID 5 DAYS CELLULITIS", "DisplayText" : "Cephalexin 500MG PO QID X5 DAYS", "Text" :""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO BID 5DAYS CELLULTIS", "DisplayText" : "Doxycycline 100MG PO BID X5 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 CHRONIC BACTERIAL PROSTATITIS", "DisplayText" : "Chronic Bacterial Prostatitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Alternative for Fluoroquinolone Allergy:", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Chronic Bacterial Prostatitis. Sanford Guide. June 8, 2020"}, 
{"Row" : 13, "Column" : 1, "Text" : "Meyrier A, Fekete T. Chronic Bacterial Prostatitis. Up To Date. May 2020"}, 
{"Row" : 17, "Column" : 1, "Text" : "LAST UPDATED UNE 2020", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 CIPROFLOXACIN 500MG PO BID X28 DAYS PROSTATITIS", "DisplayText" : "Ciprofloxacin 500MG PO BID X28 DAYS", "Text" : ""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 BACTRIM DS PO BID X28 DAYS PROSTATITIS", "DisplayText" : "Bactrim DS PO BID X28 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 CLOSTRIDIUM DIFICLE (C. DIFF) COLITIS", "DisplayText" : "Clostricium Dificile (C. Diff) Colitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Discontinue any antimicrobials that might have induced C. difficile,", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "if possible and avoid high-risk antibiotics. Discontinue laxatives and antacids,", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "if possible. C. difficile PCR testing should be performed to confirm", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "the diagnosis of C. difficile infection.", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Initial Episode:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Recurrence:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Alternative Agent:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 VANCOMYCIN PO X10 DAYS C.DIFF", "DisplayText" : "Vancomycin 125MG PO QID X10 DAYS", "Text" : ""},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 VANCOMYCIN TAPER C.DIFF", "DisplayText" : "Vancomycin Taper", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "May consider the use of fidaxomicin in veterans with recurrent infections"}, 
{"Row" : 17, "Column" : 1, "Text" : "or those at high risk for recurrence. Fidaxomicin requires prior"}, 
{"Row" : 18, "Column" : 1, "Text" : "authorization/NF request and has national criteria for use."}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID FIDAMOXICIN 200MG PO BID X10 DAYS", "DisplayText" : "Fidamoxicin 200MG PO BID X 10 DAYS", "Text" :""},
{"Row" : 21, "Column" : 1, "Item" : "ORZ NON FORMULARY CONSULT", "DisplayText" : "PRIOR AUTH/NF CONSULT", "Text" : ""},
{"Row" : 26, "Column" : 1, "Text" : "Johnson, S, et al. Clinical Practice Guideline by the Infectious Diseases"}, 
{"Row" : 27, "Column" : 1, "Text" : "Society of America (IDSA) and Society for Healthcare Epidemiology  of America"}, 
{"Row" : 28, "Column" : 1, "Text" : "(SHEA): 2021 Focused Update Guidelines on Management of Clostridioides"}, 
{"Row" : 29, "Column" : 1, "Text" : "difficile Infection in Adults. Clinical Infectious Diseases. 2021."}, 
{"Row" : 32, "Column" : 1, "Text" : "Last Updated May 2022", "Header" : 1}
]},
{"Name" : "ORZID3 COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Community Aquired Pneumonia ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "Preferred Outpatient Treatment for PREVIOUSLY HEALTHY PATIENT", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Preferred Outpatient Treatment for PATIENTS WITH COMORBIDITIES", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Alternative for Beta Lactam Allergy", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "LAST UPDATED JULY 2020", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE X5DAYS COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Doxycycline 100MG PO BID X5 DAYS", "Text" : ""},
{"Row" : 9, "Column" : 1, "Item" : "ORZID3 CEFUROXIME & DOXYCYCLINE COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Cefuroxime 500MG PO BID & Doxycycline 100MG PO BID X5 DAYS", "Text" :""},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 LEVOFLOXACIN 750MG COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Levofloxacin 750MG PO Q24H X5 DAYS", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "Metlay, et al. Diagnosis and Treatment of Adults with Community-acquired"}, 
{"Row" : 17, "Column" : 1, "Text" : "Pneumonia - An Official Practice Guideline of the American Thoracic Society"}, 
{"Row" : 18, "Column" : 1, "Text" : "and Infectious Diseases Society of America. Am J Respir Crit Care Med."}, 
{"Row" : 19, "Column" : 1, "Text" : "2019 Oct 1:200(7):e45-e67."}
]},
{"Name" : "ORZID3 CONJUNCTIVITIS", "DisplayText" : "Conjunctivitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Viral conjunctivitis presents with watery discharge while bacterial infections", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "present with a thick exudate. Viral conjunctivitis is self-limited", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "and antivirals provide no benefit.", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Treatment for Acute Bacterial Conjunctivitis:", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment for Severe Acute Bacterial Conjunctivitis:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "LAST UPDATED MAY 2020", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "ORZID3 POLYTRIM CONJUNCTIVITIS", "DisplayText" : "Polytrim 1 DROP AFFECTED EYE Q3H X7 DAYS", "Text" :""},
{"Row" : 12, "Column" : 1, "Text" : "Involving suppuration or contact lens wearers."}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 CIPROFLOXACIN CONJUNCTIVITIS", "DisplayText" : "Ciprofloxacin 1 DROP IN AFFECTED EYE Q2H X2 DAYS, THEN 1 DROP Q4H X5 DAYS", "Text" :""},
{"Row" : 18, "Column" : 1, "Text" : "Sanford Guide: Conjunctivitis, bacterial (accessed 5-27-20)"}, 
{"Row" : 20, "Column" : 1, "Text" : "John Hopkins ABX Guide: Conjunctivitis (accessed 5-27-20)"}, 
{"Row" : 22, "Column" : 1, "Text" : "Up to Date: Conjunctivitis (accessed 5-27-20)"}
]},
{"Name" : "ORZID3 DENTAL INFECTIONS", "DisplayText" : "Dental Infections  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "TOOTH ABSCESS AND OTHER SUPPURATIVE ODONTOGENIC INFECTIONS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Antibiotics are generally indicated if fever and regional lymphadenopathy"}, 
{"Row" : 6, "Column" : 1, "Text" : "are present or when the infection and perforated the bony cortex and has spread"}, 
{"Row" : 7, "Column" : 1, "Text" : "into the surrounding soft tissue. These infections require drainage and"}, 
{"Row" : 8, "Column" : 1, "Text" : "debridement in addition to antibiotics."}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Alternative for Penicillin Allergy", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "LAST UPDATED MAY 2020", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Item" : "ORZID3 AUGMENTIN 875/125MG PO BID DENTAL INFECTION", "DisplayText" : "Amoxicillin 875/Clavulanate 125MG PO BID X7 DAYS", "Text" : ""},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 MOXIFLOXACIN 400MG PO DENTAL INFECTION", "DisplayText" : "Moxifloxacin 400MG PO Q24H X7 DAYS", "Text" :""},
{"Row" : 18, "Column" : 1, "Text" : "Sanford Guide: Tooth, Odontogenic Infection, Ludwig's Angina (accessed"}, 
{"Row" : 19, "Column" : 1, "Text" : "ON 05-19-21)"}, 
{"Row" : 21, "Column" : 1, "Text" : "Up to Date: Complications, diagnosis, and treatment of odontogenic infections"}, 
{"Row" : 22, "Column" : 1, "Text" : "accessed on 05-19-21)"}, 
{"Row" : 24, "Column" : 1, "Text" : "Stephens, et al. Dental Problems in Primary Care. Am Fam Physician. 2018"}, 
{"Row" : 25, "Column" : 1, "Text" : "Dec 1: 98(1):654-660"}
]},
{"Name" : "ORZID3 DIVERTICULITIS", "DisplayText" : "Diverticulitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "Preferred Treatment:", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Alternative for Fluoroquinolone:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "LAST UPDATED SEPTEMBER 2020", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZID3 MOXIFLOXACIN 400MG PO X7 DAYS DIVERTICULITIS", "DisplayText" : "Moxifloxacin 400MG PO Q24H X7 DAYS", "Text" :""},
{"Row" : 9, "Column" : 1, "Item" : "ORZID3 AUGMENTIN 875MG X7 DAYS DIVERTICULITIS", "DisplayText" : "Augmentin 875MG PO Q12H X7 DAYS", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "Sanford Guide: Diverticulitis, Perirectal Abscess (accessed 9-21-20)"}, 
{"Row" : 18, "Column" : 1, "Text" : "Up to Date: Acute colonic diverticulitis: Medical management (accessed 9-21-20)"}
]},
{"Name" : "ORZID3 FOOT ULCER IN PATIENT WITH DIABETES MELLITUS", "DisplayText" : "Foot Ulcer in Patients with Diabetes Mellitus ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Foot Ulcers WITHOUT Infection of Surrounding Tissues", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "No antibiotics indicated. Provide wound care and improved diabetes control."}, 
{"Row" : 6, "Column" : 1, "Text" : "Foot Ulcers WITH Infection of Surrounding Tissues", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Treatment of Mild Infections (Superficial Inflammation):"}, 
{"Row" : 9, "Column" : 1, "Text" : "--OR--"}, 
{"Row" : 13, "Column" : 1, "Text" : "If MRSA Coverage Needed:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "--OR--"}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment of Moderate Infections (Extension into Deeper Tissues):", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "May be best treated initially with parenteral agents and then switch to an"}, 
{"Row" : 20, "Column" : 1, "Text" : "oral agent following clinical improvement.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 21, "Column" : 1, "Text" : "CDSS for IV treatment options."}, 
{"Row" : 28, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Lipsky BA, et al. Clinical Infectious Disease 2012:54:e132"}, 
{"Row" : 31, "Column" : 1, "Text" : "Sanford Guide: Diabetic Foot (accessed 12-2020)"}, 
{"Row" : 35, "Column" : 1, "Text" : "LAST UPDATED DECEMBER 2020", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "ORZID3 AUGMENTIN 875MG PO BID 7DAYS FOOT ULCER", "DisplayText" : "Augmentin 875MG PO BID X7 DAYS", "Text" : ""},
{"Row" : 10, "Column" : 1, "Item" : "CEPHALEXIN 500MG PO BID 7DAYS FOOT ULCER", "DisplayText" : "Cephalexin 500MG PO QID X7 DAYS", "Text" :""},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO BID 7DAYS FOOT ULCER", "DisplayText" : "Doxycycline 100MG PO BID X7 DAYS", "Text" : ""},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 BACTRIM DS BID 7DAYS FOOT ULCER", "DisplayText" : "Bactrim DS BID PO X7 DAYS", "Text" :""},
{"Row" : 23, "Column" : 1, "Item" : "ORZID3 AUGMENTIN 875MG BID & BACTRIM DS BID 14DAYS FOOT ULCER", "DisplayText" : "Augmentin 875MG PO BID X14 DAYS & Bactrim DS PO BID X14 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 GMENU ACUTE BACT PROSTATITIS", "DisplayText" : "Acute bacterial prostatitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ACUTE BACTERIAL PROSTATITIS"}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 14 DAYS", "Text" :""},
{"Row" : 28, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 28 DAYS", "DisplayText" : "Bactrim DS PO BID 28 DAYS", "Text" :""},
{"Row" : 12, "Column" : 1, "Text" : "Acute bacterial prostatitis is an acute infection in young and middle aged"}, 
{"Row" : 13, "Column" : 1, "Text" : "men that is usually caused by the same organisms that cause urinary tract"}, 
{"Row" : 14, "Column" : 1, "Text" : "infection.  It is mostly caused by gram negative bacteria such as E. coli,"}, 
{"Row" : 15, "Column" : 1, "Text" : "coliforms, and enterococcus species but sexually transmitted pathogens"}, 
{"Row" : 16, "Column" : 1, "Text" : "such as Neisseria gonorrhoeae and Chlamydia trachomatis can also be the"}, 
{"Row" : 17, "Column" : 1, "Text" : "cause in sexually active men.  Typical symptoms include fever, chills,"}, 
{"Row" : 18, "Column" : 1, "Text" : "malaise, myalgia, dysuria, pelvic/perineal pain, and cloudy urine.  The"}, 
{"Row" : 19, "Column" : 1, "Text" : "prostate is generally warm, red, firm, and very tender.  Complications that"}, 
{"Row" : 20, "Column" : 1, "Text" : "can occur, especially with a delay in antibiotics, include bacteremia,"}, 
{"Row" : 21, "Column" : 1, "Text" : "epididymitis, prostatic abscess, extension or metastasis to other locations,"}, 
{"Row" : 22, "Column" : 1, "Text" : "and conversion to chronic prostatitis."}, 
{"Row" : 24, "Column" : 1, "Text" : "NOT AT RISK OF STI", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "WITH RISK OF STI", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSOZID CEFTRIAXONE 250MG IM THEN DOXY 100MG PO BID 10DAYS", "DisplayText" : "Ceftriaxone 250MG IM ONCE THEN Doxycycline 100MG PO BID 10 DAYS", "Text" : ""},
{"Row" : 35, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Meyrier A, Fekete T.  Acute Bacterial Prostatitis.  Up To Date.  July, 2014."}, 
{"Row" : 39, "Column" : 1, "Text" : "Acute Bacterial Prostatitis.  Sanford Guide.  August 26, 2013."}
]},
{"Name" : "ORZID3 GMENU ACUTE SINUSITIS MILD TO MOD", "DisplayText" : "Acute sinusitis--mild to moderate disease (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Consult ENT", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ GMENU CT OPT MENU 11/11", "DisplayText" : "CT MENU", "Text" : "Order CT scan", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "ACUTE SINUSITIS--MILD TO MODERATE DISEASE"}, 
{"Row" : 13, "Column" : 1, "Text" : "Most cases of acute sinusitis are viral.  Most of these resolve within 7 days."}, 
{"Row" : 14, "Column" : 1, "Text" : "Nasal congestion, purulent nasal discharge, and tooth or facial pain can be"}, 
{"Row" : 15, "Column" : 1, "Text" : "treated with decongestants, analgesics, and nasal saline.  Bacterial infection"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID3 GMENU SEVERE SINUSITIS", "DisplayText" : "Acute sinusitis--Severe disease (Outpatient)", "Text" : "Link to severe sinusitis", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "If symptoms fail to respond or recur after 3-5 days of antimicrobial"}, 
{"Row" : 25, "Column" : 1, "Text" : "therapy, puncture and aspiration of sinuses is necessary to identify pathogens."}, 
{"Row" : 26, "Column" : 1, "Text" : "ENT consultation is recommended."}, 
{"Row" : 28, "Column" : 1, "Text" : "Treatment of mild to moderate cases for FIRST 10 DAYS OF ILLNESS", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Treat with decongestants, analgesics, and nasal saline spray."}, 
{"Row" : 31, "Column" : 1, "Text" : "Treatment of mild to moderate cases that have NOT IMPROVED IN 10 DAYS despite", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "treatment with decongestants, analgesics, and nasal saline."}, 
{"Row" : 37, "Column" : 1, "Text" : "Alternative for penicillin allergy:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Recommended Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "is more likely the causative agent when symptoms are present for =10 days,"}, 
{"Row" : 17, "Column" : 1, "Text" : "fever =102oF and purulent discharge or facial pain for 3-4 consecutive days,"}, 
{"Row" : 18, "Column" : 1, "Text" : "or  worsening symptoms following a typical viral infection. Antimicrobials"}, 
{"Row" : 19, "Column" : 1, "Text" : "are indicated in these instances. Nasal saline and intranasal corticosteroids"}, 
{"Row" : 20, "Column" : 1, "Text" : "are beneficial as adjunctive therapy."}, 
{"Row" : 41, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Gilbert, DN et al eds. The Sanford Guide to Antimicrobial Therapy, 44th ed."}, 
{"Row" : 44, "Column" : 1, "Text" : "Sperryville, VA: Antimicrobial Therapy INC 2014. Pages 112"}, 
{"Row" : 45, "Column" : 1, "Text" : "Hwang P, et al. Acute sinusitis + Rhinosinusitis in adults. Up-to-Date website."}, 
{"Row" : 46, "Column" : 1, "Text" : "Updated 02/26/2014."}, 
{"Row" : 47, "Column" : 1, "Text" : "Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for"}, 
{"Row" : 48, "Column" : 1, "Text" : "acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012"},
{"Row" : 49, "Column" : 1, "Text" : "54(8):e72-e112.Aring et al. Am Fam Phys. 2011"}, 
{"Row" : 50, "Column" : 1, "Text" : "Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness"}, 
{"Row" : 51, "Column" : 1, "Text" : "and safety of short vs. long duration of antibiotic therapy for acute bacterial"}, 
{"Row" : 52, "Column" : 1, "Text" : "sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol. 2009"},
{"Row" : 53, "Column" : 1, "Text" : "67(2):161-71.alagas et al. Br Journ Clin Pharm. 2009"}, 
{"Row" : 54, "Column" : 1, "Text" : "Ahovuo-saloranta A, Rautakorpi UM, Borisenko OV, Liira H, Williams JW, Mkel M."}, 
{"Row" : 55, "Column" : 1, "Text" : "Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev."}, 
{"Row" : 56, "Column" : 1, "Text" : "2014"}, 
{"Row" : 35, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 5 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H 5 DAYS", "Text" : ""},
{"Row" : 38, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 5 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H 5 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 GMENU ACUTE SPON BACT PERITONITIS", "DisplayText" : "Spontaneous Bacterial Peritonitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "SBP is infection of the peritoneal cavity in the absence of an apparent trauma"}, 
{"Row" : 13, "Column" : 1, "Text" : "or other obvious cause. SBP occurs primarily in people with end-stage liver"}, 
{"Row" : 14, "Column" : 1, "Text" : "disease and ascites.  The diagnosis is made when a peritoneal fluid sample has"}, 
{"Row" : 15, "Column" : 1, "Text" : "more than 250 polymorphonuclear leukocyte cells per microliter, or when"}, 
{"Row" : 16, "Column" : 1, "Text" : "bacterial pathogens are isolated."}, 
{"Row" : 18, "Column" : 1, "Text" : "Long-term SBP prophylaxis is indicated for patients who survive their first"}, 
{"Row" : 19, "Column" : 1, "Text" : "episode of SBP.  Short-term SBP prophylaxis is indicated for patients with"}, 
{"Row" : 20, "Column" : 1, "Text" : "variceal bleeding, or for patients who have low-protein refractory ascites (<1"}, 
{"Row" : 21, "Column" : 1, "Text" : "gm albumin/dl ascitic fluid).  Some give long-term antimicrobials to patients"}, 
{"Row" : 22, "Column" : 1, "Text" : "with low-protein refractory ascites.  Consult Gastroenterology for more"}, 
{"Row" : 23, "Column" : 1, "Text" : "information."}, 
{"Row" : 25, "Column" : 1, "Text" : "Acute SBP", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS for treatment."}, 
{"Row" : 28, "Column" : 1, "Text" : "Prophylaxis in a patient with a PREVIOUS SBP EPISODE", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO Q24H 90 DAYS", "DisplayText" : "Bactrim DS PO Q24H 90 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO qday($0.09/day) [R,DI]  < OR >", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 750MG PO Q1WEEK", "DisplayText" : "Ciprofloxacin 750MG PO EVERY WEEK", "Text" : "Ciprofloxacin 750 mg PO q week ($0.14/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 32, "Column" : 1, "Text" : "Prophylaxis in a patient with CIRRHOSIS and VARICEAL HEMORRHAGE", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID for 7 days ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 39, "Column" : 1, "Text" : "Such J  Clin Infect Dis  1998, 27: 669"}, 
{"Row" : 41, "Column" : 1, "Text" : "Parsi MA  Clev Clin J Med  2004, 71: 569"}, 
{"Row" : 42, "Column" : 1, "Text" : "Frazee LA  Ann Pharmacother  2005, 39: 908"}, 
{"Row" : 43, "Column" : 1, "Text" : "Runyon BA  Gastroenterol 1991, 100: 1737"}, 
{"Row" : 44, "Column" : 1, "Text" : "Novella M  Hepatol 1997, 25: 532"}, 
{"Row" : 45, "Column" : 1, "Text" : "Soares-Weiser K  Cochrane Database Systematic Reviews 3, 2005"}, 
{"Row" : 38, "Column" : 1, "Text" : "\"Sanford\" keyword: peritonitis"}, 
{"Row" : 40, "Column" : 1, "Text" : "Up-to-Date: Peritonitis"}, 
{"Row" : 10, "Column" : 1, "Text" : "SPONTANEOUS BACTERIAL PERITONITIS (SBP)"}
]},
{"Name" : "ORZID3 GMENU ANTIVIRAL TREATMENT 2014-2015", "DisplayText" : "Antiviral Treatment Recommendations  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Disease", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "Antiviral Therapy Recommendations:", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Who to Treat:", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "The decision to treat should be based on clinical symptoms and/or presence of"}, 
{"Row" : 12, "Column" : 1, "Text" : "a high risk condition, and should NOT be delayed until laboratory test"}, 
{"Row" : 13, "Column" : 1, "Text" : "results are available."}, 
{"Row" : 15, "Column" : 1, "Text" : "It is important to use antiviral drugs early to treat influenza in people"}, 
{"Row" : 16, "Column" : 1, "Text" : "are very sick with influenza (for example hospitalized people) and people"}, 
{"Row" : 17, "Column" : 1, "Text" : "are sick with influenza and have a greater chance of getting severe"}, 
{"Row" : 5, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary Consult", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Text" : "complications. If a patient is not in a high-risk group or is not hospital"}, 
{"Row" : 19, "Column" : 1, "Text" : "healthcare providers should use clinical judgment to guide treatment decisions."}, 
{"Row" : 20, "Column" : 1, "Text" : "People who have a greater chance of serious influenza complications include:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Adults 65 years and older"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Pregnant women and women up to 2 weeks from end of pregnancy"}, 
{"Row" : 23, "Column" : 1, "Text" : "*People with certain chronic medical conditions (such as asthma, heart"}, 
{"Row" : 24, "Column" : 1, "Text" : "failure, chronic lung disease) and people with a weak immune system (due to"}, 
{"Row" : 25, "Column" : 1, "Text" : "illnesses such as diabetes and HIV) or people with neurologic and"}, 
{"Row" : 26, "Column" : 1, "Text" : "neurodevelopment conditions (including disorders of brain and spinal cord)"}, 
{"Row" : 27, "Column" : 1, "Text" : "*People younger than 19 years of age who are receiving long-term aspirin"}, 
{"Row" : 28, "Column" : 1, "Text" : "therapy"}, 
{"Row" : 29, "Column" : 1, "Text" : "* American Indians/Alaska Natives"}, 
{"Row" : 30, "Column" : 1, "Text" : "*People who are morbidly obese (i.e., body-mass index greater than or"}, 
{"Row" : 31, "Column" : 1, "Text" : "equal to 40)"}, 
{"Row" : 33, "Column" : 1, "Text" : "Antiviral Treatment:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "If indicated, antivirals should be started as soon as possible.  Maximal"}, 
{"Row" : 35, "Column" : 1, "Text" : "benefit occurs when started within 48 hours of symptom onset.  However,"}, 
{"Row" : 36, "Column" : 1, "Text" : "antivirals should not be withheld if symptoms began more than 48 hours prior"}, 
{"Row" : 37, "Column" : 1, "Text" : "and the patient meets criteria for treatment and remains severely ill."}, 
{"Row" : 39, "Column" : 1, "Text" : "Oseltamivir or zanamivir are the only two antiviral drugs the Center for"}, 
{"Row" : 40, "Column" : 1, "Text" : "Disease Control is recommending for this influenza season. Neither"}, 
{"Row" : 41, "Column" : 1, "Text" : "amantadine nor rimantadine are recommended for treatment or"}, 
{"Row" : 42, "Column" : 1, "Text" : "chemoprophylaxis this influenza season."}, 
{"Row" : 44, "Column" : 1, "Text" : "Treatment Dosing:", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Patients with chronic respiratory disease like asthma or chronic obstructive"}, 
{"Row" : 46, "Column" : 1, "Text" : "pulmonary disease may have bronchospasm with zanamivir, and zanamivir shou"}, 
{"Row" : 47, "Column" : 1, "Text" : "avoided in these patients. If zanamivir must be used, and patients are using"}, 
{"Row" : 48, "Column" : 1, "Text" : "inhaled bronchodilator, zanamivir should be taken just after the bronchodilator"}, 
{"Row" : 50, "Column" : 1, "Text" : "Duration of antiviral treatment is 5 days.  Extending the treatment may be"}, 
{"Row" : 51, "Column" : 1, "Text" : "needed for those patients with prolonged illness or who are immnunosuppressed."}, 
{"Row" : 53, "Column" : 1, "Text" : "Recommended:", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Item" : "PSOZID OSELTAMIVIR 75MG PO BID X 5DAYS", "DisplayText" : "OSELTAMIVIR 75 MG PO BID X 5DAYS", "Text" : "Oseltamivir 75 mg po bid for 5 days ($14/day) [R]", "Mnemonic" : "14"},
{"Row" : 56, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 60, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "Centers for Disease Control (CDC)"}, 
{"Row" : 62, "Column" : 1, "Text" : "(http://www.cdc.gov/flu/about/season/index.htm)"}, 
{"Row" : 57, "Column" : 1, "Text" : "Requires Infectious Disease Approval"}, 
{"Row" : 58, "Column" : 1, "Text" : "Zanamivir 2 inhalations (2 x 5 mg) BID for 5 days ($8/day) [O]"}
]},
{"Name" : "ORZID3 GMENU APPENDICITIS W/ PERFORATION", "DisplayText" : "Appendicitis with perforation (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ ONCOLOGY OPT CONSULT", "DisplayText" : "ONCOLOGY OPT", "Text" : "Hematology-Oncology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "APPENDICITIS WITH PERFORATION"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU APPENDICITIS W/O PERFORATION", "DisplayText" : "Appendicitis without perforation (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "APPENDICITIS WITHOUT PERFORATION"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU APPRO TO FOOT ULCERS W/ INFECT", "DisplayText" : "Approach to foot ulcers with infection (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PODIATRY OPT", "DisplayText" : "PODIATRY OPT", "Text" : "Podiatry consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Orthopedic surgery consult", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Text" : "Whenever possible, material should be obtained for Gram stain and culture."}, 
{"Row" : 14, "Column" : 1, "Text" : "Specimens from deep ulcer biopsy, aspiration, or bone biopsy are superior to"}, 
{"Row" : 15, "Column" : 1, "Text" : "wound swab or drainage.  Pathogen identification is especially important because"}, 
{"Row" : 16, "Column" : 1, "Text" : "therapy is often given for weeks."}, 
{"Row" : 18, "Column" : 1, "Text" : "While foot ulcers in patients with diabetes typically have many bacterial"}, 
{"Row" : 19, "Column" : 1, "Text" : "species on the surface, disease is usually caused by only one or two.  When"}, 
{"Row" : 20, "Column" : 1, "Text" : "Staphylococcus aureus is present in a surface culture, it is usually a pathogen"}, 
{"Row" : 21, "Column" : 1, "Text" : "in the deeper tissues.  Therapy can usually be directed against the predominant"}, 
{"Row" : 22, "Column" : 1, "Text" : "or virulent organisms found on surface cultures and need not be active against"}, 
{"Row" : 23, "Column" : 1, "Text" : "every isolate.  To reduce uncertainty it is better to obtain deeper cultures."}, 
{"Row" : 25, "Column" : 1, "Text" : "Bacteria that are most likely to be responsible for invasive infection include"}, 
{"Row" : 26, "Column" : 1, "Text" : "S. aureus, streptococci, enteric gram-negative bacilli, Pseudomonas aeruginosa,"}, 
{"Row" : 27, "Column" : 1, "Text" : "and anaerobes typical of the human enteric flora.  When there is no evidence"}, 
{"Row" : 28, "Column" : 1, "Text" : "directed against these organisms."}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}, 
{"Row" : 11, "Column" : 1, "Text" : "APPROACH TO FOOT ULCER WITH INFECTION"}
]},
{"Name" : "ORZID3 GMENU ASPIRATION PNEUMONIA", "DisplayText" : "Aspiration pneumonia (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ASPIRATION PNEUMONIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Aspiration of oropharyngeal or gastric contents induces inflammation and is"}, 
{"Row" : 13, "Column" : 1, "Text" : "often accompanied by fever and/or an infiltrate.  Bacterial pneumonia occurs in"}, 
{"Row" : 14, "Column" : 1, "Text" : "a minority of patients who aspirate, typically about 3 days later.  The patient"}, 
{"Row" : 15, "Column" : 1, "Text" : "usually improves for the first 2 days and then worsens as bacterial pneumonia"}, 
{"Row" : 16, "Column" : 1, "Text" : "develops with increased fever, new or progressive infiltrates, leukocytosis, and"}, 
{"Row" : 17, "Column" : 1, "Text" : "newly purulent sputum."}, 
{"Row" : 19, "Column" : 1, "Text" : "Antimicrobials have no role for treatment of aspiration and their use entails"}, 
{"Row" : 20, "Column" : 1, "Text" : "risk of side effects and selection of resistant organisms."}, 
{"Row" : 22, "Column" : 1, "Text" : "Antimicrobials used for community-acquired pneumonia are appropriate for cases"}, 
{"Row" : 23, "Column" : 1, "Text" : "that develop after an episode of aspiration.  For more information, consult"}, 
{"Row" : 24, "Column" : 1, "Text" : "pulmonary or Infectious Diseases."}, 
{"Row" : 26, "Column" : 1, "Text" : "Treatment for patients with pneumonitis but WITHOUT LUNG ABSCESS or putrid", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "sputum", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Therapy directed towards anaerobic pathogens is usually unnecessary.  If"}, 
{"Row" : 29, "Column" : 1, "Text" : "pneumonia is confirmed, treat as"}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID3 GMENU COMM ACQ PNEUMONIA", "DisplayText" : "Community acquired pneumonia (Outpatient)", "Text" : "Community acquired pneumonia (CAP)  < OR >", "Mnemonic" : "12"},
{"Row" : 34, "Column" : 1, "Text" : "Treament for patients WITH LUNG ABSCESS", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID3 GMENU LUNG ABSCESS", "DisplayText" : "Lung abscess (Outpatient)", "Text" : "Lung abscess", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 32, "Column" : 1, "Text" : "Refer to Nosocomial Pneumonia in the Inpatient Antimicrobial CDSS."}, 
{"Row" : 40, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18:939"}, 
{"Row" : 41, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 42, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 43, "Column" : 1, "Text" : "\"Mandell\" chapter: Infectious Diseases"}, 
{"Row" : 44, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37:1405"}, 
{"Row" : 45, "Column" : 1, "Text" : "Roig J  J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 46, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 47, "Column" : 1, "Text" : "Up-to-date: Aspiration Pneumonia"}, 
{"Row" : 48, "Column" : 1, "Text" : "Anonymous  Am J Respir Crit Care Med 2005, 171: 388"}
]},
{"Name" : "ORZID3 GMENU BACTEREMIA", "DisplayText" : "Bacteremia (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "BACTEREMIA"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU BACTERIAL VAGINOSIS", "DisplayText" : "Bacterial vaginosis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "BACTERIAL VAGINOSIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Vaginitis usually presents with discharge, itching, irritation, odor, or pain."}, 
{"Row" : 14, "Column" : 1, "Text" : "Bacterial vaginosis is the most common form of vaginitis. The vaginal flora is"}, 
{"Row" : 15, "Column" : 1, "Text" : "disrupted by one or more of the following common pathogens: Gardnerella"}, 
{"Row" : 16, "Column" : 1, "Text" : "vaginalis, Mycobacterium hominis, or Gram negative anaerobes.  Vaginal pH should"}, 
{"Row" : 17, "Column" : 1, "Text" : "be measured and  the specimen should be examined under the microscope."}, 
{"Row" : 19, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "The vaginal pH is greater than 4.5, the discharge is homogenous and  gray-white,"}, 
{"Row" : 21, "Column" : 1, "Text" : "and  the specimen has a positive amine or \"whiff\" test characterized by a fishy"}, 
{"Row" : 22, "Column" : 1, "Text" : "odor before or after addition of 10% KOH."}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID2 METRONI 7DS 500MG PO BID", "DisplayText" : "Metronidazole 500mg po bid for 7 days", "Text" : "Metronidazole 500 mg PO BID for 7 days ($0.64/day) [DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Item" : "PSOZID2 METRONIDAZOLE 0.75% VAG GEL 1 APPL INTRAVAG QHS 5DS", "DisplayText" : "Metronidazole vaginal 0.75% gel 1 applicatorful intravaginally qhs 5days", "Text" : "Metronidazole topical gel, contents of 1 applicator intravaginally QHS for 5", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "days ($0.64/day) [DI]"}, 
{"Row" : 29, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 7DS 300MG PO BID", "DisplayText" : "Clindamycin 300mg po bid for 7 days", "Text" : "Clindamycin 300 mg PO BID for 7 days ($3.36/day) [H,O]  < OR >", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN PHOSPHATE VAG 2% CRM 5GM QHS 5DS", "DisplayText" : "Clindamycin phosphate vaginal cream 5gm qhs 5 days", "Text" : "Clindamycin phosphate vaginal cream 5 gram (contents of 1 applicator)", "Mnemonic" : "20"},
{"Row" : 32, "Column" : 1, "Text" : "intravaginally QHS for 5 days ($3.36/day) [H,O]"}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 37, "Column" : 1, "Text" : "\"Mandell\" chapter: Vulvovaginitis and cervicitis"}, 
{"Row" : 38, "Column" : 1, "Text" : "Up-to-Date website: Vulvovaginitis and cervicitis"}
]},
{"Name" : "ORZID3 GMENU BELL PALSY", "DisplayText" : "Bell's palsy (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORWDQ 14BD6E97", "DisplayText" : "Smoker's treat", "Text" : "Consult Gastroenterology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ NEURO OPT", "DisplayText" : "Neurology", "Text" : "Consult Neurology", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "BELL'S PALSY"}, 
{"Row" : 10, "Column" : 1, "Text" : "Herpes simplex is one cause of Bell's palsy.  Others include Borrelia"}, 
{"Row" : 11, "Column" : 1, "Text" : "burgdorferi, zoster, and trauma.  Some cases are idiopathic.  Neurology consult"}, 
{"Row" : 12, "Column" : 1, "Text" : "is encouraged - treatment is not effective."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Text" : "If Lyme disease is suspected"}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU LYME DISEASE", "DisplayText" : "Lyme Disease (Outpatient)", "Text" : "Lyme Disease", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Text" : "Gilden DH  NEJM 2004, 351: 1323"}
]},
{"Name" : "ORZID3 GMENU BITE WNDS EIKENELLA CORRODENS", "DisplayText" : "Bite wounds with Eikenella corrodens (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic surgery", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY OPT", "DisplayText" : "RHEUMATOLOGY OPT", "Text" : "Consult Rheumatology", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH EIKENELLA CORRODENS"}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 10DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 10 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R]", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" keyword:  Bites"}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 13, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment for infection without joint involvement", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 10DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 10 days", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI]", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment for infection with joint involvement", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 14DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 14 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R]", "Mnemonic" : "18"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 14DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 14 days", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI]", "Mnemonic" : "20"}
]},
{"Name" : "ORZID3 GMENU BITE WNDS METH RES S. AUREUS", "DisplayText" : "Bite wounds with Methicillin-resistant S. aureus (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic surgery", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY OPT", "DisplayText" : "RHEUMATOLOGY OPT", "Text" : "Consult Rheumatology", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS"}, 
{"Row" : 13, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment for infection without joint involvement", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 10 DAYS", "DisplayText" : "Bactrim DS PO BID 10 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 10DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 10 days", "Text" : "Minocycline 100 mg PO BID ($1.06/day) [DI]  < OR >", "Mnemonic" : "16"},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 10DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 10 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "18"},
{"Row" : 22, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment for infection with joint involvement", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "20"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 14DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 14 days", "Text" : "Minocycline 100 mg PO BID ($1.06/day) [DI]  < OR >", "Mnemonic" : "22"},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 14DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 14 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "24"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" keyword:  Bites"}, 
{"Row" : 35, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}
]},
{"Name" : "ORZID3 GMENU BITE WNDS METH SUSC S. AUREUS", "DisplayText" : "Bite wounds with Methicillin-susceptible Staphylococcus aureus (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic surgery", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY OPT", "DisplayText" : "RHEUMATOLOGY OPT", "Text" : "Consult Rheumatology", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 10 DAYS", "DisplayText" : "Bactrim DS PO BID 10 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 10DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 10 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]  < OR >", "Mnemonic" : "16"},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 10DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 10 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI]", "Mnemonic" : "18"},
{"Row" : 27, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "20"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" keyword:  Bites"}, 
{"Row" : 35, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment for infection without joint involvement", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment for infection with joint involvement", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Treat for 14-21 days."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 14DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 14 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]  < OR >", "Mnemonic" : "22"},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 DICLOX 14DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 14 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI]", "Mnemonic" : "24"}
]},
{"Name" : "ORZID3 GMENU BITE WNDS P. MULTOCIDA", "DisplayText" : "Bite wounds with Pasteurella multocida (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic surgery", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY OPT", "DisplayText" : "RHEUMATOLOGY OPT", "Text" : "Consult Rheumatology", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH PASTEURELLA MULTOCIDA"}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 10DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 10 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R]", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 10DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 10 days", "Text" : "Doxycycline 100mg PO BID ($0.16/day) [DI]", "Mnemonic" : "16"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" keyword:  Bites"}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment for infection without joint involvement", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment for infection with joint involvement", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 14DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 14 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R]", "Mnemonic" : "18"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 14DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 14 days", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI]", "Mnemonic" : "20"}
]},
{"Name" : "ORZID3 GMENU BITE WNDS STREPTOCOCCI", "DisplayText" : "Bite wounds with Streptococci (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic surgery", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY OPT", "DisplayText" : "RHEUMATOLOGY OPT", "Text" : "Consult Rheumatology", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "BITE WOUNDS WITH STREPTOCOCCI"}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 10 DAYS", "DisplayText" : "Bactrim DS PO BID 10 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 10DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 10 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]  < OR >", "Mnemonic" : "16"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 10DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 10 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI]", "Mnemonic" : "18"},
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 35, "Column" : 1, "Text" : "\"Sanford\" keyword:  Bites"}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 13, "Column" : 1, "Text" : "Infection but no arthritis - 10 days joint involved - 14-21 days"}, 
{"Row" : 14, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment for infection without joint involvement", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment for infection with joint involvement", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "20"},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 14DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 14 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]  < OR >", "Mnemonic" : "22"},
{"Row" : 30, "Column" : 1, "Item" : "PSOZID2 DICLOX 14DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 14 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI]", "Mnemonic" : "24"}
]},
{"Name" : "ORZID3 GMENU BITE WOUNDS", "DisplayText" : "Bite wounds (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "BITE WOUNDS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Bite wounds are prone to infection because of the pathogenic oral flora carried"}, 
{"Row" : 13, "Column" : 1, "Text" : "into tissues by teeth.  Antimicrobial therapy against likely pathogens should be"}, 
{"Row" : 14, "Column" : 1, "Text" : "given to all patients unless the wound is trivial and superficial.  For"}, 
{"Row" : 15, "Column" : 1, "Text" : "superficial wounds, cleanse the area and observe for signs and symptoms of"}, 
{"Row" : 16, "Column" : 1, "Text" : "infection."}, 
{"Row" : 18, "Column" : 1, "Text" : "Consider rabies post-exposure prophylaxis for all animal bite cases.  Contact"}, 
{"Row" : 23, "Column" : 1, "Text" : "Common pathogens include Eikenella corrodens, usually from human bites, and"}, 
{"Row" : 24, "Column" : 1, "Text" : "Pasteurella multocida, often from dog or cat bites, streptococci and"}, 
{"Row" : 25, "Column" : 1, "Text" : "staphylococci."}, 
{"Row" : 27, "Column" : 1, "Text" : "Treat deep wounds for the first 5 days after a bite to prevent infection.  For"}, 
{"Row" : 28, "Column" : 1, "Text" : "wounds that later develop evidence of infection but without arthritis, treat"}, 
{"Row" : 29, "Column" : 1, "Text" : "with antimicrobials for 10 days.  For wounds that develop infection of a joint,"}, 
{"Row" : 30, "Column" : 1, "Text" : "treat 14 to 21 days."}, 
{"Row" : 32, "Column" : 1, "Text" : "Wounds several days old that appear infected should be treated with"}, 
{"Row" : 33, "Column" : 1, "Text" : "antimicrobials.  In these cases, therapy should be directed against pathogens"}, 
{"Row" : 34, "Column" : 1, "Text" : "identified by Gram stain and culture whenever possible."}, 
{"Row" : 36, "Column" : 1, "Text" : "Pathogen-directed bite wound therapy", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID3 GMENU BITE WNDS P. MULTOCIDA", "DisplayText" : "Bite wounds with Pasteurella multocida (Outpatient)", "Text" : "Pasteurella multocida", "Mnemonic" : "12"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID3 GMENU BITE WNDS EIKENELLA CORRODENS", "DisplayText" : "Bite wounds with Eikenella corrodens (Outpatient)", "Text" : "Eikenella corrodens", "Mnemonic" : "14"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID3 GMENU BITE WNDS METH SUSC S. AUREUS", "DisplayText" : "Bite wounds with Methicillin-susceptible Staphylococcus aureus (Outpatient)", "Text" : "Methicillin-susceptible Staphylococcus aureus", "Mnemonic" : "16"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID3 GMENU BITE WNDS STREPTOCOCCI", "DisplayText" : "Bite wounds with Streptococci (Outpatient)", "Text" : "Streptococci", "Mnemonic" : "18"},
{"Row" : 47, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 5DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125 mg po bid for 5 days", "Text" : "Amoxicillin-clavulanate 875-125 mg PO BID ($1.56/day) [R]", "Mnemonic" : "20"},
{"Row" : 49, "Column" : 1, "Text" : "Alternative for patients with penicillin allergy", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Item" : "ORZ SET ABX OP MOXIFL 5DS 400MG PO CLINDA 10DS 300MG", "DisplayText" : "", "Text" : "Moxifloxacin 400 mg PO qday ($1.19/day) [DI] <AND> clindamycin 300 mg PO QID", "Mnemonic" : "22"},
{"Row" : 65, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "28"},
{"Row" : 68, "Column" : 1, "Text" : "\"Mandell\" Chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 21, "Column" : 1, "Text" : "Consult Orthopedic surgery for all bite wounds involving the hand."}, 
{"Row" : 19, "Column" : 1, "Text" : "Infectious Diseases for assistance."}, 
{"Row" : 51, "Column" : 1, "Text" : "mg PO QID ($3.36/day) [H,O]"}, 
{"Row" : 67, "Column" : 1, "Text" : "\"Sanford\" keyword:  Bites"}, 
{"Row" : 44, "Column" : 1, "Text" : "Pre-emptive therapy for deep wounds without evidence of infection", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "____________________________________________________________________", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "____________________________________________________________________", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "____________________________________________________________________", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "____________________________________________________________________", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Text" : "Empirical therapy of wounds that appear infected", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "Treat for 10 days"}, 
{"Row" : 58, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 10DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 10 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R]", "Mnemonic" : "24"},
{"Row" : 60, "Column" : 1, "Text" : "Alternative for patients with penicillin allergy", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Item" : "ORZ SET ABX OP MOXIFL 10DS 400MG PO CLINDA 300MG QID", "DisplayText" : "", "Text" : "Moxifloxacin 400 mg PO q24h ($1.19/day) [R,DI] <AND> clindamycin 300 mg PO", "Mnemonic" : "26"},
{"Row" : 62, "Column" : 1, "Text" : "PO QID ($3.36/day) [H,O] 150mg caps"}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID3 GMENU BITE WNDS METH RES S. AUREUS", "DisplayText" : "Bite wounds with Methicillin-resistant S. aureus (Outpatient)", "Text" : "Methicillin-resistant Staphylococcus aureus", "Mnemonic" : "17"}
]},
{"Name" : "ORZID3 GMENU BRONCHITIS", "DisplayText" : "Bronchitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary"},
{"Row" : 10, "Column" : 1, "Text" : "BRONCHITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Acute bronchitis should not be treated with antimicrobials except in specific"}, 
{"Row" : 13, "Column" : 1, "Text" : "circumstances. If pneumonia is suspected, order a chest x-ray.  If an infiltrate"}, 
{"Row" : 14, "Column" : 1, "Text" : "is not present, the patient does not have pneumonia and need not be treated for"}, 
{"Row" : 15, "Column" : 1, "Text" : "it."}, 
{"Row" : 17, "Column" : 1, "Text" : "Acute bronchitis in an otherwise HEALTHY PATIENT", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Antimicrobials provide no benefit.  If bronchitis persists beyond 2 weeks,"}, 
{"Row" : 19, "Column" : 1, "Text" : "additional diagnostic workup is needed to find a cause.  If a patient has"}, 
{"Row" : 20, "Column" : 1, "Text" : "persistent cough with inspiratory \"whoop,\" consider a diagnosis of pertussis."}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID3 GMENU PERTUSSIS", "DisplayText" : "Pertussis (Outpatient)", "Text" : "Pertussis"},
{"Row" : 24, "Column" : 1, "Text" : "Acute bronchitis in patients with COPD", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Cornerstones of therapy include oxygen, bronchodilators, and in some cases"}, 
{"Row" : 26, "Column" : 1, "Text" : "corticosteroids.  Antimicrobials provide small benefit for about 50% of"}, 
{"Row" : 27, "Column" : 1, "Text" : "patients.  Typically, antimicrobials shorten duration of symptoms by about half"}, 
{"Row" : 28, "Column" : 1, "Text" : "a day.  Antibiotics should only be used for severe cases.  Repeated courses of"}, 
{"Row" : 29, "Column" : 1, "Text" : "antimicrobials are associated with colonization by resistant organisms and other"}, 
{"Row" : 30, "Column" : 1, "Text" : "adverse drug events."}, 
{"Row" : 32, "Column" : 1, "Text" : "Treatment if sputum is newly purulent or if purulent sputum has increased in", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "volume", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Treat for 7 days"}, 
{"Row" : 55, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References"},
{"Row" : 35, "Column" : 1, "Text" : "Preferred:", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Normal renal function (CrCl>30 ml/min)", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" :""},
{"Row" : 40, "Column" : 1, "Text" : "Impaired renal function", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 500/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 500/125MG PO BID", "Text" :""},
{"Row" : 47, "Column" : 1, "Text" : "Alternative (if patient has penicillin allergy)", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 500/125MG PO Q24H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 500/125MG PO Q24H", "Text" : ""},
{"Row" : 38, "Column" : 1, "Item" : "PSOZID CEFUROXIME 500MG PO Q12H 7 DAYS", "DisplayText" : "Cefuroxime 500MG PO Q12H", "Text" : ""},
{"Row" : 51, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG X1D THEN 250MG X6D", "DisplayText" : "Levofloxacin 500MG X 1 dose then 250MG x 6 doses", "Text" : ""},
{"Row" : 50, "Column" : 1, "Text" : "(CrCl 20-49ml/min)", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Text" : "(CrCl <20ml/min)", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG X1D THEN 250MG Q48H 6 DAYS", "DisplayText" : "Levofloxacin 500MG X 1 Dose then 250MG Q48H X 6 days", "Text" :""},
{"Row" : 41, "Column" : 1, "Text" : "(CrCl 10-30ml/min)", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "(CrCl <10ml/min)", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "Siddiqi A, Sethi S. Int J COPD 2008"}, 
{"Row" : 58, "Column" : 1, "Text" : "Sanford Guide \"Bronchitis, Chronic with Acute Exacerbation\""}, 
{"Row" : 59, "Column" : 1, "Text" : "Accessed 11 March 2014"}, 
{"Row" : 60, "Column" : 1, "Text" : "Up To Date \"Management of infection in acute exacerbations of chronic"}, 
{"Row" : 61, "Column" : 1, "Text" : "obstructive pulmonary disease\". Accessed 11 March 2014"}, 
{"Row" : 62, "Column" : 1, "Text" : "Murphy TF, et al. CHEST 2000"}, 
{"Row" : 45, "Column" : 1, "Item" : "PSOZID CEFUROXIME 250MG Q24H 7 DAYS", "DisplayText" : "Cefuroxime 250MG Q24H", "Text" : ""},
{"Row" : 48, "Column" : 1, "Text" : "Normal Renal Function", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H 7 DAYS", "DisplayText" : "Levofloxacin 500MG PO q24h ($0.19/day)[R,DI]", "Text" : ""}
]},
{"Name" : "ORZID3 GMENU C. DIFFICILE COLITIS", "DisplayText" : "Antibiotic associated colitis (C. difficile colitis) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 13, "Column" : 1, "Text" : "The preferred route of antimicrobial therapy is by mouth.  Intravenous"}, 
{"Row" : 14, "Column" : 1, "Text" : "metronidazole should only be used when oral therapy cannot be used to deliver"}, 
{"Row" : 15, "Column" : 1, "Text" : "drug to the colon.  Intravenous vancomycin does not get into colonic contents"}, 
{"Row" : 16, "Column" : 1, "Text" : "and is not effective."}, 
{"Row" : 18, "Column" : 1, "Text" : "Most cases respond to antimicrobials.  Relapse is usually due to failure of"}, 
{"Row" : 19, "Column" : 1, "Text" : "normal colonic flora to re-establish itself, rather than antimicrobial treatment"}, 
{"Row" : 20, "Column" : 1, "Text" : "failure.  If symptoms do not respond to antimicrobials, re-consider diagnosis."}, 
{"Row" : 21, "Column" : 1, "Text" : "Relapse occurs in 10 to 20% of people after their first episode of C. difficile"}, 
{"Row" : 22, "Column" : 1, "Text" : "disease."}, 
{"Row" : 24, "Column" : 1, "Text" : "________________________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "________________________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Initial episode", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Discontinue antimicrobials that might have induced C. difficile disease if"}, 
{"Row" : 29, "Column" : 1, "Text" : "possible.  Mild cases usually respond to discontinuation of antimicrobials"}, 
{"Row" : 30, "Column" : 1, "Text" : "alone.  For more severe or persistent disease or if antimicrobials cannot be"}, 
{"Row" : 31, "Column" : 1, "Text" : "stopped, give:"}, 
{"Row" : 35, "Column" : 1, "Text" : "________________________________________________________________", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "________________________________________________________________", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Relapsing disease", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Gastroenterology or Infectious Disease consultation suggested."}, 
{"Row" : 40, "Column" : 1, "Text" : "Treat First Relapse", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Treat Second Relapse", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References"},
{"Row" : 10, "Column" : 1, "Text" : "ANTIBIOTIC ASSOCIATED COLITIS (CLOSTRIDIUM DIFFICILE COLITIS) WITHOUT ILEUS OR"}, 
{"Row" : 11, "Column" : 1, "Text" : "TOXIC MEGACOLON"}, 
{"Row" : 33, "Column" : 1, "Item" : "PSOZID2 METRONIDAZOLE 500MG PO TID 14 DAYS", "DisplayText" : "Metronidazole 500MG PO TID 14 DAYS", "Text" :""},
{"Row" : 41, "Column" : 1, "Item" : "PSOZID2 METRONIDAZOLE 500MG PO TID 14 DAYS", "DisplayText" : "Metronidazole 500MG PO TID 14 DAYS", "Text" :""},
{"Row" : 44, "Column" : 1, "Item" : "PSOZID2 VANCOMYCIN SOLN 125MG PO Q6H 14 DAYS", "DisplayText" : "Vancomycin 125MG PO Q6H 14 DAYS", "Text" :""},
{"Row" : 46, "Column" : 1, "Text" : "Third or more recurrence", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Consult ID"}, 
{"Row" : 49, "Column" : 1, "Text" : "________________________________________________________________", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Text" : "Refractory Disease (No Improvement after 3 days of Treatment)", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "________________________________________________________________", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Text" : "Select a different antimicrobial and treat for 14 days after antibiotic change"}, 
{"Row" : 53, "Column" : 1, "Item" : "PSOZID2 VANCOMYCIN SOLN 125MG PO Q6H 14 DAYS", "DisplayText" : "Vancomycin 125MG PO Q6H 14 DAYS", "Text" :""},
{"Row" : 56, "Column" : 1, "Text" : "Sanford Guide. Clostridium Difficile accessed 03/10/14"}, 
{"Row" : 58, "Column" : 1, "Text" : "Surawicz, C, et al. Guidelines for Diagnosis, Treatment and Prevention"}, 
{"Row" : 59, "Column" : 1, "Text" : "of Clostridium difficile Infections. The American Journal of Gastroenterology."}, 
{"Row" : 60, "Column" : 1, "Text" : "April 2013"}, 
{"Row" : 62, "Column" : 1, "Text" : "Cohen, S, et al. Clinical Practice Guidelines for Clostridium difficile"}, 
{"Row" : 63, "Column" : 1, "Text" : "Infection in Adults: 2010 Update by the Society for Healthcare"}, 
{"Row" : 64, "Column" : 1, "Text" : "Epidemiology of American (SHEA) and the Infectious"}, 
{"Row" : 66, "Column" : 1, "Text" : "Disease Society of America (IDSA). Infection Control and Hosptial"}, 
{"Row" : 67, "Column" : 1, "Text" : "Epidemiology. May 2010"}, 
{"Row" : 69, "Column" : 1, "Text" : "John Hopkins Antibiotic Guidelines. \"Clostridium difficile\". 2013"}
]},
{"Name" : "ORZID3 GMENU CANDIDA VULVO-VAGINITIS", "DisplayText" : "Candida vulvo-vaginitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "CANDIDA VULVO-VAGINITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "The vaginal pH is 4 to 4.5.  The discharge is typically thick and curdy.  In 70%"}, 
{"Row" : 15, "Column" : 1, "Text" : "of cases, yeast will be seen on the KOH prep used for identifying fungus or"}, 
{"Row" : 16, "Column" : 1, "Text" : "yeast."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID2 FLUCONAZOLE 150MG PO ONCE", "DisplayText" : "Fluconazole 150mg po once", "Text" : "Fluconazole 150 mg PO ONCE ($0.20/day) [R,DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 CLOTRIMAZOLE VAG 1% CRM 1 APP QHS 7DS", "DisplayText" : "Clotrimazole vaginal 1% cream 1 applicatorful qhs 7 days", "Text" : "Clotrimazole vaginal cream 1 applicator full QHS for 7 to 14 days ($2/tube)", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Text" : "[M]  < OR >"}, 
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 TERCONAZOLE 0.4% VAG CRM QHS 7DS", "DisplayText" : "Terconazole 0.4% vaginal cream 1 applicatorful qhs 7days", "Text" : "Terconazole 0.4% vaginal cream 1 applicator full QHS for 7 days ($20/tube)", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Text" : "[M]"}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 30, "Column" : 1, "Text" : "\"Mandell\" chapter: Vulvovaginitis and cervicitis"}, 
{"Row" : 31, "Column" : 1, "Text" : "Up-to-Date website: Vulvovaginitis and cervicitis"}
]},
{"Name" : "ORZID3 GMENU CAP ANAEROBES", "DisplayText" : "CAP with Anaerobes (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH ANAEROBIC BACTERIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 14DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 14 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 14DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 14 days", "Text" : "Amoxicillin-clavulanate 875/125mg PO BID ($1.56/day) [R]", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 24, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 25, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 26, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 27, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 28, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU CAP CHLAMYDIA PNEUMONIAE", "DisplayText" : "CAP with Chlamydophila (Chlamydia) pneumoniae - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH CHLAMYDOPHILA (CHLAMYDIA) PNEUMONIAE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 10DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 10 days", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI] for 10 to 21 days", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO qday ($4/day) for", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Text" : "4 days [M]"}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 23, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 24, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 25, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 26, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 27, "Column" : 1, "Text" : "Up-to-date accessed 6/24/05"}, 
{"Row" : 29, "Column" : 1, "Text" : "Reviewed August 2005"}
]},
{"Name" : "ORZID3 GMENU CAP LEGIONELLA PNEUMOPHILA", "DisplayText" : "CAP with Legionella pneumophila (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH LEGIONELLA PNEUMOPHILA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID2 AZITHROMYCIN 10DS 500MG PO QDAY", "DisplayText" : "Azithromycin 500mg po qday for 10 days", "Text" : "Azithromycin 500 mg PO qday for 10 days ($8/day) [M]  < OR >", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 21DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 21 days", "Text" : "Moxifloxacin 400 mg PO qday for 21 days ($1.19/day) [DI]", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 20, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 21, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 22, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 23, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 24, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU CAP MYCOPLASMA PNEUMONIAE", "DisplayText" : "CAP with Mycoplasma pneumoniae (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH MYCOPLASMA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 100MG PO BID 7DAYS", "DisplayText" : "Doxycycline 100mg po BID for 7 days", "Text" : "Doxycycline 100 mg PO BID for 7 to 10 days ($0.16/day) [DI] < OR >", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO qday ($4/day) for", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Text" : "4 days [M]"}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 20, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 21, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 22, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 23, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 24, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 25, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU CAP P. AERUGINOSA", "DisplayText" : "CAP with Pseudomonas aeruginosa (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH PSEUDOMONAS AERUGINOSA"}, 
{"Row" : 9, "Column" : 1, "Text" : "For intravenous regimens, refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 11, "Column" : 1, "Text" : "Oral therapy (usually given after several days of intravenous therapy)", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "08"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 18, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 19, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 20, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 21, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 22, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU CAP S. AUREUS", "DisplayText" : "CAP with Staphylococcus aureus (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH STAPHYLOCOCCUS AUREUS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Methicillin-SUSCEPTIBLE Staphylococcus aureus pneumonia", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 14DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 14 days", "Text" : "Minocycline 100 mg PO BID ($1.06/day) [DI] < OR >", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID2 DICLOX 14DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 14 days", "Text" : "Dicloxacillin 500mg PO QID ($0.32/day) [R] < OR >", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 14DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 14 days", "Text" : "Cephalexin 500mg PO QID ($0.16/day) [R]", "Mnemonic" : "16"},
{"Row" : 20, "Column" : 1, "Text" : "Methicillin-RESISTANT Staphylococcus aureus pneumonia", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "18"},
{"Row" : 22, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 14DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 14 days", "Text" : "Minocycline 100 mg PO BID ($1.06/day) [DI]  < OR >", "Mnemonic" : "20"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 14DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 14 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "22"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 12, "Column" : 1, "Text" : "For intravenous regimens, refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 28, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 29, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 30, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 31, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 32, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU CAP STREPTOCOCCUS PNEUMONIAE", "DisplayText" : "CAP with Streptococcus pneumoniae ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH STREPTOCOCCUS PNEUMONIAE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treat until the patient is afebrile for 72 hours.  For severe pneumococcal"}, 
{"Row" : 13, "Column" : 1, "Text" : "pneumonia with bacteremia, combination treatment with a cephalosporin and a"}, 
{"Row" : 14, "Column" : 1, "Text" : "macrolide may be superior to monotherapy."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE DISEASE", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 7DS 1000MG PO TID", "DisplayText" : "Amoxicillin 1000mg po tid for 7 days", "Text" : "Amoxicillin 1000 mg PO TID ($0.84/day) [R]  < OR >", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 7DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 7 days", "Text" : "Moxifloxacin 400 mg PO qday ($1.19/day) [DI]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "Treatment for SEVERE DISEASE", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 28, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 29, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 30, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 31, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 32, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU CAP TREATED IN OUTPT SETTING", "DisplayText" : "CAP treated in an outpatient setting (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA (CAP) TREATED IN AN OUTPATIENT SETTING"}, 
{"Row" : 12, "Column" : 1, "Text" : "Preferred outpatient treatment for PREVIOUSLY HEALTHY PATIENT", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "(without chronic obstructive pulmonary disease, diabetes, renal failure,"}, 
{"Row" : 14, "Column" : 1, "Text" : "congestive heart failure, or malignancy)"}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred outpatient treatment for PATIENTS WITH COMORBIDITIES", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "(chronic obstructive pulmonary disease, diabetes, renal failure, congestive"}, 
{"Row" : 22, "Column" : 1, "Text" : "heart failure, or malignancy)"}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO qday ($4) for 4", "Mnemonic" : "20"},
{"Row" : 24, "Column" : 1, "Text" : "days [M]  < OR >"}, 
{"Row" : 26, "Column" : 1, "Text" : "Alternative Treatment", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 7DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 7 days", "Text" : "Moxifloxacin 400 mg PO qday ($1.19/day)for 7 days [DI]  < OR >", "Mnemonic" : "22"},
{"Row" : 29, "Column" : 1, "Item" : "ORZ SET ABX OP AMOXI 1000 TID AZITH 500 THEN 250MG QDAY", "DisplayText" : "", "Text" : "Amoxicillin 1000 mg PO TID ($0.84/day) [R] for 7 to 10 days <AND>", "Mnemonic" : "24"},
{"Row" : 33, "Column" : 1, "Item" : "ORZ SET ABX OP AMOX/CLAV XR AZITH 500 X1 THEN 250 QD", "DisplayText" : "", "Text" : "Amoxicillin-clavulanate XR 2 gm PO BID ($11/day)for 7 to 10 days[R] <AND>", "Mnemonic" : "26"},
{"Row" : 37, "Column" : 1, "Text" : "Preferred outpatient treatment for PATIENTS WITH INFLUENZA WITH BACTERIAL", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "SUPERINFECTION", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Common pathogens include Streptococcus pneumoniae and Staphylococcus aureus."}, 
{"Row" : 40, "Column" : 1, "Text" : "Obtain Gram stain and culture to guide therapy."}, 
{"Row" : 42, "Column" : 1, "Text" : "Treat for 7 to 14 days."}, 
{"Row" : 44, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 7DS 1000MG PO TID", "DisplayText" : "Amoxicillin 1000mg po tid for 7 days", "Text" : "Amoxicillin 1000 mg PO TID ($0.84/day) [R] < OR >", "Mnemonic" : "28"},
{"Row" : 45, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 7DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 7 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.60/day) [DI]< OR >", "Mnemonic" : "30"},
{"Row" : 46, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 7DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 7 days", "Text" : "Moxifloxacin 400 mg PO qday ($1.19/day) [DI]", "Mnemonic" : "32"},
{"Row" : 49, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "34"},
{"Row" : 51, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 52, "Column" : 1, "Text" : "Craven DE Infect Dis Clin N Am 2004, 18: 939"}, 
{"Row" : 53, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 54, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 55, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37: 1405"}, 
{"Row" : 56, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 30, "Column" : 1, "Text" : "azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO QDAY ($4/day)"}, 
{"Row" : 34, "Column" : 1, "Text" : "azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO QDAY ($4/day)"}, 
{"Row" : 35, "Column" : 1, "Text" : "for 4 days [M]"}, 
{"Row" : 31, "Column" : 1, "Text" : "for 4 days [M] < OR >"}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG PO Q24H", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" :""}
]},
{"Name" : "ORZID3 GMENU CARDIOVASCULAR", "DisplayText" : "Cardiovascular (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "CARDIOVASCULAR"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU CELLULITIS", "DisplayText" : "Cellulitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CELLULITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Cellulitis refers to inflammation of the skin and subcutaneous tissue and is"}, 
{"Row" : 13, "Column" : 1, "Text" : "often associated with bacterial pathogens.  The most common pathogens are group"}, 
{"Row" : 14, "Column" : 1, "Text" : "A streptococci and Staphylococcus aureus.  Group B streptococci are associated"}, 
{"Row" : 15, "Column" : 1, "Text" : "with cellulitis in elderly people, in those with diabetes mellitus, and on feet"}, 
{"Row" : 16, "Column" : 1, "Text" : "and legs of patients with athlete's foot (tinea pedis)."}, 
{"Row" : 18, "Column" : 1, "Text" : "Mild to moderate cases can be treated with oral antimicrobials.  Severe cases"}, 
{"Row" : 22, "Column" : 1, "Text" : "In addition to antimicrobial therapy, several non-pharmacological treatments"}, 
{"Row" : 23, "Column" : 1, "Text" : "improve the outcome of cellulitis.Elevation and immobilization of the"}, 
{"Row" : 24, "Column" : 1, "Text" : "affected limb reduces swelling.  Heat reduces discomfort."}, 
{"Row" : 26, "Column" : 1, "Text" : "Prevent tinea pedis infection by keeping feet clean and dry.  In patients with"}, 
{"Row" : 27, "Column" : 1, "Text" : "peripheral edema, good skin hygiene and support stockings reduce the incidence"}, 
{"Row" : 28, "Column" : 1, "Text" : "of recurrent infection."}, 
{"Row" : 30, "Column" : 1, "Text" : "In many cases of cellulitis, the affected area is usually not well-"}, 
{"Row" : 31, "Column" : 1, "Text" : "differentiated from unaffected areas of the skin. Erysipelas is a special case"}, 
{"Row" : 32, "Column" : 1, "Text" : "with typically a well-defined border and raised, \"orange-peel\" appearance."}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZID3 GMENU ERYSIPELAS", "DisplayText" : "Erysipelas (Outpatient)", "Text" : "Erysipelas", "Mnemonic" : "14"},
{"Row" : 35, "Column" : 1, "Text" : "Use broad-spectrum therapy for cellulitis arising in feet of patients with"}, 
{"Row" : 36, "Column" : 1, "Text" : "advanced diabetes."}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID3 GMENU FOOT ULCER IN PT W/ DM", "DisplayText" : "Foot ulcer in patient with diabetes mellitus (Outpatient)", "Text" : "Foot ulcer in patient with diabetes mellitus", "Mnemonic" : "16"},
{"Row" : 39, "Column" : 1, "Text" : "Empirical treatment for for MILD TO MODERATE cellulitis", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Treat for 10-14 days."}, 
{"Row" : 41, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 10DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 10 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI] < OR >", "Mnemonic" : "18"},
{"Row" : 42, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 10DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 10 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R] < OR >", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 10DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 10 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "22"},
{"Row" : 45, "Column" : 1, "Text" : "Treatment of community-acquired methicillin-RESISTANT Staphylococcus aureus", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "(MRSA):", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 10 DAYS", "DisplayText" : "Bactrim DS PO BID 10 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "24"},
{"Row" : 48, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 10DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 10 days", "Text" : "Minocycline 100 mg PO BID ($1.14/day) [DI]", "Mnemonic" : "26"},
{"Row" : 54, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "28"},
{"Row" : 56, "Column" : 1, "Text" : "Schwartz MN New Eng J Med 2004, 350: 904"}, 
{"Row" : 19, "Column" : 1, "Text" : "should be treated initially with intravenous antimicrobials.  Switch to oral"}, 
{"Row" : 20, "Column" : 1, "Text" : "drugs after clinical improvement."}, 
{"Row" : 50, "Column" : 1, "Text" : "Empirical treatment for SEVERE cellulitis", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 57, "Column" : 1, "Text" : "\"Sanford\" keyword: Cellulitis"}, 
{"Row" : 59, "Column" : 1, "Text" : "Up-to-Date: Cellulitis"}, 
{"Row" : 58, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}
]},
{"Name" : "ORZID3 GMENU CHLAMYDIA URETHRITIS", "DisplayText" : "Chlamydia urethritis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "CHLAMYDIA URETHRITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment for non-gonococcal urethritis (usually due to Chlamydia)", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 100MG PO BID 7DAYS", "DisplayText" : "Doxycycline 100mg po BID for 7 days", "Text" : "Doxycycline 100 mg PO BID for 7 days ($0.16/day) [DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Item" : "PSOZID2 AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1gm po once", "Text" : "Azithromycin 1 gm PO ONCE ($4.09/day) [M]", "Mnemonic" : "16"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 20, "Column" : 1, "Text" : "CDC MMWR 2002, 51: RR-06"}, 
{"Row" : 21, "Column" : 1, "Text" : "\"Sanford\" keyword: Urethritis"}
]},
{"Name" : "ORZID3 GMENU CHOLANGITIS", "DisplayText" : "Cholangitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "CHOLANGITIS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU CHOLECYSTITIS", "DisplayText" : "Cholecystitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "CHOLECYSTITIS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU CHRON PROS/CHRON PELVIC PAIN SYN", "DisplayText" : "Chronic prostatitis/Chronic pelvic pain syndrome (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CHRONIC PROSTATITIS / CHRONIC PELVIC PAIN SYNDROME"}, 
{"Row" : 12, "Column" : 1, "Text" : "This syndrome presents with intermittent perineal and/or low back pain,"}, 
{"Row" : 13, "Column" : 1, "Text" : "obstructive voiding symptoms, relatively normal examination, and  negative urine"}, 
{"Row" : 14, "Column" : 1, "Text" : "cultures. Suggest urology consult."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "For pain control, try for symptomatic relief. Treat for 2 to 3 weeks."}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 IBUPROFEN 14DS 400MG PO TID", "DisplayText" : "Ibuprofen 400mg PO TID 14 days", "Text" : "Ibuprofen 200-800 mg PO TID", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Text" : "\"Mandell\" chapter: Urinary tract infections"}, 
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" keyword: Prostatitis"}
]},
{"Name" : "ORZID3 GMENU CHRONIC BACT PROSTATITIS", "DisplayText" : "Chronic bacterial prostatitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 10, "Column" : 1, "Text" : "CHRONIC BACTERIAL PROSTATITIS"}, 
{"Row" : 21, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Chronic Bacterial Prostatitis involves chronic inflammation of the prostate"}, 
{"Row" : 13, "Column" : 1, "Text" : "with positive urine or prostatic fluid cultures.  Patients may present with"}, 
{"Row" : 14, "Column" : 1, "Text" : "recurrent urinary tract infections with repeated isolation of the same"}, 
{"Row" : 15, "Column" : 1, "Text" : "pathogen in the urine.  Some patients maybe asymptomatic but have"}, 
{"Row" : 16, "Column" : 1, "Text" : "recurrent bacteriuria.  Common symptoms may include urinary frequency,"}, 
{"Row" : 17, "Column" : 1, "Text" : "dysuria, urgency, perineal discomfort, and low grade fever.  Common"}, 
{"Row" : 18, "Column" : 1, "Text" : "pathogens associated with infection are Enterobacteriaceae, Enterococci, P."}, 
{"Row" : 19, "Column" : 1, "Text" : "aeruginosa, and less commonly Burkholderia pseudomallei."}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 42 DAYS", "DisplayText" : "Bactrim DS PO BID 42 DAYS", "Text" :""},
{"Row" : 28, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Meyrier A, Fekete T.  Chronic Bacterial Prostatitis.  Up To Date.  July, 2014."}, 
{"Row" : 32, "Column" : 1, "Text" : "Chronic Bacterial Prostatitis.  Sanford Guide.  January 26, 2013."}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 750MG PO Q24H 28 DAYS", "DisplayText" : "Levofloxacin 750MG PO Q24H 28 DAYS", "Text" :""}
]},
{"Name" : "ORZID3 GMENU CHRONIC PNEUMONIA", "DisplayText" : "Chronic pneumonia (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "CHRONIC PNEUMONIA"}, 
{"Row" : 9, "Column" : 1, "Text" : "Chronic pneumonia presents with symptoms for over weeks or months.  Diagnosis is"}, 
{"Row" : 10, "Column" : 1, "Text" : "essential and empirical therapy is not indicated.  Consult Infectious Diseases"}, 
{"Row" : 11, "Column" : 1, "Text" : "and/or Pulmonary."}
]},
{"Name" : "ORZID3 GMENU CHRONIC SINUSITIS", "DisplayText" : "Chronic sinusitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Consult ENT", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "CHRONIC SINUSITIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Surgery is usually required for treatment.  ENT consultation is necessary."}, 
{"Row" : 10, "Column" : 1, "Text" : "Nasal saline irrigations and topical corticosteroids may relieve symptoms.  If"}, 
{"Row" : 11, "Column" : 1, "Text" : "an acute exacerbation of chronic bacterial sinusitis occurs, treat the episode"}, 
{"Row" : 12, "Column" : 1, "Text" : "as acute bacterial sinusitis. Long-term antibiotic use for the"}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU ACUTE SINUSITIS MILD TO MOD", "DisplayText" : "Acute sinusitis--mild to moderate disease (Outpatient)", "Text" : "Acute sinusitis--MILD TO MODERATE disease"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 GMENU SEVERE SINUSITIS", "DisplayText" : "Acute sinusitis--Severe disease (Outpatient)", "Text" : "Acute sinusitis--SEVERE disease"},
{"Row" : 13, "Column" : 1, "Text" : "management of chronic sinusitis is not strongly supported by evidence."}, 
{"Row" : 19, "Column" : 1, "Text" : "REFERENCES"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hamilos D. Management of chronic rhinosinusitis. Up-to-Date. UPDATED 6/19/2014"}, 
{"Row" : 22, "Column" : 1, "Text" : "Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for"}, 
{"Row" : 23, "Column" : 1, "Text" : "acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012"}, 
{"Row" : 24, "Column" : 1, "Text" : "54(8):e72-e112.Aring et al. Am Fam Phys. 2011"}, 
{"Row" : 25, "Column" : 1, "Text" : "Desrosiers M, Evans GA, Keith PK, et al. Canadian clinical practice guidelines"}, 
{"Row" : 26, "Column" : 1, "Text" : "for acute and chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2011"}, 
{"Row" : 27, "Column" : 1, "Text" : "40 Suppl 2:S99-193."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adelson RT, Adappa ND. What is the proper role of oral antibiotics in the"}, 
{"Row" : 29, "Column" : 1, "Text" : "treatment of patients with chronic sinusitis? Curr Opin Otolaryngol Head"}, 
{"Row" : 30, "Column" : 1, "Text" : "Neck Surg. 2013: 21(1):61-8"}
]},
{"Name" : "ORZID3 GMENU CMV COLITIS/ESOPHAGITIS", "DisplayText" : "CMV colitis or esophagitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CMV DISEASE IN GENERAL"}, 
{"Row" : 12, "Column" : 1, "Text" : "Immunocompetent patient", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Infection is usually asymptomatic.  Mononucleosis can be associated with CMV,"}, 
{"Row" : 14, "Column" : 1, "Text" : "but is more commonly associated with Epstein Barr virus.  Antiviral treatment is"}, 
{"Row" : 15, "Column" : 1, "Text" : "rarely necessary."}, 
{"Row" : 17, "Column" : 1, "Text" : "Immunocompromised patient", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Patients in whom the risk for CMV disease is increased include solid organ and"}, 
{"Row" : 19, "Column" : 1, "Text" : "bone marrow transplant recipients, persons receiving prolonged immunosuppressive"}, 
{"Row" : 20, "Column" : 1, "Text" : "chemotherapy, and persons with advanced HIV disease indicated by a CD4 count of"}, 
{"Row" : 21, "Column" : 1, "Text" : "less than 50 cells/microliter."}, 
{"Row" : 23, "Column" : 1, "Text" : "CMV COLITIS OR ESOPHAGITIS"}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment is complex and requires Infectious Diseases consultation.  Several"}, 
{"Row" : 26, "Column" : 1, "Text" : "initial treatment regimens are equivalent.  The major toxicities of both"}, 
{"Row" : 27, "Column" : 1, "Text" : "ganciclovir and valganciclovir are neutropenia.  The major toxicities of both"}, 
{"Row" : 28, "Column" : 1, "Text" : "cidofovir and foscarnet are nephrotoxicity.  Intravenous therapy is used for"}, 
{"Row" : 29, "Column" : 1, "Text" : "severe disease.  Valganciclovir given by mouth is effective for mild or moderate"}, 
{"Row" : 30, "Column" : 1, "Text" : "disease, or after severe disease has improved."}, 
{"Row" : 32, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Treat for 3 to 6 weeks."}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID2 VALGANCICLOVIR 21DS 900MG PO BID", "DisplayText" : "Valganciclovir 900mg po bid for 21 days", "Text" : "Valganciclovir 900 mg PO BID ($68/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 36, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 42, "Column" : 1, "Text" : "\"Sanford\" keyword: Cytomegalovirus"}, 
{"Row" : 43, "Column" : 1, "Text" : "\"Mandell\" chapter: Cytomegalovirus"}
]},
{"Name" : "ORZID3 GMENU CMV ENCEPHALITIS", "DisplayText" : "CMV encephalitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CMV ENCEPHALITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU CMV PNEUMONIA", "DisplayText" : "CMV pneumonia (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "CMV PNEUMONIA"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU CMV POLYRADICULOPATHY", "DisplayText" : "CMV polyradiculopathy (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CMV DISEASE IN GENERAL"}, 
{"Row" : 12, "Column" : 1, "Text" : "Immunocompetent patient", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Infection is usually asymptomatic.  Mononucleosis can be associated with CMV,"}, 
{"Row" : 14, "Column" : 1, "Text" : "but is more commonly associated with Epstein Barr virus.  Antiviral treatment is"}, 
{"Row" : 15, "Column" : 1, "Text" : "rarely necessary."}, 
{"Row" : 17, "Column" : 1, "Text" : "Immunocompromised patient", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Patients in whom the risk for CMV disease is increased include solid organ and"}, 
{"Row" : 19, "Column" : 1, "Text" : "bone marrow transplant recipients, persons receiving prolonged immunosuppressive"}, 
{"Row" : 20, "Column" : 1, "Text" : "chemotherapy, and persons with advanced HIV disease indicated by a CD4 count of"}, 
{"Row" : 21, "Column" : 1, "Text" : "less than 50 cells/microliter."}, 
{"Row" : 23, "Column" : 1, "Text" : "CMV POLYRADICULOPATHY"}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment is complex and requires Infectious Diseases consultation.  Several"}, 
{"Row" : 26, "Column" : 1, "Text" : "initial treatment regimens are equivalent.  The major toxicities of both"}, 
{"Row" : 27, "Column" : 1, "Text" : "ganciclovir and valganciclovir are neutropenia.  The major toxicities of both"}, 
{"Row" : 28, "Column" : 1, "Text" : "cidofovir and foscarnet are nephrotoxicity.  Intravenous therapy is used for"}, 
{"Row" : 29, "Column" : 1, "Text" : "severe disease.  Valganciclovir given by mouth is effective for mild or moderate"}, 
{"Row" : 30, "Column" : 1, "Text" : "disease, or after severe disease has improved."}, 
{"Row" : 32, "Column" : 1, "Text" : "Preferred Treatment", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID2 VALGANCICLOVIR 14DS 900MG PO BID", "DisplayText" : "Valganciclovir 900mg po bid for 14 days", "Text" : "Valganciclovir 900 mg PO BID ($68/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 36, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 42, "Column" : 1, "Text" : "\"Sanford\" keyword: Cytomegalovirus"}, 
{"Row" : 43, "Column" : 1, "Text" : "\"Mandell\" chapter: Cytomegalovirus"}
]},
{"Name" : "ORZID3 GMENU CMV RETINITIS", "DisplayText" : "CMV retinitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CMV DISEASE IN GENERAL"}, 
{"Row" : 12, "Column" : 1, "Text" : "Immunocompetent patient", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Infection is usually asymptomatic.  Mononucleosis can be associated with CMV,"}, 
{"Row" : 14, "Column" : 1, "Text" : "but is more commonly associated with Epstein Barr virus.  Antiviral treatment is"}, 
{"Row" : 15, "Column" : 1, "Text" : "rarely necessary."}, 
{"Row" : 17, "Column" : 1, "Text" : "Immunocompromised patient", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Patients in whom the risk for CMV disease is increased include solid organ and"}, 
{"Row" : 19, "Column" : 1, "Text" : "bone marrow transplant recipients, persons receiving prolonged immunosuppressive"}, 
{"Row" : 20, "Column" : 1, "Text" : "chemotherapy, and persons with advanced HIV disease indicated by a CD4 count of"}, 
{"Row" : 21, "Column" : 1, "Text" : "less than 50 cells/microliter."}, 
{"Row" : 23, "Column" : 1, "Text" : "CMV RETINITIS"}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment is complex and requires Infectious Diseases consultation.  Several"}, 
{"Row" : 26, "Column" : 1, "Text" : "initial treatment regimens are equivalent.  The major toxicities of both"}, 
{"Row" : 27, "Column" : 1, "Text" : "ganciclovir and valganciclovir are neutropenia.  The major toxicities of both"}, 
{"Row" : 28, "Column" : 1, "Text" : "cidofovir and foscarnet are nephrotoxicity.  Intravenous therapy is used for"}, 
{"Row" : 29, "Column" : 1, "Text" : "severe disease.  Valganciclovir given by mouth is effective for mild or moderate"}, 
{"Row" : 30, "Column" : 1, "Text" : "disease, or after severe disease has improved."}, 
{"Row" : 32, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 34, "Column" : 1, "Text" : "Preferred initial treatment", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "PSOZID2 VALGANCICLOVIR 14DS 900MG PO BID", "DisplayText" : "Valganciclovir 900mg po bid for 14 days", "Text" : "Valganciclovir 900 mg PO BID ($68/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 37, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 43, "Column" : 1, "Text" : "\"Sanford\" keyword: Cytomegalovirus"}, 
{"Row" : 44, "Column" : 1, "Text" : "\"Mandell\" chapter: Cytomegalovirus"}
]},
{"Name" : "ORZID3 GMENU COM ACQ DIARRHEA/NO TRAVEL", "DisplayText" : "Community acquired diarrhea (no recent travel) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Obtain Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY ACQUIRED DIARRHEA (NO RECENT TRAVEL)"}, 
{"Row" : 12, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Acute (< 14 days of symptoms)", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Empirical antimicrobials should be given only in cases of severe acute disease."}, 
{"Row" : 18, "Column" : 1, "Text" : "If the patient has taken antimicrobials in the preceding two months, consider"}, 
{"Row" : 19, "Column" : 1, "Text" : "Clostridium difficile infection."}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID3 GMENU C. DIFFICILE COLITIS", "DisplayText" : "Antibiotic associated colitis (C. difficile colitis) - Outpatient", "Text" : "Clostridium difficile", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "Cases with enterohemorrhagic E. coli typically have bloody diarrhea, abdominal"}, 
{"Row" : 24, "Column" : 1, "Text" : "pain, and tenderness but no fever.  In these cases anti-motility agents and"}, 
{"Row" : 25, "Column" : 1, "Text" : "antimicrobials increase the risk of hemolytic uremic syndrome and should not be"}, 
{"Row" : 26, "Column" : 1, "Text" : "given.  If there is blood, abdominal pain, tenderness, or dehydration and fever,"}, 
{"Row" : 27, "Column" : 1, "Text" : "send stool for culture and O&P."}, 
{"Row" : 29, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Subacute or chronic (>= 14 days of symptoms)", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Empiric antimicrobial therapy is not indicated.  Investigate for the cause of"}, 
{"Row" : 34, "Column" : 1, "Text" : "diarrhea.  Gastroenterology and/or Infectious Diseases involvement is"}, 
{"Row" : 35, "Column" : 1, "Text" : "encouraged."}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 40, "Column" : 1, "Text" : "\"Sanford\": key term: diarrhea"}, 
{"Row" : 41, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 42, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296-305"}, 
{"Row" : 43, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 44, "Column" : 1, "Text" : "Up-to-Date: Diarrhea"}, 
{"Row" : 45, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 46, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 47, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}
]},
{"Name" : "ORZID3 GMENU COMM ACQ PNEUMONIA", "DisplayText" : "Community acquired pneumonia (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary"},
{"Row" : 7, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA (CAP)"}, 
{"Row" : 9, "Column" : 1, "Text" : "Empirical regimens listed here cover the usual pathogens associated with CAP,"}, 
{"Row" : 10, "Column" : 1, "Text" : "including \"atypical\" pathogens.  Specific therapy should be guided by culture"}, 
{"Row" : 11, "Column" : 1, "Text" : "results."}, 
{"Row" : 12, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Empirical treatment", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Item" : "ORZID3 GMENU CAP TREATED IN OUTPT SETTING", "DisplayText" : "CAP treated in an outpatient setting (Outpatient)", "Text" : "CAP treated in OUTPATIENT setting"},
{"Row" : 52, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "Treatment for selected pathogens", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "Certain respiratory pathogens that are usually treated in unique ways are listed"}, 
{"Row" : 57, "Column" : 1, "Text" : "here.  Most other pathogens, not listed here, are treated with drugs generally"}, 
{"Row" : 58, "Column" : 1, "Text" : "effective in cases of pneumonia and that are active against the patients'"}, 
{"Row" : 59, "Column" : 1, "Text" : "isolates."}, 
{"Row" : 61, "Column" : 1, "Text" : "Pathogen-specific CAP treatment regimens", "Header" : 1}, 
{"Row" : 62, "Column" : 1, "Item" : "ORZID3 GMENU CAP CHLAMYDIA PNEUMONIAE", "DisplayText" : "CAP with Chlamydophila (Chlamydia) pneumoniae - Outpatient", "Text" : "Chlamydophila (Chlamydia) pneumoniae"},
{"Row" : 63, "Column" : 1, "Item" : "ORZID3 GMENU CAP LEGIONELLA PNEUMOPHILA", "DisplayText" : "CAP with Legionella pneumophila (Outpatient)", "Text" : "Legionella pneumophila"},
{"Row" : 64, "Column" : 1, "Item" : "ORZID3 GMENU CAP MYCOPLASMA PNEUMONIAE", "DisplayText" : "CAP with Mycoplasma pneumoniae (Outpatient)", "Text" : "Mycoplasma pneumoniae"},
{"Row" : 65, "Column" : 1, "Item" : "ORZID3 GMENU CAP P. AERUGINOSA", "DisplayText" : "CAP with Pseudomonas aeruginosa (Outpatient)", "Text" : "Pseudomonas aeruginosa"},
{"Row" : 66, "Column" : 1, "Item" : "ORZID3 GMENU CAP S. AUREUS", "DisplayText" : "CAP with Staphylococcus aureus (Outpatient)", "Text" : "Staphylococcus aureus"},
{"Row" : 67, "Column" : 1, "Item" : "ORZID3 GMENU CAP STREPTOCOCCUS PNEUMONIAE", "DisplayText" : "CAP with Streptococcus pneumoniae", "Text" : "Streptococcus pneumoniae"},
{"Row" : 70, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References"},
{"Row" : 48, "Column" : 1, "Text" : ">>Setting specific treatment regimens<<"}, 
{"Row" : 15, "Column" : 1, "Text" : "The CURB 65 Score is a tool to determine how aggressively to treat a"}, 
{"Row" : 16, "Column" : 1, "Text" : "patient's pneumonia and whether the patient can be treated safely"}, 
{"Row" : 17, "Column" : 1, "Text" : "outside of the hospital. The CURB 65 Score is a guide and should be used"}, 
{"Row" : 18, "Column" : 1, "Text" : "to augment clinical judgment. If social circumstances or cognitive"}, 
{"Row" : 19, "Column" : 1, "Text" : "dysfunction would interfere with success of outpatient treatment, the"}, 
{"Row" : 20, "Column" : 1, "Text" : "patient should be hospitalized."}, 
{"Row" : 22, "Column" : 1, "Text" : "CURB 65 Pneumonia Severity Score:"}, 
{"Row" : 23, "Column" : 1, "Text" : "Confusion (1 point)"}, 
{"Row" : 24, "Column" : 1, "Text" : "Urea (BUN > 19mg/dL) (1 point)"}, 
{"Row" : 25, "Column" : 1, "Text" : "Respiratory Rate >30 per minute (1 point)"}, 
{"Row" : 26, "Column" : 1, "Text" : "Blood Pressure: diastolic <60mmHg or systolic <90mmHg (1 point)"}, 
{"Row" : 27, "Column" : 1, "Text" : "Age >/= 65 years (1 point)"}, 
{"Row" : 28, "Column" : 1, "Text" : "(0 TO 1 total points, treat as OUTPATIENT)"}, 
{"Row" : 29, "Column" : 1, "Text" : "(2 to 5 points, treat as INPATIENT)"}, 
{"Row" : 36, "Column" : 1, "Text" : "Presence of risk factors for HCAP:"}, 
{"Row" : 37, "Column" : 1, "Text" : "1. hospitalization for 2 days or more in the preceding 90 days"}, 
{"Row" : 38, "Column" : 1, "Text" : "2. residence in a nursing home or extended care facility"}, 
{"Row" : 39, "Column" : 1, "Text" : "3. home infusion therapy (including antibiotics)"}, 
{"Row" : 40, "Column" : 1, "Text" : "4. chronic dialysis within 30 days"}, 
{"Row" : 41, "Column" : 1, "Text" : "5. home wound care"}, 
{"Row" : 42, "Column" : 1, "Text" : "6. family member with multi-drug resistant pathogen"}, 
{"Row" : 35, "Column" : 1, "Text" : "Immunosuppressive disease and/or therapy"}, 
{"Row" : 32, "Column" : 1, "Text" : "Current hospitalization of at least 5 days"}, 
{"Row" : 33, "Column" : 1, "Text" : "Antimicrobial therapy within the past 90 days"}, 
{"Row" : 34, "Column" : 1, "Text" : "High frequency of Abx resistance in the community or hospital unit"}
]},
{"Name" : "ORZID3 GMENU COMM INFECT PNEUMO", "DisplayText" : "Pneumonia (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "++  PNEUMONIA - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Item" : "ORZID3 GMENU CHRONIC PNEUMONIA", "DisplayText" : "Chronic pneumonia (Outpatient)", "Text" : "Chronic pneumonia", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 GMENU ASPIRATION PNEUMONIA", "DisplayText" : "Aspiration pneumonia (Outpatient)", "Text" : "Aspiration pneumonia", "Mnemonic" : "10"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID3 GMENU COMM ACQ PNEUMONIA", "DisplayText" : "Community acquired pneumonia (Outpatient)", "Text" : "Community-acquired pneumonia (CAP)", "Mnemonic" : "12"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU NOSOCOMIAL PNEUMONIA", "DisplayText" : "Nosocomial pneumonia (Outpatient)", "Text" : "Nosocomial pneumonia (including HAP, VAP, and HCAP)", "Mnemonic" : "14"}
]},
{"Name" : "ORZID3 GMENU COMPLICATED CYSTITIS", "DisplayText" : "Complicated Cystitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "COMPLICATED CYSTITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "____________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "____________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Empirical treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 14 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet BID ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment for specific pathogens", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Treatment if Enterococcus identified", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 14DS 500MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid for 14 days", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R]", "Mnemonic" : "20"},
{"Row" : 31, "Column" : 1, "Text" : "Treatment if Pseudomonas identified", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 14 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "22"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 21, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Mandell\" chapter: Urinary tract infections"}, 
{"Row" : 38, "Column" : 1, "Text" : "\"Sanford\" keyword: Cystitis"}
]},
{"Name" : "ORZID3 GMENU CONJUNCTIVITIS", "DisplayText" : "Conjunctivitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT OPHTHALMOLOGY", "DisplayText" : "OPHTHALMOLOGY", "Text" : "Need help with an eye issue?  Obtain ophthalmology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CONJUNCTIVITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Conjunctivitis is associated with viral or bacterial pathogens.  Viral"}, 
{"Row" : 13, "Column" : 1, "Text" : "conjunctivitis presents with watery discharge.  Bacterial infections are more"}, 
{"Row" : 14, "Column" : 1, "Text" : "likely to present with thick exudate and conjunctival injection.  Allergic"}, 
{"Row" : 15, "Column" : 1, "Text" : "conjunctivitis typically presents with stringy mucus.  If there is pus"}, 
{"Row" : 16, "Column" : 1, "Text" : "(hypopion), corneal involvement, possible bacterial conjunctivitis, or"}, 
{"Row" : 17, "Column" : 1, "Text" : "keratitis, consult ophthalmology."}, 
{"Row" : 19, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Viral conjunctivitis", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Viral conjunctivitis is self-limited and antivirals provide no benefit."}, 
{"Row" : 24, "Column" : 1, "Text" : "Symptomatic treatment with ophthalmic antihistamine/decongestants and warm or"}, 
{"Row" : 25, "Column" : 1, "Text" : "cool compresses may relieve symptoms."}, 
{"Row" : 27, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Bacterial conjunctivitis", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Bacterial conjunctivitis is generally self-limited, but topical antimicrobials"}, 
{"Row" : 32, "Column" : 1, "Text" : "reduce duration of symptoms and limit person-to-person spread of infection.  If"}, 
{"Row" : 33, "Column" : 1, "Text" : "symptoms do not improve after 2 days of antimicrobial therapy, the patient"}, 
{"Row" : 34, "Column" : 1, "Text" : "should be seen by an ophthalmologist."}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment for ACUTE BACTERIAL CONJUNCTIVITIS", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Treat for 7 days."}, 
{"Row" : 38, "Column" : 1, "Item" : "PSOZID2 ERYTHROMYCIN OPH OINT 1/2 INCH QID 7DAYS", "DisplayText" : "Erythromycin oph ointment 1/2 inch ribbon qid for 7 days", "Text" : "Erythromycin ophthalmic ointment: one-half inch ribbon of ointment to", "Mnemonic" : "12"},
{"Row" : 39, "Column" : 1, "Text" : "affected eye(s) QID ($0.96/tube) [M] < OR >"}, 
{"Row" : 41, "Column" : 1, "Item" : "PSOZID2 SULFACETAMIDE 10% SOLN OPH 2 DRPS Q3H 7DAYS", "DisplayText" : "Sulfacetamide 10% soln oph 2 drops q3h", "Text" : "Sulfacetamide ophthalmic drops: 1-2 drops in affected eye(s) q3h, may", "Mnemonic" : "14"},
{"Row" : 42, "Column" : 1, "Text" : "decrease to twice daily after symptoms improve ($0.08/bottle) [M]"}, 
{"Row" : 44, "Column" : 1, "Text" : "Treatment for SEVERE CASES involving suppuration", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Consult ophthalmology and begin topical antimicrobials."}, 
{"Row" : 46, "Column" : 1, "Item" : "PSOZID2 OFLOXACIN 0.3% SOLN OPH 2 DRPS Q2H 7DS", "DisplayText" : "Ofloxacin 0.3% soln oph 2 drops q2h 7ds", "Text" : "Ofloxacin 1-2 drops in affected eye q2h while awake ($19) [M]", "Mnemonic" : "18"},
{"Row" : 49, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 51, "Column" : 1, "Text" : "Johns Hopkins website: Conjunctivitis"}, 
{"Row" : 53, "Column" : 1, "Text" : "Baum J Clin Infect Dis 1995, 21: 479"}, 
{"Row" : 54, "Column" : 1, "Text" : "Up-to-Date website: Conjunctivitis"}, 
{"Row" : 52, "Column" : 1, "Text" : "\"Mandell\" chapter: Microbial conjunctivitis"}
]},
{"Name" : "ORZID3 GMENU CUTANEOUS ABSCESS", "DisplayText" : "Cutaneous abscess (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Consult General Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CUTANEOUS ABSCESS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Incise and drain and cover the site with a dry dressing.  For small abscesses,"}, 
{"Row" : 13, "Column" : 1, "Text" : "systemic antimicrobial therapy is rarely necessary."}, 
{"Row" : 18, "Column" : 1, "Text" : "If the patient is neutropenic, has multiple lesions, or has fever or"}, 
{"Row" : 19, "Column" : 1, "Text" : "leukocytosis, antimicrobial treatment may be necessary.  Contact Infectious"}, 
{"Row" : 20, "Column" : 1, "Text" : "Diseases for assistance."}, 
{"Row" : 22, "Column" : 1, "Text" : "Incise and drain perirectal abscesses.  If systemic antimicrobial treatment is"}, 
{"Row" : 23, "Column" : 1, "Text" : "needed, broader empirical treatment is necessary."}, 
{"Row" : 25, "Column" : 1, "Text" : "For the few CUTANEOUS ABSCESSES away from the rectal area that need a systemic", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "antimicrobial", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : "Cephalexin 250-500 mg PO QID ($0.18-0.36/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID DICLOXACILLIN 500MG PO QID 7 DAYS", "DisplayText" : "Dicloxacillin 500MG PO QID", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Text" : "For SEVERE PERIRECTAL ABSCESSES", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R] < OR >", "Mnemonic" : "18"},
{"Row" : 33, "Column" : 1, "Item" : "ORZ SET ABX OP CIPRO 10DS 500 BID METRO 10DS 500 TID", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI] <AND> metronidazole 500 mg PO", "Mnemonic" : "20"},
{"Row" : 34, "Column" : 1, "Text" : "TID ($0.48/day) [DI]"}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" keyword:  Skin infections"}, 
{"Row" : 15, "Column" : 1, "Text" : "If abscess is CA-MRSA and there is no surrounding evidence of cellulitis,"}, 
{"Row" : 16, "Column" : 1, "Text" : "antibiotics may NOT be needed after I&D."}
]},
{"Name" : "ORZID3 GMENU DECUBITIS ULCERS", "DisplayText" : "Decubitis ulcers (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ OSTOMY OPT CONSULT", "DisplayText" : "Ostomy/Wound/Continence", "Text" : "Wound Care (ET) Nurse consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT DIETARY HYPERTENSION", "DisplayText" : "GMRCT DIETARY HYPERTENSION", "Text" : "Dietician consult", "Mnemonic" : "12"},
{"Row" : 9, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Vascular surgery consult", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "DECUBITUS ULCERS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Relieve pressure and friction, provide good nutrition, and debride the ulcer."}, 
{"Row" : 16, "Column" : 1, "Text" : "Decubitus ulcers are colonized with bacteria.  Antimicrobial therapy is"}, 
{"Row" : 17, "Column" : 1, "Text" : "unnecessary unless the patient has infection of surrounding tissues signified by"}, 
{"Row" : 18, "Column" : 1, "Text" : "erythema, warmth, local tenderness, or purulent discharge.  Rectal or groin"}, 
{"Row" : 19, "Column" : 1, "Text" : "decubitus ulcers with surrounding infection need broad spectrum antimicrobials."}, 
{"Row" : 20, "Column" : 1, "Text" : "Ulcers located in other sites are usually treated with antimicrobials for"}, 
{"Row" : 21, "Column" : 1, "Text" : "staphylococci and streptococci."}, 
{"Row" : 23, "Column" : 1, "Text" : "For deep abscesses away from the rectal area, obtain material for Gram stain and"}, 
{"Row" : 24, "Column" : 1, "Text" : "culture and treat with:"}, 
{"Row" : 26, "Column" : 1, "Text" : "Treament", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 7DS 250MG PO QID", "DisplayText" : "Cephalexin 250mg po qid for 7 days", "Text" : "Cephalexin 250-500 mg PO QID ($0.18-0.36/day) [R] < OR >", "Mnemonic" : "16"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 7DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 7 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI] < OR >", "Mnemonic" : "18"},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 CLINDAM 7DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 7 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "20"},
{"Row" : 31, "Column" : 1, "Text" : "For deep PERIRECTAL ABSCESSES that need a systemic antimicrobial", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R] < OR >", "Mnemonic" : "22"},
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX OP CIPRO 10DS 500 BID METRO 10DS 500 TID", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI] <AND> metronidazole 500 mg PO", "Mnemonic" : "24"},
{"Row" : 35, "Column" : 1, "Text" : "TID ($0.48/day) [DI]"}, 
{"Row" : 37, "Column" : 1, "Text" : "If there are signs and/or symptoms of cellulitis or osteomyelitis, refer to the"}, 
{"Row" : 38, "Column" : 1, "Text" : "advice page for the appropriate syndrome.  Contact the ET nurse, Infectious"}, 
{"Row" : 39, "Column" : 1, "Text" : "Diseases, Dietician, or Vascular surgery for more information."}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZID3 GMENU CELLULITIS", "DisplayText" : "Cellulitis (Outpatient)", "Text" : "Cellulitis", "Mnemonic" : "26"},
{"Row" : 42, "Column" : 1, "Item" : "ORZID3 GMENU OSTEOMYELITIS", "DisplayText" : "Osteomyelitis (Outpatient)", "Text" : "Osteomyelitis", "Mnemonic" : "28"},
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "30"},
{"Row" : 49, "Column" : 1, "Text" : "Parish LC Dermatol Clin 2004, 22: 87"}, 
{"Row" : 47, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 48, "Column" : 1, "Text" : "Up-to-Date website: Cellulitis and subcutaneous tissue infections"}
]},
{"Name" : "ORZID3 GMENU DEEP OROPHARYN INFECT", "DisplayText" : "Deep Oropharyngeal Infections (Lugwig's angina) - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Consult ENT", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "DEEP OROPHARYNGEAL INFECTIONS"}, 
{"Row" : 8, "Column" : 1, "Text" : "(LUDWIG'S ANGINA)"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 15, "Column" : 1, "Text" : "\"Mandell\" chapter: Infections of the Oral Cavity, Neck, and Head"}
]},
{"Name" : "ORZID3 GMENU DEVICE-RELATED INFECT", "DisplayText" : "Device-related infections (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ ADD MENU NEUROSURGERY CONSULT", "DisplayText" : "Neurosurgery Consult", "Text" : "Consult Neurosurgery", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "DEVICE-RELATED INFECTIONS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU DIAGNOSIS PERTUSSIS", "DisplayText" : "Diagnosis of pertussis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Need help with an ENT issue?  Obtain ENT consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "DIAGNOSIS OF PERTUSSIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Laboratory testing is recommended to confirm a clinical diagnosis of pertussis."}, 
{"Row" : 10, "Column" : 1, "Text" : "Nasopharyngeal samples should be obtained with calcium alginate swabs.  The"}, 
{"Row" : 11, "Column" : 1, "Text" : "appropriate diagnostic strategy depends upon the duration of coughing symptoms."}, 
{"Row" : 13, "Column" : 1, "Text" : ">>  During the first 3 weeks of coughing", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Obtain two nasopharyngeal samples, one for culture and one for PCR"}, 
{"Row" : 16, "Column" : 1, "Text" : ">>  Between 3 and 4 weeks of coughing", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Obtain nasopharyngeal sample for PCR"}, 
{"Row" : 18, "Column" : 1, "Text" : "Obtain serum sample for IgG antibodies to Bordetella pertussis"}, 
{"Row" : 20, "Column" : 1, "Text" : ">>  More than 4 weeks of coughing", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Obtain serum sample for IgG antibodies to Bordetella pertussis"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 26, "Column" : 1, "Text" : "Hewlett EL NEJM 2005, 352: 1215"}, 
{"Row" : 27, "Column" : 1, "Text" : "Up-to-date website: Bordetella species"}, 
{"Row" : 30, "Column" : 1, "Text" : "\"Mandell\" Chapter: Bordetella species"}, 
{"Row" : 28, "Column" : 1, "Text" : "\"Sanford\" keyword: Pertussis"}, 
{"Row" : 29, "Column" : 1, "Text" : "CDC MMWR 2006, 55(RR03): 1-34"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA AEROMONAS", "DisplayText" : "Diarrhea with Aeromonas (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH AEROMONAS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 3 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID for 3 days ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 3 DAYS", "DisplayText" : "Bactrim DS PO BID 3 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet BID ($0.18/day) for 3 days [R,DI]", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 24, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 26, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 27, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 28, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 21, "Column" : 1, "Text" : "\"Sanford\" keyword: Aeromonas"}, 
{"Row" : 23, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 25, "Column" : 1, "Text" : "Up-to-Date: Aeromonas"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA C. CAYETANENSIS", "DisplayText" : "Diarrhea with Cyclospora cayetanensis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH CYCLOSPORA CAYETANENSIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 7 DAYS", "DisplayText" : "Bactrim DS PO BID 7 DAYS", "Text" : ""},
{"Row" : 18, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 22, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 20, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 16, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "UpToDate. Cyclospora infection. Last updated 1/30/2014"}, 
{"Row" : 26, "Column" : 1, "Text" : "Sanford Guide-web edition. Cyclosporiasis. Last updated 9/2/13"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA C. PARVUM", "DisplayText" : "Diarrhea with Crytosporidium parvum (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH CRYPTOSPORIDIUM PARVUM"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antibiotics are usually used in immunocompromised persons and for severe cases"}, 
{"Row" : 13, "Column" : 1, "Text" : "in immunocompetent persons."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID2 NITAZOXANIDE 3DS 500MG PO BID", "DisplayText" : "Nitazoxanide 500mg po bid for 3 days", "Text" : "Nitazoxanide 500 mg PO BID for 3 days ($13.36) [M] < OR >", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID2 PARONOMYCIN 7DS 750MG PO TID", "DisplayText" : "Paronomycin 750mg po tid for 7 days", "Text" : "Paromomycin 750 mg PO TID for 7 days ($8.46) [M]", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 25, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 27, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 28, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 29, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 22, "Column" : 1, "Text" : "\"Sanford\" keyword: Cryptosporidium"}, 
{"Row" : 24, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 26, "Column" : 1, "Text" : "Up-to-Date: Cryptosporidium"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA CAMPYLOBACTER", "DisplayText" : "Diarrhea with Campylobacter (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH CAMPYLOBACTER"}, 
{"Row" : 12, "Column" : 1, "Text" : "Fluoroquinolone resistance is increasing worldwide. Macrolide resistance is"}, 
{"Row" : 13, "Column" : 1, "Text" : "rare."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG PO Q24H", "Text" : "Azithromycin 500 mg PO qday for 3 days ($8/day) [M]", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 5 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 5 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID for 5 days($0.18/day) [R,DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 ERYTHROMYCIN 5DS 500MG PO QID", "DisplayText" : "Erythromycin 500mg po qid for 5 days", "Text" : "Erythromycin 500 mg QID for 5 days ($0.42/day) [DI]", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 26, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 28, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 30, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 31, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 32, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" keyword: Campylobacter"}, 
{"Row" : 27, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 29, "Column" : 1, "Text" : "Up-to-Date: Campylobacter"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA E. HISTOLYTICA", "DisplayText" : "Diarrhea with Entamoeba histolytica (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH ENTAMOEBA HISTOLYTICA"}, 
{"Row" : 12, "Column" : 1, "Text" : ">>  Treatment for INTESTINAL or EXTRAINTESTINAL disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 22, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 20, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID METRO 750MG 10D THEN PAROMOMYCIN 25-35MG/KG/DAY 7DAYS", "DisplayText" : "Metronidazole 750MG Q8H 10DAYS THEN Paromomycin 25-35MG/KG/DAY Q8H 7 DAYS", "Text" :""},
{"Row" : 16, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "UpToDate. Intestinal Entamoeba histolytica amebiasis. Last updated 4/13/15"}, 
{"Row" : 26, "Column" : 1, "Text" : "Sanford Guide-web edition. Amebiasis. Last updated 8/24/15"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA ENTEROHEM E. COLI", "DisplayText" : "Diarrhea with enterohemorrhagic E. Coli (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Text" : "Enterohemorrhagic E. coli disease is usually associated with bloody diarrhea."}, 
{"Row" : 14, "Column" : 1, "Text" : "It is more common in people who have eaten raw hamburger and seed sprouts."}, 
{"Row" : 16, "Column" : 1, "Text" : "When E. coli predominates in a stool culture, the microbiology laboratory will"}, 
{"Row" : 17, "Column" : 1, "Text" : "determine if the E. coli are O157:H7.  If they are, this will be reported.  If"}, 
{"Row" : 18, "Column" : 1, "Text" : "not, the report will read \"normal flora.\"  If enterohemorrhagic E. coli are"}, 
{"Row" : 19, "Column" : 1, "Text" : "suspected, the microbiology laboratory should be notified so that further"}, 
{"Row" : 20, "Column" : 1, "Text" : "testing can be done."}, 
{"Row" : 22, "Column" : 1, "Text" : "Do not use antimotility or antimicrobial agents as they often increase exposure"}, 
{"Row" : 23, "Column" : 1, "Text" : "to shiga-toxin and increase the risk of hemolytic uremia syndrome (HUS)."}, 
{"Row" : 28, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 32, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH ENTEROHEMORRHAGIC ESCHERICHIA COLI"}, 
{"Row" : 30, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 25, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "UpToDate. Clinical Manifestations, diagnosis and treatment of"}, 
{"Row" : 35, "Column" : 1, "Text" : "enterohemorrhagic Eschericia coli (EHEC) infection. Last updated 1/10/14"}, 
{"Row" : 37, "Column" : 1, "Text" : "Sanford Guide-web edition. Enterohemorrhagic E. Coli (EHEC). Last updated"}, 
{"Row" : 38, "Column" : 1, "Text" : "09/29/15"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA G. LAMBLIA", "DisplayText" : "Diarrhea with Giardia lamblia (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH GIARDIA LAMBLIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment is only necessary when the patient has symptoms attributable to"}, 
{"Row" : 13, "Column" : 1, "Text" : "giardiasis."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 25, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 23, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID METRONIDAZOLE 250MG PO Q8H 7 DAYS", "DisplayText" : "Metronidazole 250MG PO Q8H 7 DAYS", "Text" : ""},
{"Row" : 19, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "UpToDate. Treatment and prevention of Giardiasis. Last 6/16/15"}, 
{"Row" : 29, "Column" : 1, "Text" : "Sanford Guide-web edition. Giardiasis. Last updated 8/24/15"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA ISOSPORA BELLI", "DisplayText" : "Diarrhea with Isospora belli (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH ISOSPORA BELLI"}, 
{"Row" : 12, "Column" : 1, "Text" : "I. belli is associated with diarrhea in persons with HIV/AIDS and only rarely in"}, 
{"Row" : 13, "Column" : 1, "Text" : "immunocompetent persons."}, 
{"Row" : 15, "Column" : 1, "Text" : ">>  Treatment of persons WITHOUT HIV/AIDS", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 7 DAYS", "DisplayText" : "Bactrim DS PO BID 7 DAYS", "Text" : ""},
{"Row" : 19, "Column" : 1, "Text" : "Consult Infectious Disease"}, 
{"Row" : 24, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 28, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 26, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment of persons WITH HIV/AIDS", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "UpToDate. Clinical management of patients with Cystoisospora infection."}, 
{"Row" : 31, "Column" : 1, "Text" : "Last Updated 8/25/14"}, 
{"Row" : 33, "Column" : 1, "Text" : "Sanford Guide-web edition. Cystoisopora belli. Last updated 8/24/15"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA MICROSPORIDIA", "DisplayText" : "Diarrhea with Microsporidia (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial therapy is necessary in immunocompromised patients, but not for"}, 
{"Row" : 13, "Column" : 1, "Text" : "immunocompetent patients.  Treatment must include dietary supplementation for"}, 
{"Row" : 14, "Column" : 1, "Text" : "weight loss.  In persons with AIDS, highly active anti-retroviral therapy"}, 
{"Row" : 15, "Column" : 1, "Text" : "(HAART) is beneficial because recovery of host defenses helps to control"}, 
{"Row" : 16, "Column" : 1, "Text" : "microsporidial disease."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID ALBENDAZOLE 400MG PO BID 21 DAYS", "DisplayText" : "Albendazole 400MG PO BID 21 DAYS", "Text" : ""},
{"Row" : 24, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 28, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH MICROSPORIDIA"}, 
{"Row" : 26, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "UpToDate. Microsporidiosis. Last 12/17/14"}, 
{"Row" : 32, "Column" : 1, "Text" : "Sanford Guide-web edition. Microsporidiosis. Last updated 8/27/15"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA SALMONELLA", "DisplayText" : "Diarrhea with Salmonella (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH SALMONELLA (NON-TYPHI SPECIES)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment is not recommended for mild or moderate cases.  Antimicrobials can"}, 
{"Row" : 13, "Column" : 1, "Text" : "prolong the carrier state and increase the risk of relapse.  If disease is"}, 
{"Row" : 14, "Column" : 1, "Text" : "severe, if the patient is more than 50 years old, if the"}, 
{"Row" : 15, "Column" : 1, "Text" : "patient is immunocompromised or has another debilitating underlying disease,"}, 
{"Row" : 16, "Column" : 1, "Text" : "treatment should be considered. Consider treatment in food handlers/"}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 30, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 28, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 17, "Column" : 1, "Text" : "health care workers."}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 7 DAYS", "Text" : ""},
{"Row" : 25, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "UpToDate. Approach to the patient with nontyphoidal Salmonella in a stool"}, 
{"Row" : 33, "Column" : 1, "Text" : "culture. Last updated 1/22/15"}, 
{"Row" : 35, "Column" : 1, "Text" : "Sanford Guide-web edition. Gastroenteritis, Salmonella: Non-typhi."}, 
{"Row" : 36, "Column" : 1, "Text" : "Last updated 8/21/14"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA SHIGELLA", "DisplayText" : "Diarrhea with Shigella (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH SHIGELLA (BACILLARY DYSENTERY)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole resistance occurs in up to 20% of isolates,"}, 
{"Row" : 13, "Column" : 1, "Text" : "especially in foreign travelers."}, 
{"Row" : 15, "Column" : 1, "Text" : ">>  Treatment if there is NO recent foreign travel", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 3 DAYS", "DisplayText" : "Bactrim DS PO BID 3 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet BID ($0.18/day) for 3 days [R,DI]", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : ">>  Treatment if there is RECENT FOREIGN TRAVEL", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 3 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) for 3 days [R,DI]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 27, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 29, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 30, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 31, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" keyword: Shigella"}, 
{"Row" : 26, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 28, "Column" : 1, "Text" : "Up-to-Date: Shigella"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA VIBRIO CHOLERA", "DisplayText" : "Diarrhea with Vibrio cholera (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH CHOLERA (VIBRIO CHOLERAE)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Aggressive hydration and electrolyte replacement are essential."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 300MG PO ONCE", "DisplayText" : "Doxycycline 300MG PO ONCE", "Text" : "Doxycycline 300 mg PO ONCE ($0.24/day) [DI]  < OR >", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO ONCE", "DisplayText" : "Ciprofloxacin 500MG PO ONCE", "Text" : "Ciprofloxacin 500-1000 mg PO ONCE ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 3 DAYS", "DisplayText" : "Bactrim DS PO BID 3 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID for 3 days ($0.18/day)", "Mnemonic" : "16"},
{"Row" : 18, "Column" : 1, "Text" : "[R,DI]"}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 24, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 26, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 28, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 29, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 30, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 23, "Column" : 1, "Text" : "\"Sanford\" keyword: Cholera"}, 
{"Row" : 25, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 27, "Column" : 1, "Text" : "Up-to-Date: Cholera"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA VIBRIO NON CHOLERA", "DisplayText" : "Diarrhea with non-cholera vibrio (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH NON-CHOLERA VIBRIO"}, 
{"Row" : 12, "Column" : 1, "Text" : "Non-cholera vibrio are associated with gastroenteritis, septicemia, and wound"}, 
{"Row" : 13, "Column" : 1, "Text" : "infections.  Vibrio vulnificans infections are acquired from contact with"}, 
{"Row" : 14, "Column" : 1, "Text" : "seawater or seafood, especially raw oysters.  V. vulnificans cases are more"}, 
{"Row" : 15, "Column" : 1, "Text" : "severe than cases with other species.  V. parahaemolyticus causes"}, 
{"Row" : 16, "Column" : 1, "Text" : "gastroenteritis."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment of Gastroenteritis", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 300MG PO ONCE", "DisplayText" : "Doxycycline 300MG PO ONCE", "Text" :""},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 3 DAYS", "Text" : ""},
{"Row" : 28, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 32, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment of Severe Disease", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 30, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 26, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "UpToDate. Minor Vibrio and Vibrio like species associated with human disease."}, 
{"Row" : 35, "Column" : 1, "Text" : "Last Updated 7/6/15"}, 
{"Row" : 37, "Column" : 1, "Text" : "Sanford Guide-web edition. Gastroenteritis, vibrio sp. Last updated 7/22/15"}
]},
{"Name" : "ORZID3 GMENU DIARRHEA Y. ENTEROCOLITICA", "DisplayText" : "Diarrhea with Yersinia enterocolitica (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIARRHEA WITH YERSINIA ENTEROCOLITICA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobials are only indicated in cases of severe disease or if the patient"}, 
{"Row" : 13, "Column" : 1, "Text" : "is immunocompromised. Treat intestinal disease 3 to 5 days."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 26, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 24, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 5 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 5 DAYS", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO Q12H 5 DAYS", "DisplayText" : "Bactrim DS PO Q12H 5 DAYS", "Text" :""},
{"Row" : 20, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "UpToDate. Treatment and prevention of Yersinia enterocolitica and Yersinia"}, 
{"Row" : 29, "Column" : 1, "Text" : "pseudotuberculosis infection. Last Updated 7/14/15"}, 
{"Row" : 31, "Column" : 1, "Text" : "Sanford Guide-web edition. Gastroenteritis, Yersinia enterocolitica."}, 
{"Row" : 32, "Column" : 1, "Text" : "Last updated 6/23/14"}
]},
{"Name" : "ORZID3 GMENU DISKITIS", "DisplayText" : "Diskitis and vertebral osteomyelitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Surgical consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "DISKITIS AND VERTEBRAL OSTEOMYELITIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU DIVERTICULITIS", "DisplayText" : "Diverticulitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DIVERTICULITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "MILD disease", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Treat for 7 to 10 days."}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZ SET ABX OP CIPROF 500MG PO BID METRO 500MG PO QID", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day)  [R,DI] <AND> metronidazole 500 mg", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R]  < OR >", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "ORZ SET ABX OP TRIMETH/SULFA 1DS BID METRO 500MG PO QID", "DisplayText" : "", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]  < AND>", "Mnemonic" : "16"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 28, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "MODERATE to SEVERE disease", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" keyword: Diverticulitis"}, 
{"Row" : 37, "Column" : 1, "Text" : "Solomkin JS  Clin Infect Dis 2003, 37: 997"}, 
{"Row" : 38, "Column" : 1, "Text" : "Up-to-Date: Diverticulitis"}, 
{"Row" : 18, "Column" : 1, "Text" : "PO QID ($0.64/day) [DI]  < OR >"}, 
{"Row" : 23, "Column" : 1, "Text" : "metronidazole 500 mg PO QID ($0.64/day) [DI]"}, 
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H 7 DAYS", "DisplayText" : "Levofloxacin 500MG PO q24h ($0.19/day)[R,DI]", "Text" : "", "Mnemonic" : "17"}
]},
{"Name" : "ORZID3 GMENU EARLY TREATMENT 2011-2012", "DisplayText" : "Antiviral Treatment Recommendations  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Disease", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "Antiviral Therapy Recommendations:", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Who to Treat:", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "The decision to treat should be based on clinical symptoms and/or presence of"}, 
{"Row" : 12, "Column" : 1, "Text" : "a high risk condition, and should NOT be delayed until laboratory test"}, 
{"Row" : 13, "Column" : 1, "Text" : "results are available."}, 
{"Row" : 15, "Column" : 1, "Text" : "It is important to use antiviral drugs early to treat influenza in people"}, 
{"Row" : 16, "Column" : 1, "Text" : "are very sick with influenza (for example hospitalized people) and people"}, 
{"Row" : 17, "Column" : 1, "Text" : "are sick with influenza and have a greater chance of getting severe"}, 
{"Row" : 5, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary Consult", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Text" : "complications. If a patient is not in a high-risk group or is not hospital"}, 
{"Row" : 19, "Column" : 1, "Text" : "healthcare providers should use clinical judgment to guide treatment decisions."}, 
{"Row" : 20, "Column" : 1, "Text" : "People who have a greater chance of serious influenza complications include:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "*Adults 65 years and older"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Pregnant women and women up to 2 weeks from end of pregnancy"}, 
{"Row" : 23, "Column" : 1, "Text" : "*People with certain chronic medical conditions (such as asthma, heart"}, 
{"Row" : 24, "Column" : 1, "Text" : "failure, chronic lung disease) and people with a weak immune system (due to"}, 
{"Row" : 25, "Column" : 1, "Text" : "illnesses such as diabetes and HIV) or people with neurologic and"}, 
{"Row" : 26, "Column" : 1, "Text" : "neurodevelopment conditions (including disorders of brain and spinal cord)"}, 
{"Row" : 27, "Column" : 1, "Text" : "*People younger than 19 years of age who are receiving long-term aspirin"}, 
{"Row" : 28, "Column" : 1, "Text" : "therapy"}, 
{"Row" : 29, "Column" : 1, "Text" : "* American Indians/Alaska Natives"}, 
{"Row" : 30, "Column" : 1, "Text" : "*People who are morbidly obese (i.e., body-mass index greater than or"}, 
{"Row" : 31, "Column" : 1, "Text" : "equal to 40)"}, 
{"Row" : 33, "Column" : 1, "Text" : "Antiviral Treatment:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "If indicated, antivirals should be started as soon as possible.  Maximal"}, 
{"Row" : 35, "Column" : 1, "Text" : "benefit occurs when started within 48 hours of symptom onset.  However,"}, 
{"Row" : 36, "Column" : 1, "Text" : "antivirals should not be withheld if symptoms began more than 48 hours prior"}, 
{"Row" : 37, "Column" : 1, "Text" : "and the patient meets criteria for treatment and remains severely ill."}, 
{"Row" : 39, "Column" : 1, "Text" : "Oseltamivir or zanamivir are the only two antiviral drugs the Center for"}, 
{"Row" : 40, "Column" : 1, "Text" : "Disease Control is recommending for this influenza season. Neither"}, 
{"Row" : 41, "Column" : 1, "Text" : "amantadine nor rimantadine are recommended for treatment or"}, 
{"Row" : 42, "Column" : 1, "Text" : "chemoprophylaxis this influenza season."}, 
{"Row" : 44, "Column" : 1, "Text" : "Treatment Dosing:", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Patients with chronic respiratory disease like asthma or chronic obstructive"}, 
{"Row" : 46, "Column" : 1, "Text" : "pulmonary disease may have bronchospasm with zanamivir, and zanamivir shou"}, 
{"Row" : 47, "Column" : 1, "Text" : "avoided in these patients. If zanamivir must be used, and patients are using"}, 
{"Row" : 48, "Column" : 1, "Text" : "inhaled bronchodilator, zanamivir should be taken just after the bronchodilator"}, 
{"Row" : 50, "Column" : 1, "Text" : "Duration of antiviral treatment is 5 days.  Extending the treatment may be"}, 
{"Row" : 51, "Column" : 1, "Text" : "needed for those patients with prolonged illness or who are immnunosuppressed."}, 
{"Row" : 53, "Column" : 1, "Text" : "Recommended:", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 75MG PO BID", "DisplayText" : "Oseltamivir 75MG PO BID", "Text" : "Oseltamivir 75 mg po bid for 5 days ($12/day) [R]", "Mnemonic" : "14"},
{"Row" : 56, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 60, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "Centers for Disease Control (CDC) (Accessed 10/21/11)"}, 
{"Row" : 62, "Column" : 1, "Text" : "(http://www.cdc.gov/flu/about/season/index.htm)"}, 
{"Row" : 57, "Column" : 1, "Text" : "Requires Infectious Disease Approval"}, 
{"Row" : 58, "Column" : 1, "Text" : "Zanamivir 2 inhalations (2 x 5 mg) BID for 5 days ($8/day) [O]"}
]},
{"Name" : "ORZID3 GMENU EARLY TREATMENT OR CHEMOPROPHYLAXIS NEW", "DisplayText" : "Early Treatment or Chemoprophylaxis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Disease", "Mnemonic" : "08"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Pulmonary Consult", "Mnemonic" : "06"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 52, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "Centers for Disease Control (CDC)"}, 
{"Row" : 54, "Column" : 1, "Text" : "(http://www.cdc.gov/flu/about/season/index.htm)"}, 
{"Row" : 8, "Column" : 1, "Text" : "Early treatment as alternative to chemoprophylaxis:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "In most cases, if a person is suspected of having been exposed to influenza"}, 
{"Row" : 10, "Column" : 1, "Text" : "early treatment should signs or symptoms develop is preferred rather than"}, 
{"Row" : 11, "Column" : 1, "Text" : "chemoprophylaxis."}, 
{"Row" : 13, "Column" : 1, "Text" : "The provider should explain the early signs and symptoms of influenza to the"}, 
{"Row" : 14, "Column" : 1, "Text" : "patient and advise the patient to immediately contact a health care provider"}, 
{"Row" : 15, "Column" : 1, "Text" : "for evaluation and possible early treatment if these symptoms or signs"}, 
{"Row" : 16, "Column" : 1, "Text" : "develop. Influenza-like symptoms or signs include fever, cough, sore throat"}, 
{"Row" : 17, "Column" : 1, "Text" : "runny or stuffy nose, body aches, headache, chills, fatigue, vomiting, and"}, 
{"Row" : 18, "Column" : 1, "Text" : "diarrhea. Influenza can present without fever."}, 
{"Row" : 19, "Column" : 1, "Text" : "Health care providers should use clinical judgment regarding situations where"}, 
{"Row" : 20, "Column" : 1, "Text" : "early recognition of illness and treatment might be an appropriate"}, 
{"Row" : 21, "Column" : 1, "Text" : "alternative to chemoprophylaxis."}, 
{"Row" : 23, "Column" : 1, "Text" : "Early treatment alternative or chemoprophylaxis may be considered for:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "*Persons who are part of a high-risk group and are household or close"}, 
{"Row" : 25, "Column" : 1, "Text" : "contacts of someone with influenza-like illness"}, 
{"Row" : 26, "Column" : 1, "Text" : "*Health care personnel who have occupational exposures"}, 
{"Row" : 28, "Column" : 1, "Text" : "Chemoprophylaxis can be considered for:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "*Resident of a long term care facility that had close contact with another"}, 
{"Row" : 30, "Column" : 1, "Text" : "resident or staff with influenza-like illness."}, 
{"Row" : 31, "Column" : 1, "Text" : "*Atypical situations (such as case clusters).  Contact state"}, 
{"Row" : 32, "Column" : 1, "Text" : "Department of Health for consultation."}, 
{"Row" : 34, "Column" : 1, "Text" : "Antiviral Chemoprophylaxis Dosing:", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Duration of antiviral treatment is 10 days.  Among long-term care residentS"}, 
{"Row" : 36, "Column" : 1, "Text" : "the antiviral use should be re-evaluated after 10 days. If no further"}, 
{"Row" : 37, "Column" : 1, "Text" : "exposures have occurred, antivirals should be discontinued."}, 
{"Row" : 39, "Column" : 1, "Text" : "Zanamivir is not recommended for patients with chronic respiratory disease"}, 
{"Row" : 40, "Column" : 1, "Text" : "as asthma or chronic obstructive pulmonary disease. These patients may have"}, 
{"Row" : 41, "Column" : 1, "Text" : "bronchospasm with zanamivir. If zanamivir must be used, and patients are using"}, 
{"Row" : 42, "Column" : 1, "Text" : "an inhaled bronchodilator, zanamivir should be taken just after the"}, 
{"Row" : 43, "Column" : 1, "Text" : "bronchodilator."}, 
{"Row" : 45, "Column" : 1, "Text" : "Recommended:", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Item" : "PSOZID OSELTAMIVIR 75 MG PO QDAY X10DAYS", "DisplayText" : "OSELTAMIVIR 75 MG PO QDAY X10DAYS", "Text" : "Oseltamivir 75 mg po q daily for 10 days ($7/day) [R]", "Mnemonic" : "14"},
{"Row" : 48, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "Requires Infectious Disease Approval"}, 
{"Row" : 50, "Column" : 1, "Text" : "Zanamivir 2 inhalations (2 x 5 mg)daily for 10 days($4/day) [O]"}
]},
{"Name" : "ORZID3 GMENU EMPYEMA", "DisplayText" : "Empyema (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic surgery"},
{"Row" : 8, "Column" : 1, "Text" : "EMPYEMA"}
]},
{"Name" : "ORZID3 GMENU ENDOPHTHALMITIS", "DisplayText" : "Endophthalmitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT OPHTHALMOLOGY", "DisplayText" : "OPHTHALMOLOGY", "Text" : "Consult Ophthamology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ENDOPHTHALMITIS"}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 12, "Column" : 1, "Text" : "Endophthalmitis presents with eye pain and visual loss.  Endophthalmitis is a"}, 
{"Row" : 13, "Column" : 1, "Text" : "medical emergency.  Call Ophthalmology immediately.  The opthalmologist will"}, 
{"Row" : 14, "Column" : 1, "Text" : "obtain a vitreous fluid sample for gram stain and culture and begin"}, 
{"Row" : 15, "Column" : 1, "Text" : "intravitreous antimicrobials."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment with intravitreous antimicrobials", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1MG INTRAVITREOUS AMIK 0.4MG INTR INJ", "DisplayText" : "Vancomycin 1mg intravitreous inj Amikacin 0.4mg intravitreous inj", "Text" : "Vancomycin 1 mg intravitreous injection <AND> amikacin 0.4 mg intravitreous", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "injection ($25/day) [M] < OR >"}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1MG INTRA INJ CEFTAZ 2.25MG INTRA INJ", "DisplayText" : "Vancomycin 1mg intravitreous inject Ceftazidime 2.25mg intrav inj", "Text" : "Vancomycin 1 mg intravitreous injection <AND> ceftazidime 2.25 mg", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "intravitreous injection ($25/day) [M]"}, 
{"Row" : 24, "Column" : 1, "Text" : "Systemic antifungal therapy for Candidal endophthalmitis", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Infectious Disease involvement is essential."}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 32, "Column" : 1, "Text" : "\"Mandell\" chapter: Endophthalmitis"}, 
{"Row" : 33, "Column" : 1, "Text" : "Baum J Clin Infect Dis 1995, 21: 479"}, 
{"Row" : 27, "Column" : 1, "Text" : "Intravenous therapy is indicated.  Refer to Inpatient Antimicrobial CDSS for"}, 
{"Row" : 28, "Column" : 1, "Text" : "treatment."}
]},
{"Name" : "ORZID3 GMENU EPIDIDYMITIS", "DisplayText" : "Epididymitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "EPIDIDYMITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Most cases in men under age 35 are associated with N. gonorrhoeae and  C."}, 
{"Row" : 13, "Column" : 1, "Text" : "trachomatis.  Most cases in older men are associated with enteric Gram negative"}, 
{"Row" : 14, "Column" : 1, "Text" : "rods.  Management should include bed rest, analgesics, and  scrotal elevation."}, 
{"Row" : 15, "Column" : 1, "Text" : "Older men should have their residual urinary volume checked.  If the residual"}, 
{"Row" : 16, "Column" : 1, "Text" : "volume is elevated, the patient should be seen by a urologist as epididymitis is"}, 
{"Row" : 17, "Column" : 1, "Text" : "unlikely to respond if the prostate is blocking the vas deferens."}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment in men <= 35 years or for cases associated with gonococci or Chlamydia", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZ SET ABX OP CEFT 250MG IM X1 DOXYC 10DS 100MG PO BID", "DisplayText" : "", "Text" : "Ceftriaxone 250 mg IM ONCE ($16.71/day) [M] <AND> doxycycline 100 mg PO BID", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "for 10 days ($0.15/day) [DI]"}, 
{"Row" : 23, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 10 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 10 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "Treatment in men > 35 years (except for cases with gonococci or Chlamydia)", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 10 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 10 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" keyword: Epididymitis"}
]},
{"Name" : "ORZID3 GMENU EPIGLOTTITIS", "DisplayText" : "Epiglottitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Consult ENT", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "EPIGLOTTITIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 14, "Column" : 1, "Text" : "\"Sanford\" keyword: Epiglottitis"}, 
{"Row" : 15, "Column" : 1, "Text" : "\"Mandell\" chapter: Epiglottitis"}, 
{"Row" : 16, "Column" : 1, "Text" : "Johns Hopkins Website"}, 
{"Row" : 17, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU ERCP PROPHYLAXIS", "DisplayText" : "ERCP Prophylaxis (in absence of infection) - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "ERCP PROPHYLAXIS (IN ABSENCE OF INFECTION)"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU ERYSIPELAS", "DisplayText" : "Erysipelas (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ERYSIPELAS"}, 
{"Row" : 11, "Column" : 1, "Text" : "In contrast to cellulitis, erysipelas has sharply demarcated borders and a"}, 
{"Row" : 12, "Column" : 1, "Text" : "characteristic raised, \"orange-peel\" appearance.  Most cases are associated with"}, 
{"Row" : 13, "Column" : 1, "Text" : "streptococcus.  In a minority of cases, especially those involving the face,"}, 
{"Row" : 14, "Column" : 1, "Text" : "Staphylococcus aureus is also a potential pathogen.  In severe cases,"}, 
{"Row" : 15, "Column" : 1, "Text" : "methicillin-resistant Staphylococcus aureus (MRSA) coverage must be provided"}, 
{"Row" : 16, "Column" : 1, "Text" : "until microbiology results are available."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treat for 10 to 14 days."}, 
{"Row" : 19, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Facial", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 10DS 250MG PO QID", "DisplayText" : "Dicloxacillin 250mg po qid for 10 days", "Text" : "Dicloxacillin 250-500 mg PO QID ($0.24-0.48/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 10DS 250MG PO QID", "DisplayText" : "Cephalexin 250mg po qid for 10 days", "Text" : "Cephalexin 250-500 mg PO QID ($0.18-0.36/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 26, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 10DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 10 days", "Text" : "Minocycline 100 mg PO BID ($1.14/day) [DI]", "Mnemonic" : "14"},
{"Row" : 31, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Non-facial", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Item" : "PSOZID2 PENICILLIN VK 10DS 250MG PO QID", "DisplayText" : "Penicillin VK 250mg po qid for 10 days", "Text" : "Penicillin VK 250 - 500 mg PO QID ($0.60-1.20/day) [R]", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Item" : "PSOZID2 ERYTHROMYCIN 10DS 250MG PO QID", "DisplayText" : "Erythromycin 250mg po qid for 10 days", "Text" : "Erythromycin 250-500 mg PO QID ($0.21-0.42/day) [DI]", "Mnemonic" : "18"},
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 50, "Column" : 1, "Text" : "Stulberg DL Am Fam Phys 2002, 66: 119"}, 
{"Row" : 51, "Column" : 1, "Text" : "Stevens DL Clin Infect Dis 2005, 41: 1373"}, 
{"Row" : 28, "Column" : 1, "Text" : "SEVERE disease", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 41, "Column" : 1, "Text" : "SEVERE disease", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 47, "Column" : 1, "Text" : "\"Sanford\" keyword: Erysipelas"}, 
{"Row" : 49, "Column" : 1, "Text" : "Up-to-Date website: Erysipelas"}, 
{"Row" : 48, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}
]},
{"Name" : "ORZID3 GMENU FEVER OF UNKNOWN ORIGIN", "DisplayText" : "Fever of Unknown Origin (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "FEVER OF UNKNOWN ORIGIN"}, 
{"Row" : 8, "Column" : 1, "Text" : "Cases with fever of unknown origin are often classified in four categories:(1)"}, 
{"Row" : 9, "Column" : 1, "Text" : "classical, (2) neutropenic, (3) nosocomial, and (4) fever in persons with"}, 
{"Row" : 10, "Column" : 1, "Text" : "HIV/AIDS.  Empirical antimicrobial therapy rarely indicated in these patients."}, 
{"Row" : 11, "Column" : 1, "Text" : "Note that for fever of unknown origin in neutropenic patients refers to"}, 
{"Row" : 12, "Column" : 1, "Text" : "persistent fever that has remained undiagnosed after extensive diagnostic work"}, 
{"Row" : 13, "Column" : 1, "Text" : "and empirical antimicrobial therapy.  New fever in patients with profound"}, 
{"Row" : 14, "Column" : 1, "Text" : "neutropenia is a different syndrome and does require empirical antimicrobial"}, 
{"Row" : 15, "Column" : 1, "Text" : "therapy.  Infectious Diseases should be involved in any case where empirical"}, 
{"Row" : 16, "Column" : 1, "Text" : "treatment for fever of unknown origin is being considered."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 GMENU NEUTROPENIC FEVER", "DisplayText" : "Neutropenic fever (Outpatient)", "Text" : "Link to neutropenic fever", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID3 GMENU FOLLICULITIS", "DisplayText" : "Folliculitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Dermatology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "FOLLICULITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Folliculitis is usually associated with Staphylococcus aureus.  In patients"}, 
{"Row" : 13, "Column" : 1, "Text" : "exposed to swimming pools or hot tubs, folliculitis may be associated with"}, 
{"Row" : 14, "Column" : 1, "Text" : "Pseudomonas aeruginosa. Candida albicans can cause folliculitis in patients"}, 
{"Row" : 15, "Column" : 1, "Text" : "receiving antimicrobials and/or corticosteroids. For folliculitis in patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "with severe acne, consult Dermatology.  For extensive folliculitis or in"}, 
{"Row" : 17, "Column" : 1, "Text" : "patients with HIV, consult Infectious Diseases."}, 
{"Row" : 19, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "For most cases, treat with daily saline compresses until symptoms resolve."}, 
{"Row" : 22, "Column" : 1, "Text" : "For cases associated with Candida albicans", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Treat for 7 days."}, 
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 CLOTRIMAZOLE 1% CRM TOP TID 7DS", "DisplayText" : "Clotrimazole 1% cream topical tid 7days", "Text" : "Clotrimazole cream TID or QID ($1.05/tube) [M]", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Text" : "Up-to-Date website accessed 8/4/05"}, 
{"Row" : 30, "Column" : 1, "Text" : "\"Sanford\" keyword: Folliculitis"}
]},
{"Name" : "ORZID3 GMENU FOOT ULCER IN PT W/ DM", "DisplayText" : "Foot ulcer in patient with diabetes mellitus (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "FOOT ULCER IN PATIENT WITH DIABETES MELLITUS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Foot ulcers in patients with diabetes mellitus are colonized with bacteria."}, 
{"Row" : 10, "Column" : 1, "Text" : "Antimicrobials should not be used to treat colonization."}, 
{"Row" : 12, "Column" : 1, "Text" : "Cases with infection of surrounding tissues signified by erythema, warmth, local"}, 
{"Row" : 13, "Column" : 1, "Text" : "tenderness, or purulent discharge should be treated with antimicrobials. Pain"}, 
{"Row" : 14, "Column" : 1, "Text" : "may not be present in patients with neuropathy.  In patients with substantial"}, 
{"Row" : 15, "Column" : 1, "Text" : "vascular disease, erythema and warmth may not be present and instead the tissues"}, 
{"Row" : 16, "Column" : 1, "Text" : "will be dusky, mottled, or cool.  Capillary refill may be impaired.  Patients"}, 
{"Row" : 17, "Column" : 1, "Text" : "with diabetes and ulcers are at risk for gangrenous infections.  If there is any"}, 
{"Row" : 18, "Column" : 1, "Text" : "suggestion of gangrene, consult surgery immediately."}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 GMENU FOOT ULCERS W/O INFECT SURR TISS", "DisplayText" : "Foot ulcers WITHOUT infection of surrounding tissues (Outpatient)", "Text" : "Foot ulcers WITHOUT infection of surrounding tissues", "Mnemonic" : "08"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID3 GMENU FOOT ULCERS W/ INFECT SURR TISSUES", "DisplayText" : "Foot ulcers WITH infection of surrounding tissues (Outpatient)", "Text" : "Foot ulcers WITH infection of surrounding tissues", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}
]},
{"Name" : "ORZID3 GMENU FOOT ULCERS DRUG SELECTION", "DisplayText" : "Drug selection (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PODIATRY OPT", "DisplayText" : "PODIATRY OPT", "Text" : "Podiatry consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Orthopedic surgery consult", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "DRUG SELECTION"}, 
{"Row" : 13, "Column" : 1, "Text" : "MILD TO MODERATE INFECTIONS are treated with drugs that cover Gram positive"}, 
{"Row" : 14, "Column" : 1, "Text" : "cocci such as S. aureus and Streptococcus spp unless there is reason to suspect"}, 
{"Row" : 15, "Column" : 1, "Text" : "a different pathogen."}, 
{"Row" : 17, "Column" : 1, "Text" : "SEVERE INFECTIONS or infections that have failed previous antimicrobial therapy"}, 
{"Row" : 18, "Column" : 1, "Text" : "should be treated initially with broad-spectrum intravenous antimicrobials."}, 
{"Row" : 20, "Column" : 1, "Text" : "If methicillin-resistant S. aureus (MRSA) is suspected, use vancomycin for"}, 
{"Row" : 21, "Column" : 1, "Text" : "severe cases and trimethoprim-sulfamethoxazole or minocycline for mild or"}, 
{"Row" : 22, "Column" : 1, "Text" : "moderate cases."}, 
{"Row" : 24, "Column" : 1, "Text" : "Use oral antimicrobial therapy for mild-moderate cases.  Use intravenous therapy"}, 
{"Row" : 25, "Column" : 1, "Text" : "for severe cases or when oral therapy is not feasible."}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}
]},
{"Name" : "ORZID3 GMENU FOOT ULCERS DURA OF THERAPY", "DisplayText" : "Duration of therapy (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PODIATRY OPT", "DisplayText" : "PODIATRY OPT", "Text" : "Podiatry consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Orthopedic surgery consult", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "DURATION OF THERAPY"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat mild infections for 1 to 2 weeks.  When osteomyelitis is present, treat"}, 
{"Row" : 14, "Column" : 1, "Text" : "for 4 to 6 weeks.  For moderate to severe disease, give intravenous therapy for"}, 
{"Row" : 15, "Column" : 1, "Text" : "1 to 2 weeks followed by oral therapy.  For mild cases, start with oral therapy"}, 
{"Row" : 16, "Column" : 1, "Text" : "or give intravenous therapy for only a few days followed by oral therapy for the"}, 
{"Row" : 17, "Column" : 1, "Text" : "balance of 4 to 6 weeks.  Do not place a long-term intravascular access device"}, 
{"Row" : 18, "Column" : 1, "Text" : "(e.g. a PICC line) until it is clear the patient will need long term intravenous"}, 
{"Row" : 19, "Column" : 1, "Text" : "therapy. Consult Infectious Diseases or Orthopedic Surgery for more information."}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID3 GMENU OSTEOMYELITIS", "DisplayText" : "Osteomyelitis (Outpatient)", "Text" : "Osteomyelitis", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}
]},
{"Name" : "ORZID3 GMENU FOOT ULCERS W/ INFECT SURR TISSUES", "DisplayText" : "Foot ulcers WITH infection of surrounding tissues (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PODIATRY OPT", "DisplayText" : "PODIATRY OPT", "Text" : "Podiatry consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Orthopedic surgery consult", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "FOOT ULCERS WITH INFECTION OF SURROUNDING TISSUES"}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 GMENU APPRO TO FOOT ULCERS W/ INFECT", "DisplayText" : "Approach to foot ulcers with infection (Outpatient)", "Text" : "Approach to foot ulcers with infection", "Mnemonic" : "14"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 GMENU FOOT ULCERS DRUG SELECTION", "DisplayText" : "Drug selection (Outpatient)", "Text" : "Drug selection", "Mnemonic" : "16"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU FOOT ULCERS DURA OF THERAPY", "DisplayText" : "Duration of therapy (Outpatient)", "Text" : "Duration of therapy", "Mnemonic" : "18"},
{"Row" : 17, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Oral regimens for MILD TO MODERATE infections", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R] < OR >", "Mnemonic" : "20"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 7DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 7 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI]  < OR >", "Mnemonic" : "22"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 CEPHALEX 7DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 7 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]", "Mnemonic" : "24"},
{"Row" : 26, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 CLINDAM 7DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 7 days", "Text" : "Clindamycin 300 mg po QID ($3.36/day) [H,O]  < OR >", "Mnemonic" : "26"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 7 DAYS", "DisplayText" : "Bactrim DS PO BID 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]", "Mnemonic" : "28"},
{"Row" : 30, "Column" : 1, "Text" : "Oral regimens for MODERATE infections", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 LEVOFLOXACIN 10DS 400MG PO QDAY", "DisplayText" : "Levofloxacin 500mg po q24h ($0.19/day)[R,DI] for 10 days", "Text" : "", "Mnemonic" : "30"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "32"},
{"Row" : 39, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}, 
{"Row" : 33, "Column" : 1, "Text" : "Regimens for SEVERE infections", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU FOOT ULCERS W/O INFECT SURR TISS", "DisplayText" : "Foot ulcers WITHOUT infection of surrounding tissues (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PODIATRY OPT", "DisplayText" : "PODIATRY OPT", "Text" : "Podiatry consult", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ZORZ IV HEPARIN INFUSION", "DisplayText" : "HEPARIN INFUSION", "Text" : "Metabolic consult", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "FOOT ULCERS WITHOUT INFECTION OF SURROUNDING TISSUES"}, 
{"Row" : 10, "Column" : 1, "Text" : "Topical antimicrobials are not helpful, are associated with allergic reactions,"}, 
{"Row" : 11, "Column" : 1, "Text" : "and select for resistant organisms.  In general, local treatment should consist"}, 
{"Row" : 12, "Column" : 1, "Text" : "of dressings with frequent changes, soaks, and debridement.Patients with"}, 
{"Row" : 13, "Column" : 1, "Text" : "edema or impaired venous return should keep the limb elevated.  Wound care and"}, 
{"Row" : 14, "Column" : 1, "Text" : "improved control of diabetes can improve outcomes of infection and prevent"}, 
{"Row" : 15, "Column" : 1, "Text" : "future complications."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Text" : "Lipsky BA Clin Infect Dis 2004, 39: 885"}
]},
{"Name" : "ORZID3 GMENU FUNGI", "DisplayText" : "Fungi (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  FUNGI - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Always consider disease or syndrome, site of infection, penetration of drug(s)"}, 
{"Row" : 9, "Column" : 1, "Text" : "into site, and whether organism is pathogen, colonizer, or contaminant.  See"}, 
{"Row" : 10, "Column" : 1, "Text" : "disease/syndrome section for more information."}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI ASPERGILLUS SPP.", "DisplayText" : "Aspergillus spp. (Outpatient)", "Text" : "Aspergillus spp.", "Mnemonic" : "06"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI BLASTOMYCES DERM", "DisplayText" : "Blastomyces dermatitidis (Outpatient)", "Text" : "Blastomyces dermatitidis", "Mnemonic" : "08"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI C. ALBICANS", "DisplayText" : "Candida albicans (Outpatient)", "Text" : "Candida albicans", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI C. GLABRATA", "DisplayText" : "Candida glabrata (Outpatient)", "Text" : "Candida glabrata", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI C. KRUSEI", "DisplayText" : "Candida krusei (Outpatient)", "Text" : "Candida krusei", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI COCCIDIOIDOMYCES", "DisplayText" : "Coccidioidomyces (Outpatient)", "Text" : "Coccidioidomyces", "Mnemonic" : "16"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI W/ HIV C. NEOFORMANS", "DisplayText" : "Crytococcus neoformans--Treatment for patients with HIV (Outpatient)", "Text" : "Cryptococcus neoformans (Patients with HIV)", "Mnemonic" : "18"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI W/O HIV C. NEOFORMANS", "DisplayText" : "Cryptococcus neoformans--Treatment for patients without HIV (Outpatient)", "Text" : "Cryptococcus neoformans (Patients without HIV)", "Mnemonic" : "20"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI H. CAPSULATUM", "DisplayText" : "Histoplasma capsulatum (Outpatient)", "Text" : "Histoplasma capsulatum", "Mnemonic" : "22"}
]},
{"Name" : "ORZID3 GMENU FUNGI ASPERGILLUS SPP.", "DisplayText" : "Aspergillus spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ASPERGILLUS SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "For localized disease (\"fungus ball\"), antifungal therapy is ineffective."}, 
{"Row" : 12, "Column" : 1, "Text" : "Consult Surgery and Pulmonary for cases of localized disease without systemic"}, 
{"Row" : 13, "Column" : 1, "Text" : "infection.  Treat invasive disease with intravenous antifungals initially, then"}, 
{"Row" : 14, "Column" : 1, "Text" : "switch to oral antifungals for a total duration of therapy of at least 10 weeks."}, 
{"Row" : 15, "Column" : 1, "Text" : "Consult Infectious Diseases in all cases."}, 
{"Row" : 17, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 19, "Column" : 1, "Text" : "Oral medications for use after disease has stabilized", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID VORICONAZOLE 200MG PO BID", "DisplayText" : "Voriconazole 200mg po bid", "Text" : "Voriconazole 200 mg PO BID ($36/day) [R,H,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID ITRACONAZOLE 200MG PO BID", "DisplayText" : "Itraconazole 200mg po bid", "Text" : "Itraconazole 200 mg PO BID ($18/day) [DI]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 27, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID3 GMENU FUNGI BLASTOMYCES DERM", "DisplayText" : "Blastomyces dermatitidis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BLASTOMYCES DERMATITIDIS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Contact Infectious Diseases in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Disease outside of thecentral nervous system", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "or oral therapy for use after intravenous amphotericin", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID ITRACONAZOLE 200MG PO BID", "DisplayText" : "Itraconazole 200mg po bid", "Text" : "Itraconazole 200 mg PO BID  ($18/day) [DI]", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 25, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400MG PO Q24H", "Text" : "Fluconazole 400-800 mg PO QDAY ($0.40/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Central nervous system infection", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 37, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 38, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID3 GMENU FUNGI C. ALBICANS", "DisplayText" : "Candida albicans (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CANDIDA ALBICANS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Avoid using fluconazole empirically to treat candidal infections in patients who"}, 
{"Row" : 12, "Column" : 1, "Text" : "have received an imidazole in the previous year."}, 
{"Row" : 14, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Oral or pharyngeal candidiasis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Topical therapy usually suffices.  Treat for 7 for 14 days after improvement."}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 NYSTATIN SWISH/SWALLOW 5ML QID 14DAYS", "DisplayText" : "Nystatin 5ml swish and swallow qid for 14 days", "Text" : "Nystatin swish and swallow QID ($1.39/day) [M] < OR >", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Item" : "PSOZID CLOTRIMAZOLE TROCHE 10MG PO 5X/D", "DisplayText" : "Clotrimazole troche 10mg po 5x/d", "Text" : "Clotrimazole troche 10 mg PO 5X/day ($3.30/day) [M]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Esophageal candidiasis", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Esophageal infection requires systemic therapy.  Treat for 14 to 21 days after"}, 
{"Row" : 29, "Column" : 1, "Text" : "improvement."}, 
{"Row" : 31, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 200MG PO ONCE THEN 100MG PO Q24H 6 DAYS", "DisplayText" : "Fluconazole 200MG PO ONCE THEN 100MG Q24H 6 DAYS", "Text" : "Fluconazole 200 mg PO ONCE, then 100 mg PO qday ($0.20/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 34, "Column" : 1, "Text" : "Alternative for patient who cannot swallow tablets", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 37, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Systemic candidal infection", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Fluconazole is preferred empirical therapy in most cases.  Amphotericin B should"}, 
{"Row" : 42, "Column" : 1, "Text" : "be used empirically in patients who have received an \"azole\" antifungal drug"}, 
{"Row" : 43, "Column" : 1, "Text" : "recently, or in patients who are critically ill."}, 
{"Row" : 45, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 47, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400MG PO Q24H", "Text" : "Fluconazole 400-800 mg PO QDAY ($0.40/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 51, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 53, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 54, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID3 GMENU FUNGI C. GLABRATA", "DisplayText" : "Candida glabrata (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CANDIDA GLABRATA"}, 
{"Row" : 11, "Column" : 1, "Text" : "C. glabrata is often resistant to fluconazole and occasionally has some degree"}, 
{"Row" : 12, "Column" : 1, "Text" : "of resistance to amphotericin.  When amphotericin B is used, use 1 mg/kg/day if"}, 
{"Row" : 13, "Column" : 1, "Text" : "possible."}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 18, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID VORICONAZOLE 400MG PO BID 1DAY THEN 200MG BID", "DisplayText" : "Voriconazole 400mg po bid 1 day then 200mg po bid", "Text" : "Voriconazole 400 mg PO BID for 2 doses, then 200 mg PO BID ($36/day)", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Text" : "[R,H,DI]"}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 26, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID3 GMENU FUNGI C. KRUSEI", "DisplayText" : "Candida krusei (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CANDIDA KRUSEI"}, 
{"Row" : 11, "Column" : 1, "Text" : "C. krusei is resistant to fluconazole, and often has some degree of resistance"}, 
{"Row" : 12, "Column" : 1, "Text" : "to amphotericin.  When amphotericin B is used, use 1 mg/kg/day if possible."}, 
{"Row" : 14, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID VORICONAZOLE 400MG PO BID 1DAY THEN 200MG BID", "DisplayText" : "Voriconazole 400mg po bid 1 day then 200mg po bid", "Text" : "Voriconazole 400 mg PO BID for 2 doses, then 200 mg PO BID ($36/day)", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "[R,H,DI]"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 25, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID3 GMENU FUNGI COCCIDIOIDOMYCES", "DisplayText" : "Coccidioidomyces (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Text" : "COCCIDIOIDOMYCES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Pulmonary and Infectious Diseases consultations are essential for diagnosis and"}, 
{"Row" : 13, "Column" : 1, "Text" : "treatment."}, 
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Observation alone is indicated for some cases. Consult Infectious Diseases for"}, 
{"Row" : 20, "Column" : 1, "Text" : "more information.  If antifungal treatment is indicated:"}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID ITRACONAZOLE 200MG PO BID", "DisplayText" : "Itraconazole 200mg po bid", "Text" : "Itraconazole 200 mg PO BID ($18/day) [DI]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400MG PO Q24H", "Text" : "Fluconazole 400 mg PO QDAY ($0.40/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 28, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "________________________________________________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "SEVERE disease (diffuse pneumonia or central nervous system infection)", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 37, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 38, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID3 GMENU FUNGI H. CAPSULATUM", "DisplayText" : "Histoplasma capsulatum (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 10, "Column" : 1, "Text" : "HISTOPLASMA CAPSULATUM"}, 
{"Row" : 12, "Column" : 1, "Text" : "Intravenous antifungals are indicated initially for severe or progressive"}, 
{"Row" : 13, "Column" : 1, "Text" : "disease.After disease has stabilized, oral antifungals may be used to"}, 
{"Row" : 14, "Column" : 1, "Text" : "complete the course, which ranges from weeks to months.  Contact Infectious"}, 
{"Row" : 15, "Column" : 1, "Text" : "Diseases and Pulmonary services for advice.  Contact HIV expert for advice on"}, 
{"Row" : 16, "Column" : 1, "Text" : "cases involving patients with HIV."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred initial therapy for MENINGITIS, SEVERE PULMONARY or DISSEMINATED", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "DISEASE", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment after disease has STABILIZED", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Itraconazole is more effective than fluconazole, but fluconazole may be used in"}, 
{"Row" : 25, "Column" : 1, "Text" : "patients who cannot tolerate itraconazole."}, 
{"Row" : 27, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID ITRACONAZOLE 200MG PO BID", "DisplayText" : "Itraconazole 200mg po bid", "Text" : "Itraconazole 200 mg PO BID ($18/day) [DI]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400MG PO Q24H", "Text" : "Fluconazole 400-800 mg PO qday ($0.40/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 36, "Column" : 1, "Text" : "Wheat J, et al.  Practice guidelines for the management of patients with"}, 
{"Row" : 37, "Column" : 1, "Text" : "Histoplasmosis.  Clin Infect Dis 2000, 30: 68"}
]},
{"Name" : "ORZID3 GMENU FUNGI W/ HIV C. NEOFORMANS", "DisplayText" : "Crytococcus neoformans--Treatment for patients with HIV (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CRYPTOCOCCUS NEOFORMANS--TREATMENT FOR PATIENTS WITH HIV"}, 
{"Row" : 11, "Column" : 1, "Text" : "Consult HIV expert in all cases. Begin treatment with amphotericin and"}, 
{"Row" : 12, "Column" : 1, "Text" : "flucytosine and consult Infectious Diseases for assistance."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment of CENTRAL NERVOUS SYSTEM or BLOODSTREAM infection", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment PULMONARY or OTHER LOCALIZED infection or switch to oral therapy after", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "disease has stabilized", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400MG PO Q24H", "Text" : "Fluconazole 200-400 mg PO qday ($0.40/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID ITRACONAZOLE 200MG PO BID", "DisplayText" : "Itraconazole 200mg po bid", "Text" : "Itraconazole 200 mg PO BID ($18/day) [DI]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "Saag MS, et al.  Practice guidelines for the management of cryptococcal disease."}, 
{"Row" : 27, "Column" : 1, "Text" : "Clin Infect Dis 2000, 30: 710"}, 
{"Row" : 28, "Column" : 1, "Text" : "\"Sanford\" key term: Desensitization"}
]},
{"Name" : "ORZID3 GMENU FUNGI W/O HIV C. NEOFORMANS", "DisplayText" : "Cryptococcus neoformans--Treatment for patients without HIV (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CRYPTOCOCCUS NEOFORMANS--TREATMENT FOR PATIENTS WITHOUT HIV"}, 
{"Row" : 11, "Column" : 1, "Text" : "Consult Infectious Diseases."}, 
{"Row" : 13, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Infection OUTSIDE of the central nervous system", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment of MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400MG PO Q24H", "Text" : "Fluconazole 200-400 mg PO qday ($0.40/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID ITRACONAZOLE 200MG PO BID", "DisplayText" : "Itraconazole 200mg po bid", "Text" : "Itraconazole 200 mg PO BID ($18/day) [DI]", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "Treatment of SEVERE disease", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 24, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Infection INSIDE the central nervous system", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "Pappas PG, et al.  Guidelines for treatment of candidiasis.  Clin Infect Dis"}, 
{"Row" : 34, "Column" : 1, "Text" : "2004, 38: 161"}
]},
{"Name" : "ORZID3 GMENU FURUNCLES AND CARBUNCLES", "DisplayText" : "Furuncles and Carbuncles (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ OSTOMY OPT CONSULT", "DisplayText" : "Ostomy/Wound/Continence", "Text" : "Wound care (ET) nurse consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "FURUNCLES AND CARBUNCLES"}, 
{"Row" : 12, "Column" : 1, "Text" : "A furuncle is an inflamed nodule that usually develops as a complication of"}, 
{"Row" : 13, "Column" : 1, "Text" : "folliculitis.  A carbuncle is a more extensive lesion that extends further into"}, 
{"Row" : 14, "Column" : 1, "Text" : "the subcutaneous tissue.  Nearly all furuncles and carbuncles are caused by S."}, 
{"Row" : 15, "Column" : 1, "Text" : "aureus.  Mild cases without evidence of invasive infections are treated with"}, 
{"Row" : 16, "Column" : 1, "Text" : "moist heat.  Contact a wound care nurse for more information.  Incise and drain"}, 
{"Row" : 17, "Column" : 1, "Text" : "deeper infections."}, 
{"Row" : 19, "Column" : 1, "Text" : "For cases with cellulitis or deep invasion, treat with antimicrobials for 5 to"}, 
{"Row" : 20, "Column" : 1, "Text" : "14 days."}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID2 DICLOX 5DS 250MG PO Q6H", "DisplayText" : "Dicloxacillin 250mg po q6h for 5 days", "Text" : "Dicloxacillin 250-500 mg PO QID ($0.24-0.48/day) [DI]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID2 ERYTHROMYCIN 5DS 250MG PO QID", "DisplayText" : "Erythromycin 250mg po qid for 5 days", "Text" : "Erythromycin 250-500 mg PO QID ($0.21-0.42/day) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 5DS 150MG PO QID", "DisplayText" : "Clindamycin 150mg po qid for 5 days", "Text" : "Clindamycin 150-300 mg PO QID ($1.68-3.36/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Text" : "If methicillin-RESISTANT Staphylococcus aureus (MRSA) is suspected or proved", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 5DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 5 days", "Text" : "Minocycline 100 mg PO BID ($1/day) [DI] < OR >", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 5 DAYS", "DisplayText" : "Bactrim DS PO BID 5 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]", "Mnemonic" : "20"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 36, "Column" : 1, "Text" : "Up-to-Date website: Furuncle, carbuncle"}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Sanford\" keyword: Furuncle, carbuncle"}
]},
{"Name" : "ORZID3 GMENU GASTROINT OUTPT MAIN", "DisplayText" : "Gastrointestinal (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  GASTROINTESTINAL - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 7, "Column" : 2, "Text" : "Diarrhea", "Header" : 1}, 
{"Row" : 8, "Column" : 2, "Item" : "ORZID3 GMENU INFECT DIARRHEA/GASTROENT", "DisplayText" : "Infectious diarrhea/Gastroenteritis (Outpatient)", "Text" : "Infectious diarrhea/Gastroenteritis", "Mnemonic" : "38"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID3 GMENU COM ACQ DIARRHEA/NO TRAVEL", "DisplayText" : "Community acquired diarrhea (no recent travel) - Outpatient", "Text" : "Community acquired diarrhea", "Mnemonic" : "40"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID3 GMENU TRAVELER DIARRHEA", "DisplayText" : "Traveler's diarrhea", "Text" : "Traveler's diarrhea", "Mnemonic" : "42"},
{"Row" : 12, "Column" : 2, "Text" : "Specific-pathogen diarrhea treatment regimens", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU ABX HEPATITIS A", "DisplayText" : "Hepatitis A", "Text" : "Hepatitis A", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX HEPATITIS B", "DisplayText" : "Hepatitis B", "Text" : "Hepatitis B", "Mnemonic" : "16"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX HEPATITIS C", "DisplayText" : "Hepatitis C", "Text" : "Hepatitis C", "Mnemonic" : "18"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 GMENU DIVERTICULITIS", "DisplayText" : "Diverticulitis (Outpatient)", "Text" : "Diverticulitis", "Mnemonic" : "22"},
{"Row" : 21, "Column" : 1, "Text" : "Clostridium difficile disease", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID3 GMENU H. PYLORI INFECT", "DisplayText" : "Helicobacter pylori infection (Outpatient)", "Text" : "Helicobacter pylori infection", "Mnemonic" : "30"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID3 GMENU ACUTE SPON BACT PERITONITIS", "DisplayText" : "Spontaneous Bacterial Peritonitis (Outpatient)", "Text" : "Acute Spontaneous Bacterial Peritonitis (SBP)", "Mnemonic" : "32"},
{"Row" : 28, "Column" : 1, "Text" : "Peritonitis", "Header" : 1}, 
{"Row" : 13, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA AEROMONAS", "DisplayText" : "Diarrhea with Aeromonas (Outpatient)", "Text" : "Aeromonas", "Mnemonic" : "44"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA CAMPYLOBACTER", "DisplayText" : "Diarrhea with Campylobacter (Outpatient)", "Text" : "Campylobacter", "Mnemonic" : "46"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA C. PARVUM", "DisplayText" : "Diarrhea with Crytosporidium parvum (Outpatient)", "Text" : "Cryptospodium parvum", "Mnemonic" : "48"},
{"Row" : 16, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA C. CAYETANENSIS", "DisplayText" : "Diarrhea with Cyclospora cayetanensis (Outpatient)", "Text" : "Cyclospora cayetanensis", "Mnemonic" : "50"},
{"Row" : 17, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA E. HISTOLYTICA", "DisplayText" : "Diarrhea with Entamoeba histolytica (Outpatient)", "Text" : "Entamoeba histolytica", "Mnemonic" : "52"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA ENTEROHEM E. COLI", "DisplayText" : "Diarrhea with enterohemorrhagic E. Coli (Outpatient)", "Text" : "Escherichia coli", "Mnemonic" : "54"},
{"Row" : 19, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA G. LAMBLIA", "DisplayText" : "Diarrhea with Giardia lamblia (Outpatient)", "Text" : "Giardia lamblia", "Mnemonic" : "56"},
{"Row" : 20, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA ISOSPORA BELLI", "DisplayText" : "Diarrhea with Isospora belli (Outpatient)", "Text" : "Isospora belli", "Mnemonic" : "58"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA MICROSPORIDIA", "DisplayText" : "Diarrhea with Microsporidia (Outpatient)", "Text" : "Microsporidia", "Mnemonic" : "60"},
{"Row" : 22, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA SALMONELLA", "DisplayText" : "Diarrhea with Salmonella (Outpatient)", "Text" : "Salmonella", "Mnemonic" : "62"},
{"Row" : 23, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA SHIGELLA", "DisplayText" : "Diarrhea with Shigella (Outpatient)", "Text" : "Shigella (bacillary dysentery)", "Mnemonic" : "64"},
{"Row" : 24, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA VIBRIO CHOLERA", "DisplayText" : "Diarrhea with Vibrio cholera (Outpatient)", "Text" : "Vibrio cholera", "Mnemonic" : "66"},
{"Row" : 25, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA VIBRIO NON CHOLERA", "DisplayText" : "Diarrhea with non-cholera vibrio (Outpatient)", "Text" : "Vibrio non-cholerae", "Mnemonic" : "68"},
{"Row" : 26, "Column" : 2, "Item" : "ORZID3 GMENU DIARRHEA Y. ENTEROCOLITICA", "DisplayText" : "Diarrhea with Yersinia enterocolitica (Outpatient)", "Text" : "Yersinia enterocolitica", "Mnemonic" : "70"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID3 GMENU PANCREATITIS", "DisplayText" : "Pancreatitis (Outpatient)", "Text" : "Pancreatitis", "Mnemonic" : "20"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID3 GMENU SECONDARY PERITONITIS", "DisplayText" : "Secondary peritonitis (Outpatient)", "Text" : "Secondary peritonitis", "Mnemonic" : "34"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 GMENU CHOLECYSTITIS", "DisplayText" : "Cholecystitis (Outpatient)", "Text" : "Cholecystitis", "Mnemonic" : "12"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU CHOLANGITIS", "DisplayText" : "Cholangitis (Outpatient)", "Text" : "Cholangitis", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID3 GMENU SURG ERCP", "DisplayText" : "Endoscopic Retrograde Cholangiopancreatography (ERCP) - Outpatient", "Text" : "ERCP Prophylaxis", "Mnemonic" : "24"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID3 GMENU ILEUS/TOXI MEGACOLON", "DisplayText" : "Severe C. Difficile disease - Ileus/Toxic megacolon (Outpatient)", "Text" : "Cases WITH ileus or toxic megacolon", "Mnemonic" : "28"},
{"Row" : 8, "Column" : 1, "Text" : "Appendicitis", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Item" : "ORZID3 GMENU APPENDICITIS W/O PERFORATION", "DisplayText" : "Appendicitis without perforation (Outpatient)", "Text" : "Appendicitis without perforation", "Mnemonic" : "06"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 GMENU APPENDICITIS W/ PERFORATION", "DisplayText" : "Appendicitis with perforation (Outpatient)", "Text" : "Appendicitis with perforation", "Mnemonic" : "08"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID3 GMENU TYPHLITIS", "DisplayText" : "Neutropenic enterocolitis (Typhlitis) - Outpatient", "Text" : "Neutropenic enterocolitis (Typhlitis)", "Mnemonic" : "29"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID3 GMENU C. DIFFICILE COLITIS", "DisplayText" : "Antibiotic associated colitis (C. difficile colitis) - Outpatient", "Text" : "Cases WITHOUT ileus or toxic megacolon"}
]},
{"Name" : "ORZID3 GMENU GENITAL HERPES", "DisplayText" : "Genital herpes (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Dermatology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GENITAL HERPES"}, 
{"Row" : 12, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Initial treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment of the initial episode decreases the duration of pain, lesions, and"}, 
{"Row" : 18, "Column" : 1, "Text" : "viral shedding by 1 to 2 days.  Treatment of the initial episode does not"}, 
{"Row" : 19, "Column" : 1, "Text" : "decrease likelihood of recurrent episodes."}, 
{"Row" : 21, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 10DS 400MG PO TID", "DisplayText" : "Acyclovir 400mg po tid for 10 days", "Text" : "Acyclovir 400 mg PO TID ($0.29/day) [R]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 10DS 1GM PO BID", "DisplayText" : "Valacyclovir 1gm po bid for 10 days", "Text" : "Valacyclovir 1 gm PO BID ($9/day) [R]", "Mnemonic" : "14"},
{"Row" : 28, "Column" : 1, "Text" : "Episodic therapy for relapses", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Treatment of recurrent episodes must be started within 24 hours of symptom"}, 
{"Row" : 30, "Column" : 1, "Text" : "onset.  Treatment decreases the duration of pain and lesions, and viral shedding"}, 
{"Row" : 31, "Column" : 1, "Text" : "by 1 to 2 days.  Consider suppressive treatment for patients with more than 6"}, 
{"Row" : 32, "Column" : 1, "Text" : "episodes per year."}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 5DS 400MG PO TID", "DisplayText" : "Acyclovir 400mg po tid for 5 days", "Text" : "Acyclovir 400 mg PO TID for 5 days ($0.29/day) [R]  < OR >", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 2DS 800MG PO TID", "DisplayText" : "Acyclovir 800mg po tid for 2 days", "Text" : "Acyclovir 800 mg PO TID for 2 days ($0.58/day) [R]  < OR >", "Mnemonic" : "18"},
{"Row" : 36, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 3DS 500MG PO BID", "DisplayText" : "Valacyclovir 500mg po bid for 3 days", "Text" : "Valacyclovir 500 mg PO BID for 3 days ($4/day) [R]", "Mnemonic" : "20"},
{"Row" : 38, "Column" : 1, "Text" : "Chronic therapy for suppression of symptomatic episodes", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Suppressive therapy is indicated in patients with more than 6 episodes per year."}, 
{"Row" : 40, "Column" : 1, "Text" : "Suppressive therapy is optional, and some patients may find episodic treatment"}, 
{"Row" : 41, "Column" : 1, "Text" : "more convenient.  The frequency of recurrences usually decreases after 1 to 5"}, 
{"Row" : 42, "Column" : 1, "Text" : "years, and suppressive therapy should be stopped every few years to see if it is"}, 
{"Row" : 43, "Column" : 1, "Text" : "still needed."}, 
{"Row" : 45, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 1YR 400MG PO BID", "DisplayText" : "Acyclovir 400mg po bid for 1 year", "Text" : "Acyclovir 400 mg PO BID ($0.19/day) [R]", "Mnemonic" : "22"},
{"Row" : 47, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 1YR 500MG PO QDAY", "DisplayText" : "Valacyclovir 500mg po qday for 1 year", "Text" : "Valacyclovir 500 mg PO qday ($2/day) [R]", "Mnemonic" : "24"},
{"Row" : 50, "Column" : 1, "Text" : "For a patient with more than 9 episodes per year", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 1YR 1000MG PO QDAY", "DisplayText" : "Valacyclovir 1000mg po qday for 1 year", "Text" : "Valacyclovir 1000 mg PO qday ($4/day) [R]", "Mnemonic" : "26"},
{"Row" : 53, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "Immunocompromised patients in whom genital herpes simplex disease is often"}, 
{"Row" : 58, "Column" : 1, "Text" : "severe include: patients with HIV infection, organ transplants, malnourishment,"}, 
{"Row" : 59, "Column" : 1, "Text" : "eczema or severe burns, and in patients receiving immunosuppressive"}, 
{"Row" : 60, "Column" : 1, "Text" : "chemotherapy."}, 
{"Row" : 62, "Column" : 1, "Text" : "Treatment for MILD to MODERATE disease", "Header" : 1}, 
{"Row" : 63, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 64, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 10DS 400MG PO TID", "DisplayText" : "Acyclovir 400mg po tid for 10 days", "Text" : "Acyclovir 400 mg PO TID ($0.29/day) [R]", "Mnemonic" : "28"},
{"Row" : 66, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 67, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 10DS 1GM PO BID", "DisplayText" : "Valacyclovir 1gm po bid for 10 days", "Text" : "Valacyclovir 1 gm PO BID ($9/day) [R]", "Mnemonic" : "30"},
{"Row" : 69, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 70, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 73, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "32"},
{"Row" : 75, "Column" : 1, "Text" : "\"Mandell\" chapter: Herpes simplex virus"}, 
{"Row" : 76, "Column" : 1, "Text" : "\"Sanford\" keyword: Herpes simplex"}
]},
{"Name" : "ORZID3 GMENU GONOCOCCAL URETHRITIS", "DisplayText" : "Gonococcal urethritis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "GONOCOCCAL URETHRITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 125MG IM ONCE", "DisplayText" : "Ceftriaxone 125MG IM ONCE", "Text" : "Ceftriaxone 125 mg IM ONCE ($16/day)", "Mnemonic" : "14"},
{"Row" : 16, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO ONCE", "DisplayText" : "Ciprofloxacin 500MG PO ONCE", "Text" : "Ciprofloxacin 500 mg PO ONCE ($0.18/day)", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Text" : "Note:  N. gonorrhea is increasingly resistant to quinolones, especially in"}, 
{"Row" : 20, "Column" : 1, "Text" : "California and Hawaii.  Ceftriaxone is the preferred treatment for infections"}, 
{"Row" : 21, "Column" : 1, "Text" : "acquired in these areas."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 26, "Column" : 1, "Text" : "CDC MMWR 2002, 51: RR-06"}, 
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" keyword: Gonorrhea"}
]},
{"Name" : "ORZID3 GMENU GRAM NEGATIVE BACTERIA", "DisplayText" : "Gram negative bacteria (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  GRAM-NEGATIVE BACTERIA - OUTPATIENT ++", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Always consider disease or syndrome, site of infection, penetration of drug(s)"}, 
{"Row" : 9, "Column" : 1, "Text" : "into site, and whether organism is pathogen, colonizer, or contaminant.  See"}, 
{"Row" : 10, "Column" : 1, "Text" : "disease/syndrome section for more information."}, 
{"Row" : 12, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Interim culture results", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 GMENU INT RS GRAM-NEG BACILLI", "DisplayText" : "Interim results:  Gram-negative bacilli (Outpatient)", "Text" : "Gram-negative bacilli", "Mnemonic" : "06"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID3 GMENU INT RS GRAM-NEG COCCI", "DisplayText" : "Iterim report of Gram-negative cocci (Outpatient)", "Text" : "Gram-negative cocci", "Mnemonic" : "08"},
{"Row" : 19, "Column" : 1, "Text" : "________________________________________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "________________________________________________________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Final culture results", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : ">>  Gram-negative bacilli  <<", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Enterobacteriaceae", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG A. BAUMANNI", "DisplayText" : "Acinetobacter baumanni (Outpatient)", "Text" : "Acinetobacter baumanni", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG CITROBACTER SPP.", "DisplayText" : "Citrobacter spp. (Outpatient)", "Text" : "Citrobacter spp.", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG ENTEROBACTER SPP.", "DisplayText" : "Enterobacter spp. (Outpatient)", "Text" : "Enterobacter spp.", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG E. COLI", "DisplayText" : "Escherichia coli (Outpatient)", "Text" : "Escherichia coli", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG KLEBSIELLA SPP.", "DisplayText" : "Klebsiella spp. (Outpatient)", "Text" : "Klebsiella spp.", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG PROTEUS SPP.", "DisplayText" : "Proteus spp. (Outpatient)", "Text" : "Proteus spp.", "Mnemonic" : "20"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG SERRATIA SPP.", "DisplayText" : "Serratia spp. (Outpatient)", "Text" : "Serratia spp.", "Mnemonic" : "22"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG BORDETELLA SPP.", "DisplayText" : "Bordetella spp. (Outpatient)", "Text" : "Bordetella spp.", "Mnemonic" : "24"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG BRUCELLA SPP.", "DisplayText" : "Brucella spp.", "Text" : "Brucella spp.", "Mnemonic" : "26"},
{"Row" : 36, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG CAMPYLOBACTER SPP.", "DisplayText" : "Campylobacter spp. (Outpatient)", "Text" : "Campylobacter spp.", "Mnemonic" : "28"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG HAEMOPHILUS SPP.", "DisplayText" : "Haemophilus spp. (Outpatient)", "Text" : "Haemophilus spp.", "Mnemonic" : "30"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID3 GMENU H. PYLORI INFECT", "DisplayText" : "Helicobacter pylori infection (Outpatient)", "Text" : "Helicobacter pylori", "Mnemonic" : "32"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG LEGIONELLA SPP.", "DisplayText" : "Legionella spp. (Outpatient)", "Text" : "Legionella spp.", "Mnemonic" : "34"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG P. MULTOCIDA", "DisplayText" : "Pasteurella multocida (Outpatient)", "Text" : "Pasteurella multocida", "Mnemonic" : "36"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG PSEUDOMONAS SPP.", "DisplayText" : "Pseudomonas spp. (Outpatient)", "Text" : "Pseudomonas spp.", "Mnemonic" : "38"},
{"Row" : 42, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG SALMONELLA SPP.", "DisplayText" : "Salmonella spp. (Outpatient)", "Text" : "Salmonella spp.", "Mnemonic" : "40"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG SHIGELLA SPP.", "DisplayText" : "Shigella spp. (Outpatient)", "Text" : "Shigella spp.", "Mnemonic" : "42"},
{"Row" : 45, "Column" : 1, "Text" : ">>  Gram-negative cocci  <<", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG N. MENINGITIDIS", "DisplayText" : "Neisseria meningitidis (Outpatient)", "Text" : "Neisseria meningitidis", "Mnemonic" : "44"},
{"Row" : 47, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG N. GONORRHOEAE", "DisplayText" : "Neisseria gonorrhoeae (Outpatient)", "Text" : "Neisseria gonorrhoeae", "Mnemonic" : "46"},
{"Row" : 48, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG M. CATARRHALIS", "DisplayText" : "Moraxella catarrhalis (Outpatient)", "Text" : "Moraxella catarrhalis", "Mnemonic" : "48"},
{"Row" : 50, "Column" : 1, "Item" : "ORZID3 GMENU GRAM-NEG BACTEROIDES SPP.", "DisplayText" : "Bacteroides spp. (Outpatient)", "Text" : "Bacteroides spp. (including Prevotella, Porphyromonas)", "Mnemonic" : "50"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG A. BAUMANNI", "DisplayText" : "Acinetobacter baumanni (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ACINETOBACTER BAUMANNII"}, 
{"Row" : 11, "Column" : 1, "Text" : "Isolation of Acinetobacter baumannii from a culture often represents"}, 
{"Row" : 12, "Column" : 1, "Text" : "contamination or colonization and not disease.  For questions about whether a"}, 
{"Row" : 13, "Column" : 1, "Text" : "patient should be treated, contact Infectious Diseases."}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 18, "Column" : 1, "Text" : "Many isolates are resistant to multiple antimicrobials.  If susceptibilities are"}, 
{"Row" : 19, "Column" : 1, "Text" : "not known, start therapy with imipenem or amikacin.  If the isolate is"}, 
{"Row" : 20, "Column" : 1, "Text" : "susceptible,Consult Infectious Diseases for more information."}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 31, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG BACTEROIDES SPP.", "DisplayText" : "Bacteroides spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BACTEROIDES SPP. (INCLUDING PREVOTELLA, PORPHYROMONAS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "These bacteria are strict anaerobes and will only grow in anaerobic media."}, 
{"Row" : 13, "Column" : 1, "Text" : "Clindamycin should not be used empirically unless the patient cannot take other"}, 
{"Row" : 14, "Column" : 1, "Text" : "recommended drugs, as many Bacteroides spp. are resistant to clindamycin."}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 18, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 21, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID METRONIDAZOLE 500MG PO QID", "DisplayText" : "Metronidazole 500mg po qid", "Text" : "Metronidazole 500 mg PO QID ($0.64/day) [DI]", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125mg PO BID ($1.56/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 26, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG BORDETELLA SPP.", "DisplayText" : "Bordetella spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BORDETELLA SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID ERYTHROMYCIN 500MG PO TID", "DisplayText" : "Erythromycin 500mg po tid", "Text" : "Erythromycin 500 mg PO TID for 14 days ($0.28/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) [M] on day 1, then 250 mg PO qday ($4/day)", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "[M]  for 4 days"}, 
{"Row" : 16, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO BID  for 14 days ($0.18/day)", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "[R,DI] < OR >"}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG BRUCELLA SPP.", "DisplayText" : "Brucella spp.", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BRUCELLA SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat for 45 days.  Treat with doxycycline and streptomycin for the first 14-21"}, 
{"Row" : 14, "Column" : 1, "Text" : "days, then finish the course with doxycycline alone."}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX OP DOXYC 100MG PO BID STREPTO 1GM IM Q24H", "DisplayText" : "", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI] <AND> streptomycin 1 g IM q24h", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Treat with both drugs for 45 days."}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ SET ABX OP DOXY 100MG PO BID RIFAMP 600MG PO QD", "DisplayText" : "", "Text" : "Doxycycline 100 mg PO BID  ($0.16/day) [DI] <AND> rifampin 600 mg PO QD", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "($2.56/day)  [DI,O]"}, 
{"Row" : 17, "Column" : 1, "Text" : "($3/day)  [R,O]"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG CAMPYLOBACTER SPP.", "DisplayText" : "Campylobacter spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CAMPYLOBACTER SPECIES"}, 
{"Row" : 15, "Column" : 1, "Text" : "For information on gastroenteritis (usually involving C. jejuni), refer to the"}, 
{"Row" : 16, "Column" : 1, "Text" : "Gastrointestinal and Intraabdominal infection section."}, 
{"Row" : 18, "Column" : 1, "Text" : "For extraintestinal infections, including central nervous system infections,"}, 
{"Row" : 19, "Column" : 1, "Text" : "intravenous treatment is necessary."}, 
{"Row" : 21, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 26, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 27, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG CITROBACTER SPP.", "DisplayText" : "Citrobacter spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CITROBACTER SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 28, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 29, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG E. COLI", "DisplayText" : "Escherichia coli (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ESCHERICHIA COLI"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For gastroenteritis, please refer to the Gastrointestinal and Intra-abdominal"}, 
{"Row" : 17, "Column" : 1, "Text" : "infections section."}, 
{"Row" : 19, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "MILD TO MODERATE infections including cystitis", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 26, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "SEVERE infections", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 35, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 36, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG ENTEROBACTER SPP.", "DisplayText" : "Enterobacter spp. (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ENTEROBACTER SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 18, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "MILD TO MODERATE infections", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "SEVERE infections", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 35, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG HAEMOPHILUS SPP.", "DisplayText" : "Haemophilus spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "HAEMOPHILUS SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID  ($1.56/day) [R]", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG KLEBSIELLA SPP.", "DisplayText" : "Klebsiella spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "KLEBSIELLA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "MILD TO MODERATE infections including cystitis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID  ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet BID  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "MODERATE TO SEVERE infections", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 33, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG LEGIONELLA SPP.", "DisplayText" : "Legionella spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "LEGIONELLA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG PO Q24H", "Text" : "Azithromycin 500 mg PO QDAY ($8/day) [M] for 10 days < OR >", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "Levofloxacin 500 mg PO qday ($0.19/day) [R,DI] for 21 days", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG M. CATARRHALIS", "DisplayText" : "Moraxella catarrhalis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 9, "Column" : 1, "Text" : "MORAXELLA CATARRHALIS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID  ($1.56/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO qday ($4/day) [M]", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "for 4 days"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG N. GONORRHOEAE", "DisplayText" : "Neisseria gonorrhoeae (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "NEISSERIA GONORRHOEAE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 23, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG N. MENINGITIDIS", "DisplayText" : "Neisseria meningitidis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "NEISSERIA MENINGITIDIS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Central nervous system infections require higher doses of antimicrobials."}, 
{"Row" : 12, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 13, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 15, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment for infections outside of the central nervous system", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment for central nervous system infections", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 29, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 35, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG P. MULTOCIDA", "DisplayText" : "Pasteurella multocida (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "PASTEURELLA MULTOCIDA"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 7 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO BID", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID  ($1.56/day) [R]", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO BID  ($0.16/day) [DI]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG PROTEUS SPP.", "DisplayText" : "Proteus spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "PROTEUS SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "MILD TO MODERATE infections including cystitis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 27, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG PSEUDOMONAS SPP.", "DisplayText" : "Pseudomonas spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "PSEUDOMONAS SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "In some severe cases, addition of an aminoglycoside or ciprofloxacin to a beta-"}, 
{"Row" : 17, "Column" : 1, "Text" : "lactam may be beneficial.  Consult Infectious Diseases for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 750MG PO BID", "DisplayText" : "Ciprofloxacin 750MG PO BID", "Text" : "Ciprofloxacin 750 mg PO BID ($0.27/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG SALMONELLA SPP.", "DisplayText" : "Salmonella spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SALMONELLA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 15, "Column" : 1, "Text" : "For gastroenteritis antimicrobials are not usually indicated.  Please refer to"}, 
{"Row" : 16, "Column" : 1, "Text" : "the Gastrointestinal and Intra-abdominal infections section for more"}, 
{"Row" : 17, "Column" : 1, "Text" : "information."}, 
{"Row" : 19, "Column" : 1, "Text" : "For localized or systemic extraintestinal infections", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 500 MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 33, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG SERRATIA SPP.", "DisplayText" : "Serratia spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SERRATIA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 18, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 25, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-NEG SHIGELLA SPP.", "DisplayText" : "Shigella spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SHIGELLA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information.  Drugs recommended below are"}, 
{"Row" : 13, "Column" : 1, "Text" : "best for most cases.  If susceptibility results or other factors make these"}, 
{"Row" : 14, "Column" : 1, "Text" : "inappropriate for this case, click \"need an alternative antimicrobial.\""}, 
{"Row" : 16, "Column" : 1, "Text" : "For gastroenteritis, please refer to the Gastrointestinal and Intra-abdominal"}, 
{"Row" : 17, "Column" : 1, "Text" : "infections section for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 21, "Column" : 1, "Text" : "Preferred treatment for systemic infections", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID", "DisplayText" : "Ciprofloxacin 500MG PO BID", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}, 
{"Row" : 24, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO qday ($4/day) [M]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "for 4 days"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS ACTINOMYCES SPP.", "DisplayText" : "Actinomyces spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "ACTINOMYCES SPP."}, 
{"Row" : 8, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 9, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID PENICILLIN 500MG PO QID", "DisplayText" : "Penicillin 500mg po qid", "Text" : "Penicillin 500mg PO QID ($1.22/day) [R] < OR >", "Mnemonic" : "06"},
{"Row" : 15, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 500 MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid", "Text" : "Amoxicillin 500mg PO TID ($0.42/day) [R]", "Mnemonic" : "08"},
{"Row" : 17, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100mg PO BID ($0.16/day) [DI]", "Mnemonic" : "10"},
{"Row" : 23, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 24, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS ANAEROBIC GPC", "DisplayText" : "Anaerobic Gram-positive cocci (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ANAEROBIC GRAM-POSITIVE COCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "Anaerobic Gram-positive cocci, including peptostreptococci, are often involved"}, 
{"Row" : 12, "Column" : 1, "Text" : "in mixed aerobic/anaerobic infections.  Beta-lactams (like ampicillin and"}, 
{"Row" : 13, "Column" : 1, "Text" : "penicillin) and clindamycin are the drugs of choice against anaerobic gram-"}, 
{"Row" : 14, "Column" : 1, "Text" : "positive cocci.  Beta-lactam/beta-lactamase inhibitors are active against"}, 
{"Row" : 15, "Column" : 1, "Text" : "peptostreptococci, so no additional \"anaerobic\" antimicrobials are needed"}, 
{"Row" : 16, "Column" : 1, "Text" : "specifically to cover peptostreptococcus when drugs such as ampicillin-"}, 
{"Row" : 17, "Column" : 1, "Text" : "sulbactam, ticarcillin-clavulanate, or piperacillin-tazobactam are used."}, 
{"Row" : 19, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 20, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 22, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 24, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 500 MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R]", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "12"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS BACILLI SPP.", "DisplayText" : "Bacilli species (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BACILLUS SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "B. cereus", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "disease/syndrome sections for more information."}, 
{"Row" : 18, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "_____________________________________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "B. anthracis", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 27, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 33, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS CLOSTRIDIUM SPP.", "DisplayText" : "Clostridium spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CLOSTRIDIUM SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "For Clostridium difficile disease refer to"}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU C. DIFFICILE COLITIS", "DisplayText" : "Antibiotic associated colitis (C. difficile colitis) - Outpatient", "Text" : "Clostridium difficile disease", "Mnemonic" : "10"},
{"Row" : 26, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 500 MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R]", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO BID  ($0.16/day) [DI]", "Mnemonic" : "14"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 14, "Column" : 1, "Text" : "Mild-moderate infections may be treated with oral antimicrobials.  For"}, 
{"Row" : 15, "Column" : 1, "Text" : "neutropenic enterocolitis, gas gangrene, or other necrotizing infection,"}, 
{"Row" : 16, "Column" : 1, "Text" : "intravenous therapy is indicated.  Combination therapy may be preferred.  Refer"}, 
{"Row" : 17, "Column" : 1, "Text" : "to the appropriate section of the CDSS or contact Infectious Diseases for more"}, 
{"Row" : 18, "Column" : 1, "Text" : "information."}, 
{"Row" : 20, "Column" : 1, "Text" : "C. perfringens food poisoning is treated with supportive care, diarrhea resolves"}, 
{"Row" : 21, "Column" : 1, "Text" : "within 24 hours."}, 
{"Row" : 23, "Column" : 1, "Text" : "For severe infection with any other Clostridium spp. call Infectious Diseases."}, 
{"Row" : 25, "Column" : 1, "Text" : "Preferred empirical treatment for MILD to MODERATE infections", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Preferred empirical therapy for SEVERE infections", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Intravenous therapy is indicated.  Please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 38, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS CORYNEBACTERIUM SPP.", "DisplayText" : "Corynebacterium spp. (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "CORYNEBACTERIUM SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "_______________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "_______________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Corynebacterium jeikeium", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "disease/syndrome sections for more information."}, 
{"Row" : 18, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 19, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 21, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Corynebacterium diphtheriae", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Diphtheria is usually severe and often fatal.  Antitoxin is the most important"}, 
{"Row" : 26, "Column" : 1, "Text" : "treatment.  Contact Infectious Diseases immediately."}, 
{"Row" : 28, "Column" : 1, "Text" : "If treatment is necessary, intravenous antimicrobials are indicated.  Refer to"}, 
{"Row" : 29, "Column" : 1, "Text" : "Inpatient Antimicrobial CDSS."}, 
{"Row" : 31, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSOZID ERYTHROMYCIN 500MG PO TID", "DisplayText" : "Erythromycin 500mg po tid", "Text" : "Erythromycin 500 mg PO TID ($0.28/day) [DI]", "Mnemonic" : "10"},
{"Row" : 34, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "12"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 40, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 41, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS GROUPS C, F, G", "DisplayText" : "Streptococci Groups C, F, G (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "STREPTOCOCCI GROUPS C, F, G"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "___________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "___________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "MILD TO MODERATE infections", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 500 MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID PENICILLIN 500MG PO QID", "DisplayText" : "Penicillin 500mg po qid", "Text" : "Pencillin V 500mg PO QID ($1.22/day) [R]", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O] < OR >", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID ERYTHROMYCIN 500MG PO TID", "DisplayText" : "Erythromycin 500mg po tid", "Text" : "Erythromycin 500 mg PO TID ($0.28/day) [DI] < OR >", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]", "Mnemonic" : "18"},
{"Row" : 27, "Column" : 1, "Text" : "___________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "___________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "SEVERE infections", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 31, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 37, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS LISTERIA SPP.", "DisplayText" : "Listeria spp. (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "LISTERIA SPP."}, 
{"Row" : 8, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 9, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 10, "Column" : 1, "Text" : "For meningitis, please refer to the meningitis section for treatment advice."}, 
{"Row" : 12, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 13, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 19, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS PROPIONIBACT SPP.", "DisplayText" : "Propionibacterium species (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "PROPIONIBACTERIUM SPECIES"}, 
{"Row" : 8, "Column" : 1, "Text" : "Isolation of Propionibacterium species from a culture often represents"}, 
{"Row" : 9, "Column" : 1, "Text" : "contamination or colonization and not disease.  For questions about whether a"}, 
{"Row" : 10, "Column" : 1, "Text" : "patient should be treated, contact Infectious Diseases."}, 
{"Row" : 12, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 13, "Column" : 1, "Text" : "disease/syndrome sections for more information."}, 
{"Row" : 15, "Column" : 1, "Text" : "If treatment is necessary, intravenous antimicrobials are indicated.  Refer to"}, 
{"Row" : 16, "Column" : 1, "Text" : "Inpatient Antimicrobial CDSS."}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 22, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS S. AGALACTIAE", "DisplayText" : "Group B (S. agalactiae) - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "GROUP B STREPTOCOCCI (S. AGALACTIAE)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Group B streptococci (Streptococcus agalactiae) are associated most commonly"}, 
{"Row" : 12, "Column" : 1, "Text" : "with bacteremia and meningitis in infants and bacteremia and urinary tract"}, 
{"Row" : 13, "Column" : 1, "Text" : "infections in elderly people and people with diabetes mellitus."}, 
{"Row" : 15, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 18, "Column" : 1, "Text" : "____________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "____________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "MILD TO MODERATE infections", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 500 MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID PENICILLIN 500MG PO QID", "DisplayText" : "Penicillin 500mg po qid", "Text" : "Pencillin V 500mg PO QID ($1.22/day) [R]", "Mnemonic" : "12"},
{"Row" : 26, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O] < OR >", "Mnemonic" : "14"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID ERYTHROMYCIN 500MG PO TID", "DisplayText" : "Erythromycin 500mg po tid", "Text" : "Erythromycin 500 mg PO TID ($0.28/day) [DI] < OR >", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "____________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "____________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "SEVERE infections", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 35, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 40, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 41, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS S. ANGINOSUS", "DisplayText" : "Streptococcus anginosus (formerly S. milleri) - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "STREPTOCOCCUS ANGINOSUS (FORMERLY S. MILLERI)"}, 
{"Row" : 8, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 9, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 11, "Column" : 1, "Text" : "Ceftriaxone or penicillin are preferred for central nervous system infection."}, 
{"Row" : 12, "Column" : 1, "Text" : "Cefazolin or penicillin are preferred for infection outside of the central"}, 
{"Row" : 13, "Column" : 1, "Text" : "nervous system."}, 
{"Row" : 15, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 16, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 22, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS S. BOVIS", "DisplayText" : "Group D Streptococci (S. bovis) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "GROUP D STREPTOCOCCI (S. BOVIS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "Bacteremia with Streptococcus bovis is associated with malignancy of the colon."}, 
{"Row" : 16, "Column" : 1, "Text" : "Resistance to penicillin is uncommon.  Vancomycin should only be used in a"}, 
{"Row" : 17, "Column" : 1, "Text" : "patient with beta-lactam allergy, or if beta-lactam resistance is strongly"}, 
{"Row" : 18, "Column" : 1, "Text" : "suspected."}, 
{"Row" : 20, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 21, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 26, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 27, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS S. PNEUMONIAE", "DisplayText" : "Streptococcus pneumoniae (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "STREPTOCOCCUS PNEUMONIAE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "Levofloxacin should be used in patients with beta-lactam allergy or if beta-"}, 
{"Row" : 15, "Column" : 1, "Text" : "lactam resistance is suspected.  Vancomycin should be used only as a last-line"}, 
{"Row" : 16, "Column" : 1, "Text" : "alternative if resistance to beta-lactams and fluoroquinolones is suspected or"}, 
{"Row" : 17, "Column" : 1, "Text" : "proved."}, 
{"Row" : 19, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 21, "Column" : 1, "Text" : "Preferred treatment for infections outside of the central nervous system", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID PENICILLIN 500MG PO QID", "DisplayText" : "Penicillin 500mg po qid", "Text" : "Penicillin 500 mg PO QID ($1.20/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 1000MG PO TID", "DisplayText" : "Amoxicillin 1000mg po tid", "Text" : "Amoxicillin 1000 mg PO TID ($0.42/day) [R]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative for patient with beta-lactam allergy, or when beta-lactam resistance", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "is suspected or proved", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "Preferred treatment for central nervous system infections", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 33, "Column" : 1, "Text" : "Alternative for patient with beta-lactam allergy, or when beta-lactam resistance", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "is suspected or proved", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "", "Mnemonic" : "16"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 41, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 42, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS S. PYOGENES", "DisplayText" : "Group A (S. pyogenes) - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "GROUP A STREPTOCOCCI (S. PYOGENES)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Group A streptococcus (Streptococcus pyogenes) is the most virulent"}, 
{"Row" : 12, "Column" : 1, "Text" : "streptococcal species.  Important syndromes include pharyngitis, cellulitis,"}, 
{"Row" : 13, "Column" : 1, "Text" : "streptococcal toxic shock syndrome, necrotizing fasciitis, and erysipelas,"}, 
{"Row" : 14, "Column" : 1, "Text" : "rheumatic fever, and post-streptococcal glomerulonephritis.  Optimal therapy"}, 
{"Row" : 15, "Column" : 1, "Text" : "depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 16, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 18, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "MILD TO MODERATE infections", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID AMOXICILLIN 500 MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID PENICILLIN 500MG PO QID", "DisplayText" : "Penicillin 500mg po qid", "Text" : "Pencillin V 500mg PO QID ($1.22/day) [R]", "Mnemonic" : "12"},
{"Row" : 26, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O] < OR >", "Mnemonic" : "14"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID ERYTHROMYCIN 500MG PO TID", "DisplayText" : "Erythromycin 500mg po tid", "Text" : "Erythromycin 500 mg PO TID ($0.28/day) [DI] < OR >", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "__________________________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "SEVERE or NECROTIZING infections (non-necrotizing)", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 40, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 41, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS TREAT S. AUREUS", "DisplayText" : "Treatment for Staphylococcus aureus (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "TREATMENT FOR STAPHYLOCOCCUS AUREUS"}, 
{"Row" : 11, "Column" : 1, "Text" : "For serious infections like bacteremia or pneumonia, intravenous antimicrobials"}, 
{"Row" : 12, "Column" : 1, "Text" : "are indicated initially.  Please refer to the Inpatient Antimicrobial CDSS."}, 
{"Row" : 14, "Column" : 1, "Text" : "If susceptibility results are known, use them to select one of the following"}, 
{"Row" : 15, "Column" : 1, "Text" : "drugs."}, 
{"Row" : 17, "Column" : 1, "Text" : "If not, use vancomycin empirically until final culture and susceptibilities are"}, 
{"Row" : 18, "Column" : 1, "Text" : "available."}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID DICLOXACILLIN 500MG PO QID 7 DAYS", "DisplayText" : "Dicloxacillin 500MG PO QID", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "Alternative for resistant organisms", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID MINOCYCLINE 100MG PO BID", "DisplayText" : "Minocycline 100MG PO BID", "Text" : "Minocycline 100 mg PO BID ($1.06/day) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "18"},
{"Row" : 29, "Column" : 1, "Text" : "Alternative for patients unable to take any of the above drugs", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Linezolid has many drug interactions and adverse effects, is expensive, and"}, 
{"Row" : 31, "Column" : 1, "Text" : "promotes bacterial resistance.  It should only be used in cases where other"}, 
{"Row" : 32, "Column" : 1, "Text" : "options are not feasible.  Contact Infectious Diseases for assistance."}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID LINEZOLID 600MG PO BID", "DisplayText" : "Linezolid 600mg po bid", "Text" : "Linezolid 600 mg PO BID ($67/day) [DI,O]", "Mnemonic" : "20"},
{"Row" : 36, "Column" : 1, "Text" : "Synergy - add one of the following to a beta-lactam antibiotic or vancomycin", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Addition of these drugs is rarely needed, and they are potentially toxic."}, 
{"Row" : 38, "Column" : 1, "Text" : "Contact Infectious Diseases for assistance."}, 
{"Row" : 40, "Column" : 1, "Item" : "PSOZID RIFAMPIN 300MG PO BID", "DisplayText" : "Rifampin 300mg po bid", "Text" : "Rifampin 300 mg PO BID ($2.56/day) [DI,O]", "Mnemonic" : "22"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 45, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 46, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU GRAM-POS VIRIDANS STREPTO", "DisplayText" : "Viridans streptococci (including S. mutans, S. mitis, ...) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "VIRIDANS STREPTOCOCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "Viridans streptococci are a heterogeneous group defined by their production of"}, 
{"Row" : 12, "Column" : 1, "Text" : "green pigment on blood agar.  Clinically important members of this group include"}, 
{"Row" : 13, "Column" : 1, "Text" : "S. mutans, S. mitis, and S. sanguis.  S. anginosus (formerly S. milleri) and"}, 
{"Row" : 14, "Column" : 1, "Text" : "Streptococcus bovis are described separately.  Viridans streptococci are"}, 
{"Row" : 15, "Column" : 1, "Text" : "important, common pathogens in endocarditis and can also be contaminants in"}, 
{"Row" : 16, "Column" : 1, "Text" : "cultures of blood and other specimens.  Consult Infectious Diseases for more"}, 
{"Row" : 17, "Column" : 1, "Text" : "information."}, 
{"Row" : 20, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 21, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 23, "Column" : 1, "Text" : "Preferred treatment is penicillin or cefazolin.  Vancomycin should be used only"}, 
{"Row" : 24, "Column" : 1, "Text" : "in patients with beta-lactam allergy, or if beta-lactam resistance is strongly"}, 
{"Row" : 25, "Column" : 1, "Text" : "suspected.  For serious disease, consider addition of gentamicin for synergy."}, 
{"Row" : 26, "Column" : 1, "Text" : "Contact Infectious Diseases for more information."}, 
{"Row" : 28, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated.  Refer to Inpatient Antimicrobial"}, 
{"Row" : 29, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU H. PYLORI INFECT", "DisplayText" : "Helicobacter pylori infection (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 10, "Column" : 1, "Text" : "HELICOBACTER PYLORI INFECTION"}, 
{"Row" : 12, "Column" : 1, "Text" : "H. pylori infection is associated with peptic ulcers, gastritis, gastric"}, 
{"Row" : 13, "Column" : 1, "Text" : "adenocarcinoma, and gastric lymphoma.  Antimicrobials should be given to"}, 
{"Row" : 14, "Column" : 1, "Text" : "patients with confirmed H. pylori infection.Antisecretory therapy is usually"}, 
{"Row" : 15, "Column" : 1, "Text" : "given concurrently.  Contact Gastroenterology for more information."}, 
{"Row" : 17, "Column" : 1, "Text" : "FIRST OCCURRENCE: triple therapy for 14 days", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 OMEPRAZOLE 20MG PO BID 14 DAYS", "DisplayText" : "Omeprazole 20MG PO BID", "Text" :""},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 1GM PO BID 14 DAYS", "DisplayText" : "Amoxicillin 1GM PO BID", "Text" :""},
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 CLARITHROMYCIN 500MG PO BID 14 DAYS", "DisplayText" : "Clarithromycin 500MG PO BID", "Text" : ""},
{"Row" : 22, "Column" : 1, "Text" : "PENICILLIN ALLERGY, FIRST OCCURRENCE: triple therapy for 14 days", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID2 OMEPRAZOLE 20MG PO BID 14 DAYS", "DisplayText" : "Omeprazole 20MG PO BID", "Text" :""},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 METRONIDAZOLE 500MG PO BID 14 DAYS", "DisplayText" : "Metronidazole 500MG PO BID", "Text" : ""},
{"Row" : 25, "Column" : 1, "Item" : "PSOZID2 CLARITHROMYCIN 500MG PO BID 14 DAYS", "DisplayText" : "Clarithromycin 500MG PO BID", "Text" : ""},
{"Row" : 27, "Column" : 1, "Text" : "RE-OCCURRENCE OR RECENT OR REPEAT EXPOSURE TO CLARITHROMYCIN OR", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "METRONIDAZOLE: quadruple therapy for 14 days", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 OMEPRAZOLE 20MG PO BID 14 DAYS", "DisplayText" : "Omeprazole 20MG PO BID", "Text" :""},
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 1GM PO BID 14 DAYS", "DisplayText" : "Amoxicillin 1GM PO BID", "Text" :""},
{"Row" : 30, "Column" : 1, "Item" : "PSOZID2 BISMUTH 524MG PO QID 14 DAYS", "DisplayText" : "Bismuth 524MG PO QID", "Text" : ""},
{"Row" : 32, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 100MG PO BID 14 DAYS", "DisplayText" : "Doxycycline 100MG PO BID", "Text" : ""},
{"Row" : 35, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Crowe S. Treatment regimens for Helicobacter pylori.  Up to Date.  July, 2014"}, 
{"Row" : 38, "Column" : 1, "Text" : "Gastric/Duodenal Ulcer, Helicobacter pylori.  Sanford Guide.  February 6, 2014"}, 
{"Row" : 40, "Column" : 1, "Text" : "Chey W, Wong B.  American College of Gastroenterology Guideline on the"}, 
{"Row" : 41, "Column" : 1, "Text" : "Management of Helicobacter pylori Infection.  American Journal of"}, 
{"Row" : 42, "Column" : 1, "Text" : "Gastroenterology.  2007."}
]},
{"Name" : "ORZID3 GMENU HERPES WHITLOW", "DisplayText" : "Herpes whitlow (Digit or Hand Cellulitis) - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Dermatology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "HERPES WHITLOW (DIGIT OR HAND CELLULITIS)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 10DS 400MG PO TID", "DisplayText" : "Acyclovir 400mg po tid for 10 days", "Text" : "Acyclovir 400 mg PO TID ($0.29/day) [R]", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Text" : "Alternative for easier compliance schedule", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 10DS 1GM PO BID", "DisplayText" : "Valacyclovir 1gm po bid for 10 days", "Text" : "Valacyclovir 1 gm PO BID ($9/day) [R]", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "\"Mandell\" chapter: Herpes simplex virus"}, 
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" keyword: Whitlow, herpetic"}
]},
{"Name" : "ORZID3 GMENU HSV ENCEPHALITIS", "DisplayText" : "HSV encephalitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORWDQ 14BD6E97", "DisplayText" : "Smoker's treat", "Text" : "Consult Gastroenterology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ NEURO OPT", "DisplayText" : "Neurology", "Text" : "Consult Neurology", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "HERPES SIMPLEX VIRUS ENCEPHALITIS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU IG DEFICIENCY HIS", "DisplayText" : "Immunoglobulin deficiency (Humoral immune system) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "IMMUNOGLOBULIN DEFICIENCY (HUMORAL IMMUNE SYSTEM)"}, 
{"Row" : 8, "Column" : 1, "Text" : "Antibody deficiency typically leads to recurrent, severe respiratory tract"}, 
{"Row" : 9, "Column" : 1, "Text" : "infections associated with encapsulated bacteria, especially Streptococcus"}, 
{"Row" : 10, "Column" : 1, "Text" : "pneumoniae and Haemophilus influenzae, and to a lesser extent, Staphylococcus"}, 
{"Row" : 11, "Column" : 1, "Text" : "aureus. Recurrent otitis media, sinusitis, and pneumonia are common syndromes."}, 
{"Row" : 12, "Column" : 1, "Text" : "Gastrointestinal disease associated with Salmonella, Shigella, Campylobacter, or"}, 
{"Row" : 13, "Column" : 1, "Text" : "rotavirus is also common in some patients."}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred empirical treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS"}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 21, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 22, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID3 GMENU ILEUS/TOXI MEGACOLON", "DisplayText" : "Severe C. Difficile disease - Ileus/Toxic megacolon (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 7, "Column" : 1, "Text" : "ANTIBIOTIC ASSOCIATED COLITIS (CLOSTRIDIUM DIFFICILE COLITIS) WITH ILEUS OR"}, 
{"Row" : 8, "Column" : 1, "Text" : "TOXIC MEGACOLON"}
]},
{"Name" : "ORZID3 GMENU IMMUNOCOM COMP DEFICIENCY", "DisplayText" : "Complement Deficiency (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "COMPLEMENT DEFICIENCY"}, 
{"Row" : 8, "Column" : 1, "Text" : "Complement deficiency can be inherited or acquired complement deficiency."}, 
{"Row" : 9, "Column" : 1, "Text" : "Acquired defects are usually a consequence of other diseases like systemic lupus"}, 
{"Row" : 10, "Column" : 1, "Text" : "erythematosus.  Complement deficiency leads to increased rates of infections,"}, 
{"Row" : 11, "Column" : 1, "Text" : "usually of the upper respiratory tract, but also occasionally with bacteremia or"}, 
{"Row" : 12, "Column" : 1, "Text" : "meningitis.  Pathogens are usually Streptococcus pneumoniae, Neisseria"}, 
{"Row" : 13, "Column" : 1, "Text" : "meningitidis, and Neisseria gonorrhea."}, 
{"Row" : 15, "Column" : 1, "Text" : "Patients presenting with fever or other symptoms suggesting systemic bacterial"}, 
{"Row" : 16, "Column" : 1, "Text" : "infection should be treated immediately with antimicrobials active against these"}, 
{"Row" : 17, "Column" : 1, "Text" : "pathogens."}, 
{"Row" : 19, "Column" : 1, "Text" : "Preferred empirical treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 25, "Column" : 1, "Text" : "Rich RR et al, eds.  Clinical Immunology"}, 
{"Row" : 26, "Column" : 1, "Text" : "Roitt I et al, eds.  Immunology"}
]},
{"Name" : "ORZID3 GMENU IMMUNOCOM MALIGNANCY", "DisplayText" : "Malignancy (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ ONCOLOGY OPT CONSULT", "DisplayText" : "ONCOLOGY OPT", "Text" : "Consult Hematology-Oncology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MALIGNANCY"}, 
{"Row" : 9, "Column" : 1, "Text" : "Malignancies affect host defenses in many ways.  Hematogenous malignancies can"}, 
{"Row" : 10, "Column" : 1, "Text" : "diminish the effectiveness of neutrophils and other cells involved in host"}, 
{"Row" : 11, "Column" : 1, "Text" : "defense.  Tumors often disrupt mucous membranes or blood vessels and allow"}, 
{"Row" : 12, "Column" : 1, "Text" : "contaminating organisms into hollow cavities or the bloodstream.  Chemotherapy"}, 
{"Row" : 13, "Column" : 1, "Text" : "used to treat these malignancies often impairs mucus membranes and suppresses"}, 
{"Row" : 14, "Column" : 1, "Text" : "neutrophil production and function."}, 
{"Row" : 16, "Column" : 1, "Text" : "Empirical antimicrobials are not indicated for patients with malignancy and"}, 
{"Row" : 17, "Column" : 1, "Text" : "fever unless they have neutropenia or a specific infectious disease, except in"}, 
{"Row" : 18, "Column" : 1, "Text" : "specific circumstances."}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 GMENU NEUTROPENIC FEVER", "DisplayText" : "Neutropenic fever (Outpatient)", "Text" : "Neutropenic fever", "Mnemonic" : "08"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 27, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID3 GMENU IMMUNOCOM NEUROL DYSFUNCT", "DisplayText" : "Neurologial Dysfunction (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "NEUROLOGICAL DYSFUNCTION"}, 
{"Row" : 8, "Column" : 1, "Text" : "Several types of neurological dysfunction predispose patients to infectious"}, 
{"Row" : 9, "Column" : 1, "Text" : "diseases.  Comatose patients are unable to keep weight off dependent tissues,"}, 
{"Row" : 10, "Column" : 1, "Text" : "predisposing them to decubitus ulcers and pressure necrosis.  Atelectasis is"}, 
{"Row" : 11, "Column" : 1, "Text" : "common in obtunded patients who cannot cough or breathe deeply.  When patients"}, 
{"Row" : 12, "Column" : 1, "Text" : "require artificial ventilation, intubation compounds the risk of respiratory"}, 
{"Row" : 13, "Column" : 1, "Text" : "infection."}, 
{"Row" : 15, "Column" : 1, "Text" : "Neurological dysfunction of the bladder can interfere with normal bladder"}, 
{"Row" : 16, "Column" : 1, "Text" : "emptying and predisposes patients to bacteriuria.  The risk of bacteruria"}, 
{"Row" : 17, "Column" : 1, "Text" : "increases if patients are catheterized.  Antimicrobial treatment is not"}, 
{"Row" : 18, "Column" : 1, "Text" : "indicated for asymptomatic bacteriuria.  It provides no benefit and increases"}, 
{"Row" : 19, "Column" : 1, "Text" : "risk of colonization with resistant organisms."}, 
{"Row" : 21, "Column" : 1, "Text" : "Neurological dysfunction of the gastrointestinal or pulmonary systems"}, 
{"Row" : 22, "Column" : 1, "Text" : "predisposes patients to aspiration of oropharyngeal or gastric contents."}, 
{"Row" : 23, "Column" : 1, "Text" : "Aspiration causes fever, inflammation, and/or pulmonary infiltrate, but does not"}, 
{"Row" : 24, "Column" : 1, "Text" : "require antimicrobial treatment. Bacterial pneumonia occurs in a minority of"}, 
{"Row" : 25, "Column" : 1, "Text" : "patients who experience significant aspiration, typically about 3 days later."}, 
{"Row" : 26, "Column" : 1, "Text" : "The patient usually improves for the first 2 days and then worsens as bacterial"}, 
{"Row" : 27, "Column" : 1, "Text" : "pneumonia develops with increased fever, new or progressive infiltrates,"}, 
{"Row" : 28, "Column" : 1, "Text" : "leukocytosis, and newly purulent sputum."}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID3 GMENU ASPIRATION PNEUMONIA", "DisplayText" : "Aspiration pneumonia (Outpatient)", "Text" : "Aspiration pneumonia", "Mnemonic" : "06"},
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 35, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 36, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID3 GMENU IMMUNOCOM SPLEEN ABS/DYSFUNCT", "DisplayText" : "Absent or Dysfunctional Spleen (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "ABSENT OR DYSFUNCTIONAL SPLEEN"}, 
{"Row" : 8, "Column" : 1, "Text" : "Patients with absent or dysfunctional spleens are at risk of sepsis, most"}, 
{"Row" : 9, "Column" : 1, "Text" : "commonly with Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus"}, 
{"Row" : 10, "Column" : 1, "Text" : "influenzae.  Less common pathogens include Babesia microtii (from Ixodes tick"}, 
{"Row" : 11, "Column" : 1, "Text" : "bites), Capnocytophaga phagocytosis, and Capnocytophaga canimorsus (from dog"}, 
{"Row" : 12, "Column" : 1, "Text" : "bites)."}, 
{"Row" : 14, "Column" : 1, "Text" : "The risk of severe infection is related to the reason for splenectomy and the"}, 
{"Row" : 15, "Column" : 1, "Text" : "time since splenectomy.  Risk is greatest during the first year after"}, 
{"Row" : 16, "Column" : 1, "Text" : "splenectomy and then decreases with time but never reaches the risk level of"}, 
{"Row" : 17, "Column" : 1, "Text" : "immunocompetent patients.  Patients who have had a splenectomy as a result of"}, 
{"Row" : 18, "Column" : 1, "Text" : "Hodgkin disease or thalassemia are at greatest risk of infection.  The risk is"}, 
{"Row" : 19, "Column" : 1, "Text" : "intermediate in patients who have had splenectomy for spherocytosis, idiopathic"}, 
{"Row" : 20, "Column" : 1, "Text" : "thrombocytopenic purpura, or portal hypertension, and lowest in patients who"}, 
{"Row" : 21, "Column" : 1, "Text" : "lost their spleen from trauma."}, 
{"Row" : 23, "Column" : 1, "Text" : "When asplenic patients present with fever or other symptoms suggesting systemic"}, 
{"Row" : 24, "Column" : 1, "Text" : "bacterial infection, obtain blood cultures and treat immediately with"}, 
{"Row" : 25, "Column" : 1, "Text" : "antimicrobials active against the likely pathogens.  For early empirical"}, 
{"Row" : 26, "Column" : 1, "Text" : "treatment, some patients are given a supply of antimicrobials and instructed to"}, 
{"Row" : 27, "Column" : 1, "Text" : "take them when they first become ill and then to seek medical attention"}, 
{"Row" : 28, "Column" : 1, "Text" : "immediately thereafter.  Some patients at high risk of infection are treated"}, 
{"Row" : 29, "Column" : 1, "Text" : "with antimicrobials continuously to prevent infections.  Contact Infectious"}, 
{"Row" : 30, "Column" : 1, "Text" : "Diseases for more information."}, 
{"Row" : 32, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Give Haemophilus influenzae, meningococcal and pneumococcal vaccines to prevent"}, 
{"Row" : 34, "Column" : 1, "Text" : "infection with these potential pathogens."}, 
{"Row" : 36, "Column" : 1, "Text" : "Empirical therapy", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS"}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 42, "Column" : 1, "Text" : "Up-to-date"}, 
{"Row" : 43, "Column" : 1, "Text" : "Rich RR, et al, eds.  Clinical Immunology"}, 
{"Row" : 44, "Column" : 1, "Text" : "Roitt I, et al, eds.  Immunology"}
]},
{"Name" : "ORZID3 GMENU IMMUNOCOMPROMISED PT", "DisplayText" : "Infections in Immunocompromised patients (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++ INFECTIONS IN IMMUNOCOMPROMISED PATIENTS - OUTPATIENT ++", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM BASIC CONCEPTS", "DisplayText" : "Basic concepts", "Text" : "Basic concepts", "Mnemonic" : "06"},
{"Row" : 10, "Column" : 1, "Text" : "Innate defects", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU IMMUNOCOM COMP DEFICIENCY", "DisplayText" : "Complement Deficiency (Outpatient)", "Text" : "Complement deficiency", "Mnemonic" : "10"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID3 GMENU IMMUNOCOM SPLEEN ABS/DYSFUNCT", "DisplayText" : "Absent or Dysfunctional Spleen (Outpatient)", "Text" : "Spleen absent or dysfunctional", "Mnemonic" : "26"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM MALNUTRITION", "DisplayText" : "Malnutrition", "Text" : "Malnutrition", "Mnemonic" : "18"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM DIABETES MELLITUS", "DisplayText" : "Diabetes Mellitus", "Text" : "Diabetes Mellitus", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 GMENU IMMUNOCOM NEUROL DYSFUNCT", "DisplayText" : "Neurologial Dysfunction (Outpatient)", "Text" : "Neurological dysfunction", "Mnemonic" : "20"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM TOBACCO SMOKE", "DisplayText" : "Tobacco smoke", "Text" : "Tobacco smoke", "Mnemonic" : "30"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM STRESS", "DisplayText" : "Stress", "Text" : "Stress", "Mnemonic" : "28"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM HYPOCHLORHYDRIA", "DisplayText" : "Hypochlorhydria", "Text" : "Hypochlorhydria", "Mnemonic" : "14"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM ALTERED MICRO FLORA", "DisplayText" : "Altered microbial flora", "Text" : "Altered microbial flora", "Mnemonic" : "08"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU IMMUNOCOM NEUTROPENIA", "DisplayText" : "Neutropenia", "Text" : "Neutropenia", "Mnemonic" : "22"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 GMENU NEUTROPENIC FEVER", "DisplayText" : "Neutropenic fever (Outpatient)", "Text" : "Neutropenic fever", "Mnemonic" : "24"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 GMENU IMMUNOCOM MALIGNANCY", "DisplayText" : "Malignancy (Outpatient)", "Text" : "Malignancy", "Mnemonic" : "16"},
{"Row" : 10, "Column" : 2, "Text" : "Immune defects", "Header" : 1}, 
{"Row" : 11, "Column" : 2, "Item" : "ORZID2 GMENU CMI DEFECTS", "DisplayText" : "Cell-mediated immunity (CMI) defects", "Text" : "Cell-mediated immunity (CMI) defects", "Mnemonic" : "34"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU TRANSPLANTATION", "DisplayText" : "Transplantation", "Text" : "Transplantation", "Mnemonic" : "38"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID3 GMENU IG DEFICIENCY HIS", "DisplayText" : "Immunoglobulin deficiency (Humoral immune system) - Outpatient", "Text" : "Immunoglobulin deficiency (humoral immune system)", "Mnemonic" : "36"}
]},
{"Name" : "ORZID3 GMENU IMPETIGO", "DisplayText" : "Impetigo (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "IMPETIGO"}, 
{"Row" : 11, "Column" : 1, "Text" : "Impetigo is a superficial skin infection that rarely causes systemic symptoms."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID2 MUPIROCIN 2% OINT TOP TO AFFECT AREA TID 10DS", "DisplayText" : "Mupirocin 2% ointment topical to affected area tid for 10 days", "Text" : "Mupirocin ointment to affected area TID ($23/tube)", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Text" : "Alternative for patient with numerous lesions or whose symptoms have not", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "responded to topical treatment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 ERYTHROMYCIN 10DS 250MG PO QID", "DisplayText" : "Erythromycin 250mg po qid for 10 days", "Text" : "Erythromycin 250 mg PO QID ($0.21/day) [DI] < OR >", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 10DS 250MG PO QID", "DisplayText" : "Cephalexin 250mg po qid for 10 days", "Text" : "Cephalexin 250 mg PO QID ($0.18/day) [R] < OR >", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 10DS 250MG PO QID", "DisplayText" : "Dicloxacillin 250mg po qid for 10 days", "Text" : "Dicloxacillin 250 mg PO QID ($0.24/day) [DI]", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 29, "Column" : 1, "Text" : "Stevens DL Clin Infect Dis 41: 1373, 2005"}, 
{"Row" : 27, "Column" : 1, "Text" : "\"Mandell\" chapter: Cellulitis and subcutaneous tissue infections"}, 
{"Row" : 28, "Column" : 1, "Text" : "Up-to-Date website"}
]},
{"Name" : "ORZID3 GMENU INFECT DIARRHEA/GASTROENT", "DisplayText" : "Infectious diarrhea/Gastroenteritis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "INFECTIOUS DIARRHEA / GASTROENTERITIS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Most episodes of acute diarrhea are self limited and do not need to be evaluated"}, 
{"Row" : 12, "Column" : 1, "Text" : "or treated.  In most mild to moderate cases, antimicrobial therapy does not"}, 
{"Row" : 13, "Column" : 1, "Text" : "provide benefit and may prolong symptoms or shedding.  Antimicrobial therapy is"}, 
{"Row" : 14, "Column" : 1, "Text" : "detrimental in cases involving enterohemorrhagic Escherichia coli."}, 
{"Row" : 16, "Column" : 1, "Text" : "The decision for whether to obtain stool culture and O&P or not depends on"}, 
{"Row" : 17, "Column" : 1, "Text" : "severity, duration, and host factors like likelihood of specific infectious"}, 
{"Row" : 18, "Column" : 1, "Text" : "agents and severity of any underlying diseases.  Send stool sample for culture"}, 
{"Row" : 19, "Column" : 1, "Text" : "and O&P and consider prescribing antimicrobials when patients are dehydrated,"}, 
{"Row" : 20, "Column" : 1, "Text" : "stools are visibly bloody, temperature is >38.4 C, there is no improvement after"}, 
{"Row" : 21, "Column" : 1, "Text" : "48 hours, the case is part of a new community outbreak, there is severe"}, 
{"Row" : 22, "Column" : 1, "Text" : "abdominal pain in a person >50 years old, the patient is >69 years old, or the"}, 
{"Row" : 23, "Column" : 1, "Text" : "patient is substantially immunocompromised.  Replace fluid losses and correct"}, 
{"Row" : 24, "Column" : 1, "Text" : "electrolyte imbalances."}, 
{"Row" : 26, "Column" : 1, "Text" : "Cases with enterohemorrhagic E. coli typically have bloody diarrhea, abdominal"}, 
{"Row" : 27, "Column" : 1, "Text" : "pain, and tenderness but no fever.  In these cases anti-motility agents and"}, 
{"Row" : 28, "Column" : 1, "Text" : "antimicrobials increase the risk of hemolytic uremic syndrome and should not be"}, 
{"Row" : 29, "Column" : 1, "Text" : "given."}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID3 GMENU COM ACQ DIARRHEA/NO TRAVEL", "DisplayText" : "Community acquired diarrhea (no recent travel) - Outpatient", "Text" : "Community acquired diarrhea (no recent travel)", "Mnemonic" : "10"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID3 GMENU TRAVELER DIARRHEA", "DisplayText" : "Traveler's diarrhea", "Text" : "Traveler's diarrhea", "Mnemonic" : "12"},
{"Row" : 34, "Column" : 1, "Text" : "Treatment of diarrhea with specific organisms", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA AEROMONAS", "DisplayText" : "Diarrhea with Aeromonas (Outpatient)", "Text" : "Aeromonas", "Mnemonic" : "14"},
{"Row" : 36, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA CAMPYLOBACTER", "DisplayText" : "Diarrhea with Campylobacter (Outpatient)", "Text" : "Campylobacter", "Mnemonic" : "16"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA C. PARVUM", "DisplayText" : "Diarrhea with Crytosporidium parvum (Outpatient)", "Text" : "Cryptosporidium parvum", "Mnemonic" : "18"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA C. CAYETANENSIS", "DisplayText" : "Diarrhea with Cyclospora cayetanensis (Outpatient)", "Text" : "Cyclospora cayetanensis", "Mnemonic" : "20"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA E. HISTOLYTICA", "DisplayText" : "Diarrhea with Entamoeba histolytica (Outpatient)", "Text" : "Entamoeba histolytica", "Mnemonic" : "22"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA ENTEROHEM E. COLI", "DisplayText" : "Diarrhea with enterohemorrhagic E. Coli (Outpatient)", "Text" : "Enterohemorrhagic Escherichia coli", "Mnemonic" : "24"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA G. LAMBLIA", "DisplayText" : "Diarrhea with Giardia lamblia (Outpatient)", "Text" : "Giardia lamblia", "Mnemonic" : "26"},
{"Row" : 42, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA ISOSPORA BELLI", "DisplayText" : "Diarrhea with Isospora belli (Outpatient)", "Text" : "Isospora belli", "Mnemonic" : "28"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA MICROSPORIDIA", "DisplayText" : "Diarrhea with Microsporidia (Outpatient)", "Text" : "Microsporidia", "Mnemonic" : "30"},
{"Row" : 44, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA SALMONELLA", "DisplayText" : "Diarrhea with Salmonella (Outpatient)", "Text" : "Salmonella", "Mnemonic" : "32"},
{"Row" : 45, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA SHIGELLA", "DisplayText" : "Diarrhea with Shigella (Outpatient)", "Text" : "Shigella", "Mnemonic" : "34"},
{"Row" : 46, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA VIBRIO CHOLERA", "DisplayText" : "Diarrhea with Vibrio cholera (Outpatient)", "Text" : "Vibrio cholerae", "Mnemonic" : "36"},
{"Row" : 48, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA Y. ENTEROCOLITICA", "DisplayText" : "Diarrhea with Yersinia enterocolitica (Outpatient)", "Text" : "Yersinia enterocolitica", "Mnemonic" : "40"},
{"Row" : 51, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "42"},
{"Row" : 54, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 56, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 58, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 59, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 60, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 47, "Column" : 1, "Item" : "ORZID3 GMENU DIARRHEA VIBRIO NON CHOLERA", "DisplayText" : "Diarrhea with non-cholera vibrio (Outpatient)", "Text" : "Vibrio non-cholerae", "Mnemonic" : "38"},
{"Row" : 53, "Column" : 1, "Text" : "\"Sanford\" keyword: diarrhea"}, 
{"Row" : 55, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 57, "Column" : 1, "Text" : "Up-to-Date: Diarrhea"}
]},
{"Name" : "ORZID3 GMENU INFLUENZA", "DisplayText" : "Influenza (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "SEASONAL INFLUENZA"}, 
{"Row" : 14, "Column" : 1, "Text" : "The infection control section  should be notified if a patient has"}, 
{"Row" : 15, "Column" : 1, "Text" : "suspected or confirmed influenza disease."}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment is effective only if started within 48 hours of onset of illness."}, 
{"Row" : 23, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Treat for 5 days."}, 
{"Row" : 36, "Column" : 1, "Item" : "PSOZID2 OSELTAMIVIR 5DS 75MG PO BID", "DisplayText" : "Oseltamivir 75mg po bid for 5 days", "Text" : "Oseltamivir 75 mg PO BID ($8/day) [R]", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Annual vaccination is recommended for high risk persons, their caretakers, their"}, 
{"Row" : 43, "Column" : 1, "Text" : "household contacts, and healthcare workers who care for high-risk patients."}, 
{"Row" : 44, "Column" : 1, "Text" : "High risk persons are those > 50 years of age, nursing home residents, those"}, 
{"Row" : 45, "Column" : 1, "Text" : "with chronic pulmonary or cardiac conditions, chronic metabolic diseases (e.g.,"}, 
{"Row" : 46, "Column" : 1, "Text" : "diabetes mellitus, renal failure), immunosuppression, and women in their 2nd or"}, 
{"Row" : 47, "Column" : 1, "Text" : "3rd trimester of pregnancy."}, 
{"Row" : 48, "Column" : 1, "Text" : "Give influenza vaccine."}, 
{"Row" : 50, "Column" : 1, "Text" : "The use of antiviral drugs for prevention of influenza in high risk persons is"}, 
{"Row" : 51, "Column" : 1, "Text" : "only recommended during an outbreak.  Consult with the public health department"}, 
{"Row" : 52, "Column" : 1, "Text" : "if an outbreak is suspected."}, 
{"Row" : 56, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 58, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "Prevention during an outbreak", "Header" : 1}, 
{"Row" : 67, "Column" : 1, "Text" : "Give influenza vaccine <AND>"}, 
{"Row" : 68, "Column" : 1, "Item" : "PSOZID2 OSELTAMIVIR 14DS 75MG PO QDAY", "DisplayText" : "Oseltamivir 75mg po qday for 14 days", "Text" : "Oseltamivir 75 mg PO qday ($4/day) [R]", "Mnemonic" : "22"},
{"Row" : 70, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 71, "Column" : 1, "Text" : "CDC MMWR 2006, 55: 1"}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment depends on type.  A rapid influenza test to confirm diagnosis"}, 
{"Row" : 18, "Column" : 1, "Text" : "and determine type (A or B) is encouraged."}, 
{"Row" : 19, "Column" : 1, "Text" : "CPRS Order Pathway for Rapid Influenza Test:"}, 
{"Row" : 20, "Column" : 1, "Text" : "Laboratory-->Special Test Menu-->Micro-->Influenza A/B Ag(Meritcare)"}, 
{"Row" : 27, "Column" : 1, "Text" : "Influenza A (strain H1N1) OR Type Unknown", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Influenza A (strain H3N2) OR Influenza B", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "For 64 and Younger"}, 
{"Row" : 72, "Column" : 1, "Text" : "CDC Health Advisory (12/19/08):"}, 
{"Row" : 73, "Column" : 1, "Text" : "http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279r"}, 
{"Row" : 29, "Column" : 1, "Item" : "ORZ SET ABX OSELTAMIVIR 75MG BID RIMANTADINE 100MG QDAY 5DS", "DisplayText" : "Oseltamivir 75 mg po bid <AND> Rimantadine 100 mg po qday 5days", "Text" : "Oseltamivir 75 mg po bid ($8/day) [R] <AND>", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Text" : "Rimantadine 100 mg po qday ($1/day) [R,O]"}, 
{"Row" : 28, "Column" : 1, "Text" : "For Age 65 and Older"}, 
{"Row" : 33, "Column" : 1, "Text" : "Rimantadine 100 mg po bid ($2/day) [R,O]"}, 
{"Row" : 32, "Column" : 1, "Item" : "ORZ SET ABX OSELTAMIVIR 75MG BID AND RIMANTADINE 100MG BID 5DS", "DisplayText" : "", "Text" : "Oseltamivir 75 mg po bid ($8/day) [R,O]  <AND>", "Mnemonic" : "14"},
{"Row" : 53, "Column" : 1, "Text" : "<<To be maximally effective as chemoprophylaxis, the drug must"}, 
{"Row" : 54, "Column" : 1, "Text" : "be taken each day for the duration of influenza activity"}, 
{"Row" : 55, "Column" : 1, "Text" : "in the community.>>"}, 
{"Row" : 66, "Column" : 1, "Text" : "Influenza A (strain H3N2) OR Influenza B", "Header" : 1}, 
{"Row" : 59, "Column" : 1, "Text" : "Influenza A (strain H1N1) OR Type Unknown", "Header" : 1}, 
{"Row" : 60, "Column" : 1, "Text" : "Give Influenza vaccine <AND>"}, 
{"Row" : 61, "Column" : 1, "Text" : "For Age 65 and Older"}, 
{"Row" : 63, "Column" : 1, "Text" : "For Age 64 and Younger"}, 
{"Row" : 62, "Column" : 1, "Item" : "PSOZID RIMANTADINE 100 MG PO QDAY 14 DS", "DisplayText" : "Rimantadine 100 mg po qday 14 days", "Text" : "Rimantadine 100 mg po qday 14 day supply ($1/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 64, "Column" : 1, "Item" : "PSOZID RIMANTADINE 100 MG PO BID 14DS", "DisplayText" : "Rimantadine 100 mg po bid 14 days", "Text" : "Rimantadine 100 mg po bid 14 day supply ($2/day) [R,O]", "Mnemonic" : "20"},
{"Row" : 11, "Column" : 1, "Text" : "Follow facility specific guidelines for prescribing and dispensing Oseltamivir", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "(Tamiflu).", "Header" : 1}
]},
{"Name" : "ORZID3 GMENU INFLUENZA 2010-11", "DisplayText" : "Influenza 2010-11  ", "Version" : "Fargo", "Contents" : [
{"Row" : 6, "Column" : 1, "Text" : "Seasonal Influenza 2010-2011", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Information contained on these pages will be updated regularly as"}, 
{"Row" : 8, "Column" : 1, "Text" : "new information becomes available during the influenza season."}, 
{"Row" : 10, "Column" : 1, "Text" : "10Influenza Vaccination Recommendations", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "|12Antiviral Treatment Recommendations"}, 
{"Row" : 12, "Column" : 1, "Text" : "14Early Treatment OR Chemoprophylaxis Recommendations"}
]},
{"Name" : "ORZID3 GMENU INFLUENZA H1N1 NOVEL", "DisplayText" : "NOVEL H1N1 INFLUENZA  ", "Version" : "Fargo", "Contents" : [
{"Row" : 8, "Column" : 1, "Text" : "NOVEL H1N1 INFLUENZA"}, 
{"Row" : 10, "Column" : 1, "Text" : "Follow facility specific guidelines for prescribing and dispensing Oseltamivir", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "(Tamiflu).", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Definitions of Influenza Cases", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "CDC defines a confirmed case of H1N1 infection as a person with an acute febrile"}, 
{"Row" : 15, "Column" : 1, "Text" : "respiratory illness with laboratory confirmed H1N1 infection at CDC."}, 
{"Row" : 17, "Column" : 1, "Text" : "A probable case of H1N1 infection is defined as a person with an acute febrile"}, 
{"Row" : 18, "Column" : 1, "Text" : "respiratory illness who is positive for influenza A, but negative for H1 and H3"}, 
{"Row" : 19, "Column" : 1, "Text" : "by influenza RT-PCR."}, 
{"Row" : 21, "Column" : 1, "Text" : "CDC defines suspected cases of H1N1 infection as a person with acute febrile"}, 
{"Row" : 22, "Column" : 1, "Text" : "respiratory illness with onset"}, 
{"Row" : 23, "Column" : 1, "Text" : ">within 7 days of close contact with a person who is a confirmed case of"}, 
{"Row" : 24, "Column" : 1, "Text" : "H1N1 infection, or"}, 
{"Row" : 25, "Column" : 1, "Text" : ">within 7 days of travel to community either within the United States or"}, 
{"Row" : 26, "Column" : 1, "Text" : "internationally where there are one or more confirmed cases of H1N1"}, 
{"Row" : 27, "Column" : 1, "Text" : "infection, or"}, 
{"Row" : 28, "Column" : 1, "Text" : ">resides in a community where there are one or more confirmed cases of"}, 
{"Row" : 29, "Column" : 1, "Text" : "H1N1 infection."}, 
{"Row" : 31, "Column" : 1, "Text" : "Acute respiratory illness is defined as recent onset of at least two of the"}, 
{"Row" : 32, "Column" : 1, "Text" : "following: rhinorrhea or nasal congestion\\sore throat or cough (with or without"}, 
{"Row" : 33, "Column" : 1, "Text" : "fever or feverishness.)"}, 
{"Row" : 35, "Column" : 1, "Text" : "CDC Recommendations", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment:", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Treatment is effective only if started within 48 hours of onset of illness."}, 
{"Row" : 39, "Column" : 1, "Text" : "At present CDC recommends that treatment be considered for patients with"}, 
{"Row" : 40, "Column" : 1, "Text" : "confirmed, probable or suspected cases of H1N1.  Hospitalized patients and"}, 
{"Row" : 41, "Column" : 1, "Text" : "patients at higher risk for influenza complications [those with chronic"}, 
{"Row" : 42, "Column" : 1, "Text" : "cardiopulmonary disease, diabetes or renal disease] should have priority."}, 
{"Row" : 44, "Column" : 1, "Text" : "Recommended treatment dosing:", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Oseltamivir 75 mg po bid for five days ($8/day) [R]"}, 
{"Row" : 46, "Column" : 1, "Text" : "For Creatinine Clearance less than 30 ml/min reduce dose to:"}, 
{"Row" : 47, "Column" : 1, "Text" : "Oseltamivir 75 mg po q day for five days ($4/day) [R]"}, 
{"Row" : 49, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Text" : "Prophylaxis dosing:", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "Oseltamivir 75 mg po q day for ten days ($4/day) [R]"}, 
{"Row" : 52, "Column" : 1, "Text" : "For Creatinine Clearance less than 30 ml/min reduce dose to:"}, 
{"Row" : 53, "Column" : 1, "Text" : "Oseltamivir 75 mg po every other day for ten days ($4/day) [R]"}, 
{"Row" : 55, "Column" : 1, "Text" : "Prophylaxis is recommended for:", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "influenza (e.g., persons with certain chronic medical conditions, persons"}, 
{"Row" : 58, "Column" : 1, "Text" : "65 or older, children younger than 5 years old and pregnant women) of a"}, 
{"Row" : 59, "Column" : 1, "Text" : "confirmed or probable case."}, 
{"Row" : 60, "Column" : 1, "Text" : ">Health care workers or public health workers who were not using"}, 
{"Row" : 61, "Column" : 1, "Text" : "appropriate personal protective equipment during close contact with an ill"}, 
{"Row" : 62, "Column" : 1, "Text" : "confirmed, probable, or suspect case of swine-origin influenza A (H1N1)"}, 
{"Row" : 63, "Column" : 1, "Text" : "virus infection during the case's infectious period."}, 
{"Row" : 65, "Column" : 1, "Text" : "Prophylaxis can be considered for:", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Text" : ">Household close contacts who are at high-risk for complications of"}, 
{"Row" : 67, "Column" : 1, "Text" : "influenza (e.g., persons with certain chronic medical conditions, persons"}, 
{"Row" : 68, "Column" : 1, "Text" : "65 years or older, children younger than 5 years old, and pregnant women)"}, 
{"Row" : 69, "Column" : 1, "Text" : "of a suspected case."}, 
{"Row" : 70, "Column" : 1, "Text" : ">Children attending school or daycare who are at high-risk for"}, 
{"Row" : 71, "Column" : 1, "Text" : "complications of influenza (children with certain chronic medical"}, 
{"Row" : 72, "Column" : 1, "Text" : "conditions) and who had close contact (face-to-face) with a confirmed,"}, 
{"Row" : 73, "Column" : 1, "Text" : "probable, or suspected case."}, 
{"Row" : 74, "Column" : 1, "Text" : ">Health care workers who are at high-risk for complications of influenza"}, 
{"Row" : 75, "Column" : 1, "Text" : "(e.g., persons with certain chronic medical conditions, persons 65 or"}, 
{"Row" : 76, "Column" : 1, "Text" : "older, and pregnant women) who are working in an area of the healthcare"}, 
{"Row" : 77, "Column" : 1, "Text" : "facility that contains patients with confirmed swine-origin influenza A"}, 
{"Row" : 78, "Column" : 1, "Text" : "(H1N1) cases, or who is caring for patients with any acute febrile"}, 
{"Row" : 79, "Column" : 1, "Text" : "respiratory illness."}, 
{"Row" : 56, "Column" : 1, "Text" : ">Household close contacts who are at high-risk for complications of"}, 
{"Row" : 80, "Column" : 1, "Text" : ">Travelers to Mexico who are at high-risk for complications of influenza"}, 
{"Row" : 81, "Column" : 1, "Text" : "(e.g., persons with certain chronic medical conditions, persons 65 or"}, 
{"Row" : 82, "Column" : 1, "Text" : "older, children younger than 5 years old, and pregnant women)."}, 
{"Row" : 83, "Column" : 1, "Text" : ">First responders who are at high-risk for complications of influenza"}, 
{"Row" : 84, "Column" : 1, "Text" : "(e.g., persons with certain chronic medical conditions, persons 65 or"}, 
{"Row" : 85, "Column" : 1, "Text" : "older, children younger than 5 years old, and pregnant women) and who are"}, 
{"Row" : 86, "Column" : 1, "Text" : "working in areas with confirmed cases of swine-origin influenza A (H1N1)"}, 
{"Row" : 87, "Column" : 1, "Text" : "virus infection."}, 
{"Row" : 89, "Column" : 1, "Text" : "References:", "Header" : 1}, 
{"Row" : 90, "Column" : 1, "Text" : "CDC Advisory"}, 
{"Row" : 91, "Column" : 1, "Text" : "http://www.cdc.gov/h1n1flu/recommendations.htm"}, 
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion", "Mnemonic" : "06"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]=minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "08"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Disease", "Mnemonic" : "10"}
]},
{"Name" : "ORZID3 GMENU INFLUENZA OUTPT", "DisplayText" : "Influenza Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 6, "Column" : 1, "Text" : "Seasonal Influenza", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Information contained on this page will be updated regularly as new information"}, 
{"Row" : 9, "Column" : 1, "Text" : "becomes available during the flu season."}, 
{"Row" : 11, "Column" : 1, "Item" : "ORZID3 GMENU ANTIVIRAL TREATMENT 2014-2015", "DisplayText" : "Antiviral Treatment Recommendations", "Text" : "Antiviral Treatment Recommendations", "Mnemonic" : "12"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU EARLY TREATMENT OR CHEMOPROPHYLAXIS NEW", "DisplayText" : "Early Treatment or Chemoprophylaxis", "Text" : "Early Treatment or Chemoprophylaxis Recommendations", "Mnemonic" : "14"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCT PULMONARY INP", "DisplayText" : "PULMONARY INP", "Text" : "Consult Pulmonary", "Mnemonic" : "04"}
]},
{"Name" : "ORZID3 GMENU INT RS GRAM-NEG BACILLI", "DisplayText" : "Interim results:  Gram-negative bacilli (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "INTERIM RESULTS: GRAM-NEGATIVE BACILLI"}, 
{"Row" : 8, "Column" : 1, "Text" : "Pseudomonas, Bordetella, and Brucella spp. usually grow aerobically (but can"}, 
{"Row" : 9, "Column" : 1, "Text" : "show up in an anaerobic bottle).  Bacteroides, Fusobacterium, Porphyromonas, and"}, 
{"Row" : 10, "Column" : 1, "Text" : "Prevotella spp. usually grow anaerobically (but can show up in an aerobic"}, 
{"Row" : 11, "Column" : 1, "Text" : "bottle).  Most other gram-negative bacilli are facultative, i.e. they can grow"}, 
{"Row" : 12, "Column" : 1, "Text" : "in aerobic or anaerobic culture conditions."}, 
{"Row" : 14, "Column" : 1, "Text" : "Some antimicrobial combinations are synergistic in vitro against some Gram-"}, 
{"Row" : 15, "Column" : 1, "Text" : "negative bacilli.Combination therapy has not been shown to improve outcomes"}, 
{"Row" : 16, "Column" : 1, "Text" : "in most circumstances.  Single drug therapy is used in most cases.  Contact"}, 
{"Row" : 17, "Column" : 1, "Text" : "Infectious Diseases for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "Use susceptibility information to select an antimicrobial when a pathogen is"}, 
{"Row" : 20, "Column" : 1, "Text" : "identified."}, 
{"Row" : 22, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU INT RS GRAM-NEG COCCI", "DisplayText" : "Iterim report of Gram-negative cocci (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "INTERIM REPORT OF GRAM-NEGATIVE COCCI"}, 
{"Row" : 8, "Column" : 1, "Text" : "Gram-negative cocci may represent meningococci, gonococci, or Moraxella."}, 
{"Row" : 10, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 15, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 16, "Column" : 1, "Text" : "Anonymous Med Letter Treatment Guidelines 2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU INT RS GRAM-POS BACILLI", "DisplayText" : "Interim report of Gram-positive Bacilli (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "INTERIM REPORT OF GRAM-POSITIVE BACILLI"}, 
{"Row" : 8, "Column" : 1, "Text" : "There are three typical morphologies (1)large and regular, (2)medium sized and"}, 
{"Row" : 9, "Column" : 1, "Text" : "variable, and (3)small and pleomorphic.  The large, uniformly rod-shaped Gram-"}, 
{"Row" : 10, "Column" : 1, "Text" : "positive bacilli are usually Bacillus spp. (aerobic) or Clostridium species"}, 
{"Row" : 11, "Column" : 1, "Text" : "(anaerobic).  Bacillus spp. include Bacillus subtilis (usually a contaminant),"}, 
{"Row" : 12, "Column" : 1, "Text" : "Bacillus cereus, and Bacillus anthracis.  Medium-sized Gram-positive bacilli are"}, 
{"Row" : 13, "Column" : 1, "Text" : "usually Lactobacilli (anaerobic).  Small and pleomorphic bacilli are usually"}, 
{"Row" : 14, "Column" : 1, "Text" : "Listeria (aerobic), diphtheroids (aerobic), Propionibacteria (anaerobic), and"}, 
{"Row" : 15, "Column" : 1, "Text" : "Corynebacteria (aerobic)."}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID3 GMENU LRG UNIF BAC AEROBIC BOT", "DisplayText" : "Large uniform bacilli in an aerobic bottle (Outpatient)", "Text" : "LARGE UNIFORM BACILLI in an AEROBIC bottle", "Mnemonic" : "06"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 GMENU LRG UNIF BAC ANAEROBIC BOT", "DisplayText" : "Large uniform bacilli in an anaerobic bottle (Outpatient)", "Text" : "LARGE UNIFORM BACILLI in an ANAEROBIC bottle", "Mnemonic" : "08"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 GMENU SM UNIF BAC ANAEROBIC BOT", "DisplayText" : "Small uniform bacilli in an anaerobic bottle (Outpatient)", "Text" : "SMALL PLEOMORPHIC BACILLI in ANAEROBIC bottle", "Mnemonic" : "10"}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID3 GMENU SM UNIF BAC AEROBIC BOT", "DisplayText" : "Small uniform bacillin in an aerobic bottle (Outpatient)", "Text" : "SMALL PLEOMORPHIC BACILLI in AEROBIC bottle", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"}
]},
{"Name" : "ORZID3 GMENU INT RS GRAM-POS COCCI PAIRS", "DisplayText" : "Interim report of Gram-positive cocci in pairs (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "INTERIM REPORT OF GRAM-POSITIVE COCCI IN PAIRS"}, 
{"Row" : 8, "Column" : 1, "Text" : "A preliminary report of gram-positive cocci in pairs suggests staphylococci,"}, 
{"Row" : 9, "Column" : 1, "Text" : "streptococci, or enterococci.  If the patient is severely ill, is likely"}, 
{"Row" : 10, "Column" : 1, "Text" : "colonized with resistant organisms, or if staphylococci or enterococci are"}, 
{"Row" : 11, "Column" : 1, "Text" : "likely, treat with vancomycin until susceptibility results are known."}, 
{"Row" : 12, "Column" : 1, "Text" : "Cephalosporins are not active against enterococci or methicillin-resistant"}, 
{"Row" : 13, "Column" : 1, "Text" : "staphylococcus aureus.  If streptococci are likely, treat with cefazolin."}, 
{"Row" : 15, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 20, "Column" : 1, "Text" : "Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA.  The Sanford Guide to"}, 
{"Row" : 21, "Column" : 1, "Text" : "Antimicrobial Therapy.  35th ed.  Hyde Park, VT: Antimicrobial Therapy Inc,"}, 
{"Row" : 22, "Column" : 1, "Text" : "2005."}, 
{"Row" : 23, "Column" : 1, "Text" : "Mandell GL, Bennett JE, Dolin R, eds.  Principles and Practice of Infectious"}, 
{"Row" : 24, "Column" : 1, "Text" : "Diseases.  6th ed.  Philadelphia, PA: Churchill-Livingston, 2005."}, 
{"Row" : 25, "Column" : 1, "Text" : "Anonymous.  Choice of antibacterial drugs.  Med Letter Treatment Guidelines"}, 
{"Row" : 26, "Column" : 1, "Text" : "2004, 2: 13"}
]},
{"Name" : "ORZID3 GMENU INTRAVASC CATH-ASSOC INFECT", "DisplayText" : "Intravascular catheter-associated infection (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "INTRAVASCULAR CATHETER-ASSOCIATED INFECTION"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU KERATITIS", "DisplayText" : "Keratitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT OPHTHALMOLOGY", "DisplayText" : "OPHTHALMOLOGY", "Text" : "Need help with an eye issue?  Obtain Ophthamology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "KERATITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Keratitis is an emergency requiring prompt treatment to prevent vision loss."}, 
{"Row" : 13, "Column" : 1, "Text" : "Contact ophthalmology immediately."}, 
{"Row" : 15, "Column" : 1, "Text" : "Keratitis is associated with viral or bacterial infection, trauma, foreign"}, 
{"Row" : 16, "Column" : 1, "Text" : "bodies, or allergies.  About half of cases of infectious keratitis are caused by"}, 
{"Row" : 17, "Column" : 1, "Text" : "bacterial pathogens, most commonly Staphylococcus spp., Streptococcus spp., and"}, 
{"Row" : 18, "Column" : 1, "Text" : "gram negative bacilli.  Viruses are the second leading cause.  Fungi and"}, 
{"Row" : 19, "Column" : 1, "Text" : "parasites have also been associated with corneal infection.  Obtain corneal"}, 
{"Row" : 20, "Column" : 1, "Text" : "scrapings for gram stain and bacterial and viral cultures and start empirical"}, 
{"Row" : 21, "Column" : 1, "Text" : "therapy immediately."}, 
{"Row" : 23, "Column" : 1, "Text" : "If bacterial keratitis is likely, contact ophthalmology to obtain a corneal"}, 
{"Row" : 24, "Column" : 1, "Text" : "scraping and give empirical antibacterial drops immediately.  Modify therapy"}, 
{"Row" : 25, "Column" : 1, "Text" : "based on ophthalmology and/or infectious disease recommendations.  Ophthalmic"}, 
{"Row" : 26, "Column" : 1, "Text" : "corticosteroids are contraindicated in patients with keratitis.  Antiviral"}, 
{"Row" : 27, "Column" : 1, "Text" : "therapy depends on ophthalmological evaluation."}, 
{"Row" : 29, "Column" : 1, "Text" : "Empirical treament for suspected bacterial keratitis", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSOZID2 OFLOXACIN 0.3% OPH 1 DROP Q1H 7DAYS", "DisplayText" : "Ofloxacin 0.3% oph 1 drop q1h 7 days", "Text" : "Ofloxacin 0.3% ophthalmic drops: 1 drop in affected eye(s) every 1", "Mnemonic" : "12"}, 
{"Row" : 31, "Column" : 1, "Text" : "hour ($9/bottle) [M]"}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 36, "Column" : 1, "Text" : "Johns Hopkins website: Keratitis"}, 
{"Row" : 38, "Column" : 1, "Text" : "Baum J Clin Infect Dis 1995, 21: 479"}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Mandell\" chapter: Microbial keratitis"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" keyword: Keratitis"}
]},
{"Name" : "ORZID3 GMENU LRG UNIF BAC AEROBIC BOT", "DisplayText" : "Large uniform bacilli in an aerobic bottle (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "LARGE UNIFORM BACILLI IN AN AEROBIC BOTTLE"}, 
{"Row" : 8, "Column" : 1, "Text" : "LARGE UNIFORM BACILLI in an AEROBIC bottle usually suggest Bacillus species."}, 
{"Row" : 9, "Column" : 1, "Text" : "Bacillus subtilis is usually a contaminant, Bacillus cereus is uncommon but"}, 
{"Row" : 10, "Column" : 1, "Text" : "usually pathogenic.  If Bacillus anthracis is suspected or isolated contact"}, 
{"Row" : 11, "Column" : 1, "Text" : "Infectious Diseases immediately."}, 
{"Row" : 13, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "For non-anthracis Bacillus spp. associated with disease", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 20, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "For Bacillus anthracis", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 29, "Column" : 1, "Text" : "Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA.  The Sanford Guide to"}, 
{"Row" : 30, "Column" : 1, "Text" : "Antimicrobial Therapy.  35th ed.  Hyde Park, VT: Antimicrobial Therapy Inc,"}, 
{"Row" : 31, "Column" : 1, "Text" : "2005."}, 
{"Row" : 32, "Column" : 1, "Text" : "Mandell GL, Bennett JE, Dolin R, eds.  Principles and Practice of Infectious"}, 
{"Row" : 33, "Column" : 1, "Text" : "Diseases.  6th ed.  Philadelphia, PA: Churchill-Livingston, 2005."}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous.  Choice of antibacterial drugs.  Med Letter Treatment Guidelines"}, 
{"Row" : 35, "Column" : 1, "Text" : "2004, 2: 13"}, 
{"Row" : 36, "Column" : 1, "Text" : "Anonymous.  Antifungal drugs.  Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID3 GMENU LRG UNIF BAC ANAEROBIC BOT", "DisplayText" : "Large uniform bacilli in an anaerobic bottle (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "LARGE UNIFORM BACILLI IN AN ANAEROBIC BOTTLE"}, 
{"Row" : 8, "Column" : 1, "Text" : "LARGE UNIFORM BACILLI in an ANAEROBIC bottle usually suggest Clostridium, a"}, 
{"Row" : 9, "Column" : 1, "Text" : "potentially severe pathogen.  Combination therapy is recommended for necrotizing"}, 
{"Row" : 10, "Column" : 1, "Text" : "infections."}, 
{"Row" : 12, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 17, "Column" : 1, "Text" : "Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA.  The Sanford Guide to"}, 
{"Row" : 18, "Column" : 1, "Text" : "Antimicrobial Therapy.  35th ed.  Hyde Park, VT: Antimicrobial Therapy Inc,"}, 
{"Row" : 19, "Column" : 1, "Text" : "2005."}, 
{"Row" : 20, "Column" : 1, "Text" : "Mandell GL, Bennett JE, Dolin R, eds.  Principles and Practice of Infectious"}, 
{"Row" : 21, "Column" : 1, "Text" : "Diseases.  6th ed.  Philadelphia, PA: Churchill-Livingston, 2005."}, 
{"Row" : 22, "Column" : 1, "Text" : "Anonymous.  Choice of antibacterial drugs.  Med Letter Treatment Guidelines"}, 
{"Row" : 23, "Column" : 1, "Text" : "2004, 2: 13"}, 
{"Row" : 24, "Column" : 1, "Text" : "Anonymous.  Antifungal drugs.  Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID3 GMENU LUNG ABSCESS", "DisplayText" : "Lung abscess (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic surgery"},
{"Row" : 11, "Column" : 1, "Text" : "LUNG ABSCESS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Pulmonary and/or Infectious Diseases consultations are strongly encouraged for"}, 
{"Row" : 14, "Column" : 1, "Text" : "all cases.  Obtain samples for gram stain and culture from fine needle"}, 
{"Row" : 15, "Column" : 1, "Text" : "aspiration whenever possible.  Sputum culture is less helpful because it will be"}, 
{"Row" : 16, "Column" : 1, "Text" : "contaminated with upper respiratory flora.  Classically, lung abscess is a"}, 
{"Row" : 17, "Column" : 1, "Text" : "complication of mixed anaerobic and aerobic pulmonary infection. The initial"}, 
{"Row" : 18, "Column" : 1, "Text" : "infection may or may not be clinically apparent.  Malaise, weight loss, fever,"}, 
{"Row" : 19, "Column" : 1, "Text" : "chills, and malodorous sputum typically develop over a period of weeks."}, 
{"Row" : 21, "Column" : 1, "Text" : "Cavitation and/or abscess can occur in cases of pneumonia from a single"}, 
{"Row" : 22, "Column" : 1, "Text" : "pathogen, commonly Staphylococcus aureus or Pseudomonas aeruginosa."}, 
{"Row" : 23, "Column" : 1, "Text" : "Antimicrobial treatment should be directed against the specific pathogen."}, 
{"Row" : 25, "Column" : 1, "Text" : "Treat for 6 to 8 weeks and adjust treatment based on clinical response.  Oral"}, 
{"Row" : 26, "Column" : 1, "Text" : "medications should be used in patients who can take them."}, 
{"Row" : 28, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Lorber B. Bacterial lung abscess. In: Mandell GL, Bennett JC, Dolin R, eds."}, 
{"Row" : 43, "Column" : 1, "Text" : "Mandell, Douglas, and Bennett's: Principles and Practice of Infectious Disease."}, 
{"Row" : 44, "Column" : 1, "Text" : "Vol 1. 7th ed. Philadelphia, PA: Elsevier"},
{"Row" : 46, "Column" : 1, "Text" : "Kasper DL, Cohen-Poradosu R. Infections due to mixed anaerobic organisms."}, 
{"Row" : 47, "Column" : 1, "Text" : "In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds."}, 
{"Row" : 48, "Column" : 1, "Text" : "Harrison's Principles of Internal Medicine. 18th ed. New York, NY:"}, 
{"Row" : 49, "Column" : 1, "Text" : "McGraw-Hill"},
{"Row" : 51, "Column" : 1, "Text" : "Up-to-Date: Parapneumonic effusion and empyema in adults"}, 
{"Row" : 53, "Column" : 1, "Text" : "Sanford Guide: Empyema"}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H", "Text" : ""},
{"Row" : 32, "Column" : 1, "Item" : "PSOZID LUNG ABSCESS LEVOFLOXACIN 500MG AND METRONIDAZOLE 500MG", "DisplayText" : "Levofloxacin 500MG <AND> Metronidazole 500MG", "Text" : ""},
{"Row" : 33, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : ""},
{"Row" : 35, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "May substitute Clindamycin 300MG PO Q6H in place of metronidazole"}
]},
{"Name" : "ORZID3 GMENU LUNGS AND MEDIASTINUM", "DisplayText" : "Lungs and Mediastinum (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  LUNGS AND MEDIASTINUM - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "ORZID3 GMENU BRONCHITIS", "DisplayText" : "Bronchitis (Outpatient)", "Text" : "Bronchitis", "Mnemonic" : "06"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID3 GMENU EMPYEMA", "DisplayText" : "Empyema (Outpatient)", "Text" : "Empyema", "Mnemonic" : "08"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID3 GMENU INFLUENZA OUTPT", "DisplayText" : "Influenza Outpatient", "Text" : "Influenza", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU LUNG ABSCESS", "DisplayText" : "Lung abscess (Outpatient)", "Text" : "Lung abscess", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 GMENU MEDIASTINITIS", "DisplayText" : "Mediastinitis (Outpatient)", "Text" : "Mediastinitis", "Mnemonic" : "14"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 GMENU PERTUSSIS", "DisplayText" : "Pertussis (Outpatient)", "Text" : "Pertussis", "Mnemonic" : "16"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU TUBERCULOSIS", "DisplayText" : "Tuberculosis (Outpatient)", "Text" : "Tuberculosis", "Mnemonic" : "18"},
{"Row" : 8, "Column" : 2, "Text" : "Pneumonia", "Header" : 1}, 
{"Row" : 9, "Column" : 2, "Item" : "ORZID3 GMENU CHRONIC PNEUMONIA", "DisplayText" : "Chronic pneumonia (Outpatient)", "Text" : "Chronic pneumonia", "Mnemonic" : "20"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID3 GMENU ASPIRATION PNEUMONIA", "DisplayText" : "Aspiration pneumonia (Outpatient)", "Text" : "Aspiration pneumonia", "Mnemonic" : "22"},
{"Row" : 11, "Column" : 2, "Item" : "ORZID3 GMENU COMM ACQ PNEUMONIA", "DisplayText" : "Community acquired pneumonia (Outpatient)", "Text" : "Community-acquired pneumonia (CAP)", "Mnemonic" : "24"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID3 GMENU NOSOCOMIAL PNEUMONIA", "DisplayText" : "Nosocomial pneumonia (Outpatient)", "Text" : "Nosocomial pneumonia (including HAP, VAP, and HCAP)", "Mnemonic" : "26"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 GMENU BRONCHITIS", "DisplayText" : "Bronchitis (Outpatient)", "Text" : "Exacerbation of chronic obstructive pulmonary disease (COPD)", "Mnemonic" : "09"}
]},
{"Name" : "ORZID3 GMENU LYME ACUTE NEURO DISEASE", "DisplayText" : "Acute neurological disease associated with Lyme disease (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ACUTE NEUROLOGICAL DISEASE ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Isolated facial palsy (Bell's palsy) is treated with oral antimicrobials.  More"}, 
{"Row" : 12, "Column" : 1, "Text" : "extensive neurological disease is treated with intravenous antimicrobials."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment of ISOLATED FACIAL PARESTHESIA (Bell's palsy)", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 14DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 14 days", "Text" : "Doxycycline 100mg PO BID ($0.16/day) [DI] < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 14DS 500MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid for 14 days", "Text" : "Amoxicillin 500mg PO TID ($0.42/day) [R]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Text" : "Treatment of neurological disease other than Bell's palsy", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 25, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 26, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU LYME ARTHRITIS ASSOC", "DisplayText" : "Arthritis associated with Lyme disease (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY OPT", "DisplayText" : "RHEUMATOLOGY OPT", "Text" : "Consult Rheumatology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ARTHRITIS ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Most cases respond to a 28 day course of oral antimicrobials.  If symptoms"}, 
{"Row" : 13, "Column" : 1, "Text" : "persist or recur, consult Infectious Diseases or Rheumatology."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 28DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 28 days", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI] < OR >", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 28DS 500MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid for 28 days", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R]", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 23, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU LYME CARDIAC DISEASE", "DisplayText" : "Cardiac disease associated with Lyme disease (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT CARDIOLOGY OPT (TRANSPLANT)", "DisplayText" : "CARDIOLOGY OPT (TRANSPLANT)", "Text" : "Consult Cardiology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CARDIAC DISEASE ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treat for 14 to 21 days.  Cardiology consult recommended."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment of FIRST DEGREE or SECOND DEGREE heart block", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 14DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 14 days", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI] < OR >", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 14DS 500MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid for 14 days", "Text" : "Amoxicillin 500 mg PO TID ($0.42) [R]", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Text" : "Treatment of THIRD DEGREE heart block or other manifestation", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 25, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU LYME DISEASE", "DisplayText" : "Lyme Disease (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "LYME DISEASE"}, 
{"Row" : 8, "Column" : 1, "Text" : "Lyme disease results from the transmission of Borrelia burgdorferi from an"}, 
{"Row" : 9, "Column" : 1, "Text" : "Ixodes spp. tick bite.  Patients who display signs of illness or fever within 30"}, 
{"Row" : 10, "Column" : 1, "Text" : "days of removing an attached tick should be evaluated for tick-borne illness."}, 
{"Row" : 11, "Column" : 1, "Text" : "In the upper Midwest these are Lyme disease, human anaplasmosis (formerly"}, 
{"Row" : 12, "Column" : 1, "Text" : "granulocytic ehrlichiosis, HGE), and babesiosis.  Patients who have been bitten"}, 
{"Row" : 13, "Column" : 1, "Text" : "by an Ixodes spp. tick (\"deer tick\") but who do not display signs or symptoms of"}, 
{"Row" : 14, "Column" : 1, "Text" : "infection should not be treated with antimicrobials unless they have been"}, 
{"Row" : 15, "Column" : 1, "Text" : "exposed in an area with an extremely high risk of Lyme disease from tick bites."}, 
{"Row" : 16, "Column" : 1, "Text" : "In the U.S., these areas exist only in small foci in the mid-Atlantic states."}, 
{"Row" : 17, "Column" : 1, "Text" : "Preventive antimicrobial treatment may be beneficial in certain patients who"}, 
{"Row" : 18, "Column" : 1, "Text" : "have been bitten while in endemic areas.  Contact Infectious Diseases for more"}, 
{"Row" : 19, "Column" : 1, "Text" : "information."}, 
{"Row" : 21, "Column" : 1, "Text" : "Except for erythema migrans, Lyme disease is a complicated, difficult disease to"}, 
{"Row" : 22, "Column" : 1, "Text" : "diagnose and treat.  Infectious Diseases consultation is strongly encouraged."}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZID3 GMENU LYME ERYTHEMA MIGRANS", "DisplayText" : "Erythema migrans associated with Lyme disease (Outpatient)", "Text" : "Erythema migrans associated with Lyme disease", "Mnemonic" : "06"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID3 GMENU LYME ACUTE NEURO DISEASE", "DisplayText" : "Acute neurological disease associated with Lyme disease (Outpatient)", "Text" : "Acute neurological disease associated with Lyme disease", "Mnemonic" : "08"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID3 GMENU LYME ARTHRITIS ASSOC", "DisplayText" : "Arthritis associated with Lyme disease (Outpatient)", "Text" : "Arthritis associated with Lyme disease", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID3 GMENU LYME CARDIAC DISEASE", "DisplayText" : "Cardiac disease associated with Lyme disease (Outpatient)", "Text" : "Cardiac disease associated with Lyme disease", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"}
]},
{"Name" : "ORZID3 GMENU LYME ERYTHEMA MIGRANS", "DisplayText" : "Erythema migrans associated with Lyme disease (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ERYTHEMA MIGRANS ASSOCIATED WITH LYME DISEASE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Erythema migrans is the first manifestation of Lyme disease in half of cases."}, 
{"Row" : 12, "Column" : 1, "Text" : "It is typically an erythematous circular rash with induration and central"}, 
{"Row" : 13, "Column" : 1, "Text" : "clearing (although other patterns occur) and it usually develops at the site of"}, 
{"Row" : 14, "Column" : 1, "Text" : "the bite and/or in one or more distant locations.  The rash occurs 3 to 30 days"}, 
{"Row" : 15, "Column" : 1, "Text" : "after the bite.  Rashes with onset less than 3 days after a tick bite are not"}, 
{"Row" : 16, "Column" : 1, "Text" : "from Lyme disease."}, 
{"Row" : 18, "Column" : 1, "Text" : "A recent study showed that a 10 day course of antimicrobials is as effective as"}, 
{"Row" : 19, "Column" : 1, "Text" : "a 21 day course in treating erythema migrans."}, 
{"Row" : 21, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Treat for 10 days."}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 10DS 100MG PO BID", "DisplayText" : "Doxycycline 100mg po bid for 10 days", "Text" : "Doxycycline 100 mg PO BID  ($0.16/day) [DI]  < OR >", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 500MG PO TID 10DS", "DisplayText" : "Amoxicillin 500mg po tid 10 days", "Text" : "Amoxicillin 500 mg PO TID ($0.42/days) [R]", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Text" : "Wormser GPClin Infect Dis 2000, 31: S1"}, 
{"Row" : 30, "Column" : 1, "Text" : "\"Sanford\" keyword: Antimicrobial Therapy"}, 
{"Row" : 31, "Column" : 1, "Text" : "Wormser GP Ann Intern Med 2003, 138: 697"}, 
{"Row" : 32, "Column" : 1, "Text" : "Wormser GP Clin Infect Dis 2000, 31: S1"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID3 GMENU MALIGN OTITIS EXTERNA", "DisplayText" : "Malignant otitis externa (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Need help with an ENT issue?  Obtain ENT consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "MALIGNANT OTITIS EXTERNA"}, 
{"Row" : 12, "Column" : 1, "Text" : "This occurs most often in persons with diabetes mellitus.  Most cases are"}, 
{"Row" : 13, "Column" : 1, "Text" : "associated with Pseudomonas aeruginosa, but other pathogens can be involved."}, 
{"Row" : 14, "Column" : 1, "Text" : "Obtain culture to identify etiologic agent and susceptibilities.  Obtain a CT"}, 
{"Row" : 15, "Column" : 1, "Text" : "scan to determine whether osteomyelitis is present.  Treat for 4 to 6 weeks. ENT"}, 
{"Row" : 16, "Column" : 1, "Text" : "and Infectious Disease consultations are recommended."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment of MILD disease", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 750MG PO BID 28 DAYS", "DisplayText" : "Ciprofloxacin 750MG PO BID 28 DAYS", "Text" : "Ciprofloxacin 750 mg PO BID ($0.27/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "\"Mandell\" chapter: Otitis Externa, Otitis Media, and Mastoiditis"}, 
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" keyword: Otitis Externa"}
]},
{"Name" : "ORZID3 GMENU MASTOIDITIS", "DisplayText" : "Mastoiditis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "MASTOIDITIS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Mastoiditis results from extension of otitis media.  Direct treatment at the"}, 
{"Row" : 12, "Column" : 1, "Text" : "pathogens most commonly associated with otitis media, S. pneumoniae and H."}, 
{"Row" : 13, "Column" : 1, "Text" : "influenzae.  If symptoms have been present for more than 2 weeks, consider"}, 
{"Row" : 14, "Column" : 1, "Text" : "coverage against S. aureus and enteric gram-negative bacteria."}, 
{"Row" : 16, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Acute Mastoiditis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment of MILD to MODERATE disease", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Chronic Mastoiditis", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Mandell\" chapter: Otitis Externa, Otitis Media, and Mastoiditis"}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Sanford\": keyword: Mastoiditis"}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 28DS 500MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid for 28 days", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R]", "Mnemonic" : "10"},
{"Row" : 23, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 28 DAYS", "DisplayText" : "Bactrim DS PO BID 28 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Item" : "PSOZID2 AZITHROMYCIN 10DS 500MG PO QDAY", "DisplayText" : "Azithromycin 500mg po qday for 10 days", "Text" : "Azithromycin 500 mg PO qday x 10 days ($8/day) [M]", "Mnemonic" : "14"}
]},
{"Name" : "ORZID3 GMENU MEDIASTINITIS", "DisplayText" : "Mediastinitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic surgery", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "MEDIASTINITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU NASAL PACKING", "DisplayText" : "Prevention of infection in patients with nasal packing (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Need help with an ENT issue?  Obtain ENT consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF INFECTION IN PATIENTS WITH NASAL PACKING"}, 
{"Row" : 12, "Column" : 1, "Text" : "Discontinue systemic antimicrobials when the nasal packing is removed."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 500MG PO QID 5DS", "DisplayText" : "Cephalexin 500mg po qid for 5 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 500MG PO QID 5DS", "DisplayText" : "Dicloxacillin 500mg po qid for 5 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.60/day) [DI]", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Text" : "Alternative for beta-lactam antibiotic allergies", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 5DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 5 days", "Text" : "Clindamycin 300 mg PO QID ($3/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 24, "Column" : 1, "Text" : "\"Mandell\" Chapter: Infections of the Oral Cavity, Neck, and Head"}
]},
{"Name" : "ORZID3 GMENU NECROTIZING INFECTIONS", "DisplayText" : "Necrotizing infections (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "NECROTIZING INFECTIONS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "NEED AN ALTERNATIVE ANTIMICROBIAL?"}, 
{"Row" : 3, "Column" : 1, "Text" : "If you cannot use the recommended antimicrobials or you believe another one"}, 
{"Row" : 4, "Column" : 1, "Text" : "would be better for your patient, you can order another drug.  Please"}, 
{"Row" : 5, "Column" : 1, "Text" : "indicate the reason you need an alternative drug below."}, 
{"Row" : 7, "Column" : 1, "Item" : "ZZORZ SET ABX OP PT ALLERGIC TO RECOM DRUGS", "DisplayText" : "", "Text" : "Patient allergic to recommend drug(s)", "Mnemonic" : "[1]"},
{"Row" : 8, "Column" : 1, "Item" : "ZZORZ SET ABX OP DECREASED RENAL CLR", "DisplayText" : "", "Text" : "Decreased renal clearance", "Mnemonic" : "[2]"},
{"Row" : 9, "Column" : 1, "Item" : "ZZORZ SET ABX OP LIVER SEC METAB IMPAIR", "DisplayText" : "", "Text" : "Liver secretory or metabolic impairment", "Mnemonic" : "[3]"},
{"Row" : 10, "Column" : 1, "Item" : "ZZORZ SET ABX OP DRUG INTERACTION", "DisplayText" : "", "Text" : "Drug interaction", "Mnemonic" : "[4]"},
{"Row" : 11, "Column" : 1, "Item" : "ZZORZ SET ABX OP PT HAS MULT INFECT REQ ABX", "DisplayText" : "", "Text" : "Patient has multiple infections requiring antimicrobials", "Mnemonic" : "[5]"},
{"Row" : 12, "Column" : 1, "Item" : "ZZORZ SET ABX OP ADJ THERA BASED ON ABX SUSP", "DisplayText" : "", "Text" : "Adjust therapy based on antimicrobial susceptibility", "Mnemonic" : "[6]"},
{"Row" : 13, "Column" : 1, "Item" : "ZZORZ SET ABX OP OTHER ADVERSE DRUG AFFECT", "DisplayText" : "", "Text" : "Other adverse drug affect", "Mnemonic" : "[7]"},
{"Row" : 20, "Column" : 1, "Text" : "Clarification/Comments:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "ZZORZID3 GMENU CONTACT CDSS PROJECT", "DisplayText" : "Contact the CDSS Project Staff", "Text" : "Please Click Here to send comments to the CDSS team", "Mnemonic" : "08"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG ALLERGIES", "DisplayText" : "Drug allergies", "Text" : "Information about drug allergies...", "Mnemonic" : "10"},
{"Row" : 25, "Column" : 1, "Item" : "GMRCT INFECTIOUS DISEASE INP", "DisplayText" : "INFECTIOUS DISEASE-INP", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "ZZORZ SET ABX OP ALTERNATIVE OTHER REASON", "DisplayText" : "", "Text" : "Other reason", "Mnemonic" : "[8]"},
{"Row" : 16, "Column" : 1, "Text" : "Note:  Alternative antimicrobial selections will be reviewed and we may contact"}, 
{"Row" : 17, "Column" : 1, "Text" : "prescribers to learn more about situations that need alternatives, improve the"}, 
{"Row" : 18, "Column" : 1, "Text" : "CDSS, and in some cases offer suggestions."}
]},
{"Name" : "ORZID3 GMENU NEUT CAND ORAL THERAPY", "DisplayText" : "Neutropenic fever--Patient IS a candidate for oral therapy (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ONCOLOGY OPT CONSULT", "DisplayText" : "ONCOLOGY OPT", "Text" : "Hematology-Oncology consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "NEUTROPENIC FEVER--PATIENT IS A CANDIDATE FOR ORAL THERAPY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Can the patient be treated with oral therapy?", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER SCORING TOOL", "DisplayText" : "Scoring tool to identify low risk febrile neutropenic patients", "Text" : "Link to a scoring tool that identifies low risk patients for oral therapy", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX OP CIPRO 500 BID AMOX-CLAV 875/125 BID", "DisplayText" : "Ciprofloxacin 500MG PO BID & Amox/Clav 875/125MG PO BID", "Text" :""},
{"Row" : 22, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "NCCN Guidelines Version 1.2013. Prevention and Treatment of Cancer-"}, 
{"Row" : 25, "Column" : 1, "Text" : "Related Infections."}, 
{"Row" : 18, "Column" : 1, "Text" : "ALTERNATIVE", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : ""}
]},
{"Name" : "ORZID3 GMENU NEUT NOT CAND ORAL THERAPY", "DisplayText" : "Neutropenic fever--Patient is NOT a candidate for oral therapy (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "NEUTROPENIC FEVER--PATIENT IS NOT A CANDIDATE FOR ORAL THERAPY"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU NEUTROPENIC FEVER", "DisplayText" : "Neutropenic fever (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ONCOLOGY OPT CONSULT", "DisplayText" : "ONCOLOGY OPT", "Text" : "Hematology-Oncology consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "NEUTROPENIC FEVER"}, 
{"Row" : 9, "Column" : 1, "Text" : "The risk of severe, rapidly progressive infections increases when the absolute"}, 
{"Row" : 10, "Column" : 1, "Text" : "neutrophil count (ANC, segmented neutrophils plus bands) is less than 500"}, 
{"Row" : 11, "Column" : 1, "Text" : "cells/microliter.  The risk increases dramatically when the ANC is <100"}, 
{"Row" : 12, "Column" : 1, "Text" : "cells/microliter.  Because of these risks, patients with fever and neutropenia"}, 
{"Row" : 13, "Column" : 1, "Text" : "to this degree should receive empirical antimicrobial therapy immediately."}, 
{"Row" : 14, "Column" : 1, "Text" : "Empirical therapy should also be given to patients with fever and ANC 500-1000"}, 
{"Row" : 15, "Column" : 1, "Text" : "cells/microliter when the concentration is expected to be <500 cells/microliter"}, 
{"Row" : 16, "Column" : 1, "Text" : "within the next 48 hours.  For this purpose, fever is defined as a single"}, 
{"Row" : 17, "Column" : 1, "Text" : "temperature greater than 38.3 degrees Celsius."}, 
{"Row" : 19, "Column" : 1, "Text" : "Initial therapy", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Since infection can be rapidly progressive and severe, broad-spectrum"}, 
{"Row" : 21, "Column" : 1, "Text" : "antimicrobials are given urgently to patients with neutropenic fever as defined"}, 
{"Row" : 22, "Column" : 1, "Text" : "above.  Vancomycin should only be given when there are clear indications for its"}, 
{"Row" : 23, "Column" : 1, "Text" : "use."}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID3 GMENU NEUT CAND ORAL THERAPY", "DisplayText" : "Neutropenic fever--Patient IS a candidate for oral therapy (Outpatient)", "Text" : "If patient IS a candidate for oral therapy", "Mnemonic" : "08"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID3 GMENU NEUT NOT CAND ORAL THERAPY", "DisplayText" : "Neutropenic fever--Patient is NOT a candidate for oral therapy (Outpatient)", "Text" : "If patient is NOT a candidate for oral therapy", "Mnemonic" : "10"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU NEUT FEVER SCORING TOOL", "DisplayText" : "Scoring tool to identify low risk febrile neutropenic patients", "Text" : "Link to a scoring tool that identifies low risk patients for oral therapy", "Mnemonic" : "12"},
{"Row" : 41, "Column" : 1, "Text" : "Modifcation to therapy", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS"}, 
{"Row" : 25, "Column" : 1, "Text" : "Candidates for empirical treatment with oral antimicrobials include those who:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "-Are able to seek immediate medical care if their condition worsens at home"}, 
{"Row" : 27, "Column" : 1, "Text" : "-Are outpatient at the time of fever development"}, 
{"Row" : 28, "Column" : 1, "Text" : "-Have no associated comorbid illness which would independently indicate"}, 
{"Row" : 29, "Column" : 1, "Text" : "inpatient treatment or close observation"}, 
{"Row" : 30, "Column" : 1, "Text" : "-Have an anticipated duration of neutropenia </= 100 cells/mcL for <7 days"}, 
{"Row" : 31, "Column" : 1, "Text" : "-Have a good performance status (ECOG 0-1)"}, 
{"Row" : 32, "Column" : 1, "Text" : "-Do not have renal or hepatic insufficiency"}, 
{"Row" : 33, "Column" : 1, "Text" : "*OR*"}, 
{"Row" : 34, "Column" : 1, "Text" : "-Have a MASCC Risk Index score of 21 or greater"}, 
{"Row" : 45, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "NCCN Guidelines Version 1.2013. Prevention and Treatment of Cancer-"}, 
{"Row" : 48, "Column" : 1, "Text" : "Related Infections."}
]},
{"Name" : "ORZID3 GMENU NOSO SINUSITIS", "DisplayText" : "Nosocomial sinusitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Consult ENT", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "NOSOCOMIAL SINUSITIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to inpatient antimicrobial CDSS."}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 14, "Column" : 1, "Text" : "\"Sanford\": keyword: Sinusitis"}, 
{"Row" : 15, "Column" : 1, "Text" : "Up-to-Date website: Sinusitis"}, 
{"Row" : 16, "Column" : 1, "Text" : "\"Mandell\" chapter: Sinusitis"}, 
{"Row" : 17, "Column" : 1, "Text" : "Scheid DC Am Fam Phys 2004, 70: 1697"}, 
{"Row" : 18, "Column" : 1, "Text" : "Snow V Ann Intern Med 2001, 1234: 495"}
]},
{"Name" : "ORZID3 GMENU NOSOCOMIAL PNEUMONIA", "DisplayText" : "Nosocomial pneumonia (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "NOSOCOMIAL PNEUMONIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU OROLABIAL HERPES", "DisplayText" : "Orolabial herpes (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Dermatology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "OROLABIAL HERPES"}, 
{"Row" : 12, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Antiviral therapy is not beneficial after formation of vesicles.  However, when"}, 
{"Row" : 17, "Column" : 1, "Text" : "started as soon as prodromal symptoms of burning or tingling occur, antivirals"}, 
{"Row" : 18, "Column" : 1, "Text" : "reduce duration of pain and lesions."}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 400MG PO 5X/D 5DS", "DisplayText" : "Acyclovir 400mg po 5x/d for 5 days", "Text" : "Acyclovir 400 mg PO 5x/day for 5 days ($0.48/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 1DAY 2GM PO BID", "DisplayText" : "Valacyclovir 2gm po bid for 1 day", "Text" : "Valacyclovir 2 gm BID for 1 day ($9/day) [R]", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Immunocompromised patients in whom herpes simplex infections can be more severe"}, 
{"Row" : 28, "Column" : 1, "Text" : "include: patients with HIV infection, organ transplant recipients, patients"}, 
{"Row" : 29, "Column" : 1, "Text" : "undergoing chemotherapy, malnourished patients, and those with compromised skin"}, 
{"Row" : 30, "Column" : 1, "Text" : "integrity."}, 
{"Row" : 32, "Column" : 1, "Text" : "Treatment for MILD to MODERATE disease", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 14DS 400MG PO 5X/D", "DisplayText" : "Acyclovir 400mg po 5x/d for 14 days", "Text" : "Acyclovir 400 mg PO 5x/day ($0.48/day) [R] < OR >", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 7DS 1GM PO BID", "DisplayText" : "Valacyclovir 1gm po bid for 7 days", "Text" : "Valacyclovir 1 gm BID for 7 days ($9/day) [R]", "Mnemonic" : "18"},
{"Row" : 37, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Text" : "\"Mandell\" chapter: Herpes simplex virus"}, 
{"Row" : 44, "Column" : 1, "Text" : "\"Sanford\" keyword: Herpes simplex"}, 
{"Row" : 45, "Column" : 1, "Text" : "Jensen LA Ann Pharmacother 2004, 38: 705"}
]},
{"Name" : "ORZID3 GMENU OSTEOM EMP THERAPY", "DisplayText" : "Empirical therapy for Osteomyelitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Orthopedic consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ADD MENU NEUROSURGERY CONSULT", "DisplayText" : "Neurosurgery Consult", "Text" : "Neurosurgery consult", "Mnemonic" : "12"},
{"Row" : 9, "Column" : 1, "Item" : "GMRCT PODIATRY OPT", "DisplayText" : "PODIATRY OPT", "Text" : "Podiatry consult", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "EMPIRICAL THERAPY FOR OSTEOMYELITIS"}, 
{"Row" : 14, "Column" : 1, "Text" : "Therapy should be modified when culture results and patient response to therapy"}, 
{"Row" : 15, "Column" : 1, "Text" : "are known.  If cultures cannot be obtained, the oral regimens listed below can"}, 
{"Row" : 16, "Column" : 1, "Text" : "be used for empirical therapy or to complete a treatment course after the"}, 
{"Row" : 17, "Column" : 1, "Text" : "patient's disease has improved. Consult Infectious Diseases for more"}, 
{"Row" : 18, "Column" : 1, "Text" : "information."}, 
{"Row" : 20, "Column" : 1, "Text" : "ORAL treatment for MILD to MODERATE disease or for completion of treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "course", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 28 DAYS", "DisplayText" : "Bactrim DS PO BID 28 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 28DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 28 days", "Text" : "Clindamycin 300mg PO QID ($3.36/day) [R,DI] < OR >", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Item" : "PSOZID2 CEPHALEX 28DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 28 days", "Text" : "Cephalexin 500mg PO QID ($0.36/day) [R] < OR >", "Mnemonic" : "20"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 28DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 28 days", "Text" : "Moxifloxacin 400 mg PO qday ($1.19/day) [DI]", "Mnemonic" : "24"},
{"Row" : 30, "Column" : 1, "Text" : "INTRAVENOUS treatment for MODERATE to SEVERE disease", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 38, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 39, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 DICLOX 28DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 28 days", "Text" : "Dicloxacillin 500mg PO QID ($0.32/day) [DI] < OR >", "Mnemonic" : "22"},
{"Row" : 36, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 37, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 40, "Column" : 1, "Text" : "Johns Hopkins website: Osteomyelitis"}
]},
{"Name" : "ORZID3 GMENU OSTEOM GNB", "DisplayText" : "Osteomyelitis with Gram negative bacilli (other than Pseudomonas) - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "OSTEOMYELITIS WITH GRAM NEGATIVE BACILLI (OTHER THAN PSEUDOMONAS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 28DS 875/125 MG PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125 mg po bid for 28 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 28DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 28 days", "Text" : "Moxifloxacin 400 mg PO QDAY ($1.19/day) [DI]", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 21, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 18, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 19, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 22, "Column" : 1, "Text" : "Johns Hopkins website: Osteomyelitis"}
]},
{"Name" : "ORZID3 GMENU OSTEOM PSEUDOMONAS AERUGINOSA", "DisplayText" : "Osteomyelitis with Pseudomonas aeruginosa (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "OSTEOMYELITIS WITH PSEUDOMONAS AERUGINOSA"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 750MG PO BID 28 DAYS", "DisplayText" : "Ciprofloxacin 750MG PO BID 28 DAYS", "Text" : "Ciprofloxacin 750 mg PO BID ($0.27/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 20, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 17, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 18, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 21, "Column" : 1, "Text" : "Johns Hopkins website: Osteomyelitis"}
]},
{"Name" : "ORZID3 GMENU OSTEOM STAPHYLOCOCCUS AUREUS", "DisplayText" : "Osteomyelitis with Staphylococcus aureus (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "OSTEOMYELITIS WITH STAPHYLOCOCCUS AUREUS"}, 
{"Row" : 11, "Column" : 1, "Text" : "________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "________________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Methicillin-SUSCEPTIBLE S. aureus", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 28 DAYS", "DisplayText" : "Bactrim DS PO BID 28 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID2 CEPHALEX 28DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 28 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 DICLOX 28DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 28 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI]", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "________________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Methicillin-RESISTANT S. aureus", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 28 DAYS", "DisplayText" : "Bactrim DS PO BID 28 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Item" : "PSOZID2 MINOCYCLINE 28DS 100MG PO BID", "DisplayText" : "Minocycline 100mg po bid for 28 days", "Text" : "Minocycline 100 mg PO BID ($1.06/day) [DI] < OR >", "Mnemonic" : "18"},
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 28DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 28 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "20"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 34, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 35, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 36, "Column" : 1, "Text" : "Johns Hopkins website: Osteomyelitis"}
]},
{"Name" : "ORZID3 GMENU OSTEOM STREPTOCOCCI", "DisplayText" : "Osteomyelitis with Streptococci (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "OSTEOMYELITIS WITH STREPTOCOCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 28 DAYS", "DisplayText" : "Bactrim DS PO BID 28 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI] < OR >", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "PSOZID2 CEPHALEX 28DS 500MG PO QID", "DisplayText" : "Cephalexin 500mg po qid for 28 days", "Text" : "Cephalexin 500 mg PO QID ($0.36/day) [R]  < OR >", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "PSOZID2 DICLOX 28DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 28 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.48/day) [DI]", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 21, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 22, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 19, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 20, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 23, "Column" : 1, "Text" : "Johns Hopkins website: Osteomyelitis"}
]},
{"Name" : "ORZID3 GMENU OSTEOMYELITIS", "DisplayText" : "Osteomyelitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Orthopedic consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ADD MENU NEUROSURGERY CONSULT", "DisplayText" : "Neurosurgery Consult", "Text" : "Neurosurgery consult", "Mnemonic" : "12"},
{"Row" : 9, "Column" : 1, "Item" : "GMRCT PODIATRY OPT", "DisplayText" : "PODIATRY OPT", "Text" : "Podiatry consult", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Text" : "OSTEOMYELITIS"}, 
{"Row" : 14, "Column" : 1, "Text" : "In acute osteomyelitis, symptoms have been present for several days to weeks."}, 
{"Row" : 15, "Column" : 1, "Text" : "Chronic osteomyelitis is characterized by a longer duration of symptoms,"}, 
{"Row" : 16, "Column" : 1, "Text" : "sometimes months or years, and often dead, necrotic bone is present.  There is"}, 
{"Row" : 17, "Column" : 1, "Text" : "considerable overlap between the syndromes of acute and chronic osteomyelitis."}, 
{"Row" : 18, "Column" : 1, "Text" : "Symptom duration may be unreliable in a patient with neuropathy."}, 
{"Row" : 20, "Column" : 1, "Text" : "Obtain material for gram stain and culture before initiating antimicrobials."}, 
{"Row" : 21, "Column" : 1, "Text" : "Blood and bone cultures are ideal.  Sinus tracts are often colonized with"}, 
{"Row" : 22, "Column" : 1, "Text" : "multiple species and usually only one or two are pathogens in bone.  If"}, 
{"Row" : 23, "Column" : 1, "Text" : "Staphylococcus aureus is present, it is likely to be a pathogen in bone."}, 
{"Row" : 25, "Column" : 1, "Text" : "Empirical antimicrobial therapy is the same for acute and chronic osteomyelitis,"}, 
{"Row" : 26, "Column" : 1, "Text" : "but necrotic bone must often be removed for cure of chronic osteomyelitis.  If"}, 
{"Row" : 27, "Column" : 1, "Text" : "complete debridement is not possible, long-term suppressive antimicrobials may"}, 
{"Row" : 28, "Column" : 1, "Text" : "be needed.  Consult Infectious Diseases for more information."}, 
{"Row" : 30, "Column" : 1, "Text" : "The most important pathogens are S. aureus and streptococci.  Gram negative"}, 
{"Row" : 31, "Column" : 1, "Text" : "bacilli are common pathogens in osteomyelitis associated with diabetic foot"}, 
{"Row" : 32, "Column" : 1, "Text" : "infection."}, 
{"Row" : 37, "Column" : 1, "Text" : "Pathogen-directed treatment regimens", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID3 GMENU OSTEOM STAPHYLOCOCCUS AUREUS", "DisplayText" : "Osteomyelitis with Staphylococcus aureus (Outpatient)", "Text" : "Osteomyelitis with Staphylococcus aureus", "Mnemonic" : "16"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID3 GMENU OSTEOM STREPTOCOCCI", "DisplayText" : "Osteomyelitis with Streptococci (Outpatient)", "Text" : "Osteomyelitis with Streptococci", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID3 GMENU OSTEOM GNB", "DisplayText" : "Osteomyelitis with Gram negative bacilli (other than Pseudomonas) - Outpatient", "Text" : "Osteomyelitis with Gram negative bacilli (other than Pseudomonas)", "Mnemonic" : "20"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID3 GMENU OSTEOM PSEUDOMONAS AERUGINOSA", "DisplayText" : "Osteomyelitis with Pseudomonas aeruginosa (Outpatient)", "Text" : "Osteomyelitis with Pseudomonas aeruginosa", "Mnemonic" : "22"},
{"Row" : 43, "Column" : 1, "Text" : "Recommend Orthopedic, Neurosurgery (for spine or skull osteomyelitis), Podiatry"}, 
{"Row" : 44, "Column" : 1, "Text" : "(for foot infections), and Infectious Diseases consults."}, 
{"Row" : 46, "Column" : 1, "Text" : "Treat for 4 to 6 weeks.  Do not place a long-term intravascular access device"}, 
{"Row" : 47, "Column" : 1, "Text" : "(e.g. a PICC line) until it is clear the patient will need long-term intravenous"}, 
{"Row" : 48, "Column" : 1, "Text" : "therapy.  Consult Infectious Diseases or Orthopedic Surgery for more"}, 
{"Row" : 49, "Column" : 1, "Text" : "information."}, 
{"Row" : 51, "Column" : 1, "Text" : ">>  For patients with infections associated with prosthetic materials see"}, 
{"Row" : 52, "Column" : 1, "Item" : "ORZID3 GMENU PROSTHESIS BONE JOINT INFECT", "DisplayText" : "Infections in bone or joint prostheses (Outpatient)", "Text" : "Infections in bone or joint prostheses", "Mnemonic" : "24"},
{"Row" : 59, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "34"},
{"Row" : 63, "Column" : 1, "Text" : "Lew DP Lancet 2004, 364: 369"}, 
{"Row" : 64, "Column" : 1, "Text" : "Cunha BA Clin Infect Dis 2002, 35: 287"}, 
{"Row" : 34, "Column" : 1, "Text" : "Empirical treatment regimens", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID3 GMENU OSTEOM EMP THERAPY", "DisplayText" : "Empirical therapy for Osteomyelitis (Outpatient)", "Text" : "Empirical therapy for osteomyelitis", "Mnemonic" : "15"},
{"Row" : 54, "Column" : 1, "Text" : ">>  For patients with sternal infection associated with chest surgery, refer to"}, 
{"Row" : 55, "Column" : 1, "Text" : "mediastinitis, under \"Lungs and Mediastinum\", in the Inpatient Antimicrobial"}, 
{"Row" : 56, "Column" : 1, "Text" : "CDSS."}, 
{"Row" : 61, "Column" : 1, "Text" : "\"Sanford\" keyword: Osteomyelitis"}, 
{"Row" : 62, "Column" : 1, "Text" : "\"Mandell\" chapter: Osteomyelitis"}, 
{"Row" : 65, "Column" : 1, "Text" : "Johns Hopkins website: Osteomyelitis"}
]},
{"Name" : "ORZID3 GMENU OTHER PATHOGENS", "DisplayText" : "Other Pathogens (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  OTHER PATHOGENS - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Always consider disease or syndrome, site of infection, penetration of drug(s)"}, 
{"Row" : 9, "Column" : 1, "Text" : "into site, and whether organism is pathogen, colonizer, or"}, 
{"Row" : 10, "Column" : 1, "Text" : "contaminant.  See disease/syndrome section for more information."}, 
{"Row" : 12, "Column" : 1, "Text" : "Mycobacteria", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 GMENU PATHO M. TUBERCULOSIS", "DisplayText" : "Mycobacterium tuberculosis (Outpatient)", "Text" : "Mycobacterium tuberculosis", "Mnemonic" : "06"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 GMENU PATH M. AVIUM INTRACELL", "DisplayText" : "Mycobacterium avium intracellulare complex (a.k.a. MAI or MAC) - Outpatient", "Text" : "Mycobacterium avium intracellulare complex (a.k.a. MAI or MAC)", "Mnemonic" : "08"},
{"Row" : 16, "Column" : 1, "Text" : "Mycoplasma", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID3 GMENU PATH MYCOPLASMA PNEUMO", "DisplayText" : "Mycoplasma pneumonia (Outpatient)", "Text" : "Mycoplasma pneumonia", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "Ehrlichia and Coxiella", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 GMENU PATH E. CHAFFEENSIS", "DisplayText" : "Ehrlichia chaffeensis (Human Monocytotropic Ehrlichiosis) - Outpatient", "Text" : "Ehrlichia chaffeensis (Human Monocytotropic Ehrlichiosis)", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID3 GMENU PATH A. PHAGOCYTOPHILUM", "DisplayText" : "Anaplasma phagocytophilum (Human Granulocytotropic Anaplasmosis) - Outpatient", "Text" : "Anaplasma phagocytophilum (Human Granulocytotropic Anaplasmosis)", "Mnemonic" : "14"}
]},
{"Name" : "ORZID3 GMENU OTITIS EXTERNA", "DisplayText" : "Otitis externa (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Need help with an ENT issue?  Obtain ENT consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "OTITIS EXTERNA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment of ACUTE LOCALIZED disease", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "This is usually associated with Staphylococcus aureus.  Treat with incision and"}, 
{"Row" : 14, "Column" : 1, "Text" : "drainage."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment of ACUTE DIFFUSE and CHRONIC otitis externa", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Acute diffuse otitis externa is also known as swimmer's ear.  Acute diffuse and"}, 
{"Row" : 18, "Column" : 1, "Text" : "chronic otitis externa are both treated with irrigation.  Avoid products that"}, 
{"Row" : 19, "Column" : 1, "Text" : "contain neomycin if the tympanic membrane is perforated."}, 
{"Row" : 21, "Column" : 1, "Text" : "Treat with topical agents for 7 to 10 days."}, 
{"Row" : 23, "Column" : 1, "Item" : "PSOZID NEOMYCIN/POLYMYXIN/HYDROC EAR 2 DRPS QID", "DisplayText" : "Neomycin-polymixin-hydrocortisone ear drops 2 drops in affected ear(s) QID", "Text" : "Neomycin-polymixin-hydrocortisone ear drops 5 drops in affected ear(s) QID", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "($1.57/bottle) [M]"}, 
{"Row" : 26, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 OFLOXACIN EAR 10 DRPS BID 7DAYS", "DisplayText" : "Ofloxacin ear drops 10 drops in affected ear(s) BID 7 days", "Text" : "Ofloxacin ear drops 10 drops in affected ear(s) BID ($24/bottle) [M]", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Text" : "Treatment for cases RESISTANT to topical therapy", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Culture secretions to guide therapy.  If empirical treatment is needed use"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 DICLOXACILLIN 7DS 500MG PO QID", "DisplayText" : "Dicloxacillin 500mg po qid for 7 days", "Text" : "Dicloxacillin 500 mg PO QID ($0.60/day) [DI]", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 7DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 7 days", "Text" : "Moxifloxacin 400 mg PO q24h ($1.19/day) [DI]", "Mnemonic" : "18"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 39, "Column" : 1, "Text" : "\"Mandell\" chapter: Otitis Externa, Otitis Media, and Mastoiditis"}, 
{"Row" : 40, "Column" : 1, "Text" : "\"Sanford\" keyword: Otitis Externa"}
]},
{"Name" : "ORZID3 GMENU OTITIS MEDIA", "DisplayText" : "Otitis media (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Consult ENT", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "OTITIS MEDIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 500MG PO TID 10DS", "DisplayText" : "Amoxicillin 500mg po tid 10 days", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) for 10 days [R]", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 10 DAYS", "DisplayText" : "Bactrim DS PO BID 10 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS PO BID ($0.18/day)for 10 days [R,DI]", "Mnemonic" : "14"},
{"Row" : 17, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO qday ($4/day) for", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Text" : "4 days [M]"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 24, "Column" : 1, "Text" : "\"Mandell\" chapter: Otitis Externa, Otitis Media, and Mastoiditis"}, 
{"Row" : 25, "Column" : 1, "Text" : "\"Sanford\" keyword: Otitis media"}
]},
{"Name" : "ORZID3 GMENU PANCREATITIS", "DisplayText" : "Pancreatitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "PANCREATITIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU PARASITE BABESIA SPP.", "DisplayText" : "Babesia spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "BABESIA SPECIES"}, 
{"Row" : 11, "Column" : 1, "Text" : "Consult Infectious Diseases in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZ SET ABX OP CLINDA 600MG TID QUININE 600MG TID", "DisplayText" : "", "Text" : "Clindamycin 600 mg PO TID ($5.04/day) [H,O] <AND> quinine 650 mg PO TID", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Text" : "($0.78/day) [M] for 7 days"}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX OP AZITH 500 THEN 250 X6DS ATOVAQUONE 750MG Q12H", "DisplayText" : "", "Text" : "Azithromycin 500 mg PO once ($8) on day 1, then 250 mg PO qday ($4/day) [M] for", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "\"Sanford\" keyword: Babesia"}, 
{"Row" : 19, "Column" : 1, "Text" : "6 days <AND> atovaquone 750 mg PO BID ($19/day) [M] for 7 days"}
]},
{"Name" : "ORZID3 GMENU PARASITE G. LAMBLIA", "DisplayText" : "Giardia lamblia (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "GIARDIA LAMBLIA"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treat patients with symptoms attributable to giardiasis only, for 5 days."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID METRONIDAZOLE 500MG PO Q8H", "DisplayText" : "Metronidzole 500MG PO Q8H", "Text" : "Metronidazole 250-750 mg PO TID for 5 days ($0.24-0.72/day) [DI]", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "\"Sanford\" keyword: Giardia"}
]},
{"Name" : "ORZID3 GMENU PARASITE TOXOPLASMA SPP.", "DisplayText" : "Toxoplasma spp. (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "TOXOPLASMA SPP."}, 
{"Row" : 11, "Column" : 1, "Text" : "Consult Infectious Diseases in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX OP PYRIMETH 200 SULFADIA 1GM LEUCORV 10MG", "DisplayText" : "", "Text" : "Pyrimethamine 200 mg PO once, then 75-100 mg PO qday ($0.71-0.94/day) [DI,O]", "Mnemonic" : "10"},
{"Row" : 20, "Column" : 1, "Item" : "ORZ SET ABX OP PYRIMETH 200 CLINDA 300 LEUCOV 10MG", "DisplayText" : "", "Text" : "Pyrimethamine 200 mg PO once, then 75-100 mg PO qday($0.71-0.94/day) [DI,O]", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "<AND> clindamycin 300 mg PO QID ($3.36/day) [H,O] <AND> leucovorin  10-15 mg"}, 
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID TRIMETH 5MG/KG-SULFA 25MG/KG PO BID", "DisplayText" : "Trimethoprim 5 mg/kg-sulfamethoxazole 25 mg/kg PO bid", "Text" : "Trimethoprim 5 mg/kg-sulfamethoxazole 25 mg/kg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\" keyword: Toxoplasmosis"}, 
{"Row" : 18, "Column" : 1, "Text" : "mg PO QDAY ($4-6/day) [M]  < OR >"}, 
{"Row" : 22, "Column" : 1, "Text" : "PO QDAY ($4-6/day) [M]"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZ SET ABX OP PYRIMETH 200 ATOVAQUONE 750 LEUCOV 10MG", "DisplayText" : "", "Text" : "Pyrimethamine 200 mg PO once ($1.88/day) [DI,O] then 75-100 mg PO QDAY", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "($0.71-0.94/day) [DI,O] <AND> atovaquone 750 mg PO BID ($18.92/day) [M]"}, 
{"Row" : 27, "Column" : 1, "Text" : "<AND>  leucovorin  10-15 mg PO QDAY ($4-6/day) [M] < OR >"}, 
{"Row" : 17, "Column" : 1, "Text" : "<AND> sulfadiazine 1-1.5 gm PO QID ($1/day) [DI,O] <AND> leucovorin  10-15"}
]},
{"Name" : "ORZID3 GMENU PARASITES MAIN", "DisplayText" : "Parasites (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  PARASITES - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Always consider disease or syndrome, site of infection, penetration of drug(s)"}, 
{"Row" : 9, "Column" : 1, "Text" : "into site, and whether organism is pathogen, colonizer, or contaminant.  See"}, 
{"Row" : 10, "Column" : 1, "Text" : "disease/syndrome section for more information."}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU PARASITE BABESIA SPP.", "DisplayText" : "Babesia spp. (Outpatient)", "Text" : "Babesia spp.", "Mnemonic" : "06"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 GMENU PARASITE G. LAMBLIA", "DisplayText" : "Giardia lamblia (Outpatient)", "Text" : "Giardia lamblia", "Mnemonic" : "08"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 GMENU PARASITE TOXOPLASMA SPP.", "DisplayText" : "Toxoplasma spp. (Outpatient)", "Text" : "Toxoplasma spp.", "Mnemonic" : "10"}
]},
{"Name" : "ORZID3 GMENU PATH A. PHAGOCYTOPHILUM", "DisplayText" : "Anaplasma phagocytophilum (Human Granulocytotropic Anaplasmosis) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "ANAPLASMA PHAGOCYTOPHILUM (HUMAN GRANULOCYTOTROPIC ANAPLASMOSIS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI]", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}
]},
{"Name" : "ORZID3 GMENU PATH DISS M. AVIUM DISEASE", "DisplayText" : "Disseminated Mycobacterium avium disease (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT PHARMACY CONSULT BLUE TEAM", "DisplayText" : "PHARMACY CONSULT BLUE TEAM", "Text" : "Consult Pharmacy", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "DISSEMINATED MYCOBACTERIUM AVIUM DISEASE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Many of these patients have HIV/AIDS.  Management is complex.  Consult"}, 
{"Row" : 13, "Column" : 1, "Text" : "Infectious Diseases."}, 
{"Row" : 15, "Column" : 1, "Text" : "Rifabutin is optional for disseminated disease.  Rifabutin can improve cure"}, 
{"Row" : 16, "Column" : 1, "Text" : "rates, but may decrease blood concentrations of many drugs.  Consult Infectious"}, 
{"Row" : 17, "Column" : 1, "Text" : "Diseases or Pharmacy for more information."}, 
{"Row" : 19, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Two-drug treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX OP CLARITHRO 500MG ETHAMBU 15 MG/KG", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO BID  ($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg", "Mnemonic" : "12"},
{"Row" : 27, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "ORZ SET ABX OP AZITHRO 250 MG ETHAMBUTOL 15 MG/KG", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO qday ($4/day) [M] <AND> ethambutol 15 mg/kg PO qday [R]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "_____________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Three-drug treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZ SET ABX OP CLARITH 500 ETHAMB 15 RIFABUTIN 300", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO BID($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg PO", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Item" : "ORZ SET ABX OP AZITH 250 ETHAMB 15 RIFABUTIN 300", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO qday ($4/day) M <AND> ethambutol 15 mg/kg PO qday [R]", "Mnemonic" : "18"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 45, "Column" : 1, "Text" : "\"Sanford\" keyword: MAC"}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Mandell\" chapter: Mycobacterium avium complex"}, 
{"Row" : 25, "Column" : 1, "Text" : "PO QDAY ($2.52/day) [R]"}, 
{"Row" : 36, "Column" : 1, "Text" : "QDAY ($2.52/day) [R] <AND> rifabutin 300 mg PO QDAY ($4.18/day) [R,DI]"}, 
{"Row" : 40, "Column" : 1, "Text" : "<AND> rifabutin 300 mg QDAY ($4.18/day) [R,DI]"}
]},
{"Name" : "ORZID3 GMENU PATH E. CHAFFEENSIS", "DisplayText" : "Ehrlichia chaffeensis (Human Monocytotropic Ehrlichiosis) - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "EHRLICHIA CHAFFEENSIS (HUMAN MONOCYTOTROPIC EHRLICHIOSIS)"}, 
{"Row" : 11, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO BID($0.16/day) [DI]", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "\"Sanford\" Table 2: Recommended antimicrobial agents"}
]},
{"Name" : "ORZID3 GMENU PATH M. AVIUM INTRACELL", "DisplayText" : "Mycobacterium avium intracellulare complex (a.k.a. MAI or MAC) - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Pulmonary consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MYCOBACTERIUM AVIUM INTRACELLULARE (MAI OR MAC)"}, 
{"Row" : 9, "Column" : 1, "Text" : "Most isolates at the Minneapolis VAMC represent colonization in patients with"}, 
{"Row" : 10, "Column" : 1, "Text" : "chronic lung disease.  These patients should not be treated with antimicrobials."}, 
{"Row" : 12, "Column" : 1, "Text" : "Occasionally, MAI causes pulmonary disease in patients who are not"}, 
{"Row" : 13, "Column" : 1, "Text" : "immunosuppressed.  Diagnosis and management are complex.  Consult Infectious"}, 
{"Row" : 14, "Column" : 1, "Text" : "Diseases and/or Pulmonary."}, 
{"Row" : 16, "Column" : 1, "Text" : "MAI causes systemic disease commonly in patients with HIV/AIDS.  Most of these"}, 
{"Row" : 17, "Column" : 1, "Text" : "cases do not involve the lungs.  After treatment, long-term prophylaxis is"}, 
{"Row" : 18, "Column" : 1, "Text" : "usually given.  Consult Infectious Diseases in all cases."}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 GMENU PATH M. AVIUM PNEUMONIA", "DisplayText" : "Mycobacterium avium pneumonia (Outpatient)", "Text" : "Treatment for pneumonia", "Mnemonic" : "08"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID3 GMENU PATH DISS M. AVIUM DISEASE", "DisplayText" : "Disseminated Mycobacterium avium disease (Outpatient)", "Text" : "Treatment for disseminated disease", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID3 GMENU PATH PRO M. AVIUM W/ HIV", "DisplayText" : "Prophylaxis against Mycobacterium avium disease... (Outpatient)", "Text" : "Prophylaxis", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\" keyword: MAC"}, 
{"Row" : 28, "Column" : 1, "Text" : "\"Mandell\" chapter: Mycobacterium avium complex"}
]},
{"Name" : "ORZID3 GMENU PATH M. AVIUM PNEUMONIA", "DisplayText" : "Mycobacterium avium pneumonia (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Pulmonary Consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "MYCOBACTERIUM AVIUM PNEUMONIA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Diagnosis and treatment are complex. Regimens containing 3 or 4 drugs are"}, 
{"Row" : 13, "Column" : 1, "Text" : "usually recommended, but two drug regimens may be sufficient in some cases."}, 
{"Row" : 14, "Column" : 1, "Text" : "Consult Infectious Diseases and/or Pulmonary in all cases."}, 
{"Row" : 16, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Three-drug regimens", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ SET ABX OP CLARITH 500 ETHAMB 15 RIFABUTIN 300", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO BID($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg PO", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZ SET ABX OP AZITH 250 ETHAMB 15 RIFABUTIN 300", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO qday ($4/day) [M] <AND> ethambutol 15 mg/kg PO qday [R]", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "<AND> rifabutin 300 mg QD ($4.18/day) [R,DI]"}, 
{"Row" : 28, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "___________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Four-drug regimens", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZ SET ABX OP CLARITHRO 500 ETHAMB 15 RIFAB 300 STREPT", "DisplayText" : "", "Text" : "Clarithromycin 500 mg PO BID  ($2.84/day) [R,DI] <AND> ethambutol 15 mg/kg", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Text" : "streptomycin 15 mg/kg (no more than 1 gm/day) IM 3 times/week ($3/day) [R,O]"}, 
{"Row" : 37, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZ SET ABX OP AZITHRO 250 ETHAM 15 RIFAB 300 STREPT 15", "DisplayText" : "", "Text" : "Azithromycin 250 mg PO qday ($4/day) [M] <AND> ethambutol 15 mg/kg PO QD [R]", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Text" : "more than 1 gm/day) IM 3 times/week ($3/day) [R,O]"}, 
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 45, "Column" : 1, "Text" : "\"Sanford\" keyword: MAC"}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Mandell\" chapter: Mycobacterium avium complex"}, 
{"Row" : 22, "Column" : 1, "Text" : "QDAY ($2.52/day) [R] <AND> rifabutin 300 mg PO QDAY ($4.18/day) [R,DI]"}, 
{"Row" : 34, "Column" : 1, "Text" : "PO QDAY ($2.52/day) [R] <AND> rifabutin 300 mg PO QDAY ($4.18/day) [R,DI]"}, 
{"Row" : 39, "Column" : 1, "Text" : "[R] <AND> rifabutin 300 mg QDAY ($4.18/day) [R,DI] <AND> streptomycin 15"}
]},
{"Name" : "ORZID3 GMENU PATH MYCOPLASMA PNEUMO", "DisplayText" : "Mycoplasma pneumonia (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "MYCOPLASMA PNEUMONIAE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Optimal therapy depends on both the disease or syndrome and the pathogen.  See"}, 
{"Row" : 12, "Column" : 1, "Text" : "diagnosis/syndrome section for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO BID ($0.16/day) [DI]  < OR >", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) on day 1, then 250 mg PO qday ($4/day) for", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "4 days [M]"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Text" : "\"Sanford\" keyword: Mycoplasma pneumoniae"}
]},
{"Name" : "ORZID3 GMENU PATH PRO M. AVIUM W/ HIV", "DisplayText" : "Prophylaxis against Mycobacterium avium disease... (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "PROPHYLAXIS AGAINST MYCOBACTERIUM AVIUM DISEASE IN PERSONS WITH HIV/AIDS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Infectious Diseases should be involved in all cases."}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 1200MG PO Q WEEK", "DisplayText" : "Azithromycin 1200mg po q week", "Text" : "Azithromycin 1200 mg PO q week ($16/day) [M]", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID CLARITHROMYCIN 500MG PO BID", "DisplayText" : "Clarithromycin 500mg po bid", "Text" : "Clarithromycin 500 mg PO BID ($2.84/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "\"Sanford\" keyword: MAC"}, 
{"Row" : 23, "Column" : 1, "Text" : "\"Mandell\" chapter: Mycobacterium avium Complex"}
]},
{"Name" : "ORZID3 GMENU PATHO M. TUBERCULOSIS", "DisplayText" : "Mycobacterium tuberculosis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Pulmonary consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "MYCOBACTERIUM TUBERCULOSIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Management of tuberculosis is complex.  Contact Infectious Diseases and/or"}, 
{"Row" : 10, "Column" : 1, "Text" : "Pulmonary service for more information."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"}
]},
{"Name" : "ORZID3 GMENU PBE DENTAL ORAL RESP PROC", "DisplayText" : "Drugs for pt undergoing dental, oral, resp... (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 10, "Column" : 1, "Text" : "DRUGS FOR PATIENTS UNDERGOING DENTAL, ORAL, RESPIRATORY TRACT, OR ESOPHAGEAL"}, 
{"Row" : 11, "Column" : 1, "Text" : "PROCEDURES TO PREVENT BACTERIAL ENDOCARDITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 2GM PO ONCE 'C'", "DisplayText" : "Amoxicillin 2gm po once", "Text" : "Amoxicillin 2 gm PO 1 hour before procedure ($0.56/day) [R]", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Text" : "Patients unable to take oral medications", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IV ONCE 'C'", "DisplayText" : "Ampicillin 2GM IVPB ONCE", "Text" : "Ampicillin 2 gm IV over 20 minutes, beginning 60 minutes before incision", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "($12/day) [R]"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 2GM PO ONCE 'C'", "DisplayText" : "Cephalexin 2gm po once", "Text" : "Cephalexin 2 gm PO 1 hour before procedure ($0.36/day) [R]  < OR >", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 600MG PO ONCE 'C'", "DisplayText" : "Clindamycin 600mg po once", "Text" : "Clindamycin 600 mg PO 1 hour before procedure ($1.68/day) [H,O]  < OR >", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE 'C'", "DisplayText" : "Azithromycin 500mg po once", "Text" : "Azithromycin 500 mg PO 1 hour before procedure ($8.16/day) [M]", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Text" : "Patients unable to take oral medications", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 1GM IV ONCE 'C'", "DisplayText" : "Cefazolin 1GM IVPB ONCE", "Text" : "Cefazolin 1 gm IV ($2.73/day) [R] over 20 minutes, beginning 60 minutes", "Mnemonic" : "20"},
{"Row" : 27, "Column" : 1, "Text" : "before incision < OR >"}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV ($1.44/day) [H,O] over 30 minutes, beginning 60 minutes", "Mnemonic" : "22"}, 
{"Row" : 30, "Column" : 1, "Text" : "before incision"}, 
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ DENTAL OPT", "DisplayText" : "DENTAL", "Text" : "Consult Dental Service", "Mnemonic" : "09"},
{"Row" : 35, "Column" : 1, "Text" : "Dajani AS JAMA 1997, 277: 1794"}
]},
{"Name" : "ORZID3 GMENU PBE GU GI PROCEDURES", "DisplayText" : "Drugs for pt undergoing GU, GI procedures... (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "DRUGS FOR PATIENTS UNDERGOING GENITOURINARY OR GASTROINTESTINAL PROCEDURES TO"}, 
{"Row" : 10, "Column" : 1, "Text" : "PREVENT BACTERIAL ENDOCARDITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Use this link to determine a patients degree of risk of infection"}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZ GTX URL PREVENTION OF BACT ENDOCARD LINKS", "DisplayText" : "Prevention of Bacterial Endocarditis links", "Text" : "http://circ.ahajournals.org/cgi/content/full/96/1/358 (Circulation 1997; 96:", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Text" : "358)"}, 
{"Row" : 16, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Patients at MODERATE RISK for infection", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 2GM PO ONCE 'C'", "DisplayText" : "Amoxicillin 2gm po once", "Text" : "Amoxicillin 2 gm PO 1 hour before procedure ($0.56/day) )[R]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "Patients unable to take oral medications", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IV ONCE 'C'", "DisplayText" : "Ampicillin 2GM IVPB ONCE", "Text" : "Ampicillin 2 gm IV ($12/day) [R] over 20 minutes, beginning 60 minutes", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "before incision"}, 
{"Row" : 27, "Column" : 1, "Text" : "Alternative for patient with penicillin allergy", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE", "DisplayText" : "Vanco Pharmacy To Dose 1000MG ONCE", "Text" : "Vancomycin 1 gm IV ($2.94/day)[R] over 60 minutes beginning 120 minutes", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Text" : "before incision"}, 
{"Row" : 31, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Patients at HIGH RISK for infection", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZ SET ABX AMPI 2GM GENT 1.5MG/KG AMPI 1GM IV", "DisplayText" : "", "Text" : "Ampicillin 2 gm IV ($12/day) [R] over 20 minutes <AND> gentamicin 1.5 mg/kg", "Mnemonic" : "18"},
{"Row" : 37, "Column" : 1, "Text" : "(no more than 120 mg) IV ($3/day) [R,O] over 20 minutes, both beginning 60"}, 
{"Row" : 38, "Column" : 1, "Text" : "minutes before incision <AND> 6 hours later - ampicillin 1 gm IV ($6/day)"}, 
{"Row" : 39, "Column" : 1, "Text" : "[R] over 20 minutes < OR >"}, 
{"Row" : 41, "Column" : 1, "Item" : "ORZ SET ABX AMPI 2GM IV GENT 1.5MG/KG AMOXI 1GM PO", "DisplayText" : "", "Text" : "Ampicillin 2 gm IV ($12/day) [R] over 20 minutes AND gentamicin 1.5 mg/kg", "Mnemonic" : "20"},
{"Row" : 42, "Column" : 1, "Text" : "(no more than 120 mg) IV ($3/day)[R,O] over 20 minutes, both beginning 60"}, 
{"Row" : 43, "Column" : 1, "Text" : "minutes before incision <AND> 6 hours later - amoxicillin 1 gm PO"}, 
{"Row" : 44, "Column" : 1, "Text" : "($0.28/day) [R]"}, 
{"Row" : 46, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1GM IV 60MIN GENT 1.5MG/KG IV 20MIN", "DisplayText" : "", "Text" : "Vancomycin 1 gm IV ($2.94/day) [R] over 60 minutes beginning 120 minutes", "Mnemonic" : "22"},
{"Row" : 48, "Column" : 1, "Text" : "before incision <AND> gentamicin 1.5 mg/kg (no more than 120 mg) IV ($3/day)"}, 
{"Row" : 49, "Column" : 1, "Text" : "[R,O] over 20 minutes, both beginning 60 minutes before incision"}, 
{"Row" : 52, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 54, "Column" : 1, "Text" : "Dajani AS JAMA 1997, 277: 1794"}
]},
{"Name" : "ORZID3 GMENU PELVIC INFLAM DISORDER", "DisplayText" : "Pelvic inflammatory disorder (PID) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 5, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH OPT CONSULT", "DisplayText" : "Women's Health", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PELVIC INFLAMMATORY DISEASE (PID)"}, 
{"Row" : 13, "Column" : 1, "Text" : "Pelvic inflammatory disease (PID) refers to bacterial infection of the upper"}, 
{"Row" : 14, "Column" : 1, "Text" : "female reproductive tract.  Likely bacterial pathogens include Neisseria"}, 
{"Row" : 15, "Column" : 1, "Text" : "gonorrhoeae, Chlamydia trachomatis, anaerobes, enteric Gram-negative rods, and"}, 
{"Row" : 16, "Column" : 1, "Text" : "Streptococcus agalactiae.  PID should be considered in sexually active women"}, 
{"Row" : 17, "Column" : 1, "Text" : "with pelvic tenderness and  signs of lower genital tract inflammation.  Signs"}, 
{"Row" : 18, "Column" : 1, "Text" : "and  symptoms may be mild or non-specific, and  providers should have a low"}, 
{"Row" : 19, "Column" : 1, "Text" : "threshold to initiate treatment. Male sex partners of patients with PID should"}, 
{"Row" : 20, "Column" : 1, "Text" : "be examined and  treated if they had sexual contact within the 60 days preceding"}, 
{"Row" : 21, "Column" : 1, "Text" : "the patient's onset of symptoms."}, 
{"Row" : 23, "Column" : 1, "Text" : "Judge severity of infection based on clinical signs and symptoms, including"}, 
{"Row" : 24, "Column" : 1, "Text" : "blood pressure, pulse, mental status, and degree of fever."}, 
{"Row" : 26, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZ SET ABX OP CIPROFL 500MG PO BID METRO 14DS 500MG", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI] <AND> metronidazole 500 mg PO", "Mnemonic" : "14"},
{"Row" : 32, "Column" : 1, "Text" : "BID ($0.32/day) [DI] < OR >"}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX OP CEFT IM DOXY 10DS 100MG METRO 14DS 500MG", "DisplayText" : "", "Text" : "Ceftriaxone 250 mg IM ONCE($16/day) [M] <AND> doxycycline 100 mg PO BID", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Text" : "($0.16/day) [DI] <AND> metronidazole 500 mg PO BID ($0.32/day) [DI]"}, 
{"Row" : 37, "Column" : 1, "Text" : "Preferred treatment of sex partner", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Treat for both Chlamydia and Gonorrhea"}, 
{"Row" : 39, "Column" : 1, "Item" : "ORZ SET ABX OP CEFTR 125MG IM X1 DOXYC 7DS 100 PO BID", "DisplayText" : "", "Text" : "Ceftriaxone 125 mg IM ONCE ($16/day) [M] <AND> doxycycline 100 mg PO BID for", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Text" : "7 days ($0.16/day) [DI] < OR >"}, 
{"Row" : 42, "Column" : 1, "Item" : "ORZ SET ABX OP CEF 125MG IM ONCE AZITH 1GM PO ONCE", "DisplayText" : "", "Text" : "Ceftriaxone 125 mg IM once ($16/day) [M] <AND> azithromycin 1 gm PO ONCE", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Text" : "($4.09/day) [M]"}, 
{"Row" : 52, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 45, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 54, "Column" : 1, "Text" : "MMWR 2002, 51: RR-06 Sexually transmitted diseases: treatment guide"}, 
{"Row" : 55, "Column" : 1, "Text" : "\"Sanford\" keyword: Pelvic inflammatory disease"}
]},
{"Name" : "ORZID3 GMENU PERIODENTAL DISEASE", "DisplayText" : "Periodental disease (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ DENTAL OPT", "DisplayText" : "DENTAL", "Text" : "Need help with dental issues?  Consult Dental service", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PERIODONTAL DISEASE"}, 
{"Row" : 12, "Column" : 1, "Text" : "Periodontal disease is often treated with local chlorhexidine rinse.  Patients"}, 
{"Row" : 13, "Column" : 1, "Text" : "with periodontal disease should be referred to dental clinic."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment of periodontal disease", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Treat for 1-2 weeks, or as directed by dental service."}, 
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 CHLORHEXIDINE 0.12% ORAL SWISH BID 7DAYS", "DisplayText" : "Chlorhexidine 0.12% oral rinse swish for 30secs then spit 15ml 2x/daily", "Text" : "Chlorhexidine 0.12% oral rinse swish for 30 seconds, then spit 15 ml twice", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "daily ($1.90/bottle) [M]"}, 
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "Johnson BS Inf Dis Clin N Amer 1999, 13: 851"}
]},
{"Name" : "ORZID3 GMENU PERTUSSIS", "DisplayText" : "Pertussis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Need help with an ENT issue?  Obtain ENT consult", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Text" : "Pertussis is associated with persistent cough in adolescents and adults."}, 
{"Row" : 13, "Column" : 1, "Text" : "Immunity conferred by pertussis vaccine wanes after about 10 years. The first 1"}, 
{"Row" : 14, "Column" : 1, "Text" : "to 2 weeks of disease resembles viral upper respiratory infection.  After this,"}, 
{"Row" : 15, "Column" : 1, "Text" : "the characteristic cough with \"whoop\" is present for 1 to 6 weeks, followed by a"}, 
{"Row" : 16, "Column" : 1, "Text" : "2 to 3 week period of gradual resolution."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 GMENU DIAGNOSIS PERTUSSIS", "DisplayText" : "Diagnosis of pertussis (Outpatient)", "Text" : "Diagnosis of pertussis", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID3 GMENU PREVENTION PERTUSSIS", "DisplayText" : "Prevention of pertussis (Outpatient)", "Text" : "Prevention of pertussis", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID2 ERYTHROMYCIN 14DS 500MG PO TID", "DisplayText" : "Erythromycin 500mg po tid for 14 days", "Text" : "Erythromycin 500 mg PO TID ($0.28/day) for 14 days [DI] < OR >", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO ONCE THEN 250MG Q24H 4 DAYS", "DisplayText" : "Azithromycin 500MG ONCE THEN 250MG 4 DAYS", "Text" : "Azithromycin 500 mg PO once ($8/day) then 250 mg qday ($4/day) for 4 days [M]", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Text" : "Alternative for macrolide intolerant or allergic patients", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO BID ($0.18/day)for 14 days", "Mnemonic" : "20"},
{"Row" : 27, "Column" : 1, "Text" : "[R,DI]"}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 32, "Column" : 1, "Text" : "Hewlett EL NEJM 2005, 352: 1215"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-date website: Bordetella species"}, 
{"Row" : 34, "Column" : 1, "Text" : "\"Sanford\": key term: Pertussis"}, 
{"Row" : 36, "Column" : 1, "Text" : "\"Mandell\" Chapter: Bordetella species"}, 
{"Row" : 10, "Column" : 1, "Text" : "PERTUSSIS"}, 
{"Row" : 35, "Column" : 1, "Text" : "CDC MMWR 2006, 55(RR03): 1-34"}
]},
{"Name" : "ORZID3 GMENU PHARYNGITIS", "DisplayText" : "Pharyngitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "PHARYNGITIS"}, 
{"Row" : 11, "Column" : 1, "Text" : "Most cases are viral.  Antimicrobials are not indicated.  Warm saltwater gargle"}, 
{"Row" : 12, "Column" : 1, "Text" : "rinses and throat lozenges provide temporary relief of throat pain.  Five to 10%"}, 
{"Row" : 13, "Column" : 1, "Text" : "of cases are caused by group A Streptococcus.  Antimicrobial treatment reduces"}, 
{"Row" : 14, "Column" : 1, "Text" : "symptoms by one day, and does not appreciably decrease risk of complications of"}, 
{"Row" : 15, "Column" : 1, "Text" : "streptococcal pharyngitis in adults.  The major reason for treatment is to"}, 
{"Row" : 16, "Column" : 1, "Text" : "prevent rheumatic fever, an uncommon disease in US adults."}, 
{"Row" : 18, "Column" : 1, "Text" : "Streptococcal pharyngitis should be suspected when patients have fever and"}, 
{"Row" : 19, "Column" : 1, "Text" : "exudate on the pharyngeal wall or tonsils without symptoms like cough, nasal"}, 
{"Row" : 20, "Column" : 1, "Text" : "congestion, or runny nose that suggest viral infection or common cold.  If"}, 
{"Row" : 21, "Column" : 1, "Text" : "streptococcal pharyngitis is suspected in adults, perform a throat culture for"}, 
{"Row" : 22, "Column" : 1, "Text" : "group A streptococci and treat only if positive."}, 
{"Row" : 24, "Column" : 1, "Text" : "Neisseria gonorrhoeae is a rare cause of pharyngitis.  N. gonorrhoeae should be"}, 
{"Row" : 25, "Column" : 1, "Text" : "considered for patients with risk factors for sexually transmitted diseases.  N."}, 
{"Row" : 26, "Column" : 1, "Text" : "gonorrhoeae infections must be reported to the state health department and this"}, 
{"Row" : 27, "Column" : 1, "Text" : "will be done by Infection Control if the culture is positive."}, 
{"Row" : 29, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Pharyngitis associated with Group A streptococci", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID2 PENICILLIN V 500MG PO BID 10DS", "DisplayText" : "Penicillin V 500mg po bid for 10 days", "Text" : "Penicillin V 500 mg PO BID ($0.60/day) for 10 days [R] < OR >", "Mnemonic" : "12"},
{"Row" : 35, "Column" : 1, "Item" : "ZZPSOZID2 BENZATHINE PENICILLIN 1.2MU IM", "DisplayText" : "", "Text" : "Benzathine penicillin 1.2 million units IM once ($15/day) [M]", "Mnemonic" : "14"},
{"Row" : 37, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Item" : "PSOZID2 ERYTHROMYCIN 500MG PO TID 10DS", "DisplayText" : "Erythromycin 500mg po tid for 10 days", "Text" : "Erythromycin 500 mg PO TID ($0.28/day)for 10 days [DI]", "Mnemonic" : "16"},
{"Row" : 40, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "_______________________________________________________", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Gonococcal pharyngitis", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "Patients who have gonococcal pharyngitis should also be treated for C."}, 
{"Row" : 45, "Column" : 1, "Text" : "trachomatis infection (typically asymptomatic urethritis) which is commonly"}, 
{"Row" : 46, "Column" : 1, "Text" : "present in patients with gonococcal disease."}, 
{"Row" : 48, "Column" : 1, "Text" : "Preferred therapy", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Item" : "ORZ SET ABX OP CEFT 125MG IM ONCE DOXY 100MG PO BID", "DisplayText" : "", "Text" : "Ceftriaxone 125 mg IM once ($16/day) <AND> doxycycline 100 mg PO BID", "Mnemonic" : "18"},
{"Row" : 50, "Column" : 1, "Text" : "($0.16/day) DI for 7 days  < OR >"}, 
{"Row" : 52, "Column" : 1, "Item" : "ORZ SET ABX OP CEF 125MG IM ONCE AZITH 1GM PO ONCE", "DisplayText" : "", "Text" : "Ceftriaxone 125 mg IM once ($16/day) <AND> azithromycin 1 gm PO once ($16/day)", "Mnemonic" : "20"},
{"Row" : 53, "Column" : 1, "Text" : "[M]"}, 
{"Row" : 55, "Column" : 1, "Text" : "Alternative for cephalosporins allergy", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Item" : "ORZ SET ABX OP CIPRO 500MG PO ONCE DOXYC 100MG PO BID 7DS", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO once ($0.18/day) [R,DI] <AND> doxycycline 100 mg PO", "Mnemonic" : "22"},
{"Row" : 57, "Column" : 1, "Text" : "BID ($0.16) [DI] for 7 days  < OR >"}, 
{"Row" : 63, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 65, "Column" : 1, "Text" : "Bisno AL Clin Infect Dis 2002, 35: 113"}, 
{"Row" : 66, "Column" : 1, "Text" : "Vincent MT Am Fam Phys 2004, 69: 1465"}, 
{"Row" : 67, "Column" : 1, "Text" : "Snow V Ann Intern Med 2001, 134: 506"}, 
{"Row" : 59, "Column" : 1, "Item" : "ORZ SET ABX OP CIPRO 500 PO ONCE AZITH 1GM PO ONCE", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO once ($0.18/day) [R,DI] <AND> azithromycin 1 gm PO", "Mnemonic" : "24"},
{"Row" : 60, "Column" : 1, "Text" : "once ($16/day) [M]"}
]},
{"Name" : "ORZID3 GMENU POSTSEPTAL CELLULITIS", "DisplayText" : "Postseptal cellulitis (Orbital cellulitis) - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT OPHTHALMOLOGY", "DisplayText" : "OPHTHALMOLOGY", "Text" : "Need help with an eye issue?  Obtain Ophthamology consult", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Otolaryngology consult", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "POSTSEPTAL CELLULITIS (ORBITAL CELLULITIS)"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU PRESEPTAL CELLULITIS", "DisplayText" : "Preseptal cellulitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT OPHTHALMOLOGY", "DisplayText" : "OPHTHALMOLOGY", "Text" : "Need help with an eye issue?  Obtain Ophthamology consult", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Otolaryngology consult", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PRESEPTAL CELLULITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Preseptal cellulitis involves soft tissues in front of the orbital septum and"}, 
{"Row" : 14, "Column" : 1, "Text" : "the eyelids.  Infection does not involve the orbital contents.  Postseptal"}, 
{"Row" : 15, "Column" : 1, "Text" : "cellulitis (orbital cellulitis) requires immediate consultation with"}, 
{"Row" : 16, "Column" : 1, "Text" : "otolaryngology and ophthalmology.  Urgent surgical drainage may be necessary."}, 
{"Row" : 17, "Column" : 1, "Text" : "Most preseptal and or postseptal cellulitis in adults is preceded by sinusitis."}, 
{"Row" : 18, "Column" : 1, "Text" : "The most common organisms in adults are streptococci, Haemophilus influenzae,"}, 
{"Row" : 19, "Column" : 1, "Text" : "anaerobes, and Staphylococcus aureus."}, 
{"Row" : 21, "Column" : 1, "Text" : "Intravenous antimicrobials are indicated initially for treatment of moderate to"}, 
{"Row" : 22, "Column" : 1, "Text" : "severe disease.  Switch to oral antimicrobials when the patient's symptoms"}, 
{"Row" : 23, "Column" : 1, "Text" : "improve and the patient can tolerate oral medications."}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment of MILD disease", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Treat for 10 to 14 days under the guidance of ophthalmology and/or"}, 
{"Row" : 27, "Column" : 1, "Text" : "otolaryngology."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 10DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 10 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 10DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 10 days", "Text" : "Clindamycin 300 mg PO QID ($3.36/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "Treatment of MODERATE to SEVERE disease", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Text" : "Johns Hopkins website: Periocular infections"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Mandell\" chapter: Periocular infections"}
]},
{"Name" : "ORZID3 GMENU PREV BACT ENDOCARD", "DisplayText" : "Prevention of bacterial endocarditis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "PREVENTION OF BACTERIAL ENDOCARDITIS"}, 
{"Row" : 8, "Column" : 1, "Text" : "Endocarditis usually develops in people with structural cardiac defects.  Most"}, 
{"Row" : 9, "Column" : 1, "Text" : "cases present without a known antecedent infection, but rare cases follow"}, 
{"Row" : 10, "Column" : 1, "Text" : "invasive dental or surgical procedures.  Still, the risk of endocarditis after a"}, 
{"Row" : 11, "Column" : 1, "Text" : "dental or surgical procedure is extremely small.  A decision about whether to"}, 
{"Row" : 12, "Column" : 1, "Text" : "administer antimicrobial prophylaxis should be based on both the risk of"}, 
{"Row" : 13, "Column" : 1, "Text" : "endocarditis conferred by the patient's cardiac defect and the risk of"}, 
{"Row" : 14, "Column" : 1, "Text" : "bacteremia from the dental or surgical procedure.  Antimicrobials should be"}, 
{"Row" : 15, "Column" : 1, "Text" : "given for high risk lesions and procedures, but risks outweigh benefits for low"}, 
{"Row" : 16, "Column" : 1, "Text" : "risk lesions and procedures."}, 
{"Row" : 18, "Column" : 1, "Text" : "To decide whether a patient should receive prophylaxis, take these steps:"}, 
{"Row" : 20, "Column" : 1, "Text" : "Step 1:  Follow the link to the guidelines and determine the risk of"}, 
{"Row" : 21, "Column" : 1, "Text" : "endocarditis for your patient's cardiac lesion (table 1)"}, 
{"Row" : 22, "Column" : 1, "Text" : "http://circ.ahajournals.org/cgi/content/full/96/1/358 (Circulation"}, 
{"Row" : 23, "Column" : 1, "Text" : "1997, 96: 358)"}, 
{"Row" : 26, "Column" : 1, "Text" : "Step 2:  In the same guidelines, determine the risk of bacteremia with organisms"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ GTX URL PREVENTION OF BACT ENDOCARD LINKS", "DisplayText" : "Prevention of Bacterial Endocarditis links", "Text" : "Or Click Here to go directly to the Prevention of Endocarditis website", "Mnemonic" : "06"},
{"Row" : 27, "Column" : 1, "Text" : "likely to cause endocarditis from the planned procedure (table 2 or 3)."}, 
{"Row" : 28, "Column" : 1, "Text" : "Step 3:  If your patient should receive prophylaxis, order the drug(s) with the"}, 
{"Row" : 29, "Column" : 1, "Text" : "quick orders below."}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID3 GMENU PBE DENTAL ORAL RESP PROC", "DisplayText" : "Drugs for pt undergoing dental, oral, resp... (Outpatient)", "Text" : "Drugs for patients undergoing dental, oral, respiratory tract, or esophageal", "Mnemonic" : "08"},
{"Row" : 32, "Column" : 1, "Text" : "procedures"}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID3 GMENU PBE GU GI PROCEDURES", "DisplayText" : "Drugs for pt undergoing GU, GI procedures... (Outpatient)", "Text" : "Drugs for patients undergoing genitourinary or gastrointestinal procedures", "Mnemonic" : "10"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 39, "Column" : 1, "Text" : "Dajani AS  JAMA 1997, 277: 1794"}
]},
{"Name" : "ORZID3 GMENU PREV INFECT ANTIBACT PROPHYL", "DisplayText" : "Prevention of infection in a patient with malignancy (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ONCOLOGY OPT CONSULT", "DisplayText" : "ONCOLOGY OPT", "Text" : "Consult Hematology-Oncology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF BACTERIAL INFECTIONS IN A PATIENT WITH MALIGNANCY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial prophylaxis is often given to patients likely to have profound,"}, 
{"Row" : 13, "Column" : 1, "Text" : "prolonged neutropenia.  Profound neutropenia is less than 100 neutrophils and"}, 
{"Row" : 14, "Column" : 1, "Text" : "bands per microliter, and such neutropenia is considered prolonged when it is"}, 
{"Row" : 15, "Column" : 1, "Text" : "expected to last more than 7 days.  Most patients who should receive prophylaxis"}, 
{"Row" : 16, "Column" : 1, "Text" : "have received stem cell transplants or are undergoing induction chemotherapy for"}, 
{"Row" : 17, "Column" : 1, "Text" : "acute leukemia."}, 
{"Row" : 19, "Column" : 1, "Text" : "If antibacterial prophylaxis is indicated", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 7DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 7 days", "Text" : "Moxifloxacin 400 mg PO qday ($1.19/day) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 7 DAYS", "DisplayText" : "Bactrim DS PO BID 7 DAYS", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO BID  ($0.18/day) [R,DI] < OR >", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 7DS 500/125MG PO BID", "DisplayText" : "Amoxicillin/clavulanate 500/125 mg po bid for 7 days", "Text" : "Amoxicillin-clavulanate 500 mg/125 mg PO BID  ($1.56/day) [R]", "Mnemonic" : "18"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 29, "Column" : 1, "Text" : "Hughes WT  Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 31, "Column" : 1, "Text" : "\"Mandell\" chapter:  Prophylaxis and empirical therapy for infection in cancer"}, 
{"Row" : 32, "Column" : 1, "Text" : "patients"}
]},
{"Name" : "ORZID3 GMENU PREV INFECT FUNGAL PROPHYL", "DisplayText" : "Prevention of fungal infection in a patient with malignancy  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ONCOLOGY OPT CONSULT", "DisplayText" : "ONCOLOGY OPT", "Text" : "Consult Hematology-Oncology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF FUNGAL INFECTIONS IN A PATIENT WITH MALIGNANCY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antifungal chemoprophylaxis is often given to patients undergoing induction"}, 
{"Row" : 13, "Column" : 1, "Text" : "chemotherapy for acute leukemia expected to have profound neutropenia (less than"}, 
{"Row" : 14, "Column" : 1, "Text" : "100 neutrophils and bands per milliliter) for more than 10 days and for patients"}, 
{"Row" : 15, "Column" : 1, "Text" : "receiving allogeneic stem cell transplantation.  For most other patients the"}, 
{"Row" : 16, "Column" : 1, "Text" : "expected benefits do not outweigh the risks of adverse effects and selection of"}, 
{"Row" : 17, "Column" : 1, "Text" : "resistant fungi."}, 
{"Row" : 19, "Column" : 1, "Text" : "Fluconazole is usually given until the absolute neutrophil concentration"}, 
{"Row" : 20, "Column" : 1, "Text" : "increases to more than 500 cells/microliter in patients undergoing induction"}, 
{"Row" : 21, "Column" : 1, "Text" : "chemotherapy for leukemia.  Duration is 100 days for patients undergoing stem"}, 
{"Row" : 22, "Column" : 1, "Text" : "cell transplantation.  Some physicians continue prevention after 100 days if"}, 
{"Row" : 23, "Column" : 1, "Text" : "corticosteroids are part of the immunosuppressive regimen.Contact Hematology-"}, 
{"Row" : 24, "Column" : 1, "Text" : "Oncology for more information."}, 
{"Row" : 26, "Column" : 1, "Text" : "Patients who have had invasive fungal infection in the recent past and who are"}, 
{"Row" : 27, "Column" : 1, "Text" : "about to become neutropenic may require chemoprophylaxis.  Contact Hematology-"}, 
{"Row" : 28, "Column" : 1, "Text" : "Oncology or Infectious Diseases for more information."}, 
{"Row" : 30, "Column" : 1, "Text" : "If antifungal prophylaxis is indicated", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 FLUCONAZOLE 10DS 100MG PO QDAY", "DisplayText" : "Fluconazole 100mg po qday for 10 days", "Text" : "Fluconazole 100-200 mg PO qday ($0.10-0.20/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 36, "Column" : 1, "Text" : "Hughes WT  Clin Infect Dis 2002, 34: 730"}, 
{"Row" : 37, "Column" : 1, "Text" : "Glasmacher A  J Antimicrob Chemother 2005, 56(S1): 23"}, 
{"Row" : 38, "Column" : 1, "Text" : "De Pauw B  J Antimicrob Chemother 2004, 53: 130"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Mandell\" chapter: Prophylaxis and empirical therapy for infection in cancer"}, 
{"Row" : 40, "Column" : 1, "Text" : "patients"}
]},
{"Name" : "ORZID3 GMENU PREVENTION OF INFECT", "DisplayText" : "Prevention of Infection - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  PREVENTION OF INFECTION - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "ORZID3 GMENU PREV BACT ENDOCARD", "DisplayText" : "Prevention of bacterial endocarditis (Outpatient)", "Text" : "Prevention of bacterial endocarditis", "Mnemonic" : "06"},
{"Row" : 10, "Column" : 1, "Text" : "Prevention of prosthetic joint infection", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Item" : "ORZID3 GMENU PROS JOINT DENTAL PROC", "DisplayText" : "Prevention of prosthetic joint infection before dental... (Outpatient)", "Text" : "Before dental procedures", "Mnemonic" : "08"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU PROS JOINT GU PROC", "DisplayText" : "Prevention of prosthetic joint infection before genitour... (Outpatient)", "Text" : "Before genitourinary procedures", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Text" : "Prevention of infection in patient with malignancy", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU PREV INFECT ANTIBACT PROPHYL", "DisplayText" : "Prevention of infection in a patient with malignancy (Outpatient)", "Text" : "Antibacterial prophylaxis", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 GMENU PREV INFECT FUNGAL PROPHYL", "DisplayText" : "Prevention of fungal infection in a patient with malignancy", "Text" : "Antifungal prophylaxis", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Text" : "Prevention of in infection in patients with liver disease", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID3 GMENU ACUTE SPON BACT PERITONITIS", "DisplayText" : "Spontaneous Bacterial Peritonitis (Outpatient)", "Text" : "Spontaneous bacterial peritonitis", "Mnemonic" : "16"}
]},
{"Name" : "ORZID3 GMENU PREVENTION PERTUSSIS", "DisplayText" : "Prevention of pertussis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Need help with an ENT issue?  Obtain ENT consult", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "PREVENTION OF PERTUSSIS"}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "08"},
{"Row" : 17, "Column" : 1, "Text" : "Hewlett EL NEJM 2005, 352: 1215"}, 
{"Row" : 18, "Column" : 1, "Text" : "Up-to-date website: Bordetella species"}, 
{"Row" : 21, "Column" : 1, "Text" : "\"Mandell\" Chapter: Bordetella species"}, 
{"Row" : 9, "Column" : 1, "Text" : "Pertussis vaccine is given to children. A tetanus-diphtheria-acellular pertussis"}, 
{"Row" : 10, "Column" : 1, "Text" : "vaccine (Tdap) is indicated for adults.  A single dose of Tdap replaces one dose"}, 
{"Row" : 11, "Column" : 1, "Text" : "of tetanus-diphtheria (Td) in the adult immunization schedule. Antimicrobial"}, 
{"Row" : 12, "Column" : 1, "Text" : "prophylaxis is sometimes used during pertussis outbreaks.  Consult Infectious"}, 
{"Row" : 13, "Column" : 1, "Text" : "Diseases for more information on vaccination and antimicrobial prophylaxis."}, 
{"Row" : 19, "Column" : 1, "Text" : "\"Sanford\" keyword: Pertussis"}, 
{"Row" : 20, "Column" : 1, "Text" : "CDC MMWR 2006, 55(RR03): 1-34"}
]},
{"Name" : "ORZID3 GMENU PRIM INFECT CHICKENPOX", "DisplayText" : "Primary infection (Chickenpox) - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Dermatology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PRIMARY INFECTION (CHICKENPOX)"}, 
{"Row" : 13, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Vaccinate susceptible persons, including persons with immunocompromised family"}, 
{"Row" : 19, "Column" : 1, "Text" : "members, teachers, health care workers, child care workers, institutional"}, 
{"Row" : 20, "Column" : 1, "Text" : "residents and workers, college students, inmates, and adults and adolescents"}, 
{"Row" : 21, "Column" : 1, "Text" : "living in households with children.  Test antibody first in adults who have"}, 
{"Row" : 22, "Column" : 1, "Text" : "uncertain history of chickenpox or vaccination."}, 
{"Row" : 23, "Column" : 1, "Text" : "Give Varicella vaccine x 2, 2nd dose 4-8 weeks after 1st dose."}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Therapy must be started within 24 hrs onset of rash."}, 
{"Row" : 27, "Column" : 1, "Text" : "Treat for 5 to 7 days."}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 5DS 800MG PO 5X/D", "DisplayText" : "Acyclovir 800mg po 5x/d for 5 days", "Text" : "Acyclovir 800 mg PO 5x/d ($0.96/day) [R]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 5DS 1GM PO TID", "DisplayText" : "Valacyclovir 1gm po tid for 5 days", "Text" : "Valacyclovir 1 gm PO TID ($13/day) [R]", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Immunocompromised patients without prior immunity to varicella who are at risk"}, 
{"Row" : 39, "Column" : 1, "Text" : "for disease include: patients with malignancy, current immunosuppressive"}, 
{"Row" : 40, "Column" : 1, "Text" : "therapy, or HIV infection.  Vaccination is not recommended while patients are"}, 
{"Row" : 41, "Column" : 1, "Text" : "immunocompromised.  For household or healthcare-associated exposure to"}, 
{"Row" : 42, "Column" : 1, "Text" : "varicella, varicella zoster immune globulin should be given within 96 hours of"}, 
{"Row" : 46, "Column" : 1, "Text" : "Treatment for MILD to MODERATE disease", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Item" : "PSOZID2 ACYCLOVIR 5DS 800MG PO 5X/D", "DisplayText" : "Acyclovir 800mg po 5x/d for 5 days", "Text" : "Acyclovir 800 mg PO 5x/day ($1/day) [R] < OR >", "Mnemonic" : "18"},
{"Row" : 48, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 5DS 1GM PO TID", "DisplayText" : "Valacyclovir 1gm po tid for 5 days", "Text" : "Valacyclovir 1000 mg PO TID ($13/day) [R]", "Mnemonic" : "20"},
{"Row" : 50, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 54, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 43, "Column" : 1, "Text" : "exposure.  This product is currently unavailable as the manufacturer has ceased"}, 
{"Row" : 44, "Column" : 1, "Text" : "production.  Contact Infectious Diseases for more information."}, 
{"Row" : 56, "Column" : 1, "Text" : "\"Sanford\" keyword: Varicella"}, 
{"Row" : 57, "Column" : 1, "Text" : "\"Mandell\" chapter: Varicella"}
]},
{"Name" : "ORZID3 GMENU PROS B/J EMP THERAPY", "DisplayText" : "Empirical therapy for prosthetic joint infection (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GMENU RENAL URINE 2WK", "DisplayText" : "URINE STUDIES: 2 WEEKS", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "EMPIRICAL THERAPY FOR PROSTHETIC JOINT INFECTION"}, 
{"Row" : 12, "Column" : 1, "Text" : "Therapy should be modified when culture results and patient response to therapy"}, 
{"Row" : 13, "Column" : 1, "Text" : "are known.  If cultures cannot be obtained, the oral regimens listed below can"}, 
{"Row" : 14, "Column" : 1, "Text" : "be used for empirical therapy or to complete a treatment course after the"}, 
{"Row" : 15, "Column" : 1, "Text" : "patient's disease has improved. Consult Infectious Diseases for more"}, 
{"Row" : 16, "Column" : 1, "Text" : "information."}, 
{"Row" : 18, "Column" : 1, "Text" : "ORAL treatment for MILD to MODERATE disease or for completion of treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "course", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID TRIMETH/SULFA 1 DS TABLET PO BID", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 ds po bid", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h ($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Item" : "PSOZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300MG PO Q6H", "Text" : "Clindamycin 300mg PO q6h ($3.36/day) [R,DI] < OR >", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : "Cephalexin 500mg PO q6h ($0.36/day) [R] < OR >", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H", "DisplayText" : "Levofloxacin 500MG PO Q24H", "Text" : "", "Mnemonic" : "18"},
{"Row" : 26, "Column" : 1, "Text" : "INTRAVENOUS treatment for MODERATE to SEVERE disease", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 32, "Column" : 1, "Text" : "\"Mandell\" Chapter: Infections with prostheses in bones and joints"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-Date website"}, 
{"Row" : 34, "Column" : 1, "Text" : "Zimmerli W  New Eng J Med 2004, 351: 1645"}
]},
{"Name" : "ORZID3 GMENU PROS B/J ENTEROCOCCI", "DisplayText" : "Enterococci infections in bone or joint prostheses (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ENTEROCOCCI INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Text" : "Zimmerli W  New Eng J Med 2004, 351: 1645"}, 
{"Row" : 14, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 19, "Column" : 1, "Text" : "\"Mandell\" chapter: Infections with prostheses in bones and joints"}, 
{"Row" : 20, "Column" : 1, "Text" : "Up-to-Date website"}, 
{"Row" : 13, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}
]},
{"Name" : "ORZID3 GMENU PROS B/J GNB", "DisplayText" : "Gram neg bacilli (other than pseudomonas) infections in bone or joint prostheses  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GRAM NEGATIVE BACILLI INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Refer to Inpatient CDSS"}
]},
{"Name" : "ORZID3 GMENU PROS B/J P. AERUGINOSA", "DisplayText" : "Pseudomonas aeringunosa infections in bone or joint prostheses (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PSEUDOMONAS AERUGINOSA INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 750MG PO BID", "DisplayText" : "Ciprofloxacin 750MG PO BID", "Text" : "Ciprofloxacin 750 mg PO BID ($0.27/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Text" : "Zimmerli W  New Eng J Med 2004, 351: 1645"}, 
{"Row" : 21, "Column" : 1, "Text" : "\"Mandell\" chapter: Infections with prostheses in bones and joints"}, 
{"Row" : 22, "Column" : 1, "Text" : "Up-to-Date website"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat with antimicrobials for 4-6 weeks, followed by 2-4 weeks of observation"}, 
{"Row" : 14, "Column" : 1, "Text" : "without antimicrobials."}
]},
{"Name" : "ORZID3 GMENU PROS B/J S. AUREUS", "DisplayText" : "Staphylococcus aureus infections in bone or joint prostheses (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 3, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 9, "Column" : 1, "Text" : "STAPHYLOCOCCUS AUREUS INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 11, "Column" : 1, "Text" : "___________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "___________________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Methicillin-SUSCEPTIBLE Staphylococcus aureus", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "___________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "___________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Methicillin-RESISTANT S. aureus", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "PREFERRED TREATMENT", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID DICLOXACILLIN 500MG PO Q6H", "DisplayText" : "Dicloxacillin 500MG PO Q6H", "Text" : ""},
{"Row" : 19, "Column" : 1, "Text" : "ALTERNATIVE TREATMENT", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO Q12H", "DisplayText" : "Bactrim DS PO Q12H", "Text" : ""},
{"Row" : 27, "Column" : 1, "Text" : "PREFERRED TREATMENT", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID MINOCYCLINE 100MG PO BID", "DisplayText" : "Minocycline 100MG PO BID", "Text" : ""},
{"Row" : 29, "Column" : 1, "Text" : "*OR*"}, 
{"Row" : 30, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" :""}
]},
{"Name" : "ORZID3 GMENU PROS B/J STREPTOCOCCI", "DisplayText" : "Streptococci infections in bone or joint prostheses (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "STREPTOCOCCAL INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 12, "Column" : 1, "Text" : "PREFERRED TREATMENT", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : ""},
{"Row" : 15, "Column" : 1, "Text" : "ALTERNATIVE TREATMENT", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750MG PO Q24H", "Text" : ""}
]},
{"Name" : "ORZID3 GMENU PROS JOINT DENTAL PROC", "DisplayText" : "Prevention of prosthetic joint infection before dental... (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ DENTAL OPT", "DisplayText" : "DENTAL", "Text" : "Consult Dental Service", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF PROSTHETIC JOINT INFECTION BEFORE DENTAL PROCEDURES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Prosthetic joints have a small risk (<1 to 5% for the time the prosthesis is in"}, 
{"Row" : 13, "Column" : 1, "Text" : "place) of infection from hematogenous seeding.  The risk of joint infection"}, 
{"Row" : 14, "Column" : 1, "Text" : "after dental or surgical procedures is exceedingly small.  Existing data do not"}, 
{"Row" : 15, "Column" : 1, "Text" : "support the use of prophylactic antimicrobial prophylaxis for patients with"}, 
{"Row" : 16, "Column" : 1, "Text" : "prosthetic joints undergoing procedures.  Since the overall risk of prosthesis"}, 
{"Row" : 17, "Column" : 1, "Text" : "infection is slightly higher during the first 2 years after implantation, some"}, 
{"Row" : 18, "Column" : 1, "Text" : "physicians give prophylactic antimicrobials for patients during the first 2"}, 
{"Row" : 19, "Column" : 1, "Text" : "years after implantation.  In addition, antimicrobials are given for theoretical"}, 
{"Row" : 20, "Column" : 1, "Text" : "reasons to persons with neutropenia (less than 500 neutrophils and bands per"}, 
{"Row" : 21, "Column" : 1, "Text" : "milliliter)."}, 
{"Row" : 23, "Column" : 1, "Text" : "If antimicrobials are given during dental procedures to prevent prosthetic joint"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection, give the following:"}, 
{"Row" : 26, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 2GM PO ONCE 'C'", "DisplayText" : "Amoxicillin 2gm po once", "Text" : "Amoxicillin 2 gm PO 1 hour before procedure ($0.56/day) [R] < OR >", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Item" : "PSOZID2 CEPHALEXIN 2GM PO ONCE 'C'", "DisplayText" : "Cephalexin 2gm po once", "Text" : "Cephalexin 2 gm PO 1 hour before procedure ($0.36/day) [R]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Text" : "Alternative for patients with penicillin allergy", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID2 CLINDAM 600MG PO ONCE '30MIN'", "DisplayText" : "Clindamycin 600mg po once", "Text" : "Clindamycin 600 mg PO 30 minutes before procedure ($1.68/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "Patients unable to take oral medications", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 2GM IV ONCE 'C'", "DisplayText" : "Ampicillin 2GM IVPB ONCE", "Text" : "Ampicillin 2 gm IV ($12/day) [R] over 20 minutes, beginning 60 minutes", "Mnemonic" : "18"},
{"Row" : 35, "Column" : 1, "Text" : "before incision < OR >"}, 
{"Row" : 37, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 1GM IV ONCE 'C'", "DisplayText" : "Cefazolin 1GM IVPB ONCE", "Text" : "Cefazolin 1 gm IV ($2.73/day) [R] over 20 minutes, beginning 60 minutes", "Mnemonic" : "20"},
{"Row" : 38, "Column" : 1, "Text" : "before incision"}, 
{"Row" : 40, "Column" : 1, "Text" : "Alternative for patients with penicillin allergy", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes, beginning 60 minutes before incision", "Mnemonic" : "22"},
{"Row" : 42, "Column" : 1, "Text" : "($1.44/day) [H,O]"}, 
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 47, "Column" : 1, "Text" : "Anonymous  J Am Dent Assoc 2003, 134: 895"}
]},
{"Name" : "ORZID3 GMENU PROS JOINT GU PROC", "DisplayText" : "Prevention of prosthetic joint infection before genitour... (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "PREVENTION OF PROSTHETIC JOINT INFECTION BEFORE GENITOURINARY PROCEDURES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Prosthetic joints have a small risk (<1 to 5% for the time the prosthesis is in"}, 
{"Row" : 13, "Column" : 1, "Text" : "place) of infection from hematogenous seeding.  The risk of joint infection"}, 
{"Row" : 14, "Column" : 1, "Text" : "after dental or surgical procedures is exceedingly small.  Existing data do not"}, 
{"Row" : 15, "Column" : 1, "Text" : "support the use of prophylactic antimicrobial prophylaxis for patients with"}, 
{"Row" : 16, "Column" : 1, "Text" : "prosthetic joints undergoing procedures.  Since the overall risk of prosthesis"}, 
{"Row" : 17, "Column" : 1, "Text" : "infection is slightly higher during the first 2 years after implantation, some"}, 
{"Row" : 18, "Column" : 1, "Text" : "physicians give prophylactic antimicrobials for patients during the first 2"}, 
{"Row" : 19, "Column" : 1, "Text" : "years after implantation.  In addition, antimicrobials are given for theoretical"}, 
{"Row" : 20, "Column" : 1, "Text" : "reasons to persons with neutropenia (less than 500 neutrophils and bands per"}, 
{"Row" : 21, "Column" : 1, "Text" : "milliliter)."}, 
{"Row" : 23, "Column" : 1, "Text" : "If antimicrobials are given during genitourinary procedures to prevent"}, 
{"Row" : 24, "Column" : 1, "Text" : "prosthetic joint infection, give the following:"}, 
{"Row" : 26, "Column" : 1, "Text" : "Preferred", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "ORZ SET ABX AMPICIL 2GM IV ONCE GENT 1.5MG/KG IV ONCE", "DisplayText" : "", "Text" : "Ampicillin 2 gm IV ($12/day) [R] over 20 minutes <AND> gentamicin 1.5 mg/kg", "Mnemonic" : "12"},
{"Row" : 28, "Column" : 1, "Text" : "(no more than 120 mg) IV ($3/day) [R,O] over 20 minutes, both beginning 60"}, 
{"Row" : 29, "Column" : 1, "Text" : "minutes before incision  < OR >"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO ONCE 'C'", "DisplayText" : "Ciprofloxacin 500MG PO ONCE", "Text" : "Ciprofloxacin 500 mg PO x 1 ($0.09/day) [R,DI] 1 to 2 hours before procedure", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX VANCO 1GM IV 60MIN GENT 1.5MG/KG IV 20MIN", "DisplayText" : "", "Text" : "Vancomycin 1 gm IV ($2.94/day) [R] over 60 minutes beginning 120 minutes", "Mnemonic" : "16"},
{"Row" : 35, "Column" : 1, "Text" : "before incision <AND> gentamicin 1.5 mg/kg (no more than 120 mg) IV ($3/day)"}, 
{"Row" : 36, "Column" : 1, "Text" : "[R,O] over 20 minutes beginning 60 minutes before incision < OR >"}, 
{"Row" : 38, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO ONCE 'C'", "DisplayText" : "Ciprofloxacin 500MG PO ONCE", "Text" : "Ciprofloxacin 500 mg PO ($0.09/day) [R,DI] 1 to 2 hours before procedure", "Mnemonic" : "18"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Text" : "Anonymous  J Urol  2003, 169: 1796"}
]},
{"Name" : "ORZID3 GMENU PROSTHESIS BONE JOINT INFECT", "DisplayText" : "Infections in bone or joint prostheses (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "INFECTIONS IN BONE OR JOINT PROSTHESES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Common important pathogens include coagulase-negative staphylococci,"}, 
{"Row" : 13, "Column" : 1, "Text" : "Staphylococcus aureus, streptococci, enterococci, and gram negative bacilli."}, 
{"Row" : 14, "Column" : 1, "Text" : "Obtain material for gram stain and culture before starting antimicrobial"}, 
{"Row" : 15, "Column" : 1, "Text" : "therapy.  Blood, joint fluid, and affected tissue and/or bone are ideal"}, 
{"Row" : 16, "Column" : 1, "Text" : "specimens to culture.  Sinus tracts are often colonized and the organisms seen"}, 
{"Row" : 17, "Column" : 1, "Text" : "or cultured from them may not be pathogens.  If Staphylococcus aureus is"}, 
{"Row" : 18, "Column" : 1, "Text" : "present, it is likely to be a pathogen in the bone."}, 
{"Row" : 20, "Column" : 1, "Text" : "Pathogen-directed treatment regimens", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZID3 GMENU PROS B/J S. AUREUS", "DisplayText" : "Staphylococcus aureus infections in bone or joint prostheses (Outpatient)", "Text" : "Staphylococcus aureus infections", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID3 GMENU PROS B/J STREPTOCOCCI", "DisplayText" : "Streptococci infections in bone or joint prostheses (Outpatient)", "Text" : "Streptococci infections", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID3 GMENU PROS B/J ENTEROCOCCI", "DisplayText" : "Enterococci infections in bone or joint prostheses (Outpatient)", "Text" : "Enterococci infections", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID3 GMENU PROS B/J GNB", "DisplayText" : "Gram neg bacilli (other than pseudomonas) infections in bone or joint prostheses", "Text" : "Gram Negative Bacilli Infections", "Mnemonic" : "18"},
{"Row" : 26, "Column" : 1, "Text" : "Cure is most likely if the prosthesis is removed, but this entails at a minimum"}, 
{"Row" : 27, "Column" : 1, "Text" : "weeks without a functional joint and several surgical procedures.  Treat with"}, 
{"Row" : 28, "Column" : 1, "Text" : "antimicrobials for 4-6 weeks, followed by 2-4 weeks of observation without"}, 
{"Row" : 29, "Column" : 1, "Text" : "antimicrobials.  When infection has been eradicated, new joint materials can be"}, 
{"Row" : 30, "Column" : 1, "Text" : "implanted."}, 
{"Row" : 32, "Column" : 1, "Text" : "Acute infections can often be cured with incision and drainage followed by"}, 
{"Row" : 33, "Column" : 1, "Text" : "antimicrobials.  Finally, some cases can be managed with long-term suppressive"}, 
{"Row" : 34, "Column" : 1, "Text" : "antimicrobial therapy.  Long-term suppressive antimicrobial therapy is most"}, 
{"Row" : 35, "Column" : 1, "Text" : "effective when started soon after infection onset.  Even then, relapse occurs in"}, 
{"Row" : 36, "Column" : 1, "Text" : "more than half of cases.  Consult Infectious Diseases for more information."}, 
{"Row" : 38, "Column" : 1, "Text" : "Infectious Disease and Orthopedics consultations are essential."}, 
{"Row" : 44, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 48, "Column" : 1, "Text" : "Zimmerli W  New Eng J Med 2004, 351: 1645"}, 
{"Row" : 40, "Column" : 1, "Text" : "Empirical treatment regimens", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Mandell\" chapter: Infections with prostheses in bones and joints"}, 
{"Row" : 47, "Column" : 1, "Text" : "Up-to-Date website"}
]},
{"Name" : "ORZID3 GMENU PYELONEPHRITIS", "DisplayText" : "Pyelonephritis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PYELONEPHRITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Most cases are caused by Escherichia coli.  Judge severity of infection based on"}, 
{"Row" : 14, "Column" : 1, "Text" : "clinical signs and symptoms, including blood pressure, pulse, mental status, and"}, 
{"Row" : 15, "Column" : 1, "Text" : "degree of fever.  Resistant organisms are more likely if the patient has been in"}, 
{"Row" : 16, "Column" : 1, "Text" : "the hospital for more than 48 hours or received a course of antibiotics.  Obtain"}, 
{"Row" : 17, "Column" : 1, "Text" : "a urine Gram stain immediately to guide therapy.  Drugs active against"}, 
{"Row" : 18, "Column" : 1, "Text" : "enterococcus (ampicillin, piperacillin) or staphylococci needn't be used if Gram"}, 
{"Row" : 19, "Column" : 1, "Text" : "negative bacilli predominate on the smear.  In older men with pyelonephritis,"}, 
{"Row" : 20, "Column" : 1, "Text" : "obtain a renal ultrasound to rule out obstruction.  Consult urology if"}, 
{"Row" : 21, "Column" : 1, "Text" : "abnormalities are found."}, 
{"Row" : 23, "Column" : 1, "Item" : "ORZID3 GMENU PYELONEPHRITIS SPECIFIC PATHOGEN", "DisplayText" : "Pyelonephritis with specific pathogen (Outpatient)", "Text" : "Treatment for specific pathogens", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 33, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 14 DAYS", "DisplayText" : "Bactrim DS PO BID 14 DAYS", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet BID ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "16"},
{"Row" : 34, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 14 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "20"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 29, "Column" : 1, "Text" : "Consider oral therapy with ciprofloxacin initially and  consider switching from"}, 
{"Row" : 30, "Column" : 1, "Text" : "IV to oral later for all patient who have responded to IV therapy."}, 
{"Row" : 36, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 45, "Column" : 1, "Text" : "\"Mandell\" chapter: Urinary tract infections"}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Sanford\" keyword: Pyelonephritis"}, 
{"Row" : 47, "Column" : 1, "Text" : "Ramakrishanan K  Am Fam Phys 2005, 71: 933"}
]},
{"Name" : "ORZID3 GMENU PYELONEPHRITIS SPECIFIC PATHOGEN", "DisplayText" : "Pyelonephritis with specific pathogen (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "PYELONEPHRITIS WITH SPECIFIC PATHOGEN"}, 
{"Row" : 13, "Column" : 1, "Text" : "_____________________________________________________________________", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "_____________________________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment regimens apply to mild, moderate, and severe cases", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Infections with Enterococcus and  Pseudomonas require specific therapy."}, 
{"Row" : 19, "Column" : 1, "Text" : "If ENTEROCOCCUS identified", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 14DS 500MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid for 14 days", "Text" : "Amoxicillin 500 mg PO TID ($0.40/day) [R]", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Text" : "If PSEUDOMONAS identified", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 14 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 14 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "16"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 30, "Column" : 1, "Text" : "\"Mandell\" chapter: Urinary tract infections"}, 
{"Row" : 31, "Column" : 1, "Text" : "\"Sanford\" keyword: Pyelonephritis"}
]},
{"Name" : "ORZID3 GMENU PYOMYOSITIS", "DisplayText" : "Pyomyositis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "PYOMYOSITIS"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU REACT PRIM INFECT ZOSTER", "DisplayText" : "Reactivation of primary infection (Zoster or \"Shingles\") - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GMENU FEE BASIS CONSULT OPTIONS", "DisplayText" : "FEE BASIS CONSULT OPTIONS", "Text" : "Consult Dermatology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "REACTIVATION OF PRIMARY INFECTION (ZOSTER OR \"SHINGLES\")"}, 
{"Row" : 13, "Column" : 1, "Text" : "Zoster represents reactivation of varicella-zoster virus.  After primary"}, 
{"Row" : 14, "Column" : 1, "Text" : "infection, virus remains latent in the sensory dorsal root ganglia."}, 
{"Row" : 15, "Column" : 1, "Text" : "Reactivation syndrome is characterized by painful, unilateral, vesicular,"}, 
{"Row" : 16, "Column" : 1, "Text" : "dermatomal rash."}, 
{"Row" : 18, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment in persons >=50 years", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment with antivirals can shorten duration of pain and rash in patients over"}, 
{"Row" : 24, "Column" : 1, "Text" : "50 years old.  Treatment must be started within 72 hours of onset."}, 
{"Row" : 26, "Column" : 1, "Text" : "Treat for 7 days."}, 
{"Row" : 27, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 7DS 1000MG PO TID", "DisplayText" : "Valacyclovir 1000mg po tid for 7 days", "Text" : "Valacyclovir 1000 mg PO TID ($13/day) [R]", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Text" : "Treatment in persons <50 years", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Treatment is not beneficial, none is recommended."}, 
{"Row" : 32, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Immunocompromised patients at increased risk for complications of VZV disease"}, 
{"Row" : 38, "Column" : 1, "Text" : "include: patients with malignancy, current immunosuppressive therapy, or HIV"}, 
{"Row" : 39, "Column" : 1, "Text" : "infection.  Treatment with antivirals shortens duration of symptoms and reduces"}, 
{"Row" : 40, "Column" : 1, "Text" : "incidence of complications.  Treatment must be started within 72 hours of onset"}, 
{"Row" : 41, "Column" : 1, "Text" : "in order to provide benefit."}, 
{"Row" : 43, "Column" : 1, "Text" : "Treatment for MILD to MODERATE disease", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "Treat for 7 days."}, 
{"Row" : 45, "Column" : 1, "Item" : "PSOZID2 VALACYCLOVIR 7DS 1000MG PO TID", "DisplayText" : "Valacyclovir 1000mg po tid for 7 days", "Text" : "Valacyclovir 1000 mg PO TID ($13/day) [R]", "Mnemonic" : "16"},
{"Row" : 47, "Column" : 1, "Text" : "Treatment for SEVERE disease", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 51, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 53, "Column" : 1, "Text" : "\"Sanford\" keyword: Varicella"}, 
{"Row" : 54, "Column" : 1, "Text" : "\"Mandell\" chapter: Varicella"}
]},
{"Name" : "ORZID3 GMENU RECURRENT/PERSISTENT URETHRITIS", "DisplayText" : "Recurrent or persistent urethritis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology )", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "RECURRENT OR PERSISTENT URETHRITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment for recurrent or persistent urethritis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 20, "Column" : 1, "Text" : "MMWR 2002, 51: RR-06"}, 
{"Row" : 21, "Column" : 1, "Text" : "\"Sanford\" keyword: Urethritis"}, 
{"Row" : 14, "Column" : 1, "Item" : "ORZ SET ABX OP METRO 30DS 2GM PO X1 ERYTH BASE 500 QID", "DisplayText" : "", "Text" : "Metronidazole 2 gm PO ONCE ($0.64/day) [DI] <AND> erythromycin base 500 mg", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Text" : "PO QID for 7 days ($0.37/day) [DI]"}
]},
{"Name" : "ORZID3 GMENU RETINITIS", "DisplayText" : "Retinitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT OPHTHALMOLOGY", "DisplayText" : "OPHTHALMOLOGY", "Text" : "Consult Ophthamology", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ NEURO OPT", "DisplayText" : "Neurology", "Text" : "Consult Neurology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "RETINITIS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Retinitis is a subset of uveitis.  Retinitis is rare in immunocompetent people"}, 
{"Row" : 11, "Column" : 1, "Text" : "and is usually associated in these individuals with varicella-zoster or herpes"}, 
{"Row" : 12, "Column" : 1, "Text" : "simplex viruses."}, 
{"Row" : 14, "Column" : 1, "Text" : "Retinitis is more common in immunocompromised patients.  Cytomegalovirus is the"}, 
{"Row" : 15, "Column" : 1, "Text" : "most common pathogen (see cytomegalovirus section).  Other retinitis pathogens"}, 
{"Row" : 16, "Column" : 1, "Text" : "include Toxoplasma gondii, Bartonella henslae, Histoplasma capsulatum, and"}, 
{"Row" : 17, "Column" : 1, "Text" : "Treponema pallidum.  In most cases, patients have other neurological symptoms or"}, 
{"Row" : 18, "Column" : 1, "Text" : "signs.Patients with candidemia may present with 1-3 mm white punctate retinal"}, 
{"Row" : 19, "Column" : 1, "Text" : "lesions called \"cotton-wool\" spots.  These may only be visible on slit-lamp"}, 
{"Row" : 20, "Column" : 1, "Text" : "examination.  Treat candidal retinitis with systemic antifungal therapy."}, 
{"Row" : 21, "Column" : 1, "Text" : "Contact ophthalmology, infectious diseases, or neurology for help."}, 
{"Row" : 23, "Column" : 1, "Text" : "Ophthalmology consultation is essential."}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID3 GMENU CMV RETINITIS", "DisplayText" : "CMV retinitis (Outpatient)", "Text" : "Link to cytomegalovirus retinitis", "Mnemonic" : "10"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID3 GMENU FUNGI", "DisplayText" : "Fungi (Outpatient)", "Text" : "Link to candida (part of specific pathogens)", "Mnemonic" : "14"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 33, "Column" : 1, "Text" : "Ray S Int Ophth Clin 2001, 41: 83"}, 
{"Row" : 31, "Column" : 1, "Text" : "\"Mandell\" chapter: Infectious causes of uveitis"}, 
{"Row" : 32, "Column" : 1, "Text" : "\"Sanford\" keyword: retinitis"}
]},
{"Name" : "ORZID3 GMENU SECONDARY PERITONITIS", "DisplayText" : "Secondary peritonitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Gastroenterology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "SECONDARY PERITONITIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU SEPSIS AND SEPTIC SHOCK", "DisplayText" : "Sepsis, severe sepsis, and septic shock (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "SEPSIS, SEVERE SEPSIS, AND SEPTIC SHOCK"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU SEPTIC ARTH ENTEROCOCCI", "DisplayText" : "Septic arthritis (Native Joint) with Enterococci - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH ENTEROCOCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment, MILD-MODERATE infections", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSOZID2 AMOXICILLIN 14DS 500MG PO TID", "DisplayText" : "Amoxicillin 500mg po tid for 14 days", "Text" : "Amoxicillin 500 mg PO TID ($0.42/day) [R]", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Text" : "Treatment, SEVERE infections", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 20, "Column" : 1, "Text" : "\"Mandell\" chapter: Infectious arthritis of native joints"}, 
{"Row" : 21, "Column" : 1, "Text" : "\"Sanford\" keyword: Septic arthritis"}, 
{"Row" : 22, "Column" : 1, "Text" : "Johns Hopkins website: Septic arthritis"}
]},
{"Name" : "ORZID3 GMENU SEPTIC ARTH GNB", "DisplayText" : "Septic arthritis (Native Joint ) with Gram negative Bacilli - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH GRAM NEGATIVE BACILLI (OTHER THAN"}, 
{"Row" : 10, "Column" : 1, "Text" : "PSEUDOMONAS)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSOZID2 AMOX/CLAV 875/125MG 14DS PO BID", "DisplayText" : "Amoxicillin/clavulanate 875/125mg po bid for 14 days", "Text" : "Amoxicillin-clavulanate 875/125 mg PO BID ($1.56/day) [R] < OR >", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 14DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 14 days", "Text" : "Moxifloxacin 400 mg PO QDAY ($1.19/day) [DI]", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Text" : "\"Mandell\" chapter: Infectious arthritis of native joints"}, 
{"Row" : 20, "Column" : 1, "Text" : "\"Sanford\" keyword: Septic arthritis"}, 
{"Row" : 21, "Column" : 1, "Text" : "Johns Hopkins website: Septic arthritis"}
]},
{"Name" : "ORZID3 GMENU SEPTIC ARTH N. GONORRHOEAE", "DisplayText" : "Septic arthritis (Native Joint) with N. gonorrhoeae - Outpatient", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH NEISSERIA GONORRHOEAE"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treat presumptively also for Chlamydia trachomatis infection (asymptomatic"}, 
{"Row" : 12, "Column" : 1, "Text" : "urethritis) and test for HIV.  Infection control will report cases with N."}, 
{"Row" : 13, "Column" : 1, "Text" : "gonorrhea isolated to the Minnesota Department of Health."}, 
{"Row" : 15, "Column" : 1, "Text" : "Treatment for N. gonorrheae", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IVPB Q24H 7 DAYS", "DisplayText" : "Ceftriaxone 2GM IVPB Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($17/day) [M]", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 7 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 7 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "Concomitant treatment for C. trachomatis", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSOZID2 DOXYCYCLINE 100MG PO BID 7DAYS", "DisplayText" : "Doxycycline 100mg po BID for 7 days", "Text" : "Doxycycline 100 mg PO BID for 7 days ($0.16/day) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 23, "Column" : 1, "Item" : "PSOZID2 AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1gm po once", "Text" : "Azithromycin 1000 mg PO once ($16/day) [M]", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 28, "Column" : 1, "Text" : "\"Mandell\" chapter: Infectious arthritis of native joints"}, 
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" keyword: Septic arthritis"}, 
{"Row" : 30, "Column" : 1, "Text" : "Johns Hopkins website: Septic arthritis"}
]},
{"Name" : "ORZID3 GMENU SEPTIC ARTH P. AERUGINOSA", "DisplayText" : "Septic arthritis (Native Joint) with P. aeruginosa - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH PSEUDOMONAS AERUGINOSA"}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 750MG PO BID 14 DAYS", "DisplayText" : "Ciprofloxacin 750MG PO BID 14 DAYS", "Text" : "Ciprofloxacin 750 mg PO BID ($0.27/day) [R,DI]", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Text" : "\"Mandell\" chapter: Infectious arthritis of native joints"}, 
{"Row" : 18, "Column" : 1, "Text" : "\"Sanford\" keyword: Septic arthritis"}, 
{"Row" : 19, "Column" : 1, "Text" : "Johns Hopkins website: Septic arthritis"}
]},
{"Name" : "ORZID3 GMENU SEPTIC ARTH S. AUREUS", "DisplayText" : "Septic arthristis (Native Joint) with S. aureus - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 9, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH STAPHYLOCOCCUS AUREUS"}, 
{"Row" : 11, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Methicillin-SUSCEPTIBLE Staphylococcus aureus", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Methicillin-RESISTANT S. aureus", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "PSOZID DICLOXACILLIN 500MG PO Q6H", "DisplayText" : "Dicloxacillin 500MG PO Q6H", "Text" : ""},
{"Row" : 19, "Column" : 1, "Text" : "PENICILLIN ALLERGY", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO Q12H", "DisplayText" : "Bactrim DS PO Q12H", "Text" : ""},
{"Row" : 27, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO Q12H", "DisplayText" : "Bactrim DS PO Q12H", "Text" : ""},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID MINOCYCLINE 100MG PO BID", "DisplayText" : "Minocycline 100MG PO BID", "Text" : ""},
{"Row" : 30, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 31, "Column" : 1, "Item" : "PSOZID DOXYCYCLINE 100MG PO Q12H 7 DAYS", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" :""}
]},
{"Name" : "ORZID3 GMENU SEPTIC ARTH STREPTOCOCCI", "DisplayText" : "Septic arthritis (Native Joint) with Streptococci - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 9, "Column" : 1, "Text" : "SEPTIC ARTHRITIS (NATIVE JOINT) WITH STREPTOCOCCI"}, 
{"Row" : 11, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "PSOZID CEPHALEXIN 500MG PO QID", "DisplayText" : "Cephalexin 500MG PO QID", "Text" : ""},
{"Row" : 14, "Column" : 1, "Text" : "PENICILLIN ALLERGY", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO Q12H", "DisplayText" : "Bactrim DS PO Q12H", "Text" : ""}
]},
{"Name" : "ORZID3 GMENU SEPTIC BURSITIS", "DisplayText" : "Septic bursitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedic surgery", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "GMRCT RHEUMATOLOGY OPT", "DisplayText" : "RHEUMATOLOGY OPT", "Text" : "Consult Rheumatology", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "SEPTIC BURSITIS"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU SEVERE SINUSITIS", "DisplayText" : "Acute sinusitis--Severe disease (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Consult ENT", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ GMENU CT OPT MENU 11/11", "DisplayText" : "CT MENU", "Text" : "Order CT scan", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "SEVERE SINUSITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Most cases of acute sinusitis are viral.  Most of these resolve within 7 days."}, 
{"Row" : 14, "Column" : 1, "Text" : "Symptoms such as nasal congestion, purulent nasal discharge, and tooth or facial"}, 
{"Row" : 15, "Column" : 1, "Text" : "pain can be treated with decongestants, analgesics, and nasal saline.  Bacterial"}, 
{"Row" : 16, "Column" : 1, "Text" : "infection is more likely the causative agent when symptoms are present"}, 
{"Row" : 17, "Column" : 1, "Text" : "=10 days, fever =102oF and purulent discharge or facial pain for"}, 
{"Row" : 22, "Column" : 1, "Text" : "For patients who present with severe symptoms, like intense periorbital swelling"}, 
{"Row" : 23, "Column" : 1, "Text" : "and facial pain or changes in mental status, initiate empiric antimicrobials and"}, 
{"Row" : 24, "Column" : 1, "Text" : "obtain CT scan of sinuses to determine the extent of infection.  If the CT shows"}, 
{"Row" : 25, "Column" : 1, "Text" : "extension of sinusitis infection into surrounding structures (i.e., the cranium"}, 
{"Row" : 26, "Column" : 1, "Text" : "or orbit) consult ENT immediately.  Closely monitor all patients who present"}, 
{"Row" : 27, "Column" : 1, "Text" : "with severe signs and symptoms to ensure that signs and symptoms improve within"}, 
{"Row" : 28, "Column" : 1, "Text" : "72 hours."}, 
{"Row" : 30, "Column" : 1, "Text" : "If symptoms fail to respond or recur after 3-5 days of antimicrobial"}, 
{"Row" : 31, "Column" : 1, "Text" : "therapy, puncture and aspiration of sinuses is necessary to identify pathogens."}, 
{"Row" : 32, "Column" : 1, "Text" : "ENT consultation is recommended."}, 
{"Row" : 41, "Column" : 1, "Text" : "Alternative for Fluoroqinolone allergy", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "Treatment for patients that FAIL TO RESPOND to antimicrobial therapy or recur", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "after antimicrobial therapy has been completed consult ENT for puncture", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "and aspiration of sinuses.", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "3-4 consecutive days, or  worsening symptoms following a typical viral"}, 
{"Row" : 19, "Column" : 1, "Text" : "infection. Antimicrobials are indicated in these instances. Nasal  saline and"}, 
{"Row" : 20, "Column" : 1, "Text" : "intranasal corticosteroids are beneficial as adjunctive therapy."}, 
{"Row" : 34, "Column" : 1, "Text" : "Treatment of severe disease (high fever >39C or >102F and purulent nasal", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "discharge, intense periorbital swelling and facial pain lasting for at least 3-4", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "consecutive days at the beginning of illness, or changes in mental status)", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Recommended Treatment", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO Q24H 5 DAYS", "DisplayText" : "Levofloxacin 500MG PO Q24H 5 DAYS", "Text" : ""},
{"Row" : 42, "Column" : 1, "Item" : "PSOZID AMOXICILLIN/CLAVULANATE 875/125MG PO Q12H 5 DAYS", "DisplayText" : "Amoxicillin/Clavulanate 875/125MG PO Q12H 5 DAYS", "Text" : ""},
{"Row" : 51, "Column" : 1, "Text" : "Gilbert, DN et al eds. The Sanford Guide to Antimicrobial Therapy, 44th ed."}, 
{"Row" : 52, "Column" : 1, "Text" : "Sperryville, VA: Antimicrobial Therapy INC 2014. Pages 112"}, 
{"Row" : 53, "Column" : 1, "Text" : "Hwang P, et al. Acute sinusitis and rhinosinusitis in adults: treatment."}, 
{"Row" : 54, "Column" : 1, "Text" : "Up-to-Date website. Updated 02/26/2014. Accessed 03/05/2015."}, 
{"Row" : 55, "Column" : 1, "Text" : "Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for"}, 
{"Row" : 56, "Column" : 1, "Text" : "acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012"}, 
{"Row" : 57, "Column" : 1, "Text" : "54(8):e72-e112.Aring et al. Am Fam Phys. 2011"}, 
{"Row" : 58, "Column" : 1, "Text" : "Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, Dimopoulos G, Falagas ME."}, 
{"Row" : 59, "Column" : 1, "Text" : "Fluoroquinolones compared with beta-lactam antibiotics for the treatment"}, 
{"Row" : 60, "Column" : 1, "Text" : "of acute bacterial sinusitis: a meta-analysis of randomized controlled trials."}, 
{"Row" : 61, "Column" : 1, "Text" : "CMAJ. 2008"}, 
{"Row" : 62, "Column" : 1, "Text" : "Aring AM, Chan MM. Acute rhinosinusitis in adults. Am Fam Physician"}, 
{"Row" : 63, "Column" : 1, "Text" : "2011"}
]},
{"Name" : "ORZID3 GMENU SM UNIF BAC AEROBIC BOT", "DisplayText" : "Small uniform bacillin in an aerobic bottle (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "SMALL PLEOMORPHIC BACILLI IN AEROBIC BOTTLE"}, 
{"Row" : 8, "Column" : 1, "Text" : "SMALL PLEOMORPHIC BACILLI in AEROBIC bottle are usually diphtheroids.  These are"}, 
{"Row" : 9, "Column" : 1, "Text" : "usually contaminants. Rarely such organisms prove to be Listeria monocytogenes,"}, 
{"Row" : 10, "Column" : 1, "Text" : "which when present in a blood culture is likely a pathogen.  Listeria is more"}, 
{"Row" : 11, "Column" : 1, "Text" : "likely in patients with impaired cell-mediated immunity, pregnant women,"}, 
{"Row" : 12, "Column" : 1, "Text" : "elderly, patients on immunosuppressive therapy for transplantation."}, 
{"Row" : 14, "Column" : 1, "Text" : "For intravenous treatment options, please refer to Inpatient Antimicrobial CDSS."}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 19, "Column" : 1, "Text" : "Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA.  The Sanford Guide to"}, 
{"Row" : 20, "Column" : 1, "Text" : "Antimicrobial Therapy.  35th ed.  Hyde Park, VT: Antimicrobial Therapy Inc,"}, 
{"Row" : 21, "Column" : 1, "Text" : "2005."}, 
{"Row" : 22, "Column" : 1, "Text" : "Mandell GL, Bennett JE, Dolin R, eds.  Principles and Practice of Infectious"}, 
{"Row" : 23, "Column" : 1, "Text" : "Diseases.  6th ed.  Philadelphia, PA: Churchill-Livingston, 2005."}, 
{"Row" : 24, "Column" : 1, "Text" : "Anonymous.  Choice of antibacterial drugs.  Med Letter Treatment Guidelines"}, 
{"Row" : 25, "Column" : 1, "Text" : "2004, 2: 13"}, 
{"Row" : 26, "Column" : 1, "Text" : "Anonymous.  Antifungal drugs.  Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID3 GMENU SM UNIF BAC ANAEROBIC BOT", "DisplayText" : "Small uniform bacilli in an anaerobic bottle (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Help, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "SMALL PLEOMORPHIC BACILLI IN AN ANAEROBIC BOTTLE"}, 
{"Row" : 8, "Column" : 1, "Text" : "SMALL PLEOMORPHIC BACILLI in ANAEROBIC bottle usually suggest diphtheroids or"}, 
{"Row" : 9, "Column" : 1, "Text" : "propionibacteria.  These are often contaminants."}, 
{"Row" : 11, "Column" : 1, "Text" : "If treatment is necessary, intravenous antimicrobials are indicated.  Refer to"}, 
{"Row" : 12, "Column" : 1, "Text" : "Inpatient Antimicrobial CDSS."}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "06"},
{"Row" : 17, "Column" : 1, "Text" : "Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA.  The Sanford Guide to"}, 
{"Row" : 18, "Column" : 1, "Text" : "Antimicrobial Therapy.  35th ed.  Hyde Park, VT: Antimicrobial Therapy Inc,"}, 
{"Row" : 19, "Column" : 1, "Text" : "2005."}, 
{"Row" : 20, "Column" : 1, "Text" : "Mandell GL, Bennett JE, Dolin R, eds.  Principles and Practice of Infectious"}, 
{"Row" : 21, "Column" : 1, "Text" : "Diseases.  6th ed.  Philadelphia, PA: Churchill-Livingston, 2005."}, 
{"Row" : 22, "Column" : 1, "Text" : "Anonymous.  Choice of antibacterial drugs.  Med Letter Treatment Guidelines"}, 
{"Row" : 23, "Column" : 1, "Text" : "2004, 2: 13"}, 
{"Row" : 24, "Column" : 1, "Text" : "Anonymous.  Antifungal drugs.  Med Letter Treatment Guidelines 2005, 3: 7"}
]},
{"Name" : "ORZID3 GMENU SUPP ODONTOGENIC INFECT", "DisplayText" : "Suppurative odontogenic infections (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ DENTAL OPT", "DisplayText" : "DENTAL", "Text" : "Need help with dental issues?  Consult Dental service", "Mnemonic" : "10"},
{"Row" : 27, "Column" : 1, "Text" : "Treatment of MILD TO MODERATE disease", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 PENICILLIN V 7DS 500MG PO QID", "DisplayText" : "Penicillin V 500mg po qid for 7 days", "Text" : "Penicillin V 500 mg PO QID ($1.20/day) [R]  < OR >", "Mnemonic" : "12"},
{"Row" : 34, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "PSOZID2 CLINDAMYCIN 10DS 300MG PO QID", "DisplayText" : "Clindamycin 300mg po qid for 10 days", "Text" : "Clindamycin 300 mg PO QID ($3/day) [H,O]", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Text" : "\"Mandell\" Chapter: Infections of the Oral Cavity, Neck, and Head"}, 
{"Row" : 10, "Column" : 1, "Text" : "TOOTH ABSCESS AND OTHER SUPPURATIVE ODONTOGENIC INFECTIONS"}, 
{"Row" : 12, "Column" : 1, "Text" : "For apical infections and pulpitis, antimicrobials are ineffective.  Dental"}, 
{"Row" : 13, "Column" : 1, "Text" : "intervention is essential."}, 
{"Row" : 15, "Column" : 1, "Text" : "Periapical infections and deep space infections and gingivitis require drainage"}, 
{"Row" : 16, "Column" : 1, "Text" : "and debridement as well as systemic antimicrobials for cure.  Periodontal"}, 
{"Row" : 17, "Column" : 1, "Text" : "disease is treated with antimicrobial mouth rinse alone."}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID3 GMENU PERIODENTAL DISEASE", "DisplayText" : "Periodental disease (Outpatient)", "Text" : "Link to periodontal disease", "Mnemonic" : "11"},
{"Row" : 21, "Column" : 1, "Text" : "Penicillin is the drug of choice for treatment of dental infections.  Patients"}, 
{"Row" : 22, "Column" : 1, "Text" : "with immunocompromising conditions or recent hospitalization may be more likely"}, 
{"Row" : 23, "Column" : 1, "Text" : "to be infected with Gram-negative anaerobes that are resistant to penicillin."}, 
{"Row" : 24, "Column" : 1, "Text" : "In these patients, adding metronidazole to penicillin may be beneficial."}, 
{"Row" : 25, "Column" : 1, "Text" : "Clindamycin is the alternative for patients who are allergic to penicillin."}, 
{"Row" : 28, "Column" : 1, "Text" : "Treat for 7 days"}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZ SET ABX OP PENICILLIN 500MG QID METRONI 500MG QID", "DisplayText" : "", "Text" : "Penicillin V 500 mg PO QID ($1.20/day) [R]  <AND> metronidazole 500 mg PO", "Mnemonic" : "14"},
{"Row" : 32, "Column" : 1, "Text" : "QID ($0.64/day) [DI]"}
]},
{"Name" : "ORZID3 GMENU SURG APPENDECTOMY W/O PERFO", "DisplayText" : "Appendectomy without perforation (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "APPENDECTOMY WITHOUT PERFORATION"}, 
{"Row" : 12, "Column" : 1, "Text" : "In cases without evidence of perforation or rupture, antimicrobials are"}, 
{"Row" : 13, "Column" : 1, "Text" : "necessary only just before and during surgery.  Administer antimicrobials 60"}, 
{"Row" : 14, "Column" : 1, "Text" : "minutes before the first incision is made."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ZZORZ SET ABX CEFAZO 2 GM '20MIN' METRO 500MG '20MIN'", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV  ($1.86/day) [R] <AND> metronidazole 500 mg IV ($1/day)", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Text" : "[DI] both given over 20 minutes beginning 60 minutes before incision  < OR >"}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZ SET ABX GENTAM 80MG IV 20MIN METRO 500MG IV X1", "DisplayText" : "", "Text" : "Gentamicin 80 mg IV x 1 ($1/day) [R,O] <AND> metronidazole 500 mg IV", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Text" : "($1/day) [DI] both given over 20 minutes beginning 60 minutes before"}, 
{"Row" : 22, "Column" : 1, "Text" : "incision"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "\"Sanford\": key term: Appendicitis"}, 
{"Row" : 28, "Column" : 1, "Text" : "Solomkin JS  Clin Infect Dis 2003, 37: 997-1005"}, 
{"Row" : 29, "Column" : 1, "Text" : "Up-to-date: Appendicitis"}
]},
{"Name" : "ORZID3 GMENU SURG BILIARY SURGERY", "DisplayText" : "Biliary surgery (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "BILIARY SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Prophylaxis is indicated for patients over 70 years of age or patients with"}, 
{"Row" : 13, "Column" : 1, "Text" : "acute cholecystitis, common duct stones, biliary obstruction, or a non-"}, 
{"Row" : 14, "Column" : 1, "Text" : "functioning gall bladder."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "($1.72/day) [R] < OR >"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 31, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 33, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"}
]},
{"Name" : "ORZID3 GMENU SURG CARDIAC SURGERY", "DisplayText" : "Cardiac surgery and implantation of pacemaker (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Cardiothoracic Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "CARDIAC SURGERY AND IMPLANTATION OF PACEMAKER"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial prophylaxis is not indicated before cardiac catheterization."}, 
{"Row" : 14, "Column" : 1, "Text" : "No evidence supports the use of post-operative prophylactic antimicrobials."}, 
{"Row" : 15, "Column" : 1, "Text" : "However, due to the potentially devastating consequences of sternal wound"}, 
{"Row" : 16, "Column" : 1, "Text" : "infection, expert opinion supports use of a limited number of post-operative"}, 
{"Row" : 17, "Column" : 1, "Text" : "doses.  Discontinue antimicrobials by 48 hours after the procedure, regardless"}, 
{"Row" : 18, "Column" : 1, "Text" : "of the presence of postoperative drains or tubes."}, 
{"Row" : 20, "Column" : 1, "Text" : "Cefazolin is preferred for prophylaxis, as it is more active than vancomycin"}, 
{"Row" : 21, "Column" : 1, "Text" : "against susceptible staphylococci.  Vancomycin should be used when methicillin-"}, 
{"Row" : 22, "Column" : 1, "Text" : "resistant Staphylococcus aureus infection is likely.  Consult Cardiothoracic"}, 
{"Row" : 23, "Column" : 1, "Text" : "Surgery or Infectious Diseases for more information."}, 
{"Row" : 25, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "If vancomycin is used give 1000 mg to patients weighing less than 100 kg.  Give"}, 
{"Row" : 27, "Column" : 1, "Text" : "1500 mg if the patient weights 100 or more kg."}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID CEFAZ 2GM IV ONCE THEN 2GM IV Q8H", "DisplayText" : "Cefazolin 2gm iv once then 2gm iv q8h for 5 doses", "Text" : "Cefazolin 2 gm IV ($5.16/day) [R] over 20 minutes beginning 60 minutes", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Text" : "before incision, then 2 gm q8h for 5 doses post-operatively < OR >"}, 
{"Row" : 32, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE THEN Q12H 3 DOSES", "DisplayText" : "Vanco Pharmacy To Dose 1000MG ONCE, THEN Q12H 3 DOSES", "Text" : "Vancomycin 1 gm IV ($2.94/day) [R] over 60 minutes beginning 120 minutes", "Mnemonic" : "14"},
{"Row" : 33, "Column" : 1, "Text" : "before incision, then 1 gm IV q12h for 3 doses post-operatively  < OR >"}, 
{"Row" : 35, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG ONCE, 1GM Q12H 3 DOSES", "DisplayText" : "Vanco Pharmacy To Dose 1500MG ONCE, 1000MG Q12H 3 DOSES", "Text" : "Vancomycin 1500 mg IV ($4.41/day) [R] over 60 minutes beginning 120 minutes", "Mnemonic" : "16"},
{"Row" : 36, "Column" : 1, "Text" : "before incision, then 1 gm IV q12h for 3 doses post-operatively"}, 
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 41, "Column" : 1, "Text" : "Bratzler, DW Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 42, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 43, "Column" : 1, "Text" : "\"Sanford\" keyword: Antimicrobial Therapy"}, 
{"Row" : 44, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 45, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 46, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 47, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID3 GMENU SURG COLON RECTAL SURG", "DisplayText" : "Colon and rectal surgery (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Consult General Surgery", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "COLON AND RECTAL SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Bowel cleansing preparations and orally administered antimicrobials are"}, 
{"Row" : 13, "Column" : 1, "Text" : "sufficient for some elective procedures.  For procedures like colectomy, bowel"}, 
{"Row" : 14, "Column" : 1, "Text" : "cleansing preparations and oral antimicrobials are given in addition to"}, 
{"Row" : 16, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Bowel preparation", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZ SET ABX OP METOCLOPRAMIDE 10MG GOLYTELY 4L PO", "DisplayText" : "", "Text" : "Metoclopramide 10 mg PO once <AND> Golytely 4 L PO starting in the afternoon", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "the day before the procedure"}, 
{"Row" : 23, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Oral antimicrobials", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Item" : "ORZ SET ABX OP ERYTH BASE 1GM PO NEOMYCIN 1GM PO", "DisplayText" : "", "Text" : "Erythromycin base 1 g PO ($0.19/day) [DI] <AND> neomycin 1 g PO ($1.40/day)", "Mnemonic" : "14"},
{"Row" : 28, "Column" : 1, "Text" : "[M] for 3 doses, both given once 3 hours and 4 hours after starting"}, 
{"Row" : 29, "Column" : 1, "Text" : "Golytely, and at 23:00 the day before surgery only"}, 
{"Row" : 31, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "_____________________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Intravenous antimicrobials", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Cefazolin alone may be sufficient if pre-operative bowel preparations and oral"}, 
{"Row" : 36, "Column" : 1, "Text" : "antimicrobials have been given.  If surgery is emergent, metronidazole and"}, 
{"Row" : 37, "Column" : 1, "Text" : "cefazolin should be given."}, 
{"Row" : 39, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "($1.72/day) [R] < OR >"}, 
{"Row" : 43, "Column" : 1, "Item" : "ZZORZ SET ABX CEFAZO 2 GM '20MIN' METRO 500MG '20MIN'", "DisplayText" : "", "Text" : "Cefazolin 2gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "18"},
{"Row" : 44, "Column" : 1, "Text" : "($1.72/day) [R] <AND> metronidazole 500 mg IV over 20 minutes beginning 60"}, 
{"Row" : 45, "Column" : 1, "Text" : "minutes before incision (1$/day) [DI]"}, 
{"Row" : 47, "Column" : 1, "Text" : "Alternative for severe penicillin allergy", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Item" : "PSJIZID GENT 80MG IV ONCE 'C'", "DisplayText" : "Gentamicin 80mg iv once", "Text" : "Gentamicin 80 mg IV over 20 minutes ($1/day) [R,O] beginning 60 minutes", "Mnemonic" : "20"},
{"Row" : 49, "Column" : 1, "Text" : "before incision < OR >"}, 
{"Row" : 51, "Column" : 1, "Item" : "ORZ SET ABX GENTAM 80MG IV 20MIN METRO 500MG IV X1", "DisplayText" : "", "Text" : "Gentamicin 80 mg IV over 20 minutes ($1/day) [R,O] beginning 60 minutes", "Mnemonic" : "22"},
{"Row" : 52, "Column" : 1, "Text" : "before incision <AND> metronidazole 500 mg IV ($1/day) [DI] over 20 minutes"}, 
{"Row" : 53, "Column" : 1, "Text" : "beginning 60 minutes before incision"}, 
{"Row" : 56, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "24"},
{"Row" : 15, "Column" : 1, "Text" : "intravenous antimicrobials."}, 
{"Row" : 58, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 59, "Column" : 1, "Text" : "Anonymous  Med Lett 2001, 43: 92"}, 
{"Row" : 60, "Column" : 1, "Text" : "\"Sanford\" keyword: Guide to Antimicrobial Therapy"}, 
{"Row" : 61, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 62, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 63, "Column" : 1, "Text" : "Anonymous  J Urol 2003, 169: 1796"}, 
{"Row" : 64, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 24"}, 
{"Row" : 40, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "16"}
]},
{"Name" : "ORZID3 GMENU SURG ERCP", "DisplayText" : "Endoscopic Retrograde Cholangiopancreatography (ERCP) - Outpatient ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP)"}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID AMPICIL 1GM IV ONCE '20MIN - 60MIN'", "DisplayText" : "Ampicillin 1GM IVPB ONCE 60MIN Prior to Incision", "Text" : "Ampicillin 1 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"},
{"Row" : 22, "Column" : 1, "Text" : "($6/day) [R]  < OR >"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX AMPICI 1GM IV 20MIN GENT 80MG IV 20MIN", "DisplayText" : "", "Text" : "Ampicillin 1 gm IV over 20 minutes ($6/day) [R] < AND > gentamicin 80 mg", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "over 20 minutes ($3/day) [R,O] both beginning 60 minutes before incision"}, 
{"Row" : 27, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy to Dose 1000MG", "Text" : "Vancomycin 1 gm IV over 60 minutes beginning 120 minutes before incision", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Text" : "($3/day) [R] < OR >"}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZ SET ABX VANCOM 1GM IV 60MIN GENT 80MG IV ONCE", "DisplayText" : "", "Text" : "Vancomycin 1 gm IV over 60 minutes beginning 120 minutes before incision", "Mnemonic" : "18"},
{"Row" : 32, "Column" : 1, "Text" : "($3/day) [R] < AND > gentamicin 80 mg ($3/day) [R,O] over 20 minutes"}, 
{"Row" : 33, "Column" : 1, "Text" : "beginning 60 minutes before incision"}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 38, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 39, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 40, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 41, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 42, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 43, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 44, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobials are not indicated in the absence of obstruction or intervention."}, 
{"Row" : 13, "Column" : 1, "Text" : "If obstruction is present or intervention is likely give a Gram-positive"}, 
{"Row" : 14, "Column" : 1, "Text" : "antimicrobial.  Use of gentamicin is optional.  Contact Gastroenterology for"}, 
{"Row" : 15, "Column" : 1, "Text" : "more information.  If drainage is incomplete, prophylactic antimicrobials after"}, 
{"Row" : 16, "Column" : 1, "Text" : "ERCP may be indicated."}, 
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 GMENU SURG ERCP IMCOMP DRAINAGE", "DisplayText" : "Antimicrobial Prophylaxis After ERCP with Incomplete Drainage (Outpatient)", "Text" : "Antimicrobial prophylaxis after ERCP with incomplete drainage", "Mnemonic" : "11"}
]},
{"Name" : "ORZID3 GMENU SURG ERCP IMCOMP DRAINAGE", "DisplayText" : "Antimicrobial Prophylaxis After ERCP with Incomplete Drainage (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "See drug information Page.  Important drug properties: [R]=renal excretion,", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Text" : "[H]=hepatic excretion, [DI]=important drug interactions, [O]=other."}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ANTIMICROBIAL PROPHYLAXIS AFTER ERCP WITH INCOMPLETE DRAINAGE"}, 
{"Row" : 12, "Column" : 1, "Text" : "No antimicrobials are needed after ERCP if adequate drainage is accomplished."}, 
{"Row" : 13, "Column" : 1, "Text" : "When drainage is incomplete or if dye may be trapped in the biliary tract,"}, 
{"Row" : 14, "Column" : 1, "Text" : "patients are at a higher risk of sepsis.  In these cases, give a 5 day course of"}, 
{"Row" : 15, "Column" : 1, "Text" : "oral antimicrobials."}, 
{"Row" : 17, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 5 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 5 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID($0.18/day) [R,DI] < OR >", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "PSOZID2 MOXIFLOXACIN 5DS 400MG PO QDAY", "DisplayText" : "Moxifloxacin 400mg po qday for 5 days", "Text" : "Moxifloxacin 400 mg PO qday ($1.19/day) [DI]", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 23, "Column" : 1, "Text" : "Byl B  Clin Infect Dis 1995, 20: 1236"}, 
{"Row" : 24, "Column" : 1, "Text" : "Harris A  Endoscopy 1999, 31: 718"}
]},
{"Name" : "ORZID3 GMENU SURG ESOPHAGEAL SURGERY", "DisplayText" : "Esophageal surgery (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ESOPHAGEAL SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Cefazolin is preferred for prophylaxis unless the patient is colonized or was"}, 
{"Row" : 13, "Column" : 1, "Text" : "recently infected with methicillin-resistant Staphylococcus aureus (MRSA)."}, 
{"Row" : 15, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX CEFAZO 2GM IV '20MIN' METRON 500 IV '30MIN'", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV  over 20 minutes ($1.72/day) [R] <AND> metronidazole 500", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Text" : "mg IV ($0.94/day) [DI] over 30 minutes both beginning 60 minutes before"}, 
{"Row" : 18, "Column" : 1, "Text" : "incision"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative for patient with severe penicillin allergy", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes, beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 24, "Column" : 1, "Text" : "Alternative for patient colonized or recently infected with MRSA", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy to Dose 1000MG", "Text" : "Vancomycin 1 gm IV over 60 minutes beginning 120 minutes before incision", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Text" : "($2.94/day) [R]"}, 
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "Bratzler, DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" keyword: prophylaxis"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 35, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 36, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 37, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID3 GMENU SURG GASTROINTESTINAL SURG", "DisplayText" : "Gastrointestinal surgery (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GASTROINTESTINAL SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Prophylaxis is indicated only in patients with unusual risk for infection."}, 
{"Row" : 13, "Column" : 1, "Text" : ">>  Patients with high gastric pH or acid-suppression therapy,"}, 
{"Row" : 14, "Column" : 1, "Text" : ">>  Patients with decreased gastrointestinal motility due to obstruction,"}, 
{"Row" : 16, "Column" : 1, "Text" : ">>  Obese patients"}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "($1.72/day) [R]"}, 
{"Row" : 22, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "($5.51/day)[H,O]"}, 
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 15, "Column" : 1, "Text" : "hemorrhage, gastric ulcer, malignancy, or diabetic gastroparesis, or"}, 
{"Row" : 29, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 31, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 33, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 35, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"}
]},
{"Name" : "ORZID3 GMENU SURG GYNECOLOGICAL SURGERY", "DisplayText" : "Gynecological surgery (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT GYNECOLOGY OPT", "DisplayText" : "GYNECOLOGY OPT", "Text" : "Consult Gynecology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "GYNECOLOGICAL SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "For abdominal or vaginal hysterectomy cefazolin alone is sufficient for most"}, 
{"Row" : 13, "Column" : 1, "Text" : "procedures.  Metronidazole may be added in cases where additional anaerobic"}, 
{"Row" : 14, "Column" : 1, "Text" : "coverage is desired."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "($1.72/day) [R]"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative if additional anaerobic coverage is desired", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "ZZORZ SET ABX CEFAZO 2 GM '20MIN' METRO 500MG '20MIN'", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV ($1.72/day) [R] <AND> metronidazole 500 mg IV ($1/day]", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "[DI] over 20 minutes beginning 60 minutes before incision"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "Bratzler DW Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 31, "Column" : 1, "Text" : "Magnus G Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 33, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"}
]},
{"Name" : "ORZID3 GMENU SURG HEAD AND NECK SURG", "DisplayText" : "Head and neck surgery (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "HEAD AND NECK SURGERY"}, 
{"Row" : 11, "Column" : 1, "Text" : "Prophylaxis is only indicated before procedures that involve incision through"}, 
{"Row" : 12, "Column" : 1, "Text" : "oral or pharyngeal mucosa.  For procedures that enter the pharynx post-"}, 
{"Row" : 13, "Column" : 1, "Text" : "operateive doses should be discontinued within 24 hours."}, 
{"Row" : 15, "Column" : 1, "Text" : "Procedures that INVOLVE INCISION through oral mucosa but DO NOT enter the", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "pharynx", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 1GM IV ONCE 'C'", "DisplayText" : "Cefazolin 1GM IVPB ONCE", "Text" : "Cefazolin 1 gm IV ($0.86/day) [R] over 20 minutes beginning 60 minutes", "Mnemonic" : "10"},
{"Row" : 19, "Column" : 1, "Text" : "before incision"}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes ($5.51/day) [H,O] beginning 60 minutes", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "before incision"}, 
{"Row" : 25, "Column" : 1, "Text" : "Procedures that ENTER THE PHARYNX", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "PSJIZID CEFAZO 1GM IV ONCE THEN Q8H '2DOSES'", "DisplayText" : "Cefazolin 1GM IVPB ONCE THEN Q8H X2DOSES", "Text" : "Cefazolin 1 gm IV ($0.86/day) [R] over 20 minutes beginning 60 minutes", "Mnemonic" : "14"},
{"Row" : 27, "Column" : 1, "Text" : "before incision, then q8h for 2 doses post-operatively"}, 
{"Row" : 29, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID CLINDAMY 600MG IV ONCE '30MIN' THEN Q8H", "DisplayText" : "Clindamycin 600mg iv once then q8h 2 doses", "Text" : "Clindamycin 600 mg IV over 30 minutes ($5.51/day) [H,O] beginning 60 minutes", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Text" : "before incision, then q8h for 2 doses post-operatively"}, 
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 36, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 37, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 38, "Column" : 1, "Text" : "\"Sanford\" keyword: Antimicrobial Therapy"}, 
{"Row" : 39, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 40, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 41, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 42, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID3 GMENU SURG HERNIA REPAIR SURG", "DisplayText" : "Hernia repair surgery with abdominal mesh (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Consult General Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "HERNIA REPAIR SURGERY WITH ABDOMINAL MESH"}, 
{"Row" : 12, "Column" : 1, "Text" : "Hernia repair surgery without mesh is a clean surgery that does not require"}, 
{"Row" : 13, "Column" : 1, "Text" : "prophylaxis.  When mesh is implanted, prophylaxis is indicated because infection"}, 
{"Row" : 14, "Column" : 1, "Text" : "is difficult to cure."}, 
{"Row" : 16, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "($1.72/day) [R]"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative for penicillin allergy", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 28, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 29, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 30, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 31, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 33, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"}
]},
{"Name" : "ORZID3 GMENU SURG MORE INFO UROLO PROC", "DisplayText" : "Approach to antimicrobial prophylaxis for urological procedures ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "618392", "DisplayText" : "", "Text" : "Consult Urology", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GMENU HEPARIN INFUSIONS", "DisplayText" : "HEPARIN ORDER SHEET", "Text" : "Consult Infectious Diseases", "Mnemonic" : "06"}
]},
{"Name" : "ORZID3 GMENU SURG NEUROSURGERY", "DisplayText" : "Neurosurgery (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ ADD MENU NEUROSURGERY CONSULT", "DisplayText" : "Neurosurgery Consult", "Text" : "Consult Neurosurgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "NEUROSURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "The antimicrobials listed are indicated for prophylaxis of craniotomy,"}, 
{"Row" : 13, "Column" : 1, "Text" : "implantation of cerebrospinal fluid (CSF) shunt, spinal fusion surgery, and"}, 
{"Row" : 14, "Column" : 1, "Text" : "spinal surgery involving prosthetic material.  For procedures that involve"}, 
{"Row" : 15, "Column" : 1, "Text" : "incision through the oral or pharyngeal mucosa, coverage for oral flora is"}, 
{"Row" : 16, "Column" : 1, "Text" : "needed."}, 
{"Row" : 18, "Column" : 1, "Text" : "Cefazolin is preferred for most patients as it penetrates into the cerebrospinal"}, 
{"Row" : 19, "Column" : 1, "Text" : "fluid and is more active than vancomycin against susceptible staphylococci."}, 
{"Row" : 20, "Column" : 1, "Text" : "Vancomycin should be used when the patient is colonized or has been recently"}, 
{"Row" : 21, "Column" : 1, "Text" : "infected with methicillin-resistant Staphylococcus aureus.  Consult Neurosurgery"}, 
{"Row" : 22, "Column" : 1, "Text" : "or Infectious Diseases for more information."}, 
{"Row" : 24, "Column" : 1, "Text" : "_____________________________________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "_____________________________________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "For procedures that DO NOT involve incision through oral or pharyngeal mucosa", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Preferred prophylaxis", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "($1.72/day) [R]"}, 
{"Row" : 32, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1500MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy To Dose 1500MG ONCE", "Text" : "Vancomycin 1500 mg IV over 90 minutes beginning 120 minutes before incision", "Mnemonic" : "14"},
{"Row" : 34, "Column" : 1, "Text" : "($8.82/day) [R]"}, 
{"Row" : 36, "Column" : 1, "Text" : "_____________________________________________________________________________", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "_____________________________________________________________________________", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "For procedures that INVOLVE INCISION through oral or pharyngeal mucosa", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Item" : "PSJIZID CLINDAMY 900MG IV ONCE '30MIN-60MIN'", "DisplayText" : "Clindamycin 900mg iv once", "Text" : "Clindamycin 900 mg IV over 30 minutes beginning 60 minutes of incision", "Mnemonic" : "16"},
{"Row" : 41, "Column" : 1, "Text" : "($8.87/day) [H,O] < OR >"}, 
{"Row" : 43, "Column" : 1, "Item" : "ZZORZ SET ABX CEFAZO 2 GM '20MIN' METRO 500MG '20MIN'", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV ($1.72/day) [R] <AND> metronidazole 500 mg IV ($0.94/day)", "Mnemonic" : "18"},
{"Row" : 44, "Column" : 1, "Text" : "[DI], both over 20 minutes beginning 60 minutes before incision"}, 
{"Row" : 47, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 49, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 50, "Column" : 1, "Text" : "Anonymous  Med Lett 2001, 43: 92"}, 
{"Row" : 51, "Column" : 1, "Text" : "\"Sanford\" keyword: Guide to Antimicrobial Therapy"}, 
{"Row" : 52, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 53, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 54, "Column" : 1, "Text" : "Anonymous  J Urol 2003, 169: 1796"}, 
{"Row" : 55, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 24"}, 
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "12"}
]},
{"Name" : "ORZID3 GMENU SURG ORTHOPEDIC SURGERY", "DisplayText" : "Orthopedic surgery (including joint arthroplasty) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ ORTHOPEDICS OPT", "DisplayText" : "Orthopedics OPT", "Text" : "Consult Orthopedics Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "ORTHOPAEDIC SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Orthopaedic procedures usually do not require antimicrobial prophylaxis."}, 
{"Row" : 13, "Column" : 1, "Text" : "Antimicrobial prophylaxis is indicated in cases involving joint replacement,"}, 
{"Row" : 14, "Column" : 1, "Text" : "internal fixation, or fracture repair."}, 
{"Row" : 16, "Column" : 1, "Text" : "Cefazolin is preferred for prophylaxis, as it is more active than vancomycin"}, 
{"Row" : 17, "Column" : 1, "Text" : "against susceptible staphylococci, the most common surgical pathogens."}, 
{"Row" : 18, "Column" : 1, "Text" : "Vancomycin should be used when methicillin-resistant Staphylococcus aureus"}, 
{"Row" : 19, "Column" : 1, "Text" : "infection, in patients who are colonized or were recently infected with"}, 
{"Row" : 20, "Column" : 1, "Text" : "methicillin-resistant Staphylococcus aureus."}, 
{"Row" : 22, "Column" : 1, "Text" : "No evidence supports the use of post-operative prophylactic antimicrobials."}, 
{"Row" : 23, "Column" : 1, "Text" : "However, due to the serious consequences of post-operative hip infection,"}, 
{"Row" : 24, "Column" : 1, "Text" : "clinical practice is often to give antimicrobials after hip operations.  These"}, 
{"Row" : 25, "Column" : 1, "Text" : "should be continued for no more than 24 hours.  Longer durations provide no"}, 
{"Row" : 26, "Column" : 1, "Text" : "additional benefit and are associated with side effects, increased costs, and"}, 
{"Row" : 27, "Column" : 1, "Text" : "bacterial resistance."}, 
{"Row" : 29, "Column" : 1, "Text" : "Prophylaxis for surgery INVOLVING THE HIP", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "In clinical practice, antimicrobials are usually continued for 24 hours after"}, 
{"Row" : 31, "Column" : 1, "Text" : "the procedure in orthopedic surgery involving the hip."}, 
{"Row" : 34, "Column" : 1, "Text" : "($5.16/day) [R] < OR >"}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG Q12H 2 DOSES", "DisplayText" : "Vanco Pharmacy To Dose 1000MG Q12H 2 DOSES", "Text" : "Vancomycin 1 gm IV q12h for 2 doses beginning 120 min before first incision", "Mnemonic" : "14"},
{"Row" : 37, "Column" : 1, "Text" : "($5.88/day) [R]"}, 
{"Row" : 39, "Column" : 1, "Text" : "Prophylaxis for surgery involving a JOINT OTHER THAN THE HIP", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "One prophylactic dose is sufficient for orthopedic surgery involving joints"}, 
{"Row" : 41, "Column" : 1, "Text" : "other than hips.  For joint replacement, internal fixation, or repair of"}, 
{"Row" : 42, "Column" : 1, "Text" : "fracture"}, 
{"Row" : 44, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 20 minutes beginning 60 minutes before incision", "Mnemonic" : "16"},
{"Row" : 47, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy to Dose 1000MG", "Text" : "Vancomycin 1 gm IV over 60 minutes beginning 120 minutes before incision", "Mnemonic" : "18"},
{"Row" : 48, "Column" : 1, "Text" : "($2.94/day) [R]"}, 
{"Row" : 45, "Column" : 1, "Text" : "($1.72/day) [R] < OR >"}, 
{"Row" : 51, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 53, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 54, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 55, "Column" : 1, "Text" : "\"Sanford\" keyword: Prophylaxis"}, 
{"Row" : 56, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 57, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 58, "Column" : 1, "Text" : "Anonymous J Urol 2003, 169: 1796"}, 
{"Row" : 59, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}, 
{"Row" : 33, "Column" : 1, "Item" : "PSJIZID CEFAZO 2GM IV ONCE '20MIN'", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV q8h for 3 doses beginning 60 min before first incision", "Mnemonic" : "12"}
]},
{"Name" : "ORZID3 GMENU SURG SITE INFECT", "DisplayText" : "Surgical site infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "SURGICAL SITE INFECTION"}, 
{"Row" : 8, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU SURG THORACIC SURGERY", "DisplayText" : "Thoracic surgery (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT THORACIC/CARD/VASCULAR INP", "DisplayText" : "THORACIC/CARD/VASCULAR INP", "Text" : "Consult Thoracic Surgery", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "THORACIC SURGERY"}, 
{"Row" : 12, "Column" : 1, "Text" : "Cefazolin is preferred for prophylaxis unless the patient is colonized or was"}, 
{"Row" : 13, "Column" : 1, "Text" : "recently infected with methicillin-resistant Staphylococcus aureus (MRSA)."}, 
{"Row" : 15, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZ SET ABX CEFAZO 2GM IV '20MIN' METRON 500 IV '30MIN'", "DisplayText" : "", "Text" : "Cefazolin 2 gm IV over 20 minutes ($1.72/day) [R] <AND> metronidazole 500 mg", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Text" : "IV ($0.94/day) [DI] over 30 minutes both beginning 60 minutes before"}, 
{"Row" : 18, "Column" : 1, "Text" : "incision"}, 
{"Row" : 20, "Column" : 1, "Text" : "Alternative for patient with severe penicillin allergy", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes, beginning 60 minutes before incision", "Mnemonic" : "14"},
{"Row" : 22, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 24, "Column" : 1, "Text" : "Alternative for patient colonized or recently infected with MRSA", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSJUZID VANCO PHARMACY TO DOSE 1000MG ONCE 'BEGIN 120MIN'", "DisplayText" : "Vanco Pharmacy to Dose 1000MG", "Text" : "Vancomycin 1 gm IV over 60 minutes beginning 120 minutes before incision", "Mnemonic" : "16"},
{"Row" : 26, "Column" : 1, "Text" : "($2.94/day) [R]"}, 
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 31, "Column" : 1, "Text" : "Bratzler, DW.  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 32, "Column" : 1, "Text" : "Anonymous Med Lett 2001, 43: 92"}, 
{"Row" : 33, "Column" : 1, "Text" : "\"Sanford\" keyword: Antimicrobial Therapy"}, 
{"Row" : 34, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 35, "Column" : 1, "Text" : "Magnus G  Curr Opin Urol 2001, 11: 81"}, 
{"Row" : 36, "Column" : 1, "Text" : "Anonymous  J Urol 2003, 169: 1796"}, 
{"Row" : 37, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 250"}
]},
{"Name" : "ORZID3 GMENU SURG UROLOGICAL PROCED", "DisplayText" : "Urological procedures (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, restrictions, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "UROLOGICAL PROCEDURES"}, 
{"Row" : 12, "Column" : 1, "Text" : "Many procedures do not need antimicrobial prophylaxis."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU SURG MORE INFO UROLO PROC", "DisplayText" : "Infomation on antimicrobial prophylaxis in urological procedures", "Text" : "Click here for information on antimicrobial prophylaxis in urological", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Text" : "procedures"}, 
{"Row" : 16, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment of bacteriuria before procedures", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Before procedures where prosthetic material will not be placed, treat for 2 to 3"}, 
{"Row" : 21, "Column" : 1, "Text" : "days.  Before procedures where prosthetic material will be placed, treat for 5"}, 
{"Row" : 22, "Column" : 1, "Text" : "to 7 days."}, 
{"Row" : 24, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 3 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID($0.18/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Prophylaxis", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID CIPROFL 400MG IV ONCE '60-120MIN'", "DisplayText" : "Ciprofloxacin 400MG IVPB ONCE", "Text" : "Ciprofloxacin 400 mg IV ($3/day) [R,DI] over 60 minutes beginning 120", "Mnemonic" : "16"},
{"Row" : 31, "Column" : 1, "Text" : "minutes before incision < OR >"}, 
{"Row" : 33, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO ONE '120MIN'", "DisplayText" : "Ciprofloxacin 500MG PO ONCE", "Text" : "Ciprofloxacin 500 mg PO ($0.09/day) [R,DI] beginning 120 minutes before", "Mnemonic" : "18"},
{"Row" : 34, "Column" : 1, "Text" : "incision"}, 
{"Row" : 36, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "____________________________________________________________________________", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "For cases that involve incisions through colo-rectal tissues", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Bowel preparation and oral antimicrobials should be given in addition to"}, 
{"Row" : 41, "Column" : 1, "Text" : "intravenous antimicrobials."}, 
{"Row" : 43, "Column" : 1, "Text" : "Bowel preparation and oral antimicrobials", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Item" : "ORZ SET ABX OP METOCLOP, GOLYTELY, ERYTH BS, NEOMYCIN", "DisplayText" : "", "Text" : "Metoclopramide 10 mg PO x 1, then Golytely 4 L PO starting in the afternoon", "Mnemonic" : "20"},
{"Row" : 45, "Column" : 1, "Text" : "the day before the procedure <AND> erythromycin base 1 g ($0.19/day) [DI]"}, 
{"Row" : 46, "Column" : 1, "Text" : "< AND > neomycin 1 g PO ($1.40/day) [R] for 3 doses, both given once 3 hours"}, 
{"Row" : 47, "Column" : 1, "Text" : "and 4 hours after starting Golytely, and at 23:00 the day before surgery"}, 
{"Row" : 48, "Column" : 1, "Text" : "only"}, 
{"Row" : 50, "Column" : 1, "Text" : "Intravenous antimicrobials", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Item" : "ZZORZ SET ABX CEFAZO 2 GM '20MIN' METRO 500MG '20MIN'", "DisplayText" : "", "Text" : "Cefazolin 2gm IV over 20 minutes ($1.72/day) [R] beginning 60 minutes before", "Mnemonic" : "22"},
{"Row" : 52, "Column" : 1, "Text" : "incision < AND > metronidazole 500 mg IV over 20 minutes ($1/day) [DI] 60"}, 
{"Row" : 53, "Column" : 1, "Text" : "minutes before incision < OR >"}, 
{"Row" : 55, "Column" : 1, "Item" : "ORZ SET ABX GENTAM 80MG IV 20MIN METRO 500MG IV X1", "DisplayText" : "", "Text" : "Gentamicin 80 mg IV over 20 minutes ($1/day) [R,O] beginning 60 minutes", "Mnemonic" : "24"},
{"Row" : 56, "Column" : 1, "Text" : "before incision < AND > metronidazole 500 mg IV ($1/day) [DI] over 20"}, 
{"Row" : 57, "Column" : 1, "Text" : "minutes beginning 60 minutes before incision"}, 
{"Row" : 60, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 62, "Column" : 1, "Text" : "Bratzler DW  Clin Infect Dis 2004, 38: 1706"}, 
{"Row" : 63, "Column" : 1, "Text" : "Anonymous  Med Lett 2001, 43: 92"}, 
{"Row" : 64, "Column" : 1, "Text" : "\"Sanford\" keyword: Guide to Antimicrobial Therapy"}, 
{"Row" : 65, "Column" : 1, "Text" : "Anonymous  Am J Health-Syst Pharm 1999, 56: 1839"}, 
{"Row" : 66, "Column" : 1, "Text" : "Magnus G.  Perioperative antibiotic prophylaxis in urology.  Curr Opin Urol"}, 
{"Row" : 67, "Column" : 1, "Text" : "2001, 11: 81"}, 
{"Row" : 68, "Column" : 1, "Text" : "Anonymous  J Urol 2003, 169: 1796"}, 
{"Row" : 69, "Column" : 1, "Text" : "Mangram AJ Infect Control Hosp Epidemiol 1999, 20: 24"}
]},
{"Name" : "ORZID3 GMENU THRUSH", "DisplayText" : "Thrush (Oropharyngeal and Esophageal candidiasis) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases"},
{"Row" : 9, "Column" : 1, "Text" : "THRUSH (OROPHARYNGEAL AND ESOPHAGEAL CANDIDIASIS)"}, 
{"Row" : 10, "Column" : 1, "Text" : "Oropharyngeal candidiasis and esophageal candidiasis are opportunistic"}, 
{"Row" : 11, "Column" : 1, "Text" : "infections that primarily occur in patients on inhaled corticosteroids,"}, 
{"Row" : 12, "Column" : 1, "Text" : "patients that wear dentures, cancer patients on cytotoxic chemotherapy"}, 
{"Row" : 13, "Column" : 1, "Text" : "or radiation to the head or neck, and patients that are HIV seropositive"}, 
{"Row" : 14, "Column" : 1, "Text" : "especially if their CD4+ is less than 200 cells/microliter."}, 
{"Row" : 16, "Column" : 1, "Text" : "Oropharyngeal candidiasis, usually from candida albicans, appears in one"}, 
{"Row" : 17, "Column" : 1, "Text" : "of two major forms:pseudomembranous form or atrophic form.  The"}, 
{"Row" : 18, "Column" : 1, "Text" : "pseudomembranous form is the most common and appears a white"}, 
{"Row" : 19, "Column" : 1, "Text" : "plaques on the tongue, palate, mouth mucosa, or oropharynx.  The"}, 
{"Row" : 20, "Column" : 1, "Text" : "atrophic form (denture stomatitis) is most often found underneath upper"}, 
{"Row" : 21, "Column" : 1, "Text" : "dentures and appears as redness without plaques.  Patients are often"}, 
{"Row" : 22, "Column" : 1, "Text" : "asymptomatic, but may feel cotton mouth, loss of taste, and occasionally"}, 
{"Row" : 23, "Column" : 1, "Text" : "pain during eating and swallowing.  Patients with atrophic form usually"}, 
{"Row" : 24, "Column" : 1, "Text" : "have pain symptoms.  Dysphagia and hoarseness is usually associated"}, 
{"Row" : 25, "Column" : 1, "Text" : "with a lower tract candidiasis such as esophageal candidiasis."}, 
{"Row" : 27, "Column" : 1, "Text" : "Oropharyngeal Candidiasis", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : "PSOZID CLOTRIMAZOLE TROCHE 10MG PO 5 TIMES DAILY 7 DAYS", "DisplayText" : "Clotrimazole Troche 10MG PO 5 TIMES DAILY 7 DAYS", "Text" : ""},
{"Row" : 29, "Column" : 1, "Item" : "PSOZID NYSTATIN SUSP 500,000 UNITS S&S QID 7 DAYS", "DisplayText" : "Nystatin Susp 500,000 UNITS SWISH AND SWALL QID 7 DAYS", "Text" : ""},
{"Row" : 31, "Column" : 1, "Text" : "Moderate to Severe and/or HIV-positive patients", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 200MG PO ONCE THEN 100MG PO Q24H 6 DAYS", "DisplayText" : "Fluconazole 200MG PO ONCE THEN 100MG Q24H 6 DAYS", "Text" : ""},
{"Row" : 34, "Column" : 1, "Text" : "Esophageal Candidiasis", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Item" : "PSOZID FLUCONAZOLE 200MG PO Q24H 14 DAYS", "DisplayText" : "Fluconazole 200MG PO Q24H 14 DAYS", "Text" : ""},
{"Row" : 38, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Pappas Pg, Kauffman Ca, Andes D, et al. Clinical Practice Guidelines for"}, 
{"Row" : 41, "Column" : 1, "Text" : "the Management of Candidiasis: 2009 update by the Infectious Disease"}, 
{"Row" : 42, "Column" : 1, "Text" : "Society of America.  Clinical Infectious Disease 2009; 48:503"}, 
{"Row" : 44, "Column" : 1, "Text" : "Kauffman C.  Treatment of oropharyngeal and esophageal candidiasis."}, 
{"Row" : 45, "Column" : 1, "Text" : "Up to Date. July 2014."}, 
{"Row" : 47, "Column" : 1, "Text" : "Kauffman C.  Clinical manifestations of oropharyngeal and esophageal"}, 
{"Row" : 48, "Column" : 1, "Text" : "candidiasis.  Up to Date. July 2014.  Oropharyngeal Candidiasis.  Sanford"}, 
{"Row" : 49, "Column" : 1, "Text" : "Guide.  July 13, 2014."}, 
{"Row" : 51, "Column" : 1, "Text" : "Esophageal Candidiasis.  Sanford Guide.  July 14, 2014."}
]},
{"Name" : "ORZID3 GMENU TONSILLITIS", "DisplayText" : "Tonsillitis (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ ENT OPT CONSULT", "DisplayText" : "ENT GENERAL OPT", "Text" : "Need help with an ENT issue?  Obtain ENT consult", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "TONSILLITIS"}, 
{"Row" : 12, "Column" : 1, "Text" : "Etiology and management of tonsillitis are similar to the management of"}, 
{"Row" : 13, "Column" : 1, "Text" : "pharyngitis.  If abscess develops, consult ENT"}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU PHARYNGITIS", "DisplayText" : "Pharyngitis (Outpatient)", "Text" : "Pharyngitis", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 20, "Column" : 1, "Text" : "\"Sanford\" keyword: tonsillitis"}
]},
{"Name" : "ORZID3 GMENU TRAVELER DIARRHEA", "DisplayText" : "Traveler's diarrhea", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ NVCC GASTROENTEROLOGY", "DisplayText" : "Gastroenterology", "Text" : "Obtain Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Text" : "TRAVELER'S DIARRHEA"}, 
{"Row" : 12, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Acute (< 14 days of symptoms)", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Most cases are mild and self limited.  Treat these cases with fluids.  If a"}, 
{"Row" : 17, "Column" : 1, "Text" : "patients has a fever or if symptoms persist for longer than 48 hours, treat"}, 
{"Row" : 18, "Column" : 1, "Text" : "with:"}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 3 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID for 3 days ($0.18/day) [R,DI]", "Mnemonic" : "12"},
{"Row" : 23, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : "PSOZID2 AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1gm po once", "Text" : "Azithromycin 1000 mg PO once dose ($16/day) [M]  < OR >", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Item" : "PSOZID AZITHROMYCIN 500MG PO Q24H 3 DAYS", "DisplayText" : "Azithromycin 500MG PO Q24H", "Text" : "Azithromycin 500 mg PO qday for 3 days ($8/day) [M]", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Subacute (>= 14 days of symptoms)", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Attempt to make a diagnosis with, for example, stool cultures, analysis for ova"}, 
{"Row" : 32, "Column" : 1, "Text" : "and parasites, and endoscopy.  If bloody diarrhea, fever or abdominal"}, 
{"Row" : 33, "Column" : 1, "Text" : "pain/tenderness is present the case should be evaluated by Gastroenterology"}, 
{"Row" : 34, "Column" : 1, "Text" : "and/or Infectious Diseases.  Empirical antimicrobial therapy is not indicated."}, 
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 40, "Column" : 1, "Text" : "Guerrant RL  Clin Infect Dis 2001, 32: 331"}, 
{"Row" : 42, "Column" : 1, "Text" : "Thielman NM  NEJM  2004, 350: 38"}, 
{"Row" : 44, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 1996, 22: 124"}, 
{"Row" : 45, "Column" : 1, "Text" : "Dryden MS  Clin Infect Dis 1996, 22: 1019"}, 
{"Row" : 46, "Column" : 1, "Text" : "DuPont HL  Clin Infect Dis 2001, 33: 1807"}, 
{"Row" : 39, "Column" : 1, "Text" : "\"Sanford\" keyword: diarrhea"}, 
{"Row" : 41, "Column" : 1, "Text" : "Casburn-Jones AC  Gut  2004, 53: 296"}, 
{"Row" : 43, "Column" : 1, "Text" : "Up-to-Date: Diarrhea"}
]},
{"Name" : "ORZID3 GMENU TRICHOMONAS VAGINITIS", "DisplayText" : "Trichomonas vaginitis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "TRICHOMONAS VAGINITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Male sexual partners of women with trichomonas vaginitis will not have symptoms"}, 
{"Row" : 14, "Column" : 1, "Text" : "but should be treated to prevent recurrent vaginitis in the female sexual"}, 
{"Row" : 15, "Column" : 1, "Text" : "partner."}, 
{"Row" : 17, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "The discharge is purulent, malodorous, and  thin.  The vaginal pH is greater"}, 
{"Row" : 19, "Column" : 1, "Text" : "than 4.5.  Diagnosis is most accurate when trichomonads are observed on a wet"}, 
{"Row" : 20, "Column" : 1, "Text" : "mount or identified in culture."}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment of symptomatic woman", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnant women with trichomonas infection may be treated with metronidazole"}, 
{"Row" : 24, "Column" : 1, "Text" : "during any trimester."}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID2 METRONIDAZOLE 2GM PO ONCE", "DisplayText" : "Metronidazole 2gm po once", "Text" : "Metronidazole 2 gm PO ONCE ($0.64/day) [DI]  < OR >", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Item" : "PSOZID2 METRONI 7DS 500MG PO BID", "DisplayText" : "Metronidazole 500mg po bid for 7 days", "Text" : "Metronidazole 500 mg PO BID for 7 days ($0.64/day) [DI]", "Mnemonic" : "16"},
{"Row" : 28, "Column" : 1, "Text" : "Treatment of male sex partners", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Item" : "PSOZID2 METRONIDAZOLE 2GM PO ONCE", "DisplayText" : "Metronidazole 2gm po once", "Text" : "Metronidazole 2 gm PO ONCE ($0.64/day) [DI]", "Mnemonic" : "18"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 34, "Column" : 1, "Text" : "\"Mandell\" chapter: Vulvovaginitis and cervicitis"}, 
{"Row" : 35, "Column" : 1, "Text" : "Up-to-Date website: Vulvovaginitis and cervicitis"}
]},
{"Name" : "ORZID3 GMENU TUBERCULOSIS", "DisplayText" : "Tuberculosis (Outpatient)", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCT PULMONARY OPT", "DisplayText" : "PULMONARY OPT", "Text" : "Consult Pulmonary", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "TUBERCULOSIS"}, 
{"Row" : 9, "Column" : 1, "Text" : "Evaluation and management are complex.  Consult Pulmonary and/or Infectious"}, 
{"Row" : 10, "Column" : 1, "Text" : "Diseases."}, 
{"Row" : 12, "Column" : 1, "Text" : "Patients with suspected or proven pulmonary tuberculosis must be in respiratory"}, 
{"Row" : 13, "Column" : 1, "Text" : "isolation."}
]},
{"Name" : "ORZID3 GMENU TYPHLITIS", "DisplayText" : "Neutropenic enterocolitis (Typhlitis) - Outpatient  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ ONCOLOGY OPT CONSULT", "DisplayText" : "ONCOLOGY OPT", "Text" : "Hematology-Oncology consult", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZ GENERAL SURGERY OPT", "DisplayText" : "General surgery", "Text" : "Surgery consult", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "NEUTROPENIC ENTEROCOLITIS (TYPHLITIS)"}, 
{"Row" : 10, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS."}
]},
{"Name" : "ORZID3 GMENU UNCOMPLICATED CYSTITIS", "DisplayText" : "Uncomplicated Cystitis (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "UNCOMPLICATED CYSTITIS"}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Treat for 3 days."}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternatives", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO BID 3 DAYS", "DisplayText" : "Bactrim DS PO BID 3 DAYS", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO BID ($0.18/day) [R,DI]", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Item" : "PSOZID CIPROFLOXACIN 500MG PO BID 3 DAYS", "DisplayText" : "Ciprofloxacin 500MG PO BID 3 DAYS", "Text" : "Ciprofloxacin 500 mg PO BID for 3 days ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Item" : "PSOZID2 NITROFURANTOIN 7DS 100MG PO QID", "DisplayText" : "", "Text" : "Nitrofurantoin 100 mg PO QID for 7 days ($2.44/day) [R,O]", "Mnemonic" : "18"},
{"Row" : 21, "Column" : 1, "Text" : "Suppression", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "For pre-menopausal women with 3 or more episodes per year of recurrent"}, 
{"Row" : 23, "Column" : 1, "Text" : "uncomplicated cystitis, suppressive therapy is indicated after infection is"}, 
{"Row" : 24, "Column" : 1, "Text" : "eradicated."}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOZID BACTRIM SS PO Q24H 1 YEAR", "DisplayText" : "Bactrim SS PO Q24H 1 YEAR", "Text" : "Trimethoprim/sulfamethoxazole 1 SS tablet PO qday ($0.18/day) [R,DI]  < OR >", "Mnemonic" : "20"},
{"Row" : 27, "Column" : 1, "Item" : "PSOZID BACTRIM DS 2 TABS PO ONCE", "DisplayText" : "Bactrim DS 2 TABS ONCE", "Text" : "Trimethoprim/sulfamethoxazole 2 DS tablets PO once as a single patient-", "Mnemonic" : "22"},
{"Row" : 28, "Column" : 1, "Text" : "initiated dose at onset of symptoms ($0.18/day) [R,DI]  < OR >"}, 
{"Row" : 30, "Column" : 1, "Item" : "PSOZID BACTRIM DS PO ONCE POST-COITUS Q24 1 YEAR", "DisplayText" : "Bactrim DS PO Q24H 1 YEAR", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO once post-coitus ($0.18/day)", "Mnemonic" : "24"},
{"Row" : 31, "Column" : 1, "Text" : "[R,DI]"}, 
{"Row" : 33, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Item" : "PSOZID2 NITROFURAN 30DS 50MG PO QDAY 11 RF", "DisplayText" : "Nitrofurantoin 50mg po qday for 30 days 11 refills", "Text" : "Nitrofurantoin 50-100 mg PO qday ($2.44/day) [R,O]", "Mnemonic" : "26"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "28"},
{"Row" : 39, "Column" : 1, "Text" : "Warren JW  Clin Infect Dis 1999, 29: 745"}, 
{"Row" : 40, "Column" : 1, "Text" : "\"Mandell\" chapter: Urinary tract infections"}, 
{"Row" : 41, "Column" : 1, "Text" : "\"Sanford\" keyword: Cystitis"}
]},
{"Name" : "ORZID3 GMENU URETHRITIS ASSOC STD", "DisplayText" : "Urethritis associated with sexually transmitted disease (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "ORZ WOMENS HEALTH APPT", "DisplayText" : "Womens Health Appt:", "Text" : "Consult Women's Clinic", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "URETHRITIS ASSOCIATED WITH SEXUALLY TRANSMITTED DISEASES"}, 
{"Row" : 13, "Column" : 1, "Text" : "The main differential in a person who presents with dysuria is between cystitis"}, 
{"Row" : 14, "Column" : 1, "Text" : "and  urethritis.  Bacterial urethritis is more likely in people with mild"}, 
{"Row" : 15, "Column" : 1, "Text" : "dysuria, onset over a few days, or recent sexual contact."}, 
{"Row" : 17, "Column" : 1, "Text" : "The two most common sexually transmitted urethritis pathogens are Neisseria"}, 
{"Row" : 18, "Column" : 1, "Text" : "gonorrhoeae and  Chlamydia trachomatis.  Nucleic acid amplification tests for"}, 
{"Row" : 19, "Column" : 1, "Text" : "these pathogens are more sensitive than culture and  should be used for patients"}, 
{"Row" : 20, "Column" : 1, "Text" : "at risk for sexually transmitted urethritis."}, 
{"Row" : 22, "Column" : 1, "Item" : "LRZ CHLAMYDIA/GC AMPLIFIED PROBE", "DisplayText" : "CHLAMYDIA/GC AMPLIFIED PROBE", "Text" : "CHLAMYDIA/GC AMPLIFIED PROBE", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "For patients who have recently been treated for urethritis", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID3 GMENU RECURRENT/PERSISTENT URETHRITIS", "DisplayText" : "Recurrent or persistent urethritis (Outpatient)", "Text" : "Treatment of recurrent or persistent urethritis", "Mnemonic" : "16"},
{"Row" : 27, "Column" : 1, "Text" : "When dysuria is from a sexually transmitted disease, the patient's sexual"}, 
{"Row" : 28, "Column" : 1, "Text" : "partner(s) during the previous 60 days should be evaluated for urethritis."}, 
{"Row" : 29, "Column" : 1, "Text" : "If diagnostic tests for the cause of urethritis are not feasible, therapy for"}, 
{"Row" : 30, "Column" : 1, "Text" : "both N. gonorrhoeae and C. trachomatis should be given to partners."}, 
{"Row" : 32, "Column" : 1, "Text" : "Initial treatment of patients and sex partners", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Patients and partners are often infected with both N. gonorrhoeae and C."}, 
{"Row" : 34, "Column" : 1, "Text" : "trachomatis.  Treat for both pathogens unless one is ruled out by lab test."}, 
{"Row" : 35, "Column" : 1, "Item" : "ORZID3 GMENU GONOCOCCAL URETHRITIS", "DisplayText" : "Gonococcal urethritis (Outpatient)", "Text" : "Treatment for gonococcal urethritis", "Mnemonic" : "18"},
{"Row" : 36, "Column" : 1, "Item" : "ORZID3 GMENU CHLAMYDIA URETHRITIS", "DisplayText" : "Chlamydia urethritis (Outpatient)", "Text" : "Treatment for chlamydia urethritis", "Mnemonic" : "20"},
{"Row" : 38, "Column" : 1, "Text" : "Preferred treatment for N. gonorrhoaeae AND C. trachomatis", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Item" : "ORZ SET ABX OP CEFTR 125MG IM X1 DOXYC 7DS 100 PO BID", "DisplayText" : "", "Text" : "Ceftriaxone 125 mg IM ONCE ($16/day) [M] <AND> doxycycline 100 mg PO BID for", "Mnemonic" : "22"},
{"Row" : 40, "Column" : 1, "Text" : "7 days ($0.16/day) [DI]  < OR >"}, 
{"Row" : 42, "Column" : 1, "Item" : "ORZ SET ABX OP CEF 125MG IM ONCE AZITH 1GM PO ONCE", "DisplayText" : "", "Text" : "Ceftriaxone 125 mg IM ONCE ($16/day) [M] <AND> azithromycin 1 gm PO ONCE", "Mnemonic" : "24"},
{"Row" : 43, "Column" : 1, "Text" : "($4.09/day) [M]"}, 
{"Row" : 45, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Item" : "ORZ SET ABX OP CIPRO 500MG PO ONCE DOXYC 100MG PO BID 7DS", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO ONCE ($0.18/day) [R,DI] <AND> doxycycline 100 mg PO", "Mnemonic" : "26"},
{"Row" : 47, "Column" : 1, "Text" : "BID for 7 days ($0.16/day) [DI] < OR >"}, 
{"Row" : 49, "Column" : 1, "Item" : "ORZ SET ABX OP CIPRO 500 PO ONCE AZITH 1GM PO ONCE", "DisplayText" : "", "Text" : "Ciprofloxacin 500 mg PO ONCE ($0.18/day) [R,DI] <AND> azithromycin 1 gm PO", "Mnemonic" : "28"},
{"Row" : 50, "Column" : 1, "Text" : "ONCE ($4.09/day) [M]"}, 
{"Row" : 52, "Column" : 1, "Text" : "Note:  N. gonorrhea is increasingly resistant to quinolones, especially in"}, 
{"Row" : 53, "Column" : 1, "Text" : "California and Hawaii.  Ceftriaxone is the preferred treatment for infections"}, 
{"Row" : 54, "Column" : 1, "Text" : "acquired in these areas."}, 
{"Row" : 57, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "30"},
{"Row" : 59, "Column" : 1, "Text" : "CDC MMWR 2002, 51: RR-06"}, 
{"Row" : 60, "Column" : 1, "Text" : "\"Sanford\" keyword: Urethritis"}
]},
{"Name" : "ORZID3 GMENU URINARY TRACT INFECTION", "DisplayText" : "Urinary Tract Infection (Outpatient) ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "GMRCT UROLOGY OPT", "DisplayText" : "UROLOGY OPT", "Text" : "Consult Urology", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Text" : "URINARY TRACT INFECTION (UTI)"}, 
{"Row" : 11, "Column" : 1, "Text" : "Cystitis refers to infection of the urinary bladder, but inflammation often"}, 
{"Row" : 12, "Column" : 1, "Text" : "extends into the urethra. Typical symptoms and  signs include dysuria, increased"}, 
{"Row" : 13, "Column" : 1, "Text" : "urinary frequency, urgency, and/or suprapubic tenderness."}, 
{"Row" : 15, "Column" : 1, "Text" : "Most cases of UNCOMPLICATED CYSTITIS occur in pre-menopausal, non-pregnant,"}, 
{"Row" : 16, "Column" : 1, "Text" : "sexually active young women. In men with mild to moderate symptoms without"}, 
{"Row" : 17, "Column" : 1, "Text" : "complicating conditions and  without recent treatment relapse or recurrence,"}, 
{"Row" : 18, "Column" : 1, "Text" : "cystitis is considered uncomplicated.  Most cases of COMPLICATED CYSTITIS are"}, 
{"Row" : 19, "Column" : 1, "Text" : "associated with Escherichia coli, but more resistant pathogens occur, including"}, 
{"Row" : 20, "Column" : 1, "Text" : "the Gram positive pathogens staphylococci and  enterococci.  Urine culture"}, 
{"Row" : 21, "Column" : 1, "Text" : "should be obtained before antimicrobials are given."}, 
{"Row" : 23, "Column" : 1, "Text" : "Complicating conditions", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Cystitis is considered complicated when one or more of the following is present:"}, 
{"Row" : 26, "Column" : 1, "Text" : "> Structural abnormalities (e.g. presence of obstruction, catheter or"}, 
{"Row" : 27, "Column" : 1, "Text" : "nephrostomy tubes, neurogenic bladder)"}, 
{"Row" : 28, "Column" : 1, "Text" : "> Metabolic abnormalities that reduce local host defenses (e.g. diabetes,"}, 
{"Row" : 29, "Column" : 1, "Text" : "pregnancy, neutropenia, pelvic irradiation)"}, 
{"Row" : 30, "Column" : 1, "Text" : "> Unusual or resistant pathogen"}, 
{"Row" : 31, "Column" : 1, "Text" : "> Treatment failure or relapse or recurrence of infection"}, 
{"Row" : 33, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "__________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "When a patient presents with symptoms of cystitis, urinalysis should be"}, 
{"Row" : 37, "Column" : 1, "Text" : "performed to check for the presence of white blood cells.  Increased numbers of"}, 
{"Row" : 38, "Column" : 1, "Text" : "leukocytes (usually >25) in the presence of cystitis symptoms indicates"}, 
{"Row" : 39, "Column" : 1, "Text" : "inflammation and  thus cystitis.  The bacterial etiology is so predictable that"}, 
{"Row" : 40, "Column" : 1, "Text" : "urine culture is unnecessary and  empirical treatment is indicated.  The"}, 
{"Row" : 41, "Column" : 1, "Text" : "clinical significance of pyuria in the absence of cystitis symptoms is unclear."}, 
{"Row" : 42, "Column" : 1, "Text" : "Antimicrobial therapy is not indicated for pyuria in the absence of symptoms."}, 
{"Row" : 44, "Column" : 1, "Text" : "____________________________________", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "____________________________________", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Item" : "ORZID3 GMENU UNCOMPLICATED CYSTITIS", "DisplayText" : "Uncomplicated Cystitis (Outpatient)", "Text" : "Treatment for UNCOMPLICATED CYSTITIS", "Mnemonic" : "10"},
{"Row" : 49, "Column" : 1, "Item" : "ORZID3 GMENU COMPLICATED CYSTITIS", "DisplayText" : "Complicated Cystitis (Outpatient)", "Text" : "Treatment for COMPLICATED CYSTITIS", "Mnemonic" : "12"},
{"Row" : 50, "Column" : 1, "Item" : "ORZID3 GMENU PYELONEPHRITIS", "DisplayText" : "Pyelonephritis (Outpatient)", "Text" : "Treatment for PYELONEPHRITIS", "Mnemonic" : "14"},
{"Row" : 53, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "16"}
]},
{"Name" : "ORZID3 GMENU VIRUSES OUTPT MAIN", "DisplayText" : "Viruses (Outpatient)  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ INFECTIOUS DISEASE OPT CONSULT", "DisplayText" : "INFECTIOUS DISEASE OPT", "Text" : "Consult Infectious Diseases", "Mnemonic" : "04"},
{"Row" : 6, "Column" : 1, "Text" : "++  VIRUSES - OUTPATIENT  ++", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 GMENU INFLUENZA OUTPT", "DisplayText" : "Influenza Outpatient", "Text" : "Seasonal Influenza", "Mnemonic" : "06"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX PARAINFLUENZA", "DisplayText" : "Parainfluenza", "Text" : "Parainfluenza", "Mnemonic" : "10"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX RSV", "DisplayText" : "RSV", "Text" : "RSV", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Text" : "Cytomegalovirus (CMV)", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 GMENU CMV COLITIS/ESOPHAGITIS", "DisplayText" : "CMV colitis or esophagitis (Outpatient)", "Text" : "CMV colitis or esophagitis", "Mnemonic" : "14"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID3 GMENU CMV ENCEPHALITIS", "DisplayText" : "CMV encephalitis (Outpatient)", "Text" : "CMV encephalitis", "Mnemonic" : "16"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 GMENU CMV POLYRADICULOPATHY", "DisplayText" : "CMV polyradiculopathy (Outpatient)", "Text" : "CMV polyradiculopathy", "Mnemonic" : "18"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 GMENU CMV RETINITIS", "DisplayText" : "CMV retinitis (Outpatient)", "Text" : "CMV retinitis", "Mnemonic" : "20"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 GMENU CMV PNEUMONIA", "DisplayText" : "CMV pneumonia (Outpatient)", "Text" : "CMV pneumonia", "Mnemonic" : "22"},
{"Row" : 7, "Column" : 2, "Text" : "Herpes simplex viruses", "Header" : 1}, 
{"Row" : 8, "Column" : 2, "Item" : "ORZID3 GMENU BELL PALSY", "DisplayText" : "Bell's palsy (Outpatient)", "Text" : "Bell's palsy", "Mnemonic" : "24"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID3 GMENU HSV ENCEPHALITIS", "DisplayText" : "HSV encephalitis (Outpatient)", "Text" : "Encephalitis", "Mnemonic" : "26"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID3 GMENU GENITAL HERPES", "DisplayText" : "Genital herpes (Outpatient)", "Text" : "Genital herpes", "Mnemonic" : "28"},
{"Row" : 11, "Column" : 2, "Item" : "ORZID3 GMENU HERPES WHITLOW", "DisplayText" : "Herpes whitlow (Digit or Hand Cellulitis) - Outpatient", "Text" : "Herpes Whitlow (digit or hand cellulitis)", "Mnemonic" : "30"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID3 GMENU OROLABIAL HERPES", "DisplayText" : "Orolabial herpes (Outpatient)", "Text" : "Orolabial herpes", "Mnemonic" : "32"},
{"Row" : 14, "Column" : 2, "Text" : "Varicella-zoster", "Header" : 1}, 
{"Row" : 15, "Column" : 2, "Item" : "ORZID3 GMENU PRIM INFECT CHICKENPOX", "DisplayText" : "Primary infection (Chickenpox) - Outpatient", "Text" : "Primary infection (Chickenpox)", "Mnemonic" : "34"},
{"Row" : 16, "Column" : 2, "Item" : "ORZID3 GMENU REACT PRIM INFECT ZOSTER", "DisplayText" : "Reactivation of primary infection (Zoster or \"Shingles\") - Outpatient", "Text" : "Reactivation of primary infection (Zoster or \"Shingles\")", "Mnemonic" : "36"},
{"Row" : 18, "Column" : 2, "Text" : "Viral hepatitis", "Header" : 1}, 
{"Row" : 19, "Column" : 2, "Item" : "ORZID2 GMENU ABX HEPATITIS A", "DisplayText" : "Hepatitis A", "Text" : "Hepatitis A", "Mnemonic" : "38"},
{"Row" : 20, "Column" : 2, "Item" : "ORZID2 GMENU ABX HEPATITIS B", "DisplayText" : "Hepatitis B", "Text" : "Hepatitis B", "Mnemonic" : "40"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU ABX HEPATITIS C", "DisplayText" : "Hepatitis C", "Text" : "Hepatitis C", "Mnemonic" : "42"}
]},
{"Name" : "ORZID3 HELICOBACTER PYLORI INFECTION", "DisplayText" : "Helicobacter Pylori Infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 6, "Column" : 1, "Text" : "Treatment Regimen:", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Alternative Treatment Regimen:", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Failure of initial therapy: duration 14 days (Do NOT repeat initial therapy)", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 OMEP + AMOX + METRONID + CLARITHRO H.PYLORI", "DisplayText" : "Clarithromycin Quadruple", "Text" : ""},
{"Row" : 11, "Column" : 1, "Item" : "ORZID3 BISMUTH + OMEP + METRONID + TETRACY H.PYLORI", "DisplayText" : "Bismuth Quadruple", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "ORZID3 OMEPRAZOLE + AMOXICILLIN + LEVOFLOXACIN H.PYLORI", "DisplayText" : "Levofloxacin Therapy", "Text" : ""},
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 OMEP + AMOX + METRONID + CLARITHRO H.PYLORI", "DisplayText" : "Clarithromycin Quadruple", "Text" : ""},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 BISMUTH + OMEP + METRONID + TETRACY H.PYLORI", "DisplayText" : "Bismuth Quadruple", "Text" : ""},
{"Row" : 8, "Column" : 1, "Text" : "(OMEPRAZOLE + AMOXICILLIN + METRONIDAZOLE + CLARITHROMYCIN)"}, 
{"Row" : 12, "Column" : 1, "Text" : "(BISMUTH + OMEPRAZOLE + METRONIDAZOLE + TETRACYCLINE)"}, 
{"Row" : 18, "Column" : 1, "Text" : "(OMEPRAZOLE + AMOXICILLIN + LEVOFLOXACIN)"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Kim, K. Gastric/Duodenal Ulcer, Helicobacter pylori. Sanford Guude."}, 
{"Row" : 23, "Column" : 1, "Text" : "AUg 31, 2022."}, 
{"Row" : 25, "Column" : 1, "Text" : "*Chey, William D MD, FACG1: Leontiadis, Grigorios I MD, PhD2: Howden,"}, 
{"Row" : 26, "Column" : 1, "Text" : "Colin W MD, FACG3: Moss, Steven F MD, FACG4. ACG Clinical Guideline:"}, 
{"Row" : 27, "Column" : 1, "Text" : "Treatment of Helicobacter pylori Infection. American Journal of"}, 
{"Row" : 28, "Column" : 1, "Text" : "Gastroenterology 112(2):212-239, February 2017."}, 
{"Row" : 30, "Column" : 1, "Text" : "*Lamont, J.T. Treatment regimens for Helicobacter pylori in adults."}, 
{"Row" : 31, "Column" : 1, "Text" : "UpToDate. June 20, 2023."}, 
{"Row" : 33, "Column" : 1, "Text" : "THIS MENU UPDATED SEPTEMBER 2023", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Antimicrobials should be given to patient with confirmed H. pylori infections", "Header" : 1}
]},
{"Name" : "ORZID3 MAIN MENU", "DisplayText" : "Antibiotic Therapy OPT", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Welcome. Please click on the diagnosis or syndrome you wish to treat.", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Head and Neck", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Pulmonary", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Gastrointestinal and Intraabdominal", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Genitourinary", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Skin, Soft Tissue, Bone and Joint Infections", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZID3 OTITIS MEDIA", "DisplayText" : "Otitis Media", "Text" : ""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 DENTAL INFECTIONS", "DisplayText" : "Dental Infections", "Text" : ""},
{"Row" : 8, "Column" : 1, "Item" : "ORZID3 PHARYNGITIS", "DisplayText" : "Pharyngitis", "Text" : ""},
{"Row" : 9, "Column" : 1, "Item" : "ORZID3 THRUSH (OROPHARYNGEAL AND ESOPHAGEAL CONDIDIASIS)", "DisplayText" : "Thrush (Oropharyngeal and Esophageal Candidiasis)", "Text" :""},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 ACUTE SINUSITIS", "DisplayText" : "Acute Sinusitis", "Text" : ""},
{"Row" : 11, "Column" : 1, "Item" : "ORZID3 CONJUNCTIVITIS", "DisplayText" : "Conjunctivitis", "Text" : ""},
{"Row" : 14, "Column" : 1, "Item" : "ORZID3 BRONCHITIS/COPD EXACERBATION", "DisplayText" : "Bronchitis/COPD Exacerbation", "Text" :""},
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 COMMUNITY ACQUIRED PNEUMONIA", "DisplayText" : "Community Aquired Pneumonia", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 DIVERTICULITIS", "DisplayText" : "Diverticulitis", "Text" : ""},
{"Row" : 19, "Column" : 1, "Item" : "ORZID3 CLOSTRIDIUM DIFICLE (C. DIFF) COLITIS", "DisplayText" : "Clostricium Dificile (C. Diff) Colitis", "Text" : ""},
{"Row" : 20, "Column" : 1, "Item" : "ORZID3 HELICOBACTER PYLORI INFECTION", "DisplayText" : "Helicobacter Pylori Infection", "Text" : ""},
{"Row" : 23, "Column" : 1, "Item" : "ORZID3 URINARY TRACT INFECTION", "DisplayText" : "Urinary Tract Infection", "Text" : ""},
{"Row" : 24, "Column" : 1, "Item" : "ORZID3 PYELONEPHRITIS", "DisplayText" : "Pyelonephritis", "Text" : ""},
{"Row" : 26, "Column" : 1, "Item" : "ORZID3 URETHRITIS ASSOCIATED WITH SEXUALLY TRANSMITTED DISEASES", "DisplayText" : "Urethritis Associated with Sexually Transmitted Diseases", "Text" : ""},
{"Row" : 29, "Column" : 1, "Item" : "ORZID3 CELLULITIS", "DisplayText" : "Cellulitis", "Text" : ""},
{"Row" : 30, "Column" : 1, "Item" : "ORZID3 ABSCESSES (CUTANEOUS ABSCESS, FUNUNCLES, CARBUNCLES)", "DisplayText" : "Abscesses (Cutaneous Abscess, Furuncles, Carbuncles)", "Text" : ""},
{"Row" : 31, "Column" : 1, "Item" : "ORZID3 FOOT ULCER IN PATIENT WITH DIABETES MELLITUS", "DisplayText" : "Foot Ulcer in Patients with Diabetes Mellitus", "Text" :""},
{"Row" : 25, "Column" : 1, "Item" : "ORZID3 BACTERIAL PROSTATITIS", "DisplayText" : "Bacterial Prosatitis", "Text" : ""}
]},
{"Name" : "ORZID3 OMEP + AMOX + METRONID + CLARITHRO H.PYLORI", "DisplayText" : "Clarithromycin Quadruple ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID3 OMEPRAZOLE 20MG PO BID X14 DAYS H.PYLORI", "DisplayText" : "Omeprazole 20MG PO BID X14 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID3 AMOXICILLIN 1000MG PO BID X14 DAYS H.PYLORI", "DisplayText" : "Amoxicillin 1000MG PO BID X14 DAYS", "Text" :""},
{"Row" : 3.0 , "Item" : "ORZID3 METRONIDAZOLE 500MG BID X14 DAYS H.PYOLORI", "DisplayText" : "METRONIDAZOLE 500MG BID X14 DAYS", "Text" : ""},
{"Row" : 4.0 , "Item" : "ORZID3 CLARITHROMYCIN 500MG PO BID X14 DAYS H.PYLORI", "DisplayText" : "Clarithromycin 500MG PO BID X14 DAYS", "Text" : ""}
]},
{"Name" : "ORZID3 OMEPRAZOLE + AMOXICILLIN + LEVOFLOXACIN H.PYLORI", "DisplayText" : "Levofloxacin Therapy  ", "Version" : "Fargo", "Contents" : [
{"Row" : 1.0 , "Item" : "ORZID3 OMEPRAZOLE 20MG PO BID X14 DAYS H.PYLORI", "DisplayText" : "Omeprazole 20MG PO BID X14 DAYS", "Text" :""},
{"Row" : 2.0 , "Item" : "ORZID3 AMOXICILLIN 1000MG PO BID X14 DAYS H.PYLORI", "DisplayText" : "Amoxicillin 1000MG PO BID X14 DAYS", "Text" :""},
{"Row" : 3.0 , "Item" : "ORZID3 LEVOFLOXACIN 500MG PO Q24H X14 DAYS H.PYLORI", "DisplayText" : "Levofloxain 500MG PO Q24H X14 DAYS", "Text" :""}
]},
{"Name" : "ORZID3 OTITIS MEDIA", "DisplayText" : "Otitis Media ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Alternative for Non-Severe Penicillin Allergy", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Alternative for Severe Penicillin Allergy", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Last Updated January 2021", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 AMOXICILLIN 1000MG PO TID OTITIS MEDIA", "DisplayText" : "Amoxicillin 1000MG PO TID X10 DAYS", "Text" :""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 CEFUROXIME 500MG PO BID OTITIS MEDIA", "DisplayText" : "Cefuroxime 500MG PO BID X10 DAYS", "Text" : ""},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO Q12H OTITIS MEDIA", "DisplayText" : "Doxycycline 100MG PO Q12H X10 DAYS", "Text" :""},
{"Row" : 13, "Column" : 1, "Text" : "Sanford Guide: Otitis media (accessed on 1/29/21)"}, 
{"Row" : 14, "Column" : 1, "Text" : "Up to Date: Acute otitis media in adults (accessed on 1-29-21)"}
]},
{"Name" : "ORZID3 PHARYNGITIS", "DisplayText" : "Pharyngitis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Most cases are viral and antimicrobials are not indicated.", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Group A Streptococci Pharyngitis", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Alternative for Non-Severe Penicillin Allergy", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternative for Severe Penicillin Allergy", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Gonococcal Pharyngiti", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "LAST UPDATED MAY 2020", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Treatment only indicated if there is a positive culture."}, 
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 PENICILLIN V 500MG PO BID PHARYNGITIS", "DisplayText" : "Penicillin V 500MG PO BID X10 DAYS", "Text" :""},
{"Row" : 11, "Column" : 1, "Text" : "-- OR --"}, 
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 CEPHALEXIN 500MG PO BID PHARYNGITIS", "DisplayText" : "Cephalexin 500MG PO BID X10 DAYS", "Text" : ""},
{"Row" : 18, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO BID PHARYNGITIS", "DisplayText" : "Doxycycline 100MG PO BID X10 DAYS", "Text" : ""},
{"Row" : 25, "Column" : 1, "Item" : "ORZID3 CEFTRIAXONE 500MG IM PHARYNGITIS", "DisplayText" : "Ceftriaxone 500mg IM X1 DOSE", "Text" :""},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 BENZATHINE PENICILLIN 1.2 MILLION UNITS PHARYNGITIS", "DisplayText" : "Benzathine Penicillin 1.2 MILLION UNITS IM X1", "Text" : ""},
{"Row" : 28, "Column" : 1, "Text" : "CDC STD 2015 Guidelines: MMWR 64(RR-3):1, 2015"}, 
{"Row" : 30, "Column" : 1, "Text" : "Sanford Guide: Gonorrhea: Gonococcal Pharyngitis (accessed 5-22-20)"}, 
{"Row" : 32, "Column" : 1, "Text" : "Sanford Guide: Streptococcus pyogenes, Beta hemolytic, Group A, B, C, F, G"}, 
{"Row" : 33, "Column" : 1, "Text" : "Strep (accessed 5-22-20)"}, 
{"Row" : 35, "Column" : 1, "Text" : "IDSA Updates Guideline for Managing Group A Streptococcal Pharyngitis."}, 
{"Row" : 36, "Column" : 1, "Text" : "Am Fam Physician. 2013 Sep 1: 88(5):338-340"}
]},
{"Name" : "ORZID3 PYELONEPHRITIS", "DisplayText" : "Pyelonephritis  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment for Mild to Moderate Disease:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Treatment for Severe Disease:", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Sanford Guide: Pyelonephritis Acute (Accessed 12-11-20)"}, 
{"Row" : 15, "Column" : 1, "Text" : "LAST UPDATED DECEMBER 2020", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 CIPROFLOXACIN 500MG PO BID X7 DAYS PYELONEPHRITIS", "DisplayText" : "Ciprofloxain 500MG PO BID X7 DAYS", "Text" : ""},
{"Row" : 7, "Column" : 1, "Text" : "Refer to Inpatient Antimicrobial CDSS"}
]},
{"Name" : "ORZID3 THRUSH (OROPHARYNGEAL AND ESOPHAGEAL CONDIDIASIS)", "DisplayText" : "Thrush (Oropharyngeal and Esophageal Candidiasis)", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Oropharyngeal Candidiasis", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment in HIV Positive Patients or Those Who Fail to Respond to Above:", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Esophageal Candidiasis", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "TREATMENT", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "LAST UPDATED MAY 2020", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Item" : "ORZID3 CLOTRIMAZOLE TROCHE 10MG THRUSH", "DisplayText" : "Clotrimazole Troche 10MG PO 5X/DAY  X7 DAYS", "Text" :""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 NYSTATIN SUSP THRUSH", "DisplayText" : "Nystatin Suspension QID X7 DAYS", "Text" :""},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 FLUCONAZOLE THRUSH", "DisplayText" : "Fluconazole 200MG PO X1 THEN 100MG PO Q24H X6 DAYS", "Text" : ""},
{"Row" : 17, "Column" : 1, "Item" : "ORZID3 FLUCONAZOLE 200MG PO Q24H 14 DAYS THRUSH", "DisplayText" : "Fluconazole 200MG PO Q24H X14 DAYS", "Text" :""},
{"Row" : 22, "Column" : 1, "Text" : "Clinical Practice Guideline for the Management of Candidiasis: 2016 Update"}, 
{"Row" : 23, "Column" : 1, "Text" : "by the Infectious Disease Society of America. Clinical Infectious Disease."}, 
{"Row" : 24, "Column" : 1, "Text" : "2106 February 15: 62(4):e1-e50"}, 
{"Row" : 26, "Column" : 1, "Text" : "Sanford Guide: Candidiasis, Esophageal (accessed 5-22-20)"}, 
{"Row" : 28, "Column" : 1, "Text" : "Sanford Guide: Candidiasis, Oropharyngeal (accessed 5-22-20)"}
]},
{"Name" : "ORZID3 URETHRITIS ASSOCIATED WITH SEXUALLY TRANSMITTED DISEASES", "DisplayText" : "Urethritis Associated with Sexually Transmitted Diseases  ", "Version" : "Fargo", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Treatment for N. gonorrhoeae", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "** For patients weighting >/= 150kg", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment of C. trachomatis", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "--OR--"}, 
{"Row" : 20, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "CDC: STD Treatment Guidelines: MMWR (2015)"}, 
{"Row" : 23, "Column" : 1, "Text" : "CDC Update to Treatment Guidelines for Gonococcal Infection: MMWR (2020)"}, 
{"Row" : 25, "Column" : 1, "Text" : "North Dakota Health Alert Network: New Recommended Treatment for Gonococcal"}, 
{"Row" : 26, "Column" : 1, "Text" : "Infections. 2021."}, 
{"Row" : 30, "Column" : 1, "Text" : "LAST UPDATED JANUARY 2021", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID3 CEFTRIAXONE 500MG IM ONCE URETHRITIS", "DisplayText" : "Ceftriaxone 500MG IM ONCE", "Text" :""},
{"Row" : 7, "Column" : 1, "Item" : "ORZID3 CEFTRIAXONE 1GM IM ONCE URETHRITIS", "DisplayText" : "Ceftriaxone 1GM IM ONCE", "Text" : ""},
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 DOXYCYCLINE 100MG PO Q12H 7 DAYS URETHRITIS", "DisplayText" : "Doxycycline 100MG PO Q12H X7 DAYS", "Text" : ""},
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 AZITHROMYCIN 1GM PO ONCE URETHRITIS", "DisplayText" : "Azithromycin 1GM PO ONCE (Recommended in pregnancy)", "Text" : ""}
]},
{"Name" : "ORZID3 URINARY TRACT INFECTION", "DisplayText" : "Urinary Tract Infection  ", "Version" : "Fargo", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "ASYMPTOMATIC BACTERIURIA", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Text" : "Asymptomatic bacteriuria should not be treated except during pregnancy"}, 
{"Row" : 4, "Column" : 1, "Text" : "or prior to an invasive urologic procedure"}, 
{"Row" : 6, "Column" : 1, "Text" : "UNCOMPLICATED CYSTITS", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Occurs in pre-menopausal, non-pregnant, sexually active young women."}, 
{"Row" : 9, "Column" : 1, "Text" : "Treatment:", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Suppression:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "For pre-menopausal women with 3 or more episodes per year of recurrent"}, 
{"Row" : 21, "Column" : 1, "Text" : "uncomplicated cystitis, suppressive therapy is indicated after the infection"}, 
{"Row" : 22, "Column" : 1, "Text" : "is eradicated."}, 
{"Row" : 29, "Column" : 1, "Text" : "COMPLICATED CYSTITIS", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Men, Pregnant Women, Structural abnormalities (presence of obstruction,"}, 
{"Row" : 31, "Column" : 1, "Text" : "catheter, nephrostomy tubes, neurogenic bladder), metabolic abnormalities"}, 
{"Row" : 32, "Column" : 1, "Text" : "that reduce local host defenses (diabetes, neutropenia, pelvic irradiation),"}, 
{"Row" : 33, "Column" : 1, "Text" : "unusual or resistant pathogen, or treatment failure or relapse."}, 
{"Row" : 35, "Column" : 1, "Text" : "Treatment:", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "REFERENCES", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Gupta K, et al. IDSA Clinical Practice Guidelines (2011)."}, 
{"Row" : 48, "Column" : 1, "Text" : "Sanford Guide - Urinary Tract Infections (accessed 12-11-20)"}, 
{"Row" : 50, "Column" : 1, "Text" : "LAST UPDATED DECEMBER 2020", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Item" : "ORZID3 NITROFUANTOIN 100MG X5DAYS UTI", "DisplayText" : "Nitrofuantoin 100MG PO BID X5 DAYS (only if CrCl >= 30ml/min)", "Text" :""},
{"Row" : 11, "Column" : 1, "Text" : "--OR--"}, 
{"Row" : 12, "Column" : 1, "Item" : "ORZID3 BACTRIM DS UTI", "DisplayText" : "Bactrim DS BID X3 DAYS", "Text" :""},
{"Row" : 15, "Column" : 1, "Item" : "ORZID3 CIPROFLOXACIN PO X3 DAYS UTI", "DisplayText" : "Ciprofloxacin 250MG PO BID X3 DAYS", "Text" :""},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 CEFUROXIME 250MG PO BID X5 DAYS UTI", "DisplayText" : "Cefuroxime 250MG PO BID X5 DAYS", "Text" :""},
{"Row" : 24, "Column" : 1, "Item" : "ORZID3 BACTRIM DS ONCE POST COITUS UTI", "DisplayText" : "Bactrim DS PO ONCE POST-COITUS", "Text" : ""},
{"Row" : 25, "Column" : 1, "Text" : "--OR--"}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID3 BACTRIM SS PO Q24H X30 DAYS UTI", "DisplayText" : "Bactrim SS PO Q24H X30 DAYS", "Text" : ""},
{"Row" : 36, "Column" : 1, "Item" : "ORZID3 BACTRIM DS PO BID X7 DAYS UTI", "DisplayText" : "Bactrim DS PO BID X7 DAYS", "Text" :""},
{"Row" : 37, "Column" : 1, "Text" : "--OR--"}, 
{"Row" : 38, "Column" : 1, "Item" : "ORZID3 NITROFUANTOIN 100MG PO BID X7 DAYS UTI", "DisplayText" : "Nitrofurantoin 100MG PO BID X7 DAYS (if CrCl =/> 60ml/min)", "Text" :""},
{"Row" : 41, "Column" : 1, "Item" : "ORZID3 CIPROFLOXACIN 500MG PO BID X7 DAYS UTI", "DisplayText" : "Ciprofloxacin 500MG PO BID X7 DAYS", "Text" :""},
{"Row" : 42, "Column" : 1, "Item" : "ORZID3 CEFUROXIME 250MG PO BID X7 DAYS UTI", "DisplayText" : "Cefuroxime 250MG PO BID X7 DAYS", "Text" :""}
]}
]